【発明の詳細な説明】
H+−ATPaseとしての複素環式化合物
技術分野
この発明は、新規複素環式化合物および医薬として許容されるそれらの塩に関
する。
より詳しくは、この発明は、液胞型H+−アデノシントリホスファターゼ(H+
−ATPase)、特に破骨細胞H+−ATPaseの阻害活性および骨吸収阻
害活性を有し、したがって骨吸収阻害剤または骨転移阻害剤としてヒトまたは動
物における異常骨代謝による骨疾患の予防および/または治療に有用な新規複素
環式化合物および医薬として許容されるそれらの塩に関する。
さらに、この発明は、前記の化合物の製造方法、それらを含有する医薬組成物
、ヒトまたは動物における前記の疾患の予防および/または治療方法、ならびに
前記の化合物および医薬として許容されるそれらの塩の、ヒトまたは動物におけ
る前記の疾患の予防および/または治療のための用途に関する。
背景技術
たとえば、J.Chem.Soc.Pak.(1995)、17(4)、23
2−6;J.Am.Chem.Soc.(1994)、116(24)、110
14−19;またはChem.Pharm.Bull.(1990)、38(1
0)、2841−6に記載されているように、いくつかの複素環式化合物が知ら
れている。しかしながら、前記の化合物が液胞型H+−ATPaseの阻害活性
または骨吸収阻害活性を有することは知られていない。
発明の開示
この発明の目的複素環式化合物は新規であり、下記の一般式[I]
[式中、R1は複素環基またはアリール基、その各々は適当な置換基で置換され
ていてもよい、
Aは−CONH−または−NHCO−、
nは0または1の整数、
(式中、R2は水素、ハロゲン、低級アルキル基、低級アルコキシ基またはハ
ロ(低級)アルキル基、
R3は水素、ハロゲン、低級アルキル基、低級アルコキシ基またはハロ(低
級)アルキル基、
R4は水素、ハロゲン、低級アルキル基、低級アルコキシ基またはハロ(低
級)アルキル基、
X1はO、SまたはNH、
をそれぞれ示す。)で表される基、
(式中、R5は水素または低級アルキル基、
R8およびR9はそれぞれ低級アルキル基、
R6は水素、ハロゲン、シアノ基、アミノ基、低級アルキル基、置換された
低級アルキル基、低級アルケニル基、置換された低級アルケニル基、低級アルキ
ニル基、置換された低級アルキニル基、低級アルキルチオ基、低級アルキルスル
フィニル基、低級アルキルスルホニル基、複素環チオ基、アシル基、アシルアミ
ノ基、アリール基、置換されたアリール基または複素環基で、
R7は水素、ハロゲン、低級アルキル基、置換された低級アルキル基、低級ア
ルケニル基、置換された低級アルケニル基、アジド基、アミノ基、置換されたア
ミノ基、ヒドラジノ基、置換されたヒドラジノ基、セミカルバジド基、置換され
たセミカルバジド基、チオセミカルバジド基、置換されたチオセミカルバジド基
、ヒドロキシ基、置換されたヒドロキシ基、メルカプト基、置換されたメルカプ
ト基、アシル基、または置換または非置換の複素環基であるか、または
R6およびR7は、一緒になって、式
(式中、R10は水素または低級アルキル基、
R11は水素、アシル基、または複素環基および低級アルコキシよりなる群
から選ばれる置換基で任意に置換されていてもよい低級アルキル基、
R12はヒドロキシ基、
R15はOまたはN−R16、ここでR16は水素またはアシル基、
をそれぞれ示す。)で表される基を形成する、
をそれぞれ示す。)で表される基、
をそれぞれ意味する。ただし、R6およびR7がそれぞれ水素である場合、
R1は2,6−ジクロロフェニル基である]
で表すことができる。
目的化合物[I]またはその塩は、下記の反応式で示す諸方法によって製造す
ることができる。製造法1
製造法2
製造法3
製造法4
製造法5
製造法6
[上記各式中、R13は水素、またはヒドロキシおよび低級アルコキシよりなる群
から選ばれる置換基で任意に置換されていてもよい低級アルキル基で、
R14は水素;ハロ(低級)アルキルで任意に置換されていてもよいアリール基
;またはヒドロキシ、低級アルコキシおよび複素環基よりなる群から選ばれる置
換基で任意に置換されていてもよい低級アルキル基であるか;または
R13およびR14は、結合した窒素原子と共に、低級アルキルで任意に置換され
ていてもよい複素環基を形成する、
Q1は低級アルキレン基、
置換または非置換のN−含有複素環−N−イル基、
R17は水素または低級アルキル基、
R18はアシル基、
R19は水素または低級アルキル基、
Q2は低級アルキレン基、
X2はOまたはS、
ぞれ前記定義の通り、
をそれぞれ示す。]
この明細書の以上および以下の記述において、この発明の範囲に包含される種
々の定義の好適な例を次に詳細に説明する。
「低級」とは、特記ない限り、炭素原子数1ないし6を有する基を意味する。
これに関し、種々の定義中の低級アルケニル部分または低級アルキニル部分に
おける「低級」とは、炭素原子2ないし6個を有する基を意味する。
これに関し、種々の定義中の低級アルケノイル部分、低級アルキノイル部分お
よびシクロ(低級)アルキル部分における「低級」とは、炭素原子3ないし6個
を有する基を意味する。
好適な「複素環基」および「複素環(低級)アルキル」、「複素環カルボニル
」、「複素環チオ」などのこの明細書および請求の範囲に記載された種々の定義
におけるすべての好適な複素環部分としては、窒素原子、酸素原子または硫黄原
子のような複素原子を少なくとも1個有する飽和または不飽和の単環式または多
環式のもの、より好ましくはN,Oおよび/またはS含有複素環基を挙げること
ができ、より好ましいものとしては、モルホリニル、ピペラジニル、ピリジル、
ジヒドロピリジル、テトラヒドロピリジル、ピリミジニル、ヘキサヒドロピリミ
ジニル、ピペリジル、チエニル、フリル、オキサゾリル、オキサゾリジニル、イ
ソオキサゾリル、チアゾリル、チアゾリニル、オキサジアゾリル、チアジアゾリ
ル、トリアゾリル、テトラゾリル、イミダゾリル、ピロリジニル、ピロリル、オ
キシラニル、テトラヒドロフリル、ピペロニル、インドリル、キノリル、イソキ
ノリル、ベンズイミダゾリル、ベンズイミダゾリジニル、イミダゾリニル、イミ
ダゾリジニル、ヒラゾリル、ピラゾリジニル、イミダゾ[4,5−b]ピリジル
などを挙げることができる。
好適な「アリール」および「アリールオキシ」における好適なアリール部分と
しては、フェニル、ナフチル、フルオレニル、低級アルキルで置換されたフェニ
ル[たとえばトリル、キシリル、メシチル、クメニル、ジ(第三級ブチル)フェ
ニルなど]などを挙げることができ、より好ましいものとしては、フェニル、ナ
フチルおよびトリルを挙げることができる。
好適な「ハロゲン」としては、フッ素、塩素、臭素およびヨウ素を挙げること
ができる。
好適な「低級アルコキシ」および「低級アルコキシ(低級)アルキル」におけ
る好適な低級アルコキシ部分としては、直鎖または分枝状のもの、たとえばメト
キシ、エトキシ、プロポキシ、イソプロポキシ、ブトキシ、イソブトキシ、第三
級ブトキシ、ペンチルオキシ、ヘキシルオキシなどを挙げることができ、より好
ましいものとしては、C1−C4アルコキシ、たとえばメトキシ、エトキシまたは
イソプロポキシを挙げることができる。
好適な「低級アルキル」および「複素環(低級)アルキル」、「ヒドロキシ(
低級)アルキル」、「低級アルコキシ(低級)アルキル」、「低級アルキルチオ
」、「低級アルキルスルフィニル」、「低級アルキルスルホニル」、「低級アル
キルアミノ」などのこの明細書および請求の範囲に記載された種々の定義におけ
るすべての好適な低級アルキル部分としては、直鎖または分枝状のもの、たとえ
ばメチル、エチル、プロピル、イソプロピル、ブチル、イソブチル、第三級ブチ
ル、ペンチル、ヘキシルなどを挙げることができ、より好ましいものとしては、
C1−C4アルキル、たとえばメチル、エチル、プロピル、イソブチルまたは第三
級ブチルを挙げることができる。
好適な「低級アルケニル」としては、ビニル、アリル、1−プロペニル、メチ
ルプロペニル、ブテニル、ペンテニルなどを挙げることができる。
好適な「低級アルキニル」としては、エチニル、プロピニル、ブチニル、ペン
チニル、ヘキシニルなどを挙げることができる。
好適な「アシル」および「アシルアミノ」、「アシル(低級)アルキル」およ
び「アシルオキシ」における好適なアシル部分としては、低級アルカノイル[た
とえばホルミル、アセチル、プロピオニル、ブチリル、イソブチリル、バレリル
、イソバレリル、ピバロイル、ヘキサノイル、3,3−ジメチルブチリルなど]
、ヒドロキシ(低級)アルカノイル[たとえばグリコロイル、ラクトイル、3−
ヒドロキシプロビオニル、ヒドロキシブチリル、3−ヒドロキシ−3−メチ
ルブチリルなど]、低級アルカノイルオキシ(低級)アルカノイル[たとえばア
セチルオキシアセチル、アセチルオキシプロピオニルなど]、低級アルコキシ(
低級)アルカノイル[たとえばメトキシアセチル、メトキシプロピオニル、エト
キシアセチルなど]、低級アルカノイルアミノ(低級)アルカノイル[たとえば
アセチルアミノアセチル、アセチルアミノプロピオニルなど]、低級アルキルア
ミノ(低級)アルカノイル[たとえばメチルアミノアセチル、ジメチルアミノア
セチル、ジメチルアミノプロピオニルなど]、ハロ(低級)アルカノイル[たと
えばクロロアセチル、トリフルオロアセチルなど]、カルボキシ(低級)アルカ
ノイル[たとえばカルボキシアセチル、カルボキシプロピオニル、カルボキシブ
チリルなど]、アル(低級)アルカノイル[たとえばフェニルアセチル、フェニ
ルプロピオニルなど]、複素環(低級)アルカノイル[たとえばチエニルアセチ
ル、イミダゾリルアセチル、ピリジルアセチル、ピリジルプロピオニルなど]、
低級アルケノイル[たとえばアクリロイル、メタクリロイル、クロトノイル、イ
ソクロトノイルなど]、アル(低級)アルケノイル[たとえばシンナモイルなど
]、シクロ(低級)アルキルカルボニル[たとえばシクロプロピルカルボニル、
シクロブチルカルボニル、シクロペンチルカルボニル、シクロヘキシルカルボニ
ルなど]、カルボキシ、たとえば低級アルコキシカルボニル[たとえばメトキシ
カルボニル、エトキシカルボニル、プロポキシカルボニル、イソプロポキシカル
ボニル、ブトキシカルボニル、イソブトキシカルボニル、第三級ブトキシカルボ
ニル、ベンチルオキシカルボニル、ヘキシルオキシカルボニルなど]などのエス
テル化されたカルボキシ、置換基で置換されていてもよい複素環カルボニル[た
とえばフロイル、テノイル、ピリジルカルボニル、イミダゾリルカルボニル、モ
ルホリノカルボニル、ピペリジノカルボニル、1−メチルイミダゾリルカルボニ
ル、4−メチル−1−ピペラジニルカルボニル、4−エチル−1−ピペラジニル
カルボニル、ジメチルアミノピペリジノカルボニル、4−メチルカルボニル−1
−ピペラジニルカルボニル、4−アセチル−1−ピペラジニルカルボニル、4−
フェニル−1−ピペラジニルカルボニル、クロロテノイル、1,2,3,6−テ
トラヒドロピリジルカルボニル、ピロリジニルカルボニル、インドリルカルボニ
ルなど]、置換基で置換されていてもよいアロイル[たとえばベンゾイル、ナフ
トイル、メトキシベンゾイル、ジクロロベンゾイル、トリフルオロメチルベンゾ
イルなど]、オキサモイル、たとえばカルバモイル、低級アルキルカルバモイル
[たとえばメチルカルバモイル、エチルカルバモイル、プロピルカルバモイル、
イソプロピルカルバモイル、ブチルカルバモイル、イソブチルカルバモイル、第
三級ブチルカルバモイル、ペンチルカルバモイル、ジメチルカルバモイル、ジエ
チルカルバモイル、N−エチル−N−メチルカルバモイルなど]、N−(低級ア
ルコキシ)−N−(低級アルキル)カルバモイル[たとえばN−メトキシ−N−
メチルカルバモイル、N−メトキシ−N−エチルカルバモイルなど]、カルボキ
シ(低級)アルキルカルバモイル[たとえばカルボキシメチルカルバモイル、カ
ルボキシエチルカルバモイルなど]、たとえば低級アルコキシカルボニル(低級
)アルキルカルバモイル[たとえばメトキシカルボニルメチルカルバモイル、エ
トキシカルボニルメチルカルバモイル、エトキシカルボニルエチルカルバモイル
など]などのエステル化されたカルボキシ(低級)アルキルカルバモイル、ヒド
ロキシ(低級)アルキルカルバモイル[たとえばヒドロキシエチルカルバモイル
、ヒドロキシプロピルカルバモイル、ジ(ヒドロキシエチル)カルバモイル、ジ
ヒドロキシプロピルカルバモイル、1,1−ジメチル−2−ヒドロキシエチルカ
ルバモイルなど]、低級アルコキシ(低級)アルキルカルバモイル[たとえばメ
トキシエチルカルバモイル、メトキシプロピルカルバモイル、ジ(メトキシエチ
ル)カルバモイルなど]、N−[低級アルコキシ(低級)アルキル]−N−(低
級アルキル)カルバモイル[たとえばN−メトキシメチル−N−メチルカルバモ
イル、N−メトキシエチル−N−メチルカルバモイル、N−メトキシエチル−N
−エチルカルバモイルなど]、カルバモイル(低級)アルキルカルバモイル[た
とえばカルバモイルメチルカルバモイル、カルバモイルエチルカルバモイルなど
]、たとえばアリールカルバモイル[たとえばフェニルカルバモイル、トリルカ
ルバモイル、キシリルカルバモイル、ナフチルカルバモイル、エチルフェニルカ
ルバモイルなど]、ハロ(低級)アルキルアリールカルバモイル[たとえばトリ
フルオロメチルフェニルカルバモイルなど]などの置換または非置換のアリール
カルバモイル、複素環カルバモイル[たとえばピリジルカルバモイル、イミダゾ
リルカルバモイル、ピラゾリルカルバモイルなど]、たとえば複素環(低
級)アルキルカルバモイル[たとえばピリジルメチルカルバモイル、ピリジルエ
チルカルバモイル、オキサジアゾリルメチルカルバモイル、フリルメチルカルバ
モイル、チエニルメチルカルバモイル、テトラヒドロフリルメチルカルバモイル
、ピペロニルメチルカルバモイル、インドリルエチルカルバモイル、イミダゾリ
ルエチルカルバモイルなど]、低級アルキル複素環(低級)アルキルカルバモイ
ル[たとえばメチルピリジルメチルカルバモイル、メチルオキサジアゾリルメチ
ルカルバモイルなど]などの置換または非置換の複素環(低級)アルキルカルバ
モイルなどの置換または非置換のカルバモイル、低級アルキルスルホニル[たと
えばメチルスルホニル、エチルスルホニル、プロピルスルホニルなど]、アリー
ルスルホニル[たとえばフェニル、トリルスルホニルなど]、置換基で置換され
ていてもよい複素環スルホニル[たとえばピリジルスルホニル、チエニルスルホ
ニル、フリルスルホニル、チアゾリルスルホニル、2−アセトアミド−4−メチ
ル−5−チアゾリルスルホニルなど]、アル(低級)アルキルスルホニル[たと
えばベンジルスルホニル、フェネチルスルホニルなど]、アル(低級)アルケニ
ルスルホニル[たとえばスチリルスルホニル、シンナミルスルホニルなど]など
を挙げることができる。
好適な「ハロ(低級)アルキル」としては、クロロメチル、ブロモメチル、ジ
クロロメチル、ジフルオロメチル、トリフルオロメチルなどを挙げることができ
る。
好適な「低級アルキレン」としては、直鎖または分枝状のもの、たとえばメチ
レン、エチレン、トリメチレン、メチルメチレン、テトラメチレン、エチルエチ
レン、プロピレン、ペンタメチレン、ヘキサメチレンなどを挙げることができ、
最も好ましいものとしては、メチレンを挙げることができる。
好適な「アル(低級)アルキル」としては、ベンジル、フェネチル、ベンズヒ
ドリル、トリチル、ナフチルメチルなどを挙げることができる。
R1の「複素環基またはアリール基、その各々は適当な置換基で置換されてい
てもよい」における好適な置換基としては、ハロゲン;ヒドロキシ;低級アルキ
ル;低級アルコキシ;ハロ(低級)アルキル;ニトロ;低級アルキルまたはアシ
ル[より好ましくは低級アルカノイルなど]で任意に置換されていてもよいアミ
ノ;アリール;アシル[より好ましくはカルボキシ、低級アルコキシカルボニル
、低級アルキルカルバモイルなど];低級アルキルで任意に置換されていてもよ
い複素環基;などを挙げることができ、より好ましいものとしては、ハロゲン、
低級アルキル、低級アルコキシ、ハロ(低級)アルキルまたはニトロを挙げるこ
とができる。好ましくは、R1の「複素環基またはアリール基」は上記の1個ま
たは2個の置換基で置換される。R1がフェニルである場合、これらの置換基の
好ましい位置としては、フェニル基の2および/または6の位置を挙げることが
できる。
「置換された低級アルキル」の低級アルキルの好適な置換基としては、アリー
ル、ニトロ、ハロゲン、シアノ、ヒドロキシ、低級アルコキシ、低級アルキルチ
オ、アリールオキシ、アシルオキシ、アシル、ヒドロキシイミノ、アミノ、低級
アルキルアミノ、N−[低級アルコキシ(低級)アルキル]−N−(低級アルキ
ル)アミノ、N−[ヒドロキシ(低級)アルキル]−N−(低級アルキル)アミ
ノ、置換または非置換の複素環基、複素環チオなどを挙げることができる。
「置換された低級アルケニル」の低級アルケニルの好適な置換基としては、ア
シルなどを挙げることができる。
「置換された低級アルキニル」の低級アルキニルの好適な置換基としては、低
級アルキル、ヒドロキシ、複素環基などを挙げることができる。
「置換されたアリール」のアリールの好適な置換基としては、アミノ、アシル
アミノ、低級アルコキシ、複素環基などを挙げることができる。
「置換されたアミノ」のアミノの好適な置換基としては、低級アルキル、アル
(低級)アルキル、ヒドロキシ(低級)アルキル、低級アルコキシ(低級)アル
キル、アミノ(低級)アルキル、低級アルキルアミノ(低級)アルキル、複素環
(低級)アルキル、低級アルコキシ、アリール、置換されたアリール、N−アシ
ル−N−(低級アルキル)アミノ(低級)アルキル、アシル、置換または非置換
の複素環基などを挙げることができる。
「置換されたヒドロキシ」のヒドロキシの好適な置換基としては、低級アルキ
ル、低級アルコキシ(低級)アルキル、アル(低級)アルキル、複素環(低級)
アルキル、アシル(低級)アルキル、低級アルケニル、アリール、置換されたア
リール、アシル、アル(低級)アルケニル[たとえばスチリル、シンナミルなど
]、置換または非置換の複素環基、アリールオキシ(低級)アルキル[たとえば
フェノキシメチル、フェノキシエチルなど]、フタルイミド(低級)アルキル[
たとえばフタルイミドメチルなど]などを挙げることができる。
「置換されたメルカプト」のメルカプトの好適な置換基としては、アシル(低
級)アルキル、置換または非置換の複素環基などを挙げることができる。
「置換または非置換の複素環基」または「置換または非置換のN−含有複素環
−N−イル基」の複素環基の好適な置換基としては、ハロゲン、低級アルキル、
低級アルキルアミノ(低級)アルキル、低級アルキルチオ、オキソ、チオキソ、
ヒドロキシ、アリール、アル(低級)アルキル、複素環基などを挙げることがで
きる。
「置換されたヒドラジノ」のヒドラジノの好適な置換基としては、低級アルキ
ル、低級アルキリデン[たとえばイソプロピリデンなど]、ヒドロキシ(低級)
アルキル、低級アルコキシ(低級)アルキル、アシルなどを挙げることができる
。
「置換されたセミカルバジド」または「置換されたチオセミカルバジド」のセ
ミカルバジドまたはチオセミカルバジドの好適な置換基としては、低級アルキル
、アリールなどを挙げることができる。
R13、R14および結合した窒素原子で形成された好適な「複素環基」としては
、モルホリノ、チオモルホリノ、ピロリジン−1−イル、ピペリジノ、1,2,
3,6−テトラヒドロピリジン−1−イル、ピペラジン−1−イルなどを挙げる
ことができる。
好適な「N−含有複素環−N−イル基」としては、モルホリノ、チオモルホリ
ノ、ピロリジン−1−イル、ピペリジノ、1,2,3,6−テトラヒドロピリジ
ン−1−イル、ピペラジン−1−イル、イミダゾール−1−イル、イミダゾリン
−1−イル、イミダゾリジン−1−イル、ベンズイミダゾール−1−イル、ベン
ズイミダゾリジン−1−イル、ピラゾール−1−イル、ピラゾリジン−1−イル
、ヘキサヒドロピリミジン−1−イルなどを挙げることができる。
目的化合物[I]の好適な医薬として許容される塩は、慣用の無毒の塩であっ
て、金属塩、たとえばアルカリ金属塩[たとえばナトリウム塩、カリウム塩な
ど]およびアルカリ土類金属塩[たとえばカルシウム塩、マグネシウム塩など]
、アンモニウム塩、有機塩基塩[たとえばトリメチルアミン塩、トリエチルアミ
ン塩、ピリジン塩、ピコリン塩、ジシクロヘキシルアミン塩、N,N’−ジベン
ジルエチレンジアミン塩など]、有機酸付加塩[たとえば蟻酸塩、酢酸塩、トリ
フルオロ酢酸塩、マレイン酸塩、酒石酸塩、シュウ酸塩、メタンスルホン酸塩、
ベンゼンスルホン酸塩、トルエンスルホン酸塩など]、無機酸付加塩[たとえば
塩酸塩、臭化水素酸塩、硫酸塩、燐酸塩など]、アミノ酸との塩[たとえばアル
ギニン塩、アスパラギン酸塩、グルタミン酸塩など]、分子内塩などを挙げるこ
とができる。
製造法1ないし6における化合物[Ia]ないし[Ij]の塩については、こ
れらの化合物は化合物[I]の範囲に包含されるので、これらの化合物の塩の好
適な例としては、目的化合物[I]で示したのと同じものを挙げることができる
。
目的化合物[I]の好ましい具体例としては、以下のものを挙げることができ
る。
R1は複素環基またはアリール基、その各々はハロゲン、低級アルキル、低級
アルコキシ、低級アルキルで任意に置換されていてもよいイミダゾリル、ヒドロ
キシ、ニトロ、アミノ、アシルアミノ、ハロ(低級)アルキルおよびアシルより
なる群から選ばれる置換基で置換され、[より好ましくは、1固または2個のハ
ロゲンで置換されたフェニル、ニトロで置換されたフェニル、ハロ(低級)アル
キルで置換されたフェニルおよび1固または2個のハロゲンで置換されたピリジ
ル]、
nは0または1の整数、
Aは−CONH−または−NHCO−、
[式中、R2は水素、ハロゲン、低級アルキル基、低級アルコキシ基またはハロ
(低級)アルキル基、
R3は水素、ハロゲン、低級アルキル基、低級アルコキシ基またはハロ(低級
)アルキル基、
R4は水素、ハロゲン、低級アルキル基、低級アルコキシ基またはハロ(低級
)アルキル基、
R5は水素または低級アルキル基、
低級アルキル基[より好ましくは、アリール、ニトロ、ハロゲン、ヒドロキシ、
低級アルコキシ、低級アルキルチオ、アリールオキシ、アシルオキシ(たとえば
低級アルカノイルオキシ、低級アルキルカルバモイルオキシなど)、アシル(た
とえばカルボキシ、低級アルコキシカルボニル、カルバモイル、低級アルキルカ
ルバモイルなど)、ヒドロキシイミノ、複素環基(たとえばイミダゾリル、ベン
ズイミダゾリル、モルホリニルなど)および複素環チオ基(たとえばイミダゾリ
ルチオ、ピリジルチオなど)よりなる群から選ばれる置換基で置換された低級ア
ルキル基]、低級アルケニル基、置換された低級アルケニル基[より好ましくは
、アシル(たとえばカルボキシ、低級アルコキシカルボニル、カルバモイル、低
級アルキルカルバモイルなど)で置換された低級アルケニル基]、低級アルキニ
ル基、置換された低級アルキニル基[より好ましくは、低級アルキル、ヒドロキ
シおよび複素環基(たとえばピリジルなど)よりなる群から選ばれる置換基で置
換された低級アルキニル基]、低級アルキルチオ基、低級アルキルスルフィニル
基、低級アルキルスルホニル基、複素環チオ基(た
とえばピリジルチオなど)、アシル基[より好ましくは、低級アルカノイル、カ
ルボキシ、低級アルコキシカルボニル、カルバモイル、低級アルキルカルバモイ
ル、N−(低級アルコキシ)−N−(低級アルキル)カルバモイルまたは複素環
カルボニル(たとえばモルホリノカルボニル、ピペリジノカルボニルなど)]、
アシルアミノ基[より好ましくは、低級アルカノイルアミノまたは低級アルコキ
シカルボニルアミノ]、アリール基、置換されたアリール基[より好ましくは、
アミノで置換されたアリール基]または複素環基[より好ましくは、ピリジル]
、
好ましくは、ハロゲン、シアノ、ヒドロキシ、低級アルコキシ、アシルオキシ(
たとえば低級アルカノイルオキシなど)、アシル(たとえばカルボキシ、低級ア
ルコキシカルボニル、カルバモイル、低級アルキルカルバモイル、複素環(低級
)アルキルカルバモイル(たとえばピリジル(低級)アルキルカルバモイルなど
)、ヒドロキシ(低級)アルキルカルバモイル、N−[低級アルコキシ(低級)
アルキル]−N−(低級アルキル)カルバモイル、置換または非置換のアリール
カルバモイル(たとえばフェニルカルバモイル、ハロ(低級)アルキルフェニル
カルバモイルなど)、置換または非置換の複素環カルボニル(たとえばモルホリ
ノカルボニル、ピペリジノカルボニル、低級アルキルピペラジニルカルボニルな
ど)など)、アミノ、低級アルキルアミノ、N−[低級アルコキシ(低級)アル
キル]−N−(低級アルキル)アミノ、N−[ヒドロキシ(低級)アルキル]−
N−(低級アルキル)アミノ、置換または非置換の複素環基(たとえば低級アル
キル、低級アルキルチオまたはフェニルで任意に置換されていてもよいイミダゾ
リル;ベンズイミダゾリル;モルホリニル;ピリジル;低級アルキルで任意に置
換されていてもよいイミダゾリニル;低級アルキルおよび/またはオキソで任意
に置換されていてもよいイミダゾリジニル;など)および複素環チオ(たとえば
イミダゾリルチオ、ピリジルチオなど)よりなる群から選ばれる置換基で置換さ
れた低級アルキル基]、低級アルケニル基、置換された低級アルケニル基[より
好ましくは、アシル(たとえばカルボキシ、低級アルコキシカルボニル、カルバ
モイル、低級アルキルカルバ
モイルなど)で置換された低級アルケニル基]、アジド基、アミノ基、置換され
たアミノ基[より好ましくは、低級アルキル、低級アルコキシ、低級アルコキシ
(低級)アルキル、ヒドロキシ(低級)アルキル、アル(低級)アルキル(たと
えばベンジル、フェネチルなど)、アミノ(低級)アルキル、低級アルキルアミ
ノ(低級)アルキル、複素環(低級)アルキル(たとえばピリジル(低級)アル
キルなど)、アリール(たとえばフェニル、トリルなど)、置換されたアリール
(たとえばアミノで置換されたフェニル、ピリジルカルボニルアミノで置換され
たフェニルなど)、N−アシル−N−(低級アルキル)アミノ(低級)アルキル
(たとえばN−ピリジルカルボニル−N−(低級アルキル)アミノ(低級)アル
キル、N−イミダゾリルカルボニル−N−(低級アルキル)アミノ(低級)アル
キル、N−ピリジルカルバモイル−N−(低級アルキル)アミノ(低級)アルキ
ルなど)、アシル(たとえば低級アルカノイルなど)および置換または非置換の
複素環基(たとえばピラゾリル、イミダゾリル、トリアゾリル、モルホリノ、低
級アルキルで任意に置換されていてもよいピペラジニル、オキソで任意に置換さ
れていてもよいオキサゾリジニル、オキソで任意に置換されていてもよいピロリ
ジニルなど)よりなる群から選ばれる置換基で置換されたアミノ基]、ヒドラジ
ノ基、置換されたヒドラジノ基[より好ましくは、低級アルキル、低級アルキリ
デン、ヒドロキシ(低級)アルキル、低級アルコキシ(低級)アルキルおよびア
シル(たとえば低級アルカノイル、ハロ(低級)アルカノイル、シクロ(低級)
アルキルカルボニル、カルボキシ、低級アルコキシカルボニル、カルボキシ(低
級)アルカノイル、ヒドロキシ(低級)アルカノイル、低級アルカノイルオキシ
(低級)アルカノイル、低級アルコキシ(低級)アルカノイル、低級アルカノイ
ルアミノ(低級)アルカノイル、低級アルキルアミノ(低級)アルカノイル、オ
キサモイル、低級アルケノイル、低級アルキルスルホニル、アリールスルホニル
、チエニルスルホニル、チアゾリルスルホニルで該チアゾリルスルホニルは低級
アルキルおよび/または低級アルカノイルアミノで任意に置換されていてもよい
、アル(低級)アルキルスルホニル、アル(低級)アルケニルスルホニル、アロ
イルで該アロイルは低級アルコキシまたはハロ(低級)アルキルで任意に置換さ
れていてもよい、
アル(低級)アルケノイル、チエニル(低級)アルカノイル、イミダゾリル(低
級)アルカノイル、ピリジル(低級)アルカノイル、チエニルカルボニル、フロ
イル、低級アルキルで任意に置換されていてもよいイミダゾリルカルボニル、ピ
リジルカルボニルなど)よりなる群から選ばれる置換基で置換されたヒドラジノ
基]、セミカルバジド基、置換されたセミカルバジド基[より好ましくは、低級
アルキルまたはフェニルで置換されたセミカルバジド基]、チオセミカルバジド
基、置換されたチオセミカルバジド基[より好ましくは、低級アルキルまたはフ
ェニルで置換されたチオセミカルバジド基]、ヒドロキシ基、置換されたヒドロ
キシ基[より好ましくは、低級アルキル、低級アルコキシ(低級)アルキル、ア
ル(低級)アルキル、複素環(低級)アルキル(たとえばフリル(低級)アルキ
ル、ピリジル(低級)アルキル、ベンズイミダゾリル(低級)アルキルなど)、
アシル(低級)アルキル(たとえばカルボキシ(低級)アルキル、低級アルコキ
シカルボニル(低級)アルキル、カルバモイル(低級)アルキル、低級アルキル
カルバモイル(低級)アルキルなど)、低級アルケニル、アリール、置換された
アリール(たとえば低級アルコキシで置換されたフェニル、イミダゾリルで置換
されたフェニル)、アシル(たとえばジクロロベンゾイルなど)、アル(低級)
アルケニル(たとえばスチリル、シンナミルなど)、置換または非置換の複素環
基(たとえばピリジル、ベンズイミダゾリル、ハロゲンで置換されたピリジル、
低級アルキルで置換されたピリジル、低級アルキルアミノ(低級)アルキルで置
換されたピリジルなど)、アリールオキシ(低級)アルキルおよびフタルイミド
(低級)アルキルよりなる群から選ばれる置換基で置換されたヒドロキシ基]、
メルカプト基、置換されたメルカプト基[より好ましくは、アシル(低級)アル
キル(たとえばカルボキシ(低級)アルキル、低級アルコキシカルボニル(低級
)アルキル、カルバモイル(低級)アルキル、低級アルキルカルバモイル(低級
)アルキル、複素環(低級)アルキルカルバモイル(低級)アルキル(たとえば
ピリジル(低級)アルキルカルバモイル(低級)アルキルなど)など)および置
換または非置換の複素環基(たとえばイミダゾリル、ピリジル、低級アルキルイ
ミダゾリル、イミダゾ[4,5−b]ピリジル、ピリミジニル、ベンズイミダゾ
リル、
チアゾリル、チアゾリニル、低級アルキルで任意に置換されていてもよいチアジ
アゾリル、低級アルキルで任意に置換されていてもよいテトラゾリル、低級アル
キルで任意に置換されていてもよいトリアゾリルなど)よりなる群から選ばれる
置換基で置換されたメルカプト基]、アシル基[より好ましくは、低級アルカノ
イル、カルボキシ、低級アルコキシカルボニル、カルバモイルまたは低級アルキ
ルカルバモイル]または置換または非置換の複素環基[より好ましくは、低級ア
ルキルまたは低級アルキルカルバモイルで任意に置換されていてもよいイミダゾ
リル;ピリジルで任意に置換されていてもよいベンズイミダゾリル;オキソで任
意に置換されていてもよいジヒドロピリジル;モルホリノ;ピペリジノ;低級ア
ルキルで任意に置換されていてもよいピペラジニル;ヒドロキシで任意に置換さ
れていてもよいピラゾリル;ヒドロキシで任意に置換されていてもよいインドリ
ル;トリアゾリル;低級アルキル、アル(低級)アルキル、オキソおよび/また
はチオキソで任意に置換されていてもよいイミダゾリジニル;低級アルキル、ア
ル(低級)アルキル、オキソおよび/またはチオキソで任意に置換されていても
よいヘキサヒドロピリミジニル;低級アルキル、アル(低級)アルキル、オキソ
および/またはチオキソで任意に置換されていてもよいベンズイミダゾリジニル
;または低級アルキル、アル(低級)アルキル、オキソおよび/またはチオキソ
で任意に置換されていてもよいピラゾリジニル]、
R8は低級アルキル基、
R9は低級アルキル基、
R10は水素または低級アルキル基、
R11は水素、アシル基[より好ましくは、低級アルカノイルまたは低級アルコ
キシカルボニル]、または複素環基(たとえばピリジルなど)および低級アルコ
キシよりなる群から選ばれる置換基で任意に置換されていてもよい低級アルキル
基、
R12はヒドロキシ基、
R15はOまたはN−R16、ここでR16は水素またはアシル基(より好ましくは
低級アルカノイル)、
X1はO、SまたはNH、
をそれぞれ示す。]で表される基、
である。
目的化合物[I]の製造法を次に詳細に説明する。製造法1
目的化合物[Ia]またはその塩は、化合物[II]またはアミノ基における
その反応性誘導体またはその塩を、化合物[III]またはカルボキシ基におけ
るその反応性誘導体またはその塩と反応させることによって製造することができ
る。
化合物[II]のアミノ基における好適な反応性誘導体は、化合物[II]を
ビス(トリメチルシリル)アセトアミドまたはモノ(トリメチルシリル)アセト
アミドなどと反応させて生成されるシリル誘導体であってもよい。
化合物[II]およびその反応性誘導体の好適な塩としては、化合物[I]で
示したのと同じものを挙げることができる。
化合物[III]のカルボキシ基における好適な反応性誘導体としては、酸ハ
ロゲン化物、酸無水物、活性アミド、活性エステルなどを挙げることができる。
反応性誘導体の好適な例としては、酸塩化物;酸アジド;ジアルキル燐酸、硫
酸、脂肪族カルボン酸または芳香族カルボン酸などの酸との混合酸無水物;対称
酸無水物;イミダゾールとの活性アミド;または活性エステル[たとえばp−ニ
トロフェニルエステルなど]を挙げることができる。これらの反応性誘導体は、
使用する化合物[III]の種類に応じて任意に選択できる。
化合物[III]およびその反応性誘導体の好適な塩としては、化合物[I]
で示したのと同じものを挙げることができる。
この反応は、通常、塩化メチレン、クロロホルム、塩化エチレン、ピリジン、
ジオキサン、テトラヒドロフラン、N,N−ジメチルホルムアミドなどの慣用の
溶媒中で行われる。化合物[III]が遊離酸または塩の形態で使用される場合
、この反応は、N,N’−ジシクロヘキシルカルボジイミドなどの慣用の縮合剤
の存在下で行われることが好ましい。
反応温度は特に限定されず、冷却下、室温または加熱下で行われる。
この反応は、慣用の無機塩基または慣用の有機塩基の存在下で行われることが
好ましい。製造法2
目的化合物[Ib]またはその塩は、化合物[IV]またはカルボキシ基にお
けるその反応性誘導体またはその塩を、化合物[V]またはアミノ基におけるそ
の反応性誘導体またはその塩と反応させることによって製造することができる。
化合物[IV]および[V]およびそれらの反応性誘導体の好適な塩としては
、化合物[I]で示したのと同じものを挙げることができる。
この反応は、製造法1と実質的に同様に実施されるので、この反応の反応形式
ならびに反応条件は、製造法1の記載を参照すればよい。製造法3
目的化合物[Id]またはその塩は、化合物[Ic]またはカルボキシ基にお
けるその反応性誘導体またはその塩を、化合物[VI]またはアミノ基における
その反応性誘導体またはその塩と反応させることによって製造することができる
。
化合物[VI]およびその反応性誘導体の好適な塩としては、化合物[I]で
示したのと同じものを挙げることができる。
この反応は、製造法1と実質的に同様に実施されるので、この反応の反応形式
ならびに反応条件は、製造法1の記載を参照すればよい。製造法4
目的化合物[If]またはその塩は、化合物[Ie]またはその塩を化合物[
VII]またはその塩と反応させることによって製造することができる。
化合物[VII]の好適な塩としては、化合物[I]で示したのと同じものを
挙げることができる。
この反応は、通常、テトラヒドロフラン、ジオキサン、N,N−ジメチルホル
ムアミド、N−メチルピロリドンなどの慣用の溶媒中で行われる。
反応温度は特に限定されず、通常、加温ないし加熱下で行われる。製造法5
目的化合物[Ih]またはその塩は、化合物[Ig]またはその塩をアシル化
することによって製造することができる。
アシル化はアシル化剤の存在下で行われる。
好適なアシル化剤としては、式R18−OH(式中、R18はアシル基を示す。)
によって表されるカルボン酸またはスルホン酸化合物、それらの反応性誘導体お
よび対応するイソシアン酸またはイソチオシアン酸化合物を挙げることができる
。
好適な前記反応性誘導体としては、酸ハロゲン化物、酸無水物、活性アミドお
よび活性エステルを挙げることができる。好適な例としては、酸塩化物および酸
臭化物などの酸ハロゲン化物、種々の酸[たとえば、たとえばジアルキル燐酸の
ような置換された燐酸、硫酸、脂肪族カルボン酸、芳香族カルボン酸など]との
混合酸無水物、対称酸無水物、種々のイミダゾールとの活性アミド、およびp−
ニトロフェニルエステルおよびN−ヒドロキシスクシンイミドエステルなどの活
性エステルを挙げることができる。この種の反応性誘導体は、導入するアシル基
の種類に応じて選択できる。
この反応は、通常、塩化メチレン、クロロホルム、ピリジン、ジオキサン、テ
トラヒドロフラン、N,N−ジメチルホルムアミドなどの慣用の溶媒中で行われ
る。アシル化剤が液体である場合、それもまた溶媒として使用できる。カルボン
酸またはスルホン酸化合物が、遊離酸または塩の形態でアシル化剤として使用さ
れる場合、1−エチル−3−(3−ジメチルアミノプロピル)カルボジイミド、
N,N’−ジシクロヘキシルカルボジイミドなどの慣用の縮合剤の存在下で反応
を実施するのが好ましい。
反応温度は特に限定されず、冷却下、室温または加熱下で行われる。
この反応は、慣用の無機塩基または慣用の有機塩基の存在下で実施するのが好
ましい。製造法6
目的化合物[Ij]は、化合物[Ii]またはその塩をカルボニル基またはチ
オカルボニル基の導入反応に付すことによって製造することができる。
この反応は、カルボニル基またはチオカルボニル基を導入する試薬、たとえば
ホスゲン、ハロ蟻酸化合物[たとえばクロロ蟻酸エチル、クロロ蟻酸トリクロロ
メチルなど]、1,1’−カルボニルジイミダゾール、1,1’−チオカルボニ
ルジイミダゾールなどの存在下で行われる。
この反応は、通常、たとえばジオキサン、テトラヒドロフラン、ベンゼン、ト
ルエン、クロロホルム、塩化メチレン、N,N−ジメチルホルムアミドまたは反
応に悪影響を及ぼさない他の有機溶媒中で行われる。
反応温度は特に限定されず、通常、冷却ないし加熱下で行われる。
目的化合物[I]および出発化合物は、以下に示す製造例および実施例の方法
それらと同様の方法または慣用の方法によっても製造することができる。
前記の製造法に従って得られた化合物は、粉砕、再結晶、クロマトグラフィー
再沈殿などの慣用の方法で分離し、精製することができる。
化合物[I]および他の化合物には、不斉炭素原子および二重結合に基づく立
体異性体および幾何異性体が1個またはそれ以上存在することがあるが、これら
の異性体およびそれらの混合物のすべてもまたこの発明の範囲に含まれる。
式[I]の化合物およびその塩は、溶媒和物であることもあり、それもまたこ
の発明の範囲に含まれる。好ましい溶媒和物としては、水和物およびエタノレー
トを挙げることができる。
目的化合物[I]および医薬として許容されるその塩は、液胞型H+−ATP
ase、特に破骨細胞H+−ATPaseの阻害活性および骨吸収阻害活性を有
し、したがって骨吸収阻害剤または骨転移阻害剤としてヒトまたは動物における
異常骨代謝による骨疾患、たとえば骨粗鬆症(特に閉経後骨粗鬆症);高カルシ
ウム血症;上皮小体機能亢進症;骨パジェット病;骨溶解;骨転移を伴うまたは
伴わない悪性高カルシウム血症;リウマチ性関節炎;歯周炎;変形性関節炎;骨
痛;オステオペニア;癌悪液質;悪性腫瘍などの予防および/または治療に有用
である。
さらに、この発明の目的化合物[I]および医薬として許容されるその塩は、
ヒトまたは動物における腫瘍、特に腎癌、黒色腫、大腸癌、肺癌および白血病に
関わる腫瘍;ウイルス性症状(たとえばセムリキ森林熱、水疱性口内炎、ニュー
カッスル病、インフルエンザA型およびB型、HIVウイルスに関わるもの);
潰瘍(たとえば慢性胃炎、ヘリコバクターピロリに誘発される消化性潰瘍);自
己免疫疾患;臓器移植;高コレステロール血症およびアテローム硬化性疾患;エ
イズ;アルツハイマー病;糖尿病性網膜症、乾癬および充実性腫瘍などの血管由
来の疾患;などの予防および/または治療に有用であり、ならびにヒトまたは動
物における男性受精能力の調整に有用であると期待される。
目的化合物[I]の有用性を示すために、化合物[I]のいくつかの代表的化
合物の薬理学試験データを以下に示す。試験1
(液胞型H+−ATPaseプロトン輸送の阻害)試験方法
(a) マウス腹腔マクロファージからのミクロソームの調製
7週令雄性ddyマウスに、2mlの3%チオグリコレート培地を腹腔内注射
した。3ないし5日後マウスを断頭し、5〜6mlのハンクス液(HBSS)で
腹腔洗浄して、腹腔マクロファージを得た。細胞を冷HBSSで2回洗浄した。
小胞は細胞から調整し、ダウンス型ホモジナイザーを用いて、10mlの250
mM蔗糖、5mMトリス、1mM EGTA、1mM KHCO3および1mMジ
チオトレイトル(4℃でpH7.0)中で20回ホモジナイズした。最初の遠心
分離(1000xgで5分間)後、上清を遠心分離(6000xgで15分間)
して、ミトコンドリアおよびリソゾームを取り除いた。上清を42000xgで
30分間遠心分離して、ミクロソームペレットを集めて、−80℃で保存した。
(b) プロトン輸送の測定
プロトン輸送は、150mM KCl、10mMビス−トリスプロパン、2m
MMgCl2、10mMアクリジンオレンジ、1mMバリノマイシン、10mg
/mlオリゴマイシンおよび試験化合物(濃度:1x10-6M)を含む反応緩衝
液(pH7.0)300mlに懸濁した膜小胞のアリコートを用いてアクリジン
オレンジの取り込みを二重波長分光光度計(リファレンス波長540nm、測定
波長492nm)でモニターすることで測定した[H.C.Blair、J.C
ell.Biol.、102、1164(1986)]。反応は1mM ATP
の添加によって開始した。結果を対照に対する阻害率で表した。試験結果
試験2 (骨組織培養)試験方法
ウィスターラットから頭蓋冠を摘出し、試験化合物(濃度:1x10-6M)の
存在下で、10%ウシ胎仔血清および10-8Mヒト副甲状腺ホルモン片(1−3
4)[PTH]を加えた2mlのダルベッコ修正最少必須培地を含む12穴培養
皿のウェル内で培養した。対照ウェルには、PTHを加えなかった。対照および
PTH対照は等濃度の媒質にさらした。6日後、培地内のカルシウム([Ca]
)濃度をメチルキシレノールブルー法で測定し、PTH誘発骨吸収の阻害率を以
下の式によって計算した。
CP: PTH対照ウェルの[Ca]
CD: 試験化合物ウェルの[Ca]
CO: 対照ウェルの[Ca]試験結果
治療のためには、この発明の化合物[I]および医薬として許容されるその塩
を、前記化合物の一つを有効成分として、経口投与;静脈内、筋肉内、皮下また
は関節内投与などの非経口投与;経皮のような外用、腸内、直腸内、経膣、吸入
、眼内、鼻内または舌下投与に適した有機または無機の固体、半固体または液体
の賦形剤などの医薬として許容される担体と共に含有する医薬製剤の形で用いる
ことができる。前記医薬製剤は、カプセル剤、錠剤、糖剤、顆粒、坐剤、液剤、
ローション剤、懸濁剤、乳剤、軟膏、ゲル剤、クリームなどであってもよい。必
要ならば、上記製剤に、補助剤、安定化剤、湿潤剤または乳化剤、緩衝剤および
他の常用添加剤を含有させてもよい。
化合物[I]の用量は、患者の年齢および症状により変動するが、化合物[I
]の平均一回量約0.1mg、1mg、10mg、50mg、100mg、25
0mg、500mgおよび1000mgが、前記の疾患の予防および/または治
療に有効である。一般的には、1日当たり0.1mgないし約1000mgの範
囲の量を一人当たりに投与すればよい。
実施例
以下の製造例および実施例は、この発明を説明するために示したものである。製造例1
8−ニトロ−4−メチルキノリン(250mg)、塩化第二鉄六水和物(7.
18mg)と活性炭(38mg)のメタノール中の攪拌混合物に、ヒドラジン−
水和物(266mg)を65℃で加え、混合物を同温で1時間攪拌した。不溶物
を濾去し、濾液を真空中で濃縮した。混合物を酢酸エチルに溶解し、食塩水で洗
浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去して、8−アミノ−4−
メチルキノリン(208.8mg)を得た。
mp: 76-77℃
NMR(CDCl3,δ): 2.65(3H,s),4.99(2H,br s),6.92
(1H,d,J=8Hz),7.20(1H,d,J=4Hz),7.25-7.50(2H,m),8.62
(1H,d,J=4Hz)製造例2
(1) 3−アセチル−1,4−ジヒドロ−8−ニトロ−4−オキソキノリン(
500mg)と塩化ホスホリルの混合物を115℃で15分間加熱した。冷却後
、混合物を氷水に注ぎ、酢酸エチルで抽出した。有機層を飽和重炭酸ナトリウム
溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去して、
3−アセチル−4−クロロ−8−ニトロキノリン(485mg)を得た。
NMR(CDCl3,δ): 2.80(3H,s),7.81 (1H,t,J=8Hz),
8.15(1H,d,J=8Hz),8.61(1H,d,J=8Hz),9.08(1H,s)
(2) 3−アセチル−4−クロロ−8−ニトロキノリン(339mg)のジク
ロロメタン中の溶液に、28%ナトリウムメトキシドのメタノール溶液(0.5
2mg)を氷冷下で加え、混合物を室温で30分間攪拌した。混合物を酢酸エチ
ルで希釈し、水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を
留去した。残留物をシリカゲルカラムクロマトグラフィー(酢酸エチル:n−ヘ
キサン、2:3、v/v)で精製して、3−アセチル−4−メトキシ−8−ニト
ロキノリン(239.3mg)を得た。
mp: 100-105℃
NMR(CDCl3,δ): 2.77(3H,s),4.13(3H,s),7.68
(1H,t,J=8Hz),8.11(1H,d,J=8Hz),8.48(1H,d,J=8Hz),9.18
(1H,s)
(3) 3−アセチル−4−メトキシ−8−ニトロキノリン(230mg)、塩
化アンモニウム(30mg)と鉄(313mg)のエタノール(3ml)と水(
0.8ml)中の混合物を2時間還流した。不溶物を濾去し、濾液を真空中で濃
縮した。残留物を酢酸エチルに溶解し、溶液を飽和重炭酸ナトリウム溶液と食塩
水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去して、3−アセチ
ル−8−アミノ−4−メトキシキノリン(175.7mg)を得た。
mp: 76-77℃
NMR(CDCl3,δ): 2.76(3H,s),4.07(3H,s),5.01
(2H,br s),7.00(1H,d,J=8Hz),7.38(1H,t,J=8Hz),7.49
(1H,d,J=8Hz),8.95(1H,s)製造例3
4−クロロ−3−エトキシカルボニル−8−ニトロキノリンを、製造例2−(
1)と同様にして、3−エトキシカルボニル−1,4−ジヒドロ−8−ニトロ−
4−オキソキノリンから得た。
mp: 81-83℃
NMR(CDCl3,δ): 1.47(3H,t,J=7Hz),4.52(2H,q,
J=7Hz),7.80(1H,t,J=8Hz),8.14(1H,d,J=8Hz),8.65(1H,d,
J=8Hz),9.33(1H,s)製造例4
4−エトキシ−3−エトキシカルボニル−8−ニトロキノリンを、製造例2−
(2)と同様にして、4−クロロ−3−エトキシカルボニル−8−ニトロキノリ
ンとナトリウムエトキシドとを反応させて得た。
NMR(CDCl3,δ): 1.45(3H,t,J=7Hz),1.55(3H,t,
J=7Hz),4.39(2H,q,J=7Hz),4.48(2H,q,J=7Hz),7.65(1H,t,
J=8Hz),8.10(1H,d,J=8Hz),8.51(1H,d,J=8Hz),9.27(1H,s)製造例5
4−クロロ−3−エトキシカルボニル−8−ニトロキノリン(199mg)、
ジメチルアミン塩酸塩(63.6mg)とトリエチルアミン(78.9mg)の
ジオキサン中の混合物を3時間還流した。冷却後、混合物を酢酸エチルで希釈し
、水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を
シリカゲルカラムクロマトグラフィー(酢酸エチル:n−ヘキサン、1:2、v
/v)で精製して、4−ジメチルアミノ−3−エトキシカルボニル−8−ニトロ
キノリン(122mg)を得た。
mp: 76-77℃
NMR(CDCl3,δ): 1.43(3H,t,J=7Hz),3.14(6H,s),
4.45(2H,q,J=7Hz),7.55(1H,d,J=8Hz),7.97(1H,t,J=8Hz),
8.35(1H,d,J=8Hz),8.99(1H,s)製造例6
(1) 1,4−ジヒドロ−4−オキソ−8−ニトロキノリン(10g)のジメ
チルホルムアミド(100ml)中の攪拌混合物に、N−ブロモスクシンイミド
(9.83g)を氷冷下で2分間かけて滴下し、混合物を4℃で30分間攪拌し
た。それに水を氷冷下で加え、混合物を1時間攪拌した。生じた沈殿物を濾過に
より集め、残留物を水と熱いエタノールで洗浄して、3−ブロモ−1,4−ジヒ
ドロ−8−ニトロ−4−オキソキノリン(12.12g)を得た。
mp: 279-282℃
NMR(DMSO-d6,δ): 7.57(1H,t,J=7.5Hz),8.34(1H,
s),8.60(1H,d,J=7.5Hz),8.68(1H,d,J=7.5Hz)
(2) 3−ブロモ−4−クロロ−8−ニトロキノリンを製造例2−(1)と同
様にして得た。
mp: 135-136℃
NMR(CDCl3,δ): 7.76(1H,t,J=7.5Hz),8.09(1H,d,
J=7.5Hz),8.49(1H,d,J=7.5Hz),9.07(1H,s)製造例7
(1) マロン酸ジエチル(368mg)とN−メチルピロリドンの混合物に、
カリウム第三級ブトキシド(246mg)を0℃で加え、混合物を室温で30分
間攪拌した。混合物に3−ブロモ−4−クロロ−8−ニトロキノリン(300m
g)を加え、混合物を室温で30分間、50℃で30分間攪拌した。混合物を飽
和塩化アンモニウム溶液に注ぎ、酢酸エチルで抽出した。有機層を水と食塩水で
洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去して、4−[ビス(エ
トキシカルボニル)メチル]−3−ブロモ−8−ニトロキノリン(315.6m
g)を得た。
mp: 94-95℃
NMR(CDCl3,δ): 1.23(6H,t,J=7Hz),4.15-4.35(4H,
m),5.79(1H,s),7,65(1H,t,J=8Hz),8.00(1H,d,J=8Hz),
8.25(1H,d,J=8Hz),9,13(1H,s)
(2) 4−[ビス(エトキシカルボニル)メチル]−3−ブロモ−8−ニトロ
キノリン(316mg)、塩化リチウム(65.1mg)と水(13.8mg)
のジメチルスルホキシド中の混合物を130℃で20分間攪拌した。混合物を酢
酸エチルと水との間に分配し、有機層を食塩水で洗浄し、硫酸マグネシウムで乾
燥後、真空中で溶媒を留去して、3−ブロモ−4−エトキシカルボニルメチル−
8−ニトロキノリン(236.8mg)を得た。
mp: 163-164℃
NMR(CDCl3,δ): 1.24(3H,t,J=7Hz),4.19(2H,q,
J=7Hz),4.35(2H,s),7.70(1H,t,J=8Hz),8.02(1H,d,
J=8Hz),8.19(1H,d,J=8Hz),9.11(1H,s)製造例8
(1) 4−ヒドロキシ−8−ニトロキノリン(200mg)と臭化アリル(1
40mg)のジメチルホルムアミド(2ml)中の溶液に、炭酸カリウム(29
0mg)を0℃で加え、混合物を50℃で6時間攪拌した。混合物をジクロロメ
タンで希釈し、水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去し
た。残留物を熱い酢酸エチル(2ml)に溶解し、溶液を室温で攪拌した。生じ
た沈殿物を濾過により集めて、4−アリルオキシ−8−ニトロキノリン(120
mg)を得た。
mp: 127℃
NMR(CDCl3,δ): 4.81(2H,d,J=7Hz),5.43(1H,d,
J=10Hz),5.53(1H,d,J=15Hz),6.05-6.22(1H,m),6.85(1H,d,
J=5Hz),7.54(1H,t,J=7.5Hz),8.00(1H,d,J=7.5Hz),8.46
(1H,d,J=7.5Hz),8.87(1H,d,J=7.5Hz)
(2) 4−アリルオキシ−8−ニトロキノリン(110mg)と鉄(268m
g)の酢酸(0.4ml)とエタノール(1.6ml)中の混合物を1時間還流
した。不溶物を濾去し、濾液を真空中で濃縮した。残留物をジクロロメタンに溶
解し、溶液を飽和重炭酸ナトリウム溶液と水で洗浄し、硫酸マグネシウムで乾燥
後、真空中で溶媒を留去した。残留物をフラッシュクロマトグラフィー(酢酸エ
チル−n−ヘキサン)で精製して、8−アミノ−4−アリルオキシキノリン(8
7mg)を得た。
NMR(CDCl3,δ): 4.74(2H,d,J=5Hz),4.90(2H,br s),
5.37(1H,d,J=11Hz),5.51(1H,d,J=17Hz),6.05-6.21(1H,m),
6.70(1H,d,J=4Hz),6.92(1H,d,J=7.5Hz),7.29(1H,t,
J=7.5Hz),7.54(1H,d,J=7.5Hz),8.59(1H,d,J=7.5Hz)製造例9
(1) 4−ベンジルオキシ−8−ニトロキノリンを、製造例8−(1)と同様
にして、4−ヒドロキシ−8−ニトロキノリンと臭化ベンジルとを反応させて得
た。
mp: 162.3℃
NMR(CDCl3,δ): 5.32(2H,s),6.92(1H,d,J=5Hz),
7.35-7.54(5H,m),7.55(1H,t,J=7.5Hz),8.00(1H,d,
J=7.5Hz),8.46(1H,d,J=7.5Hz),8.86(1H,d,J=7.5Hz)
(2) 8−アミノ−4−ベンジルオキシキノリンを製造例8−(2)と同様に
して得た。
mp: 114.8℃
NMR(CDCl3,δ): 4.91(2H,br s),5.26(2H,s),6.77
(1H,d,J=5Hz),6.93(1H,d,J=7.5Hz),7.21-7.54(6H,m),7.58
(1H,d,J=7.5Hz),8.59(1H,d,J=5Hz)製造例10
(1) 4−エトキシカルボニルメトキシ−8−ニトロキノリンを、製造例8−
(1)と同様にして、4−ヒドロキシ−8−ニトロキノリンとブロモ酢酸エチル
とを反応させて得た。
mp: 108.4℃
NMR(CDCl3,δ): 1.31(3H,t,J=7.5Hz),4.31(2H,q,
J=7.5Hz),4.88(2H,s),6.74(1H,d,J=5Hz),7.60(1H,t,
J=7.5Hz),8.04(1H,d,J=7.5Hz),8.53(1H,d,J=7.5Hz),8.89
(1H,d,J=7.5Hz)
(2) 4−エトキシカルボニルメトキシ−8−ニトロキノリン(404mg)
と10%パラジウム炭素のエタノール(5ml)とジオキサン(5ml)中の混
合物を水素雰囲気下で室温で5時間攪拌した。不溶物を濾去し、濾液を真空中で
濃縮した。残留物をジエチルエーテルで粉砕して、8−アミノ−4−(エトキシ
カルボニルメトキシ)キノリン(234mg)を得た。
mp: 94℃
NMR(CDCl3,δ): 1.30(3H,t,J=7.5Hz),4.30(2H,q,
J=7.5Hz),4.82(2H,s),4.92(2H,br s),6.58(1H,d,J=5Hz),
6.94(1H,d,J=7.5Hz),7.30(1H,t,J=7.5Hz),7.60(1H,d,
J=7.5Hz),8.60(1H,d,J=5Hz)製造例11
(1) 4−アリルオキシ−8−ニトロキノリン(3.72g)のビフェニル(
2.59g)とジフェニルエーテル(7.4g)中の溶液を200℃で10分間
加熱した。冷却後、それにn−ヘキサン(40ml)を加え、混合物を90℃に
加温した。冷却後、生じた沈殿物を濾過により集めて、3−アリル-1,4−ジ
ヒドロ−8−ニトロ−4−オキソキノリン(3.13g)を得た。
mp: 242.3℃
NMR(CDCl3,δ): 3.36(2H,br d,J=7Hz),5.12-5.25
(2H,m),5.90-6.08(1H,m),7.43(1H,t,J=7.5Hz),7.65(1H,
d,J=6Hz),8.65(1H,d,J=7.5Hz),8.83(1H,d,J=7.5Hz),11.08
(1H,br s)
(2) 4−クロロ−8−ニトロ−3−アリルキノリンを製造例2−(1)と同
様にして得た。
mp: 64-66℃
NMR(CDCl3,δ): 3.77(2H,d,J=8Hz),5.10-5.30(2H,
m),6.00(1H,m),7.71(1H,t,J=8Hz),8.03(1H,d,J=8Hz),
8.19(1H,d,J=8Hz),8.89(1H,s)
(3) 4−ジメチルアミノ−8−ニトロ−3−(1−プロペニル)キノリンを
、製造例5と同様にして、4−クロロ−8−ニトロ−3−アリルキノリンとジメ
チルアミン塩酸塩とを反応させて得た。
mp: 121-123℃
NMR(CDCl3,δ): 2.00(3H,d,J=7Hz),6.21(1H,dq,
J=7,15Hz),6.63(1H,d,J=15Hz),7.49(1H,t,J=8Hz),7.87
(1H,d,J=8Hz),8.26(1H,d,J=8Hz),8.91(1H,s)
(4) 8−アミノ−4−ジメチルアミノ−3−プロピルキノリンを、製造例1
0−(2)と同様にして、4−ジメチルアミノ−8−ニトロ−3−(1−プロペ
ニル)キノリンから得た。
NMR(CDCl3,δ): 1.01(3H,t,J=7Hz),1.65(2H,m),
2.76(2H,m),3.04(6H,s),4.90(2H,br s),6.84(1H,d,
J=8Hz),7.25(1H,t,J=8Hz),7.38(1H,d,J=8Hz),8.51(1H,s)製造例12
(1) 4−ヒドロキシ−8−ニトロキノリン(5.0g)、2,6−ルチジン
(4.23g)とジメチルアミノピリジン(321mg)の攪拌混合物に、トリ
フルオロメタンスルホン酸無水物(8.16g)のジクロロメタン(100ml
)中の溶液を氷冷下で30分間かけて滴下し、混合物を同温で2時間、室温で1
時間攪拌した。混合物に飽和塩化アンモニウム溶液を加え、ジクロロメタンで抽
出した。有機層を水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶
媒を留去した。残留物をフラッシュクロマトグラフィー(ジクロロメタン−n−
ヘキサン)で精製して、8−ニトロ−4−(トリフルオロメタンスルホニルオキ
シ)キノリン(6.17g)を得た。
mp: 108℃
NMR(CDCl3,δ): 7.58(1H,d,J=4Hz),7.80(1H,t,
J=7.5Hz),8.15(1H,d,J=7.5Hz),8.30(1H,d,
J=7.5Hz),9.14(1H,d,J=4Hz)
(2) 8−ニトロ−4−(トリフルオロメタンスルホニルオキシ)キノリン(
6.0g)、トリ−n−ブチル(ビニル)錫(6.49g)、テトラキス(トリ
フェニルホスフィン)パラジウム(0)(1.08g)と塩化リチウム(2.3
7g)のジオキサン(120ml)中の混合物を1.5時間還流した。混合物を
真空中で濃縮し、酢酸エチル(200ml)を残留物に加えた。混合物を1時間
攪拌し、不溶物を濾去した。残留物をフラッシュクロマトグラフィー(酢酸エチ
ル−n−ヘキサン)で精製して、8−ニトロ−4−ビニルキノリン(2.39g
)を得た。
mp: 134℃
NMR(CDCl3,δ): 5.76(1H,d,J=11Hz),6.04(1H,d,
J=18Hz),7.40(1H,dd,J=18,11Hz),7.60(1H,d,J=4Hz),7.65
(1H,t,J=7.5Hz),8.00(1H,d,J=7.5Hz),8.30(1H,d,
J=7.5Hz),9.02(1H,d,J=4Hz)製造例13
8−アミノ−3−ブロモキノリン(200mg)とナトリウムチオメトキシド
(109mg)のN,N−ジメチルホルムアミド(2ml)中の混合物を室温で
2日間攪拌した。酢酸エチルで希釈後、生じた混合物を水と食塩水で洗浄し、無
水硫酸ナトリウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲルクロ
マトグラフィー(n−ヘキサン−酢酸エチル)で精製して、8−アミノ−3−メ
チルチオキノリン(113mg)を油状物として得た。
NMR(CDCl3,δ): 2.60(3H,s),4.86-4.99(2H,m),6.86
(1H,d,J=8Hz),7.05(1H,d,J=8Hz),7.31(1H,t,J=8Hz),7.83
(1H,s),8.65(1H,s)製造例14
8−ニトロ−3−ブロモキノリン(300mg)、トリ−n−ブチル(ビニル
)錫(491mg)とテトラキス(トリフェニルホスフィン)パラジウム
(0)(28mg)のジメトキシエタン(6ml)中の混合物を1時間還流した
。混合物を真空中で濃縮し、残留物をシリカゲルカラムクロマトグラフィー(n
−ヘキサン−トルエン)で精製して、8−ニトロ−3−ビニルキノリン(127
mg)を得た。
mp: 116-117℃
NMR(CDCl3,δ): 5.59(1H,d,J=12Hz),6.05(1H,d,
J=17Hz),6.90(1H,dd,J=12,17Hz),7.62(1H,t,J=8Hz),8.02
(2H,d,J=8Hz),8.17(1H,s),9.19(1H,s)製造例15
8−ニトロ−3−(1−ペンチニル)キノリンを、製造例14と同様にして、
3−ブロモ−8−ニトロキノリンとトリ−n−ブチル(1−ペンチニル)錫から
得た。
mp: 71-73℃
NMR(CDCl3,δ): 1.10(3H,t,J=7Hz),1.63-1.78(2H,
m),2.49(2H,t,J=7Hz),7.62(1H,t,J=8Hz),7.88(1H,d,
J=8Hz),8.02(1H,d,J=8Hz),8.25(1H,s),9.00(1H,s)製造例16
(1) 3−ブロモ−8−ニトロキノリン(253mg)、フェニルホウ酸(1
59mg)、テトラキス(トリフェニルホスフィン)パラジウム(0)(23m
g)と2M炭酸ナトリウム水溶液(2.5ml)の1,2−ジメトキシエタン(
3.5ml)中の混合物を4時間還流した。混合物にフェニルホウ酸(122m
g)を加え、混合物をさらに3時間還流した。生じた混合物を、酢酸エチルで希
釈後、3%重炭酸ナトリウム水溶液と食塩水で洗浄し、無水硫酸ナトリウムで乾
燥後、真空中で溶媒を留去した。残留物をシリカゲルクロマトグラフィー(n−
ヘキサン−酢酸エチル)で精製し、得られた油状物をジエチルエーテルから結晶
化して、8−ニトロ−3−フェニルキノリン(104mg)を得た。
mp: 112-114℃
NMR(CDCl3,δ): 7.46-7.61(3H,m),7.67(1H,t,
J=8Hz),7.72(2H,d,J=8Hz),8.07(1H,d,J=8Hz),8.11(1H,d,
J=8Hz),8.40(1H,s),9.35(1H,s)
(2) 8−アミノ−3−フェニルキノリンを製造例1と同様にして得た。
mp: 64-66℃
NMR(CDCl3,δ): 4.42-5.07(2H,m),6.93(1H,d,
J=8Hz),7.23(1H,t,J=8Hz),7.38(1H,t,J=8Hz),7.44(1H,d,
J=8Hz),7.50(1H,d,J=8Hz),7.53(1H,d,J=8Hz),7.71(2H,d,
J=8Hz),8.21(1H,s),
9.02(1H,s)製造例17
(1) 4−[ビス(エトキシカルボニル)メチル]−8−ニトロキナゾリンを
、製造例7−(1)と同様にして、4−クロロ−8−ニトロキナゾリンとマロン
酸ジエチルとを反応させて得た。
mp: 157-159℃
NMR(CDCl3,δ): 1.28-1.40(6H,m),4.28(2H,q,
J=7Hz),4.36(2H,q,J=7Hz),7.39(1H,t,J=8Hz),7.83(1H,d,
J=8Hz),7.87(1H,d,J=8Hz),7.95(1H,s)
(2) 4−(エトキシカルボニルメチル)−8−ニトロキナゾリンを製造例7
−(2)と同様にして得た。
mp: 162-164℃
NMR(CDCl3,δ): 1.33(3H,t,J=7Hz),4.23(2H,q,
J=7Hz),5.57(2H,s),7.41(1H,t,J=8Hz),7.80-7.93(3H,m)製造例18
3−アセチル−4−クロロ−8−ニトロキノリン(140mg)とメチルヒド
ラジン(77.2mg)の塩化エチレン中の混合物を30分間還流した。混合物
を真空中で濃縮し、残留物をシリカゲルカラムクロマトグラフィー(メタノール
−ジクロロエタン)で精製して、2,3−ジメチル−6−ニトロ−2H−ピラゾ
ロ[4,3−c]キノリン(61.2mg)を得た。
mp: 235-236℃
NMR(CDCl3,δ): 2.70(3H,s),4.49(3H,s),7.73(1H,
t,J=8Hz),7.97(1H,d,J=8Hz),8.56(1H,d,J=8Hz),9.22(1H,
s)製造例19
(1) 3−ホルミル−8−ニトロキノリンを、実施例29と同様にして、8−
ニトロ−3−ビニルキノリンから得た。
NMR(CDCl3,δ): 7.78(1H,t,J=8Hz),8.20(1H,d,
J=8Hz),8.26(1H,d,J=8Hz),8.76(1H,s),9.52(1H,s),10.32
(1H,s)
(2) 3−ホルミル−8−ニトロキノリン(65mg)と(トリフェニルホス
ホラニリデン)酢酸エチル(123mg)のジクロロメタン(3ml)中の混合
物を室温で2時間攪拌した。混合物を真空中で濃縮し、残留物をシリカゲルカラ
ムクロマトグラフィー(酢酸エチル−n−ヘキサン)で精製して、3−((E)
−2−エトキシカルボニルビニル)−8−ニトロキノリン(92mg)を得た。
NMR(CDCl3,δ): 1.39(3H,t,J=7Hz),4.33(2H,q,
J=7Hz),6.71(1H,d,J=16Hz),7.68(1H,t,J=8Hz),7.84(1H,
d,J=16Hz),8.09(2H,d,J=8Hz),8.32(1H,d,J=2Hz),9.24
(1H,d,J=2Hz)製造例20
4−メチル−8−ニトロキノリン(2.80g)と酸化セレン(IV)(1.
82g)のエタノール(45ml)中の混合物を4時間還流した。混合物を活性
炭で処理し、セライトパッドで濾過した。濾液を真空中で濃縮して、褐色固形物
を得た。この残留物をメタノール(10ml)とテトラヒドロフラン(10ml
)の混合物に溶解し、氷浴内で冷却した。この溶液に水素化ホウ素ナトリウム(
170mg)を加え、同温で半時間攪拌した。この混合物に飽和塩化アンモニウ
ム溶液を加え、塩化メチレンで抽出した。有機層を無水硫酸マグネシウムで乾燥
後、減圧下で溶媒を留去した。残留物を、塩化メチレン、次いで塩化メチレン中
の3%メタノールを溶離溶媒として用いるシリカゲルフラッシュクロマトグラフ
ィーで精製して、固形物を得た。この固形物をジエチルエーテルで凝固させて、
4−ヒドロキシメチル−8−ニトロキノリン(665mg)を褐色固形物として
得た。
mp: 148℃
NMR(CDCl3-CD3OD,δ): 5.18(2H,s),7.64(1H,t,
J=7.5Hz),7.72(1H,d,J=4Hz),8.02(1H,d,J=7.5Hz),8.21
(1H,d,J=7.5Hz),8.98(1H,d,J=4Hz)製造例21
3−ブロモ−8−ニトロキノリン(300mg)、トリメチルシリルアセチレ
ン(140mg)、塩化バラジウム(II)(38mg)、触媒量のヨウ化銅(
I)、トリエチルアミン(3ml)とトリフェニルホスフィン(113mg)の
アセトニトリル(3ml)中の混合物を室温で3時間攪拌した。混合物をジエチ
ルエーテルで希釈し、不溶物を濾去した。濾液を真空中で濃縮し、残留物をシリ
カゲルカラムクロマトグラフィー(n−ヘキサン−酢酸エチル)で精製して、8
−ニトロ−3−(トリメチルシリルエチニル)キノリン(210mg)を得た。
NMR(CDCl3,δ): 0.30(9H,s),7.26(1H,s),7.63(1H,
t,J=8Hz),7.99(1H,d,J=8Hz),8.03(1H,d,J=8Hz),8.32(1H,
s),9.03(1H,s)製造例22
下記の化合物を製造例21と同様にして得た。
(1) 8−ニトロ−3−[(2−ピリジル)エチニル]キノリン
(3−ブロモ−8−ニトロキノリンと2−エチニルピリジンから)
mp: 185-187℃
NMR(CDCl3,δ): 7.33(1H,m),7.62(1H,d,J=8Hz),
7.70(1H,d,J=8Hz),7.77(1H,t,J=8Hz),8.03(1H,d,J=8Hz),
8.08(1H,d,J=8Hz),8.48(1H,s),8.68(1H,d,J=8Hz),9.19
(1H,s)
(2) 3−(3−ヒドロキシ−3−メチル−1−ブチニル)−8−ニトロキノ
リン
(3−ブロモ−8−ニトロキノリンと3−ヒドロキシ−3−メチル−1−ブチ
ンから)
mp: 120-121℃
NMR(CDCl3,δ): 1.68(6H,s),2.13(1H,s),7.63(1H,
t,J=8Hz),7.98(1H,d,J=8Hz),8.03(1H,d,J=8Hz),8.30(1H,
s),9.00(1H,s)製造例23
(1) 4−クロロ−3−エトキシカルボニル−8−ニトロキノリン(500m
g)と第三級ブトキシカルボニルヒドラジン(283mg)のジオキサン中の混
合物を1時間還流した。混合物を真空中で濃縮して、2−第三級ブトキシカルボ
ニル−2,3−ジヒドロ−6−ニトロ−1H−ピラゾロ[4,3−c]キノリン
−3−オン(458mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 1.56(9H,s),7.71(1H,t,J=8Hz),
8.41(1H,s),8.53(1H,d,J=8Hz),8.58(1H,d,J=8Hz)
(2) 2−第三級ブトキシカルボニル−2,3−ジヒドロ−6−ニトロ−1H
−ピラゾロ[4,3−c]キノリン−3−オン(450mg)と炭酸カリウム(
565mg)のジメチルホルムアミド中の混合物に、ヨウ化メチル(580mg
)を加え、混合物を60℃で2時間攪拌した。混合物を水に注ぎ、酢酸エチルで
抽出した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒
を留去した。残留物をシリカゲルカラムクロマトグラフィー(ジクロロメタン−
酢酸エチル)で精製して、2−第三級ブトキシカルボニル−2,3−ジヒドロ−
1−メチル−6−ニトロ−1H−ピラゾロ[4,3−c]キノリン−3−オン(
114mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 1.60(9H,s),3.82(3H,s),7.89
(1H,d,J=8Hz),8.42(1H,d,J=8Hz),8.67(1H,d,J=8Hz),9.09
(1H,s)
(3) 6−アミノ−2−第三級ブトキシカルボニル−2,3−ジヒドロ−1−
メチル−1H−ピラゾロ[4,3−c]キノリン−3−オンを製造例10−(2
)と同様にして得た。
mp: >250℃
NMR(CDCl3-CD3OD,δ): 1.62(9H,s),4.40(3H,s),
7.04(1H,d,J=8Hz),7.45(1H,t,J=8Hz),7.66(1H,d,J=8Hz),
8.82(1H,s)製造例24
下記の化合物を製造例2−(3)と同様にして得た。
(1) 8−アミノ−4−クロロ−3−エトキシカルボニルキノリン
mp: 112-113℃
NMR(CDCl3,δ): 1.46(3H,t,J=7Hz),4.50(2H,q,
J=7Hz),5.05(2H,br s),7.03(1H,d,J=8Hz),7.47(1H,t,
J=8Hz),7.68(1H,d,J=8Hz),9.02(1H,s)
(2) 8−アミノ−4−エトキシ−3−エトキシカルボニルキノリン
NMR(CDCl3,δ): 1.45(3H,t,J=7Hz),1.53(3H,t,
J=7Hz),4.29(2H,q,J=7Hz),4.45(2H,q,J=7Hz),4.98(2H,br
s),6.99(1H,d,J=8Hz),7.35(1H,t,J=8Hz),7.56(1H,d,
J=8Hz),9.05(1H,s)
(3) 8−アミノ−4−ジメチルアミノ−3−エトキシカルボニルキノリン
NMR(CDCl3,δ): 1.43(3H,t,J=7Hz),3.09(6H,s),
4.44(2H,q,J=7Hz),4.96(2H,br s),6.91(1H,d,J=8Hz),
7.29(1H,t,J=8Hz),7.44(1H,d,J=8Hz),8.77(1H,s)
(4) 8−アミノ−3−ブロモ−4−クロロキノリン
mp: 130-131℃
NMR(DMSO-d6,δ): 5.02(2H,br s),6.95(1H,d,
J=8Hz),7.42(1H,t,J=8Hz),7.50(1H,,d,J=8Hz),8.75(1H,
s)
(5) 8−アミノ−3−ブロモ−4−(エトキシカルボニルメチル)キノリン
mp: 139-140℃
NMR(CDCl3,δ): 1.22(3H,t,J=7Hz),4.17(2H,q,
J=7Hz),4.26(2H,s),5.03(2H,br s),6.93(1H,d,J=8Hz),
7.22(1H,d,J=8Hz),7.37(1H,t,J=8Hz),8.79(1H,s)
(6) 8−アミノ−4−クロロ−3−アリルキノリン
mp: 111-112℃
NMR(CDCl3,δ): 3.70(2H,d,J=7Hz),5.01(2H,br s),
5.00-5.20(2H,m),6.02(1H,m),6.92(1H,d,J=8Hz),7.40
(1H,t,J=8Hz),7.53(1H,d,J=8Hz),8.56(1H,s)
(7) 8−アミノ−4−ビニルキノリン
NMR(CDCl3,δ): 5.01(2H,br s),5.60(1H,d,
J=11Hz),5.93(1H,d,J=17Hz),6.91(1H,d,J=7.5Hz),7.27-
7.54(4H,m),8.80(1H,d,J=4Hz)
(8) 8−アミノ−3−ビニルキノリン
NMR(CDCl3,δ): 4.84-5.03(2H,m),5.43(1H,d,
J=12Hz),5.97(1H,d,J=17Hz),6.80-6.93(2H,m),7.15(1H,d,
J=8Hz),7.32(1H,t,J=8Hz),8.00(1H,s),8.88(1H,s)
(9) 8−アミノ−3−(1−ベンチニル)キノリン
mp: 75-76℃
NMR(CDCl3,δ): 1.09(3H,t,J=7Hz),1.62-1.76(2H,
m),2.45(2H,t,J=7Hz),4.86-5.02(2H,m),6.89(1H,d,
J=8Hz),7.08(1H,d,J=8Hz),7.31(1H,t,J=8Hz),8.08(1H,d,
J=2Hz),8.71(1H,d,J=2Hz)
(10) 8−アミノ−3−[(2−ピリジル)エチニル]キノリン
mp: 105-107℃
NMR(CDCl3,δ): 4.92-5.03(2H,m),6.95(1H,d,
J=8Hz),7.14(1H,d,J=8Hz),7.25-7.32(1H,m),7.38(1H,t,
J=8Hz),7.60(1H,d,J=8Hz),7.73(1H,t,J=8Hz),8.31(1H,
s),8.67(1H,m),8.89(1H,s)
(11) 8−アミノ−3−(3−ヒドロキシ−3−メチル−1−ブチニル)キ
ノリン
mp: 130-131℃
NMR(CDCl3,δ): 1.67(6H,s),2.24(1H,s),4.90-5.00
(2H,m),6.92(1H,d,J=8Hz),7.10(1H,d,J=8Hz),7.33(1H,
t,J=8Hz),8.12(1H,s),8.72(1H,s)
(12) 8−アミノ−4−(エトキシカルボニルメチル)キナゾリン
mp: 132-134℃
(13) 6−アミノ−2,3−ジメチル−2H−ピラゾロ[4,3−c]キノ
リン
mp: 214-215℃
NMR(CDCl3,δ): 2.65(3H,s),4.41(3H,s),5.11(2H,
br s),7.00(1H,d,J=8Hz),7.42(1H,t,J=8Hz),7.67(1H,d,
J=8Hz),8.94(1H,s)
(14) 8−アミノ−3−((E)−2−エトキシカルボニルビニル)キノリ
ン
NMR(CDCl3,δ): 1.38(3H,t,J=7Hz),4.30(2H,q,
J=7Hz),4.90-5.02(2H,m),6.63(1H,d,J=15Hz),6.95(1H,d,
J=8Hz),7.18(1H,d,J=8Hz),7.38(1H,t,J=8Hz),7.81(1H,d,
J=15Hz),8.15(1H,d,J=2Hz),8.91(1H,d,J=2Hz)
(15) 8−アミノ−4−ヒドロキシメチルキノリン
NMR(DMSO-d6,δ): 4.95(2H,d,J=6Hz),5.50(1H,t,
J=6Hz),5.93(2H,br s),6.85(1H,d,J=7.5Hz),7.04(1H,d,
J=7.5Hz),7.28(1H,t,J=7.5Hz),7.54(1H,d,J=4Hz),8.69
(1H,d,J=4Hz)
(16) 8−アミノ−1,4−ジヒドロ−4−オキソキノリン
NMR(CDCl3-CD3OD,δ): 3.35(2H,m),6.30(1H,d,
J=6Hz),6.99(1H,d,J=7.5Hz),7.18(1H,t,J=7.5Hz),7.64-
7.83(2H,m)
(17) 8−アミノ−3−(トリメチルシリルエチニル)キノリン
mp: 78-80℃
NMR(CDCl3,δ): 0.30(9H,s),4.88-5.01(2H,m),6.92
(1H,d,J=8Hz),6.99(1H,d,J=8Hz),7.33(1H,t,J=8Hz),8.15
(1H,s),8.73(1H,s)製造例25
8−アミノ−4−クロロ−3−エトキシカルボニルキノリン(45mg)、ト
リエチルアミン(0.026ml)と10%パラジウム炭素(15mg)のジオ
キサン中の混合物を3気圧の水素雰囲気下で室温で7時間攪拌した。不溶物を濾
去し、濾液を真空中で濃縮した。残留物をシリカゲルカラムクロマトグラフィー
(酢酸エチル−ジクロロメタン)で精製して、8−アミノ−3−エトキシカルボ
ニルキノリン(24.5mg)を得た。
mp: 95-96℃
NMR(CDCl3,δ): 1.46(3H,t,J=7Hz),4.47(2H,q,
J=7Hz),5.04(2H,br s),7.02(1H,d,J=8Hz),
7.25(1H,d,J=8Hz),7.40(1H,t,J=8Hz),8.74(1H,s),9.28
(1H,s)実施例1
8−アミノ−6−メトキシキノリン(121mg)、2,6−ジクロロベンゾ
イルクロライド(175mg)とトリエチルアミン(91.4mg)の塩化エチ
レン(3ml)中の混合物を3時間還流した。冷却後、混合物を酢酸エチルで希
釈し、水、飽和重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾
燥後、真空中で溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィー
(酢酸エチル:n−ヘキサン、1:2、v/v)で精製して、8−(2,6−ジ
クロロベンゾイルアミノ)−6−メトキシキノリン(164.5mg)を得た。
mp: 180-182℃
NMR(CDCl3,δ): 3.97(3H,s),6.88(1H,s),7.30-7.50
(4H,m),8.06(1H,d,J=8Hz),8.60(1H,m),8.70(1H,s)
その塩酸塩
mp: 236-244℃
NMR(DMSO-d6,δ): 3.93(3H,s),7.22(1H,s),7.40-
7.70(4H,m),8.34(1H,d,J=8Hz),8.43(1H,s),8.73(1H,d,
J=8Hz)実施例2
下記の化合物を実施例1と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−7−メチルキノリン
mp: 200-201℃
NMR(DMSO-d6,δ): 2.57(3H,s),7.40-7.60(5H,m),
7.87(1H,d,J=8Hz),8.37(1H,d,J=8Hz),8.91(1H,m)
その塩酸塩
mp: 235-247℃
NMR(DMSO-d6,δ): 2.58(3H,s),7.40-7.70(5H,m),
7.91(1H,d,J=8Hz),8.46(1H,d,J=8Hz),
8.95(1H,d,J=5Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−メチルキノリン
mp: 231-232℃
NMR(CDCl3,δ): 2.72(3H,s),7.45-7.60(4H,m),
7.68(1H,t,J-8Hz),7.89(1H,d,J=8Hz),8.70-8.75(2H,m)
その塩酸塩
mp: 230-231℃
NMR(DMSO-d6,δ): 2.74(3H,s),7.45-7.65(4H,m),
7.70(1H,t,J=8Hz),7.92(1H,d,J=8Hz),8.74(1H,d,J=8Hz),
8.77(1H,d,J=6Hz)
(3) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン
mp: 215-217℃
NMR(CDCl3,δ): 7.30-7.50(3H,m),7.56(1H,d,
J=5Hz),7.72(1H,t,J=8Hz),7.99(1H,d,J=8Hz),8.64(1H,d,
J=5Hz),9.03(1H,d,J=8Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−メトキシキノリン
mp: 236-237℃
NMR(CDCl3,δ): 4.07(3H,s),6.79(1H,d,J=6Hz),
7.30-7.50(3H,m),7.57(1H,t,J=8Hz),7.94(1H,d,J=8Hz),
8.62(1H,d,J=6Hz),8.95(1H,s)
その塩酸塩
mp: 197-199℃
NMR(CDCl3-CD3OD,δ): 4.34(3H,s),7.21(1H,d,
J=7Hz),7.30-7.50(3H,m),7.87(1H,t,J=8Hz),8.19(1H,d,
J=8Hz),8.92(1H,d,J=7Hz),9.14(1H,d,J=8Hz)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリン
mp: 219-220℃
NMR(CDCl3,δ): 2.53(3H,s),7.30-7.50(3H,m),7.53
(1H,d,J=8Hz),7.58(1H,t,J=8Hz),7.96(1H,s),8.63(1H,
s),8.89(1H,d,J=8Hz)
その塩酸塩
mp: 242-256℃
NMR(DMSO-d6,δ): 2.52(3H,s),7.40-7.80(5H,m),
8.22(1H,s),8.45(1H,d,J=8Hz),8.77(1H,s)
(6) 3−アセチル−8−(2,6−ジクロロベンゾイルアミノ)−4−メト
キシキノリン
mp: 179-180℃
NMR(CDCl3,δ): 2.77(3H,s),4.12(3H,s),7.30-7.50
(3H,m),7.68(1H,t,J=8Hz),7.96(1H,d,J=8Hz),8.97(1H,
s),9.05(1H,d,J=8Hz)
その塩酸塩
mp: 143-148℃(分解)
NMR(CDCl3,δ): 2.79(3H,s),4.25(3H,s),7.30-7.50
(3H,m),7.87(1H,t,J=8Hz),8.18(1H,d,J=8Hz),9.03(1H,
s),9.24(1H,d,J=8Hz)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
キノリン
mp: 199-200℃
NMR(DMSO-d6,δ): 1.40(3H,t,J=7Hz),4.43(2H,q,
J=7Hz),7.50-7.60(3H,m),7.78(1H,t,J=8Hz),8.03(1H,d,
J=8Hz),8.85(1H,d,J=8Hz),9.07(1H,s),9.29(1H,s)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−4−エトキシ−3−エト
キシカルボニルキノリン
mp: 155-156℃
NMR(CDCl3,δ): 1.45(3H,t,J=7Hz),1.56(3H,t,
J=7Hz),4.34(2H,q,J=7Hz),4.47(2H,q,J=7Hz),7.30-7.50
(3H,m),7.65(1H,t,J=8Hz),8.03(1H,d,J=8Hz),9.04(1H,
d,J=8Hz),9.07(1H,s)
その塩酸塩
mp: 220-222℃
NMR(CDCl3,δ): 1.45(3H,t,J=7Hz),1.62(3H,t,
J=7Hz),4.48(2H,q,J=7Hz),4.63(2H,q,J=7Hz),7.30-7.50
(3H,m),7.88(1H,t,J=8Hz),8.26(1H,d,J=8Hz),9.18(1H,
s),9.26(1H,d,J=8Hz)
(9) 8−(2,6−ジクロロベンゾイルアミノ)−4−ジメチルアミノ−3
−エトキシカルボニルキノリン
mp: 163-165℃
NMR(CDCl3,δ): 1.42(3H,t,J=7Hz),3.13(6H,s),
4.43(2H,q,J=7Hz),7.30-7.50(3H,m),7.57(1H,t,J=8Hz),
7.89(1H,d,J=8Hz),8.75(1H,s),8.95(1H,d,J=8Hz)
その塩酸塩
mp: 200-202℃
NMR(CDCl3,δ): 1.43(3H,t,J=7Hz),4.42(2H,q,
J=7Hz),7.30-7.50(3H,m),7.72(1H,t,J=8Hz),8.01(1H,d,
J=8Hz),8.83(1H,s),8.99(1H,d,J=8Hz)
(10) 3−ブロモ−4−クロロ−8−(2,6−ジクロロベンゾイルアミ
ノ)キノリン
mp: 240-242℃
NMR(CDCl3,δ): 7.30-7.50(3H,m),7.75(1H,t,
J=8Hz),8.00(1H,d,J=8Hz),8.81(1H,s),9.04(1H,d,
J=8Hz),9.87(1H,s)
(11) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(エ
トキシカルボニルメチル)キノリン
mp: 166-168℃
NMR(CDCl3,δ): 1.23(3H,t,J=7Hz),4.18(2H,q,
J=7Hz),4.31(2H,s),7.30-7.50(3H,m),7.60-7.75(2H,m),
8.82(1H,s),8.98(1H,d,J=8Hz)
(12) 8−(2,6−ジクロロベンゾイルアミノ)−4−アリルオキシキノ
リン
mp: 199-243.2℃
NMR(CDCl3,δ): 4.78(2H,d,J=5Hz),5.39(1H,d,
J=10Hz),5.51(1H,d,J=15Hz),6.07-6.23(1H,m),6.77(1H,d,
J=5Hz),7.26-7.42(3H,m),7.55(1H,t,J=7.5Hz),7.97(1H,d,
J=7.5Hz),8.57(1H,d,J=7.5Hz),8.95(1H,d,J=7.5Hz)
(13) 4−ベンジルオキシ−8−(2,6−ジクロロベンゾイルアミノ)キ
ノリン
mp: 192.8℃
NMR(CDCl3,δ): 5.31(2H,s),6.84(1H,d,J=5Hz),
7.25-7.52(8H,m),7.55(1H,t,J=7.5Hz),8.00(1H,d,
J=7.5Hz),8.56(1H,d,J=5Hz),8.94(1H,d,J=7.5Hz)
(14) 8−(2,6−ジクロロベンゾイルアミノ)−4−(エトキシカルボ
ニルメトキシ)キノリン
mp: 134℃
NMR(CDCl3,δ): 1.32(3H,t,J=7.5Hz),4.30(2H,q,
J=7.5Hz),4.85(2H,s),6.65(1H,d,J=5Hz),7.30-7.42(3H,m),
7.60(1H,t,J=7.5Hz),8.04(1H,d,J=7.5Hz),8.59(1H,d,
J=5Hz),8.97(1H,d,J=7.5Hz)
(15) 8−(2,6−ジクロロベンゾイルアミノ)−4−ジメチルアミノ−
3−プロピルキノリン塩酸塩
mp: 195-200℃
NMR(DMSO-d6,δ): 0.95(3H,t,J=7Hz),1.58(2H,m),
2.83(2H,m),3.19(6H,s),7.50-7.70(4H,m),7.98(1H,d,
J=8Hz),8.56(1H,d,J=8Hz),8.60(1H,s)
(16) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−アリ
ルキノリン
mp: 127-128℃
NMR(CDCl3,δ): 3.72(2H,d,J=7Hz),5.00-5.20(2H,
m),6.00(1H,m),7.30-7.50(3H,m),7.69(1H,t,J=8Hz),7.98
(1H,d,J=8Hz),8.58(1H,s),8.96(1H,d,J=8Hz)
(17) 8−(2,6−ジクロロベンゾイルアミノ)−4−ビニルキノリン
mp: 210.2℃
NMR(CDCl3,δ): 5.70(1H,d,J=11Hz),6.00(1H,d,
J=18Hz),7.27-7.50(4H,m),7.54(1H,d,J=4Hz),7.64(1H,t,
J=7.5Hz),7.85(1H,d,J=7.5Hz),8.72(1H,d,J=4Hz),8.97
(1H,d,J=7.5Hz)
(18) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチルチオキノリ
ン
mp: 206-207℃
NMR(CDCl3,δ): 2.61(3H,s),7.31-7.45(3H,m),7.51
(1H,d,J=8Hz),7.61(1H,t,J=8Hz),7.92(1H,s),8.68(1H,
s),8.90(1H,d,J=8Hz)
(19) 8−(2,6−ジクロロベンゾイルアミノ)−3−ビニルキノリン
mp: 178-180℃
NMR(CDCl3,δ): 5.48(1H,d,J=12Hz),6.00(1H,d,
J=17Hz),6.88(1H,dd,J=12,17Hz),7.34-7.46(3H,m),7.56-
7.46(2H,m),8.12(1H,s),8.86(1H,s),8.94(1H,d,J=8Hz),
10.00(1H,br s)
(20) 8−(2,6−ジクロロベンゾイルアミノ)−3−(1−ペンチニル
)キノリン
mp: 153-154℃
NMR(CDCl3,δ): 1.10(3H,t,J=7Hz),1.62-1.77(2H,
m),2.47(2H,t,J=7Hz),7.30-7.47(3H,m),7.53(1H,d,
J=8Hz),7.62(1H,t,J=8Hz),8.20(1H,s),8.72(1H,s),8.93
(1H,d,J=8Hz)
その塩酸塩
mp: 145-147℃
NMR(CDCl3,δ): 1.09(3H,t,J=7Hz),1.62-1.76(2H,
m),2.49(2H,t,J=7Hz),7.31-7.44(3H,m),7.78(1H,d,
J=8Hz),7.90(1H,t,J=8Hz),8.69(1H,s),8.90(1H,s),9.21
(1H,d,J=8Hz)
そのメタンスルホン酸塩
mp: 139-140℃
NMR(CDCl3,δ): 1.08(3H,t,J=7Hz),1.63-1.76(2H,
m),2.49(3H,t,J=7Hz),2.53(3H,s),7.33-7.46(3H,m),7.83
(1H,d,J=8Hz),7.92(1H,t,J=8Hz),8.71(1H,s),8.95(1H,
d,J=8Hz),9.19(1H,s)
(21) 8−(2,6−ジクロロベンゾイルアミノ)−3−フェニルキノリン
mp: 190-192℃
NMR(CDCl3,δ): 7.30-7.46(4H,m),7.54(2H,t,
J=8Hz),7.60-7.76(4H,m),8.34(1H,s),8.96(1H,m),9.04
(1H,s),10.06(1H,br s)
(22) 8−(2,6−ジクロロベンゾイルアミノ)−3−[(2−ピリジル
)エチニル]キノリン塩酸塩
mp: 196-197℃
NMR(DMSO-d6,δ): 7.46-7.62(4H,m),7.72-7.82(2H,
m),7.86(1H,d,J=8Hz),7.96(1H,t,J=8Hz),8.66(1H,d,
J=6Hz),8.76-8.82(2H,m),9.06(1H,s),10.94(1H,s)
(23) 8−(2,6−ジクロロベンゾイルアミノ)−3−(3−ヒドロキシ
−3−メチル−1−ブチニル)キノリン
mp: 216-217℃
NMR(CDCl3,δ): 1.66(6H,s),2.08(1H,s),7.30-7.44
(3H,m),7.54(1H,d,J=8Hz),7.64(1H,t,J=8Hz),8.24(1H,
s),8.74(1H,s),8.96(1H,d,J=8Hz),9.90(1H,br s)
(24) 5−(2,6−ジクロロベンゾイルアミノ)−2,3−ジメチルキノ
キサリン
mp: 252-254℃
NMR(CDCl3,δ): 2.70(3H,s),2.75(3H,s),7.30-7.48
(3H,m),7.68-7.80(2H,m),8.89(1H,m),9.71(1H,br s)
(25) 5−(2,6−ジクロロベンゾイルアミノ)キノキサリン
mp: 200-201℃
NMR(CDCl3,δ): 7.30-7.47(3H,m),7.80-7.95(2H,
m),8.72(1H,s),8.93(1H,s),9.01(1H,d,J=7Hz),9.71(1H,
br s)
(26) 8−(2,6−ジクロロベンゾイルアミノ)−4−(エトキシカルボ
ニルメチル)キナゾリン
mp: 193-195℃
NMR(CDCl3,δ): 1.32(3H,t,J=7Hz),4.21(2H,q,
J=7Hz),5.50(1H,s),7.27-7.50(5H,m),7.71(1H,s),8.87
(1H,d,J=8Hz),9.41(1H,br s)
(27) 8−(2,6−ジクロロベンゾイルアミノ)−2−メチルキノリン
mp: 181-182℃
NMR(CDCl3,δ): 2.70(3H,s),7.25-7.48(4H,m),
7.50-7.60(2H,m),8.05(1H,d,J=9Hz),8.92(1H,t,J=5Hz),
10.09(1H,br s)
(28) 8−(2,6−ジクロロベンゾイルアミノ)キノリン
mp: 223-224℃
NMR(CDCl3,δ): 7.30-7.50(4H,m),7.55-7.68(2H,m),
8.20(1H,d,J=8Hz),8.78(1H,d,J=4Hz),8.98(1H,d,J=8Hz)
(29) 8−(2,6−ジクロロベンゾイルアミノ)−4−メトキシキナゾリ
ン
mp: 214-215℃
NMR(CDCl3,δ): 4.20(3H,s),7.30-7.45(3H,m),7.62
(1H,t,J=8Hz),7.89(1H,d,J=8Hz),8.72(1H,s),9.07(1H,
d,J=8Hz),9.66(1H,br s)
(30) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)キノリン
mp: 223-225℃
NMR(CDCl3,δ): 7.30-7.45(3H,m),7.52(1H,d,
J=8Hz),7.65(1H,t,J=8Hz),8.34(1H,s),8.77(1H,s),8.97
(1H,d,J=8Hz),9.33(1H,br s)
(31) 6−(2,6−ジクロロベンゾイルアミノ)−2,3−ジメチル−2
H−ピラゾロ[4,3−c]キノリン
mp: >250℃
NMR(DMSO-d6,δ): 2.62(3H,s),4.43(3H,s),7.45-
7.65(3H,m),7.78(1H,t,J=8Hz),8.34(1H,d,J=8Hz),8.80
(1H,d,J=8Hz),9.17(1H,s)
その塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 2.63(3H,s),4.45(3H,s),
7.50-7.70(3H,m),7.80(1H,t,J=8Hz),8.36(1H,d,J=8Hz),
8.78(1H,d,J=8Hz),9.22(1H,s)
(32) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メチルフェ
ニルアミノ)−3−(1−オキソブチル)キノリン
mp: 208-210℃
NMR(CDCl3,δ): 1.06(3H,t,J=7Hz),1.83(2H,m),
2.37(3H,s),3.09(2H,t,J=7Hz),6.99(1H,d,J=7Hz),7.05-
7.25(4H,m),7.30-7.45(4H,m),8.85(1H,d,J=7Hz),9.04
(1H,s)
(33) 3−(2,6−ジクロロベンゾイルアミノ)−チエノ[3,2−b]
ピリジン塩酸塩
mp: 205-232℃
NMR(DMSO-d6,δ): 7.45-7.57(4H,m),8.50-8.60(2H,
m),8.70(1H,d,J=4Hz)
(34) 8−(2,6−ジクロロベンゾイルアミノ)−3−((E)−2−エ
トキシカルボニルビニル)キノリン
mp: 186-188℃
NMR(CDCl3,δ): 1.38(3H,t,J=7Hz),4.32(2H,q,
J=7Hz),6.64(1H,d,J=17Hz),7.34-7.46(3H,m),7.60-7.72
(2H,m),7.84(1H,d,J=17Hz),8.26(1H,s),8.94(1H,s),
9.00(1H,d,J=8Hz),9.94(1H,br s)
(35) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エト
キシカルボニルキノリン
mp: 129.4℃
NMR(CDCl3,δ): 1.44(3H,t,J=7.5Hz),4.48(2H,q,
J=7.5Hz),7.30-7.46(3H,m),7.76(1H,t,J=7.5Hz),8.15(1H,
d,J=7.5Hz),9.06(1H,s),9.10(1H,d,J=7.5Hz)
(36) 8−(2,6−ジクロロベンゾイルアミノ)−3−(トリメチルシリ
ルエチニル)キノリン
mp: 201-202℃
NMR(CDCl3,δ): 0.30(9H,s),7.31-7.43(3H,m),7.53
(1H,d,J=8Hz),7.62(1H,t,J=8Hz),8.28(1H,s),8.75(1H,
s),8.97(1H,d,J=8Hz)
(37) 2−第三級ブトキシカルボニル−6−(2,6−ジクロロベンゾイル
アミノ)−2,3−ジヒドロ−1−メチル−1H−ピラゾロ[4,3−c]キノ
リン−3−オン
mp: >250℃
NMR(CDCl3,δ): 1.68(9H,s),3.78(3H,s),7.30-7.50
(3H,m),7.74(1H,d,J=8Hz),7.89(1H,d,J=8Hz),9.00(1H,
s),9.17(1H,d,J=8Hz)実施例3
(1) 8−アミノ−4−ヒドロキシメチルキノリン(85mg)、塩化2,6
−ジクロロベンゾイル(225mg)とトリエチルアミン(198mg)の塩化
エチレン(1.5ml)中の混合物を80℃で一夜攪拌した。冷却後、混合物を
ジクロロメタンで希釈し、食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中
で溶媒を留去して、4−(2,6−ジクロロベンゾイルオキシメチル)−8−(
2,6−ジクロロベンゾイルアミノ)キノリン(116mg)を得た。
mp: 237℃(分解)
NMR(DMSO-d6,δ): 6.00(2H,s),7.46-7.65(6H,m),
7.74(1H,t,J=7.5Hz),7.78(1H,d,J=4Hz),7.95(1H,d,
J=7.5Hz),8.76(1H,d,J=7.5Hz),8.92(1H,d,J=4Hz)
(2) 4−(2,6−ジクロロベンゾイルオキシメチル)−8−(2,6−ジ
クロロベンゾイルアミノ)キノリン(100mg)、1N水酸化ナトリウム溶液
(0.4ml)のエタノール(2ml)とジオキサン(1ml)中の混合物を5
時間還流した。冷却後、混合物をジクロロメタンで希釈し、飽和重炭酸ナトリウ
ム溶液で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物
をフラッシュクロマトグラフィー(酢酸エチル−n−ヘキサン)で精製して、8
−(2,6−ジクロロベンゾイルアミノ)−4−ヒドロキシメチルキノリン(2
0mg)を得た。
mp: 234.8-239.0℃
NMR(CDCl3-CD3OD,δ): 5.16(2H,s),7.30-7.46(3H,
m),7.57-7.71(3H,m),8.75(1H,d,J=5Hz),8.92(1H,d,
J=7.5Hz)
その塩酸塩
mp: 222-228℃
NMR(CDCl3-CD3OD,δ); 5.34(2H,s),7.35-7.47(3H,
m),7.87-7.98(2H,m),8.18(1H,d,J=7Hz),8.94-9.06(2H,m)実施例4
(1) 8−アミノ−4−ヒドロキシキノリン(300mg)、塩化2,6−ジ
クロロベンゾイル(432mg)、トリエチルアミン(569mg)と触媒量の
ジメチルアミノピリジンのジメチルアセトアミド(3ml)中の混合物を氷冷下
で1時間攪拌した。混合物に水(3ml)を加え、生じた沈殿物を濾過により集
めた。残留物を熱エタノール(10ml)に攪拌しながら懸濁した。生じた沈殿
物を濾過により集めて、残留物をフラッシュクロマトグラフィー(酢酸エチル−
ジクロロメタン)で精製して、8−アミノ−4−(2,6−ジクロロベンゾイル
オキシ)キノリン(240mg)を得た。
NMR(CDCl3,δ): 5.03(2H,br s),6.95(1H,d,
J=7.5Hz),7.30-7.52(6H,m),8.79(1H,d,J=5Hz)
(2) 8−アミノ−4−(2,6−ジクロロベンゾイルオキシ)キノリン(2
10mg)、塩化2,6−ジクロロベンゾイル(145mg)とトリエチルアミ
ン(191mg)の塩化エチレン(3ml)中の混合物を70℃で24時間攪拌
した。混合物をジクロロメタンで希釈し、水で洗浄し、硫酸マグネシウムで乾燥
後、真空中で溶媒を留去した。残留物をジエチルエーテルで洗浄して、4−(2
,6−ジクロロベンゾイルオキシ)−8−(2,6−ジクロロベンゾイルアミノ
)キノリン(290mg)を得た。
mp: 248℃
NMR(CDCl3,δ): 7.30-7.50(6H,m),7.58(1H,d,
J=4Hz),7.66(1H,t,J=7.5Hz),7.94(1H,d,J=7.5Hz),8.84
(1H,d,J=4Hz),9.03(1H,d,J=7.5Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−1,4−ジヒドロ−4−
オキソキノリンを実施例3−(2)と同様にして得た。
mp: 342℃
NMR(DMSO-d6,δ): 5.95-6.27(1H,m),7.31-7.46(2H,
m),7.49-7.70(3H,m),7.88-8.09(2H,m),8.12(1H,br s)実施例5
8−(2,6−ジクロロベンゾイルアミノ)−3−(トリメチルシリルエチニ
ル)キノリン(150mg)のテトラヒドロフラン(3ml)中の溶液に、1M
フッ化テトラブチルアンモニウムのテトラヒドロフラン溶液(0.04ml)を
氷冷下で加え、混合物を同温で2時間攪拌した。混合物をジクロロメタンで希釈
し、水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した
。残留物をシリカゲルカラムクロマトグラフィー(酢酸エチル:n−ヘキサン、
1:4、v/v)で精製して、8−(2,6−ジクロロベンゾイルアミノ)−3
−エチニルキノリン(111mg)を得た。
mp: 219-220℃
NMR(CDCl3,δ): 3.30(1H,s),7.30-7.46(3H,m),7.56
(1H,d,J=8Hz),7.66(1H,t,J=8Hz),8.32(1H,s),8.80(1H,
s),9.00(1H,d,J=8Hz),9.92(1H,br s)実施例6
2−第三級ブトキシカルボニル−6−(2,6−ジクロロベンゾイルアミノ)
−2,3−ジヒドロ−1−メチル−1H−ピラゾロ[4,3−c]キノリン−3
−オン(30mg)のメタノール(1ml)中の溶液に、4M塩化水素の酢酸エ
チル溶液(1ml)を室温で加え、混合物を同温で1時間攪拌した。混合物を真
空中で濃縮し、残留物をエタノール−酢酸エチルから結晶化して、6−(2,6
−ジクロロベンゾイルアミノ)−2,3−ジヒドロ−1−メチル−1H−ピラゾ
ロ[4,3−c]キノリン−3−オン塩酸塩(17.9mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 4.30(3H,s),7.50-7.70(3H,m),
7.78(1H,t,J=8Hz),8.32(1H,d,J=8Hz),8.76(1H,d,J=8Hz),
9.13(1H,s)
実施例7
6−(2,6−ジクロロベンゾイルアミノ)−2,3−ジヒドロ−1−メチル
−1H−ピラゾロ[4,3−c]キノリン−3−オン塩酸塩(85mg)、4−
クロロメチルピリジン塩酸塩(40mg)と炭酸カリウム(111mg)のジメ
チルホルムアミド(1ml)中の混合物を室温で3時間攪拌した。混合物を酢酸
エチルと水との間に分配した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾
燥後、真空中で溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィー
で精製して、6−(2,6−ジクロロベンゾイルアミノ)−2,3−ジヒドロ−
1−メチル−2−(ピリジン−4−イルメチル)−1H−ピラゾロ[4,3−c
]キノリン−3−オンを得た。
得られた化合物を塩化水素のメタノール中の溶液に溶解し、混合物を真空中で
濃縮して、6−(2,6−ジクロロベンゾイルアミノ)−2,3−ジヒドロ−1
−メチル−2−(ピリジン−4−イルメチル)−1H−ピラゾロ[4,3−c]
キ弥・ン−3−オン二塩酸塩(83mg)を得た。
mp: 226-234℃
NMR(DMSO-d6,δ): 4.33(3H,s),5.83(2H,s),
7.48-7.65(3H,m),7.80(1H,t,J=8Hz),8.18(2H,d,J=6Hz),
8.32(1H,d,J=8Hz),8.81(1H,d,J=8Hz),8.93(2H,d,J=6Hz),
9.18(1H,s)実施例8
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(100m
g)と2−メトキシエチルアミン(314mg)のN−メチルピロリドン(1m
l)中の混合物を120℃で一夜加熱した。それに水(3ml)を氷冷下で加え
、混合物を1時間攪拌した。生じた沈殿物を濾過により集め、残留物を分取薄層
クロマトグラフィー(メタノール−ジクロロメタン)で精製して、8−(2,6
−ジクロロベンゾイルアミノ)−4−(2−メトキシエチルアミノ)キノリン(
65mg)を得た。
mp: 166℃
NMR(CDCl3,δ): 3.43-3.53(2H,m),3.44(3H,s),3.71
(2H,t,J=6Hz),5.44(1H,br t,J=6Hz),6.45(1H,d,J=5Hz),
7.25-7.40(3H,m),7.42-7.55(2H,m),8.40(1H,d,J=5Hz),
8.89(1H,d,J=7.5Hz)実施例9
下記の化合物を実施例8と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)キノリン
mp: 236℃
NMR(CDCl3,δ): 7.31-7.46(6H,m),7.60(1H,d,
J=7.5Hz),7.70(1H,t,J=7.5Hz),7.88(1H,s),8.86(1H,d,
J=4Hz),9.08(1H,d,J=7.5Hz)
その塩酸塩
mp: 238-241℃
NMR(DMSO-d6,δ): 7.46-7.63(4H,m),7.81(1H,t,
J=8Hz),8.00(1H,d,J=4Hz),8.07(1H,s),8.26(1H,s),8.85
(1H,d,J=8Hz),9.14(1H,d,J=4Hz),9.69(1H,s)
(2) 4−(1H−ベンズイミダゾール−1−イル)−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリン
mp: 244.0℃
NMR(CDCl3,δ): 7.23(1H,d,J=8Hz),7.29-7.46(6H,
m),7.56(1H,d,J=5Hz),7.66(1H,t,J=7.5Hz),7.96(1H,d,
J=7.5Hz),8.19(1H,s),8.94(1H,d,J=5Hz),9.08(1H,d,
J=7.5Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(ジメチルア
ミノ)エチルアミノ]キノリン
mp: 171℃
NMR(CDCl3,δ): 2.29(6H,s),2.69(2H,t,J=7.5Hz),
3.23-3.34(2H,m),5.97(1H,m),6.40(1H,d,J=5Hz),7.24-
7.40(3H,m),7.47(1H,t,J=7.5Hz),7.54(1H,d,J=7.5Hz),
8.47(1H,d,J=5Hz),8.88(1H,d,J=7.5Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−(1−プロペニル)キノリン塩酸塩
(3−アリル−4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノ
リンとイミダゾールから)
mp: 220-229℃
NMR(DMSO-d6,δ): 1.88(3H,d,J=6Hz),6.07(1H,d,
J=15Hz),6.83(1H,m),7.06(1H,d,J=8Hz),7.45-7.60(3H,m),
7.73(1H,t,J=8Hz),7.95-8.05(2H,m),8.73(1H,d,J=8Hz),
9.27(1H,s),9.37(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(イミダゾール−1−イル)キノリン
mp: 219-220℃
NMR(CDCl3,δ): 1.17(3H,t,J=7Hz),4.23(2H,q,
J=7Hz),7.18(1H,s),7.25-7.50(5H,m),7.66(1H,s),7.71
(1H,t,J=8Hz),9.13(1H,d,J=8Hz),9.29(1H,s)
その塩酸塩
mp: 219-221℃(分解)
NMR(DMSO-d6,δ): 1.14(3H,t,J=7Hz),4.22(2H,q,
J=7Hz),7.32(1H,d,J=8Hz),7.45-7.65(3H,m),7.88(1H,t,
J=8Hz),8.00(1H,s),8.08(1H,s),8.92(1H,d,J=8Hz),9.41
(1H,s),9.45(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[(ピリジン−2−イルメチル)アミノ]キノリン二塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 1.31(3H,t,J=7Hz),4.34(2H,q,
J=7Hz),5.32(2H,br s),7.40-7.70(5H,m),7.75(1H,t,
J=8Hz),8.03(1H,t,J=8Hz),8.52(1H,d,J=8Hz),8.62(1H,d,
J=8Hz),8.70(1H,d,J=5Hz),8.85(1H,s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−モルホリノキノリン
mp: 186-187℃
NMR(CDCl3,δ): 1.44(3H,t,J=7Hz),3.37(4H,m),
3.97(4H,m),4.47(2H,q,J=7Hz),7.30-7.50(3H,m),7.61
(1H,t,J=8Hz),7.91(1H,d,J=8Hz),8.75(1H,s),8.98(1H,
d,J=8Hz)
その塩酸塩
mp: 178-181℃
NMR(DMSO-d6,δ): 1.37(3H,t,J=8Hz),3.28(4H,m),
3.87(4H,m),4.41(2H,q,J=7Hz),7.40-7.60(3H,m),7.70
(1H,t,J=8Hz),8.00(1H,d,J=8Hz),8.74(1H,d,J=8Hz),8.77
(1H,s)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(4−メチルピペラジン−1−イル)キノリン
mp: 177-178℃
NMR(CDCl3,δ): 1.41(3H,t,J=7Hz),2.43(3H,s),
2.69(4H,m),3.39(4H,m),4.44(2H,q,J=7Hz),7.30-7.50
(3H,m),7.59(1H,t,J=8Hz),7.89(1H,d,J=8Hz),8.71(1H,
s),8.95(1H,d,J=8Hz)
その塩酸塩
mp: 156-162℃
NMR(DMSO-d6,δ): 1.40(3H,t,J=7Hz),2.90(3H,s),
3.40-3.60(8H,m),4.43(2H,q,J=7Hz),7.40-7.60(3H,m),
7.74(1H,t,J=8Hz),7.97(1H,d,J=8Hz),8.78(1H,d,J=8Hz),
8.83(1H,s)
(9) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミ
ダゾール−1−イル)キノリン
mp: 220-221℃
NMR(DMSO-d6,δ): 7.06(1H,d,J=8Hz),7.30(1H,s),
7.45-7.60(3H,m),7.77(1H,t,J=8Hz),8.02(1H,s),8.79
(1H,d,J=8Hz),9.20(1H,s)
その塩酸塩
mp: 234-236℃
NMR(DMSO-d6,δ): 7.22(1H,d,J=8Hz),7.45-7.60(3H,
m),7.81(1H,t,J=8Hz),7.95(1H,s),8.02(1H,s),8.83(1H,
d,J=8Hz),9.25(1H,s),9.28(1H,s)
(10) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(4
−メチルピペラジン−1−イル)キノリン
mp: 152-153℃
NMR(CDCl3,δ): 2.43(3H,s),2.67(4H,m),3.50(4H,
m),7.30-7.50(3H,m),7.59(1H,t,J=8Hz),7.93(1H,d,
J=8Hz),8.67(1H,s),8.92(1H,d,J=8Hz)
その二塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 2.91(3H,s),3.35-4.40(8H,
br m),7.45-7.60(3H,m),7.74(1H,t,J=8Hz),8.03(1H,m),
8.73(1H,d,J=8Hz),8.87(1H,s)実施例10
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(130m
g)と2−メトキシエチルアミン(210mg)のジメチルホルムアミド(1.
5ml)中の混合物を100℃で5時間加熱した。混合物を真空中で濃縮し、残
留物を分取薄層クロマトグラフィーで精製して、8−(2,6−ジクロロベンゾ
イルアミノ)−4−ジメチルアミノキノリン(94mg)を得た。
mp: 215-216℃
NMR(CDCl3,δ): 3.06(6H,s),6.77(1H,d,J=5Hz),
7.26-7.52(3H,m),7.50(1H,t,J=7.5Hz),7.79(1H,d,
J=7.5Hz),8.48(1H,d,J=5Hz),8.89(1H,d,J=7.5Hz)実施例11
8−(2,6−ジクロロベンゾイルアミノ)−4−フェノキシキノリンを、製
造例2−(2)と同様にして、4−クロロ−8−(2,6−ジクロロベンゾイル
アミノ)キノリンとナトリウムフェノキシドとを反応させて得た。
mp: 170.4℃
NMR(CDCl3,δ): 6.60(1H,d,J=5Hz),7.14-7.53(8H,
m),7.65(1H,t,J=7.5Hz),8.11(1H,d,J=7.5Hz),8.51(1H,d,
J=5Hz),9.01(1H,d,J=7.5Hz)実施例12
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリン(1
08mg)、N−ブロモスクシンイミド(69.6mg)と2,2’−アゾビス
(2,4−ジメチル−4−メトキシバレロニトリル)(10.1mg)のジクロ
ロメタンと四塩化炭素中の混合物を2時間還流した。冷却後、混合物を酢酸エチ
ルで希釈し、水、飽和重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウ
ムで乾燥後、真空中で溶媒を留去して、3−ブロモメチル−8−(2,6−ジク
ロロベンゾイルアミノ)キノリンを含む残留物を得た。残留物をジメチルホルム
アミドに溶解し、それに酢酸(27.5mg)と炭酸カリウム(63.2mg)
を加えた。室温で3時間攪拌後、混合物を水に注ぎ、酢酸エチルで抽出した。有
機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。
残留物をシリカゲルカラムクロマトグラフィー(酢酸エチル−ジクロロメタン)
で精製して、3−アセトキシメチル−8−(2,6−ジクロロベンゾイルアミノ
)キノリン(48.4mg)を得た。
mp: 199-201℃
NMR(CDCl3,δ): 2.12(3H,s),5.30(2H,s),7.30-7.50
(3H,m),7.50-7.70(2H,m),8.19(1H,s),8.78(1H,s),8.98
(1H,d,J=8Hz)
(2) 3−アセトキシメチル−8−(2,6−ジクロロベンゾイルアミノ)キ
ノリン(25.9mg)と1N水酸化ナトリウム溶液(0.24ml)のジオキ
サン中の溶液とジメチルホルムアミド(4滴)の混合物を室温で2時間攪拌した
。
混合物を水に注ぎ、酢酸エチルで抽出した。有機層を食塩水で洗浄し、硫酸マグ
ネシウムで乾燥後、真空中で溶媒を留去した。残留物を酢酸エチル−n−ヘキサ
ンから再結晶して、8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキ
シメチルキノリン(20mg)を得た。
mp: 224-226℃
NMR(CDCl3,δ): 1.92(1H,t,J=7Hz),4.95(1H,d,
J=7Hz),7.30-7.50(3H,m),7.50-7.70(2H,m),8.18(1H,s),
8.79(1H,s),8.96(1H,d,J=8Hz)
その塩酸塩
mp: 217℃
NMR(DMSO-d6,δ): 4.75(2H,s),7.49-7.61(3H,m),
7.65(1H,t,J=8Hz),7.78(1H,d,J=8Hz),8.31(1H,s),8.68
(1H,d,J=8Hz),8.85(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチルキ
ノリン(300mg)のテトラヒドロフラン中の溶液に、四臭化炭素(573m
g)とトリフェニルホスフィン(453mg)を加え、混合物を室温で30分間
攪拌した。不溶物を濾去し、真空中で濾液から溶媒を留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ジクロロメタン)で精製して、3−ブロモメチ
ル−8−(2,6−ジクロロベンゾイルアミノ)キノリン(253.4mg)を
得た。
mp: 223-224℃
NMR(CDCl3,δ): 4.66(2H,s),7.30-7.50(3H,m),7.59
(1H,d,J=8Hz),7.66(1H,t,J=8Hz),8.18(1H,s),8.81(1H,
s),8.98(1H,d,J=8Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチルキノ
リンを、製造例2−(2)と同様にして、3−ブロモメチル−8−(2,6−ジ
クロロベンゾイルアミノ)キノリンとナトリウムメトキシドとを反応させて得た
。
mp: 163℃
NMR(CDCl3,δ): 3.47(3H,s),4.67(2H,s),7.30-7.50
(3H,m),7.50-7.70(2H,m),8.15(1H,s),8.76(1H,s),8.96
(1H,d,J=8Hz)
その塩酸塩
mp: 159-166℃
NMR(DMSO-d6,δ): 3.37(3H,s),4.67(2H,s),7.40-
7.60(3H,m),7.67(1H,t,J=8Hz),7.79(1H,d,J=8Hz),8.36
(1H,s),8.70(1H,d,J=8Hz),8.85(1H,s)
(5) 3−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ン(120mg)とフェノール(30.3mg)のジメチルホルムアミド中の溶
液に、カリウム第三級ブトキシド(72.2mg)を加え、混合物を室温で1時
間攪拌した。混合物を飽和塩化アンモニウム溶液に注ぎ、酢酸エチルで抽出した
。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去し
た。残留物をシリカゲルカラムクロマトグラフィー(酢酸エチル−n−ヘキサン
)で精製して、8−(2,6−ジクロロベンゾイルアミノ)−3−フェノキシメ
チルキノリン(87.1mg)を得た。
mp: 157℃
NMR(CDCl3,δ): 5.28(2H,s),6.90-7.10(3H,m),
7.25-7.50(5H,m),7.55-7.70(2H,m),8.26(1H,s),8.86(1H,
s),9.98(1H,d,J=8Hz)
その塩酸塩
mp: 164-171℃
NMR(DMSO-d6,δ): 4.59(2H,s),6.18(1H,t,J=8Hz),
6.20-6.30(2H,m),6.45-6.55(2H,m),6.60-6.80(3H,m),7.00
(1H,t,J=8Hz),7.14(1H,d,J=8Hz),7.90(1H,d,J=8Hz),8.29
(1H,s)実施例13
8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチルキノリン
(100mg)と塩化チオニル(1ml)のジクロロメタン(1ml)中の混合
物を室温で2時間攪拌した。濃縮後、残留物をN,N−ジメチルホルムアミド
(1ml)に溶解し、溶液に2−メルカプトイミダゾール(32mg)と炭酸カ
リウム(60mg)を加えた。混合物を室温で3時間攪拌した。生じた混合物を
冷水に注ぎ、酢酸エチルで抽出した。有機層を飽和重炭酸ナトリウム水溶液と食
塩水で洗浄し、無水硫酸ナトリウムで乾燥後、真空中で溶媒を留去した。残留物
を、ジクロロメタン:メタノール(20:1)を溶離溶媒として用いるシリカゲ
ルカラムクロマトグラフィーで精製して油状物を得た。得られた油状物を10%
メタノール性塩化水素で処理し、真空中で溶媒を留去した。生じた油状物を酢酸
エチルから結晶化して、8−(2,6−ジクロロベンゾイルアミノ)−3−[(
イミダゾール−2−イル)チオメチル]キノリン塩酸塩(102mg)を得た。
mp: >250℃
NMR(CDCl3,δ): 4.79(2H,s),7.48-7.61(3H,m),
7.63-7.72(4H,m),8.20(1H,s),8.71(1H,dd,J=15,8Hz),
8.83(1H,s)実施例14
8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリン(250m
g)、N−ブロモスクシンイミド(175mg)と2,2’−アゾビス(2,4
−ジメチル−4−メトキシバレロニトリル)(23.3mg)のジクロロメタン
中の混合物を2時間還流した。冷却後、混合物を酢酸エチルで希釈し、水、飽和
重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で
溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィー(ジクロロメタ
ン)で精製して、5−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−3
−メチルキノリン(54.2mg)を得た。
mp: 238-239℃
NMR(CDCl3,δ): 2.49(3H,s),7.30-7.50(3H,m),7.85
(1H,d,J=8Hz),8.31(1H,s),8.64(1H,s),8.78(1H,d,
J=8Hz)実施例15
8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリン(104m
g)、N−ブロモスクシンイミド(67.1mg)と2,2’−アゾビス(2,
4−ジメチル−4−メトキシバレロニトリル)(20.1mg)の四塩化炭素(
3ml)中の混合物を2時間還流した。冷却後、混合物を水、飽和重炭酸ナトリ
ウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去し
て、3−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)キノリンを
含む残留物を得た。残留物を塩化エチレンに溶解し、それにイミダゾール(64
.1mg)を加えた。60℃で2.5時間攪拌後、混合物を水と食塩水で洗浄し
、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(酢酸エチル−ジクロロメタン)で精製して、8−(2
,6−ジクロロベンゾイルアミノ)−3−(イミダゾール−1−イルメチル)キ
ノリン(36.2mg)を得た。
mp: 177-179℃
NMR(CDCl3,δ): 5.34(2H,s),6.94(1H,s),8.98(1H,
d,J=8Hz),7.15(1H,s),7.30-7.50(3H,m),7.55(1H,d,
J=8Hz),7.6-7.7(2H,m),7.90(1H,s),8.63(1H,s)実施例16
3−アセチル−8−(2,6−ジクロロベンゾイルアミノ)−4−メトキシキ
ノリン(115mg)のテトラヒドロフラン中の溶液に、水素化ホウ素ナトリウ
ム(16.8mg)を0℃で加え、混合物を同温で30分間攪拌した。混合物を
水に注ぎ、酢酸エチルで抽出した。有機層を食塩水で洗浄し、硫酸マグネシウム
で乾燥後、真空中で溶媒を留去して、8−(2,6−ジクロロベンゾイルアミノ
)−3−(1−ヒドロキシエチル)−4−メトキシキノリン(85.1mg)を
得た。
得られた化合物(75mg)の酢酸エチル中の溶液に、塩化水素の酢酸エチル
中の4N溶液(0.25ml)を加え、溶媒を真空中で除去して、8−(2,6
−ジクロロベンゾイルアミノ)−3−(1−ヒドロキシエチル)−4−メトキシ
キノリン塩酸塩(70mg)を得た。
mp: >210℃(分解)
NMR(CDCl3,δ): 1.61(3H,br s),4.32(3H,s),5.54
(1H,br s),7.30-7.50(4H,m),8.07(1H,d,J=8Hz),9.16(1H,
d,J=8Hz),9.43(1H,br s)実施例17
0.9M臭化メチルマグネシウムのテトラヒドロフラン溶液(1.8ml)に
、8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリ
ン(100mg)の無水テトラヒドロフラン(4ml)中の溶液を4℃で滴下し
、混合物を同温で30分間攪拌した。混合物に飽和塩化アンモニウム溶液を加え
、酢酸エチルで抽出した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後
、真空中で溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィー(酢
酸エチル−n−ヘキサン)で精製して、8−(2,6−ジクロロベンゾイルアミ
ノ)−3−(1−ヒドロキシ−1−メチルエチル)キノリン(55.1mg)を
得た。
mp: 187-189℃
NMR(CDCl3,δ): 1.70(6H,s),1.89(1H,s),7.30-7.50
(3H,m),7.50-7.70(2H,m),8.27(1H,s),8.90-9.00(2H,m)実施例18
8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリ
ン(300mg)と1N水酸化ナトリウム溶液(1.95ml)のテトラヒドロ
フラン(10ml)中の混合物を50℃で6時間攪拌した。混合物を真空中で濃
縮し、残留物に水を加えた。溶液をジエチルエーテルで洗浄し、水層を1N塩酸
でpH3に調整した。生じた沈殿物を濾過により集め、水で洗浄して、3−カル
ボキシ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(251.1mg
)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.40-7.60(3H,m),7.76(1H,t,
J=8Hz),8.00(1H,d,J=8Hz),8.81(1H,d,J=8Hz),9.02(1H,
s),9.29(1H,s)実施例19
3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(12
1mg)のジクロロメタン中の溶液に、塩化オキサリル(170mg)とジメチ
ルホルムアミド(1滴)を滴下し、混合物を室温で1時間攪拌した。混合物を真
空中で濃縮し、残留物を無水テトラヒドロフラン(3ml)に溶解した。溶液に
濃アンモニア溶液(5ml)を攪拌しながら加え、混合物を室温で1時間攪拌し
た。混合物を酢酸エチルで希釈し、食塩水で洗浄し、硫酸マグネシウムで乾燥後
、真空中で溶媒を留去した。残留物を酢酸エチル−n−ヘキサンから再結晶して
、3−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)キノリン(9
7.9mg)を得た。
mp: >250℃
NMR(DMSO6,δ): 7.40-7.60(3H,m),7.70-7.80(2H,
オーバーラップ),7.74(1H,t,J=8Hz),7.88(1H,d,J=8Hz),8.38
(1H,br s),8.80(1H,d,J=8Hz),8.91(1H,s),9.28(1H,s)実施例20
8−(2,6−ジクロロベンゾイルアミノ)−3−(モルホリノカルボニル)
キノリンを、実施例19と同様にして、3−カルボキシ−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリンとモルホリンから得た。
mp: 204-205℃
NMR(CDCl3,δ): 3.40-4.00(8H,m),7.30-7.50(3H,m),
7.65(1H,d,J=8Hz),7.70(1H,t,J=8Hz),8.27(1H,s),8.84
(1H,s),9.06(1H,d,J=8Hz)実施例21
8−(2,6−ジクロロベンゾイルアミノ)−4−エトキシ−3−エトキシカ
ルボニルキノリン(179mg)のテトラヒドロフラン中の溶液に、水素化ホウ
素リチウム(22.5mg)を加え、混合物を50℃で4時間攪拌した。混合物
に飽和塩化アンモニウム溶液を滴下し、酢酸エチルで抽出した。有機層を飽和重
炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶
媒を留去した。残留物をシリカゲルカラムクロマトグラフィー(酢酸エチル−n
−ヘキサン)で精製して、8−(2,6−ジクロロベンゾイルアミノ)−4−エ
トキシ−3−ヒドロキシメチルキノリン(55.9mg)を得た。
得られた化合物(50mg)の酢酸エチル中の溶液に、塩化水素の酢酸エチル
中の4N溶液(0.15ml)を加え、生じた沈殿物を濾過により集めて、8−
(2,6−ジクロロベンゾイルアミノ)−4−エトキシ−3−ヒドロキシメチル
キノリン塩酸塩(47mg)を得た。
mp: >250℃
NMR(CDCl3,δ): 1.63(3H,t,J=7Hz),4.77(2H,q,
J=7Hz),4.96(2H,s),7.30-7.50(3H,m),8.15(1H,d,J=8Hz),
9.09(1H,d,J=8Hz),9.14(1H,s)実施例22
(1) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−エ
トキシキノリンを、実施例18と同様にして、8−(2,6−ジクロロベンゾイ
ルアミノ)−4−エトキシ−3−エトキシカルボニルキノリンから得た。
mp: 207-208℃
NMR(CDCl3,δ): 1.60(3H,t,J=7Hz),4.46(2H,q,
J=7Hz),7.30-7.50(3H,m),7,70(1H,t,J=8Hz),7.96(1H,d,
J=8Hz),9.09(1H,d,J=8Hz),9.25(1H,s)
(2) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−エ
トキシキノリン(153mg)のジメチルホルムアミド中の溶液に、1−エチル
−3−(3−ジメチルアミノプロピル)カルボジイミド塩酸塩(109mg)と
1−ヒドロキシベンゾトリアゾール(76.5mg)を加え、混合物を室温で2
時間攪拌した。混合物に濃アンモニア溶液(0.2ml)を攪拌しながら加え、
混合物を室温で6時間攪拌した。混合物を水に注ぎ、酢酸エチルで抽出した。有
機層を飽和塩化アンモニウム溶液、飽和重炭酸ナトリウム溶液と食塩水で洗浄し
、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をエタノールか
ら結晶化して、3−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)
−4−エトキシキノリン(128.3mg)を得た。
mp: 242-245℃
NMR(DMSO-d6,δ): 1.44(3H,t,J=7Hz),4.38(2H,q,
J=7Hz),7.40-7.60(3H,m),7.69(1H,t,J=8Hz),7.85(1H,s),
8.00(1H,d,J=8Hz),8.10(1H,s),8.75(1H,d,J=8Hz),8.80
(1H,s)
(3) 3−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)−4−
エトキシキノリン(122mg)のジメチルホルムアミド中の溶液に、塩化チオ
ニル(53.9mg)を加え、混合物を室温で30分間攪拌した。混合物を飽和
重炭酸ナトリウム溶液に注ぎ、酢酸エチルで抽出した。有機層を食塩水で洗浄し
、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(酢酸エチル−n−ヘキサン)で精製して、3−シアノ
−8−(2,6−ジクロロベンゾイルアミノ)−4−エトキシキノリン(89.
9mg)を得た。
mp: 200-201℃
NMR(CDCl3,δ): 1.63(3H,t,J=7Hz),4.92(2H,q,
J=7Hz),7.30-7.45(3H,m),7.66(1H,t,J=8Hz),8.00(1H,d,
J=8Hz),8.66(1H,s),9.08(1H,d,J=8Hz),9.81(1H,s)
その塩酸塩
mp: 191-193℃
NMR(CDCl3-CD3OD,δ): 1.63(3H,t,J=7Hz),4.92(2H,
q,J=7Hz),7.30-7.50(3H,m),7.66(1H,t,J=8Hz),8.00(1H,
d,J=8Hz),8.66(1H,s),9.06(1H,d,J=8Hz)実施例23
8−(2,6−ジクロロベンゾイルアミノ)−4−ジメチルアミノ−3−ヒド
ロキシメチルキノリン塩酸塩を、実施例21と同様にして、8−(2,6−ジク
ロロベンゾイルアミノ)−3−エトキシカルボニル−4−ジメチルアミノキノリ
ンから得た。
mp: 124-156℃
NMR(CDCl3,δ): 3.46(6H,s),4.88(2H,s),7.30-7.50
(3H,m),7.66(1H,t,J=8Hz),7.87(1H,d,J=8Hz),8.80-8.90
(2H,m)実施例24
(1) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−ジ
メチルアミノキノリンを、実施例18と同様にして、8−(2,6−ジクロロベ
ンゾイルアミノ)−3−エトキシカルボニル−4−ジメチルアミノキノリンから
得た。
mp: 160-163℃
NMR(DMSO-d6,δ): 3.10(6H,s),7.40-7.60(4H,m),
7.98(1H,d,J=8Hz),8.72(1H,d,J=8Hz),8.76(1H,s)
(2) 3−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)−4−
ジメチルアミノキノリンを実施例22−(2)と同様にして得た。
mp: 222-223℃
NMR(DMSO-d6,δ): 3.06(6H,s),7.40-7.65(4H,m),
7.71(1H,br s),7.92(1H,d,J=8Hz),8.03(1H,br s),8.53
(1H,s),8.67(1H,d,J=8Hz)
(3) 3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−ジメチ
ルアミノキノリンを実施例22−(3)と同様にして得た。
mp: 227-228℃
NMR(DMSO-d6,δ):3.39(6H,s),7.40-7.70(4H,m),7.93
(1H,d,J=8Hz),8.64(1H,s),8.73(1H,d,J=8Hz)
その塩酸塩
mp: 219-223℃
NMR(DMSO-d6,δ): 3.40(6H,s),7.40-7.70(4H,m),
7.93(1H,d,J=8Hz),8.65(1H,s),8.73(1H,d,J=8Hz)実施例25
3−ブロモ−4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ン(120mg)のN−メチルピロリドン中の溶液に、2−メルカプトイミダゾ
ール(33.5mg)と炭酸カリウム(50.1mg)を加え、混合物を室温で
40分間、40℃で1時間、80℃で1時間、さらに90℃で1時間攪拌した。
混合物に水を加え、生じた沈殿物を濾過により集め、水とエタノールで洗浄して
、3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾー
ル
−2−イルチオ)キノリン(88.0mg)を得た。
mp: 249-251℃
NMR(DMSO-d6,δ): 6.93(1H,br s),7.18(1H,br s),
7.45-7.60(3H,m),7.70(1H,t,J=8Hz),8.07(1H,d,J=8Hz),
8.71(1H,d,J=8Hz),9.03(1H,s)
その塩酸塩
mp: 240-242℃
NMR(DMSO-d6,δ): 7.45-7.60(5H,m),7.80(1H,t,
J=8Hz),8.10(1H,d,J=8Hz),8.79(1H,d,J=8Hz),9.10(1H,s)実施例26
(1) 4−カルボキシメチル−3−ブロモ−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリンを、実施例18と同様にして、3−ブロモ−8−(2,6−
ジクロロベンゾイルアミノ)−4−(エトキシカルボニルメチル)キノリンから
得た。
mp: >250℃
NMR(CDCl3,δ): 4.33(2H,s),7.30-7.50(3H,m),7.69
(1H,t,J=8Hz),7.74(1H,d,J=8Hz),8.84(1H,s),8.99(1H,
d,J=8Hz)
(2) ジメチルホルムアミド(17.4mg)とジクロロメタンの混合物に、
塩化オキサリル(27.7mg)を加え、混合物を室温で30分間攪拌した。混
合物に3−ブロモ−4−カルボキシメチル−8−(2,6−ジクロロベンゾイル
アミノ)キノリン(90mg)を0℃で加え、混合物を同温で1時間攪拌した。
混合物に2−アミノメチルピリジン(107mg)を0℃で加え、混合物を室温
で30分間攪拌した。混合物をジクロロメタンと飽和塩化アンモニウム溶液との
間に分配した。有機層を飽和重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグ
ネシウムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマトグラフ
ィーで精製して、エタノールから再結晶して、3−ブロモ−8−(2,6−ジク
ロロベンゾイルアミノ)−4−[(ピリジン−2−イルメチル)カルバモイルメ
チル]キノリン(58.0mg)を得た。
mp: 197-199℃
NMR(DMSO-d6,δ): 4.34(2H,s),4.39(2H,d,J=7Hz),
7.27(1H,dd,J=5,8Hz),7.32(1H,d,J=8Hz),7.45-7.60(3H,
m),7.72(1H,t,J=8Hz),7.77(1H,t,J=8Hz),7.98(1H,d,
J=8Hz),8.51(1H,d,J=5Hz),8.73(1H,d,J=8Hz),8.85(1H,t,
J=7Hz),8.96(1H,s)
その塩酸塩
mp: 241-248℃
NMR(DMSO-d6,δ): 4.39(2H,s),4.56(2H,d,J=7Hz),
7.45-7.75(6H,m),7.98(1H,d,J=8Hz),8.24(1H,t,J=8Hz),
8.70(1H,d,J=5Hz),8.76(1H,d,J=8Hz),8.95(1H,s),9.06
(1H,t,J=7Hz)実施例27
(1) 4−カルボキシメトキシ−8−(2,6−ジクロロベンゾイルアミノ)
キノリンを、実施例18と同様にして、8−(2,6−ジクロロベンゾイルアミ
ノ)−4−(エトキシカルボニルメトキシ)キノリンから得た。
mp: 190-204℃
NMR(DMSO-d6,δ): 4.64(2H,s),6.87(1H,d,J=5Hz),
7.45-7.63(4H,m),7.95(1H,d,J=7.5Hz),8.63(1H,d,J=5Hz),
8.68(1H,d,J=7.5Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(ジメチルカルバモ
イルメトキシ)キノリンを、実施例22−(2)と同様にして、4−カルボキシ
メトキシ−8−(2,6−ジクロロベンゾイルアミノ)キノリンとジメチルアミ
ン塩酸塩から得た。
mp: 222-224.5℃
NMR(CDCl3,δ): 2.99(3H,s),3.14(3H,s),4.97(2H,
s),6.84(1H,d,J=4Hz),7.26-7.43(3H,m),7.57(1H,t,
J=7.5Hz),7.98(1H,d,J=7.5Hz),8.57(1H,d,J=4Hz),8.96
(1H,d,J=7.5Hz)
実施例28
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−2−イル
チオ)−3−アリルキノリンを、実施例25と同様にして、3−アリル−4−ク
ロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリンと2−メルカプトイ
ミダゾールとを反応させて得た。
mp: 206-208℃
NMR(DMSO-d6,δ): 3.91(2H,d,J=6Hz),5.00(1H,d,
J=17Hz),5.07(1H,d,J=11Hz),5.99(1H,m),7.02(2H,br s),
7.40-7.60(3H,m),7.67(1H,t,J=8Hz),8.20(1H,d,J=8Hz),
8.66(1H,d,J=8Hz),8.72(1H,s)
その二塩酸塩
mp: 138-170℃
NMR(DMSO-d6,δ): 3.90(2H,d,J=6Hz),4.94(1H,d,
J=16Hz),5.05(1H,d,J=11Hz),5.97(1H,m),7.45-7.60(3H,
m),7.74(1H,t,J=8Hz),8.00(1H,d,J=8Hz),8.74(1H,d,
J=8Hz),8.94(1H,s)実施例29
8−(2,6−ジクロロベンゾイルアミノ)−4−ビニルキノリン(150m
g)のジオキサンと水中の懸濁液に、第三級ブタノール中の触媒量の四酸化オス
ミウムを氷冷下で加え、混合物を5分間攪拌した。混合物に過ヨウ素酸ナトリウ
ム(206mg)を氷冷下で加え、混合物を同温で30分間、室温で6時間攪拌
した。混合物に飽和重炭酸ナトリウム溶液を加え、ジクロロメタンで抽出した。
有機層を硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をフラッ
シュクロマトグラフィー(ジクロロメタン−n−ヘキサン)で精製して、8−(
2,6−ジクロロベンゾイルアミノ)−4−ホルミルキノリン(85mg)を得
た。
mp: 239.3℃
NMR(CDCl3,δ): 7.29-7.46(3H,m),7.81(1H,t,
J=7.5Hz),7.86(1H,d,J=5Hz),8.70(1H,d,J=7.5Hz),9.03
(1H,d,J=5Hz),9.06(1H,d,J=7.5Hz),10.02(1H,br s),10.27
(1H,s)実施例30
8−(2,6−ジクロロベンゾイルアミノ)−4−ホルミルキノリン(100
mg)、N−(2−メトキシエチル)メチルアミン(28mg)と酢酸(17m
g)の攪拌懸濁液に、トリアセトキシ水素化ホウ素ナトリウム(91.6mg)
を室温で少しずつ5分間かけて加え、生じた混合物を同温で4時間攪拌した。粗
製生成物をジクロロメタンと飽和重炭酸ナトリウム水溶液とに分配した。有機層
を無水硫酸マグネシウムで乾燥後、濾過し、減圧下で溶媒を留去した。残留物を
分取薄層クロマトグラフィー(5%メタノール−ジクロロメタン)で精製して、
エタノールから再結晶して、8−(2,6−ジクロロベンゾイルアミノ)−4−
[N−(2−メトキシエチル)−N−メチルアミノメチル]キノリン(77mg
)を無色粉末として得た。
mp: 127.7-133.7℃
NMR(CDCl3,δ): 2.32(3H,s),2.72(2H,t,J=7.5Hz),
3.36(3H,s),3.58(2H,t,J=7.5Hz),3.99(2H,s),7.26-7.44
(3H,m),7.54(1H,d,J=5Hz),7.61(1H,t,J=7.5Hz),7.96(1H,
d,J=7.5Hz),8.70(1H,d,J=5Hz),8.95(1H,d,J=7.5Hz)実施例31
8−(2,6−ジクロロベンゾイルアミノ)−4−((E)−2−エトキシカ
ルボニルビニル)キノリンを、製造例19−(2)と同様にして、8−(2,6
−ジクロロベンゾイルアミノ)−4−ホルミルキノリンと(トリフェニルホスホ
ラニリデン)酢酸エチルとを反応させて得た。
mp: 157.4℃
NMR(CDCl3,δ): 1.39(3H,t,J=7.5Hz),4.34(2H,q,
J=7.5Hz),6.64(1H,d,J=18Hz),7.29-7.44(3H,m),7.59(1H,
d,J=4Hz),7.70(1H,t,J=7.5Hz),7.90(1H,d,J=7.5Hz),8.38
(1H,d,J=18Hz),8.77(1H,d,J=4Hz),9.01(1H,d,J=7.5Hz)実施例32
8−(2,6−ジクロロベンゾイルアミノ)−3−メチルチオキノリン(10
6mg)のジクロロメタンと水中の溶液に、m−クロロ過安息香酸(68mg)
を氷冷下で加え、混合物を1時間攪拌した。混合物を飽和重炭酸ナトリウム溶液
と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留
物を分取薄層クロマトグラフィー(ジクロロメタン−メタノール)で精製して、
8−(2,6−ジクロロベンゾイルアミノ)−3−メチルスルフィニルキノリン
(71mg)と8−(2,6−ジクロロベンゾイルアミノ)−3−メチルスルホ
ニルキノリン(68mg)を得た。
8−(2,6−ジクロロベンゾイルアミノ)−3−メチルスルフィニルキノリ
ン
mp: 229-231℃
NMR(CDCl3,δ): 2.89(3H,s),7.32-7.45(3H,m),
7.69-7.78(2H,m),8.60(1H,d,J=2Hz),8.87(1H,d,J=2Hz),
9.09(1H,d,J=8Hz)
8−(2,6−ジクロロベンゾイルアミノ)−3−メチルスルホニルキノリン
mp: 253-255℃
NMR(CDCl3,δ): 3.19(3H,s),7.35-7.48(3H,m),
7.74-7.86(2H,m),8.83(1H,s),9.16-9.22(2H,m)実施例33
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−ホルミルキノリンを
、実施例29と同様にして、8−(2,6−ジクロロベンゾイルアミノ)−3−
ビニルキノリンから得た。
mp: 232-233℃
NMR(CDCl3,δ): 7.32-7.46(3H,m),7.70-7.80(2H,m),
8.64(1H,s),9.14(1H,d,J=7.5Hz),9.24(1H,s),10.00(1H,
br s),10.28(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−ホルミルキノリン(
150mg)、ニトロメタン(1.5ml)と酢酸アンモニウム(30mg)の
ジオキサン(1ml)中の混合物を90℃で2時間攪拌した。真空中で混合物
から溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィー(ジクロロ
メタン−メタノール)で精製して、8−(2,6−ジクロロベンゾイルアミノ)
−3−(1−ヒドロキシ−2−ニトロエチル)キノリン(126mg)を得た。
mp: 190-191℃
NMR(CDCl3-CD3OD,δ): 4.62(1H,dd,J=4,14Hz),4.71
(1H,dd,J=8,14Hz),5.68(1H,dd,J=4,8Hz),7.32-7.46(3H,
m),7.60-7.70(2H,m),8.29(1H,s),8.82(1H,s),8.97(1H,
d,J=8Hz)実施例34
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−ホルミルキノリン(
700mg)とメチル=メチルスルフィニルメチル=スルフィド(302mg)
のテトラヒドロフラン中の混合物に、カリウム第三級ブトキシド(501mg)
を4℃で加え、混合物を同温で30分間攪拌し、1.5時間還流した。混合物を
冷たい飽和塩化アンモニウム溶液に注ぎ、酢酸エチルで抽出した。有機層を食塩
水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。ジクロロメ
タン中の得られた残留物(3ml)と34%塩化水素のエタノール溶液(5ml
)との混合物を室温で2時間攪拌した。混合物を真空中で濃縮し、残留物を酢酸
エチルと飽和重炭酸ナトリウム溶液との間に分配した。有機層を食塩水で洗浄し
、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(酢酸エチル−n−ヘキサン)で精製して、8−(2,
6−ジクロロベンゾイルアミノ)−3−(エトキシカルボニルメチル)キノリン
(329mg)を得た。
mp: 151℃
NMR(CDCl3,δ): 1.27(3H,t,J=7Hz),3.81(2H,s),
4.18(2H,q,J=7Hz),7.30-7.50(3H,m),7.56(1H,d,J=8Hz),
7.62(1H,t,J=8Hz),8.10(1H,s),8.70(1H,s),8.94(1H,d,
J=8Hz)
その塩酸塩
mp: 174-184℃
NMR(DMSO-d6,δ): 1.20(3H,t,J=7Hz),3.97(2H,s),
4.30(2H,オーバーラップ),7.40-7.60(3H,m),7.66(1H,t,J=8Hz),
7.75(1H,d,J=8Hz),8.31(1H,s),8.68(1H,d,J=8Hz),8.82
(1H,s)
(2) 3−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)キ
ノリンを実施例18と同様にして得た。
mp: >250℃
NMR(CDCl3,δ): 3.81(2H,s),7.30-7.50(3H,m),7.57
(1H,d,J=8Hz),7.62(1H,d,J=8Hz),8.11(1H,s),8.71(1H,
s),8.92(1H,d,J=8Hz)
(3) 3−カルバモイルメチル−8−(2,6−ジクロロベンゾイルアミノ)
キノリンを実施例22−(2)と同様にして得た。
mp: 251-253℃
NMR(DMSO-d6,δ): 3.66(2H,s),7.04(1H,br s),
7.40-7.70(5H,m),7.74(1H,d,J=8Hz),8.24(1H,s),8.67
(1H,d,J=8Hz),8.78(1H,s)
その塩酸塩
mp: 248-251℃
NMR(DMSO-d6,δ): 3.66(2H,s),7.05(1H,br s),
7.40-7.70(5H,m),7.74(1H,d,J=8Hz),8.25(1H,s),8.67
(1H,d,J=8Hz),8.79(1H,s)実施例35
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−(1−ヒドロキシエ
チル)キノリンを、実施例17と同様にして、8−(2,6−ジクロロベンゾイ
ルアミノ)−3−ホルミルキノリンと臭化メチルマグネシウムとを反応させて得
た。
mp: 215-217℃
NMR(CDCl3,δ): 1.62(3H,d,J=7Hz),2.03(1H,d,
J=5Hz),5.16(1H,m),7.30-7.50(3H,m),7.59(1H,d,J=8Hz),
7.62(1H,t,J=8Hz),8.17(1H,s),8.80(1H,s),8.93(1H,d,
J=8Hz)
その塩酸塩
mp: 200-204℃
NMR(DMSO-d6,δ): 1.46(3H,d,J=7Hz),5.01(1H,m),
7.40-7.70(4H,m),7.78(1H,d,J=8Hz),8.33(1H,s),8.67
(1H,(1,J=8Hz),8.90(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−(1−ヒドロキシエ
チル)キノリン(562mg)のジクロロメタン(20ml)中の溶液に、酸化
マンガン(IV)(2.71g)を加え、混合物を室温で一夜攪拌した。不溶物
を濾去し、濾液を真空中で濃縮した。残留物をエタノールから結晶化して、3−
アセチル−8−(2,6−ジクロロベンゾイルアミノ)キノリン(101mg)
を得た。
mp: 243-245℃
NMR(CDCl3,δ): 2.75(3H,s),7.30-7.50(3H,m),
7.60-7.80(2H,m),8.74(1H,s),9.10(1H,d,J=8Hz),9.30
(1H,s),9.98(1H,s)
(3) 3−アセチル−8−(2,6−ジクロロベンゾイルアミノ)キノリン(
399mg)、ヒドロキシルアミン塩酸塩(232mg)と重炭酸ナトリウム(
467mg)のエタノール中の混合物を5時間還流した。混合物を水に注ぎ、ジ
クロロメタンで抽出した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後
、真空中で溶媒を留去した。残留物をエタノールから結晶化して、8−(2,6
−ジクロロベンゾイルアミノ)−3−(1−ヒドロキシイミノエチル)キノリン
(313mg)を得た。
mp: 215-243℃
NMR(DMSO-d6,δ): 2.30(3H,m),7.45-7.60(3H,m),
7.69(1H,t,J=8Hz),7.84(1H,d,J=8Hz),8.59(1H,s),8.72
(1H,d,J=8Hz),9.26(1H,s),10.81(1H,s),11.66(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−3−(1−ヒドロキシイ
ミノエチル)キノリン(168mg)のピリジン中の溶液に、塩化ホスホリル(
516mg)を4℃で加え、混合物を同温で50分間攪拌した。混合物を氷に注
ぎ、ジクロロメタンで抽出した。有機層を飽和重炭酸ナトリウム溶液と食塩水で
洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をエタノ
ールと水から再結晶して、3−アセチルアミノ−8−(2,6−ジクロロベンゾ
イルアミノ)キノリン(19mg)を得た。
mp: 244-245℃
NMR(DMSO-d6,δ): 2.14(3H,s),7.40-7.65(4H,m),
7.71(1H,d,J=8Hz),8.59(1H,d,J=8Hz),8.73(1H,s),8.89
(1H,s),10.50(1H,s),10.71(1H,s)実施例36
8−(2,6−ジクロロベンゾイルアミノ)−3−(α−ヒドロキシベンジル
)キノリンを、実施例17と同様にして、8−(2,6−ジクロロベンゾイルア
ミノ)−3−ホルミルキノリンと臭化フェニルマグネシウムとを反応させて得た
。
mp: 218-220℃
NMR(DMSO-d6,δ): 6.02(1H,d,J=4Hz),6.28(1H,d,
J=4Hz),7.23(1H,t,J=7Hz),7.33(2H,t,J=7Hz),7.45(2H,d,
J=7Hz),7.50-7.60(3H,m),7.64(1H,t,J=8Hz),7.77(1H,d,
J=8Hz),8.37(1H,s),8.66(1H,d,J=8Hz),8.86(1H,s)
その塩酸塩
mp: 130-134℃
NMR(DMSO-d6,δ): 6.01(1H,s),7.23(1H,t,J=7Hz),
7.33(2H,t,J=7Hz),7.45(2H,d,J=7Hz),7.45-7.60(3H,m),
7.64(1H,t,J=8Hz),7.78(1H,d,J=8Hz),8.37(1H,s),8.66
(1H,d,J=8Hz),8.86(1H,s)実施例37
8−(2,6−ジクロロベンゾイルアミノ)−4−エトキシカルボニルメチル
キナゾリン(90mg)と1N水酸化ナトリウム溶液(1ml)のエタノール
(5ml)中の混合物を30分間還流した。混合物を水で希釈し、生じた沈殿物
を濾過により集めて、水で洗浄して、8−(2,6−ジクロロベンゾイルアミノ
)−4−メチルキナゾリン(70mg)を得た。
mp: 223-225℃
NMR(CDCl3,δ): 2.98(3H,s),7.30-7.45(3H,m),7.70
(1H,t,J=8Hz),7.84(1H,d,J=8Hz),9.09(1H,s),9.11(1H,
d,J=8Hz),9.80(1H,br s)実施例38
8−(2,6−ジクロロベンゾイルアミノ)−3−(ピリジン−2−イル)キ
ノリン塩酸塩を、製造例14と同様にして、3−ブロモ−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリンとトリ−n−ブチル(2−ピリジル)錫から得た
。
mp: 248-249℃
NMR(DMSO-d6,δ): 7.50-7.62(4H,m),7.74(1H,t,
J=8Hz),7.93(1H,d,J=8Hz),8.12(1H,t,J=8Hz),8.31(1H,d,
J=8Hz),8.78(1H,d,J=8Hz),8.82(1H,d,J=8Hz),9.13(1H,
s),9.59(1H,s)実施例39
3−(3−アミノフェニル)−8−(2,6−ジクロロベンゾイルアミノ)キ
ノリンを、製造例16−(1)と同様にして、3−ブロモ−8−(2,6−ジク
ロロベンゾイルアミノ)キノリンと3−アミノフェニルホウ酸から得た。
mp: 193-194℃
NMR(CDCl3,δ): 3.83(2H,br s),6.78(1H,dd,J=2,
8Hz),7.00(1H,d,J=2Hz),7.08(1H,d,J=8Hz),7.28-7.38(2H,
m),7.40-7.45(2H,m),7.62-7.66(2H,m),8.30(1H,d,J=2Hz),
8.95(1H,t,J=8Hz),9.00(1H,d,J=2Hz)実施例40
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−((E)−2−カル
ボキシビニル)キノリンを、実施例18と同様にして、8−(2,6−ジクロロ
ベンゾイルアミノ)−3−((E)−2−エトキシカルボニルビニル)キノリン
から得た。
mp: >250℃
NMR(CDCl3,δ): 6.89(1H,d,J=16Hz),7.45-7.60(3H,
m),7.70(1H,t,J=8Hz),7.78-7.85(2H,m),8.72(1H,d,
J=8Hz),8.77(1H,s),9.20(1H,s)
(2) 3−((E)−2−カルバモイルビニル)−8−(2,6−ジクロロベ
ンゾイルアミノ)キノリン塩酸塩を実施例19と同様にして得た。
mp: 210-225℃
NMR(DMSO-d6,δ): 6.91(1H,d,J=16Hz),7.26(1H,br
s),7.50-7.80(5H,m),7.83(1H,d,J=8Hz),8.62(1H,s),8.74
(1H,d,J=8Hz),9.11(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−[(E)−2−(ジ
メチルカルバモイル)ビニル]キノリンを実施例19と同様にして得た。
mp: 241-242℃
NMR(CDCl3,δ): 3.11(3H,s),3.22(3H,s),7.11(1H,
d,J=15Hz),7.30-7.50(3H,m),7.50-7.70(2H,m),7.82(1H,d,
J=15Hz),8.27(1H,s),8.94(1H,s),8.97(1H,d,J=8Hz)
その塩酸塩
mp: 241-243℃
NMR(CDCl3,δ): 3.12(3H,s),3.23(3H,s),7.14(1H,
d,J=15Hz),7.30-7.50(3H,m),7.60-7.80(2H,m),7.83(1H,d,
J=15Hz),8.35(1H,s),8.98(1H,s),9.02(1H,d,J=8Hz)実施例41
8−(2,6−ジクロロベンゾイルアミノ)−3−((E)−2−エトキシカ
ルボニルビニル)キノリン(40mg)と酸化白金(IV)(5mg)のジオキ
サン(1ml)中の混合物を水素雰囲気下で室温で3時間攪拌した。不溶物を濾
去し、濾液を真空中で濃縮した。残留物を分取薄層クロマトグラフィー(酢酸エ
チル−n−ヘキサン)で精製して、8−(2,6−ジクロロベンゾイルアミノ)
−3−(2−エトキシカルボニルエチル)キノリン(16mg)を得た。
mp: 110-111℃
NMR(CDCl3,δ): 1.22(3H,t,J=7Hz),2.73(2H,t,
J=7Hz),3.15(2H,t,J=7Hz),4.13(2H,q,J=7Hz),7.30-7.50
(3H,m),7.52(1H,d,J=8Hz),7.59(1H,t,J=8Hz),8.00(1H,
s),8.66(1H,s),8.91(1H,d,J=8Hz)実施例42
8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル−4−
ビニルキノリンを、製造例12−(2)と同様にして、4−クロロ−8−(2,
6−ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリンとトリ−n
−ブチル(ビニル)錫から得た。
mp: 155-156℃
NMR(CDCl3,δ): 1.42(3H,t,J=7Hz),4.43(2H,q,
J=7Hz),5.00(1H,d,J=15Hz),5.88(1H,d,J=11Hz),7.30-7.50
(4H,m),7.67(1H,t,J=8Hz),8.04(1H,d,J=8Hz),9.05(1H,
d,J=8Hz),9.17(1H,s)実施例43
下記の化合物を実施例18と同様にして得た。
(1) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−(
イミダゾール−1−イル)キノリン
mp: >250℃
NMR(DMSO-d6,δ): 7.13(1H,d,J=8Hz),7.22(1H,s),
7.50-7.70(4H,m),7.79(1H,t,J=8Hz),7.97(1H,s),8.86
(1H,d,J=8Hz),9.31(1H,s)
(2) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−モ
ルホリノキノリン
mp: 155-164℃
NMR(CDCl3,δ): 3.61(4H,m),4.07(4H,m),7.30-7.50
(3H,m),7.75(1H,t,J=8Hz),8.05(1H,d,J=8Hz),9.12(1H,
d,J=8Hz),9.53(1H,s)
(3) 3−カルボキシ−4−クロロ−8−(2,6−ジクロロベンゾイルアミ
ノ)キノリン
mp: 243-244℃
NMR(DMSO-d6,δ): 7.40-7.60(3H,m),7.90(1H,t,
J=8Hz),8.16(1H,d,J=8Hz),8.87(1H,d,J=8Hz),9.12(1H,s)実施例44
下記の化合物を実施例19または22−(2)と同様にして得た。
(1) 3−カルバモイル−8−(2,6−ジクロロベンソイルアミノ)−4−
(イミダゾール−1−イル)キノリン
mp: 232-233℃
NMR(CDCl3,δ): 5.34(1H,br s),5.67(1H,br s),
7.20-7.50(6H,m),7.73(1H,t,J=8Hz),7.79(1H,s),9.13
(1H,d,J=8Hz),9.23(1H,s)
(2) 3−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)−4−
モルホリノキノリン
mP:>250℃
NMR(DMSO-d6,δ): 3.45(4H,m),3.97(4H,m),5.95
(1H,br s),6.44(1H,br s),7.30-7.50(3H,m),7.61(1H,t,
J=8Hz),7.89(1H,d,J=8Hz),8.74(1H,s),8.95(1H,d,J=8Hz)
(3) 3−カルバモイル−4−クロロ−8−(2,6−ジクロロベンゾイルア
ミノ)キノリン
mp: >251℃
NMR(DMSO-d6,δ): 7.45-7.60(3H,m),7.87(1H,t,
J=8Hz),8.00(1H,s),8.07(1H,d,J=8Hz),8.21(1H,s),8.82
(1H,d,J=8Hz),8.84(1H,s)実施例45
3−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)−4−(4−
メチルピペラジン−1−イル)キノリンを、実施例18および22−(2)と同
様にして、8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニ
ル−4−(4−メチルピペラジン−1−イル)キノリンと濃アンモニア溶液から
得た。
mp: 195-198℃
NMR(CDCl3,δ): 2.34(3H,s),2.69(4H,m),3.50(4H,
m),5.93(1H,br s),6.74(1H,br s),7.30-7.50(3H,m),7.59
(1H,t,J=8Hz),7.91(1H,d,J=8Hz),8.82(1H,s),8.96(1H,
d,J=8Hz)実施例46
下記の化合物を実施例22−(3)と同様にして得た。
(1) 3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミ
ダゾール−1−イル)キノリン
mp: 211-212℃
NMR(CDCl3,δ): 7.30-7.50(5H,m),7.52(1H,d,
J=8Hz),7.82(1H,t,J=8Hz),7.89(1H,s),9.02(1H,s),9.23
(1H,d,J=8Hz),9.37(1H,s)
その塩酸塩
mp: 213-215℃
NMR(DMSO-d6,δ): 7.48(1H,d,J=8Hz),7.50-7.70(3H,
m),7.79(1H,s),7.92(1H,t,J=8Hz),8.06(1H,s),8.95(1H,
d,J=8Hz),9.04(1H,s),9.45(1H,s)
(2) 3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−モルホ
リノキノリン
mp: 236-237℃
NMR(CDCl3,δ): 3.76(4H,m),4.00(4H,m),7.30-7.50
(3H,m),7.62(1H,t,J=8Hz),7.73(1H,d,J=8Hz),8.62(1H,
s),9.04(1H,d,J=8Hz)
その塩酸塩
mp: 145-150℃
NMR(DMSO-d6,δ): 3.70(4H,m),3.90(4H,m),7.40-
7.60(3H,m),7.69(1H,t,J=8Hz),7.88(1H,d,J=8Hz),8.77
(1H,d,J=8Hz),8.78(1H,s)
(3) 3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−(4−
メチルピペラジン−1−イル)キノリン
mp: 196-200℃
NMR(DMSO-d6,δ): 2.30(3H,s),2.62(4H,m),3.69
(4H,m),7.40-7.60(3H,m),7.67(1H,t,J=8Hz),7.84(1H,,d,
J=8Hz),8.73(1H,s),8.76(1H,d,J=8Hz)
その二塩酸塩
mp: 211-220℃
NMR(DMSO-d6,δ): 2.90(3H,s),3.43(2H,m),3.60
(2H,m),3.80-4.20(4H,m),7.40-7.60(3H,m),7.73(1H,t,
J=8Hz),7.85(1H,d,J=8Hz),8.80(1H,d,J=8Hz),8.84(1H,s)
(4) 4−クロロ−3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)
キノリン
mp: 239-241℃
NMR(CDCl3,δ): 7.30-7.50(3H,m),7.86(1H,t,
J=8Hz),8.06(1H,d,J=8Hz),8.85(1H,s),9.20(1H,d,
J=8Hz),9.83(1H,br s)実施例47
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−(N−メトキシ−N
−メチルカルバモイル)−4−モルホリノキノリンを、実施例22−(2)と同
様にして、3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−
モルホリノキノリンとN−メトキシ−N−メチルアミン塩酸塩から得た。
mp: 236-237℃
NMR(CDCl3,δ): 3.31(4H,m),3.43(3H,s),3.47(3H,
s),3.94(4H,m),7.30-7.50(3H,m),7.59(1H,t,J=8Hz),7.82
(1H,d,J=8Hz),8.48(1H,s),8.95(1H,d,J=8Hz)
(2) 0.9M臭化メチルマグネシウムのテトラヒドロフラン溶液(1.3m
l)に、8−(2,6−ジクロロベンゾイルアミノ)−3−(N−メトキシ−N
−メチルカルバモイル)−4−モルホリノキノリン(107mg)の無水テトラ
ヒドロフラン(1ml)中の溶液を冷却しながら氷浴内で滴下した。混合物を同
温で1時間、室温で1時間、さらに50℃で2時間攪拌した。混合物を酢酸エチ
ルと飽和塩化アンモニウム水溶液との間に分配した。有機層を食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層シ
リカゲルクロマトグラフィーで精製した。得られた油状物をエタノールから結晶
化して、3−アセチル−8−(2,6−ジクロロベンゾイルアミノ)−4−モル
ホリノキノリン(19mg)を白色結晶として得た。
mp: 231-233℃
NMR(CDCl3,δ): 2.67(3H,s),3.28(4H,m),3.96(4H,
m),7.30-7.50(3H,m),7.61(1H,t,J=8Hz),7.89(1H,d,
J=8Hz),8.68(1H,s),8.97(1H,d,J=8Hz)実施例48
3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−[(ピリジン
−2−イルメチル)アミノ]キノリンを、実施例8と同様にして、4−クロロ−
8−(2,6−ジクロロベンゾイルアミノ)−3−シアノキノリンと2−アミノ
メチルピリジンとを反応させて得た。
mp: 247-249℃
NMR(DMSO-d6,δ): 5.17(2H,d,J=6Hz),7.29(1H,dd,
J=6,8Hz),7.35(1H,d,J=8Hz),7.45-7.60(3H,m),7.67(1H,
t,J=8Hz),7.78(1H,t,J=8Hz),8.20(1H,d,J=8Hz),8.45(1H,
s),8.53(1H,d,J=6Hz),8.77(1H,d,J=8Hz),8.92(1H,m)
その二塩酸塩
mp: 241-250℃
NMR(CDCl3,δ): 5.34(2H,d,J=6Hz),7.45-7.60(3H,
m),7.65-7.80(3H,m),8.24(1H,m),8.32(1H,d,J=8Hz),8.51
(1H,s),8.70-8.80(2H,m),9.13(1H,m)実施例49
(1) 4−[ビス(エトキシカルボニル)メチル]−3−シアノ−8−(2,
6−ジクロロベンゾイルアミノ)キノリンを、製造例7−(1)と同様にして、
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−シアノキノリン
とマロン酸ジエチルとを反応させて得た。
NMR(CDCl3,δ): 1.20-1.40(6H,m),4.20-4.40(4H,m),
5.61(1H,s),7.30-7.50(3H,m),7.78(1H,t,J=8Hz),7.88
(1H,d,J=8Hz),8.94(1H,s),9.15(1H,d,J=8Hz)
(2) 3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−(エト
キシカルボニルメチル)キノリンを製造例7−(2)と同様にして得た。
mp: 171-173℃
NMR(CDCl3,δ): 1.26(3H,t,J=7Hz),4.20(2H,q,
J=7Hz),4.37(2H,s),7.30-7.50(3H,m),7.79(2H,m),8.90
(1H,s),9.13(1H,m)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−シアノ−4−(エト
キシカルボニルメチル)キノリン(255mg)とジオキサン中の1N水酸化ナ
トリウム溶液の混合物を室温で20分間攪拌した。混合物を1N塩酸で中和し、
ジクロロメタンで抽出した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥
後、真空中で溶媒を留去して、4−カルボキシメチル−8−(2,6−ジクロロ
ベンゾイルアミノ)−3−シアノキノリンを含む残留物を得た。
ジメチルホルムアミド(49.9mg)とジクロロメタンの混合物に、塩化オ
キサリル(86.7mg)を加え、混合物を室温で30分間攪拌した。混合物に
上記で得られた残留物を0℃で加え、混合物を同温で20分間攪拌した。混合物
に2−アミノメチルピリジン(568mg)を0℃で加え、混合物を同温で40
分間攪拌した。混合物を酢酸エチルと飽和塩化アンモニウム溶液との間に分配し
た。有機層を飽和重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで
乾燥後、真空中で溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィ
ーで精製して、3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−
[(ピリジン−2−イルメチル)カルバモイルメチル]キノリンを得た。
得られた化合物のジクロロメタン中の溶液に、10%塩化水素のメタノール溶
液(1.2ml)を加え、混合物を真空中で濃縮して、3−シアノ−8−(2,
6−ジクロロベンゾイルアミノ)−4−[(ピリジン−2−イルメチル)カルバ
モイルメチル]キノリン塩酸塩(133.2mg)を得た。
mp: 240-245℃(分解)
NMR(DMSO-d6,δ): 4.45(2H,s),4.58(2H,d,J=6Hz),
7.40-7.60(3H,m),7.60-7.70(2H,m),7.84(1H,t,J=8Hz),
8.12(1H,d,J=8Hz),8.22(1H,t,J=8Hz),8.71(1H,d,J=5Hz),
9.15(1H,s),9.31(1H,t,J=6Hz)実施例50
3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−[(2−ヒド
ロキシエチル)カルバモイルメチル]キノリンを、実施例49−(3)と同様に
して、8−(2,6−ジクロロベンゾイルアミノ)−3−シアノ−4−エトキシ
カルボニルキノリンと2−ヒドロキシエチルアミンから得た。
mp: 234-236℃
NMR(DMSO-d6,δ): 3.16(2H,q,J=6Hz),3.44(2H,q,
J=6Hz),4.29(2H,s),4.75(1H,t,J=6Hz),7.40-7.60(3H,m),
7.83(1H,t,J=8Hz),8.03(1H,d,J=8Hz),8.49(1H,t,J=6Hz),
8.84(1H,d,J=8Hz),9.13(1H,s)実施例51
3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−メチルキノリ
ンを、実施例37と同様にして、8−(2,6−ジクロロベンゾイルアミノ)−
3−シアノ−4−(エトキシカルボニルメチル)キノリンから得た。
mp: 236-237℃
NMR(CDCl3,δ): 2.98(3H,s),7.30-7.50(3H,m),7.77
(1H,t,J=8Hz),7.85(1H,d,J=8Hz),8.83(1H,s),9.13(1H,
d,J=8Hz)実施例52
8−(2,6−ジクロロベンゾイルアミノ)−3−シアノ−4−メチルキノリ
ン(139mg)、N−ブロモスクシンイミド(312mg)と2,2’−アゾ
ビス(イソブチロニトリル)(38.8mg)の塩化エチレン(1ml)と四塩
化炭素(4ml)中の混合物を7時間還流した。冷却後、混合物を水とジクロロ
メタンとの間に分配し、有機層を飽和チオ硫酸ナトリウム溶液と食塩水で洗浄し
、硫酸マグネシウムで乾燥後、真空中で溶媒を留去して、4−ブロモメチル−8
−(2,6−ジクロロベンゾイルアミノ)−3−シアノキノリンを含む残留物を
得た。
残留物を塩化エチレンに溶解し、それにイミダゾール(79.7mg)を加え
た。65℃で30分間攪拌後、混合物を水とジクロロメタンとの間に分配した。
有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した
。残留物を分取薄層クロマトグラフィー(メタノール−ジクロロメタン)で精製
して、3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダ
ゾール−1−イルメチル)キノリンを得た。
得られた化合物のジクロロメタン中の溶液に、10%塩化水素のメタノール溶
液(0.5ml)を加え、混合物を真空中で濃縮して、3−シアノ−8−(2,
6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イルメチル)キノ
リン塩酸塩(59.8mg)を得た。
mp: >250℃
NMR(CDCl3,δ): 6.20(2H,s),7.40-7.60(3H,m),7.70
(1H,s),7.75(1H,s),7.90(1H,t,J=8Hz),8.13(1H,d,
J=8Hz),8.90(1H,d,J=8Hz),9.19(1H,s),9.27(1H,s)実施例53
(1) 4−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
シアノキノリン(238mg)と酢酸ナトリウム(94mg)のジメチルホルム
アミド(1ml)中の混合物を室温で一夜攪拌した。残留物に水を加え、酢酸エ
チルで抽出した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中
で溶媒を留去した。残留物を分取薄層クロマトグラフィー(n−ヘキサン−ジク
ロロメタン)で精製して、4−アセトキシメチル−3−シアノ−8−(2,6−
ジクロロベンゾイルアミノ)キノリン(54mg)を得た。
mp: 201-203℃
NMR(CDCl3,δ): 2.15(3H,s),5.75(2H,s),7.33-7.47
(3H,m),7.81(1H,t,J=7.5Hz),7.89(1H,d,J=7.5Hz),8.91
(1H,s),9.16(1H,d,J=7.5Hz)
(2) 3−シアノ−8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドロ
キシメチルキノリンを実施例12−(2)と同様にして得た。
mp: 249-250℃
NMR(DMSO-d6,δ): 5.81(2H,s),7.48-7.60(3H,m),
7.78-7.86(2H,m),8.88(1H,dd,J=7および4Hz),9.24(1H,br
s),11.00(1H,s)実施例54
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカル
ボニルキノリン(251mg)のN−メチルピロリドン(2ml)中の溶液に、
2−メルカプトイミダゾール(89mg)を加え、混合物を65℃で1時間攪拌
した。混合物を水に注ぎ、酢酸エチルで抽出した。有機層を飽和塩化アンモニウ
ム溶液、飽和重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥
後、真空中で溶媒を留去した。残留物をエタノールから結晶化して、4−(2,
6−ジクロロベンゾイルアミノ)−7H−イミダゾ[2’,1’:2,3][1
,3]チアジノ[5,6−c]キノリン−7−オン(248.2mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.45-7.65(4H,m),7.93(1H,t,
J=8Hz),8.15(1H,d,J=8Hz),8.30(1H,s),8.95(1H,d,
J=8Hz),9.57(1H,s),11.14(1H,s)実施例55
(1) 4−[ビス(エトキシカルボニル)メチル]−8−(2,6−ジクロロ
ベンゾイルアミノ)−3−エトキシカルボニルキノリンを、製造例7−(1)と
同様にして、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エ
トキシカルボニルキノリンとマロン酸ジエチルとを反応させて得た。
mp: 139.5℃
NMR(CDCl3,δ): 1.20(6H,t,J=7.5Hz),1.41(3H,t,
J=7.5Hz),4.11-4.30(4H,m),4.44(2H,q,J=7.5Hz),6.31(1H,
s),7.29-7.45(3H,m),7.67(1H,t,J=7.5Hz),7.85(1H,d,
J=7.5Hz),9.03(1H,d,J=7.5Hz),9.25(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(エトキシカルボニルメチル)キノリンを製造例7−(2)と同様にして
得た。
mp: 158.7℃
NMR(CDCl3,δ): 1.25(3H,t,J=7.5Hz),1.42(3H,t,
J=7.5Hz),4.17(2H,q,J=7.5Hz),4.45(2H,q,J=7.5Hz),4.63
(2H,s),7.30-7.45(3H,m),7.70(1H,t,J=7.5Hz),7.84(1H,
d,J=7.5Hz),9.05(1H,d,J=7.5Hz),9.26(1H,s)実施例56
(1) 4−[ビス(第三級ブトキシカルボニル)メチル]−8−(2,6−ジ
クロロベンゾイルアミノ)−3−エトキシカルボニルキノリンを、製造例7−(
1)と同様にして、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−
3−エトキシカルボニルキノリンとマロン酸ジ第三級ブチルとを反応させて得た
。
mp: 154℃
NMR(CDCl3,δ): 1.43(18H,s),1.44(3H,t,J=7.5Hz),
4.46(2H,q,J=7.5Hz),6.10(1H,s),7.30-7.44(3H,m),7.65
(1H,t,J=7.5Hz),7.94(1H,d,J=7.5Hz),9.00(1H,d,
J=7.5Hz),9.20(1H,s)
(2) 4−[ビス(第三級ブトキシカルボニル)メチル]−8−(2,6−ジ
クロロベンゾイルアミノ)−3−エトキシカルボニルキノリン(5.8g)のジ
クロロメタン(15ml)中の溶液に、トリフルオロ酢酸(45ml)を氷冷下
で滴下し、混合物を室温で1時間攪拌した。混合物を真空中で濃縮し、残留物を
ジエチルエーテルで粉砕して、4−カルボキシメチル−8−(2,6−ジクロロ
ベンゾイルアミノ)−3−エトキシカルボニルキノリン(4.08g)を得た。
mp: 149-159℃
NMR(CDCl3,δ): 1.44(3H,t,J=7.5Hz),4.47(2H,q,
J=7.5Hz),5.60(2H,s),7.27-7.46(3H,m),7.75(1H,t,
J=7.5Hz),7.95(1H,d,J=7.5Hz),9.07(1H,d,J=7.5Hz),9.25
(1H,s)実施例57
下記の化合物を実施例26−(2)と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[(ピリジン−2−イルメチル)カルバモイルメチル]キノリン塩酸塩
mp: 217-220℃
NMR(DMSO-d6,δ): 1.33(3H,t,J=7Hz),4.37(2H,q,
J=7Hz),4.54(2H,d,J=6Hz),4.62(2H,s),7.45-7.60(3H,m),
7.60-7.70(2H,m),7.78(1H,t,J=8Hz),8.12(1H,d,J=8Hz),
8.23(1H,m),8.70(1H,m),8.80(1H,d,J=8Hz),8.93(1H,m),
9.17(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[(2−ヒドロキシエチル)カルバモイルメチル]キノリン
mp: 131-136℃
NMR(CDCl3,δ): 1.46(3H,t,J=7Hz),2.39(1H,t,
J=6Hz),3.35(2H,m),3.67(2H,m),4.38(2H,s),4.50(2H,q,
J=7Hz),7.30-7.50(3H,m),7.77(1H,t,J=8Hz),8.32(1H,d,
J=8Hz),9.08(1H,d,J=8Hz),9.18(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(ジメチルカルバモイルメチル)キノリン
mp: 185-186℃
NMR(CDCl3,δ): 1.42(3H,t,J=7Hz),3.03(3H,s),
3.30(3H,s),4.41(2H,q,J=7Hz),4.67(2H,s),7.30-7.50
(3H,m),7.68(1H,t,J=8Hz),7.79(1H,d,J=8Hz),9.03(1H,
d,J=8Hz),9.29(1H,s)
(4) 4−カルバモイルメチル−8−(2,6−ジクロロベンゾイルアミノ)
−3−エトキシカルボニルキノリン
mp: 226-228℃
NMR(CDCl3,δ): 1.47(3H,t,J=7Hz),4.38(2H,s),
4.50(2H,q,J=7Hz),5.31(1H,br s),6.95(1H,br s),7.30-
7.50(3H,m),7.78(1H,t,J=8Hz),8.30(1H,d,J=8Hz),9.07
(1H,d,J=8Hz),9.19(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(モルホリノカルボニルメチル)キノリン
mp: 168.5℃
NMR(CDCl3,δ): 1.40(3H,t,J=7.5Hz),3.57-3.90(8H,
m),4.40(2H,q,J=7.5Hz),4.65(2H,s),7.28-7.44(3H,m),
7.68(1H,t,J=7.5Hz),7.78(1H,d,J=7.5Hz),9.02(1H,d,
J=7.5Hz),9.29(1H,s)
その塩酸塩
mp: 175℃
NMR(DMSO-d6,δ): 1.33(3H,t,J=7.5Hz),3.40-3.49
(2H,m),3.55-3.64(2H,m),3.67-3.80(4H,m),4.35(2H,q,
J=7.5Hz),4.65(2H,s),7.48-7.62(3H,m),7.76(1H,t,
J=7.5Hz),8.04(1H,d,J=7.5Hz),8.79(1H,d,J=7.5Hz),9.19
(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[N−(2−メトキシエチル)−N−メチルカルバモイルメチル]キノリ
ン
mp: 163℃
NMR(CDCl3,δ): 1.32-1.45(3H,m),3.00(1.5H,s),
3.34(1.5H,s),3.35(1.5H,s),3.47-3.53(2H,m),3.51(1.5H,
s),4.33-4.47(2H,m),4.65(1H,s),4.84(1H,s),7.27-7.44
(3H,m),7.60-7.70(1H,m),7.77(0.5H,d,J=7.5Hz),7.89
(0.5H,d,J=7.5Hz),8.94-9.05(1H,m),9.26(0.5H,s),9.27
(0.5H,s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[(3−トリフルオロメチルフェニル)カルバモイルメチル]キノリン
mp: 218-222℃
NMR(CDCl3,δ): 1.50(3H,t,J=7.5Hz),4.46(2H,s),
4.59(2H,q,J=7.5Hz),7.25-7.44(5H,m),7.70(1H,br d,
J=9Hz),7.74(1H,br s),7.82(1H,t,J=7.5Hz),8.48(1H,d,
J=7.5Hz),9.09(1H,d,J=7.5Hz),9.20(1H,s),9.97(1H,br s)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[(4−メチルピペラジン−1−イル)カルボニルメチル]キノリン
mp: 232℃
NMR(CDCl3,δ): 1.40(3H,t,J=7.5Hz),2.36(3H,s),
2.38-2.47(2H,m),2.50-2.62(2H,m),3.60-3.69(2H,m),3.70-
3.80(2H,m),4.38(2H,q,J=7.5Hz),4.65(2H,s),7.28-7.43
(3H,m),7.67(1H,t,J=7.5Hz),7.76(1H,d,J=7.5Hz),9.01
(1H,d,J=7.5Hz),9.26(1H,s)実施例58
(1) 4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−エトキシカルボニルキノリン(2.5g)の1,2−ジクロロエタン(60
ml)中の懸濁液を14時間還流した。溶媒を減圧下で除去し、残留固形物を熱
エタノール(45ml)で処理して、8−(2,6−ジクロロベンゾイルアミノ
)−3−エトキシカルボニル−4−メチルキノリン(2.08g)を無色プリズ
ムとして得た。
mp: 159-162℃
NMR(CDCl3,δ): 1.42(3H,t,J=7.5Hz),3.00(3H,s),
4.45(2H,q,J=7.5Hz),7.28-7.45(3H,m),7.69(1H,t,
J=7.5Hz),7.92(1H,d,J=7.5Hz),9.02(1H,d,J=7.5Hz),9.10
(1H,s)
その塩酸塩
mp: 171℃
NMR(DMSO-d6,δ): 1.36(3H,t,J=7.5Hz),2.94(3H,
s),4.40(2H,q,J=7.5Hz),7.46-7.61(3H,m),7.78(1H,t,
J=7.5Hz),8.09(1H,d,J=7.5Hz),8.80(1H,d,J=7.5Hz),9.07
(1H,s)
(2) 4−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
エトキシカルボニルキノリンを実施例52の第一工程と同様にして得た。
mp: 199℃
NMR(CDCl3,δ): 1.47(3H,t,J=7.5Hz),4.40(2H,q,
J=7.5Hz),5.37(2H,s),7.27-7.46(3H,m),7.79(1H,t,
J=7.5Hz),8.00(1H,d,J=7.5Hz),9.06(1H,d,J=7.5Hz),9.23
(1H,s)実施例59
4−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキ
シカルボニルキノリン(150mg)とイミダゾール(106mg)のジメトキ
シエタン中の混合物を70℃で1時間攪拌した。真空中で混合物から溶媒を留去
し、残留物を分取薄層クロマトグラフィー(メタノール−ジクロロメタン)で精
製して、8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(イミダゾール−1−イルメチル)キノリン(110mg)を得た。
NMR(CDCl3,δ): 1.41(3H,t,J=7.5Hz),4.47(2H,q,
J=7.5Hz),6.00(2H,s),6.90(1H,s),6.99(1H,s),7.30-7.47
(3H,m),7.60(1H,s),7.76(1H,t,J=7.5Hz),7.94(1H,d,
J=7.5Hz),9.08(1H,d,J=7.5Hz),9.28(1H,s)
その二塩酸塩
mp: 240-245℃
NMR(DMSO-d6,δ): 1.30(3H,t,J=7.5Hz),4.40(2H,q,
J=7.5Hz),6.18(2H,s),7.46-7.61(3H,m),7.65(1H,d,
J=2Hz),7.72(1H,d,J=2Hz),7.84(1H,t,J=7.5Hz),8.14(1H,
d,J=7.5Hz),8.84(1H,d,J=7.5Hz),9.07(1H,br s),9.30(1H,
s)実施例60
下記の化合物を実施例59と同様にして得た。
(1) 4−(1H−ベンズイミダゾール−1−イルメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリン
mp: 202℃
NMR(CDCl3,δ): 1.30(3H,t,J=7.5Hz),4.38(2H,q,
J=7.5Hz),6.10(2H,s),7.21-7.51(6H,m),7.63(1H,s),7.70
(1H,t,J=7.5Hz),7.75-7.86(2H,m),9.07(1H,d,J=7.5Hz),
9.27(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[N−(2−メトキシエチル)−N−メチルアミノメチル]キノリン
NMR(CDCl3,δ): 1.42(3H,t,J=7.5Hz),2.24(3H,s),
2.67(2H,t,J=6Hz),3.31(3H,s),3.50(2H,t,J=6Hz),4.26
(2H,s),4.43(2H,q,J=7.5Hz),7.28-7.43(3H,m),7.66(1H,
t,J=7.5Hz),8.16(1H,d,J=7.5Hz),8.91(1H,s),9.00(1H,d,
J=7.5Hz)
その塩酸塩
mp: 187-191℃
NMR(DMSO6,δ): 1.41(3H,t,J=7.5Hz),2.70(3H,s),
3.35(3H,m),3.52-3.68(2H,m),3.75-3.88(2H,m),4.46(2H,
q,J=7.5Hz),5.13-5.26(1H,m),5.30-5.41(1H,m),7.48-7.63
(3H,m),7.91(1H,t,J=7.5Hz),8.43(1H,d,J=7.5Hz),8.88
(1H,d,J=7.5Hz),9.34(1H,br s),9.40(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−ジメチルアミノメチ
ル−3−エトキシカルボニルキノリン
mp: 121℃
NMR(CDCl3,δ): 1.43(3H,t,J=7.5Hz),2.26(6H,s),
4.14(2H,s),4.44(2H,q,J=7.5Hz),7.28-7.46(3H,m),7.69
(1H,t,J=7.5Hz),8.10(1H,d,J=7.5Hz),8.94(1H,s),9.01
(1H,d,J=7.5Hz)実施例61
4−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキ
シカルボニルキノリン(100mg)、2−メトキシエチルアミン(18.7m
g)とN,N−ジイソプロピル−N−エチルアミン(134mg)の塩化エチレ
ン(1ml)中の混合物を室温で2時間攪拌した。混合物をジクロロメタンで希
釈し、飽和重炭酸ナトリウム溶液で洗浄し、硫酸マグネシウムで乾燥後、真空中
で溶媒を留去した。残留物を分取薄層クロマトグラフィー(メタノール−ジクロ
ロメタン)で精製して、6−(2,6−ジクロロベンゾイルアミノ)−2,3−
ジヒドロ−2−(2−メトキシエチル)−1H−ピロロ[3,4−c]キノリン
−3−オン(76mg)を得た。
mp: 246℃
NMR(CDCl3,δ): 3.39(3H,s),3.69(2H,t,J=6Hz),
3.88(2H,t,J=6Hz),4.95(2H,s),7.30-7.46(3H,m),7.64
(1H,t,J=7.5Hz),7.74(1H,d,J=7.5Hz),9.10(1H,d,
J=7.5Hz),9.15(1H,s)実施例62
2−メルカプトイミダゾール(27.4mg)のジメチルホルムアミド(1.
5ml)中の溶液に、炭酸カリウム(51.6mg)を氷冷下で加え、混合物を
同温で15分間攪拌した。混合物に4−ブロモメチル−8−(2,6−ジクロロ
ベンゾイルアミノ)−3−エトキシカルボニルキノリン(120mg)を氷冷下
で加え、混合物を室温で1時間攪拌した。混合物に水を氷冷下で加え、生じた沈
殿物を濾過により集め、水で洗浄して、8−(2,6−ジクロロベンゾイルアミ
ノ)−3−エトキシカルボニル−4−[(イミダゾール−2−イル)チオメチル
]キノリン(115mg)を得た。
mp: 120-123℃
NMR(CDCl3,δ): 1.44(3H,t,J=7.5Hz),4.46(2H,q,
J=7.5Hz),5.01(2H,s),6.94(1H,s),7.18(1H,s),7.29-7.46
(3H,m),7.55-7.63(2H,m),8.96-9.05(1H,m),9.10(1H,s),
9.16(1H,br s)
その塩酸塩
mp: 219-224℃
NMR(DMSO6,δ): 1.32(3H,t,J=7.5Hz),4.26(2H,q,
J=7.5Hz),5.20(2H,s),7.47-7.61(3H,m),7.75(2H,s),7.76
(1H,t,J=7.5Hz),7.97(1H,d,J=7.5Hz),8.80(1H,d,
J=7.5Hz),9.13(1H,s)実施例63
8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル−4−
[(ピリジン−4−イル)チオメチル]キノリンを実施例62と同様にして得た
。
mp: 179-181℃
NMR(CDCl3,δ): 1.39(3H,t,J=7.5Hz),4.40(2H,q,
J=7.5Hz),5.15(2H,s),7.24(2H,d,J=6Hz),7.29-7.45(3H,
m),7.72(1H,t,J=7.5Hz),7.90(1H,d,J=7.5Hz),8.86(2H,d,
J=6Hz)9.07(1H,d,J=7.5Hz),9.23(1H,s)
その塩酸塩
mp: 206℃
NMR(DMSO-d6,δ): 1.28(3H,t,J=7.5Hz),4.37(2H,q,
J=7.5Hz),5.36(2H,s),7.46-7.61(3H,m),7.84(1H,t,
J=7.5Hz),7.95(2H,d,J=7Hz),8.20(1H,d,J=7.5Hz),8.70
(2H,d,J=7Hz),8.84(1H,d,J=7.5Hz),9.21(1H,s)実施例64
4−アセトキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−エ
トキシカルボニルキノリンを実施例53−(1)と同様にして得た。
mp: 138-142℃
NMR(CDCl3,δ): 1.45(3H,t,J=7.5Hz),2.05(3H,s),
4.49(2H,q,J=7.5Hz),5.91(2H,s),7.30-7.46(3H,m),7.74
(1H,t,J=7.5Hz),7.93(1H,d,J=7.5Hz),9.05(1H,d,
J=7.5Hz),9.16(1H,s)実施例65
硫化ナトリウム九水和物(202mg)のジメチルホルムアミド(5ml)中
の混合物に、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エ
トキシカルボニルキノリン(297mg)を滴下し、混合物を室温で1時間攪拌
した。混合物に氷水を加え、混合物を1N塩酸でpH3に調整した。生じた沈殿
物を濾過により集め、水で洗浄して、8−(2,6−ジクロロベンゾイルアミノ
)−3−エトキシカルボニル−4−メルカプトキノリン(260mg)を得た。
mp: 197-199℃
NMR(CDCl3,δ): 1.43(3H,t,J=7Hz),4.47(2H,q,
J=7Hz),7.27-7.45(3H,m),7.68(1H,t,J=8Hz),7.99(1H,d,
J=8Hz),8.49(1H,s),9.03(1H,d,J=8Hz),9.21(1H,s)実施例66
(1) 4−(第三級ブトキシカルボニルメチルチオ)−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−エトキシカルボニルキノリンを、製造例8−(1)
と同様にして、8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカル
ボニル−4−メルカプトキノリンとブロモ酢酸第三級ブチルとを反応させて得た
。
NMR(CDCl3,δ): 1.24(9H,s),1.45(3H,t,J=7Hz),
3.66(2H,s),7.29-7.45(3H,m),7.76(1H,t,J=8Hz),8.88
(1H,d,J=8Hz),8.98(1H,s),9.05(1H,d,J=8Hz)
(2) 4−(第三級ブトキシカルボニルメチルチオ)−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−エトキシカルボニルキノリン(140mg)の、4
N塩化水素の酢酸エチル溶液中の溶液を室温で1時間静置させた。混合物を真空
中で濃縮し、残留物を酢酸エチルに溶解した。溶液を食塩水で洗浄し、硫酸マグ
ネシウムで乾燥後、真空中で溶媒を留去して、4−カルボキシメチルチオ−8−
(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリン(1
10mg)を得た。
mp: 174-175℃
NMR(CDCl3,δ): 1.45(3H,t,J=7Hz),3.79(2H,s),
4.51(2H,q,J=7Hz),7.30-7.46(3H,m),7.79(1H,t,J=8Hz),
8.86(1H,d,J=8Hz),8.99(1H,s),9.08(1H,d,J=8Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−[[N−(ピリジン−2−イルメチル)カルバモイル]メチルチオ]キノ
リンを、実施例22−(2)と同様にして、4−カルボキシメチルチオ−8−(
2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリンと2−
アミノメチルピリジンから得た。
NMR(DMSO-d6,δ): 1.34(3H,t,J=7Hz),3.75(2H,s),
4.22(2H,d,J=7Hz),4.39(2H,q,J=7Hz),6.96(1H,d,J=8Hz),
7.20(1H,d,J=7Hz),7.45-7.70(4H,m),7.78(1H,t,J=8Hz),
8.32(1H,d,J=8Hz),8.42(1H,m),8.55(1H,m),8.80(1H,d,
J=8Hz),8.99(1H,s)
その塩酸塩
mp: 191-194℃
NMR(DMSO-d6,δ): 1.35(3H,t,J=7Hz),3.78(2H,s),
4.35-4.50(4H,m),7.40(1H,d,J=8Hz),7.45-7.60(3H,m),
7.64(1H,t,J=7Hz),7.80(1H,t,J=8Hz),8.17(1H,t,J=7Hz),
8.32(1H,t,J=8Hz),8.64(1H,d,J=6Hz),8.75-8.85(2H,m),
8.99(1H,s)実施例67
下記の化合物を実施例25と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニル
−4−(1−メチルイミダゾール−2−イルチオ)キノリン塩酸塩
mp: 234-236℃
NMR(DMSO-d6,δ): 1.31(3H,t,J=7Hz),3.53(3H,s),
4.28(2H,q,J=7Hz),6.98(1H,s),7.30(1H,s),7.45-7.60
(3H,m),7.75(1H,t,J=8Hz),8.18(1H,d,J=8Hz),8.78(1H,
d,J=8Hz),8.98(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトギシカルボニル
−4−(ピリジン−4−イルチオ)キノリン
mp: 183-185℃
NMR(DMSO-d6,δ): 1.19(3H,t,J=7Hz),4.27(2H,q,
J=7Hz),7.04(2H,d,J=6Hz),7.45-7.62(3H,m),7.79(1H,t,
J=8Hz),8.06(1H,d,J=8Hz),8.33(2H,d,J=6Hz),8.83(1H,d,
J=8Hz),9.17(1H,s)
その塩酸塩
mp: 204-205℃
NMR(DMSO-d6,δ): 1.19(3H,t,J=7Hz),4.30(2H,q,
J=7Hz),7.45-7.65(5H,m),7.83(1H,t,J=8Hz),8.08(1H,d,
J=8Hz),8.52(2H,d,J=6Hz),8.87(1H,d,J=8Hz),9.28(1H,s)実施例68
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカル
ボニルキノリン(297mg)とヒドラジン−水和物(175mg)のエタノー
ル(3ml)中の混合物を1時間還流した。混合物に氷水を加え、生じた沈殿物
を濾過により集め、水で洗浄して、6−(2,6−ジクロロベンゾイルアミノ)
−2,3−ジヒドロ−1H−ピラゾロ[4,3−c]キノリン−3−オン(25
0mg)を得た。
得られた化合物のエタノール(20ml)中の懸濁液に、塩化水素のエタノー
ル中の溶液を加え、混合物を60℃で15分間攪拌した。生じた沈殿物を濾過に
より集め、エタノールで洗浄して、6−(2,6−ジクロロベンゾイルアミノ)
−2,3−ジヒドロ−1H−ピラゾロ[4,3−c]キノリン−3−オン塩酸塩
(220mg)を得た。
mp: >250℃
NMR(DMSO6,δ): 7.50-7.65(3H,m),7.79(1H,t,
J=8Hz),8.20(1H,d,J=8Hz),8.63(1H,d,J=8Hz),9.25(1H,s)実施例69
(1) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−メチル
キノリンを、実施例58−(1)と同様にして、3−ブロモ−4−カルボキシメ
チル−8−(2,6−ジクロロベンゾイルアミノ)キノリンから得た。
mp: >250℃
NMR(CDCl3,δ): 2.82(3H,s),7.30-7.50(3H,m),7.66
(1H,t,J=8Hz),7.79(1H,d,J=8Hz),8.77(1H,s),8.97(1H,
d,J=8Hz)
(2) 3−ブロモ−4−ブロモメチル−8−(2,6−ジクロロベンゾイルア
ミノ)キノリンを実施例52の第一工程と同様にして得た。
mp: 210-213℃
NMR(CDCl3,δ): 5.00(2H,s),7.30-7.50(3H,m),7.77
(1H,t,J=8Hz),7.85(1H,d,J=8Hz),8.82(1H,s),9.03(1H,
d,J=8Hz)
(3) 4−アセトキシメチル−3−ブロモ−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリンを実施例53−(1)と同様にして得た。
mp: 201-202℃
NMR(CDCl3,δ): 2.10(3H,s),5.70(2H,s),7.30-7.50
(3H,m),7.71(1H,t,J=8Hz),7.80(1H,d,J=8Hz),8.85(1H,
s),9.00(1H,d,J=8Hz)
(4) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドロ
キシメチルキノリンを実施例12−(2)と同様にして得た。
mp: 246-247℃
NMR(DMSO-d6,δ): 5.07(2H,d,J=5Hz),5.67(1H,t,
J=5Hz),7.45-7.60(3H,m),7.76(1H,t,J=8Hz),8.12(1H,d,
J=8Hz),8.72(1H,d,J=8Hz),8.96(1H,s)実施例70
3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾー
ル−1−イルメチル)キノリンを、実施例59と同様にして、3−ブロモ−4−
ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)キノリンとイミダゾ
ールとを反応させて得た。
mp: 217-218℃
NMR(DMSO-d6,δ): 5.84(2H,s),6.85(1H,s),7.08
(1H,s),7.45-7.60(3H,m),7.77(1H,t,J=8Hz),7.83(1H,s),
8.14(1H,d,J=8Hz),8.76(1H,d,J=8Hz),9.05(1H,s)
その塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 3.07(2H,s),7.45-7.60(3H,m),
7.67(2H,s),7.81(1H,t,J=8Hz),8.10(1H,d,J=8Hz),8.80
(1H,d,J=8Hz),9.10(2H,s)実施例71
(1) 4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−ビニルキノリンを、実施例18と同様にして、8−(2,6−ジクロロベン
ゾイルアミノ)−4−エトキシカルボニルメチル−3−ビニルキノリンから得た
。
mp: 252-253℃
NMR(DMSO-d6,δ): 4.25(2H,s),5.60(1H,d,J=13Hz),
6.02(1H,d,J=15Hz),7.21(1H,dd,J=13,15Hz),7.45-7.60
(3H,m),7.68(1H,t,J=8Hz),7.92(1H,d,J=8Hz),8.69(1H,
d,J=8Hz),9.06(1H,s)
(2) 4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−ビニルキノリン(190.1mg)の溶液に、塩化ビバロイル(62.8m
g)とトリエチルアミン(52.7mg)を0℃で加え、混合物を同温で1時間
攪拌した。混合物に2−アミノメチルピリジン(154mg)を0℃で加え、混
合物を同温で30分間、室温で1時間攪拌した。混合物をジクロロメタンと水と
の間に分配した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中
で溶媒を留去した。残留物を分取薄層クロマトグラフィー(メタノール−ジクロ
ロメタン)で精製して、8−(2,6−ジクロロベンゾイルアミノ)−4−[(
ピリジン−2−イルメチル)カルバモイルメチル]−3−ビニルキノリン(34
.4mg)を得た。
mp: 194-195℃
NMR(DMSO-d6,δ): 4.24(2H,s),4.38(2H,d,J=7Hz),
5.58(1H,d,J=12Hz),6.01(1H,d,J=17Hz),7.20-7.25(3H,m),
7.50-7.60(3H,m),7.67(1H,t,J=8Hz),7.75(1H,t,J=8Hz),
8.01(1H,d,J=8Hz),8.51(1H,d,J=6Hz),8.68(1H,d,J=8Hz),
8.86(1H,t,J=7Hz),9.05(1H,s)実施例72
ジメチルホルムアミド(80.5mg)とジクロロメタン(2ml)の混合物
に、塩化オキサリル(140mg)を加え、混合物を室温で30分間攪拌した。
混合物に4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−ビニルキノリン(340mg)を0℃で加え、混合物を同温で30分間攪拌
した。混合物に2−アミノメチルピリジン(458mg)のジクロロメタン(2
ml)中の溶液を0℃で加え、混合物を同温で30分間攪拌した。混合物をジク
ロロメタンと飽和重炭酸ナトリウム溶液との間に分配した。有機層を飽和塩化ア
ンモニウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を
留去した。残留物をシリカゲルカラムクロマトグラフィー(ジクロロメタン−メ
タノール)で精製して、4−(2,6−ジクロロベンゾイルアミノ)−9−ヒド
ロキシフェナントリジン(75.7mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.33(1H,d,J=8Hz),7.45-7.60(3H,
m),7.72(1H,t,J=8Hz),8.00(1H,s),8.13(1H,d,J=8Hz),
8.35(1H,d,J=8Hz),8.74(1H,d,J=8Hz),9.17(1H,s)実施例73
(1) 4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−エチルキノリンを、実施例41と同様にして、4−カルボキシメチル−8−
(2,6−ジクロロベンゾイルアミノ)−3−ビニルキノリンから得た。
mp: 115-116℃
NMR(CDCl3,δ): 1.27(3H,t,J=7Hz),2.37(1H,q,
J=7Hz),4.13(2H,s),7.30-7.55(3H,m),7.61(1H,t,J=8Hz),
7.68(1H,d,J=8Hz),8.63(1H,s),8.90(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−[(ピ
リジン−2−イルメチル)カルバモイルメチル]キノリンを実施例26−(2)
と同様にして得た。
mp: 162-163℃
NMR(DMSO-d6,δ): 1.21(3H,t,J=7Hz),2.89(2H,q,
J=7Hz),4.17(2H,s),4.38(2H,d,J=7Hz),7.20-7.30(2H,m),
7.45-7.65(4H,m),7.75(1H,t,J=8Hz),7.92(1H,d,J=8Hz),
8.51(1H,d,J=5Hz),8.65(1H,d,J=8Hz),8.74(1H,s),8.87
(1H,t,J=7Hz)
その二塩酸塩
mp: 223-237℃
NMR(DMSO-d6,δ): 1.19(3H,t,J=7Hz),2.88(2H,q,
J=7Hz),4.23(2H,s),4.61(1H,d,J=7Hz),
7.50-7.70(4H,m),7.70-7.80(2H,m),7.90(1H,d,J=8Hz),
8.37(1H,t,J=8Hz),8.64(1H,d,J=8Hz),8.74(1H,s),8.70-
8.80(1H,オーバーラップ),9.17(1H,t,J=7Hz)実施例74
8−(2,6−ジクロロベンゾイルアミノ)キノリン(100mg)とm−ク
ロロ過安息香酸(71mg)の塩化エチレン中の溶液を40℃で1時間攪拌した
。混合物に5%チオ硫酸ナトリウム溶液を加え、混合物をジクロロメタンと飽和
重炭酸ナトリウム溶液との間に分配した。有機層を硫酸マグネシウムで乾燥後、
真空中で溶媒を留去した。残留物をジクロロメタン−メタノールから再結晶して
、8−(2,6−ジクロロベンゾイルアミノ)キノリン・1−オキシド(48m
g)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.50-7.60(2H,m),7.60-7.67(2H,
m),7.77(1H,t,J=8Hz),7.87(1H,d,J=8Hz),8.15(1H,d,
J=8Hz),8.55(1H,d,J=8Hz),9.02(1H,d,J=8Hz)実施例75
8−キノリンカルボン酸(100mg)、塩化オキサリル(0.08ml)と
ジメチルホルムアミド(1滴)のジクロロメタン(3ml)中の混合物を室温で
4時間攪拌した。混合物を真空中で濃縮し、残留物をジクロロメタン(3ml)
に溶解した。溶液に2,6−ジクロロアニリン(93mg)とトリエチルアミン
(117mg)を加え、混合物を室温で2時間攪拌した。混合物を水で洗浄し、
硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲルカラ
ムクロマトグラフィー(n−ヘキサン−酢酸エチル)で精製して、8−[N−(
2,6−ジクロロフェニル)カルバモイル]キノリン(78mg)を得た。
mp: 168-169℃
NMR(CDCl3,δ): 7.20(1H,t,J=8Hz),7.43(2H,d,
J=8Hz),7.56(1H,m),7.75(1H,t,J=8Hz),8.06(1H,d,
J=8Hz),8.36(1H,d,J=8Hz),8.94-9.01(2H,m)実施例76
10%パラジウム活性炭(15mg)を含む、8−ニトロシンノリン(104
mg)のN,N−ジメチルアセトアミド(1ml)中の溶液を大気圧下で室温で
6時間水素化した。濾過により触媒を除去し、熱N,N−ジメチルアセトアミド
と熱クロロホルムで洗浄した。合わせた濾液を減圧下で少量になるまで濃縮した
。この溶液にトリエチルアミン(87mg)と塩化2,6−ジクロロベンゾイル
(144mg)を加え、生じた混合物を95℃で1時間攪拌した。混合物を酢酸
エチルと飽和塩化アンモニウム水溶液との間に分配した。有機層を飽和重炭酸ナ
トリウム水溶液と食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、真空中で溶
媒を留去した。残留物を分取薄層シリカゲルクロマトグラフィーで精製した。得
られた油状物をエタノールから結晶化して、8−(2,6−ジクロロベンゾイル
アミノ)シンノリン(9mg)を灰色結晶として得た。
mp: 226-228℃
NMR(CDCl3,δ): 7.30-7.50(3H,m),7.60(1H,d,
J=8Hz),7.85(1H,t,J=8Hz),7.92(1H,d,J=6Hz),9.09(1H,d,
J=8Hz),9.36(1H,d,J=6Hz)実施例77
下記の化合物を実施例22−(2)と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[(ピリジン−2−
イルメチル)カルバモイルメチル]−3−ビニルキノリン
(4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
ビニルキノリンと2−アミノメチルピリジンから)
(2) 4−カルバモイルメチル−8−(2,6−ジクロロベンゾイルアミノ)
−3−ビニルキノリン
(4−カルボキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
ビニルキノリンと濃アンモニア溶液から)
mp: 232-234℃
NMR(DMSO-d6,δ): 4.08(2H,s),5.58(1H,d,J=11Hz),
6.00(1H,d,J=17Hz),7.15(1H,brs),7.22(1H,dd,J=11,
17Hz),7.50-7.65(3H,m),7.67(1H,t,J=8Hz),7.70(1H,brs),
7.95(1H,d,J=8Hz),8.67(1H,d,J=8Hz),9.03(1H,s)
その塩酸塩
mp: 199-205℃
NMR(DMSO-d6,δ): 4.09(2H,s),5.57(1H,d,J=11Hz),
6.00(1H,d,J=17Hz),7.15(1H,brs),7.22(1H,dd,J=11,
17Hz),7.50-7.65(3H,m),7.67(1H,t,J=8Hz),7.72(1H,brs),
7.95(1H,d,J=8Hz),8.67(1H,d,J=8Hz),9.03(1H,s)実施例78
(1) 4−アセトキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−ビニルキノリンを、製造例14と同様にして、4−アセトキシメチル−3−
ブロモ−8−(2,6−ジクロロベンゾイルアミノ)キノリンとトリ−n−ブチ
ル(ビニル)錫から得た。
mp: 166-167℃
NMR(CDCl3,δ): 2.08(3H,s),5.61(2H,s),5.55-5.65
(1H,オーバーラップ),7.30-7.45(3H,m),7.68(1H,t,J=8Hz),7.85
(1H,t,J=8Hz),8.91(1H,s),8.95(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドロキシメチル−
3−ビニルキノリンを実施例12−(2)と同様にして得た。
mp: 243-244℃
NMR(DMSO-d6,δ): 4.99(2H,d,J=5Hz),5.48(1H,t,
J=5Hz),5.60(1H,d,J=12Hz),6.01(1H,d,J=16Hz),7.32(1H,
dd,J=12,16Hz),7.50-7.60(3H,m),7.69(1H,t,J=8Hz),8.09
(1H,d,J=8Hz),8.67(1H,d,J=8Hz),9.05(1H,s)
その塩酸塩
mp: 215-221℃
NMR(DMSO-d6,δ): 4.98(2H,s),5.60(1H,d,J=12Hz),
6.02(1H,d,16Hz),7.32(1H,dd,J=12,16Hz),7.50-7.60(3H,
m),7.68(1H,t,J=8Hz),8.09(1H,d,J=8Hz),8.66(1H,d,
J=8Hz),9.05(1H,s)
(3) N,N−ジメチルホルムアミド(1ml)に塩化チオニル(73.2m
g)を加え、混合物を室温で15分間攪拌した。混合物に8−(2,6−ジクロ
ロベンゾイルアミノ)−4−ヒドロキシメチル−3−ビニルキノリン(176.
7mg)を加え、混合物を室温で30分間攪拌した。混合物に飽和重炭酸ナトリ
ウム溶液(10ml)を氷冷下で加え、混合物を同温で15分間攪拌した。生じ
た沈殿物を濾過により集め、水で洗浄して、4−クロロメチル−8−(2,6−
ジクロロベンゾイルアミノ)−3−ビニルキノリン(182.8mg)を得た。
mp: 184-186℃
NMR(CDCl3,δ): 5,05(2H,s),5.70(1H,d,J=10Hz),
5.93(1H,d,J=17Hz),7.17(1H,d,J=10,17Hz),7.30-7.45(3H,
m),7.72(1H,t,J=8Hz),7.88(1H,d,J=8Hz),8.90(1H,s),
8.97(1H,d,J=8Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イルメチル)−3−ビニルキノリンを実施例59と同様にして得た。
mp: 189-191℃
NMR(DMSO-d6,δ): 5.67(1H,d,J=10Hz),5.83(2H,s),
6.10(1H,d,J=16Hz),6.82(1H,s),6.98(1H,s),7.45(1H,
dd,J=10,16Hz),7.45-7.60(3H,m),7.72(1H,t,J=8Hz),7.23
(1H,s),8.13(1H,d,J=8Hz),8.70(1H,d,J=8Hz),9.14(1H,
s)
その塩酸塩
mp: 244-247℃
NMR(DMSO-d6,δ): 5.69(1H,d,J=11Hz),6.07(2H,s),
6.13(1H,d,J=17Hz),7.38(1H,dd,J=11,17Hz),7.50-7.65
(5H,m),7.74(1H,t,J=8Hz),8.05(1H,d,J=8Hz),8.73(1H,
d,J=8Hz),9.03(1H,s),9.19(1H,s)実施例79
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−ヒドロ
キシメチルキノリンを、実施例41と同様にして、8−(2,6−ジクロロベン
ゾイルアミノ)−4−ヒドロキシメチル-3−ビニルキノリンから得た。
mp: 226-228℃
NMR(DMSO-d6,δ): 1.24(3H,t,J=7Hz),2.92(2H,q,
J=7Hz),4.95(2H,d,J=5Hz),5.39(1H,t,J=5Hz),7.50-7.60
(3H,m),7.65(1H,t,J=8Hz),8.05(1H,d,J=8Hz),8.64(1H,
d,J=8Hz),8.75(1H,s)
その塩酸塩
mp: 220-225℃
NMR(DMSO-d6,δ): 1.25(3H,t,J=7Hz),2.93(2H,q,
J=7Hz),4.95(2H,s),7.50-7.60(3H,m),7.66(1H,t,J=8Hz),
8.06(1H,d,J=8Hz),8.64(1H,d,J=8Hz),8.76(1H,s)
(2) 4−クロロメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
エチルキノリンを実施例78−(3)と同様にして得た。
mp: 193-194℃
NMR(CDCl3,δ): 1.37(3H,t,J=7Hz),2.96(2H,q,
J=7Hz),5.03(2H,s),7.30-7.55(3H,m),7.70(1H,t,J=8Hz),
7.86(1H,d,J=8Hz),8.66(1H,s),8.94(1H,d,J=8Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(イミ
ダゾール−1−イルメチル)キノリンを実施例59と同様にして得た。
NMR(CDCl3,δ): 1.23(3H,t,J=7Hz),2.92(2H,q,
J=7Hz),5.58(2H,s),6.78(1H,s),7.03(1H,s),7.30-7.55
(3H,m),7.60-7.70(2H,m),8.72(1H,s),8.94(1H,d,J=8Hz)
その塩酸塩
mp: 258-260℃(分解)
NMR(DMSO-d6,δ): 1.18(3H,t,J=7Hz),2.99(2H,q,
J=7Hz),5.99(2H,s),7.50-7.60(4H,m),7.65(1H,s),7.69
(1H,t,J=8Hz),7.91(1H,d,J=8Hz),8.71(1H,d,J=8Hz),8.92
(1H,s),9.02(1H,s)実施例80
(1) 4−ブロモメチル−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ンを、実施例52の第一工程と同様にして、8−(2,6−ジクロロベンゾイル
アミノ)−4−メチルキノリンから得た。
NMR(CDCl3,δ): 4.97(2H,s),7.30-7.45(3H,m),
7.50(1H,d,J=5Hz),7.73(1H,t,J=8Hz),7.88(1H,d,J=8Hz),
8.74(1H,d,J=5Hz),9.01(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イルメチル)キノリンを実施例59と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 5.85(2H,s),6.97(1H,d,J=4Hz),
7.00(1H,s),7.45-7.60(3H,m),7.74(1H,t,J=8Hz),7.85
(1H,s),8.01(1H,d,J=8Hz),8.77(1H,d,J=8Hz),8.83(1H,
d,J=4Hz)
その塩酸塩
mp: 167-172℃
NMR(DMSO-d6,δ): 6.08(2H,s),7.28(1H,d,J=4Hz),
7.45-7.60(3H,m),7.76(1H,s),7.78(1H,t,J=8Hz),7.83
(1H,s),8.00(1H,d,J=8Hz),8.79(1H,d,J=8Hz),8.90(1H,
d,J=4Hz),9.26(1H,s)実施例81
(1) 4−(ブロモメチル)−8−(2,6−ジクロロベンゾイルアミノ)キ
ノリンを、実施例12−(3)と同様にして、8−(2,6−ジクロロベンゾイ
ルアミノ)−4−ヒドロキシメチルキノリンから得た。
NMR(CDCl3,δ): 4.85(2H,s),7,29(3H,m),7.49
(1H,d,J=4Hz),7.73(1H,t,J=8Hz),7.87(1H,d,J=8Hz),8.72
(1H,d,J=4Hz),9.00(1H,d,J=8Hz)
(2) ベンズイミダゾール(26.5mg)のN,N−ジメチルホルムアミド
(1ml)中の攪拌溶液に、水素化ナトリウム(油状物中60%、8.3mg)
を氷浴内で加え、混合物を同温で半時間攪拌した。この混合物に4−ブロモメチ
ル−8−(2,6−ジクロロベンゾイルアミノ)キノリン(80mg)を一度に
加え、反応混合物を同温で半時間、室温で1時間攪拌した。それに水を加え、生
じた沈殿物を濾過により集めた。固形物を熱95%エタノール水溶液(1ml)
で洗浄し、室温まで冷却させた。固形物を濾過により集め、空気乾燥して、4−
(1H−ベンズベンズイミダゾール−1−イルメチル)−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリン(65mg)を灰白色固形物として得た。
mp: 248-253℃
NMR(CDCl3,δ): 5.89(2H,s),6.69(1H,d,J=4Hz),
7.17-7.25(1H,m),7.26-7.45(5H,m),7.70-7.81(2H,m),7.90
(1H,d,J=8Hz),8.01(1H,s),8.60(1H,d,J=4Hz),9.06(1H,
br d,J=8Hz)実施例82
(1) 4−[ビス(エトキシカルボニル)メチル]−8−ニトロキノリンを、
製造例7−(1)と同様にして、4−クロロ−8−ニトロキノリンとマロン酸ジ
エチルとを反応させて得た。
mp: 48-50℃
NMR(CDCl3,δ): 1.20-1.30(6H,m),4.20-4.32(4H,m),
7.63-7.72(2H,m),8.01(1H,d,J=8Hz),8.20(1H,dd,J=8,
2Hz),9.07(1H,d,J=5Hz)
(2) 8−ニトロ−4−(エトキシカルボニルメチル)キノリンを製造例7−
(2)と同様にして得た。
mp: 67-69℃
NMR(CDCl3,δ): 1.23(3H,t,J=6Hz),4.10(2H,s),
4.18(2H,q,J=6Hz),7.49(1H,d,J=4Hz),7.67(1H,t,J=8Hz),
8.00(1H,d,J=8Hz),8.23(1H,d,J=8Hz),9.00(1H,d,J=5Hz)
(3) 8−アミノ−4−(エトキシカルボニルメチル)キノリンを製造例2−
(3)と同様にして得た。
mp: 71-77℃
NMR(CDCl3,δ): 1.22(3H,t,J=6Hz),4.00(2H,s),
4.16(2H,q,J=6Hz),5.03(2H,s),6.94(1H,d,J=8Hz),7.28-
7.40(3H,m),8.70(1H,d,J=5Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(エトキシカルボニ
ルメチル)キノリンを実施例1と同様にして得た。
mp: 150-152℃
NMR(CDCl3,δ): 1.24(3H,t,J=6Hz),4.08(2H,s),
4.18(2H,q,J=6Hz),7.30-7.44(4H,m),7.65(1H,t,J=8Hz),
7.75(1H,d,J=8Hz),8.72(1H,d,J=4Hz),8.99(1H,d,J=8Hz)
(5) 4−エトキシカルボニルメチル−8−(2,6−ジクロロベンゾイルア
ミノ)キノリン(1.03g)のエタノール(6ml)中の懸濁液に、1N水酸
化ナトリウム水溶液(3.83ml)を加え、混合物を50℃で2時間攪拌した
。有機溶媒を真空中で除去し、残留物水溶液を1N塩酸で中和し、酢酸エチルで
抽出した。抽出物を乾燥し、溶媒を留去した。残留物を自然に結晶化し、それを
酢酸エチルで粉砕して、4−カルボキシメチル−8−(2,6−ジクロロベンゾ
イルアミノ)キノリン(703mg)を得た。
mp: 228-230℃
NMR(DMSO-d6,δ): 4.18(2H,s),7.50-7.64(4H,m),
7.70(1H,t,J=8Hz),7.85(1H,d,J=8Hz),8.75(1H,d,J=8Hz),
8.83(1H,d,J=4Hz)
(6) 4−(モルホリノカルボニルメチル)−8−(2,6−ジクロロベンゾ
イルアミノ)キノリンを、実施例22−(2)と同様にして、4−カルボキシメ
チル−8−(2,6−ジクロロベンゾイルアミノ)キノリンとモルホリンから得
た。
mp: 245-251℃
NMR(CDCl3,δ): 3.47(2H,t,J=6Hz),3.62(2H,t,
J=6Hz),3.70(4H,s),4.15(2H,s),7.30-7.45(4H,m),7.60-
7.70(2H,m),8.71(1H,d,J=5Hz),8.95-9.01(1H,m)実施例83
(1) 4−[シアノ(エトキシカルボニル)メチル]−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリンを、製造例7−(1)と同様にして、4−クロロ
−8−(2,6−ジクロロベンゾイルアミノ)キノリンとシアノ酢酸エチルとを
反応させて得た。
NMR(CDCl3,δ): 1.28(3H,t,J=6Hz),4.28(2H,q,
J=6Hz),5.40(1H,s),7.30-7.45(3H,m),7.20-7.77(3H,m),
8.85(1H,d,J=4Hz),9.02-9.08(1H,m)
(2) 4−シアノメチル−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ンを製造例7−(2)と同様にして得た。
mp: 234-236℃
NMR(CDCl3,δ): 4.20(2H,s),7.30-7.45(3H,m),7.60
(1H,d,J=8Hz),7.66(1H,d,J=4Hz),7.75(1H,t,J=8Hz),8.80
(1H,d,J=4Hz),9.05(1H,d,J=8Hz)実施例84
(1) 4−[ビス(エトキシカルボニル)メチル]−8−(2,6−ジクロロ
ベンゾイルアミノ)キノリンを、製造例7−(1)と同様にして、4−クロロ−
8−(2,6−ジクロロベンゾイルアミノ)キノリンとマロン酸ジエチルとを反
応させて得た。
mp: 127-128℃
NMR(CDCl3,δ): 1.38(6H,t,J=6Hz),4.28(4H,q,
J=6Hz),5.43(1H,s),7.30-7.45(3H,m),7.61(1H,d,J=5Hz),
7.64-7.76(2H,m),8.80(1H,d,J=5Hz),9.01(1H,d,J=8Hz)
(2) 4−[ビス(エトキシカルボニル)メチル]−8−(2,6−ジクロロ
ベンゾイルアミノ)キノリン(200mg)とヒドラジン−水和物(211mg
)のエタノール(2ml)中の混合物を一夜還流した。冷却後、生じた沈殿物を
濾過により集め、残留物をエタノールで洗浄して、8−(2,6−ジクロロベン
ゾイルアミノ)−4−(3,5−ジヒドロキシピラゾール−4−イル)キノリン
を固形物として得た。得られた固形物を塩化水素のエタノール溶液で処理し、沈
殿物を集め、イソプロピルアルコールから再結晶して、8−(2,6−ジクロロ
ベンゾイルアミノ)−4−(3,5−ジヒドロキシピラゾール−4−イル)キノ
リン塩酸塩(95mg)を得た。
mp: 210-230℃
NMR(DMSO-d6,δ): 7.50-7.67(5H,m),7.84(1H,d,
J=8Hz),8.65(1H,d,J=8Hz),8.78(1H,d,J=5Hz)実施例85
下記の化合物を実施例8と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メチルイミダ
ゾール−1−イル)キノリン
mp: 210-212℃
NMR(CDCl3,δ): 2.25(3H,s),7.10(1H,s),7.17-7.30
(2H,m),7.33-7.48(4H,m),7.68(1H,t,J=8Hz),8.91(1H,d,
J=4Hz),9.08(1H,d,J=8Hz)
その塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 2.46(3H,s),7.36(1H,d,J=8Hz),
7.50-7.62(3H,m),7.80(1H,t,J=8Hz),7.91-8.02(3H,m),
8.87(1H,d,J=8Hz),9.17(1H,d,J=4Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(ピラゾール−1−
イル)キノリン
mp: 194-197℃
NMR(CDCl3,δ): 6.59-6.65(1H,m),7.30-7.46(3H,m),
7.55(1H,d,J=5Hz),7.69(1H,t,J=8Hz),7.91(1H,d,J=2Hz),
7.96(1H,d,J=3Hz),7.99(1H,d,J=8Hz),8.82(1H,d,J=5Hz),
9.03(1H,d,J=8Hz)
その塩酸塩
mp: 204-207℃
NMR(DMSO-d6,δ): 6.71(1H,d,J=2Hz),7.48-7.62(3H,
m),7.70-7.81(2H,m),8.00(1H,d,J=2Hz),8.11(1H,d,
J=8Hz),8.46(1H,t,J=2Hz),8.80(1H,d,J=8Hz),8.99(1H,d,
J=6Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(1,2,4−トリ
アゾール−1−イル)キノリン
mp: 210-214℃
NMR(CDCl3,δ): 7.31-7.46(3H,m),7.56(1H,d,
J=5Hz),7.73(1H,t,J=8Hz),7.80(1H,d,J=8Hz),8.30(1H,
s),8.60(1H,s),8.90(1H,d,J=5Hz),9.09(1H,d,J=8Hz)
その塩酸塩
mp: 220-232℃
NMR(DMSO-d6,δ): 7.47-7.62(3H,m),7.75(1H,t,
J=8Hz),7.88(1H,d,J=8Hz),8.00(1H,d,J=5Hz),8.48(1H,
s),8.81(1H,d,J=8Hz),9.06(1H,d,J=5Hz),9.26(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(N−メチルアミノ
)キノリン
mp: 226-228℃
NMR(DMSO-d6,δ): 2.90(3H,d,J=6Hz),6.46(1H,d,
J=6Hz),7.37-7.68(5H,m),7.90(1H,d,J=8Hz),8.36(1H,d,
J=6Hz),8.60(1H,d,J=8Hz)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−[N−(2−メトキ
シエチル)−N−メチルアミノ]キノリン
mp: 156-158℃
NMR(CDCl3,δ): 3.05(3H,s),3.38(3H,s),3.53(2H,
t,J=5Hz),3.70(2H,t,J=5Hz),6.88(1H,d,J=5Hz),7.27-7.42
(4H,m),7.51(1H,t,J=8Hz),7.90(1H,d,J=8Hz),8.51(1H,
d,J=5Hz),8.90(1H,d,J=8Hz)
(6) 4−[(3−アミノプロピル)アミノ]−8−(2,6−ジクロロベン
ゾイルアミノ)キノリン
mp: 146-150℃
NMR(CDCl3,δ): 1.30-1.70(3H,br),1.90(2H,quint.,
J=6Hz),3.05(2H,t,J=6Hz),3.43(2H,q,J=6Hz),6.39(1H,d,
J=5Hz),7.25-7.48(4H,m),7.55(1H,d,J=8Hz),8.38(1H,d,
J=5Hz),8.88(1H,d,J=8Hz)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−4−[N−(2−メチル
アミノエチル)−N−メチルアミノ]キノリン
mp: 173-178℃
NMR(CDCl3,δ): 2.45(3H,s),2.91(2H,t,J=8Hz),
3.01(3H,s),3.44(2H,t,J=8Hz),6.87(1H,d,J=6Hz),7.27-
7.42(3H,m),7.52(1H,t,J=8Hz),7.88(1H,d,J=8Hz),8.50
(1H,d,J=6Hz),8.90(1H,d,J=8Hz)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−4−(ピラゾール−3−
イルアミノ)キノリン塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 6.45(1H,d,J=4Hz),7.52-7.65(3H,
m),7.86(1H,t,J=8Hz),7.90(1H,s),7.97(1H,ds,J=8Hz),
8.55-8.70(3H,m)
(9) 8−(2,6−ジクロロベンゾイルアミノ)−4−(1,2,4−トリ
アゾール−4−イルアミノ)キノリン
mp: 236-238℃
NMR(DMSO-d6,δ): 6.61(1H,d,J=5Hz),7.00(2H,s),
7.42(1H,t,J=8Hz),7.50-7.63(3H,m),7.93(1H,d,J=8Hz),
8.26(1H,d,J=5Hz),8.61(1H,d,J=8Hz)
(10) 3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(2
−メチルイミダゾール−1−イル)キノリン
mp: 200℃
NMR(CDCl3,δ): 2.16(3H,s),6.97(1H,s),7.04(1H,
d,J=8Hz),7.24(1H,s),7.32-7.48(3H,m),7.68(1H,t,
J=8Hz),8.97(1H,s),9.06(1H,d,J=8Hz)
その塩酸塩
mp: 269℃
NMR(DMSO6,δ): 2.41(3H,s),7.28(1H,d,J=8Hz),
7.49-7.64(3H,m),7.84(1H,t,J=8Hz),7.92(1H,s),7.96
(1H,s),8.86(1H,d,J=8Hz),9.30(1H,s)
(11) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニ
ル−4−[N−(2−ヒドロキシエチル)−N−メチルアミノ]キノリン
mp: 139-141℃
NMR(CDCl3,δ): 1.43(3H,t,J=6Hz),3.05(3H,s),
3.72-3.87(4H,m),4.48(2H,q,J=6Hz),7.28-7.43(3H,m),
7.57(1H,t,J=7Hz),7.82(1H,d,J=7Hz),8.83(1H,s),8.97
(1H,d,J=7Hz)
(12) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(ピ
ラゾール−1−イル)キノリン
mp: 236℃
NMR(CDCl3,δ): 2.30(3H,s),6.60-6.65(1H,m),7.11
(1H,d,J=8Hz),7.30-7.45(3H,m),7.57(1H,d,J=8Hz),7.65
(1H,s),7.90(1H,s),8.75(1H,s),8.93(1H,d,J=8Hz)
(13) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(1
,2,4−トリアゾール−1−イル)キノリン
mp: 248-250℃
NMR(DMSO-d6,δ): 2.26(3H,s),7.02(1H,d,J=8Hz),
7.48-7.61(3H,m),7.69(1H,t,J=8Hz),8.48(1H,s),8.73
(1H,d,J=8Hz),9.03(1H,s),9.08(1H,s)
(14) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−
4−(ピペリジノ)キノリン
NMR(CDCl3,δ): 1.67-1.88(6H,m),3.23-3.35(4H,m),
3.38(3H,s),4.63(2H,s),7.28-7.44(3H,m),7.54(1H,dd,
J=8,8Hz),7.91(1H,d,J=8Hz),8.57(1H,s),8.88(1H,d,
J=8Hz),10.12(1H,s)
(15) 8−(2,6−ジクロロベンゾイルアミノ)−4−(ピリジン−3−
イルメチルアミノ)キノリン
NMR(CDCl3,δ): 4.61(2H,d,J=6Hz),5.50(1H,t,
J=6Hz),6.46(1H,d,J=5Hz),7.25-7.42(4H,m),7.49-7.56(2H,
m),7.72(1H,d,J=8Hz),8.40(1H,d,J=5Hz),8.60(1H,d,
J=5Hz),8.69(1H,s),8.90-8.96(1H,m)
その二塩酸塩
mp:>250℃
NMR(DMSO-d6,δ): 5.03(2H,d,J=5Hz),6.95(1H,d,
J=8Hz),7.50-7.65(3H,m),7.80-7.90(2H,m),8.42(1H,d,
J=8Hz),8.55(1H,d,J=8Hz),8.55(2H,m),8.63(1H,d,
J=8Hz),8.78(1H,d,J=5Hz),9.00(1H,s)実施例86
8−(2,6−ジクロロベンゾイルアミノ)−4−メチルアミノキノリン(1
30mg)の無水酢酸(2ml)中の懸濁液を120℃で3時間加熱した。真空
中で溶媒を除去し、残留物をメタノール(3ml)に溶解した。溶液に1N水酸
化ナトリウム溶液(0.5ml)を加え、混合物を30分間攪拌した。真空中で
溶媒を除去し、残留物を熱50%エタノール(2ml)で洗浄し、濾過した。残
留物を熱95%エタノール(1ml)で洗浄し、濾液を室温になるまで静置させ
た。生じた沈殿物を濾過により集め、乾燥して、8−(2,6−ジクロロベンゾ
イルアミノ)−4−(N−メチルアセトアミド)キノリン(90mg)を得た。
mp: 227-230℃
NMR(CDCl3,δ): 1.80(3H,s),3.36(3H,s),7.29-
7.48(4H,m),7.57(1H,d,J=8Hz),7.71(1H,t,J=8Hz),8.83
(1H,d,J=5Hz),9.04(1H,d,J=8Hz)実施例87
8−(2,6−ジクロロベンゾイルアミノ)−4−[N−(2−メチルアミノ
エチル)−N−メチルアミノ]キノリン(130mg)、3−ピリジルカルバミ
ン酸フェニル(76mg)とトリエチルアミン(97.9mg)のジメチルホル
ムアミド(1.5ml)中の混合物を室温で1時間攪拌した。混合物を酢酸エチ
ルで希釈し、1N水酸化ナトリウム溶液、水と食塩水で洗浄し、硫酸マグネシウ
ムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマトグラフィー(
メタノール−ジクロロメタン)で精製して、8−(2,6−ジクロロベンゾイル
アミノ)−4−[N−[2−[1−メチル−3−(3−ピリジル)ウレイド]エ
チル]−N−メチルアミノ]キノリン(168mg)を得た。
NMR(CDCl3,δ): 2.73(3H,s),3.10(3H,s),3.60-3.75
(4H,m),6.20(1H,br s),6.88(1H,d,J=6Hz),7.22(1H,dd,
J=8,7Hz),7.28-7,41(3H,m),7.49(1H,t,J=8Hz),7.77(1H,
d,J=8Hz),7.85(1H,dd,J=7,2Hz),8.27(1H,d,J=7Hz),8.36
(1H,d,J=2Hz),8.44(1H,d,J=6Hz),8.88(1H,d,J=8Hz)
その二塩酸塩
mp: 261-266℃
NMR(DMSO-d6,δ): 2.97(3H,s),3.48(3H,s),3.71-
3.83(2H,m),3.94-4.08(2H,m),7.16(1H,d,J=8Hz),7.49-
7.67(4H,m),7.83(1H,dd,J=8,7Hz),8.11(1H,d,J=8Hz),
8.39-8.51(4H,m),9.00(1H,s),9.40(1H,br s)
実施例88
8−(2,6−ジクロロベンゾイルアミノ)−4−[N−[2−[1−メチル
−3−(4−ピリジル)ウレイド]エチル]−N−メチルアミノ]キノリンを、
実施例87と同様にして、8−(2,6−ジクロロベンゾイルアミノ)−4−[
N−(2−メチルアミノエチル)−N−メチルアミノ]キノリンと4−ピリジル
カルバミン酸フェニルとを反応させて得た。
mp: 283-290℃
NMR(CDCl3,δ): 2.74(3H,s),3.11(3H,s),3.60-3.76
(4H,m),6.32(1H,br s),6.89(1H,d,J=6Hz),7.18-7.44(5H,
m),7.49(1H,t,J=8Hz),7.77(1H,d,J=8Hz),8.35-8.46(3H,
m),8.89(1H,d,J=8Hz)実施例89
8−(2,6−ジクロロベンゾイルアミノ)−4−[N−(2−メチルアミノ
エチル)−N−メチルアミノ]キノリン(130mg)、塩化3−ピリジンカル
ボニル(60.3mg)とトリエチルアミン(97.9mg)のジクロロメタン
(2ml)中の混合物を室温で一夜攪拌した。混合物をジクロロメタンで希釈し
、水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を
エタノールから結晶化して、濾過により集めた。残留物をエタノールで洗浄して
、8−(2,6−ジクロロベンゾイルアミノ)−4−[N−[2−(N−メチル
−3−ピリジンカルボキサミド)エチル]−N−メチルアミノ]キノリン(15
0mg)を得た。
mp: 195-203℃
NMR(CDCl3,δ): 2.80(3H,br s),3.17(3H,br s),
3.36-3.93(4H,m),6.95(1H,br d),7.27-7.47(5H,m),7.53
(1H,t,J=8Hz),7.80(1H,br d),8.40-8.66(3H,m),8.90(1H,
d,J=8Hz)実施例90
(1) 4−(2−アミノフェニルアミノ)−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリンを、実施例8と同様にして、4−クロロ−8−(2,6−ジ
クロロベンゾイルアミノ)キノリンと1,2−フェニレンジアミンから得た。
mp: 224-228℃
NMR(CDCl3,δ): 3.80(2H,br s),6.36-6.46(2H,m),
6.80-6.91(2H,m),7.13-7.22(2H,m),7.29-7.44(3H,m),7.60
(1H,t,J=8Hz),7.70(1H,d,J=8Hz),8.37(1H,d,J=5Hz),8.98
(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−ピリジ
ンカルボキサミド)フェニルアミノ]キノリンを実施例89と同様にして得た。
mp: 151-154℃
NMR(CDCl3,δ): 6.63(1H,d,J=6Hz),7.37-7.70(7H,
m),7.84(1H,t,J=8Hz),7.87(1H,d,J=8Hz),8.40(1H,br d,
J=9Hz),8.47(1H,d,J=6Hz),8.52(1H,d,J=8Hz),8.73-8.81
(2H,m),9.10(1H,br s)
その塩酸塩
mp: 277-283℃
NMR(DMSO-d6,δ): 6.63(1H,d,J=6Hz),7.37-7.70(7H,
m),7.84(1H,t,J=8Hz),7.87(1H,d,J=8Hz),8.40(1H,br d,
J=9Hz),8.47(1H,d,J=6Hz),8.52(1H,d,J=8Hz),8.73-8.81
(2H,m),9.10(1H,br s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−ピリジ
ンカルボキサミド)フェニルアミノ]キノリン(150mg)の酢酸中の溶液を
60時間還流した。冷却後、混合物を真空中で濃縮し、酢酸エチルで希釈した。
溶液を飽和重炭酸ナトリウム溶液で洗浄し、硫酸マグネシウムで乾燥後、真空中
で溶媒を留去した。残留物をアセトニトリルから結晶化し、濾過により集めて、
8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−ピリジル)−1
H−ベンズイミダゾール−1−イル]キノリン(136mg)を得た。
mp: 203-204℃
NMR(CDCl3,δ): 6.93(1H,d,J=8Hz),7.20-7.48(8H,
m),7.60(1H,t,J=8Hz),7.89(1H,dd,J=8,3Hz),7.98(1H,t,
J=8Hz),8.54(1H,m),8.66(1H,d,J=3Hz),8.87(1H,m),9.08
(1H,d,J=8Hz)
その二塩酸塩
mp: 249-254℃
NMR(DMSO-d6,δ): 7.10(1H,d,J=8Hz),7.16(1H,d,
J=8Hz),7.31(1H,t,J=8Hz),7.40-7.69(6H,m),7.92-8.04(3H,
m),8.62(1H,d,J=6Hz),8.80(1H,d,J=8Hz),8.83(1H,br s),
9.10(1H,d,J=6Hz)実施例91
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−2−イル
チオ)キノリンを、実施例25と同様にして、4−クロロ−8−(2,6−ジク
ロロベンゾイルアミノ)キノリンと2−メルカプトイミダゾールとを反応させて
得た。
mp: 211-215℃
NMR(CDCl3,δ): 6.80(1H,d,J=4Hz),7.28-7.45(6H,
m),7.61(1H,d,J=8Hz),8.42(1H,d,J=4Hz),8.86(1H,d,
J=8Hz)実施例92
(1) 4−(2−アミノエチルアミノ)−8−(2,6−ジクロロベンゾイル
アミノ)キノリンを、実施例8と同様にして、4−クロロ−8−(2,6−ジク
ロロベンゾイルアミノ)キノリンとエチレンジアミンとを反応させて得た。
mp: 184-192℃
NMR(CDCl3,δ): 3.07-3.16(2H,m),3.30-3.40(2H,m),
5.78(1H,m),6.44(1H,d,J=6Hz),7.22-7.40(3H,m),7.42-
7.59(2H,m),8.39(1H,d,J=6Hz),8.90(1H,d,J=8Hz),
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−アミノエチル
アミノ)キノリン(250mg)のジオキサン(3ml)中の懸濁液に、1,1
’−カルボニルジイミダゾール(119mg)を室温で加え、混合物を同温で1
時間攪拌した。混合物に1,8−ジアザビシクロ[5.4.0]ウンデク−7
−エン(112mg)のジオキサン(1ml)中の溶液を加え、混合物を70℃
で2時間攪拌した。混合物を真空中で濃縮し、残留物をエタノールから結晶化し
て、8−(2,6−ジクロロベンゾイルアミノ)−4−(2−オキソイミダゾリ
ジン−1−イル)キノリン(200mg)を得た。
mp: 265-269℃
NMR(DMSO-d6,δ): 3.55(2H,t,J=8Hz),4.02(2H,t,
J=8Hz),7.31(1H,br s),7.47-7.65(5H,m),7.80(1H,d,
J=8Hz),8.70(1H,d,J=8Hz),8.81(1H,d,J=5Hz)実施例93
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(N−メチル
アミノ)エチルアミノ]キノリンを、実施例8と同様にして、4−クロロ−8−
(2,6−ジクロロベンゾイルアミノ)キノリンとN−メチルエチレンジアミン
とを反応させて得た。
mp: 172-175℃
NMR(CDCl3,δ): 2.49(3H,s),2.99(2H,t,J=8Hz),
3.30-3.40(2H,m),5.32-5.41(1H,m),6.43(1H,d,J=6Hz),
7.26-7.56(5H,m),8.38(1H,d,J=6Hz),8.88(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メチル−2−
オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)と同様にして
得た。
mp: 238-242℃
NMR(CDCl3,δ): 2.98(3H,s),3.65(2H,t,J=8Hz),
3.96(2H,t,J=8Hz),7.29-7.45(4H,m),7.60(1H,t,J=8Hz),
7.75(1H,d,J=8Hz),8.25(1H,d,J=6Hz),8.97(1H,d,J=8Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メチル−2−
チオキソイミダゾリジン−1−イル)キノリンを、実施例92−(2)と同様に
して、8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(N−メチルア
ミノ)エチルアミノ]キノリンと1,1’−チオカルボニルジイミダゾールとを
反応させて得た。
mp: 295℃
NMR(CDCl3,δ): 3.30(3H,s),3.87-4.09(4H,m),
7.27-7.42(3H,m),7.50(1H,d,J=5Hz),7.59-7.69(2H,m),
8.81(1H,d,J=5Hz),8.96(1H,dd,J=8,5Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メチルアミノ
エチルアミノ)キノリン(120mg)のテトラヒドロフラン(2.5ml)中
の溶液に、1,1’−カルボニルジイミダゾール(90mg)を氷冷下で加え、
混合物を室温で2時間攪拌した。混合物を真空中で濃縮し、残留物をエタノール
から結晶化して、8−(2,6−ジクロロベンゾイルアミノ)−4−[2−[N
−(1−イミダゾリルカルボニル)−N−メチルアミノ]エチルアミノ]キノリ
ン(148mg)を得た。
mp: 202℃
NMR(DMSO-d6,δ): 3.08(3H,s),3.56-3.74(4H,m),
6.66(1H,m),6.97(1H,s),7.36-7.62(6H,m),7.92(1H,d,
J=8Hz),7.98(1H,br s),8.35(1H,d,J=6Hz),8.63(1H,d,
J=8Hz)実施例94
(1) 4−(2−メチルアミノエチルアミノ)−8−ニトロキナゾリンを、実
施例8と同様にして、4−クロロ−8−ニトロキナゾリンとN−メチルエチレン
ジアミンとを反応させて得た。
mp: 166-169℃
NMR(DMSO-d6,δ): 2.31(3H,s),2.73(2H,t,J=6Hz),
3.63(2H,t,J=6Hz),7.62(1H,t,J=7Hz),8.22(1H,d,J=7Hz),
8.50(1H,d,J=7Hz),8.51(1H,s)
(2) 4−(3−メチル−2−オキソイミダゾリジン−1−イル)−8−ニト
ロキナゾリンを実施例92−(2)と同様にして得た。
mp: 207-210℃
NMR(CDCl3,δ): 3.01(3H,s),3.67(2H,t,J=6Hz),
4.23(2H,t,J=6Hz),7.59(1H,t,J=7Hz),8.20(1H,d,J=7Hz),
8.48(1H,d,J=7Hz),9.10(1H,s)
(3) 8−アミノ−4−(3−メチル−2−オキソイミダゾリジン−1−イル
)キナゾリンを製造例2−(3)と同様にして得た。
mp: 187-189℃
NMR(DMSO-d6,δ): 2.84(3H,s),3.56(2H,t,J=6Hz),
4.07(2H,t,J=6Hz),5.92(2H,br s),6.99(1H,d,J=7Hz),
7.22(1H,d,J=7Hz),7.28(1H,t,J=7Hz),8.87(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メチル−2−
オキソイミダゾリジン−1−イル)キナゾリンを実施例1と同様にして得た。
mp:>250℃
NMR(DMSO-d6,δ): 2.88(3H,s),3.60(2H,t,J=6Hz),
4.12(2H,t,J=6Hz),7.45-7.58(3H,m),7.62(1H,t,J=7Hz),
7.98(1H,d,J=7Hz),8.79(1H,d,J=7Hz),9.00(1H,s)実施例95
8−(2,6−ジクロロベンゾイルアミノ)−4−(3,4,5,6−テトラ
ヒドロ−2(1H)−ピリミジノン−1−イル)キノリンを、実施例92−(2
)と同様にして、4−(3−アミノプロピルアミノ)−8−(2,6−ジクロロ
ベンゾイルアミノ)キノリンと1,1’−カルボニルジイミダゾールとを反応さ
せて得た。
mp:>250℃
NMR(CDCl3,δ): 2.08-2.40(2H,br),3.50-3.60(2H,
m),3.64-3.82(2H,m),5.18(1H,s),7.29-7.43(4H,m),7.59-
7.62(2H,m),8.79(1H,d,J=5Hz),8.91-9.00(1H,m)実施例96
4−(ベンズイミダゾリドン−1−イル)−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリンを、実施例92−(2)と同様にして、4−(2−アミノフ
ェニルアミノ)−8−(2,6−ジクロロベンゾイルアミノ)キノリンと1,1
’−カルボニルジイミダゾールとを反応させて得た。
mp: 246-248℃
NMR(CDCl3,δ): 6.70(1H,d,J=8Hz),7.01-7.25(3H,
m),7.32-7.50(4H,m),7.58-7.68(2H,m),8.98(1H,d,J=5Hz),
9.06(1H,d,J=8Hz),9.31(1H,s)実施例97
4−(1H−イミダゾ[4,5−b]ピリジン−2−イルチオ)−8−(2,
6−ジクロロベンゾイルアミノ)キノリン塩酸塩を、実施例25と同様にして、
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリンと2−メルカ
プト−1H−イミダゾ[4,5−b]ピリジンとを反応させて得た。
mp: 182-190℃
NMR(DMSO-d6,δ): 7.44-7.63(4H,m),7.77(1H,t,
J=8Hz),7.88(1H,d,J=4Hz),8.01(1H,d,J=8Hz),8.25(1H,d,
J=8Hz),8.46(1H,d,J=4Hz),8.80(1H,d,J=8Hz),8.91(1H,d,
J=4Hz)実施例98
(1) 3−クロロ−1,4−ジヒドロ−8−ニトロ−4−オキソキノリンを、
製造例6−(1)と同様にして、1,4−ジヒドロ−8−ニトロ−4−オキソキ
ノリンとN−クロロスクシンイミドとを反応させて得た。
mp: 290-297℃
NMR(DMSO-d6,δ): 7.59(1H,t,J=8Hz),8.26(1H,s),
8.61(1H,dd,J=8,2Hz),8.78(1H,dd,J=8,2Hz)
(2) 3,4−ジクロロ−8−ニトロキノリンを製造例2−(1)と同様にし
て得た。
mp: 123℃
NMR(CDCl3,δ): 7.76(1H,t,J=8Hz),8.06(1H,d,
J=8Hz),8.45(1H,d,J=8Hz),8.98(1H,s)
(3) 4−[ビス(エトキシカルボニル)メチル]−3−クロロ−8−ニトロ
キノリンを製造例7−(1)と同様にして得た。
mp: 101.5℃
NMR(CDCl3,δ): 1.23(6H,t,J=8Hz),4.14-4.33(4H,
m),5.75(1H,s),7.67(1H,t,J=8Hz),7.99(1H,d,J=8Hz),
8.27(1H,d,J=8Hz),9.02(1H,s)
(4) 3−クロロ−4−(エトキシカルボニルメチル)−8−ニトロキノリン
を製造例7−(2)と同様にして得た。
mp: 156℃
NMR(CDCl3,δ);1.23(3H,t,J=8Hz),4.18(2H,q,
J=8Hz),4.30(2H,s),7.70(1H,t,J=8Hz),8.00(1H,d,
J=8Hz),8.16(1H,d,J=8Hz),8.98(1H,s)
(5) 8−アミノ−3−クロロ−4−(エトキシカルボニルメチル)キノリン
を製造例2−(3)と同様にして得た。
mp: 144℃
NMR(CDCl3,δ): 1.21(3H,t,J=8Hz),4.14(2H,q,
J=8Hz),4.20(2H,s),5.01(2H,br s),6.90(1H,d,J=8Hz),
7.20(1H,d,J=8Hz),7.38(1H,t,J=8Hz),8.67(1H,s)
(6) 3−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(エト
キシカルボニルメチル)キノリンを実施例1と同様にして得た。
mp: 161℃
NMR(CDCl3,δ): 1.23(3H,t,J=8Hz),4.18(2H,q,
J=8Hz),4.26(2H,s),7.30-7.45(3H,m),7.66-7.71(2H,m),
8.70(1H,s),8.91-9.01(1H,s)
(7) 4−カルボキシメチル−3−クロロ−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリンを実施例18と同様にして得た。
mp: 257-259℃
NMR(DMSO-d6,δ): 4.31(2H,s),7.47-7.61(3H,m),
7.75(1H,t,J=8Hz),7.96(1H,d,J=8Hz),8.72(1H,d,J=8Hz),
8.99(1H,s)
(8) 4−カルバモイルメチル−3−クロロ−8−(2,6−ジクロロベンゾ
イルアミノ)キノリンを実施例22−(2)と同様にして得た。
mp: >300℃
NMR(DMSO-d6,δ): 4.17(2H,s),7.20(1H,br s),
7.46-7.61(3H,m),7.70(1H,br s),7.72(1H,t,J=8Hz),7.90
(1H,d,J=8Hz),8.70(1H,d,J=8Hz),8.86(1H,s)
(9) 3−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−メチル
キノリンを、実施例37と同様にして、3−クロロ−8−(2,6−ジクロロベ
ンゾイルアミノ)−4−(エトキシカルボニルメチル)キノリンから得た。
mp: 259℃
NMR(DMSO-d6,δ): 2.76(3H,s),7.46-7.60(3H,m),
7.75(1H,t,J=8Hz),7.96(1H,d,J=8Hz),8.70(1H,d,J=8Hz),
8.80(1H,d,J=8Hz)実施例99
塩化セリウム(III)七水和物(580mg)を減圧下で150℃で乾燥し
、窒素雰囲気下で室温まで冷却し、テトラヒドロフラン(2ml)に懸濁した。
懸濁液に3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(エト
キシカルボニルメチル)キノリン(300mg)と0.9M臭化メチルマグネシ
ウムのテトラヒドロフラン溶液(3.5ml)を氷冷下で加え、混合物を1時間
攪拌した。混合物を飽和塩化アンモニウム溶液に注ぎ、酢酸エチルで抽出した。
有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した
。残留物をイソプロピルアルコールから結晶化して、3−ブロモ−8−(2,6
−ジクロロベンゾイルアミノ)−4−(2−ヒドロキシ−2−メチルプロピル)
キノリン(216mg)を得た。
mp: 260-262℃
NMR(CDCl3,δ): 1.38(6H,s),3.56(2H,s),7.30-
7.55(3H,m),7.67(1H,t,J=8Hz),8.02(1H,d,J=8Hz),8.82
(1H,s),8.97(1H,d,J=8Hz)実施例100
3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダ
ゾール−1−イル)キノリン(147.6mg)とトリエチルアミン(12.2
mg)のジオキサン中の混合物に、アジ化ジフェニルホスホリル(99.8m
g)を90℃で加え、混合物を同温で2時間攪拌した。70℃に冷却後、それに
メタノール(12.2mg)を加え、混合物を85℃で1時間攪拌した。混合物
を酢酸エチルと水との間に分配した。有機層を食塩水で洗浄し、硫酸マグネシウ
ムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマトグラフィー(
メタノール−ジクロロメタン)で精製して、イソプロピルアルコールから結晶化
して、8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−
イル)−3−(メトキシカルボニルアミノ)キノリン(21.3mg)を得た。
mp: 236-238℃
NMR(CDCl3,δ): 3.78(3H,s),6.59(1H,br s),6.96
(1H,d,J=8Hz),7.12(1H,br s),7.30-7.50(4H,m),7.60(1H,
t,J=8Hz),7.65(1H,br s),8.93(1H,d,J=8Hz),9.67(1H,s)実施例101
(1) 3−第三級ブトキシカルボニルアミノ−8−(2,6−ジクロロベンゾ
イルアミノ)−4−(イミダゾール−1−イル)キノリンを、実施例100と同
様にして、3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−
(イミダゾール−1−イル)キノリンと第三級ブタノールから得た。
mp: 205-206℃
NMR(CDCl3,δ): 1.50(9H,s),6.30(1H,s),6.94
(1H,d,J=8Hz),7.13(1H,s),7.30-7.50(4H,m),7.59(1H,t,
J=8Hz),7.67(1H,s),8.91(1H,d,J=8Hz),9.69(1H,s)
(2) 3−第三級ブトキシカルボニルアミノ−8−(2,6−ジクロロベンゾ
イルアミノ)−4−(イミダゾール−1−イル)キノリン(869mg)のジク
ロロメタン(2ml)中の溶液に、トリフルオロ酢酸(5ml)を氷冷下で加え
、混合物を室温で2時間攪拌した。混合物をジクロロメタンと飽和重炭酸ナトリ
ウム溶液との間に分配した。有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥
後、真空中で溶媒を留去した。残留物をイソプロピルアルコールから結晶化して
、3−アミノ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾー
ル−1−イル)キノリン(581.4mg)を得た。
mp:>250℃
NMR(CDCl3,δ): 4.01(2H,s),6.93(1H,d,J=8Hz),
7.12(1H,s),7.30-7.50(4H,m),7.53(1H,t,J=8Hz),7.68
(1H,s),8.51(1H,s),8.77(1H,d,J=8Hz),9.88(1H,s)
その二塩酸塩
mp: 248-250℃
NMR(DMSO-d6,δ): 6.23(2H,br),6.68(1H,d,J=8Hz),
7.45-7.60(4H,m),7.95(1H,s),8.09(1H,s),8.42(1H,d,
J=8Hz),8.71(1H,s),9.52(1H,s)実施例102
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−3−(4−ピリジルチオ)キノリンを、実施例25と同様にして、3−ブロ
モ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イ
ル)キノリンと4−メルカプトピリジンとを反応させて得た。
mp: 218-220℃
NMR(DMSO-d6,δ): 7.10-7.20(4H,m),7.45-7.60(4H,
m),7.82(1H,t,J=7Hz),7.90(1H,s),8.34(2H,d,J=5Hz),
8.86(1H,d,J=7Hz),9.03(1H,s)
そのジメタンスルホン酸塩
mp: >250℃
NMR(DMSO-d6,δ): 2.32(6H,s),7.34(1H,d,J=7Hz),
7.48-7.62(5H,m),7.88(1H,s),7.91(1H,t,J=7Hz),7.97
(1H,s),8.55(2H,d,J=6Hz),8.94(1H,d,J=7Hz),9.21(1H,
s),9.23(1H,s)実施例103
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−3−(メチルチオ)キノリン塩酸塩を、製造例13と同様にして、3−ブロ
モ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イ
ル)キノリンとナトリウムチオメトキシドとを反応させて得た。
mp: 212-216℃
NMR(DMSO-d6,δ): 2.19(3H,s),7.12(1H,d,J=7Hz),
7.47-7.63(3H,m),7.77(1H,t,J=7Hz),8.02(2H,br s),8.73
(1H,d,J=7Hz),9.14(1H,s),9.38(1H,br s)実施例104
(1) 3−クロロメチル−1,4−ジヒドロ−8−ニトロ−4−オキソキノリ
ン(2.0g)の水(30ml)中の懸濁液を15分間還流し、室温になるまで
静置させた。生じた沈殿物を濾過により集め、水で洗浄して、1,4−ジヒドロ
−3−ヒドロキシメチル−8−ニトロ−4−オキソキノリン(1.82g)を得
た。
mp: 182-184℃
NMR(DMSO-d6,δ): 4.41(2H,s),5.14(1H,br),7.49
(1H,t,J=7Hz),8.00(1H,s),8.59(1H,d,J=7Hz),8.66(1H,
d,J=7Hz)
(2) 1,4−ジヒドロ−3−ヒドロキシメチル−8−ニトロ−4−オキソキ
ノリン(3.1g)のトリフルオロ酢酸(10ml)とジクロロメタン(10m
l)中の溶液に、トリエチルシラン(6.55g)を加え、混合物を室温で一夜
攪拌した。混合物をジクロロメタンと飽和重炭酸ナトリウム溶液との間に分配し
た。有機層を食塩水で洗浄し、硫酸ナトリウムで乾燥後、真空中で溶媒を留去し
た。残留物をシリカゲルカラムクロマトグラフィーで精製して、1,4−ジヒド
ロ−3−メチル−8−ニトロ−4−オキソキノリン(2.3g)を得た。
mp: 235-243℃
NMR(CDCl3,δ): 2.16(3H,s),7.41(1H,t,J=7Hz),
7.69(1H,d,J=7Hz),8.65(1H,d,J=7Hz),8.82(1H,d,J=7Hz)
(3) 4−クロロ−3−メチル−8−ニトロキノリンを製造例2−(1)と同
様にして得た。
mp: 126℃
NMR(CDCl3,δ): 2.61(3H,s),7.68(1H,t,J=8Hz),
8.00(1H,d,J=8Hz),8.46(1H,d,J=8Hz),8.88(1H,s)
(4) 8−アミノ−4−クロロ−3−メチルキノリンを製造例2−(3)と同
様にして得た。
mp: 112-114℃
NMR(CDCl3,δ): 2.54(3H,s),4.99(2H,brs),6.90
(1H,d,J=8Hz),7.38(1H,t,J=8Hz),7.50(1H,d,J=8Hz),8.55
(1H,s)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチル
キノリンを実施例1と同様にして得た。
mp: 216-227℃
NMR(CDCl3,δ): 2.57(3H,s),7.28-7.46(3H,m),7.67
(1H,t,J=8Hz),7.96(1H,d,J=8Hz),8.59(1H,s),8.94(1H,
d,J=8Hz)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−メチルキノリンを実施例8と同様にして得た。
mp: 224-228℃
NMR(CDCl3,δ): 2.30(3H,s),7.09(1H,d,J=8Hz),
7.10(1H,s),7.30-7.45(4H,m),7.60(1H,t,J=8Hz),7.63
(1H,s),8.77(1H,s),8.96(1H,d,J=8Hz)
その塩酸塩
mp: 231-235℃
NMR(DMSO-d6,δ): 2.30(3H,s),7.11(1H,d,J=8Hz),
7.47-7.66(4H,m),7.75(1H,t,J=8Hz),8.00-8.14(2H,m),
8.75(1H,d,J=8Hz),9.08(1H,s),9.37(1H,s)実施例105
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−[2−
(N−メチルアミノ)エチルアミノ]キノリンを、実施例8と同様にして、4−
クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリンとN
−メチルエチレンジアミンとを反応させて得た。
mp: 274-278℃
NMR(DMSO-d6,δ): 2.40(3H,s),2.56(3H,s),3.07-
3.20(2H,m),3.69-3.75(2H,m),6.19(1H,br t,J=7Hz),7.41-
7.66(4H,m),8.03(1H,d,J=8Hz),8.37(1H,s),8.59(1H,d,
J=8Hz),8.74(1H,br s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(3−
メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)
と同様にして得た。
mp: 288℃
NMR(DMSO-d6,δ): 2.36(3H,s),2.81(3H,s),3.56-
3.86(4H,m),7.46-7.61(3H,m),7.65-7.70(2H,m),8.65(1H,
t,J=8Hz),8.85(1H,s)実施例106
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−ビニルキノリンを、製造例14と同様にして、3−ブロモ−8−
(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル)キノ
リンとトリ−n−ブチル(ビニル)錫から得た。
mp: 194-195℃
NMR(CDCl3,δ): 5.53(1H,d,J=11Hz),5.96(1H,d,
J=15Hz),6.45(1H,dd,J=11,15Hz),7.10-7.20(2H,オーバーラップ
ラップ),7.30-7.50(3H,m),7.63(1H,t,J=8Hz),7.66(1H,s),
9.00(1H,d,J=8Hz),9.10(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(イミ
グゾール−1−イル)キノリンを実施例41と同様にして得た。
mp: 187-188℃
NMR(CDCl3,δ): 1.21(3H,t,J=7Hz),2.63(2H,q,
J=7Hz),7.05(1H,d,J=8Hz),7.13(1H,s),7.30-7.50(4H,m),
7.60(1H,t,J=8Hz),7.64(1H,s),8.82(1H,s),8.98(1H,d,
J=8Hz)
その塩酸塩
mp: 238-242℃
NMR(DMSO-d6,δ): 1.16(3H,t,J=7Hz),2.59(2H,q,
J=7Hz),7.07(1H,d,J=8Hz),7.50-7.60(3H,m),7.75(1H,t,
J=8Hz),8.04(1H,s),8.10(1H,s),8.77(1H,d,J=8Hz),9.12
(1H,s),9.41(1H,s)実施例107
8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−メチル
イミダゾール−1−イル)キノリンを、実施例106−(1)および(2)と同
様にして、3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(2
−メチルイミダゾール−1−イル)キノリンから得た。
NMR(CDCl3,δ): 1.20(3H,t,J=8Hz),2.10(3H,s),
2.46-2.70(2H,m),6.90(1H,d,J=8Hz),6.95(1H,s),7.20-
7.71(5H,m),8.81(1H,s),8.97(1H,d,J=8Hz)
その塩酸塩
mp: 169-176℃
NMR(DMSO-d6,δ): 1.17(3H,t,J=8Hz),2.36(3H,s),
2.40-2.56(1H,m),2.58-2.76(1H,m),7.05(1H,d,J=8Hz),
7.48-7.63(3H,m),7.74(1H,t,J=8Hz),7.98-8.07(2H,m),
8.76(1H,d,J=8Hz),9.13(1H,s)実施例108
(1) 4−カルボギシメチル−8−(2,6−ジクロロベンゾイルアミノ)−
3−エチルキノリン(405mg)のジメチルホルムアミド中の溶液に、炭酸カ
リウム(305mg)とヨウ化メチル(314mg)を加え、混合物を室温で2
時間攪拌した。混合物を酢酸エチルと水との間に分配した。有機層を食塩水で洗
浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(酢酸エチル:n−ヘキサン、1:3、v/v)で
精製し、エタノール−水から結晶化して、8−(2,6−ジクロロベンゾイルア
ミノ)−3−エチル−4−(メトキシカルボニルメチル)キノリン(282mg
)を得た。
mp: 167-168℃
NMR(CDCl3,δ): 1.28(3H,t,J=7Hz),2.90(2H,q,
J=7Hz),3.69(3H,s),4.64(2H,s),7.30-7.45(3H,m),7.62
(1H,t,J=8Hz),7.72(1H,d,J=8Hz),8.63(1H,s),8.90(1H,
d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
ヒドロキシ−2−メチルプロピル)キノリンを実施例99と同様にして得た。
mp: 203-204℃
NMR(CDCl3,δ): 1.24(3H,t,J=7Hz),1.33(6H,s),
2.97(2H,q,J=7Hz),3.38(2H,s),7.30-7.45(3H,m),7.59
(1H,t,J=8Hz),7.91(1H,d,J=8Hz),8.63(1H,s),8.88(1H,
d,J=8Hz)実施例109
4−カルバモイルメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
エチルキノリンを、実施例22−(2)と同様にして、4−カルボキシメチル−
8−(2,6−ジクロロベンゾイルアミノ)−3−エチルキノリンと濃アンモニ
ア溶液から得た。
mp: 180-182℃
NMR(DMSO-d6,δ): 1.21(3H,t,J=7Hz),2.86(2H,q,
J=7Hz),4.02(2H,s),7.12(2H,brs),7.50-7.65(4H,m),7.71
(1H,br s),7.87(1H,d,J=8Hz),8.64(1H,d,J=8Hz),8.73
(1H,s)
その塩酸塩
mp: 223-227℃
NMR(DMSO-d6,δ): 1.20(3H,t,J=7Hz),2.87(2H,q,
J=7Hz),4.03(2H,s),7.13(1H,br s),7.50-7.65(4H,m),7.73
(1H,br s),7.88(1H,d,J=8Hz),8.64(1H,d,J=8Hz),8.74
(1H,s)実施例110
(1) 3−ブロモ−4−カルボキシメチル−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリン(130mg)の無水テトラヒドロフラン中の溶液に、10
Mボラン−硫化メチル錯体のテトラヒドロフラン溶液(0.286ml)を室温
で加え、混合物を同温で4時間攪拌した。1N塩酸を加えて混合物の反応を停止
させ、同温で1時間攪拌した。混合物を酢酸エチルで抽出し、抽出物を飽和重炭
酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒
を留去した。残留物をシリカゲルカラムクロマトグラフィー(酢酸エチル:n−
ヘキサン、1:2、v/v)で精製し、酢酸エチル−n−ヘキサンから結晶化し
て、3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(2−ヒド
ロキシエチル)キノリン(68.4mg)を得た。
mp: 199-200℃
NMR(CDCl3,δ): 1.53(1H,t,J=6Hz),3.58(2H,t,
J=6Hz),4.01(2H,q,J=6Hz),7.30-7.45(3H,m),7.68(1H,t,
J=8Hz),7.87(1H,d,J=8Hz),8.79(1H,s),8.98(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−ヒドロキシエ
チル)−3−ビニルキノリンを製造例14と同様にして得た。
mp: 133-135℃
NMR(CDCl3,δ): 1.50(1H,t,J=6Hz),3.48(2H,t,
J=6Hz),3.97(2H,q,J=6Hz),5.58(1H,d,J=11Hz),5.84(1H,
d,J=17Hz),7.22(1H,dd,J=11,17Hz),7.30-7.50(3H,m),7.65
(1H,t,J=8Hz),7.86(1H,d,J=8Hz),8.89(1H,s),8.94(1H,
d,J=8Hz)
その塩酸塩
mp: 187-203℃
NMR(DMSO-d6,δ): 3.36(2H,t,J=6Hz),3.65(2H,t,
J=6Hz),5.57(1H,d,J=11Hz),5.98(1H,d,J=17Hz),7.27(1H,
dd,J=11,17Hz),7.50-7.60(3H,m),7.67(1H,t,J=8Hz),8.00
(1H,d,J=8Hz),8.67(1H,d,J=8Hz),9.00(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
ヒドロキシエチル)キノリンを実施例41と同様にして得た。
mp: 180-182℃
NMR(CDCl3,δ): 1.31(3H,t,J=7Hz),1.51(1H,t,
J=6Hz),2.92(2H,q,J=7Hz),3.42(2H,t,J=6Hz),3.97(1H,q,
J=6Hz),7.30-7.45(3H,m),7.61(1H,t,J=8Hz),7.80(1H,d,
J=8Hz),8.60(1H,s),8.89(1H,d,J=8Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
ヒドロキシエチル)キノリン(405mg)のジクロロメタン中の溶液に、N−
ブロモスクシンイミド(241mg)とトリフェニルホスフィン(355mg)
を水冷下で加え、混合物を同温で30分間攪拌した。混合物を真空中で濃縮し、
残留物をシリカゲルカラムクロマトグラフィー(ジクロロメタン)で精製し、n
−ヘキサンから結晶化して、4−(2−ブロモエチル)−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−エチルキノリン(424mg)を得た。
mp: 187-188℃
NMR(CDCl3,δ): 1.32(3H,t,J=7Hz),2.90(2H,q,
J=7Hz),3.62(4H,m),7.30-7.45(3H,m),7.65(1H,t,J=8Hz),
7.73(1H,d,J=8Hz),8.62(1H,s),8.92(1H,d,J=8Hz),10.14
(1H,br s)実施例111
8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−[2−(イミ
ダゾール−2−イルチオ)エチル]キノリンを、実施例62と同様にして、4−
(2−ブロモエチル)−8−(2,6−ジクロロベンゾイルアミノ)−3−エチ
ルキノリンと2−メルカプトイミダゾールとを反応させて得た。
mp: 214-215℃
NMR(DMSO-d6,δ): 1.18(3H,t,J=7Hz),2.81(2H,q,
J=7Hz),3.20(2H,m),3.44(2H,m),7.16(2H,br s),7.50-7.70
(4H,m),7.93(1H,d,J=8Hz),8.65(1H,d,J=8Hz),8.71(1H,
s)
その二塩酸塩
mp: 233-235℃
NMR(DMSO-d6,δ): 1.18(3H,t,J=7Hz),2.79(2H,q,
J=7Hz),3.42(2H,m),3.55(2H,m),7.50-7.60(3H,m),7.65
(1H,t,J=8Hz),7.72(2H,s),7.79(1H,d,J=8Hz),8.66(1H,
d,J=8Hz),8.73(1H,s)実施例112
下記の化合物を、実施例8と同様にして、4−(2−ブロモエチル)−8−(
2,6−ジクロロベンゾイルアミノ)−3−エチルキノリンとアミンまたはイミ
ン化合物から得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(N,N−ジ
メチルアミノ)エチル]−3−エチルキノリン
mp: 73-75℃
NMR(CDCl3,δ): 1.81(3H,t,J=7Hz),2.41(6H,s),
2.55(1H,m),2.87(2H,q,J=7Hz),3.28(2H,m),7.30-7.45
(3H,m),7.61(1H,t,J=8Hz),7.78(1H,d,J=8Hz),8.58(1H,
s),8.89(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−[2−
[N−(2−ヒドロキシエチル)−N−メチルアミノ]エチル]キノリン
mp: 123-125℃
NMR(DMSO-d6,δ): 1.27(3H,t,J=7Hz),2.38(3H,s),
2.56(2H,t,J=6Hz),2.62(2H,m),2.87(2H,q,J=7Hz),3.25
(2H,m),3.50(2H,q,J=6Hz),4.42(1H,t,J=6Hz),7.45-7.60
(3H,m),7.66(1H,t,J=8Hz),7.79(1H,d,J=8Hz),9.65(1H,
d,J=7Hz),9.71(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−[2−
(イミダゾール−1−イル)エチル]キノリン
mp: 190-191℃
NMR(DMSO-d6,δ): 1.17(3H,t,J=7Hz),2.67(2H,q,
J=7Hz),3.55(2H,t,J=7Hz),4.27(2H,t,J=7Hz),6.86(1H,
s),7.20(1H,s),7.45-7.65(4H,m),7.66(1H,t,J=8Hz),7.96
(1H,d,J=8Hz),8.67(1H,d,J=8Hz),8.71(1H,s)
その二塩酸塩
mp: 219-222℃
NMR(DMSO-d6,δ): 1.20(3H,t,J=7Hz),2.77(2H,q,
J=7Hz),3.69(2H,t,J=7Hz),4.48(2H,t,J=7Hz),7.50-7.65
(3H,m),7.67(1H,t,J=8Hz),7.68(1H,s),7.89(1H,s),7.97
(1H,d,J=8Hz),8.68(1H,d,J=8Hz),8.76(1H,s),9.13(1H,
s)
(4) 4−[2−(1H−ベンズイミダゾール−1−イル)エチル]−8−(
2,6−ジクロロベンゾイルアミノ)−3−エチルキノリン
mp: 196-1907℃
NMR(DMSO-d6,δ): 1.08(3H,t,J=7Hz),2.56(2H,q,
J=7Hz),3.65(2H,t,J=7Hz),4.58(2H,t,J=7Hz),7.15-7.25
(2H,m),7.43(1H,dd,J=3,7Hz),7.45-7.70(5H,m),7.95(1H,
d,J=8Hz),8.09(1H,s),8,67(1H,s),8.68(1H,d,J=8Hz)
その二塩酸塩
mp: 236-238℃
NMR(DMSO-d6,δ): 1.17(3H,t,J=7Hz),2.75(2H,q,
J=7Hz),3.83(2H,t,J=7Hz),4.78(2H,t,J=7Hz),7.50-7.70
(6H,m),7.80-7.95(3H,m),8.68(1H,d,J=8Hz),8.75(1H,s),
9.65(1H,s)実施例113
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−ヒドロ
キシメチルキノリン(300mg)とトリエチルアミン(404mg)のジメチ
ルスルホキシド(3ml)とジクロロメタン(1ml)中の溶液に、三酸化硫黄
−ピリジン錯体(191mg)を氷冷下で加え、混合物を同温で1時間攪拌した
。混合物をジクロロエタンと水との間に分配し、有機層を水で洗浄し、硫酸マグ
ネシウムで乾燥後、真空中で溶媒を留去して、8−(2,6−ジクロロベンゾイ
ルアミノ)−3−エチル−4−ホルミルキノリン(235mg)を得た。
mp: 208℃
NMR(CDCl3,δ): 1.37(3H,t,J=8Hz),3.14(2H,q,
J=8Hz),7.30-7.47(3H,m),7.72(1H,t,J=8Hz),8.38(1H,d,
J=8Hz),8.76(1H,s),8.96(1H,d,J=8Hz),10.95(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−((E)−2−エト
キシカルボニルビニル)−3−エチルキノリンを製造例19−(2)と同様にし
て得た。
mp: 115-118℃
NMR(CDCl3,δ): 1.27(3H,t,J=7Hz),1.40(3H,t,
J=7Hz),2.86(2H,q,J=7Hz),4.35(2H,q,J=7Hz),6.30(1H,d,
J=15Hz),7.30-7.45(3H,m),7.61(1H,t,J=8Hz),7.73(1H,d,
J=8Hz),8.07(1H,d,J=15Hz),8.67(1H,s),8.93(1H,d,
J=8Hz)
(3) 4−((E)−2−カルボキシビニル)−8−(2,6−ジクロロベン
ゾイルアミノ)−3−エチルキノリンを実施例18と同様にして得た。
mp: 235-236℃
NMR(DMSO-d6,δ): 1.22(3H,t,J=7Hz),2.83(2H,q,
J=7Hz),6.28(1H,d,J=15Hz),7.50-7.60(3H,m),7.67(1H,t,
J=8Hz),7.74(1H,d,J=8Hz),7.99(1H,d,J=15Hz),8.68(1H,
d,J=8Hz),8.83(1H,s)
(4) 4−((E)−2−カルバモイルビニル)−8−(2,6−ジクロロベ
ンゾイルアミノ)−3−エチルキノリンを実施例22−(2)と同様にして得た
。
mp: >250℃
NMR(DMSO-d6,δ): 1.22(3H,t,J=7Hz),2.33(2H,q,
J=7Hz),6.43(1H,d,J=15Hz),7.40(1H,brs),7.50-7.60(3H,
m),7.67(1H,t,J=8Hz),7.77(1H,d,J=8Hz),7.80(1H,br s),
7.82(1H,d,J=15Hz),8.69(1H,d,J=8Hz),8.82(1H,s)実施例114
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−エトキシカル
ボニルエチル)−3−エチルキノリンを、実施例41と同様にして、8−(2,
6−ジクロロベンゾイルアミノ)−4−((E)−2−エトキシカルボニルビニ
ル)−3−エチルキノリンから得た。
mp: 88-90℃
NMR(CDCl3,δ): 1.29(3H,t,J=7Hz),1.31(311,t,
J=7Hz),2.63(2H,t,J=7Hz),2.87(2H,q,J=7Hz),3.43(2H,t,
J=7Hz),4.18(2H,q,J=7Hz),7.30-7.45(3H,m),7.62(1H,t,
J=8Hz),7.75(1H,d,J=8Hz),8.58(1H,s),8.89(1H,d,J=8Hz)
(2) 4−(2−カルボキシエチル)−8−(2,6−ジクロロベンゾイルア
ミノ)−3−エチルキノリンを実施例18と同様にして得た。
mp: 236-237℃
NMR(DMSO-d6,δ): 1.24(3H,t,J=7Hz),2.45-2.55(2H,
m),2.88(1H,q,J=7Hz),3.30-3.40(2H,m),7.45-7.60(3H,m),
7.67(1H,t,J=8Hz),7.90(1H,d,J=8Hz),8.66(1H,d,J=8Hz),
8.72(1H,s)
(3) 4−(2−カルバモイルエチル)−8−(2,6−ジクロロベンゾイル
アミノ)−3−エチルキノリンを実施例22−(2)と同様にして得た。
mp: 235-236℃
NMR(DMSO-d6,δ): 1.24(3H,t,J=7Hz),2.37(2H,m),
2.88(2H,q,J=7Hz),3.30-3.40(2H,m),6.91(1H,brs),7.41
(1H,brs),7.50-7.60(3H,m),7.66(1H,t,J=8Hz),7.92(1H,
d,J=8Hz),8.65(1H,d,J=8Hz),8.71(1H,s)
その塩酸塩
mp: 230-232℃
NMR(DMSO-d6,δ): 1.25(3H,t,J=7Hz),2.38(2H,t,
J=8Hz),2.88(2H,q,J=7Hz),3.32(2H,t,J=8Hz),6.92(1H,br
s),7.43(1H,brs),7.50-7.60(3H,m),7.67(1H,t,J=8Hz),
7.93(1H,d,J=8Hz),8.66(1H,d,J=8Hz),8.72(1H,s)実施例115
8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(3−ヒドロ
キシ−3−メチルブチル)キノリンを、実施例99と同様にして、8−(2,6
−ジクロロベンゾイルアミノ)−4−(2−エトキシカルボニルエチル)−3−
エチルキノリンと臭化メチルマグネシウムとを反応させて得た。
mp: 158-160℃
NMR(CDCl3,δ): 1.33(3H,t,J=7Hz),1.40(6H,s),
1.78(2H,m),2.86(2H,q,J=7Hz),3.21(2H,m),7.30-7.45
(3H,m),7.61(1H,t,J=8Hz),7.81(1H,d,J=8Hz),8.58(1H,
s),7.89(1H,d,J=8Hz)
その塩酸塩
mp: 211-214℃
NMR(CDCl3,δ): 1.41(3H,t,J=7Hz),1.78(2H,m),
2.99(2H,q,J=7Hz),3.44(2H,m),7.30-7.45(3H,m),7.91
(1H,t,J=8Hz),8.09(1H,d,J=8Hz),8.74(1H,s),9.14(1H,
d,J=8Hz)実施例116
(1) 燐酸二水素ナトリウム(395mg)と2−メチル−2−ブテン(57
8mg)の第三級ブタノール(6ml)と水(1.5ml)中の溶液に、8−(
2,6−ジクロロベンゾイルアミノ)−3−エチル−4−ホルミルキノリン(6
15mg)を室温で加え、混合物に亜塩素酸ナトリウム(298mg)を同温で
少しずつ加えた。混合物を同温で3時間攪拌した。希塩酸を加えて混合物の反応
を停止させ、ジクロロメタンで抽出した。抽出物を硫酸マグネシウムで乾燥後、
真空中で溶媒を留去した。残留物を酢酸エチル−n−ヘキサンから再結晶して、
4−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−3−エチルキノ
リン(404mg)を得た。
mp: 231-233℃
NMR(CDCl3,δ): 1.35(3H,t,J=7Hz),2.94(2H,q,
J=7Hz),7.30-7.45(3H,m),7,67(1H,t,J=8Hz),7.73(1H,d,
J=8Hz),8.73(1H,s),8.94(1H,d,J=8Hz)
(2) 4−カルバモイル−8−(2,6−ジクロロベンゾイルアミノ)−3−
エチルキノリンを実施例22−(2)と同様にして得た。
mp: 247-248℃
NMR(DMSO-d6,δ): 1.27(3H,t,J=7Hz),2.80(2H,q,
J=7Hz),7.50-7.60(4H,m),7.68(1H,t,J=8Hz),8.05(1H,br
s),8.20(1H,br s),8.66(1H,d,J=8Hz),8.85(1H,s)実施例117
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(メト
キシカルボニル)キノリンを、実施例108−(1)と同様にして、4−カルボ
キシ−8−(2,6−ジクロロベンゾイルアミノ)−3−エチルキノリンとヨウ
化メチルから得た。
mp: 160-161℃
NMR(CDCl3,δ): 1.31(3H,t,J=7Hz),2.82(2H,q,
J=7Hz),4.07(3H,s),7.30-7.50(3H,m),7.51(1H,d,J=8Hz),
7.64(1H,t,J=8Hz),8.70(1H,s),8.93(1H,d,J=8Hz)
(2) 4−アセチル−8−(2,6−ジクロロベンゾイルアミノ)−3−エチ
ルキノリンを実施例99と同様にして得た。
mp: 194-195℃
NMR(CDCl3,δ): 1.33(3H,t,J=7Hz),2.67(3H,s),
2.75(2H,q,J=7Hz),7.30-7.45(4H,m),7.64(1H,t,J=8Hz),
8.69(1H,s),8.95(1H,d,J=8Hz)実施例118
8−(2,6−ジクロロベンゾイルアミノ)−3−エチル-4−(メトキシメ
チル)キノリンを、製造例2−(2)と同様にして、4−クロロメチル−8−(
2,6−ジクロロベンゾイルアミノ)−3−エチルキノリンとナトリウムメトキ
シドとを反応させて得た。
mp: 142-143℃
NMR(CDCl3,δ): 1.29(3H,t,J=7Hz),2.95(2H,q,
J=7Hz),3.48(3H,s),4.89(2H,s),7.30-7.45(3H,m),7.63
(1H,t,J=8Hz),7.90(1H,d,J=8Hz),8.63(1H,s),8.88(1H,
d,J=8Hz)
その塩酸塩
mp: 155-163℃
NMR(CDCl3,δ): 1.38(3H,t,J=7Hz),3.06(2H,q,
J=7Hz),3.55(3H,s),5.00(2H,s),7.30-7.45(3H,m),7.92
(1H,t,J=8Hz),8.14(1H,d,J=8Hz),8.82(1H,s),9.17(1H,
d,J=8Hz)実施例119
下記の化合物を実施例59と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−ジメチルアミノメチ
ル−3−エチルキノリン
NMR(CDCl3,δ): 1.27(3H,t,J=7Hz),2.29(6H,s),
2.95(2H,q,J=7Hz),3.84(2H,s),7.30-7.45(3H,m),7.60
(1H,t,J=8Hz),8.05(1H,d,J=8Hz),8.60(1H,s),8.87(1H,
d,J=8Hz)
その塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 1.24(3H,t,J=7Hz),2.86(3H,s),
2.87(3H,s),3.05(2H,q,J=7Hz),4.88(2H,brs),7.50-7.60
(3H,m),7.77(1H,t,J=8Hz),8.15(1H,d,J=8Hz),8.73(1H,
d,J=8Hz),8.92(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
メチル−2−イミダゾリン−1−イルメチル)キノリン
mp: 203-205℃
NMR(DMSO-d6,δ): 1.23(3H,t,J=7Hz),2.17(3H,s),
2.89(2H,t,J=8Hz),2.96(2H,q,J=7Hz),3.35(2H,t,J=8Hz),
4.82(2H,s),7.50-7.60(3H,m),7.68(1H,t,J=8Hz),8.03
(1H,d,J=8Hz),8.67(1H,d,J=8Hz),8.80(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−[N−
(2−ヒドロキシエチル)−N−メチルアミノメチル]キノリン
NMR(CDCl3,δ): 1.30(3H,t,J=7Hz),2.30(3H,s),
2.65(2H,t,J=5Hz),2.95(2H,q,J=7Hz),3.60(2H,t,J=5Hz),
4.03(2H,s),7.30-7.50(3H,m),7.62(1H,t,J=8Hz),7.99
(1H,d,J=8Hz),8.62(2H,s),8.89(1H,d,J=8Hz)
その塩酸塩
mp: 215-217℃
NMR(DMSO-d6,δ): 1.24(3H,t,J=7Hz),2.73(3H,br
s),3.06(2H,q,J=7Hz),3.44(2H,m),3.91(2H,m),4.84(1H,
m),5.07(1H,m),5.58(1H,brs),7.50-7.65(3H,m),7.78
(1H,t,J=8Hz),8.16(1H,d,J=8Hz),8.74(1H,d,J=8Hz),8.92
(1H,s),9.05(1H,br s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
メチルイミダゾール−1−イルメチル)キノリン
NMR(DMSO-d6,δ): 1.24(3H,t,J=7Hz),2.63(3H,s),
2.88(2H,q,J=8Hz),5.41(2H,s),6.25(1H,s),6.80(1H,s),
7.30-7.50(3H,m),7.53(1H,d,J=8Hz),7.63(1H,t,J=8Hz),
8.73(1H,s),8.95(1H,d,J=8Hz)
その塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 1.18(3H,t,J=7Hz),2.81(3H,s),
2.92(2H,q,J=7Hz),5.80(2H,s),6.84(1H,s),7.43(1H,s),
7.50-7.65(3H,m),7.67(1H,t,J=8Hz),7.73(1H,d,J=8Hz),
8.71(1H,d,J=8Hz),8.93(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
フェニルイミダゾール−1−イルメチル)キノリン
NMR(CDCl3,δ): 1.10(3H,t,J=7Hz),2.72(2H,q,
J=7Hz),5.62(2H,s),6.47(1H,s),6.99(1H,s),7.30-7.45
(3H,m),7.45-7.65(5H,m),7.79(2H,d,J=8Hz),8.66(1H,s),
8.92(1H,d,J=8Hz)
その塩酸塩
mp: 237-239℃
NMR(DMSO-d6,δ): 1.11(3H,t,J=7Hz),2.80(2H,q,
J=7Hz),5.91(2H,s),7.19(1H,s),7.45-7.80(9H,m),7.99
(2H,d,J=8Hz),8.69(1H,d,J=8Hz),8.87(1H,s)
(6) 4−(1H−ベンズイミダゾール−1−イルメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−エチルキノリン
NMR(CDCl3,δ): 1.23(3H,t,J=7Hz),2.92(2H,q,
J=7Hz),5.71(2H,s),7.30-7.50(6H,m),7.50-7.60(3H,m),
7.83(1H,d,J=8Hz),8.77(1H,s),8.94(1H,d,J=8Hz)
その塩酸塩
mp: 246-248℃
NMR(CDCl3,δ): 1.27(3H,t,J=7Hz),3.00(2H,q,
J=7Hz),6.05(2H,br s),7.30-7.50(3H,m),7.52(1H,m),
7.60-7.70(4H,m),8.02(1H,m),8.82(1H,s),8.90-9.00(2H,
m)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(2−
メチルチオイミダゾール−1−イルメチル)キノリン
NMR(CDCl3,δ): 1.21(3H,t,J=7Hz),2.76(3H,s),
2.90(2H,q,J=7Hz),5.45(2H,s),6.37(1H,s),6.93(1H,s),
7.30-7.45(3H,m),7.55-7.65(2H,m),8.70(1H,s),8.93(1H,
d,J=8Hz)
その塩酸塩
mp: 195-203℃
NMR(DMSO-d6,δ): 1.17(3H,t,J=7Hz),2.94(2H,q,
J=7Hz),5.82(2H,s),7.20(1H,s),7.50-7.65(3H,m),7.65-
7.75(3H,m),8.71(1H,t,J=4Hz),8.93(1H,s)
実施例120
4−クロロメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−エチル
キノリン(150mg)とN−メチルエチレンジアミン(141mg)の1,2
−ジメトキシエタン中の混合物を70℃で2時間攪拌した。混合物をジクロロエ
タンと水との間に分配し、有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後
、真空中で溶媒を留去して、8−(2,6−ジクロロベンゾイルアミノ)−3−
エチル−4−[(2−メチルアミノエチルアミノ)メチル]キノリンを含む残留
物を得た。得られた残留物の1,3−ジメチル−2−イミダゾリジノン中の溶液
に、1,1’−カルボニルジイミダゾール(309mg)を加え、混合物を70
℃で30分間、100℃で1時間、さらに150℃で1時間攪拌した。混合物に
水を加え、生じた沈殿物を濾過により集めた。残留物を分取薄層クロマトグラフ
ィー(メタノール−ジクロロメタン)で精製して、イソプロピルアルコールから
結晶化して、8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−(
3−メチル−2−オキソイミダゾリジン−1−イルメチル)キノリン(28.6
mg)を得た。
mp: 202-203℃
NMR(CDCl3,δ): 1.29(3H,t,J=7Hz),2.95(2H,q,
J=7Hz),3.05(2H,m),3.18(2H,m),4.87(2H,s),7.30-7.45
(3H,m),7.63(1H,t,J=8Hz),7.99(1H,d,J=8Hz),8.62(1H,
s),8.90(1H,d,J=8Hz)実施例121
8−(2,6−ジクロロベンゾイルアミノ)−3−エチル−4−[(イミダゾ
ール−2−イル)チオメチル]キノリンを、実施例62と同様にして、4−クロ
ロメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−エチルキノリンと
2−メルカプトイミダゾールとを反応させて得た。
mp: 203-204℃
NMR(DMSO-d6,δ): 1.18(3H,t,J=7Hz),2.70(2H,q,
J=7Hz),4.70(2H,s),7.10(2H,br s),7.45-7.60(3H,m),7.63
(1H,t,J=8Hz),7.84(1H,d,J=8Hz),8.64(1H,d,J=8Hz),8.72
(1H,s)
その塩酸塩
mp: 237-239℃
NMR(DMSO-d6,δ): 1.22(3H,t,J=7Hz)2.76(2H,q,
J=7Hz),4.99(2H,s),7.50-7.65(3H,m),7.67(1H,t,J=8Hz),
7.75(2H,s),7.95(1H,t,J=8Hz),8.68(1H,t,J=8Hz),8.78
(1H,s)実施例122
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−((E)−1−プロペニル)キノリンを実施例8と同様にして、
3−アリル−4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン
とイミダゾールとを反応させて得た。
mp: 205-206℃
NMR(DMSO-d6,δ): 1.84(3H,d,J=7Hz),6.00(1H,d,
J=15Hz),6.69(1H,dq,J=7,15Hz),6.96(1H,d,J=8Hz),7.30
(1H,s),7.50-7.60(4H,m),7.67(1H,t,J=8Hz),7.94(1H,s),
8.69(1H,d,J=8Hz),9.30(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−プロピルキノリンを実施例41と同様にして得た。
mp: 160-161℃
NMR(CDCl3,δ): 0.91(3H,t,J=7Hz),1.59(2H,m),
2.58(2H,m),7.04(1H,d,J=8Hz),7.12(1H,s),7.30-7.50
(4H,m),7.61(1H,t,J=8Hz),7.64(1H,s),8.81(1H,s),8.99
(1H,d,J=8Hz)
その塩酸塩
mp: 220-222℃
NMR(CDCl3,δ): 0.94(3H,t,J=7Hz),1.63(2H,m),
2.59(2H,m),6.87(1H,d,J=8Hz),7.32(1H,s),7.35-7.50
(3H,m),7.71(1H,t,J=8Hz),7.79(1H,s),8.74(1H,s),8.88
(1H,s),9.06(1H,d,J=8Hz)実施例123
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−(トリメチルシリルエチニル)キノリンを、製造例21と同様に
して、3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダ
ゾール−1−イル)キノリンとトリメチルシリルアセチレンから得た。
mp: 213℃
NMR(CDCl3,δ): 0.20(9H,s),7.30-7.48(6H,m),7.67
(1H,t,J=8Hz),7.80(1H,br s),8.85(1H,s),9.04(1H,d,
J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−エチニル−4−(イ
ミダゾール−1−イル)キノリンを実施例5と同様にして得た。
mp: 235℃(分解)
NMR(CDCl3,δ): 3.35(1H,s),7.23-7.50(6H,m),7.69
(1H,t,J=8Hz),7.82(1H,s),8.90(1H,s),9.05(1H,d,
J=8Hz)
その塩酸塩
mp: 293℃
NMR(DMSO-d6,δ): 4.86(1H,s),7.34(1H,d,J=8Hz),
7.47-7.62(3H,m),7.83(1H,t,J=8Hz),7.99(1H,s),8.10
(1H,s),8.83(1H,d,J=8Hz),9.18(1H,s),9.44(1H,s)実施例124
(1) 1,4−ジヒドロ−8−ニトロ−4−オキソキノリン(10g)と1,
3,5−トリオキサン(23.7g)のジオキサン(100ml)と濃塩酸(2
00ml)中の混合物を90℃で3.5時間攪拌し、室温になるまで静置させた
。混合物に、氷水(700g)を加え、混合物を1時間攪拌した。生じた沈殿物
を濾過により集めて、冷水で洗浄して、3−クロロメチル−1,4−ジヒドロ−
8−ニトロ−4−オキソキノリン(6.5g)を得た。
mp: 228-235℃
NMR(DMSO-d6,δ): 4.70(2H,s),7.53(1H,t,J=7Hz),
8.25(1H,d,J=7Hz),8.59(1H,d,J=7Hz),8.66(1H,d,J=7Hz)
(2) 3−クロロメチル−1,4−ジヒドロ−8−ニトロ−4−オキソキノリ
ン(2g)のジクロロメタン(70ml)とメタノール(30ml)中の懸濁液
を15分間還流し、真空中で濃縮した。結晶性残留物を熱メタノール(30ml
)に懸濁し、混合物を室温になるまで静置させた。生じた沈殿物を濾過により集
めて、1,4−ジヒドロ−3−メトキシメチル−8−ニトロ−4−オキソキノリ
ン(1.5g)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 3.33(3H,s),4.32(2H,s),7.51
(1H,t,J=7Hz),7.98(1H,d,J=7Hz),8.59(1H,d,J=7Hz),8.67
(1H,d,J=7Hz)
(3) 4−クロロ−3−メトキシメチル-8−ニトロキノリンを製造例2−(
1)と同様にして得た。
mp: 91-94℃
NMR(CDCl3,δ): 3.51(3H,s),4.81(2H,s),7.73(1H,
t,J=8Hz),8.05(1H,d,J=8Hz),8.48(1H,d,J=8Hz),9.10(1H,
s)
(4) 8−アミノ−4−クロロ−3−(メトキシメチル)キノリンを製造例2
−(3)と同様にして得た。
mp: 107℃
NMR(CDCl3,δ: 3.50(3H,s),4.79(2H,s),5.03(2H,
brs),6.95(1H,d,J=8Hz),7.41(1H,t,J=8Hz),7.54(1H,d,
J=8Hz),8.77(1H,s)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−(メト
キシメチル)キノリンを実施例1と同様にして得た。
mp: 177℃
NMR(CDCl3,δ: 3.50(3H,s),4.79(2H,s),7.30-7.44
(3H,m),7.70(1H,t,J=8Hz),8.00(1H,d,J=8Hz),8.80(1H,
s),9.00(1H,d,J=8Hz)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−(メトキシメチル)キノリンを実施例8と同様にして得た。
mp: 145-150℃
NMR(CDCl3,δ): 3.36(3H,s),4.31(2H,s),7.14-7.22
(2H,m),7.31-7.46(4H,m),7.63(1H,t,J=8Hz),7.70(1H,s),
8.95(1H,s),9.01(1H,d,J=8Hz)
そのメタンスルホン酸塩
mp: 188-196℃
NMR(DMSO-d6,δ): 2.30(3H,s),3.22(3H,s),4.48
(2H,s),7.20(1H,d,J=8Hz),7.49-7.63(3H,m),7.80(1H,t,
J=8Hz),8.02(1H,d,J=1Hz),8.08(1H,d,J=1Hz),8.82(1H,d,
J=8Hz),9.15(1H,d,J=1Hz),9.36(1H,br s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−4
−(ピラゾール−1−イル)キノリンを、実施例8と同様にして、4−クロロ−
8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチルキノリンとピ
ラゾールから得た。
mp: 156-157℃
NMR(DMSO-d6,δ): 3.23(3H,s),4.38(2H,s),6.71
(1H,d,J=2Hz),7.15(1H,d,J=8Hz),7.48-7.62(3H,m),7.70
(1H,dd,J=8,8Hz),7.95(1H,s),8.20(1H,d,J=2Hz),8.77
(1H,d,J=8Hz),9.09(1H,s),11.00(1H,s)実施例125
(1) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−ヒ
ドロキシメチル)キノリンを、実施例18と同様にして、4−アセトキシメチル
−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカルボニルキノリ
ンから得た。
mp: 244-247℃(分解)
NMR(DMSO-d6,δ): 5.05(2H,s),7.50-7.60(3H,m),
7.76(1H,t,J=8Hz),8.21(1H,d,J=8Hz),8.78(1H,d,J=8Hz),
9.08(1H,s)
(2) 3−カルボキシ−8−(2,6−ジクロロベンゾイルアミノ)−4−ヒ
ドロキシメチルキノリン(1.11g)のジメチルホルムアミド中の溶液に、イ
ミダゾール(637mg)と塩化第三級ブチルジフェニルシリル(2.57g)
を氷冷下で加え、混合物を室温で5時間攪拌した。混合物を酢酸エチルと水との
間に分配し、有機層を食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶
媒を留去した。得られた残留物のジオキサン(10ml)中の溶液に1N水酸化
ナトリウム溶液(2.9ml)を加え、混合物を室温で30分間攪拌した。混合
物を水で希釈し、ジエチルエーテルで洗浄した。水層を1N塩酸で酸性とし、酢
酸エチルで抽出した。抽出物を水と食塩水で洗浄し、硫酸マグネシウムで乾燥後
、真空中で溶媒を留去した。残留物をイソプロピルアルコール−ジイソブロピル
エーテルに溶解し、不溶物を濾去した。濾液を真空中で濃縮して、4−(第三級
ブチルジフェニルシリルオキシメチル)−3−カルボキシ−8−(2,6−ジク
ロロベンゾイルアミノ)キノリン(1.22g)を得た。
NMR(CDCl3,δ): 1.00(9H,s),5.49(2H,s),7.30-7.50
(9H,m),7.59(1H,t,J=8Hz),7.64(4H,d,J=8Hz),7.79(1H,
d,J=8Hz),9.04(1H,d,J=8Hz),9.14(1H,s)
(3) 4−(第三級ブチルジフェニルシリルオキシメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−(N−メトキシ−N−メチルカルバモイル)
キノリンを実施例22−(2)と同様にして得た。
NMR(CDCl3,δ): 1.03(9H,s),3.24(3H,s),3.29(3H,
s),5.16(2H,s),7.30-7.50(9H,m),7.62(1H,t,J=8Hz),7.70
(4H,d,J=8Hz),7.89(1H,d,J=8Hz),8.68(1H,s),8.99(1H,
d,J=8Hz)
(4) 4−(第三級ブチルジフェニルシリルオキシメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−(N−メトキシ−N−メチルカルバモイル)
キノリン(1.03g)のテトラヒドロフラン(10ml)中の溶液に、1M水
素化ジイソブチルアルミニウムのテトラヒドロフラン溶液(15ml)を−5
5℃で滴下し、混合物を−60〜−45℃で50分間攪拌した。飽和塩化アンモ
ニウム溶液と酒石酸カリウムナトリウムの10%水溶液を加えて混合物の反応を
停止させた。ジエチルエーテル(50ml)を混合物に加え、混合物を室温で1
.5時間攪拌した。分離した水層を酢酸エチルで抽出した。合わせた有機層を食
塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を
シリカゲルカラムクロマトグラフィー(酢酸エチル−n−ヘキサン)で精製して
、4−(第三級ブチルジフェニルシリルオキシメチル)−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−ホルミルキノリン(809mg)を得た。
NMR(CDCl3,δ): 1.01(9H,s),5.48(2H,s),7.30-7.50
(10H,m),7.63(4H,cl,J=8Hz),7.77(1H,d,J=8Hz),9.06(1H,
d,J=8Hz),9.02(1H,s),10.07(1H,s),10.46(1H,s)
(5) 4−(第三級ブチルジフェニルシリルオキシメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−(ヒドロキシメチル)キノリンを実施例16
と同様にして得た。
NMR(CDCl3,δ): 1.03(9H,s),2.53(1H,t,J=6Hz),
4.78(2H,d,J=8Hz),5.22(2H,s),7.30-7.80(15H,m),8.77
(1H,s),8.92(1H,d,J=8Hz)
(6) 3−ブロモメチル-4−(第三級ブチルジフェニルシリルオキシメチル
)−8−(2,6−ジクロロベンゾイルアミノ)キノリンを実施例110−(4
)と同様にして得た。
NMR(CDCl3,δ): 1.04(9H,s),4.42(2H,s),5.22(2H,
s),7.30-7.50(9H,m),7.59(1H,t,J=8Hz),7.65-7.75(4H,m),
7.82(1H,d,J=8Hz),8.65(1H,s),8.95(1H,d,J=8Hz)
(7) 4−(第三級ブチルジフェニルシリルオキシメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−(メトキシメチル)キノリンを製造例2−(
2)と同様にして得た。
NMR(CDCl3,δ): 1.03(9H,s),3.22(3H,s),4.32(2H,
s),5.16(2H,s),7.30-7.50(9H,m),7.60(1H,t,J=8Hz),7.67
(4H,d,J=8Hz),7.96(1H,d,J=8Hz),8.68(1H,s),8.94(1H,
d,J=8Hz)
(8) 4−(第三級ブチルジフェニルシリルオキシメチル)−8−(2,6−
ジクロロベンゾイルアミノ)−3−(メトキシメチル)キノリン(359mg)
のテトラヒドロフラン中の溶液に、1Mフッ化テトラブチルアンモニウムのテト
ラヒドロフラン溶液(0.684ml)を室温で加え、混合物を同温で1時間攪
拌した。混合物を水と酢酸エチルとの間に分配し、有機層を食塩水で洗浄し、硫
酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をイソプロピルアル
コールから結晶化して、8−(2,6−ジクロロベンゾイルアミノ)−4−ヒド
ロキシメチル-3−(メトキシメチル)キノリン(186mg)を得た。
mp: 199-200℃
NMR(CDCl3,δ): 2.88(1H,t,J=7Hz),3.50(3H,s),
4.77(2H,s),5.14(2H,d,J=7Hz),7.30-7.50(3H,m),7.70
(1H,t,J=8Hz),8.02(1H,d,J=8Hz),8.71(1H,s),8.98(1H,
d,J=8Hz)
(9) 4−クロロメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−
(メトキシメチル)キノリンを実施例78−(3)と同様にして得た。
mp: 164℃
NMR(CDCl3,δ): 3.47(3H,s),4.76(2H,s),5.10(2H,
s),7.30-7.50(3H,m),7.73(1H,t,J=8Hz),7.90(1H,d,
J=8Hz),8.77(1H,s),9.00(1H,d,J=8Hz)
(10) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−
1−イルメチル)−3−(メトキシメチル)キノリンを実施例59と同様にして
得た。
mp:190-191℃
NMR(CDCl3,δ): 3.45(3H,s),4.67(2H,s),5.67(2H,
s),6.84(1H,s),7.03(1H,s),7.30-7.50(3H,m),7.53(1H,
s),7.66(1H,t,J=8Hz),7.73(1H,d,J=8Hz),8.79(1H,s),
8.99(1H,d,J=8Hz)
その塩酸塩
mp: 238-240℃
NMR(DMSO-d6,δ): 4.82(2H,s),6.02(2H,s),7.50-
7.70(5H,m),7.73(1H,t,J=8Hz),7.95(1H,d,J=8Hz),8.76
(1H,d,J=8Hz),9.00(1H,s),9.03(1H,s)実施例126
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−ホルミル−4−(イ
ミダゾール−1−イル)キノリンを、実施例29と同様にして、8−(2,6−
ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル)−3−ビニルキ
ノリンから得た。
NMR(CDCl3,δ): 7.35-7.50(7H,m),7.77(1H,t,
J=8Hz),7.84(1H,s),9.21(1H,d,J=8Hz),9.32(1H,s),9.89
(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(イミダゾール−1−イル)キノリンを実施例16と同様にして得た。
mp: 196-198℃
NMR(CDCl3,δ): 4.37(2H,d,J=6Hz),7.18(1H,d,
J=8Hz),7.21(1H,s),7.30-7.50(4H,m),7.65(1H,t,J=8Hz),
7.73(1H,s),9.03(1H,d,J=8Hz),9.06(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(イミダゾール−1−イル)キノリンを実施例8と同様にして得た。
NMR(DMSO-d6,δ): 4.44(2H,d,J=6Hz),5.59(1H,t,
J=6Hz),7.07(1H,d,J=8Hz),7.28(1H,s),7.50-7.65(4H,m),
7.70(1H,t,J=8Hz),7.97(1H,s),8.76(1H,d,J=8Hz),9.15
(1H,s)
(4) 塩化チオニル(52.8mg)をジメチルホルムアミドに室温で滴下し
、混合物を同温で10分間攪拌した。混合物に8−(2,6−ジクロロベンゾイ
ルアミノ)−3−ヒドロキシメチル−4−(イミダゾール−1−イル)キノリン
(141mg)を加え、混合物を室温で20分間攪拌した。混合物を飽和重炭酸
ナトリウム溶液と酢酸エチルとの間に分配し、有機層を食塩水で洗浄し、硫酸マ
グネシウムで乾燥後、真空中で溶媒を留去した。得られた残留物をジクロロメタ
ン−メタノールに溶解し、ナトリウム(17.3mg)を無水メタノール(1.
5ml)に加えることによって調製したナトリウムメトキシド溶液に溶液を加え
、室温で15分間攪拌した。混合物を40℃で3時間攪拌した。混合物を飽和塩
化アンモニウム溶液と酢酸エチルとの間に分配し、有機層を食塩水で洗浄し、硫
酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマト
グラフィーで精製して、8−(2,6−ジクロロベンゾイルアミノ)−4−(イ
ミダゾール−1−イル)−3−(メトキシメチル)キノリン(55mg)を得た
。
mp: 145-150℃
NMR(CDCl3,δ): 3.36(3H,s),4.31 (2H,s),7.14-7.22
(2H,m),7.31-7.46(4H,m),7.63(1H,t,J=8Hz),7.70(1H,s),
8.95(1H,s),9.01(1H,d,J=8Hz)実施例127
(1) 3−ブロモメチル-4−クロロ−8−(2,6−ジクロロベンゾイルア
ミノ)キノリンを、実施例110−(4)と同様にして、4−クロロ−8−(2
,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチルキノリンから得た。
NMR(CDCl3,δ): 4.79(2H,s),7.30-7.50(3H,m),7.74
(1H,t,J=8Hz),8.02(1H,d,J=8Hz),8.75(1H,s),9.03(1H,
d,J=8Hz)
(2) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−(メト
キシメチル)キノリンを製造例2−(2)と同様にして得た。
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−4
−[2−(メチルアミノ)エチルアミノ]キノリンを実施例8と同様にして得た
。
NMR(CDCl3,δ): 2.48(3H,s),2.88(2H,t,J=6Hz),
3.37(3H,s),3.75(2H,dt,J=6,6Hz),4.58(2H,s),6.08(1H,
br t,J=6Hz),7.27-7.49(4H,m),7.81(1H,d,J=8Hz),8.28
(1H,s),8.86(1H,d,J=8Hz),10.15(1H,br)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−4
−(3−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92
−(2)と同様にして得た。
mp: 199-201℃
NMR(DMSO-d6,δ): 2.83(3H,s),3.33(3H,s),3.59-
3.73(3H,m),3.85(1H,m),4.57(1H,d,J=12Hz),4.61(1H,d,
J=12Hz),7.48-7.62(3H,m),7.70(2x1H,d,J=7Hz),8.73(1H,
dd,J=4,4Hz)7.98(1H,d,J=8Hz),8.95(1H,s),10.86(1H,
s).
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−4
−(3−メチル−2−チオキソイミダゾリジン−1−イル)キノリンを、実施例
92−(2)と同様にして、8−(2,6−ジクロロベンゾイルアミノ)−3−
メトキシメチル−4−[2−(メチルアミノ)エチルアミノ]キノリンと1,1
’−チオカルボニルジイミダゾールから得た。
mp: 184-185℃
NMR(DMSO-d6,δ): 3.16(3H,s),3.37(3H,s),3.85-
4.08(4H,m),4.56(1H,d,J=12Hz),4.64(1H,d,J=12Hz),
6.98-7.15(4H,m),7.21(1H,dd,J=7.5,7.5Hz),8.73(1H,d,
J=7.5Hz),9.00(1H,s),10.91(1H,s)実施例128
4−クロロメチル−8−(2,6−ジクロロベンゾイルアミノ)−3−メトキ
シメチルキノリン(70mg)と炭酸カリウム(26mg)の1,2−ジメトキ
シエタンとメタノール中の混合物を2時間還流した。冷却後、混合物を飽和塩化
アンモニウム溶液とジクロロメタンとの間に分配し、有機層を食塩水で洗浄し、
硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマ
トグラフィーで精製し、イソプロピルアルコールから結晶化して、3,4−ビス
(メトキシメチル)−8−(2,6−ジクロロベンゾイルアミノ)キノリン(1
9.2mg)を得た。
mp: 160-161℃
NMR(CDCl3,δ): 3.45(3H,s),3.46(3H,s),4.73(2H,
s),4.96(2H,s),7.30-7.45(3H,m),7.66(1H,t,J=8Hz),7.97
(1H,d,J=8Hz),8.77(1H,s),8.95(1H,d,J=8Hz)実施例129
(1) 1,4−ジヒドロ−3−メチルチオメチル−8−ニトロ−4−オキソキ
ノリンを、製造例13と同様にして、3−クロロメチル−1,4−ジヒドロ−8
−ニトロ−4−オキソキノリンとナトリウムチオメトキシドとを反応させて得た
。
mp: 200-203℃
NMR(CDCl3,δ): 2.13(3H,s),3.70(2H,s),7.44(1H,
t,J=7Hz),7.90(1H,d,J=7Hz),8.67(1H,d,J=7Hz),8.82(1H,
d,J=7Hz)
(2) 4−クロロ−3−メチルチオメチル−8−ニトロキノリンを製造例2−
(1)と同様にして得た。
mp: 96-98℃
NMR(CDCl3,δ): 2.10(3H,s),4.03(2H,s),7.74(1H,
t,J=7Hz),8.06(1H,d,J=7Hz),8.49(1H,d,J=7Hz),8.98(1H,
s)
(3) 8−アミノ−4−クロロ−3−(メチルチオメチル)キノリンを製造例
2−(3)と同様にして得た。
mp: 107-108℃
NMR(CDCl3,δ): 2.08(3H,s),3.99(2H,s),5.00(2H,
br s),6.93(1H,d,J=7Hz),7.41(1H,t,J=7Hz),7.52(1H,d,
J=7Hz),8.67(1H,s)
(4) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−(メチ
ルチオメチル)キノリンを実施例1と同様にして得た。
mp: 173-175℃
NMR(CDCl3,δ): 2.09(3H,s),4.02(2H,s),7.28-7.45
(3H,m),7.72(1H,t,J=7Hz),7.99(1H,d,J=7Hz),8.72(1H,
s),9.00(1H,d,J=7Hz)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−(メチルチオメチル)キノリンを実施例8と同様にして得た。
mp: 198-200℃
NMR(DMSO-d6,δ): 1.92(3H,s),3.68(2H,s),6.98
(1H,d,J=7Hz),7.29(1H,s),7.48-7.63(3H,m),7.70(1H,t,
J=7Hz),7.99(1H,s),8.75(1H,d,J=7Hz),9.08(1H,s)
そのメタンスルホン酸塩
mp: 209-211℃
NMR(DMSO-d6,δ): 1.96(3H,s),2.31(3H,s),3.77
(1H,d,J=14Hz),3.82(1H,d,J=14Hz),7.12(1H,d,J=7Hz),
7.47-7.61(3H,m),7.76(1H,t,J=7Hz),8.02(1H,s),8.08(1H,
s),8.80(1H,s),9.15(1H,s),9.38(1H,s)実施例130
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−3−フェニルキノリンを、製造例16−(1)と同様にして、3−ブロモ−
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル)
キノリンとフェニルホウ酸から得た。
mp: 261℃
NMR(CDCl3,δ): 7.02(1H,s),7.07-7.16(2H,m),7.20
(1H,s),7.30-7.49(8H,m),7.68(1H,t,J=8Hz),8.93(1H,s),
9.05(1H,d,J=8Hz)
その塩酸塩
mp: 249-254℃
NMR(DMSO-d6,δ): 7.25-7.65(9H,m),7.78-7.90(2H,
m),7.99(1H,s),8.86(1H,d,J=8Hz),9.14(1H,s),9.24(1H,
br s)実施例131
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−3−(2−ピリジル)キノリンを、製造例12−(2)と同様にして、3−
ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)キノリンとトリ−n−ブチル(2−ピリジル)錫から得た。
mp: 253-265℃
NMR(CDCl3,δ): 6.82(1H,d,J=8Hz),7.10(1H,s),
7.23-7.30(1H,m),7.32-7.46(4H,m),7.51(1H,s),7.59(1H,
t,J=8Hz),7.67-7.75(2H,m),8.71(1H,br d,J=6Hz),9.07
(1H,d,J=7Hz),9.24(1H,s)実施例132
9−フルオレンカルボン酸(158mg)とジメチルホルムアミド(1滴)の
ジクロロメタン(2ml)中の溶液に、塩化オキサリル(191mg)を滴下し
、混合物を室温で1時間攪拌した。混合物を真空中で濃縮し、残留物を8−アミ
ノ−3−ブロモキノリン(112mg)とトリエチルアミン(152mg)の1
,3−ジメチル−2−イミダゾリジノン(1ml)中の溶液に加えた。混合物を
室温で3時間攪拌した。混合物を酢酸エチルと水との間に分配し、有機層を食塩
水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシ
リカゲルカラムクロマトグラフィーで精製して、ジエチルエーテル−ジイソプロ
ピルエーテルから結晶化して、3−ブロモ−8−[(フルオレン−9−イル)カ
ルボニルアミノ]キノリン(22mg)を得た。
mp: 196-198℃
NMR(CDCl3,δ): 5.03(1H,s),7.32-7.43(3H,m),
7.45-7.55(3H,m),7.80-7.90(4H,m),8.20(1H,s),8.50(1H,
s),8.75(1H,d,J=7Hz),9.65(1H,br s)実施例133
3−ブロモ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾー
ル−1−イル)キノリン(50mg)とN−メチルビロリドンの混合物に、イミ
ダゾール(11mg)、炭酸カリウム(22.4mg)と酸化銅(I)(7.7
4mg)を加え、混合物を60℃で1.5時間、80℃で1時間攪拌した。混合
物をジクロロメタンと水との間に分配し、有機層を食塩水で洗浄し、硫酸マグネ
シウムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマトグラフィ
ーで精製し、ジイソプロピルエーテルから結晶化して、3−ブロモ−8−[2,
6−ビス(イミダゾール−1−イル)ベンゾイルアミノ]−4−(イミダ
ゾール−1−イル)キノリン(17mg)を得た。
mp: 175-185℃
NMR(CDCl3,δ): 7.00-7.15(4H,m),7.20-7.30(1H,
オーバーラップ),7.37(1H,s),7.50-7.60(3H,m),7.67(1H,s),
7.70-7.85(3H,m),8.65(1H,d,J=8Hz),8.83(1H,s),9.55
(1H,s)実施例134
(1) 8−アミノ−1,4−ジヒドロ−4−オキソキナゾリンを、製造例1と
同様にして、1,4−ジヒドロ−8−ニトロ−4−オキソキナゾリンから得た。
mp: >250℃
NMR(DMSO-d6,δ): 5.65(2H,br s),6.98(1H,d,
J=7Hz),7.18(1H,t,J=7Hz),7.22(1H,d,J=7Hz),7.98(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2,6−ジクロロ
ベンゾイルオキシ)キナゾリンを、実施例3−(1)と同様にして、8−アミノ
−1,4−ジヒドロ−4−オキソキノリンと塩化2,6−ジクロロベンゾイルと
を反応させて得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.45-7.70(7H,m),7.90(1H,d,
J=7Hz),8.75(1H,d,J=7Hz),8.91(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2,6−ジクロロ
ベンゾイルオキシ)キナゾリン(40mg)とイミダゾール(53.7mg)の
1,3−ジメチル−2−イミダゾリジノン(0.6ml)中の混合物を室温で1
時間攪拌した。冷水を混合物に加え、生じた沈殿物を濾過により集めて、8−(
2,6−ジクロロベンゾイルアミノ)−1,4−ジヒドロ−4−オキソキナゾリ
ン(23mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.45-7.60(4H,m),7.90(1H,d,
J=7Hz),8.13(1H,s),8.70(1H,d,J=7Hz)実施例135
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシカル
ボニルキノリン(200mg)、酢酸ホルムアミジン(246mg)とN−メチ
ルピロリドンの混合物を100℃で4時間、120℃で45分間、130℃で6
時間攪拌した。混合物を水と酢酸エチルとの間に分配した。有機層を水で洗浄し
、真空中で溶媒を留去した。残留物をイソプロピルアルコールから結晶化して、
濾過により集めて、7−(2,6−ジクロロベンゾイルアミノ)−3,4−ジヒ
ドロピリミド[5,4−c]キノリン−4−オン(116mg)を得た。
mp: >250℃
NMR(DMSO-d6,δ): 7.50-7.60(3H,m),7.84(1H,t,
J=8Hz),8.57(1H,d,J=8Hz),8.60(1H,s),8.91(1H,d,
J=8Hz),9.39(1H,s)実施例136
(1) 3−(イミダゾール−1−イルチオメチル)−1,4−ジヒドロ−8−
ニトロ−4−オキソキノリンを、実施例62と同様にして、3−クロロメチル−
1,4−ジヒドロ−8−ニトロ−4−オキソキノリンと2−メルカプトイミダゾ
ールから得た。
mp: 185-189℃
NMR(DMSO-d6,δ): 4.09(2H,s),6.90-7.20(2H,m),
7.50(1H,t,J-7Hz),7.90(1H,s),8.58(1H,d,J=7Hz),8.62
(1H,d,J=7Hz)
(2) 3−(イミダゾール−1−イルチオメチル)−1,4−ジヒドロ−8−
ニトロ−4−オキソキノリン(185mg)の塩化ホスホリル(1ml)中の懸
濁液を100℃で1時間攪拌した。冷却後、それにジエチルエーテルを加え、生
じた沈殿物を濾過により集め、ジエチルエーテルで洗浄した。残留物にジクロロ
メタン−メタノールと飽和重炭酸ナトリウム溶液を加えた。分離した有機層を食
塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を
シリカゲルカラムクロマトグラフィーで精製して、4−ニトロ−7H−イミダゾ
[2’,1’:2,3][1,3]チアジノ[5,4−c]キノリン(135m
g)を得た。
mp: 236-242℃
NMR(DMSO-d6,δ): 4.39(2H,s),7.33(1H,s),7.88
(1H,t,J=7Hz),8.24(1H,s),8.36(1H,d,J=7Hz),8.60(1H,
d,J=7Hz),9.13(1H,s)
(3) 4−アミノ−7H−イミダゾ[2’,1’:2,3][1,3]チアジ
ノ[5,4−c]キノリンを製造例2−(3)と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 4.29(2H,s),6.18(2H,br s),6.93
(1H,t,J=7Hz),7.24(1H,s),7.37-7.47(2H,m),8.12(1H,s),
8.81(1H,s)
(4) 4−(2,6−ジクロロベンゾイルアミノ)−7H−イミダゾ[2’,
1’:2,3][1,3]チアジノ[5,4−c]キノリンを実施例1と同様に
して得た。
mp: >250℃
NMR(DMSO-d6,δ): 4.37(2H,s),7.32(1H,s),7.47-
7.62(3H,m),7.80(1H,t,J=7Hz),8.14(1H,d,J=7Hz),8.23
(1H,s),8.80(1H,d,J=7Hz),9.01(1H,s)実施例137
3−ブロモ−8−[2−(2−エチルイミダゾール−1−イル)ベンゾイルア
ミノ]キノリンを、実施例132と同様にして、2−(2−エチルイミダゾール
−1−イル)安息香酸と8−アミノ−3−ブロモキノリンから得た。
mp: 168-169℃
NMR(CDCl3,δ): 1.26(3H,t,J=7Hz),2.67(2H,q,
J=711z),7.00(1H,s),7.10(1H,s),7.34(1H,m),7.42(1H,d,
J=8Hz),7.57(1H,t,J=8Hz),7.60-7.70(2H,m),8.09(1H,m),
8.30(1H,d,J=2Hz),8.70(1H,d,J=2Hz),9.74(1H,br s)実施例138
(1) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(2
00mg)とヒドラジン−水和物(285mg)のエタノール(4ml)とN−
メチルピロリドン(1ml)中の混合物を100℃で一夜加熱した。冷却後、生
じた沈殿物を濾過により集め、残留物をエタノールから再結晶して、8−(2,
6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(173mg)を得
た。
mp: 204-206℃
NMR(CDCl3-CD3OD,δ): 6.92(1H,d,J=6Hz),7.28-7.59
(511,m),8.44(1H,d,J=6Hz),8.85(1H,d,J=8Hz)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)キノリンを実施例86と同様にして得た。
mp: 252℃
NMR(DMSO-d6,δ): 2.00(3H,s),6.64(1H,d,J=6Hz),
7.45-7.64(4H,m),7.99(1H,d,J=8Hz),8.41(1H,d,J=6Hz),
8.65(1H,d,J=8Hz),9.27(1H,br s),10.02(1H,br s),10.51
(1H,s)実施例139
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−3−メ
チルキノリンを、実施例8と同様にして、4−クロロ−8−(2,6−ジクロロ
ベンゾイルアミノ)−3−メチルキノリンとヒドラジン−水和物から得た。
mp: 190-197℃
NMR(CDCl3,δ): 2.30(3H,s),4.04(2H,br s),5.93
(1H,br s),7.20-7.51(4H,m),8.12(1H,d,J=8Hz),8.31(1H,
s),8.83(1H,d,J=8Hz)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3−メチルキノリンを実施例86と同様にして得た。
mp: 249-254℃
NMR(DMSO-d6,δ): 1.87(3H,s),2.35(3H,s),7.42-
7.63(4H,m),8.10(1H,d,J=8Hz),8.25(1H,s),8.33(1H,s),
8.57(1H,d,J=8Hz)実施例140
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−3−ヒドロキ
シメチルキノリン(100mg)のジクロロエタン(3ml)中の懸濁液に、無
水酢酸(30mg)を加えた。室温で7時間攪拌後、反応混合物から溶媒を留去
し、残留物を最少量の熱エタノールで粉砕して、3−アセトキシメチル−4−(
2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ンを淡黄色結晶(53mg)として得た。母液から溶媒を留去し、シリカゲルカ
ラムクロマトグラフィー(メタノール:酢酸エチル=1:10、V/V)で精製
して、4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイルア
ミノ)−3−ヒドロキシメチルキノリンを淡黄色粉末(35mg)として得た。
4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイルアミノ
)−3−ヒドロキシメチルキノリン
mp: 142-145℃
NMR(DMSO-d6,δ): 1.87(3H,s),4.73(2H,d,J=6Hz),
5.30(1H,t,J=6Hz),7.45-7.63(4H,m),8.13(1H,d,J=8Hz),
8.33(1H,s),8.58(1H,s),8.62(1H,d,J=8Hz),10.15(1H,
s),10.58(1H,s)
3−アセトキシメチル−4−(2−アセチルヒドラジノ)−8−(2,6−ジ
クロロベンゾイルアミノ)キノリン
mp: 181-183℃
NMR(DMSO-d6,δ): 1.87(3H,s),2.02(3H,s),5.23
(2H,s),7.46-7.63(4H,m),8.14(1H,d,J=8Hz),8.45(1H,s),
8.66(1H,d,J=8Hz),8.79(1H,s),10.22(1H,s),10.55(1H,
s)実施例141
下記の化合物を実施例139−(1)と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−3−メ
トキシメチルキノリン
mp: 176-178℃
NMR(DMSO-d6,δ): 3.28(3H,s),4.81(2H,s),4.82
(211,s),7.38(1H,dd,J=8,8Hz),7.49-7.63(3H,m),8.20(1H,
br s),8.29(1H,s),8.35(1H,d,J=8Hz),8.53(1H,d,J=8Hz),
10.46(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−3−イ
ソプロポキシメチルキノリン
NMR(DMSO-d6,δ): 1.25(2x3x2/3H,d,J=7Hz),1.27
(3x1/3H,d,J=7Hz),3.67(1H,qq,J=7,7Hz),4.75-4.92(4H,
m),7.34-7.63(4H,m),8.13(1x2/3H,s),8.32(1x2/3H,s),
8.45(1x2/3H,d,J=8Hz),8.48(1x1/3H,s),8.57(1x2/3H,d,
J=8Hz),8.63(1x1/3H,d,J=8Hz),8.82(1x1/3H,d,J=8Hz),
10.46(1x2/3H,s),10.55(1x1/3H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メチルヒドラ
ジノ)キノリン
mp: 223-225℃
NMR(CDCl3,δ): 3.26(3H,s),3.90(2H,s),7.07(1H,
d,J=6Hz),7.27-7.44(3H,m),7.52(1H,t,J=8Hz),8.03(1H,
d,J=8Hz),8.54(1H,d,J=6Hz),8.90(1H,d,J=8Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2,2−ジメチル
ヒドラジノ)キノリン
mp: 202-204℃
NMR(DMSO-d6,δ): 3.03(2x3H,s),6.95(1H,d,
J=6Hz),7.48-7.63(4H,m),7.84(1H,d,J=8Hz),8.55(1H,d,
J=6Hz),8.65(1H,d,J=8Hz),10.58(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−(4−メチルピペラ
ジン−1−イルアミノ)キノリン
mp: 196-200℃
NMR(CDCl3,δ): 2.44(3H,s),2.72(4H,t,J=5Hz),
3.29(4H,t,J=5Hz),6.90(1H,d,J=5Hz),7.30-7.44(3H,m),
7.53(1H,t,J=8Hz),7.75(1H,d,J=8Hz),8.58(1H,d,J=5Hz),
8.90(1H,d,J=8Hz)
その二塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 2.88(3H,d,J=4Hz),3.45-3.90(8H,
m),7.25(1H,d,J=6Hz),7.50-7.62(3H,m),7.70(1H,t,
J=8Hz),7.87(1H,d,J=8Hz),8.68(1H,d,J=8Hz),8.74(1H,d,
J=6Hz)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−(モルホリノアミノ
)キノリン
mp: 258-260℃
NMR(CDCl3,δ): 3.20-3.30(4H,m),3.95-4.63(4H,m),
6.90(1H,d,J=4Hz),7.30-7.45(3H,m),7.55(1H,t,J=8Hz),
7.75(1H,d,J=8Hz),8.60(1H,d,J=4Hz),8.92(1H,d,J=7Hz)
その塩酸塩
mp: >260℃
NMR(CDCl3,δ): 3.74-3.86(4H,m),3.99-4.09(4H,m),
7.05(1H,d,J=7Hz),7.30-7.45(3H,m),7.70-7.85(2H,m),
8.62(1H,d,J=7Hz),8.88-8.97(1H,m)実施例142
下記の化合物を実施例86と同様にして得た。
(1) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3−メトキシメチルキノリン
mp: 186-187℃
NMR(DMSO-d6,δ): 1.87(3H,s),3.32(3H,s),4.60
(2H,s),7.47-7.63(4H,m),8.15(1H,d,J=8Hz),8.46(1H,s),
8.46(1H,s),8.65(1H,d,J=8Hz),10.17(1H,s),10.57(1H,
s)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3−イソプロポキシメチルキノリン
mp: 106-110℃
NMR(DMSO-d6,δ): 1.15(2x3H,d,J=7Hz),1.87(3H,
s),3.65(1H,qq,J=7,7Hz),4.70(2H,s),7.47-7.63(4H,m),
8.14(1H,d,J=8Hz),8.32(1H,s),8.53(1H,s),8.63(1H,d,
J=8Hz),10.17(1H,s),10.55(1H,s)実施例143
8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メチルヒドラジノ)
キノリン(500mg)とトリエチルアミン(700mg)のジクロロメタン(
5ml)中の攪拌懸濁液に、無水酢酸(155mg)を室温で加え、混合物を1
0日間同温で静置させた。混合物をジクロロメタンで希釈し、水で洗浄し、真空
中で溶媒を留去した。得られた残留物をメタノール(10ml)に溶解し、それ
に28%ナトリウムメトキシドのメタノール溶液(0.53ml)を氷冷下で加
えた。混合物を同温で1時間攪拌し、1N塩酸で中和した。混合物を真空中で濃
縮し、ジクロロメタンで抽出した。有機層を水で洗浄し、硫酸マグネシウムで乾
燥後、真空中で溶媒を留去した。残留物をシリカゲルカラムクロマトグラフィー
(酢酸エチル)で精製して、エタノールから結晶化して、4−(2−アセチル−
2−メチルヒドラジノ)−8−(2,6−ジクロロベンゾイルアミノ)キノリン
(544mg)を得た。
mp: 215℃
NMR(DMSO-d6,δ): 1.80(3H,s),3.22(3H,s),7.04
(1H,d,J=6Hz),7.45-7.62(4H,m),7.98(1H,d,J=8Hz),8.59
(1H,d,J=6Hz),8.64(1H,d,J=8Hz)実施例144
4−(2−アセチル−2−メチルヒドラジノ)−8−(2,6−ジクロロベン
ゾイルアミノ)キノリン(140mg)のN−メチルピロリドン(1.5ml)
中の溶液に、カリウム第三級ブトキシド(40.9mg)を氷冷下で加え、混合
物を同温で30分間攪拌した。それにヨウ化メチル(59.1mg)を氷冷下で
加え、混合物を室温で12時間攪拌した。混合物を酢酸エチルで希釈し、水と食
塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を
分取薄層クロマトグラフィー(メタノール−ジクロロメタン)で精製し、エタノ
ールから再結晶して、4−(2−アセチル−1,2−ジメチルヒドラジノ)−8
−(2,6−ジクロロベンゾイルアミノ)キノリン(62mg)を得た。
mp: 243-244℃
NMR(DMSO-d6,δ): 2.17(3H,s),2.96(3H,s),3.34
(3H,s),6.99(1H,d,J=6Hz),7.47-7.62(4H,m),7.74(1H,d,
J=8Hz),8.63(1H,d,J=6Hz),8.70(1H,d,J=8Hz)実施例145
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(20
0mg)の塩化エチレン(2ml)中の懸濁液に、プロピオン酸無水物(82.
5mg)を室温で滴下し、混合物を同温で一夜攪拌した。真空中で混合物から溶
媒を留去し、残留物をエタノールから結晶化して、8−(2,6−ジクロロベン
ゾイルアミノ)−4−(2−プロピオニルヒドラジノ)キノリン(40mg)を
得た。
mp: 246-248℃
NMR(DMSO-d6,δ): 1.15(3H,t,J=7.5Hz),2.30(2H,q,
J=7.5Hz),6.63(1H,d,J=7.0Hz),7.50-7.62(4H,m),8.00(1H,
d,J=8.0Hz),8.42(1H,d,J=7.0Hz),8.66(1H,d,J=8.0Hz),
9.27(1H,br s)実施例146
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(20
0mg)、クロトン酸(54.5mg)、1−エチル−3−(3−ジメチルアミ
ノプロピル)カルボジイミド塩酸塩(133mg)と1−ヒドロキシベンゾトリ
アゾール(93.4mg)のジメチルホルムアミド(4ml)中の混合物を室温
で一夜攪拌した。混合物を酢酸エチルで希釈し、水、飽和重炭酸ナトリウム溶液
と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留
物をシリカゲルカラムクロマトグラフィー(メタノール−ジクロロメタン)で精
製して、4−(2−クロトノイルヒドラジノ)−8−(2,6−ジクロロベンゾ
イルアミノ)キノリン(90mg)と8−(2,6−ジクロロベンゾイルアミ
ノ)−4−(3−メチル−5−オキソピラゾリジン−1−イル)キノリン(25
mg)を得た。
4−(2−クロトノイルヒドラジノ)−8−(2,6−ジクロロベンゾイルア
ミノ)キノリン
mp: 257-259℃
NMR(DMSO-d6,δ): 1.86(3H,d,J=7.5Hz),6.10(1H,d,
J=15.0Hz),6.58(1H,d,J=6.0Hz),6.83(1H,dq,J=15.0,
7.5Hz),7.50-7.60(4H,m),8.01(1H,d,J=8.0Hz),8.43(1H,d,
J=6.0Hz),8.68(1H,d,J=8.0Hz),9.37(1H,s),10.06(1H,s),
10.26(1H,s)
8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メチル−5−オキソ
ピラゾリジン−1−イル)キノリン
mp: 228-230℃
NMR(DMSO-d6,δ): 1.32(3H,d,J=7.0Hz),2.46(1H,
dd,J=16.0,7.5Hz),2.85(1H,dd,J=16.0,7.5Hz),3.88(1H,
dddq,J=9.0,7.5,7.5,7.0Hz),6.58(1H,d,J=9.0Hz),7.48-
7.64(5H,m),7.89(1H,d,J=8.0Hz),8.70(1H,d,J=8.0Hz),
8.88(1H,d,J=5.0Hz),10.73(1H,s)実施例147
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(20
0mg)、メタクリル酸(54.5mg)、1−エチル−3−(3−ジメチルア
ミノプロピル)カルボジイミド塩酸塩(133mg)と1−ヒドロキシベンゾト
リアゾール(93.4mg)のジメチルホルムアミド(4ml)中の混合物を室
温で4.5時間攪拌した。混合物を酢酸エチルで希釈し、水、飽和重炭酸ナトリ
ウム溶液と食塩水で洗浄した。不溶物を濾過により集め、エタノールから再結晶
して、8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メタクリロイル
ヒドラジノ)キノリン(190mg)を得た。
mp: 277-280℃
NMR(DMSO-d6,δ): 1.97(3H,s),5.53(1H,s),5.87
(1H,s),6.64(1H,d,J=7.0Hz),7.48-7.60(4H,m),8.03(1H,
d,J=8.0Hz),8.44(1H,d,J=7.0Hz),8.66(1H,d,J=8.0Hz),
9.33(1H,s)実施例148
下記の化合物を実施例147と同様にして得た。
(1) 4−(2−シクロプロパンカルボニルヒドラジノ)−8−(2,6−ジ
クロロベンゾイルアミノ)キノリン
mp: 267-269℃
NMR(DMSO-d6,δ): 0.78-0.84(4H,m),1.71-1.80(1H,
m),6.61(1H,d,J=7.0Hz),7.50-7.60(4H,m),7.99(1H,d,
J=8.0Hz),8.45(1H,d,J=7.0Hz),8.66(1H,d,J=8.0Hz),9.31
(1H,s)
(2) 4−(2−シクロペンタンカルボニルヒドラジノ)−8−(2,6−ジ
クロロベンゾイルアミノ)キノリン
mp: 249-251℃
NMR(DMSO-d6,δ): 1.54-1.77(6H,m),1.86-1.93(2H,
m),2.76(1H,qn,J=7.5Hz),6.57(1H,d,J=6.0Hz),7.47-7.60
(4H,m),8.00(1H,d,J=8.0Hz),8.43(1H,d,J=6.0Hz),8.66
(1H,d,J=8.0Hz),9.30(1H,br s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メトキシアセ
チルヒドラジノ)キノリン
mp: 223-225℃
NMR(DMSO-d6,δ): 3.41(3H,s),4.08(2H,s),6.63
(1H,d,J=6Hz),7.48-7.63(4H,m),8.00(1H,d,J=8Hz),8.43
(1H,d,J=6Hz),8.67(1H,d,J=8Hz),9.30(1H,s),10.18(1H,
s),10.52(1H,s)
(4) 4−(2−アセトアミドアセチルヒドラジノ)−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリン
mp: 263-269℃
NMR(DMSO-d6,δ): 1.90(3H,s),3.85(2H,d,J=6Hz),
6.71(1H,d,J=6Hz),7.46-7.63(4H,m),8.00(1H,d,J=8Hz),
8.32(1H,t,J=6Hz),8.42(1H,d,J=6Hz),8.66(1H,t,J=8Hz),
9.32(1H,s),10.13(1H,s),10.52(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−フリル
カルボニル)ヒドラジノ]キノリン塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 6.78(1H,d,J=3Hz),6.96(1H,d,
J=5Hz),7.45(1H,d,J=4Hz),7.50-7.68(3H,m),7.86(1H,t,
J=8Hz),8.04(1H,s),8.43(1H,d,J=8Hz),8.55-8.65(2H,m)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(1−メチル
イミダゾール−2−イルカルボニル)ヒドラジノ]キノリン
mp: 217-220℃
NMR(DMSO-d6,δ): 3.95(3H,s),6.65(1H,d,J=6Hz),
7.10(1H,s),7.47(1H,s),7.49-7.63(4H,m),8.05(1H,d,
J=8Hz),8.42(1H,d,J=6Hz),8.68(1H,d,J=8Hz),9.45(1H,s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(ピリジン−
2−イルカルボニル)ヒドラジノ]キノリン二塩酸塩
mp: 200-220℃
NMR(DMSO-d6,δ): 6.95(1H,d,J=6Hz),7.52-7.68(3H,
m),7.77(1H,t,J=6Hz),7.90(1H,t,J=8Hz),8.08-8.18(2H,
m),8.50(1H,d,J=8Hz),8.55-8.67(2H,m),8.80(1H,d,
J=4Hz)実施例149
(1) 4−(2−アセトキシアセチルヒドラジノ)−8−(2,6−ジクロロ
ベンゾイルアミノ)キノリンを、実施例147と同様にして、8−(2,6−ジ
クロロベンゾイルアミノ)−4−ヒドラジノキノリンとアセトキシ酢酸から得た
。
mp: 234-236℃
NMR(DMSO-d6,δ): 2.14(3H,s),4.70(2H,s),6.68
(1H,d,J=6.0Hz),7.50-7.60(4H,m),8.00(1H,d,J=8.0Hz),
8.43(1H,d,J=6.0Hz),8.66(1H,d,J=8.0Hz),9.36(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−ヒドロキシア
セチルヒドラジノ)キノリンを実施例12−(2)と同様にして得た。
mp: 248-250℃
NMR(DMSO-d6,δ): 4.07(2H,d,J=7.0Hz),5.63(1H,t,
J=7.0Hz),6.65(1H,d,J=6.0Hz),7.48-7.61(4H,m),8.03(1H,
d,J=8.0Hz),8.43(1H,d,J=6.0Hz),8.65(1H,d,J=8.0Hz),
9.25(1H,s)実施例150
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(20
0mg)のピリジン(2ml)中の攪拌懸濁液に、クロロ蟻酸エチル(68.8
mg)のジクロロメタン(0.5ml)中の溶液を氷冷下で加え、混合物を室温
で1時間攪拌した。混合物を真空中で濃縮し、残留物をジクロロメタンで希釈し
た。混合物を水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を
留去した。残留物をエタノールから再結晶して、8−(2,6−ジクロロベンゾ
イルアミノ)−4−(2−エトキシカルボニルヒドラジノ)キノリン(115m
g)を得た。
mp: 151-155℃
NMR(DMSO-d6,δ): 1.24(3H,br t,J=8Hz),4.11(2H,
br q,J=8Hz),6.64(1H,d,J=6Hz),7.46-7.63(4H,m),7.94
(1H,d,J=8Hz),8.44(1H,d,J=5Hz),8.66(1H,d,J=8Hz),9.31
(1H,br s),9.49(1H,br s)実施例151
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(20
0mg)とイソチオシアン酸メチル(54.8mg)の塩化エチレン(4ml)
中の懸濁液を室温で2時間攪拌し、次いで穏やかに24時間還流した。混合物を
真空中で濃縮し、残留物をエタノールから再結晶して、8−(2,6−ジクロロ
ベンゾイルアミノ)−4−[4−(メチル)チオセミカルバジド]キノリン(2
13mg)を得た。
mp: >258℃
NMR(DMSO-d6,δ): 2.87(3H,d,J=5Hz),6.60(1H,d,
J=5Hz),7.47-7.64(4H,m),7.98(1H,d,J=8Hz),8.26(1H,br
q,J=5Hz),8.47(1H,d,J=5Hz),8.67(1H,d,J=8Hz),9.43(1H,
br s),9.63(1H,br s)実施例152
下記の化合物を実施例151と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(4−フェニルセミ
カルバジド)キノリン
mp: >234℃
NMR(DMSO-d6,δ): 6.77(1H,d,J=6Hz),6.94(1H,t,
J=8Hz),7.19-7.29(2H,m),7.45-7.64(6H,m),8.03(1H,d,
J=8Hz),8.47(1H,d,J=6Hz),8.53(1H,br s),8.67(1H,d,
J=8Hz),8.93(1H,br s),9.30(1H,br s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−[4−(フェニル)
チオヤミカルバジド]キノリン
mp: 227-232℃
NMR(DMSO-d6,δ): 6.71(1H,d,J=6Hz),7.16(1H,t,
J=8Hz),7.25-7.36(2H,m),7.38-7.47(2H,m),7.49-7.70(4H,
m),8.03(1H,d,J=8Hz),8.55(1H,d,J=6Hz),8.67(1H,d,
J=8Hz),9.63(1H,br s),9.91-10.13(2H,m),10.56(1H,s)実施例153
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−ヒドロ
キシエチル)ヒドラジノ]キノリンを、実施例8と同様にして、4−クロロ−8
−(2,6−ジクロロベンゾイルアミノ)キノリンと2−ヒドロキシエチルヒド
ラジンから得た。
mp: 125-137℃
NMR(CDCl3,δ): 1.92(1H,br),3.10-3.20(2H,m),
3.83-3.41(2H,m),4.05(1H,t,J=6Hz),6.57(1H,s),7.12
(1H,d,J=5Hz),7.28-7.50(4H,m),8.47(1H,d,J=5Hz),8.91
(1H,d,J=6Hz)
その二塩酸塩
mp: 153-167℃
NMR(DMSO-d6,δ): 3.02(2H,t,J=6Hz),3.54(2H,t,
J=6Hz),7.33(1H,d,J=8Hz),7.50-7.67(3H,m),7.75(1H,t,
J=6Hz),8.39(1H,d,J=8Hz),8.40-8.50(2H,m)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−オキサゾリジ
ノン−3−イルアミノ)キノリンを実施例92−(2)と同様にして得た。
mp: >250℃
NMR(CDCl3,δ): 3.92(2H,t,J=8Hz),4.58(2H,t,
J=8Hz),6.81(1H,d,J=4Hz),7.33-7.44(3H,m),7.50-7.67(2H,
m),8.53(1H,d,J=4Hz),8.93(1H,d,J=6Hz)実施例154
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(21
6mg)のピリジン(2ml)中の攪拌懸濁液に、塩化メタンスルホニル(78
.4mg)のジメチルホルムアミド中の溶液を氷冷下で加え、混合物を同温で5
0分間攪拌した。混合物を真空中で濃縮し、酢酸エチル、メタノールと水を残留
物に加えた。分離した有機層を水と食塩水で洗浄し、硫酸マグネシウムで乾燥後
、真空中で溶媒を留去した。残留物を分取薄層クロマトグラフィーで精製して、
エタノールから再結晶して、8−(2,6−ジクロロベンゾイルアミノ)−4−
(2−メタンスルホニルヒドラジノ)キノリン(16mg)を得た。
mp: 156-164℃
NMR(DMSO-d6,δ): 3.10(3H,s),7.10(1H,d,J=6Hz),
7.48-7.63(4H,m),8.05(1H,d,J=8Hz),8.50(1H,d,J=6Hz),
8.68(1H,d,J=8Hz),9.45(1H,s),9.56(1H,s),10.55(1H,s)実施例155
4−(2−ベンゼンスルホニルヒドラジノ)−8−(2,6−ジクロロベンゾ
イルアミノ)キノリンを、実施例154と同様にして、8−(2,6−ジクロロ
ベンゾイルアミノ)−4−ヒドラジノキノリンとベンゼンスルホニルクロライド
とを反応させて得た。
mp: 197-201℃
NMR(DMSO-d6,δ): 6.89(1H,d,J=6Hz),7.43-7.73(7H,
m),7.80-7.92(3H,m),8.38(1H,d,J=6Hz),8.64(1H,d,
J=8Hz),9.34(1H,s),10.12(1H,s),10.52(1H,s)実施例156
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[(2−エチルアミ
ノエチル)アミノ]キノリンを、実施例8と同様にして、4−クロロ−8−(2
,6−ジクロロベンゾイルアミノ)キノリンとN−エチルエチレンジアミンから
得た。
mp: 140-144℃
NMR(CDCl3,δ): 1.17(3H,t,J=8Hz),2.73(2H,q,
J=8Hz),3.06(2H,t,J=7Hz),3.37(2H,q,J=7Hz),5.93(1H,t,
J=7Hz),6.46(1H,d,J=6Hz),7.30-7.43(3H,m),7.45-7.57(2H,
m),8.40(1H,d,J=6Hz),8.92(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−エチル−2−
オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)と同様にして
得た。
mp: 249-253℃
NMR(CDCl3,δ): 1.25(3H,t,J=8Hz),3.45(2H,q,
J=8Hz),3.65(2H,t,J=6Hz),3.97(2H,t,J=8Hz),7.30-7.45
(4H,m),7.62(1H,t,J=8Hz),7.77(1H,d,J=8Hz),8.73(1H,
d,J=5Hz),8.98(1H,d,J=8Hz)実施例157
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(400m
g)とN−ベンジルエチレンジアミン(854mg)の混合物を130℃で6時
間攪拌した。混合物を酢酸エチルと水との間に分配し、有機層を水と食塩水で洗
浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物をシリカゲ
ルフラッシュクロマトグラフィー(メタノール−ジクロロメタン)で精製して、
4−(2−ベンジルアミノエチルアミノ)−8−(2,6−ジクロロベンゾイル
アミノ)キノリンを含む残留物を得た。得られた残留物、1,1’−カルボニル
ジイミダゾール(221mg)と1,8−ジアザビシクロ[5.4.0]ウンデ
ク−7−エン(191mg)のジメチルホルムアミド中の混合物を室温で4時間
、130℃で2時間攪拌した。混合物を酢酸エチルと水との間に分配し、有機層
を水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。
残留物をシリカゲルフラッシュクロマトグラフィー(メタノール−ジクロロメタ
ン)で精製して、4−(3−ベンジル−2−オキソイミダゾリジン−1−イル)
−8−(2,6−ジクロロベンゾイルアミノ)キノリン(150mg)を得た。
mp: 178-191℃
NMR(CDCl3,δ): 3.52(2H,t,J=8Hz),3.93(2H,t,
J=8Hz),4.55(2H,s),7.30-7.45(9H,m),7.62(1H,t,J=8Hz),
7.75(1H,d,J=8Hz),8.74(1H,d,J=5Hz),8.98(1H,d,J=8Hz)実施例158
8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メチル−3,4,5
,6−テトラヒドロ−2(1H)−ピリミジノン−1−イル)キノリンを、実施
例157と同様にして、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ
)キノリンと3−メチルアミノプロピルアミンから得た。
mp: 252-254℃
NMR(CDCl3,δ): 2.60-2.45(4H,m),3.07(3H,s),
3.47-3.85(6H,m),7.30-7.45(4H,m),7.58-7.65(2H,m),8.76
(1H,d,J=5Hz),8.90-8.98(1H,m)実施例159
8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(3−メチル
−2−チオキソイミダゾリジン−1−イル)キノリンを、実施例92−(2)と
同様にして、8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−[
(2−メチルアミノエチル)アミノ]キノリンと1,1’−チオカルボニルジ
イミダゾールから得た。
mp: 248-250℃
NMR(DMSO-d6,δ): 2.37(3H,s),3.16(3H,s),3.82-
4.08(4H,m),7.48-7.70(5H,m),8.65(1H,d,J=8Hz),8.89
(1H,s)実施例160
(1) 3−第三級ブチルジメチルシリルオキシメチル−4−クロロ−8−(2
,6−ジクロロベンゾイルアミノ)キノリンを、実施例125−(2)と同様に
して、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキ
シメチルキノリンと塩化第三級ブチルジメチルシリルから得た。
mp: 205-207℃
NMR(CDCl3,δ): 0.16(2x3H,s),0.96(3x3H,s),5.02
(2H,s),7.30-7.44(3H,m),7.70(1H,dd,J=8,8Hz),7.97(1H,
d,J=8Hz),8.93(1H,s),9.00(1H,d,J=8Hz),10.09(1H,br s)
(2) 3−第三級ブチルジメチルシリルオキシメチル−8−(2,6−ジクロ
ロベンゾイルアミノ)−4−[(2−メチルアミノエチル)アミノ]キノリンを
実施例8と同様にして得た。
NMR(DMSO-d6,δ): 0.06(2x3H,s),0.86(3x3H,s),
2.31(3H,s),2.73(2H,t,J=6Hz),3.69(2H,dt,J=6,6Hz),
4.84(2H,s),6.45(1H,t,J=6Hz),7.43-7.62(4H,m),7.98
(1H,d,J=8Hz),8.37(1H,s),8.61(1H,d,J=8Hz),10.51(1H,
s)
(3) 3−第三級ブチルジメチルシリルオキシメチル−8−(2,6−ジクロ
ロベンゾイルアミノ)−4−(3−メチル−2−オキソイミダゾリジン−1−イ
ル)キノリンを実施例92−(2)と同様にして得た。
NMR(DMSO-d6,δ): 0.10(3H,s),0.12(3H,s),0.90
(3x3H,s),2.81(3H,s),3.60(1H,m),3.63-3.75(2H,m),3.83
(1H,m),4.86(2H,s),7.47-7.61(3H,m),7.66-7.74(2H,m),
8.73(1H,m),9.00(1H,s),10.86(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(3−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例1
25−(8)と同様にして得た。
mp: 251-253℃
NMR(DMSO-d6,δ): 2.82(3H,s),3.55-3.77(3H,m),
3.83(1H,m),4.65(2H,d,J=6Hz),5.45(1H,t,J=6Hz),7.48-
7.62(3H,m),7.69(1H,d,J=5Hz),8.70(1H,dd,J=5,5Hz),
9.03(1H,s),11.06(1H,s)実施例161
(1) 3−エトキシメチル−1,4−ジヒドロ−8−ニトロ−4−オキソキノ
リンを、実施例124−(2)と同様にして、3−クロロメチル−1,4−ジヒ
ドロ−8−ニトロ−4−オキソキノリンとエタノールから得た。
mp: 175-180℃
NMR(DMSO-d6,δ): 1.17(3H,t,J=8Hz),3.55(2H,q,
J=8Hz),4.37(2H,s),7.50-7.60(1H,m),7.99(1H,d,J=6Hz),
8.57-8.69(2H,m)
(2) 4−クロロ−3−エトキシメチル−8−ニトロキノリンを製造例2−(
1)と同様にして得た。
mp: 110-126℃
NMR(CDCl3,δ): 1.30(3H,t,J=8Hz),3.68(2H,q,
J=8Hz),4.85(2H,s),7.73(1H,t,J=8Hz),8.05(1H,d,
J=8Hz),8.48(1H,d,J=8Hz),9.13(1H,s)
(3) 8−アミノ−4−クロロ−3−エトキシメチルキノリンを製造例2−(
3)と同様にして得た。
mp: 90-93℃
NMR(CDCl3,δ): 1.30(3H,t,J=8Hz),3.64(2H,q,
J=8Hz),4.82(2H,s),5.05(2H,s),6.95(1H,d,J=8Hz),7.41
(1H,t,J=8Hz),7.53(1H,d,J=8Hz),8.78(1H,s)
(4) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−エトキ
シメチルキノリンを実施例1と同様にして得た。
mp: 121-123℃
NMR(CDCl3,δ): 1.30(3H,t,J=8Hz),3.66(2H,d,
J=8Hz),4.85(2H,s),7.30-7.45(3H,m),7.71(1H,t,J=8Hz),
8.01(1H,d,J=8Hz),8.85(1H,s),9.01(1H,d,J=8Hz)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−エトキシメチル−4
−(3−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例15
7と同様にして得た。
mp: 173-177℃
NMR(CDCl3,δ): 1.25(3H,t,J=8Hz),2.98(3H,s),
3.53-3.99(6H,m),4.57-4.80(2H,m),7.28-7.44(3H,m),7.63
(2H,d,J=4Hz),8.88(1H,s),8.96(1H,t,J=4Hz)実施例162
(1) 3−第三級ブチルジフェニルシリルオキシメチル−1,4−ジヒドロ−
8−ニトロ−4−オキソキノリンを、実施例125−(2)と同様にして、1,
4−ジヒドロ−3−ヒドロキシメチル−8−ニトロ−4−オキソキノリンと塩化
第三級ブチルジフェニルシリルから得た。
mp: 168-171℃
NMR(CDCl3,δ): 1.14(9H,s),4.83(2H,s),7.32-7.47
(7H,m),7.53-7.63(4H,m),8.06(1H,d,J=7Hz),8.65(1H,d,
J=8Hz),8.76(1H,d,J=7.5Hz)
(2) 3−第三級ブチルジフェニルシリルオキシメチル−4−クロロ−8−ニ
トロキノリンを製造例2−(1)と同様にして得た。
mp: 100-105℃
NMR(CDCl3,δ): 1.11(3x3H,s),5.04(2H,s),7.33-
7.50(6H,m),7.65-7.75(5H,m),8.05(1H,d,J=7.5Hz),8.42
(1H,d,J=7.5Hz),9.40(1H,s)
(3) 8−アミノ−3−第三級ブチルジフェニルシリルオキシメチル−4−ク
ロロキノリンを製造例2−(3)と同様にして得た。
mp: 107-108℃
NMR(DMSO-d6,δ): 1.06(3x3H,s),5.04(2H,s),6.15
(2H,s),6.93(1H,d,J=8Hz),7.23(1H,d,J=8Hz),7.39-7.53
(7H,m),7.68(4x1H,d,J=7.5Hz),8.86(1H,s)
(4) 3−第三級ブチルジフェニルシリルオキシメチル−4−クロロ−8−(
2,6−ジクロロベンゾイルアミノ)キノリンを実施例1と同様にして得た。
mp: 123-124℃
NMR(DMSO-d6,δ): 1.06(3x3H,s),5.10(2H,s),7.40-
7.62(9H,m),7.67(4x1H,d,J=7.5Hz),7.82(1H,dd,J=8,
8Hz),7.97(1H,d,J=8Hz),8.82(1H,d,J=8Hz),9.06(1H,s),
10.98(1H,s)
(5) 3−第三級ブチルジフェニルシリルオキシメチル−4−(イミダゾール
−1−イル)−8−(2,6−ジクロロベンゾイルアミノ)キノリンを実施例8
と同様にして得た。
NMR(CDCl3,δ): 1.04(9H,s),4.61(2H,s),6.99(1H,
s),7.09(1H,d,J=7.5Hz),7.27(1H,d,J=7.5Hz),7.31-7.47
(9H,m),7.50-7.65(6H,m),8.98-9.05(2H,m)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(イミダゾール−1−イル)キノリンを実施例125−(8)と同様にして
得た。
mp: 205-207℃
NMR(DMSO-d6,δ): 4.44(2H,d,J=6Hz),5.59(1H,t,
J=6Hz),7.07(1H,d,J=8Hz),7.28(1H,s),7.49-7.63(4H,m),
7.70(1H,dd,J=8,8Hz),7.97(1H,s),8.76(1H,d,J=8Hz),
9.14(1H,s),11.00(1H,s)実施例163
8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−4−(
イミダゾール−1−イル)キノリン(250mg)のジクロロメタン(3ml)
中の懸濁液に、ピリジン(57.4mg)と無水酢酸(0.12ml)を室
温で滴下し、混合物を室温で22時間攪拌した。混合物を真空中で濃縮し、残留
物を酢酸エチルに溶解した。混合物を水で洗浄し、硫酸マグネシウムで乾燥後、
真空中で溶媒を留去した。残留物をシリカゲルフラッシュクロマトグラフィー(
メタノール−ジクロロメタン)で精製して、3−アセトキシメチル−8−(2,
6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル)キノリン(
270mg)を得た。
NMR(CDCl3,δ): 2.07(3H,s),5.00(1H,d,J=13.5Hz),
5.13(1H,d,J=13.5Hz),7.16-7.23(2H,m),7.34-7.45(2H,m),
7.67(1H,t,J=8.0Hz),7.74(1H,s),8.95(1H,s),9.06(1H,
d,J=8.0Hz)実施例164
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(イミダゾール−1−イル)キノリン(800mg)のジクロロメタン(1
0ml)中の懸濁液に、ピリジン(230mg)とクロロ蟻酸フェニル(333
mg)を室温で滴下し、混合物を室温で1時間攪拌した。混合物を飽和塩化アン
モニウム溶液、飽和重炭酸ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウム
で乾燥後、真空中で溶媒を留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(酢酸エチル−n−ヘキサン)で精製して、8−(2,6−ジクロロベンゾ
イルアミノ)−4−(イミダゾール−1−イル)−3−(フェノキシカルボニル
オキシメチル)キノリン(100mg)を得た。
NMR(CDCl3,δ): 5.23(2H,d,J=7.0Hz),7.12-7.45
(11H,m),7.67(1H,t,J=7.5Hz),7.75(1H,s),9.03-9.10(2H,
m)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−(フェノキシカルボ
ニルオキシメチル)−4−(イミダゾール−1−イル)キノリン(100mg)
のメタノール(4ml)中の溶液に、2Mメチルアミンのメタノール溶液(4m
l)を氷冷下で滴下し、混合物を室温で1時間攪拌した。混合物を真空中で濃縮
し、残留物をエタノールから結晶化して、8−(2,6−ジクロロベンゾイルア
ミノ)−4−(イミダゾール−1−イル)−3−(メチルカルバモイルオキシメ
チル)キノリン(50mg)を得た。
mp: 240-242℃
NMR(CDCl3,δ): 2.80(3H,d,J=6.0Hz),4.70(1H,br),
4.99(1H,d,J=8.0Hz),5.15(1H,d,J=8.0Hz),7.16(1H,d,
J=8.0Hz),7.23(1H,s),7.34-7.45(4H,m),7.65(1H,t,
J=8.0Hz),7.73(1H,s),9.00(1H,s),9.05(1H,d,J=8.0Hz)実施例165
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(イミダゾール−1−イル)キノリン(300mg)のジクロロメタン(5
ml)中の懸濁液に、トリエチルアミン(294mg)とクロロ蟻酸フェニル(
375mg)を氷冷下で滴下し、混合物を室温で2.5時間攪拌した。混合物に
クロロ蟻酸フェニル(250mg)をさらに加え、混合物を室温で1.5時間攪
拌した。不溶物を濾去し、濾液を真空中で濃縮した。残留物をジクロロメタンに
溶解し、それにクロロ蟻酸フェニル(375mg)とジイソプロピルエチルアミ
ン(0.506ml)を加えた。真空中で混合物から溶媒を留去し、残留物をシ
リカゲルフラッシュクロマトグラフィー(酢酸エチル−n−ヘキサン)で精製し
て、8−[N−(2,6−ジクロロベンゾイル)−N−フェノキシカルボニルア
ミノ]−4−[2−(フェノキシカルボニル)イミダゾール−1−イル]−3−
(フェノキシカルボニルオキシメチル)キノリン(250mg)を得た。
NMR(CDCl3,δ): 5.22(2H,d,J=8.5Hz),6.86(2H,d,
J=7.5Hz),6.93(2H,t,J=7.0Hz),7.02-7.45(14H,m),7.65-7.75
(3H,m),8.03-8.06(1H,m),9.02(1H,s),9.27(1H,s)
(2) 8−[N−(2,6−ジクロロベンゾイル)−N−フェノキシカルボニ
ルアミノ]−4−[2−(フェノキシカルボニル)イミダゾール−1−イル]−
3−(フェノキシカルボニルオキシメチル)キノリン(250mg)のメタノー
ル(4ml)中の溶液に、ジメチルアミンの50%水溶液(8ml)を加え、混
合物を室温で66時間攪拌した。混合物を真空中で濃縮し、残留物を分取薄層ク
ロマトグラフィー(酢酸エチル)で精製して、8−(2,6−ジクロロベンゾイ
ルアミノ)−4−[2−(ジメチルカルバモイル)イミダゾール−1−イル]−
3−(ジメチルカルバモイルオキシメチル)キノリン(25mg)を得た。
NMR(CDCl3,δ): 2.87(9H,s),3.54(3H,s),5.07(1H,
d,J=14.0Hz),5.16(1H,d,J=14.0Hz),6.82(1H,d,J=8.0Hz),
7.16(1H,s),7.32-7.43(4H,m),7.57(1H,t,J=8.0Hz),8.96
(1H,s),8.99(1H,d,J=8.0Hz),10.02(1H,s)実施例166
(1) 3−イソフロポキシメチル−1,4−ジヒドロ−8−ニトロ−4−オキ
ソキノリンを、実施例124−(2)と同様にして、3−クロロメチル−1,4
−ジヒドロ−8−ニトロ−4−オキソキノリンとイソプロピルアルコールから得
た。
mp: 167-170.5℃
NMR(CDCl3,δ): 1.26(2x3H,d,J=7Hz),3.79(1H,qq,
J=7,7Hz),4.55(2H,s),7.43(1H,dd,J=8,8Hz),7.95(1H,d,
J=6Hz),8.67(1H,d,J=8Hz),8.82(1H,d,J=8Hz)
(2) 4−クロロ−3−イソプロポキシメチル−8−ニトロキノリンを製造例
2−(1)と同様にして得た。
mp: 83-86℃
NMR(CDCl3,δ): 1.27(2x3H,d,J=7Hz),3.79(1H,qq,
J=7,7Hz),4.83(2H,s),7.71(1H,dd,J=8,8Hz),8.04(1H,d,
J=8Hz),8.47(1H,d,J=8Hz),9.15(1H,s)
(3) 8−アミノ−4−クロロ−3−イソプロポキシメチルキノリンを製造例
2−(3)と同様にして得た。
mp: 94-95℃
NMR(CDCl3,δ): 1.27(2x3H,d,J=7Hz),3.77(1H,qq,
J=7,7Hz),4.80(2H,s),5.02(2H,br),6.93(1H,d,J=8Hz),
7.40(1H,dd,J=8,8Hz),7.52(1H,d,J=8Hz),8.80(1H,s)
(4) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−イソプ
ロポキシメチルキノリンを実施例1と同様にして得た。
mp: 117-118℃
NMR(CDCl3,δ): 1.27(2x3H,d,J=7Hz),3.78(1H,qq,
J=7,7Hz),4.82(2H,s),7.30-7.43(3H,m),7.70(1H,dd,J=8,
8Hz),7.98(1H,d,J=8Hz),8.86(1H,s),8.98(1H,d,J=8Hz),
10.03(1H,br s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−イソプロポキシメチルキノリンを実施例8と同様にして得た。
NMR(DMSO-d6,δ): 1.05(2x3H,d,J=7Hz),3.54(1H,
qq,J=7,7Hz),4.40(2H,s),7.07(1H,d,J=8Hz),7.28(1H,
s),7.48-7.63(4H,m),7.72(1H,dd,J=8,8Hz),7.97(1H,s),
8.77(1H,d,J=8Hz),9.10(1H,s),10.98(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−3−イソプロポキシメチ
ル−4−(ピラゾール−1−イル)キノリンを、実施例8と同様にして、4−ク
ロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−イソプロポキシメチル
キノリンとピラゾールから得た。
mp: 153-154℃
NMR(DMSO-d6,δ): 1.03(2x3H,d,J=7Hz),3.54(1H,
qq,J=7,7Hz),4.43(2H,s),6.70(1H,dd,J=1.5,1Hz),7.15
(1H,d,J=8Hz),7.49-7.62(3H,m),7.70(1H,dd,J=8,8Hz),
7.95(1H,d,J=1Hz),8.20(1H,d,J=1.5Hz),8.75(1H,d,
J=8Hz),9.09(1H,s),10.46(1H,s)実施例167
2−メトキシエタノール(130mg)のN−メチルピロリドン(2ml)中
の攪拌溶液に、カリウム第三級ブトキシド(172mg)を氷冷下で加え、混合
物を室温で30分間攪拌した。混合物に4−クロロ−8−(2,6−ジクロロベ
ンゾイルアミノ)キノリン(200mg)を加え、混合物を80℃で5時間攪拌
した。混合物を酢酸エチルで希釈し、水と食塩水で洗浄し、硫酸マグネシウムで
乾燥後、真空中で溶媒を留去した。残留物をエタノールから再結晶して、8−(
2,6−ジクロロベンゾイルアミノ)−4−(2−メトキシエトキシ)キノリン
(175mg)を得た。
mp: 150-152℃
NMR(CDCl3,δ): 3.50(3H,s),3.87-3.96(2H,m),
4.30-4.40(2H,m),6.78(1H,d,J=6Hz),7.28-7.43(3H,m),
7.56(1H,t,J=8Hz),7.98(1H,d,J=8Hz),8.59(1H,d,J=6Hz),
8.94(1H,d,J=8Hz)実施例168
下記の化合物を実施例167と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メトキシエト
キシ)−3−メチルキノリン
(4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノ
リンと2−メトキシエタノールから)
mp: 118-119℃
NMR(CDCl3,δ):2.48(3H,s),3.51(3H,s),3.80-3.83
(2H,m),4.23-4.27(2H,m),7.30-7.43(3H,m),7.60(1H,t,
J=8.0Hz),7.91(1H,d,J=8.0Hz),8.58(1H,s),8.89(1H,d,
J=8.0Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−イソプロポキシメチ
ル−4−(2−メトキシエトキシ)キノリン
(4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−イソプロポ
キシメチルキノリンと2−メトキシエタノールから)
mp: 86-87℃
NMR(DMSO-d6,δ): 1.17(2x3H,d,J=7Hz),3.36(3H,
s),3.66-3.80(3H,m),4.31-4.38(2H,m),4.71(2H,s),7.48-
7.62(3H,m),7.67(1H,dd,J=8,8Hz),7.97(1H,d,J=8Hz),
8.70(1H,d,J=8Hz),8.83(1H,s),10.74(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−フリルメトキ
シ)キノリン
(4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリンと2−フ
リルメタノールから)
mp: 145-149℃
NMR(CDCl3,δ): 5.25(2H,s),6.40-6.45(1H,m),6.55
(1H,d,J=4Hz),6.94(1H,d,J=5Hz),7.30-7.43(3H,m),7.50
(1H,d,J=4Hz),7.55(1H,t,J=8Hz),7.95(1H,d,J=8Hz),8.61
(1H,d,J=5Hz),8.95(1H,d,J=8Hz)実施例169
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメ
チルキノリン(297mg)のN−メチルピロリドン(4ml)中の溶液に、ヒ
ドラジン−水和物(390mg)を加え、混合物を90℃で3時間攪拌した。混
合物を酢酸エチルで希釈し、水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、
真空中で溶媒を留去した。残留物をシリカゲルフラッシュクロマトグラフィーと
分取薄層クロマトグラフィーで精製して、8−(2,6−ジクロロベンゾイルア
ミノ)−4−ヒドラジノ−3−ヒドロキシメチルキノリン(127mg)と6−
(2,6−ジクロロベンゾイルアミノ)−1H−ピラゾロ[4,3−c]キノリ
ン(90mg)を得た。
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−3−ヒドロキ
シメチルキノリン
NMR(DMSO-d6,δ): 4.70(2H,d,J=6Hz),5.19(2H,s),
5.35(1H,t,J=6Hz),7.39(1H,dd,J=8,8Hz),7.49-7.63(3H,
m),8.15(1H,d,J=8Hz),8.28(1H,s),8.40(1H,s),8.56(1H,
d,J=8Hz),10.46(1H,s)
6−(2,6−ジクロロベンゾイルアミノ)−1H−ピラゾロ[4,3−c]
キノリン
NMR(DMSO-d6,δ): 7.49-7.63(3H,m),7.77(1H,dd,
J=8,8Hz),8.20(1H,d,J=8Hz),8.46(1H,br s),8.78(1H,d,
J=8Hz),9.25(1H,s),10.76(1H,s)実施例170
4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−シアノキノリ
ン(300mg)のN−メチルビロリドン(6ml)中の溶液に、ヒドラジン−
水和物(399mg)を滴下し、混合物を90℃で2時間攪拌した。それに水(
15ml)を加え、生じた沈殿物を濾過により集めて、3−アミノ−6−(2,
6−ジクロロベンゾイルアミノ)−1H−ピラゾロ[4,3−c]キノリン(2
60mg)を得た。
mp: >300℃
NMR(DMSO-d6,δ): 5.93(2H,br s),7.50-7.61(3H,m),
7.64(1H,t,J=8.0Hz),8.02(1H,d,J=8.0Hz),8.70(1H,d,
J=8.0Hz),9.09(1H,s)実施例171
3−アミノ−6−(2,6−ジクロロベンゾイルアミノ)−1H−ピラゾロ[
4,3−c]キノリン(200mg)の1,2−ジクロロエタン(2ml)中の
懸濁液に、無水酢酸(302mg)を加え、反応混合物を12時間還流した。溶
液を室温まで冷却させ、真空中で溶媒を留去した。残留物を水−エタノールで粉
砕し、沈殿物を集めた。粗製生成物をシリカゲルカラムクロマトグラフィー(酢
酸エチル−n−ヘキサン)で精製して、2−アセチル−6−(2,6−ジクロロ
ベンゾイルアミノ)−2,3−ジヒドロ−3−イミノ−1H−ピラゾロ[4,3
−c]キノリンを黄色結晶(60mg)として、さらに3−アセトアミド−6−
(2,6−ジクロロベンゾイルアミノ)−1H−ピラゾロ[4,3−c]キノリ
ンを白色結晶(30mg)として得た。
2−アセチル−6−(2,6−ジクロロベンゾイルアミノ)−2,3−ジヒド
ロ−3−イミノ−1H−ピラゾロ[4,3−c]キノリン
mp: >300℃
NMR(DMSO-d6,δ): 2.76(3H,s),7.47-7.60(4H,m),
7.96(1H,d,J=8.0Hz),8.46(1H,br),8.68(1H,d,J=8.0Hz),
9.05(1H,s)
3−アセトアミド−6−(2,6−ジクロロベンゾイルアミノ)−1H−ピラ
ゾロ[4,3−c]キノリン
mp: >300℃
NMR(DMSO-d6,δ): 2.16(3H,s),7.48-7.61(3H,m),
7.74(1H,t,J=8.0Hz),8.14(1H,d,J=8.0Hz),8.75(1H,d,
J=8.0Hz),9.42(1H,s),10.77(1H,s),10.98(1H,br)実施例172
(1) 5−メチル−2−ニトロアニリン(10.0g)のエタノール(20m
l)中の攪拌懸濁液に、2,2−ジメチル−1,3−ジオキサン−4,6−ジオ
ン(9.59g)とオルト蟻酸トリエチル(10.7g)を50℃で加えた。生
じた混合物を120℃で1時聞加熱し、その間にエタノール(20ml)を混合
物に加え、遊離したエタノールを留去した。冷却後、それに酢酸エチル(40m
l)を加え、生じた沈殿物を濾過により集めた。固形物を熱エタノール(40m
l)で洗浄し、室温まで冷却させた。沈殿物を濾過により集め、空気乾燥して、
(5−メチル−2−ニトロアニリノ)メチレンマロン酸イソプロピリデン(15
.2g)を黄色針状物として得た。
mp: 218-220℃
NMR(CDCl3,δ): 1.77(6H,s),2.50(3H,s),7.16(1H,
d,J=8Hz),7.40(1H,br s),8.20(1H,d,J=8Hz),8.73(1H,d,
J=15Hz)
(2) ジフェニルエーテル(37g)とビフェニル(13g)の攪拌混合物に
、(5−メチル−2−ニトロアニリノ)メチレンマロン酸イソプロピリデン(1
4.6g)を220℃で加え、混合物を同温で半時間加熱した。反応混合物を1
00℃に冷却させ、次いで混合物にn−ヘキサン(100ml)を滴下した。室
温まで冷却後、沈殿物を濾過により集めた。固形物を熱エタノール(70ml)
で洗浄し、室温まで冷却させた。固形物を濾過により集め、空気乾燥して、1,
4−ジヒドロ−5−メチル−8−ニトロ−4−オキソキノリン(8.8g)を暗
褐色固形物として得た。
mp: 219-225℃
NMR(DMSO-d6,δ): 2.87(3H,s),6.15(1H,d,J=8Hz),
7.20(1H,d,J=8Hz),7.86(1H,d,J=8Hz),8.45(1H,d,J=8Hz)
(3) 1,4−ジヒドロ−5−メチル−8−ニトロ−4−オキソキノリン(1
.5g)と1,3,5−トリオキサン(3.31g)のジオキサン(15ml)
中
の攪拌混合物に、濃塩酸(30ml)を加え、混合物を100℃で一夜攪拌した
。真空中で混合物から溶媒を留去し、残留物をアセトニトリルで処理して、1,
4−ジヒドロ−3−ヒドロキシメチル−5−メチル−8−ニトロ−4−オキソキ
ノリン(1.3g)を得た。
mp: 251-255℃
NMR(DMSO-d6,δ): 4.37(2H,s),7.20(1H,d,J=8Hz),
7.93(1H,d,J=6Hz),8.47(1H,d,J=8Hz)
(4) 1,4−ジヒドロ−3−ヒドロキシメチル−5−メチル−8−ニトロ−
4−オキソキノリン(1.12g)のジクロロメタン(10ml)中の懸濁液に
、塩化チオニル(569mg)のジクロロメタン(5ml)中の溶液を氷冷下で
滴下し、混合物を同温で1時間、室温で2時間攪拌した。混合物を真空中で濃縮
し、ジクロロメタン−メタノールに懸濁し、2時間還流した。真空中で混合物か
ら溶媒を留去し、残留物をメタノールから再結晶して、1,4−ジヒドロ−3−
メトキシメチル−5−メチル−8−ニトロ−4−オキソキノリン(889mg)
を得た。
mp: 210-213℃
NMR(CDCl3,δ): 3.05(3H,s),3.50(3H,s),4.45(2H,
s),7.14(1H,d,J=8Hz),7.77(1H,d,J=6Hz),8.48(1H,d,
J=8Hz)
(5) 4−クロロ−3−メトキシメチル−5−メチル−8−ニトロキノリンを
製造例2−(1)と同様にして得た。
mp: 120-124℃
NMR(CDCl3,δ): 3.10(3H,s),3.53(3H,s),4.76(2H,
s),7.43(1H,d,J=8Hz),7.80(1H,d,J=8Hz)9.01(1H,s)
(6) 8−アミノ−4−クロロ−3−メトキシメチル−5−メチルキノリンを
製造例2−(3)と同様にして得た。
NMR(CDCl3,δ): 2.90(3H,s),3.50(3H,s),4.75(2H,
s),4.92(2H,br s),6.82(1H,d,J=8Hz),7.16(1H,d,J=8Hz),
8.71(1H,s)
(7) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メトキ
シメチル−5−メチルキノリンを実施例1と同様にして得た。
mp: 180℃
NMR(CDCl3,δ): 3.01(3H,s),3.52(3H,s),4.75(2H,
s),7.28-7.48(4H,m),8.75(1H,s),8.82(1H,d,J=8Hz)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−メトキシメチル−5−メチルキノリンを実施例8と同様にして得
た。
mp: 179-180℃
NMR(CDCl3,δ): 1.99(3H,s),3.31(3H,s),4.15(2H,
s),7.10(1H,br s),7.31-7.48(5H,m),7.61(1H,br s),8.88
(1H,d,J=8Hz),8.90(1H,s)
その塩酸塩
mp: 207-214℃
NMR(DMSO-d6,δ): 1.94(3H,s),3.20(3H,s),4.30
(2H,s),7.48-7.63(4H,m),7.94(1H,br s),8.06(1H,br s),
8.70(1H,d,J=8Hz),9.10(1H,s),9.31(1H,br s)実施例173
(1) 4−クロロ−5−メチル−8−ニトロキノリンを、製造例2−(1)と
同様にして、1,4−ジヒドロ−5−メチル−8−ニトロ−4−オキソキノリン
から得た。
mp: 125-130℃
NMR(CDCl3,δ): 3.10(3H,s),7.44(1H,d,J=8Hz),
7.60(1H,d,J=6Hz),7.84(1H,d,J=8Hz),8.80(1H,d,J=6Hz)
(2) 8−アミノ−4−クロロ−5−メチルキノリンを製造例2−(3)と同
様にして得た。
mp: 104-107℃
NMR(CDCl3,δ): 2.90(3H,s)6.87(1H,d,J=8Hz),
7.18(1H,d,J=8Hz),7.46(1H,d,J=5Hz),8.54(1H,d,J=5Hz)
(3) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−5−メチル
キノリンを実施例1と同様にして得た。
mp: 258-260℃
NMR(DMSO-d6,δ): 2.98(3H,s),7.47-7.63(4H,m),
7.80(1H,d,J=5Hz),8.66(1H,d,J=8Hz),8.74(1H,d,J=5Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−5−メチルキノリンを実施例8と同様にして得た。
mp: 236℃
NMR(DMSO-d6,δ): 1.96(3H,s),7.19(1H,s),7.47-
7.65(6H,m),7.98(1H,s),8.68(1H,d,J=8Hz),8.97(1H,d,
J=6Hz)
その塩酸塩
mp: 220-223℃
NMR(DMSO-d6,δ): 1.98(3H,s),7.48-7.65(4H,m),
7.87(1H,d,J=4Hz),7.95(1H,br s),8.13(1H,br s),8.73
(1H,d,J=8Hz),9.09(1H,d,J=4Hz),9.46(1H,br s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−5−メ
チルキノリンを、実施例8と同様にして、4−クロロ−8−(2,6−ジクロロ
ベンゾイルアミノ)−5−メチルキノリンとヒドラジン一水和物から得た。
mp: 225-237℃
NMR(DMSO-d6,δ): 2.84(3H,s),4.40(2H,br s),
7.10-7.21(2H,m),7.46-7.65(4H,m),8.34(1H,d,J=6Hz),
8.45(1H,d,J=8Hz)
(6) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−5−メチルキノリンを実施例86と同様にして得た。
mp: 230-234℃
NMR(DMSO-d6,δ): 2.00(3H,s),2.90(3H,s),6.80
(1H,d,J=6Hz),7.27(1H,d,J=8Hz),7.48-7.62(3H,m),8.11
(1H,br s),8.40(1H,d,J=6Hz),8.51(1H,d,J=8Hz)
実施例174
(1) (4−メチル−2−ニトロアニリノ)メチレンマロン酸イソプロピリデ
ンを、実施例172−(1)と同様にして、4−メチル−2−ニトロアニリンと
マロン酸イソプロピリデンから得た。
mp: 193-195℃
NMR(DMSO-d6,δ): 1.68(2x3H,s),2.40(3H,s),7.67
(1H,dd,J=8,1Hz),7.97(1H,d,J=8Hz),8.08(1H,d,J=1Hz),
8.73(1H,d,J=14Hz)
(2) 1,4−ジヒドロ−6−メチル−8−ニトロ−4−オキソキノリンを実
施例172−(2)と同様にして得た。
mp: 209-212℃
NMR(CDCl3,δ): 2.54(3H,s),6.40(1H,d,J=7.5Hz),
7.73(1H,dd,J=7.5,7Hz),8.50(1H,s),8.60(1H,s),11.09
(1H,br)
(3) 1,4−ジヒドロ−3−ヒドロキシメチル−6−メチル−8−ニトロ−
4−オキソキノリンを実施例172−(3)と同様にして得た。
mp: >240℃
NMR(CDCl3,δ): 2.57(3H,s),3.21(1H,t,J=7Hz),
4.67(2H,d,J=7Hz),7.78(1H,d,J=7Hz),8.52(1H,d,J=1Hz),
8.61(1H,d,J=1Hz)
(4) 1,4−ジヒドロ−3−メトキシメチル−6−メチル−8−ニトロ−4
−オキソキノリンを実施例172−(4)と同様にして得た。
mp: >240℃
NMR(CDCl3,δ): 2.54(3H,s),3.50(3H,s),4.49(2H,
s),7.85(1H,d,J=7Hz),8.50(1H,d,J=1Hz),8.62(1H,d,
J=1Hz)
(5) 4−クロロ−3−メトキシメチル−6−メチル−8−ニトロキノリンを
製造例2−(1)と同様にして得た。
mp: 107-111℃
NMR(CDCl3,δ): 2.65(3H,s),3.51(3H,s),4.78(2H,
s),7.90(1H,d,J=1Hz),8.24(1H,d,J=1Hz),9.02(1H,s)
(6) 8−アミノ−4−クロロ−3−メトキシメチル−6−メチルキノリンを
製造例2−(3)と同様にして得た。
mp: 135-138℃
NMR(CDCl3,δ):2.40(3H,s),3.39(3H,s),4.70(2H,
s),6.06(2H,s),6.78(1H,s),7.08(1H,s),8.63(1H,s)
(7) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メトキ
シメチル−6−メチルキノリンを実施例1と同様にして得た。
mp: 156-158℃
NMR(CDCl3,δ): 2.61(3H,s),3.40(3H,s),4.75(2H,
s),7.48-7.60(3H,m),7.80(1H,s),8.68(1H,s),8.83(1H,
s),10.86(1H,s)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3−メトキシメチル−6−メチルキノリンを実施例8と同様にして得
た。
mp: 99-101℃
NMR(DMSO-d6,δ): 2.50(3H,s),3.24(3H,s),4.33
(2H,s),6.85(1H,s),7.28(1H,s),7.48-7.63(4H,m),7.95
(1H,s),8.67(1H,s),9.00(1H,s),10.93(1H,s)
(9) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−6
−メチル−4−[(2−メチルアミノエチル)アミノ]キノリンを、実施例8と
同様にして、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メ
トキシメチル−6−メチルキノリンとN−メチルエチレンジアミンから得た。
NMR(CDCl3,δ): 2.50(3H,s),2.57(3H,s),2.88(2H,
t,J=5Hz),3.37(3H,s),3.73(2H,dt,J=5,5Hz),4.59(2H,
s),5.92(1H,t,J=5Hz),7.27-7.42(3H,m),7.57(1H,s),8.24
(1H,s),8.75(1H,s)
(10) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−
6−メチル−4−(3−メチル−2−オキソイミダゾリジン−1−イル)キノリ
ンを実施例92−(2)と同様にして得た。
mp: 221-223℃
NMR(DMSO-d6,δ): 2.57(3H,s),2.83(3H,s),3.32
(3H,s),3.56-3.73(3H,m),3.88(1H,m),4.54(1H,d,
J=13Hz),4.57(1H,d,J=13Hz),7.47-7.61(4H,m),8.61(1H,
s),8.86(1H,s),10.79(1H,s)
(11) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−
6−メチル−4−(3−メチル−2−チオキソイミダゾリジン−1−イル)キノ
リンを、実施例92−(2)と同様にして、8−(2,6−ジクロロベンゾイル
アミノ)−3−メトキシメチル−6−メチル−4−[(2−メチルアミノエチル
)アミノ]キノリンと1,1’−チオカルボニルジイミダゾールから得た。
mp: 194-196℃
NMR(DMSO-d6,δ): 2.57(3H,s),3.17(3H,s),3.35
(3H,s),3.80-4.10(4H,m),4.54(1H,d,J=12Hz),4.61(1H,d,
J=12Hz),7.40(1H,s),7.48-7.62(3H,m),8.62(1H,s),8.91
(1H,s),10.83(1H,s)実施例175
下記の化合物を実施例1と同様にして得た。
(1) 3−ブロモ−8−(2−クロロベンゾイルアミノ)キノリン
mp: 193-195℃
NMR(CDCl3,δ): 7.36-7.54(4H,m),7.63(1H,d,
J=8Hz),7.81(1H,dd,J=8,2Hz),8.34(1H,d,J=2Hz),8.80
(1H,s),8.97(1H,d,J=8Hz)
(2) 3−ブロモ−8−(3−クロロベンゾイルアミノ)キノリン
mp: 189℃
NMR(CDCl3,δ): 7.43-7.68(4H,m),7.86-7.95(1H,m),
8.03(1H,br s),8.35(1H,d,J=2Hz),8.85(1H,d,J=2Hz),
8.91(1H,d,J=8Hz)
(3) 3−ブロモ−8−(4−クロロベンゾイルアミノ)キノリン
mp: 204℃
NMR(CDCl3,δ): 7.44-7.57(3H,m),7.63(1H,t,
J=8Hz),7.96-8.03(2H,d,J=9Hz),8.34(1H,d,J=1Hz),8.84
(1H,d,J=2Hz),8.92(1H,d,J=8Hz)
(4) 3−ブロモ−8−(2−メチルベンゾイルアミノ)キノリン
mp: 163-165℃
NMR(CDCl3,δ): 2.58(3H,s),7.26-7.49(4H,m),
7.55-7.70(2H,m),8.30(1H,d,J=2Hz),8.74(1H,d,J=2Hz),
8.94(1H,d,J=8Hz)
(5) 3−ブロモ−8−(3−メチルベンゾイルアミノ)キノリン
mp: 160-163℃
NMR(CDCl3,δ): 2.48(3H,s),7.35-7.50(3H,m),7.60
(1H,t,J=8Hz),7.80-7.90(2H,m),8.34(1H,d,J=2Hz),8.83
(1H,d,J=1Hz),8.94(1H,d,J=8Hz)
(6) 3−ブロモ−8−(4−メチルベンゾイルアミノ)キノリン
mp: 142℃
NMR(CDCl3,δ): 2.44(3H,s),7.35(2H,d,J=9Hz),
7.45(1H,d,J=8Hz),7.61(1H,d,J=8Hz),7.95(2H,d,J=9Hz),
8.33(1H,d,J=1Hz),8.83(1H,d,J=1Hz),8.94(1H,d,J=8Hz)
(7) 3−ブロモ−8−(2−メトキシベンゾイルアミノ)キノリン
mp: 192-194℃
NMR(CDCl3,δ): 4.20(3H,s),7.09(1H,d,J=8Hz),
7.15(1H,t,J=8Hz),7.44(1H,d,J=8Hz),7.54(1H,t,J=8Hz),
7.62(1H,t,J=8Hz),8.30-8.39(2H,m),8.87(1H,d,J=2Hz),
9.05(1H,d,J=8Hz)
(8) 3−ブロモ−8−(3−メトキシベンゾイルアミノ)キノリン
mp: 171℃
NMR(CDCl3,δ): 3.91(3H,s),7.11(1H,dd,J=8,
2Hz),7.40-7.50(2H,m),7.57-7.67(3H,m),8.35(1H,d,
J=2Hz),8.83(1H,s),8.95(1H,d,J=8Hz)
(9) 3−ブロモ−8−(4−メトキシベンゾイルアミノ)キノリン
mp: 158℃
NMR(CDCl3,δ): 3.89(3H,s),7.03(2H,d,J=9Hz),
7.44(1H,d,J=8Hz),7.60(1H,t,J=8Hz),8.03(2H,d,J=9Hz),
8.33(1H,d,J=2Hz),8.83(1H,d,J=2Hz),8.94(1H,d,J=8Hz)実施例176
8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン(20
0mg)の蟻酸(4ml)中の溶液に、ホルムアミド(26mg)を加え、混合
物を室温で3時間攪拌した。トルエンを用いて溶媒を共沸的に除去した。残留物
を酢酸エチルで希釈し、水と飽和重炭酸ナトリウム水溶液で洗浄し、硫酸マグネ
シウムで乾燥後、真空中で濃縮した。残留固形物を熱エタノール(2ml)で処
理し、室温まで冷却させ、濾過し、エタノールで洗浄して、8−(2,6−ジク
ロロベンゾイルアミノ)−4−(2−ホルミルヒドラジノ)キノリン(180m
g)を淡黄色結晶として得た。
mp: 261-263℃
NMR(DMSO-d6,δ): 6.70(1H,d,J=5.5Hz),7.50-7.62
(4H,m),8.00(1H,d,J=8.0Hz),8.26(1H,s),8.45(1H,d,
J=5.5Hz),8.68(1H,d,J=8.0Hz),9.34(1H,br),10.18(1H,
br),10.52(1H,s)実施例177
8−(2,6−ジクロロベンゾイルアミノ)−4−(2−ホルミル−2−メチ
ルヒドラジノ)キノリンを、実施例176と同様にして、8−(2,6−ジクロ
ロベンゾイルアミノ)−4−(2−メチルヒドラジノ)キノリンから得た。
mp: 250-262℃
NMR(DMSO-d6,δ): 3.17(3Hx1/5,d,J=6Hz),3.26
(3Hx4/5,d,J=6Hz),7.12(1Hx4/5,d,J=6Hz),7.26(1Hx1/5,d,
J=6Hz),7.47-7.67(4H,m),7.88-8.01(9/5H,m),8.37(1Hx1/5,
d,J=8Hz),8.61-8.76(2H,m),10.25(1Hx1/5,d,J=8Hz),10.57-
10.72(9/5H,m)実施例178
下記の化合物を実施例145と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−トリフルオロ
アセチルヒドラジノ)キノリン
mp: 299-302℃
NMR(DMSO-d6,δ): 6.68(1H,br s),7.50-7.63(4H,m),
7.97(1H,br),8.51(1H,br s),8.70(1H,br),9.68(1H,br
s),10.56(1H,s),11.86(1H,br s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−クロトノイル
−2−メチルヒドラジノ)キノリン
mp: 244-249℃(分解)
NMR(DMSO-d6,δ): 1.80(3H,d,J=7Hz),3.24(3H,s),
5.87(1H,d,J=15Hz),6.66(1H,dq,J=15,7Hz),7.06(1H,d,
J=6Hz),7.43-7.63(4H,m),7.96(1H,d,J=8Hz),8.60(1H,d,
J=6Hz),8.62(1H,d,J=8Hz),10.60(1H,s)実施例179
下記の化合物を実施例150と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−アクリロイル
ヒドラジノ)キノリン
mp: 232-235℃
NMR(DMSO-d6,δ): 5.81(1H,dd,J=9.0,1.5Hz),6.27
(1H,dd,J=15.5,1.5Hz),6.42(1H,dd,J=15.5,9.0Hz),6.61
(1H,d,J=7.0Hz),7.50-7.60(4H,m),8.01(1H,d,J=8.0Hz),
8.45(1H,d,J=7.0Hz),8.68(1H,d,J=8.0Hz),9.43(1H,br s),
10.48(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−チエニ
ルアセチル)ヒドラジノ]キノリン
mp: 140-142℃
NMR(DMSO-d6,δ): 3.86(2H,s),6.62(1H,d,
J=5.5Hz),6.99-7.03(2H,m),7.41(1H,d,J=5.0Hz),7.50-7.61
(4H,m),7.99(1H,d,J=8.0Hz),8.41(1H,d,J=5.0Hz),8.66
(1H,d,J=8.0Hz),9.40(1H,s),10.33(1H,s),10.52(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(4,4−ジメチル
セミカルバジド)キノリン
mp: 265-268℃
NMR(DMSO-d6,δ): 2.92(6H,s),6.70(1H,d,
J=6.0Hz),7.45-7.60(4H,m),8.03(1H,d,J=8.0Hz),8.40(1H,
d,J=6.0Hz),8.65(1H,d,J=8.0Hz),8.73(1H,s),9.05(1H,s)実施例180
下記の化合物を実施例147と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−シンナモイル
ヒドラジノ)キノリン
mp: 281-283℃
NMR(DMSO-d6,δ): 6.66(1H,d,J=7.0Hz),6.82(1H,d,
J=15.0Hz),7.43-7.68(10H,m),8.03(1H,d,J=8.0Hz),8.43
(1H,d,J=7.0Hz),8.69(1H,d,J=8.0Hz),9.47(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(4−イミダ
ゾリルアセチル)ヒドラジノ]キノリン
mp: 248-250℃
NMR(DMSO-d6,δ): 3.53(2H,br),6.71(1H,br),7.00
(1H,br),7.47-7.64(5H,m),8.00(1H,d,J=8Hz),8.40(1H,d,
J=6Hz),8.65(1H,d,J=8Hz),9.33(1H,br),10.52(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−ピリジ
ルアセチル)ヒドラジノ]キノリン二塩酸塩
mp: 208-232℃
NMR(DMSO-d6,δ): 4.27(2H,s),7.27(1H,d,
J=7.5Hz),7.52-7.62(3H,m),7.77-7.95(3H,m),8.34(1H,br
t,J=7.5Hz),8.46(1H,d,J=8.0Hz),8.61-8.67(2H,m),8.85
(1H,d,J=5.0Hz),11.24(1H,s),11.39(1H,br),11.48(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−ピリジ
ルアセチル)ヒドラジノ]キノリン
mp: 238-242℃
NMR(DMSO-d6,δ): 3.69(2H,s),6.63(1H,d,J=6Hz),
7.38(1H,dd,J=8,6Hz),7.48-7.64(4H,m),7.78(1H,br d,
J=8Hz),7.96(1H,d,J=8Hz),8.40(1H,d,J=6Hz),8.48(1H,d,
J=6Hz),8.57(1H,d,J=2Hz),8.67(1H,d,J=8Hz),9.38(1H,br
s)
その二塩酸塩
mp: 216-240℃
NMR(DMSO-d6,δ): 4.05(2H,s),7.03(1H,d,J=8Hz),
7.40-7.66(3H,m),7.82(1H,t,J=8Hz),7.96(1H,dd,J=8,
6Hz),8.36-8.49(2H,m),8.56-8.65(2H,m),8.81(1H,d,
J=6Hz),8.90(1H,br s)
(5) 4−(2−ベンゾイルヒドラジノ)−8−(2,6−ジクロロベンゾイ
ルアミノ)キノリン塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 7.00(1H,d,J=4Hz),7.50-7.75(6H,
m),7.88(1H,t,J=8Hz),8.05(2H,d,J=8Hz),8.45(1H,d,
J=8Hz),8.60(2H,t,J=8Hz)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−メトキ
シベンゾイル)ヒドラジノ]キノリン
mp: 263-266℃
NMR(DMSO-d6,δ): 3.94(3H,s),6.80(1H,d,J=5Hz),
7.08(1H,t,J=8Hz),7.20(1H,d,J=8Hz),7.48-7.61(4H,m),
7.66(1H,d,J=8Hz),8.08(1H,d,J=8Hz),8.47(1H,d,J=5Hz),
8.68(1H,d,J=6Hz),9.54(1H,s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−メトキ
シベンゾイル)ヒドラジノ]キノリン
mp: 247-252℃
NMR(DMSO-d6,δ): 3.84(3H,s),6.70(1H,d,J=5Hz),
7.19(1H,dd,J=8,2Hz),7.41-7.64(6H,m),8.07(1H,d,
J=8Hz),8.43(1H,d,J=5Hz),8.68(1H,d,J=8Hz),9.53(1H,s)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(4−メトキ
シベンゾイル)ヒドラジノ]キノリン塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 6.97(1H,d,J=4Hz),7.12(2H,d,
J=8Hz),7.53-7.68(3H,m),7.85(1H,t,J=8Hz),8.01(2H,d,
J=8Hz),8.45(1H,d,J=8Hz),8.58(2H,t,J=8Hz)
(9) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(4−トリフ
ルオロメチルベンゾイル)ヒドラジノ]キノリン塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 7.05(1H,d,J=4Hz),7.52-7.67(4H,
m),7.85(1H,t,J=8Hz),8.00(2H,d,J=8Hz),8.24(2H,d,
J=8Hz),8.40(1H,d,J=4Hz),8.60(2H,t,J=4Hz)
(10) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−フリ
ルカルボニル)ヒドラジノ]キノリン
mp: >250℃
NMR(DMSO-d6,δ): 6.68(1H,d,J=4Hz),7.00(1H,s),
7.50-7.63(4H,m),7.35(1H,s),8.06(1H,d,J=9Hz),8.40
(1H,s),8.45(1H,d,J=4Hz),8.70(1H,d,J=6Hz),9.49(1H,
s)
その塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 6.95(1H,d,J=6Hz),7.05(1H,s),
7.52-7.66(3H,m),7.80-7.95(2H,m),8.42(1H,d,J=6Hz),
8.50(1H,s),8.55-8.65(2H,m)
(11) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−チエ
ニルカルボニル)ヒドラジノ]キノリン
mp: 263-265℃
NMR(DMSO-d6,δ): 6.71(1H,d,J=7.0Hz),7.27(1H,
dd,J=5.5,4.0Hz),7.50-7.62(4H,m),7.91(1H,d,J=7.0Hz),
7.99(1H,d,J=4.0Hz),8.06(1H,d,J=8.0Hz),8.45(1H,d,
J=5.5Hz),8.70(1H,d,J=8.0Hz),9.55(1H,s)
(12) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−チエ
ニルカルボニル)ヒドラジノ]キノリン
mp: 277-279CC
NMR(DMSO-d6,δ): 6.70(1H,d,J=6.0Hz),7.49-7.65
(5H,m),7.69-7.71(1H,m),8.07(1H,d,J=8.0Hz),8.36(1H,
d,J=3.0Hz),8.45(1H,d,J=6.0Hz),8.70(1H,d,J=8.0Hz),
9.53(1H,s)
(13) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−ピリ
ジルカルボニル)ヒドラジノ]キノリン二塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 7.15(1H,d,J=6Hz),7.52-7.68(3H,
m),7.24(1H,dd,J=6,4Hz),7.90(1H,t,J=8Hz),8.48-8.55
(2H,m),8.58-8.65(2H,m),8.90(1H,d,J=4Hz),9.29(1H,s)
(14) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(4−ピリ
ジルカルボニル)ヒドラジノ]キノリン
mp: 249-251℃
NMR(DMSO-d6,δ): 6.76(1H,d,J=5Hz),7.50-7.63(4H,
m),7.90(1H,d,J=6Hz),8.07(1H,d,J=9Hz),8.46(1H,d,
J=4Hz),8.70(1H,d,J=6Hz),8.83(2H,m),9.61(1H,s)
その二塩酸塩
mp: >250℃
NMR(DMSO-d6,δ): 7.12(1H,d,J=6Hz),7.52-7.66(3H,
m),7.90(1H,t,J=8Hz),8.07(2H,m),8.50(1H,d,J=8Hz),
8.62(2H,m),8.93(2H,m)
(15) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−ヒド
ロキシ−3−メチルブチリル)ヒドラジノ]キノリン
mp: 243-245℃
NMR(DMSO-d6,δ): 1.27(2x3H,s),2.39(2H,s),4.73
(1H,s),6.75(1H,d,J=6Hz),7.48-7.63(4H,m),8.01(1H,d,
J=8Hz),8.42(1H,d,J=6Hz),8.67(1H,d,J-8Hz),9.30(1H,
s),9.95(1H,s),10.52(1H,s)
(16) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−イソブチリ
ルヒドラジノ)キノリン
mp: 269-272℃(分解)
NMR(DMSO-d6,δ): 1.15(3H,d,J=7Hz),2.60(1H,qq,
J=7,7Hz),6.59(1H,d,J=6Hz),7.47-7.64(4H,m),8.00(1H,
d,J=8Hz),8.44(1H,d,J=6Hz),8.67(1H,d,J=8Hz),9.30(1H,
s),10.03(1H,s),10.52(1H,s)
(17) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(N,N−
ジメチルアミノアセチル)ヒドラジノ]キノリン
mp: 234-238℃
NMR(DMSO-d6,δ): 2.31(2x3H,s),3.11(2H,s),6.63
(1H,d,J=6Hz),7.47-7.63(4H,m),8.00(1H,d,J=8Hz),8.43
(1H,d,J=6Hz),8.67(1H,d,J=8Hz),9.29(1H,s),10.06(1H,
s),10.52(1H,s)
(18) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−オキサモイ
ルヒドラジノ)キノリン
mp: 249-252℃(分解)
NMR(DMSO-d6,δ): 6.58(1H,d,J=6Hz),7.48-7.63(4H,
m),7.97(1H,br s),8.00(1H,d,J=8Hz),8.28(1H,br s),
8.44(1H,d,J=6Hz),8.68(1H,d,J=8Hz),9.42(1H,s),10.55
(1H,s),10.97(1H,s)実施例181
8−(2,6−ジクロロベンゾイルアミノ)−4−(4−メチルセミカルバジ
ド)キノリンを、実施例87と同様にして、8−(2,6−ジクロロベンゾイル
アミノ)−4−ヒドラジノキノリンとメチルカルバミン酸フェニルとを反応させ
て得た。
mp: 274-277℃
NMR(DMSO-d6,δ): 2.58(3H,d,J=5Hz),6.60(1H,br
q,J=5Hz),6.70(1H,d,J=6Hz),7.45-7.63(4H,m),7.99(1H,
d,j=8Hz),8.20(1H,s),8.45(1H,d,J=6Hz),8.66(1H,d,
J=8Hz),9.19(1H,s)実施例182
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノキノリン
(298mg)のジメチルホルムアミド(4ml)中の溶液に、無水コハク酸(
94mg)を加え、混合物を室温で12時間攪拌した。混合物に水(10ml)
を加え、沈殿物を集めた。固形物を熱エタノール(5ml)で処理し、室温まで
冷却させ、濾過し、水で洗浄して、8−(2,6−ジクロロベンゾイルアミノ)
−4−[2−(3−カルボキシプロパノイル)ヒドラジノ]キノリンを黄色結晶
(105mg)として得た。
mp: 166-170℃
NMR(DMSO-d6,δ): 2.36-2.62(4H,m),6.73(1H,d,
J=6Hz),7.47-7.64(4H,m),8.00(1H,d,J=8Hz),8.40(1H,d,
J=6Hz),8.66(1H,d,J=8Hz),9.31(1H,s),10.09(1H,s),
10.51(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(3−カルボ
キシプロパノイル)ヒドラジノ]キノリン(138mg)のジメチルホルムアミ
ド(3ml)中の溶液に、1−ヒドロキシベンゾトリアゾール(45.9mg)
と1−エチル−3−(3−ジメチルアミノプロピル)カルボジイミド塩酸塩(6
5.1mg)を室温で加え、混合物を同温で一夜攪拌した。混合物に水を加え、
生じた沈殿物を濾過により集めて、8−(2,6−ジクロロベンゾイルアミノ)
−4−(2,5−ジオキソピロリジン−1−イルアミノ)キノリン(72mg)
を得た。
mp: 170-173℃
NMR(DMSO-d6,δ): 2.83-2.98(4H,m),6.72(1H,d,
J=6Hz),7.48-7.68(4H,m),8.03(1H,d,J=8Hz),8.45(1H,d,
J=6Hz),9.72(1H,d,J=8Hz),9.82(1H,s),10.58(1H,s)実施例183
下記の化合物を実施例154と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−エタンスルホ
ニルヒドラジノ)キノリン
mp: 178-180℃
NMR(DMSO-d6,δ): 1.32(3H,t,J=7.5Hz),3.23(2H,q,
J=7.5Hz),7.10(1H,d,J=6.0Hz),7.48-7.60(4H,m),8.01(1H,
d,J=8.0Hz),8.52(1H,d,J=6.0Hz),8.67(1H,d,J=8.0Hz),
9.35(1H,s),9.58(1H,s),10.55(1H,s)
(2) 4−(2−ベンジルスルホニルヒドラジノ)−8−(2,6−ジクロロ
ベンゾイルアミノ)キノリン
mp: 191-193℃
NMR(DMSO-d6,δ): 4.53(2H,s),7.08(1H,d,
J=6.0Hz),7.36-7.60(9H,m),8.05(1H,d,J=8.0Hz),8.50(1H,
d,J=6.0Hz),8.69(1H,d,J=8.0Hz),9.45(1H,s),9.71(1H,
s),10.58(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(p−トルエ
ンスルホニル)ヒドラジノ]キノリン
mp: 219-221℃
NMR(DMSO-d6,δ):2.40(3H,s),6.92(1H,d,J=6.0Hz),
7.41(2H,d,J=7.5Hz),7.45-7.60(4H,m),7.74(2H,d,
J=7.5Hz),7.88(1H,d,J=8.0Hz),8.40(1H,d,J=6.0Hz),8.65
(1H,d,J=8.0Hz),9.27(1H,s),10.06(1H,s),10.56(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−スチリルスル
ホニルヒドラジノ)キノリン
mp: 188-190℃
NMR(DMSO=d6,δ): 7.14(1H,d,J=6.0Hz),7.33-7.61
(7H,m),7.70-7.75(2H,m),7.96(1H,d,J=8.0Hz),8.49(1H,
d,J=6.0Hz),8.65(1H,d,J=8.0Hz),9.46(1H,s),9.84(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(2−チエニ
ルスルホニル)ヒドラジノ]キノリン
mp: 208-210℃
NMR(DMSO-d6,δ): 6.88(1H,d,J=5.5Hz),7.21(1H,t,
J=4.0Hz),7.46-7.60(4H,m),7.66(1H,d,J=3.0Hz),7.93(1H,
d,J=8.0Hz),8.00(1H,d,J=5.0Hz),8.40(1H,d,J=5.5Hz),
8.65(1H,d,J=8.0Hz),9.43(1H,s)
(6) 4−[2−(2−アセトアミド−4−メチルチアゾール−5−イルスル
ホニル)ヒドラジノ]−8−(2,6−ジクロロベンゾイルアミノ)キノリン
mp: 181-183℃
NMR(DMSO-d6,δ): 2.17(3H,s),2.40(3H,s),6.98
(1H,d,J=5.5Hz),7.47-7.62(4H,m),7.92(1H,d,J=8.0Hz),
8.45(1H,d,J=5.5Hz),8.67(1H,d,J=8.0Hz),9.39(1H,s)実施例184
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−3−プ
ロピルキノリンを、実施例139−(1)と同様にして、4−クロロ−8−(2
,6−ジクロロベンゾイルアミノ)−3−プロピルキノリンとヒドラジン一水和
物から得た。
NMR(DMSO-d6,δ): 0.93(3H,t,J=7.5Hz),1.50(2H,
qt,J=7.5,7.5Hz),2.84(2H,t,J=7.5Hz),4.65(2H,s),7.35
(1H,t,J=8.0Hz),7.50-7.60(3H,m),7.73(1H,s),8.16(1H,
s),8.53(2H,d,J=8.0Hz)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3−プロピルキノリンを実施例86と同様にして得た。
mp: 223-226℃
NMR(DMSO-d6,δ): 0.95(3H,br t,J=7.5Hz),1.56(2H,
br),1.86(3H,s),2.76(2H,br t,J=7.5Hz),7.43-7.60(4H,
m),8.10(1H,br d,J=8.0Hz),8.16(1H,s),8.35(1H,s),8.57
(1H,br d,J=8.0Hz),10.20(1H,s),10.52(1H,s)実施例185
(1) 4−(2−アミノエチルアミノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3−メチルキノリンを、実施例8と同様にして、4−クロロ−8−(
2,6−ジクロロベンゾイルアミノ)−3−メチルキノリンとエチレンジアミン
から得た。
mp: 128-142℃
NMR(CDCl3,δ): 2.40(3H,s),3.00(2H,t,J=6Hz),
3.56(2H,q,J=6Hz),5.65(1H,br s),7.29-7.42(3H,m),7.47
(1H,t,J=8Hz),7.78(1H,d,J=8Hz),8.32(1H,s),8.83(1H,
d,J=6Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(2−
オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)と同様にして
得た。
mp: >250℃
NMR(CDCl3,δ): 2.48(3H,s),3.73-4.04(4H,m),4.94
(1H,s),7.30-7.45(3H,m),7.60-7.67(2H,m),8.70(1H,s),
8.92(1H,t,J=4Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(2−
チオキソイミダゾリジン−1−イル)キノリンを、実施例92−(2)と同様に
して、4−(2−アミノエチルアミノ)−8−(2,6−ジクロロベンゾイルア
ミノ)−3−メチルキノリンと1,1’−チオカルボニルジイミダゾールから得
た。
mp: 165-170℃
NMR(CDCl3,δ): 2.50(3H,s),3.92-4.27(4H,m),6.19
(1H,s),7.32-7.45(3H,m),7.55(1H,d,J=6Hz),7.67(1H,t,
J=6Hz),8.75(1H,s),8.95(1H,d,J=6Hz)実施例186
(1) 3−第三級ブチルジメチルシリルオキシメチル−8−(2,6−ジクロ
ロベンゾイルアミノ)−4−(3−メチル−2−チオキソイミダゾリジン−1−
イル)キノリンを、実施例92−(2)と同様にして、3−第三級ブチルジメチ
ルシリルオキシメチル−8−(2,6−ジクロロベンゾイルアミノ)−4−[(
2−メチルアミノエチル)アミノ]キノリンと1,1’−チオカルボニルジイミ
ダゾールから得た。
mp: 234-236℃
NMR(DMSO-d6,δ): 0.11(3H,s),0.13(3H,s),0.92
(3x3H,s),3.17(3H,s),3.87-4.09(4H,m),4.92(2H,s),
7.49-7.63(4H,m),7.71(1H,d,J=8Hz),8.74(1H,d,J=8Hz),
9.05(1H,s),10.91(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−ヒドロキシメチル−
4−(3−メチル−2−チオキソイミダゾリジン−1−イル)キノリンを実施例
125−(8)と同様にして得た。
mp: 253-254℃
NMR(DMSO-d6,δ): 3.15(3H,s),3.89-4.06(4H,m),
4.67(2H,d,J=6Hz),5.49(1H,t,J=6Hz),7.49-7.63(4H,m),
7.70(1H,dd,J=8,8Hz),8.70(1H,d,J=8Hz),9.07(1H,s),
10.93(1H,s)実施例187
(1) 4−(2−アミノエチルアミノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3−メトキシメチルキノリンを、実施例8と同様にして、4−クロロ
−8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチルキノリンと
エチレンジアミンから得た。
mp: 130-131℃
NMR(DMSO-d6,δ): 2.80(2H,t,J=7.0Hz),3.29(3H,
s),3.57(2H,td,J=7.0,7.0Hz),4.53(2H,s),6.60(1H,br t,
J=7.0Hz),7.43-7.60(4H,m),8.00(1H,d,J=8.0Hz),8.32(1H,
s),8.61 (1H,d,J=8.0Hz),10.50(1H,br s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−4
−(2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)と同
様にして得た。
mp: 210-212℃
NMR(DMSO-d6,δ): 3.34(3H,s),3.56-3.80(3H,m),
3.88-3.95(1H,m),4.58(1H,d,J=13.5Hz),4.63(1H,d,
J=13.5Hz),7.01(1H,s),7.47-7.59(3H,m),7.68-7.75(2H,m),
8.70-8.73(1H,m),8.94(1H,s)実施例188
(1) (5−クロロ−2−ニトロアニリノ)メチレンマロン酸イソプロピリデ
ンを、実施例172−(1)と同様にして、5−クロロ−2−ニトロアニリンと
マロン酸イソプロピリデンから得た。
mp: 217-220℃
NMR(CDCl3,δ): 1.78(6H,s),7.34(1H,d,J=7Hz),
7.62(1H,br s),8.28(1H,d,J=7Hz),8.67(1H,d,J=9Hz),
13.60(1H,br d,J=9Hz)
(2) 5−クロロ−1,4−ジヒドロ−8−ニトロ−4−オキソキノリンを実
施例172−(2)と同様にして得た。
mp: 220-225℃(分解)
NMR(DMSO-d6,δ): 6.21(1H,d,J=8Hz),7.45(1H,d,
J=8Hz),7.87(1H,t,J=8Hz),8.50(1H,d,J=8Hz),11.88(1H,
br s)
(3) 4,5−ジクロロ−8−ニトロキノリンを製造例2−(1)と同様にし
て得た。
mp: 116-118℃
NMR(CDCl3,δ): 7.68(1H,d,J=6Hz),7.74(1H,d,
J=8Hz),7.86(1H,d,J=8Hz),8.85(1H,d,J=6Hz)
(4) 8−アミノ−4,5−ジクロロキノリンを製造例2−(3)と同様にし
て得た。
mp: 135℃
NMR(CDCl3,δ): 5.10(2H,br s),6.85(1H,d,J=8Hz),
7.43(1H,d,J=8Hz),7.50(1H,d,J=6Hz),8.55(1H,d,J=6Hz)
(5) 4,5−ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ンを実施例1と同様にして得た。
mp: 243-247℃
NMR(DMSO-d6,δ): 7.46-7.61(3H,m),7.88-7.95(2H,
m),8.75(1H,d,J=8Hz),8.81(1H,d,J=4Hz)
(6) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミ
ダゾール−1−イル)キノリンを実施例8と同様にして得た。
mp: 259-263℃
NMR(DMSO-d6,δ): 7.13(1H,s),7.47-7.62(4H,m),
7.74(1H,d,J=5Hz),7.84(1H,d,J=8Hz),7.94(1H,s),8.78
(1H,d,J=8Hz),9.05(1H,d,J=5Hz)
その塩酸塩
mp: 263-272℃
NMR(DMSO-d6,δ): 7.49-7.62(3H,m),7.89-7.97(2H,
m),8.04(1H,d,J=2Hz),8.10(1H,s),8.83(1H,d,J=8Hz),
9.20(1H,d,J=4Hz),9.44(1H,br s)実施例189
(1) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラ
ジノキノリンを、実施例139−(1)と同様にして、4,5−ジクロロ−8−
(2,6−ジクロロベンゾイルアミノ)キノリンとヒドラジン一水和物から得た
。
mp: 253-263℃
NMR(DMSO-d6,δ): 4.61(2H,br s),7.23(1H,d,
J=6Hz),7.45-7.64(4H,m),8.38(1H,d,J=6Hz),8.52(1H,br
s),8.54(1H,d,J=8Hz)
(2) 4−(2−アセチルヒドラジノ)−5−クロロ−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリンを実施例86と同様にして得た。
mp: 158-161℃
NMR(DMSO-d6,δ): 2.00(3H,s),6.88(1H,d,J=6Hz),
7.47-7.63(4H,m),8.45(1H,d,J=6Hz),8.60(1H,d,J=8Hz),
8.94(1H,br s)実施例190
(1) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−[(2
−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4,5−
ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリンとN−メチルエ
チレンジアミンから得た。
mp: 233-238℃
NMR(DMSO-d6,δ): 2.33(3H,s),2.80-2.87(2H,m),
3.24-3.39(2H,m),6.63(1H,d,J=6Hz),7.48-7.62(4H,m),
7.92(1H,br t,J=7Hz),8.36(1H,d,J=6Hz),8.57(1H,d,
J=8Hz)
(2) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(3−
メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)
と同様にして得た。
mp: 259-263℃
NMR(CDCl3,δ): 2.96(3H,s),3.50-3.86(3H,m),
3.94-4.10(1H,m),7.30-7.44(4H,m),7.65(1H,d,J=8Hz),
8.75(1H,d,J=6Hz),8.87(1H,d,J=8Hz)実施例191
(1) 8−(2,6−ジクロロベンゾイルアミノ)−5−メチル−4−[(2
−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4−クロ
ロ−8−(2,6−ジクロロベンゾイルアミノ)−5−メチルキノリンとN−メ
チルエチレンジアミンから得た。
mp: 247-250℃
NMR(CDCl3,δ): 2.47(3H,s),2.92(3H,s),2.97-3.04
(2H,m),3.20-3.30(2H,m),6.37(1H,d,J=6Hz),6.60(1H,m),
7.16(1H,d,J=8Hz),7.24-7.41(3H,m),8.30(1H,d,J=6Hz),
8.70(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−5−メチル−4−(3−
メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)
と同様にして得た。
mp: 262-264℃
NMR(DMSO-d6,δ): 2.66(3H,s),2.80(3H,s),3.50-
3.64(2H,m),3.83(1H,m),3.97(1H,m),7.40(1H,d,J=8Hz),
7.48-7.61(4H,m),8.59(1H,d,J=8Hz),8.85(1H,d,J=6Hz)実施例192
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[(2−エチルアミ
ノエチル)アミノ]−5−メチルキノリンを、実施例8と同様にして、4−クロ
ロ−8−(2,6−ジクロロベンゾイルアミノ)−5−メチルキノリンとN−エ
チルエチレンジアミンから得た。
mp: 201-205℃
NMR(DMSO-d6,δ): 1.04(3H,t,J=8Hz),2.57(2H,q,
J=8Hz),2.80-2.94(2H,m),2.89(3H,s),3.18-3.29(2H,m),
6.52(1H,d,J=6Hz),6.78(1H,br s),7.19(1H,d,J=8Hz),
7.48-7.63(3H,m),8.30(1H,d,J=6Hz),8.47(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−エチル−2−
オキソイミダゾリジン−1−イル)−5−メチルキノリンを実施例92−(2)
と同様にして得た。
mp: 235-236℃
NMR(DMSO-d6,δ): 1.12(3H,t,J=8Hz),2.67(3H,s),
3.26(2H,q,J=8Hz),3.54-3.64(2H,m),3.78-3.89(1H,m),
3.91-4.07(1H,m),7.41(1H,d,J=8Hz),7.49-7.64(4H,m),
8.59(1H,d,J=8Hz),8.84(1H,d,J=6Hz)実施例193
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−5
−メチル−4−[(2−メチルアミノエチル)アミノ]キノリンを、実施例8と
同様にして、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メ
トキシメチル−5−メチルキノリンとN−メチルエチレンジアミンから得た。
NMR(CDCl3,δ): 2.46(3H,s),2.69-2.79(2H,m),2.90
(3H,s),3.32-3.47(2H,m),3.40(3H,s),4.59(2H,s),5.59
(1H,br t,J=6Hz),7.20-7.43(4H,m),8.29(1H,s),8.73(1H,
d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−5
−メチル−4−(3−メチル−2−オキソイミダゾリジン−1−イル)キノリン
を実施例92−(2)と同様にして得た。
mp: 105-112℃
NMR(CDCl3,δ): 2.74(3H,s),2.96(3H,s),3.44(3H,
s),3.58-3.85(4H,m),4.40(1H,d,J=9Hz),4.66(1H,d,
J=9Hz),7.27-7.46(4H,m),8.81(1H,d,J=8Hz),8.85(1H,s)実施例194
(1) 1,4−ジヒドロ−3−ヒドロキシメチル−5−メチル−8−ニトロ−
4−オキソキノリンを、実施例172−(3)と同様にして、1,4−ジヒドロ
−5−メチル−8−ニトロ−4−オキソキノリンから得た。
mp: 251-255℃
NMR(DMSO-d6,δ): 4.37(2H,s),7.20(1H,d,J=8Hz),
7.93(1H,d,J=6Hz),8.47(1H,d,J=8Hz)
(2) 1,4−ジヒドロ−3,5−ジメチル−8−ニトロ−4−オキソキノリ
ンを実施例104−(2)と同様にして得た。
mp: 250-262℃
NMR(DMSO-d6,δ): 1.96(3H,s),2.90(3H,s),7.17
(1H,d,J=8Hz),7.83(1H,d,J=6Hz),8.44(1H,d,J=8Hz)
(3) 4−クロロ−3,5−ジメチル−8−ニトロキノリンを製造例2−(1
)と同様にして得た。
NMR(CDCl3,δ): 2.58(3H,s),3.10(3H,s),7.41(1H,
d,J=8Hz),7.78(1H,d,J=8Hz),8.79(1H,s)
(4) 8−アミノ−4−クロロ−3,5−ジメチルキノリンを製造例2−(3
)と同様にして得た。
mp: 120-122℃
NMR(DMSO-d6,δ): 2.46(3H,s),2.81(3H,s),5.83
(2H,br s),6.76(1H,d,J=8Hz),7.15(1H,d,J=8Hz),8.60
(1H,s)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジ
メチルキノリンを実施例1と同様にして得た。
mp: 236-240℃
NMR(DMSO-d6,δ): 2.52(3H,s),2.98(3H,s),7.47-
7.61(4H,m),8.57(1H,d,J=8Hz),8.78(1H,s),10.69(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−3,5−ジメチルキノリンを実施例8と同様にして得た。
mp: 214-216℃
NMR(DMSO-d6,δ): 1.92(3H,s),2.08(3H,s),7.24
(1H,s),7.43-7.62(5H,m),7.90(1H,s),8.59(1H,d,J=8Hz),
8.93(1H,s),10.79(1H,s)実施例195
(1) (5−メトキシ−2−ニトロアニリノ)メチレンマロン酸イソプロピリ
デンを、実施例172−(1)と同様にして、5−メトキシ−2−ニトロアニリ
ンとマロン酸イソプロピリデンから得た。
mp: 210-220℃
NMR(CDCl3,δ): 1.77(6H,s),3.98(3H,s),6.84(1H,
dd,J=8,2Hz),6.98(1H,d,J=2Hz),8.32(1H,d,J=8Hz),8.70
(1H,d,J=10Hz)
(2) 1,4−ジヒドロ−5−メトキシ−8−ニトロ−4−オキソキノリンを
実施例172−(2)と同様にして得た。
mp: 195-200℃
NMR(DMSO-d6,δ): 4.00(3H,s),6.10(1H,d,J=8Hz),
7.00(1H,d,J=8Hz),7.80(1H,d,J=8Hz),8.60(1H,d,J=8Hz)
(3) 4−クロロ−5−メトキシ−8−ニトロキノリンを製造例2−(1)と
同様にして得た。
mp; 125-138℃
NMR(CDCl3,δ): 4.07(3H,s),6.92(1H,d,J=8Hz),
7.55(1H,d,J=4Hz),8.09(1H,d,J=8Hz),8.83(1H,d,J=4Hz)
(4) 8−アミノ−4−クロロ−5−メトキシキノリンを製造例2−(3)と
同様にして得た。
mp: 111-115℃
NMR(CDCl3,δ): 3.90(3H,s),4.74(2H,br s),6.87-
6.95(2H,m),7.40(1H,d,J=4Hz),8.57(1H,d,J=4Hz)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−5−メトキ
シキノリンを実施例1と同様にして得た。
mp: 238-242℃
NMR(CDCl3,δ): 4.00(3H,s),7.01(1H,d,J=8Hz),
7.30-7.45(3H,m),7.48(1H,d,J=4Hz),8.56(1H,d,J=4Hz),
8.95(1H,d,J=8Hz),9.90(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−5−メ
トキシキノリンを実施例139−(1)と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 3.97(3H,s),4.54(2H,s),6.88
(1H,d,J=6Hz),7.01(1H,d,J=4Hz),7.49-7.62(3H,m),8.28
(1H,d,J=4Hz),8.50(1H,d,J=6Hz),8.77(1H,s)
(7) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−5−メトキシキノリンを実施例86と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 2.00(3H,s),3.98(3H,s),6.68
(1H,d,J=4Hz),6.97(1H,d,J=8Hz),7.48-7.61(3H,m),8.36
(1H,d,J=4Hz),8.57(1H,d,J=8Hz),9.25(1H,s)実施例196
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−5−メトキシキノリンを、実施例8と同様にして、4−クロロ−8−(2,
6−ジクロロベンゾイルアミノ)−5−メトキシキノリンとイミダゾールから得
た。
mp: 155-189℃
NMR(CDCl3,δ): 3.70(3H,s),6.99(1H,d,J=8Hz),
7.16(1H,d,J=2Hz),7.22(1H,d,J=2Hz),7.32-7.45(4H,m),
7.66(1H,s),8.83(1H,d,J=3Hz),9.01(1H,d,J=8Hz)実施例197
(1) 8−(2,6−ジクロロベンゾイルアミノ)−5−メトキシ−4−[(
2−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4−ク
ロロ−8−(2,6−ジクロロベンゾイルアミノ)−5−メトキシキノリンとN
−メチルエチレンジアミンから得た。
mp: 210-217℃
NMR(CDCl3,δ): 2.50(3H,s),2.95(2H,t,J=6Hz),
3.35(2H,q,J=6Hz),3.99(3H,s),6.33(1H,d,J=4Hz),6.76
(1H,d,J=8Hz),7.25-7.43(4H,m),8.08(1H,br),8.27(1H,d,
J=6Hz),8.79(1H,d,J=8Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−5−メトキシ−4−(3
−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−
(2)と同様にして得た。
mp: 227-237℃
NMR(CDCl3,δ): 2.95(3H,s),3.57(2H,t,J=6Hz),
3.82(2H,t,J=6Hz),3.44(3H,s),6.97(1H,d,J=8Hz),7.30-
7.45(4H,m),8.70-8.75(1H,m),8.90(1H,d,J=8Hz)実施例198
(1) 4−クロロ−6−メチル−8−ニトロキノリンを、製造例2−(1)と
同様にして、1,4−ジヒドロ−6−メチル-8−ニトロ−4−オキソキノリン
から得た。
mp: 139-141℃
NMR(DMSO-d6,δ): 2.66(3H,s),7.60(1H,d,J=6Hz),
7.92(1H,s),8.23(1H,s),8.86(1H,d,J=6Hz)
(2) 8−アミノ−4−クロロ−6−メチルキノリンを製造例2−(3)と同
様にして得た。
mp: 115-116℃
NMR(DMSO-d6,δ): 2.40(3H,s),6.04(2H,s),6.79
(1H,s),7.05(1H,s),7.62(1H,d,J=5Hz),8.05(1H,d,
J=5Hz)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−クロロ−6−メチル
キノリンを実施例1と同様にして得た。
mp: 203-205℃
NMR(DMSO-d6,δ): 2.61(3H,s),7.48-7.61(3H,m),
7.78(1H,d,J=1Hz),7.83(1H,d,J=6Hz),8.70(1H,d,J=1Hz),
8.75(1H,d,J=6Hz),10.82(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1
−イル)−6−メチルキノリンを実施例8と同様にして得た。
mp: 260-261℃
NMR(DMSO-d6,δ): 2.54(3H,s),7.28(1H,d,J=1Hz),
7.34(1H,d,J=1Hz),7.48-7.63(3H,m),7.70(1H,d,J=5Hz),
7.73(1H,d,J=0.5Hz),8.16(1H,d,J=0.5Hz),8.71(1H,s),
8.93(1H,d,J=5Hz),10.86(1H,s)実施例199
(1) 8−(2,6−ジクロロベンゾイルアミノ)−6−メチル−4−[(2
−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4−クロ
ロ−8−(2,6−ジクロロベンゾイルアミノ)−6−メチルキノリンとN−メ
チルエチレンジアミンから得た。
NMR(DMSO-d6,δ): 0.06(2x3H,s),0.86(3x3H,s),
2.31(3H,s),2.73(2H,t,J=6Hz),3.69(2H,dt,J=6,6Hz),
4.84(2H,s),6.45(1H,t,J=6Hz),7.43-7.62(4H,m),7.98
(1H,d,J=8Hz),8.37(1H,s),8.61(1H,d,J=8Hz),10.51(1H,
s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−6−メチル−4−(3−
メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)
と同様にして得た。
mp: 277-279℃
NMR(DMSO-d6,δ): 2.54(3H,s),2.84(3H,s),3.60
(2H,t,J=7.5Hz),3.93(2H,t,J=7.5Hz),7.48(1H,d,J=6Hz),
7.50-7.62(4H,m),8.60(1H,s),8.75(1H,d,J=6Hz),10.66
(1H,s)実施例200
8−(2,6−ジクロロベンゾイルアミノ)−6−メチル−4−(3−メチル
−2−チオキソイミダゾリジン−1−イル)キノリンを、実施例92−(2)と
同様にして、8−(2,6−ジクロロベンゾイルアミノ)−6−メチル−4−[
(2−メチルアミノエチル)アミノ]キノリンと1,1’−チオカルボニルジイ
ミダゾールから得た。
mp: 264-266℃
NMR(DMSO-d6,δ): 2.55(3H,s),3.17(3H,s),3.96-
4.10(4H,m),7.47-7.65(5H,m),8.62(1H,s),8.87(1H,d,
J=6Hz),10.75(1H,s)実施例201
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−6−メ
チルキノリンを、実施例139−(1)と同様にして、4−クロロ−8−(2,
6−ジクロロベンゾイルアミノ)−6−メチルキノリンとヒドラジン一水和物か
ら得た。
mp: 221-224℃
NMR(DMSO-d6,δ): 2.48(3H,s),4.34(2H,s),6.92
(1H,d,J=6Hz),7.50-7.63(3H,m),7.73(1H,s),8.30(1H,d,
J=6Hz),8.47-8.55(2H,m),10.39(1H,s)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−6−メチルキノリンを実施例86と同様にして得た。
mp: 263-266℃
NMR(DMSO-d6,δ): 2.00(3H,s),2.53(3H,s),6.61
(1H,d,J=6Hz),7.50-7.63(3H,m),7.81(1H,s),8.36(1H,d,
J=6Hz),8.56(1H,s),9.14(1H,s),10.00(1H,s),10.46(1H,
s)実施例202
8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メタンスルホニルヒ
ドラジノ)−6−メチルキノリンを、実施例154と同様にして、8−(2,6
−ジクロロベンゾイルアミノ)−4−ヒドラジノ−6−メチルキノリンと塩化メ
シルから得た。
mp: 156-161℃
NMR(DMSO-d6,δ): 2.54(3H,s),3.10(3H,s),7.06
(1H,d,J=6Hz),7.48-7.63(3H,m),7.83(1H,s),8.44(1H,d,
J=6Hz),8.57(1H,s),9.34(1H,br s),9.53(1H,s),10.49
(1H,s)実施例203
(1) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−6−メチル
キノリン(562mg)のN−メチルピロリドン(6ml)中の溶液に、ヒドラ
ジン水和物を加え、混合物を90℃で6時間加熱した。混合物を酢酸エチルで希
釈し、水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、濃縮した。残留物を塩
化メチレンとアセトンに溶解し、濃縮した。残留固形物を熱エタノール(5ml
)で処理し、室温まで冷却させ、濾過し、エタノールで洗浄して、8−(2,6
−ジクロロベンゾイルアミノ)−6−メチル-4−(2−イソプロピリデンヒド
ラジノ)キノリン(560mg)を灰白色結晶として得た。
mp: 242-245℃
NMR(DMSO-d6,δ): 2.07(3H,s),2.12(3H,s),2.55
(3H,s),7.23(1H,d,J=6Hz),7.49-7.63(3H,m),7.85(1H,s),
8.40(1H,d,J=6Hz),8.56(1H,s),9.27(1H,s),10.46(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−6−メチル−4−(2−
イソプロピリデンヒドラジノ)キノリン(159mg)のメタノール(5ml)
中の懸濁液に、シアノ水素化ホウ素ナトリウム(25mg)と酢酸(50mg)
を加え、混合物を室温で24時間攪拌した。混合物を濃縮乾固し、残留物を水(
5ml)で粉砕し、濾過した。固形物を熱水(5ml)で処理し、室温まで冷却
させ、濾過し、水で洗浄して、8−(2,6−ジクロロベンゾイルアミノ)−6
−メチル−4−(2−イソプロピルヒドラジノ)キノリン(117mg)を淡黄
色粉末として得た。
mp: 154-156℃
NMR(DMSO-d6,δ): 1.03(2x3H,d,J=7Hz),2.54(3H,
s),3.28(1H,m),7.20(1H,m),7.51-7.68(3H,m),8.27-8.44
(3H,m),10.51(1H,s)実施例204
(1) (4−クロロ−2−ニトロアニリノ)メチレンマロン酸イソプロピリデ
ンを、実施例172−(1)と同様にして、4−クロロ−2−ニトロアニリンと
マロン酸イソプロピリデンから得た。
mp: 204-206℃
NMR(CDCl3,δ): 7.58(1H,d,J=8Hz),7.74(1H,dd,
J=8,2Hz),8.33(1H,s),8.69(1H,d,J=10Hz)
(2) 6−クロロ−1,4−ジヒドロ−8−ニトロ−4−オキソキノリンを実
施例172−(2)と同様にして得た。
mp: 238-241℃
NMR(DMSO-d6,δ): 6.27(1H,d,J=6Hz),8.00(1H,d,
J=6Hz),8.45(1H,d,J=2Hz),8.64(1H,d,J=2Hz)
(3) 4,6−ジクロロ−8−ニトロキノリンを製造例2−(1)と同様にし
て得た。
mp: 149-164℃
NMR(CDCl3,δ): 7.68(1H,d,J=4Hz),8.04(1H,d,
J=2Hz),8.45(1H,s),8.91(1H,d,J=4Hz)
(4) 8−アミノ−4,6−ジクロロキノリンを製造例2−(3)と同様にし
て得た。
mp: 132-134℃
NMR(CDCl3,δ): 5.15(2H,br s),6.90(1H,s),7.45-
7.49(2H,m),8.57(1H,d,J=4Hz)
(5) 4,6−ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリ
ンを実施例1と同様にして得た。
mp: 201-205℃
NMR(CDCl3,δ):7.32-7.45(3H,m),7.58(1H,d,
J=4Hz),7.98(1H,s),8.62(1H,d,J=4Hz),9.06(1H,d,J=2Hz)
(6) 6−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラ
ジノキノリンを実施例139−(1)と同様にして得た。
mp: 142-150℃
(7) 4−(2−アセチルヒドラジノ)−6−クロロ−8−(2,6−ジクロ
ロベンゾイルアミノ)キノリンを実施例86と同様にして得た。
mp: 117-180℃
NMR(CDCl3,δ): 2.20(3H,s),6.72(1H,d,J=4Hz),
7.28-7.40(4H,m),8.40(1H,d,J=4Hz),8.86(1H,d,J=2Hz)実施例205
6−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾー
ル−1−イル)キノリンを、実施例8と同様にして、4,6−ジクロロ−8−(
2,6−ジクロロベンゾイルアミノ)キノリンとイミダゾールから得た。
mp: 179-181℃
NMR(CDCl3,δ): 7.30-7.48(6H,m),7.57(1H,s),7.85
(1H,s),8.85(1H,d,J=4Hz),9.10(1H,s)実施例206
(1) 6−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−[(2
−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4,6−
ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリンとN−メチルエ
チレンジアミンから得た。
mp: 185-198℃
NMR(CDCl3,δ): 2.50(3H,s),3.00(2H,t,J=6Hz),
3.34(2H,q,J=6Hz),5.80(1H,br),6.45(1H,d,J=4Hz),7.30-
7.43(3H,m),7.51(1H,d,J=2Hz),8.36(1H,d,J=4Hz),8.93
(1H,s)
(2) 6−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(3−
メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)
と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 2.85(3H,s),3.60(1H,t,J=6Hz),
3.97(1H,t,J=6Hz),7.50-7.62(4H,m),7.80(1H,s),7.73
(1H,s),8.86(1H,d,J=4Hz)実施例207
(1) (4−フルオロ−2−ニトロアニリノ)メチレンマロン酸イソプロピリ
デンを、実施例172−(1)と同様にして、4−フルオロ−2−ニトロアニリ
ンとマロン酸イソプロピリデンから得た。
mp: 195-196℃
NMR(CDCl3,δ): 1.78(2x3H,s),7.53(1H,ddd,J=8,
5,3Hz),7.63(1H,dd,J=8,5Hz),8.05(1H,dd,J=8,3Hz),
8.67(1H,d,J=15Hz)
(2) 6−フルオロ−1,4−ジヒドロ−8−ニトロ−4−オキソキノリンを
実施例172−(2)と同様にして得た。
mp: 178-182℃
NMR(CDCl3,δ): 6.40(1H,d,J=7.5Hz),7.76(1H,dd,
J=7.5,7Hz),8.42(1H,dd,J=7,1Hz),8.50(1H,dd,J=8,1Hz)
(3) 4−クロロ−6−フルオロ−8−ニトロキノリンを製造例2−(1)と
同様にして得た。
mp: 120-130℃
NMR(CDCl3,δ): 7.68(1H,d,J=6Hz),7.90(1H,dd,
J=7,3Hz),8.12(1H,dd,J=8,3Hz),8.90(1H,d,J=6Hz)
(4) 8−アミノ−4−クロロ−6−フルオロキノリンを製造例2−(3)と
同様にして得た。
mp: 98-103℃
NMR(DMSO-d6,δ): 6.54(2H,s),6.72(1H,dd,J=11,
2Hz),6.87(1H,dd,J=11,2Hz),7.73(1H,d,J=5Hz),8.60(1H,
d,J=5Hz)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−6−フルオ
ロキノリンを実施例1と同様にして得た。
mp: 200-213℃
NMR(DMSO-d6,δ): 7.48-7.63(3H,m),7.70(1H,dd,
J=12,3Hz),7.94(1H,d,J=6Hz),8.71(1H,dd,J=12,3Hz),
8.82(1H,d,J=6Hz),11.27(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−6−フルオロ−4−(イ
ミダゾール−1−イル)キノリンを実施例8と同様にして得た。
mp: 154-159℃
NMR(DMSO-d6,δ): 7.21(1H,dd,J=10,2Hz),7.28(1H,
s),7.49-7.66(3H,m),7.76(1H,s),7.80(1H,d,J=4Hz),8.18
(1H,s),8.71(1H,dd,J=10,2Hz),9.00(1H,d,J=4Hz),11.31
(1H,s)実施例208
(1) 8−(2,6−ジクロロベンゾイルアミノ)−6−フルオロ−4−[(
2−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4−ク
ロロ−8−(2,6−ジクロロベンゾイルアミノ)−6−フルオロキノリンとN
−メチルエチレンジアミンから得た。
mp: 198-200℃
NMR(DMSO-d6,δ): 2.32(3H,s),2.77(2H,t,J=6Hz),
3.36(1H,dt,J=6,5Hz),6.60(1H,d,J=6Hz),7.15(1H,t,
J=5Hz),7.50-7.63(3H,m),7.87(1H,dd,J=11,2Hz),8.34(1H,
d,J=6Hz),8.50(1H,dd,J=11,2Hz),10.72(1H,br s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−6−フルオロ−4−(3
−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2
)と同様にして得た。
mp: 268-272℃
NMR(DMSO-d6,δ): 2.84(3H,s),3.59(2H,t,J=7Hz),
3.94(2H,t,J=7Hz),7.48-7.61(5H,m),8.60(1H,dd,J=11,
2Hz),8.81(1H,d,J=6Hz),11.06(1H,s)実施例209
(1) 8−(2,6−ジクロロベンゾイルアミノ)−6−フルオロ−4−ヒド
ラジノキノリンを、実施例139−(1)と同様にして、4−クロロ−8−(2
,6−ジクロロベンゾイルアミノ)−6−フルオロキノリンとヒドラジン一水和
物から得た。
mp: 208-212℃
NMR(DMSO-d6,δ): 4.51(2H,s),6.99(1H,d,J=6Hz),
7.49-7.63(3H,m),7.75(1H,dd,J=12,3Hz),8.37(1H,d,
J=6Hz),8.47(1H,dd,J=12,3Hz),8.56(1H,s),10.72(1H,s)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−6−フルオロキノリンを実施例86と同様にして得た。
mp: 250-254℃
NMR(DMSO-d6,δ): 2.01(3H,s),6.68(1H,d,J=6Hz),
7.48-7.62(3H,m),7.81(1H,dd,J=10,2Hz),8.42(1H,d,
J=6Hz),8.54(1H,dd,J=10,2Hz),9.18(1H,s),10.06(1H,s),
10.82(1H,s)実施例210
(1) (2−ニトロ−4−トリフルオロメチルアニリノ)メチレンマロン酸イ
ソプロピリデンを、実施例172−(1)と同様にして、2−ニトロ−4−トリ
フルオロメチルアニリンとマロン酸イソプロピリデンから得た。
mp: 218-220℃
NMR(CDCl3,δ): 1.79(6H,s),7.77(1H,d,J=8Hz),
8.00(1H,dd,J=8,2Hz),8.61(1H,d,J=2Hz)8.76(1H,d,
J=10Hz)
(2) 1,4−ジヒドロ−8−ニトロ−4−オキソ−6−トリフルオロメチル
キノリンを実施例172−(2)と同様にして得た。
mp: 153-156℃
NMR(DMSO-d6,δ): 6.33(1H,d,J=7.5Hz),8.03(1H,
dd,J=7.5,7Hz),8.73(1H,d,J=1Hz),8.83(1H,d,J=1Hz)
(3) 4−クロロ−8−ニトロ−6−トリフルオロメチルキノリンを製造例2
−(1)と同様にして得た。
mp: 100-107℃
NMR(CDCl3,δ): 7.77(1H,d,J=5Hz)8.25(1H,s),
8.78(1H,s),9.05(1H,d,J=5Hz)
(4) 8−アミノ−4−クロロ−6−トリフルオロメチルキノリンを製造例2
−(3)と同様にして得た。
mp: 57-58℃
NMR(CDCl3,δ): 5.15(2H,br s),7.07(1H,d,J=2Hz),
7.55(1H,d,J=6Hz),7.80(1H,br),8.70(1H,d,J=6Hz)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−6−トリフ
ルオロメチルキノリンを実施例1と同様にして得た。
mp: 150-157℃
NMR(DMSO-d6,δ): 7.47-7.61(3H,m),8.05(1H,d,
J=6Hz),8.29(1H,s),9.00(1H,d,J=2Hz),9.10(1H,s),11.15
(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−6−ト
リフルオロメチルキノリンを実施例139−(1)と同様にして得た。
mp: 228-232℃
NMR(DMSO-d6,δ): 4.61(2H,s),7.09(1H,d,J=6Hz),
7.50-7.63(3H,m),8.35(1H,s),8.37(1H,d,J=6Hz),8.85
(1H,s),9.10(1H,s),10.74(1H,s)
(7) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−6−トリフルオロメチルキノリンを実施例86と同様にして得た。
mp: 174-178℃
NMR(DMSO-d6,δ): 2.03(3H,s),6.78(1H,d,J=6Hz),
7.49-7.63(3H,m),8.54(1H,s),8.56(1H,d,J=6Hz),8.92
(1H,s),9.69(1H,s),10.15(1H,s),10.86(1H,s)実施例211
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−6−トリフルオロメチルキノリンを、実施例8と同様にして、4−クロロ−
8−(2,6−ジクロロベンゾイルアミノ)−6−トリフルオロメチルキノリン
とイミダゾールから得た。
mp: 201-203℃
NMR(DMSO-d6,δ): 7.32(1H,s),7.49-7.64(3H,m),
7.83(2x1H,s),7.93(1H,d,J=6Hz),8.25(1H,s),9.09(1H,
s),9.19(1H,d,J=6Hz),11.40(1H,s)実施例212
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−[(2−メチルアミ
ノエチル)アミノ]−6−トリフルオロメチルキノリンを、実施例8と同様にし
て、4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−6−トリフルオ
ロメチルキノリンとN−メチルエチレンジアミンから得た。
mp: 202-206℃
NMR(DMSO-d6,δ): 2.36(3H,s),2.82(2H,t,J=7Hz),
3.43(2H,dt,J=7,5Hz),6.72(1H,d,J=7Hz),7.50-7.63(3H,
m),7.74(1H,br t,J=5Hz),8.46(1H,d,J=7Hz),8.53(1H,s),
8.87(1H,s),10.75(1H,br s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メチル−2−
オキソイミダゾリジン−1−イル)−6−トリフルオロメチルキノリンを実施例
92−(2)と同様にして得た。
mp: >285℃
NMR(DMSO-d6,δ):2.87(3H,s),3.63(2H,t,J=7.5Hz),
4.02(2H,t,J=7.5Hz),7.48-7.61(3H,m),7.64(1H,d,J=6Hz),
8.13(1H,d,J=0.5Hz),8.94(1H,d,J=0.5Hz),8.98(1H,d,
J=6Hz),11.12(1H,s)実施例213
(1) (3−メチル−2−ニトロアニリノ)メチレンマロン酸イソプロピリデ
ンを、実施例172−(1)と同様にして、3−メチル−2−ニトロアニリンと
マロン酸イソプロピリデンから得た。
mp: 187-190℃
NMR(CDCl3,δ): 1.75(6H,s),2.50(3H,s),7.25(1H,
d,J=8Hz),7.35(1H,d,J=8Hz),7.52(1H,t,J=8Hz),8.55(1H,
d,J=10Hz)
(2) 1,4−ジヒドロ−7−メチル−8−ニトロ−4−オキソキノリンを実
施例172−(2)と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 2.46(3H,s),6.20-6.50(1H,br),
7.42(1H,d,J=8Hz),7.90-8.20(1H,br),8.22(1H,d,J=8Hz)
(3) 4−クロロ−7−メチル−8−ニトロキノリンを製造例2−(1)と同
様にして得た。
mp: 140-147℃
NMR(CDCl3,δ): 2.56(3H,s),3.52-3.60(2H,m),8.26
(1H,d,J=8Hz),8.83(1H,d,J=4Hz)
(4) 8−アミノ−4−クロロ−7−メチルキノリンを製造例2−(3)と同
様にして得た。
mp: 75-77℃
NMR(CDCl3,δ): 2.37(3H,s),4.98(2H,br s),7.36
(1H,d,J=8Hz),7.41(1H,d,J=4Hz),7.49(1H,d,J=8Hz),8.59
(1H,d,J=4Hz)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−7−メチル
キノリンを実施例1と同様にして得た。
mp: 202-205℃
NMR(CDCl3,δ): 2.70(3H,s),7.30-7.45(3H,m),7.48
(1H,d,J=4Hz),7.60(1H,d,J=8Hz),8.05(1H,d,J=8Hz),8.68
(1H,d,J=4Hz),9.07(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−4−ヒドラジノ−7−メ
チルキノリンを実施例139−(1)と同様にして得た。
mp: 202-204℃
NMR(DMSO-d6,δ):2.60(3H,s),7.46-7.62(3H,m),
7.70-7.78(2H,m),8.10(1H,d,J=8Hz),8.85(1H,d,J=4Hz)
(7) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−7−メチルキノリンを実施例86と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 2.00(3H,s),2.50(3H,s),6.55
(1H,d,J=4Hz),7.37-7.70(4H,m),8.06(2H,d,J=8Hz),8.45
(1H,d,J=4Hz),9.12(1H,s)
実施例214
8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−1−イル
)−7−メチルキノリンを、実施例8と同様にして、4−クロロ−8−(2,6
−ジクロロベンゾイルアミノ)−7−メチルキノリンとイミダゾールから得た。
mp: 220-222℃
NMR(DMSO-d6,δ): 2.59(3H,s),7.28(1H,s),
7.46-7.68(6H,m),7.73(1H,s),8.16(1H,s),9.02(1H,d,
J=4Hz)
その塩酸塩
mp: 170-174℃
NMR(DMSO-d6,δ): 2.62(3H,s),7.47-7.67(4H,m),
7.74(1H,d,J=8Hz),7.89(1H,d,J=4Hz),8.08(1H,d,J=2Hz),
8.28(1H,d,J=2Hz),9.17(1H,d,J=4Hz),9.72(1H,s)実施例215
(1) 8−(2,6−ジクロロベンゾイルアミノ)−7−メチル−4−[(2
−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4−クロ
ロ−8−(2,6−ジクロロベンゾイルアミノ)−7−メチルキノリンとN−メ
チルエチレンジアミンから得た。
mp: 217-230℃
NMR(CDCl3,δ): 2.50(3H,s),2.63(3H,s),3.00(2H,
t,J=6Hz),3.35(2H,q,J=6Hz),5.75(1H,br),6.40(1H,d,
J=4Hz),7.28-7.44(4H,m),7.58(1H,d,J=8Hz),8.42(1H,d,
J=4Hz)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−7−メチル−4−(3−
メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−(2)
と同様にして得た。
mp: >250℃
NMR(CDCl3,δ): 2.68(3H,s),2.98(3H,s),3.63(2H,
t,J=7Hz),3.92(2H,t,J=7Hz),7.25-7.44(4H,m),7.47(1H,
d,J=8Hz),7.79(1H,d,J=8Hz),8.75(1H,d,J=4Hz),9.12(1H,
s)実施例216
(1) (4,5−ジメチル−2−ニトロアニリノ)メチレンマロン酸イソプロ
ピリデンを、実施例172−(1)と同様にして、4,5−ジメチル−2−ニト
ロアニリンとマロン酸イソプロピリデンから得た。
mp; 242-244℃
NMR(CDCl3,δ): 1.77(6H,s),2.36(3H,s),2.41 (3H,
s),7.36(1H,s),8.07(1H,s),8.71(1H,d,J=10Hz)
(2) 1,4−ジヒドロ−5,6−ジメチル−8−ニトロ−4−オキソキノリ
ンを実施例172−(2)と同様にして得た。
mp: 197-227℃
NMR(DMSO-d6,δ): 2.40(3H,s),2.85(3H,s),6.15
(1H,d,J=8Hz),7.84(1H,d,J=8Hz),8.45(1H,s)
(3) 4−クロロ−5,6−ジメチル−8−ニトロキノリンを製造例2−(1
)と同様にして得た。
mp: 153-157℃
NMR(CDCl3,δ): 2.55(3H,s),2.96(3H,s),7.57(1H,
d,J=3Hz),7.83(1H,s),8.75(1H,d,J=3Hz)
(4) 8−アミノ−4−クロロ−5,6−ジメチルキノリンを製造例2−(3
)と同様にして得た。
mp: 95-97℃
NMR(CDCl3,δ): 2.40(3H,s),2.77(3H,s),4.85(2H,
s),6.86(1H,s),7.40(1H,d,J=6Hz),8.46(1H,d,J=4Hz)
(5) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−5,6−ジ
メチルキノリンを実施例1と同様にして得た。
mp: 190-193℃
NMR(CDCl3,δ): 2.55(3H,s),2.88(3H,s),7.29-7.44
(3H,m),7.50(1H,d,J=4Hz),8.47(1H,d,J=4Hz),8.89(1H,
s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−5,6−ジメチル−4−
ヒドラジノキノリンを実施例139−(1)と同様にして得た。
mp: 190-198℃
NMR(DMSO-d6,δ): 2.41(3H,s),2.68(3H,s),4.38
(2H,s),7.17(1H,d,J=4Hz),7.45-7.67(4H,m),8.29(1H,d,
J=4Hz),8.49(1H,s)
(7) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−5,6−ジメチルキノリンを実施例86と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 1.99(3H,s),2.45(3H,s),2.75
(3H,s),6.79(1H,d,J=4Hz),7.45-7.63(3H,m),8.33(1H,d,
J=4Hz),8.54(1H,s)実施例217
8−(2,6−ジクロロベンゾイルアミノ)−5,6−ジメチル−4−(イミ
ダゾール−1−イル)キノリンを、実施例8と同様にして、4−クロロ−8−(
2,6−ジクロロベンゾイルアミノ)−5,6−ジメチルキノリンとイミダゾー
ルから得た。
mp: 200-215℃
NMR(CDCl3,δ): 1.88(3H,s),2.52(3H,s),7.17(1H,
s),7.30-7.47(5H,m),7.67(1H,s),8.24(1H,d,J=4Hz),8.96
(1H,s)実施例218
(1) 8−(2,6−ジクロロベンゾイルアミノ)−5,6−ジメチル−4−
[(2−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4
−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−5,6−ジメチルキノ
リンとN−メチルエチレンジアミンから得た。
mp: 162-166℃
NMR(CDCl3,δ): 2.47(3H,s),2.50(3H,s),2.78(3H,
s),3.00(2H,t,J=6Hz),3.26(2H,q,J=6Hz),6.35-7.00(2H,
m),7.25-7.42(3H,m),8.26(1H,d,J=4Hz),8.75(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−5,6−ジメチル−4−
(3−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−
(2)と同様にして得た。
mp: 213-216℃
NMR(CDCl3,δ): 2.53(3H,s),2.65(3H,s),2.98(3H,
s),3.55-3.90(4H,m),7.30-7.45(4H,m),8.64(1H,d,J=4Hz),
8.85(1H,s)実施例219
下記の化合物を実施例167と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−ピリジルメト
キシ)キノリン塩酸塩
mp: 188-195℃
NMR(DMSO-d6,δ): 5.69(2H,s),7.36(1H,d,J=4Hz),
7.50-7.63(3H,m),7.70(1H,t,J=8Hz),8.03-8.11(2H,m),
8.71(1H,d,J=8Hz),8.76(1H,d,J=8Hz),8.85(1H,d,J=4Hz),
8.95(1H,d,J=4Hz),9.15(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−エトキシ−3−メチ
ルキノリン
mp: 155-157℃
NMR(DMSO-d6,δ): 1.45(3H,t,J=7.0Hz),2.43(3H,
s),4.18(2H,q,J=7.0Hz),7.47-7.65(4H,m),7.85(1H,d,
J=8.0Hz),8.15(1H,d,J=8.0Hz),8.73(1H,s),10.70(1H,s)
(3) 4−n−ブトキシ−8−(2,6−ジクロロベンゾイルアミノ)−3−
メチルキノリン
mp: 136-140℃
NMR(DMSO-d6,δ): 0.98(3H,t,J=7.0Hz),1.56(2H,
m),1.85(2H,q,J=7.0Hz),2.43(3H,s),4.11(2H,
t,J=7.0Hz),7.48-7.66(4H,m),7.84(1H,d,
J=8.0Hz),8.66(1H,d,J=8.0Hz),8.73(1H,s)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−4−イソプロポキシ−3
−メチルキノリン
mp: 145-150℃
NMR(DMSO-d6,δ): 1.35(6H,d,J=6.0Hz),2.43(3H,
s),4.59(1H,qq,J=6.0,6.0Hz),7.48-7.64(4H,m),7.86(1H,
d,J=8.0Hz),8.65(1H,d,J=8.0Hz),8.73(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(2−
プロペニルオキシ)キノリン
mp: 130-133℃
NMR(DMSO-d6,δ): 2.43(3H,s),4.67(2H,d,
J=7.0Hz),5.30(1H,dd,J=8.0,1.0Hz),5.50(1H,dd,J=17.0,
1.0Hz),6.18(1H,tdd,J=17.0,8.0,7.0Hz),7.48-7.65(4H,m),
7.85(1H,d,J=8.0Hz),8.65(1H,d,J=8.0Hz),8.76(1H,s)
(6) 4−ベンジルオキシ−8−(2,6−ジクロロベンゾイルアミノ)−3
−メチルキノリン
mp: 173-175℃
NMR(DMSO-d6,δ): 2.41(3H,s),5.19(2H,s),7.39-
7.66(9H,m),7.84(1H,d,J=8Hz),8.66(1H,d,J=8Hz),8.75
(1H,s),10.72(1H,s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(2−
フェノキシエトキシ)キノリン
mp: 149-150℃
NMR(DMSO-d6,δ): 2.45(3H,s),4.38(2H,m),4.50
(2H,m),6.93-7.00(3H,m),7.30-7.36(2H,m),7.49-7.62(4H,
m),7.97(1H,d,J=8.0Hz),8.65(1H,d,J=8.0Hz),8.73(1H,
s),10.70(1H,s)
(8) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−[3−
(2−ピリジル)プロポキシ]キノリン
mp: 106-107℃
NMR(DMSO-d6,δ): 2.29(2H,tt,J=7.5,7Hz),2.41
(3H,s),3.02(2H,t,J=7.5Hz),4.15(2H,t,J=7Hz),7.23(1H,
dd,J=7.5,5Hz),7.35(1H,d,J=7.5Hz),7.48-7.66(4H,m),
7.72(1H,dd,J=7.5,7.5Hz),7.87(1H d,J=7.5Hz),8.51(1H,
d,J=5Hz),8.66(1H,d,J=7.5Hz),8.72(1H,s),10.69(1H,s)実施例220
水素化ナトリウム(油状物中60%、28.9mg)とN−メチルピロリドン
(3ml)の混合物に、フェノール(113mg)を氷冷下で加え、混合物を3
0分間攪拌した。混合物に4−クロロ−8−(2,6−ジクロロベンゾイルアミ
ノ)−3−メチルキノリン(200mg)を加え、混合物を室温で30分間、1
20℃で4.5時間攪拌した。混合物を酢酸エチルで抽出し、抽出物を水、1N
水酸化ナトリウム溶液と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で
濃縮した。残留物をエタノールから結晶化して、8−(2,6−ジクロロベンゾ
イルアミノ)−3−メチル−4−フェノキシキノリン(170mg)を白色結晶
として得た。
mp: 168-170℃
NMR(DMSO-d6,δ): 2.26(3H,s),6.88(2H,d,
J=7.5Hz),7.09(1H,dd,J=7.5,7.5Hz),7.34(2H,dd,J=7.5,
7.5Hz),7.50-7.60(5H,m),8.66-8.70(1H,m),8.87(1H,s),
10.84(1H,s)実施例221
下記の化合物を実施例220と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(4−メトキシフェ
ノキシ)−3−メチルキノリン
mp: 149-150℃
NMR(DMSO-d6,δ): 2.26(3H,s),3.69(3H,s),6.81
(2H,d,J=8.0Hz),6.90(2H,d,J=8.0Hz),7.50-7.61(5H,m),
8.65-8.68(1H,m),8.85(1H,s),10.81(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(ピリ
ジン−3−イルオキシ)キノリン
mp: 202-204℃
NMR(DMSO-d6,δ): 2.27(3H,s),7.20(1H,dd,J=8.0,
2.0Hz),7.31-7.36(1H,m),7.49-7.64(5H,m),8.31(1H,d,
J=6.0Hz),8.40(1H,d,J=2.0Hz),8.70(1H,dd,J=7.0,2.0Hz),
8.90(1H,s),10.88(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−[4−(イミダゾー
ル−1−イル)フェノキシ]キノリン
mp: 229-232℃
NMR(DMSO-d6,δ): 6.80(1H,d,J=6Hz),7.14(1H,s),
7.46-7.65(5H,m),7.72(1H,dd,J=8,8Hz),7.79-7.89(3H,m),
8.10(1H,d,J=8Hz),8.31(1H,s),8.71(1H,d,J=6Hz),8.80
(1H,d,J=8Hz),10.77(1H,s)実施例222
(1) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチル
キノリン(500mg)の酢酸(16ml)と6N塩酸(20ml)中の溶液を
130℃で5日間加熱した。混合物を真空中で濃縮し、沈殿物を集め、水で洗浄
した。残留物をシリカゲルカラムクロマトグラフィー(メタノール:塩化メチレ
ン=1:20、V/V)で精製して、黄色結晶を得た。固形物を熱エタノール(
5ml)で処理し、室温まで冷却させ、濾過し、水で洗浄して、8−(2,6−
ジクロロベンゾイルアミノ)−1,4−ジヒドロ−3−メチル−4−オキソキノ
リン(280mg)を黄色結晶として得た。
mp: >300℃
NMR(DMSO-d6,δ): 2.00(3H,s),7.35(1H,t,
J=8.0Hz),7.52-7.57(1H,m),7.63-7.66(2H,m),7.95(1H,br),
8.04(1H,d,J=8.0Hz),8.12(1H,br d,J=8.0Hz),10.36(1H,
br),10.52(1H,br)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−1,4−ジヒドロ−3−
メチル−4−オキソキノリン(130mg)、炭酸カリウム(155mg)とN
−メチルピロリドン(3ml)の懸濁液に、臭化シンナミル(81.2mg)を
加え、混合物を室温で2.5時間攪拌した。混合物を酢酸エチルで抽出し、抽出
物を水と食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で濃縮した。残留
物をエタノールから結晶化して、4−シンナミルオキシ−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−メチルキノリン(125mg)を白色結晶として得
た。
mp: 169-171℃
NMR(DMSO-d6,δ): 2.48(3H,s),4.85(2H,d,
J=7.0Hz),6.67(1H,td,J=14.5,7.0Hz),7.25-7.38(3H,m),
7.48-7.67(6H,m),7.92(1H,d,J=8.0Hz),8.13(1H,d,
J=8.0Hz),8.75(1H,s),10.70(1H,s)実施例223
8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(フタルイミ
トメトキシ)キノリンを、実施例222−(2)と同様にして、8−(2,6−
ジクロロベンゾイルアミノ)−1,4−ジヒドロ−3−メチル-4−オキソキノ
リンと2−ブロモメチルフタルイミドから得た。
mp: 217-219℃
NMR(DMSO-d6,δ): 2.42(3H,s),5.66(2H,s),7.47-
7.60(4H,m),7.82(1H,d,J=8.0Hz),7.90-7.97(4H,m),8.62
(1H,d,J=8.0Hz),8.75(1H,s),10.73(1H,s)実施例224
下記の化合物を実施例25と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾール−2
−イルチオ)−3−メチルキノリン
mp: 193-195℃
NMR(DMSO-d6,δ): 2.58(3H,s),7.02(2H,br),7.48-
7.57(3H,m),7.65(1H,dd,J=8.0,8.0Hz),8.22(1H,d,
J=8.0Hz),8.63(1H,d,J=8.0Hz),8.82(1H,s),10.79(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(1−
メチルイミダゾール-2−イルチオ)キノリン
mp: 244-246℃
NMR(DMSO-d6,δ): 2.52(3H,s),3.56(3H,s),6.90
(1H,s),7.26(1H,s),7.47-7.58(3H,m),7.47-7.58(3H,m),
7.67(1H,dd,J=8.0,8.0Hz),8.23(1H,d,J=8.0Hz),8.67(1H,
d,J=8.0Hz),8.80(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(ピリ
ミジン−2−イルチオ)キノリン
mp: 267-270℃
NMR(DMSO-d6,δ): 2.58(3H,s),7.24(1H,dd,J=5.0,
5.0Hz),7.49-7.68(4H,m),8.06(1H,d,J=8.0Hz),8.54(2H,d,
J=5.0Hz),8.66(1H,d,J=8.0Hz),8.97(1H,s)実施例225
(1) 4−クロロ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(6
59mg)のジメチルスルホキシド(10ml)中の溶液に、アジ化ナトリウム
(487mg)を加え、混合物を90℃で8時間攪拌した。混合物を水(20m
l)で希釈し、沈殿物を濾過し、水で洗浄して、4−アジド−8−(2,6−ジ
クロロベンゾイルアミノ)キノリン(560mg)を白色固形物として得た。
mp: 188-193℃
NMR(DMSO-d6,δ): 7.48-7.61(4H,m),7.67(1H,dd,
J=8,8Hz),7.81(1H,d,J=8Hz),8.36(1H,d,J=8Hz),8.43(1H,
d,J=6Hz),10.76(1H,s)
(2) 4−アジド−8−(2,6−ジクロロベンゾイルアミノ)キノリン(5
18mg)の酢酸エチル(5ml)中の懸濁液に、トリフェニルホスフィン(3
83mg)を加え、混合物を45℃で3時間攪拌した。生じた沈殿物を濾過によ
り集め、残留物をエタノールから再結晶して、8−(2,6−ジクロロベンゾイ
ルアミノ)−4−[(トリフェニルホスホラニリデン)アミノ]キノリン(84
6mg)を白色結晶として得た。
mp: 276-281℃
NMR(CDCl3,δ); 6.17(1H,d,J=6Hz),7.21-7.39(3H,
m),7.44-7.64(10H,m),7.75-7.87(6H,m),8.05(1H,d,
J=6Hz),8.55(1H,d,J=8Hz),8.87(1H,d,J=8Hz),10.14(1H,
br s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−[(トリフェニルホ
スホラニリデン)アミノ]キノリン(310mg)、6N塩酸(5ml)と酢酸
(5ml)の混合物を130℃で3時間加熱した。冷却後、混合物を6N水酸化
ナトリウム溶液で中和し、不溶物を濾過により集めた。残留物を酢酸エチルから
再結晶して、4−アミノ−8−(2,6−ジクロロベンゾイルアミノ)キノリン
(174mg)を得た。
mp: 265-275℃
NMR(DMSO-d6,δ): 6.87(1H,d,J=7Hz),7.50-7.64(3H,
m),7.75(1H,dd,J=8,8Hz),8.34(1H,d,J=8Hz),8.40(1H,d,
J=8Hz),8.51(1H,d,J=7Hz),9.07-9.35(2H,br),11.07(1H,s)
(4) 4−アミノ−8−(2,6−ジクロロベンゾイルアミノ)キノリン(1
34mg)の無水酢酸(2ml)中の懸濁液を120℃で2時間攪拌した。混合
物を濃縮乾固し、残留物をシリカゲルフラッシュクロマトグラフィー(酢酸エチ
ル:n−ヘキサン=1:1、V/V)で精製した。カラムから初期分別を集めて
、4−(N,N−ジアセチルアミノ)−8−(2,6−ジクロロベンゾイルアミ
ノ)キノリンを白色結晶(33mg)として得た。後期分別を集めて、4−アセ
トアミド−8−(2,6−ジクロロベンゾイルアミノ)キノリンを白色結晶(1
4mg)として得た。
4−(N,N−ジアセチルアミノ)−8−(2,6−ジクロロベンゾイルアミ
ノ)キノリン
mp: 192-195℃
NMR(DMSO-d6,δ): 2.33(2x3H,s),7.32-7.50(5H,m),
7.60(1H,dd,J=8,8Hz),8.88(1H,d,J=6Hz),9.04(1H,d,
J=8Hz),10.05(1H,s)
4−アセトアミド−8−(2,6−ジクロロベンゾイルアミノ)キノリン
mp: 286-288℃(分解)
NMR(DMSO-d6,δ): 2.37(3H,s),7.30-7.43(3H,m),
7.53-7.66(2H,m),7.99(1H,s),8.38(1H,d,J=8Hz),8.70
(1H,d,J=6Hz),8.97(1H,d,J=8Hz),10.18(1H,s)実施例226
下記の化合物を実施例8と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−フェネチルアミノキ
ノリン
mp: 220-226℃
NMR(DMSO-d6,δ): 2.99(2H,t,J=7Hz),3.54(2H,dt,
J=7,5Hz),6.63(1H,d,J=6Hz),7.16-7.36(5H,m),7.42-7.63
(5H,m),7.98(1H,d,J=8Hz),8.36(1H,d,J=6Hz),8.63(1H,
d,J=6Hz),10.46(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(N−メトキシ−N
−メチルアミノ)キノリン
mp: 155-157℃
NMR(DMSO-d6,δ); 3.18(3H,s),3.64(3H,s),7.40
(1H,d,J=6.0Hz),7.49-7.65(4H,m),7.75(1H,d,J=8.0Hz),
8.69(1H,d,J=8.0Hz),8.76(1H,d,J=6.0Hz)実施例227
(1) 4−クロロ−8−(2−ニトロベンゾイルアミノ)キノリンを、実施例
1と同様にして、8−アミノ−4−クロロキノリンと塩化2−ニトロベンゾイル
から得た。
mp: 221-223℃
NMR(CDCl3,δ): 7.55(1H,d,J=4Hz),7.65-7.80(4H,
m),7.99(1H,d,J=8Hz),8.16(1H,d,J=8Hz),8.62(1H,d,
J=4Hz),8.97(1H,d,J=8Hz)
(2) 4−ヒドラジノ−8−(2−ニトロベンゾイルアミノ)キノリンを実施
例139−(1)と同様にして得た。
mp: 198-203℃
NMR(DMSO-d6,δ): 4.50(2H,s),6.98(1H,d,J=4Hz),
7.41(1H,t,J=8Hz),7.76-7.95(4H,m),8.15(1H,d,J=8Hz),
8.39(1H,d,J=4Hz),8.55(1H,d,J=8Hz),8.68(1H,s)
(3) 4−(2−アセチルヒドラジノ)−8−(2−ニトロベンゾイルアミノ
)キノリンを実施例86と同様にして得た。
mp: 232-235℃
NMR(DMSO-d6,δ): 3.32(3H,s),6.65(1H,d,J=4Hz),
7.52(1H,t,J=8Hz),7.75-7.93(3H,m),7.99(1H,d,J=8Hz),
8.17(1H,d,J=8Hz),8.45(1H,d,J=4Hz),8.60(1H,d,J=8Hz),
9.29(1H,s)実施例228
4−(イミダゾール−1−イル)−8−(2−ニトロベンゾイルアミノ)キノ
リンを、実施例8と同様にして、4−クロロ−8−(2−ニトロベンゾイルアミ
ノ)キノリンとイミダゾールから得た。
mp: 195-198℃
NMR(DMSO-d6,δ): 7.26(1H,s),7.57(1H,d,J=8Hz),
7.70-7.95(6H,m),8.18(1H,s),8.20(1H,d,J=8Hz),8.74
(1H,br d,J=8Hz),9.01(1H,d,J=2Hz)
その塩酸塩
mp: 227-235℃
NMR(DMSO-d6,δ): 7.52(1H,d,J=8Hz),7.75-8.03(6H,
m),8.17-8.24(2H,m),8.78(1H,br d,J=8Hz),9.13(1H,d,
J=5Hz),9.53(1H,s)実施例229
(1) 4−[(2−メチルアミノエチル)アミノ]−8−(2−ニトロベンゾ
イルアミノ)キノリンを、実施例8と同様にして、4−クロロ−8−(2−ニト
ロベンゾイルアミノ)キノリンとN−メチルエチレンジアミンから得た。
NMR(DMSO-d6,δ): 2.37(3H,s),2.84(2H,t,J=6Hz),
3.29-3.48(2H,m),6.59(1H,d,J=6Hz),7.30(1H,t,J=5Hz),
7.45(1H,dd,J=8,8Hz),7.75-7.96(3H,m),8.00(1H,d,
J=8Hz),8.15(1H,d,J=8Hz),8.37(1H,d,J=6Hz),8.56(1H,d,
J=7.5Hz),10.58(1H,s)
(2) 4−(3−メチル−2−オキソイミダゾリジン−1−イル)−8−(2
−ニトロベンゾイルアミノ)キノリンを実施例92−(2)と同様にして得た。
mp: 226-228℃
NMR(DMSO-d6,δ): 2.85(3H,s),3.60(2H,t,
J=7.5Hz),3.96(2H,t,J=7.5Hz),7.51(1H,d,J=6Hz),7.60
(1H,dd,J=8,8Hz),7.75-7.83(2H,m),7.85-7.94(2H,m),8.19
(1H,d,J=8Hz),8.63(1H,d,J=7Hz),8.84(1H,d,J=6Hz),
10.72(1H,s)実施例230
(1) 4−クロロ−3−メトキシメチル−8−(2−トリフルオロメチルベン
ゾイルアミノ)キノリンを、実施例1と同様にして、8−アミノ−4−クロロ−
3−メトキシメチルキノリンと塩化2−トリフルオロメチルベンゾイルから得た
。
mp: 121-122℃
NMR(DMSO-d6,δ): 3.40(3H,s),4.77(2H,s),7.74-
7.91(5H,m),8.02(1H,d,J=8.0Hz),8.73(1H,d,J=8.0Hz),
8.90(1H,s)
(2) 4−(イミダゾール−1−イル)−3−メトキシメチル−8−(2−ト
リフルオロメチルベンゾイルアミノ)キノリンを実施例8と同様にして得た。
mp: 126-127℃
NMR(DMSO-d6,δ): 3.26(3H,s),4.35(2H,s),7.08
(1H,d,J=8.0Hz),7.28(1H,s),7.56(1H,s),1.69-7.92(5H,
m),7.97(1H,s),8.72(1H,d,J=7.5Hz),9.06(1H,s)実施例231
(1) 3−メトキシメチル−4−[(2−メチルアミノエチル)アミノ]−8
−(2−トリフルオロメチルベンゾイルアミノ)キノリンを、実施例8と同様に
して、4−クロロ−3−メトキシメチル−8−(2−トリフルオロメチルベンゾ
イルアミノ)キノリンとN−メチルエチレンジアミンから得た。
NMR(DMSO-d6,δ): 2.33(3H,s),2.76(2H,t,J=6Hz),
3.17(3H,s),3.67(2H,dt,J=6,5Hz),4.53(2H,s),6.59(1H,
t,J=5Hz),7.47(1H,dd,J=8,8Hz),7.78(1H,m),7.83-7.87
(2H,m),7.90(1H,d,J=8Hz),7.97(1H,d,J=8Hz),8.32(1H,
s),8.60(1H,s),10.32(1H,s)
(2) 3−メトキシメチル−4−(3−メチル−2−オキソイミダゾリジン−
1−イル)−8−(2−トリフルオロメチルベンゾイルアミノ)キノリンを実施
例92−(2)と同様にして得た。
mp: 156℃
NMR(DMSO-d6,δ):2.82(3H,s),3.33(3H,s),3.59-
3.74(3H,m),3.85(1H,m),4.56(1H,d,J=12Hz),4.61(1H,d,
J=12Hz),7.67-7.73(2H,m),7.78(1H,m),7.83-7.88(2H,m),
7.90(1H,d,J=8Hz),8.67(1H,m),8.93(1H,s),10.45(1H,s)実施例232
(1) 8−アミノ−3−ブロモキノリン(330mg)、3−メトキシカルボ
ニル安息香酸(267mg)、1−エチル−3−(3−ジメチルアミノプロピル
)カルボジイミド塩酸塩(369mg)と1−ヒドロキシベンゾトリアゾール(
300mg)のジメチルホルムアミド(5ml)中の混合物を室温で一夜攪拌し
た。混合物に、水を加え、生じた沈殿物を濾過により集め、熱メタノールで洗浄
し、乾燥して、3−ブロモ−8−[3−(メトキシカルボニル)ベンゾイルアミ
ノ]キノリン(390mg)を淡黄色固形物として得た。
mp: 157℃
NMR(CDCl3,δ): 3.99(3H,s),7.49(1H,d,J=8Hz),
7.60-7.70(2H,m),8.22-8.30(2H,m),8.37(1H,br s),8.70
(1H,br s),8.86(1H,br s),8.95(1H,d,J=8Hz)
(2) 3−ブロモ−8−[3−(メトキシカルボニル)ベンゾイルアミノ]キ
ノリン(356mg)と1N水酸化ナトリウム水溶液(1.1ml)のメタノー
ル(5ml)とジオキサン(5ml)中の混合物を穏やかに2時間還流した。冷
却後、混合物を1N塩酸で中和した。真空中で溶媒を除去し、残留物を熱95%
エタノールで洗浄し、濾過により集めて、3−ブロモ−8−(3−カルボキシベ
ンゾイルアミノ)キノリン(397mg)を淡褐色固形物として得た。
mp: 275-277℃
NMR(DMSO-d6,δ): 7.65-7.80(3H,m),8.14-8.25(2H,
m),8.54(1H,m),8.70(1H,dd,J=8,2Hz),8.81(1H,d,
J=2Hz),9.03(1H,d,J=2Hz)
(3) 3−ブロモ−8−(3−カルボキシベンゾイルアミノ)キノリン(20
0mg)、ジメチルアミン塩酸塩(65.9mg)、1−エチル−3−(3−ジ
メチルアミノプロピル)カルボジイミド(100mg)と1−ヒドロキシベンゾ
トリアゾール(109mg)のジメチルホルムアミド(3ml)中の混合物を室
温で3時間攪拌した。混合物を酢酸エチルで希釈し、水で洗浄し、硫酸マグネシ
ウムで乾燥後、真空中で溶媒を留去した。残留物を分取薄層クロマトグラフィー
(酢酸エチル)で精製し、エタノールから再結晶して、3−ブロモ−8−[3−
(ジメチルカルバモイル)ベンゾイルアミノ]キノリン(120mg)を淡黄色
固形物として得た。
mp: 157℃
NMR(DMSO-d6,δ): 2.95(3H,br s),3.03(3H,br s),
7.64-7.80(4H,m),8.03(1H,br s),8.10(1H,m),8.68(1H,d,
J=8Hz),8.84(1H,d,J=2Hz),9.04(1H,d,J=2Hz)実施例233
(1) 3−ブロモ−8−[4−(メトキシカルボニル)ベンゾイルアミノ]キ
ノリンを、実施例232−(1)と同様にして、8−アミノ−3−ブロモキノリ
ンと4−メトキシカルボニル安息香酸から得た。
mp: 174-176℃
NMR(CDCl3,δ): 3.99(3H,s),7.48(1H,d,J=8Hz),
7.64(1H,t,J=8Hz),8.10(2H,d,J=8Hz),8.20(2H,d,J=8Hz),
8.35(1H,d,J=3Hz),8.84(1H,d,J=3Hz),8.94(1H,d,J=8Hz)
(2) 3−ブロモ−8−(4−カルボキシベンゾイルアミノ)キノリンを実施
例232−(2)と同様にして得た。
mp: >300℃
NMR(DMSO-d6,δ): 7.68-7.79(2H,m),8.07(2H,d,
J=9Hz),8.11(2H,d,J=9Hz),8.20(1H,d,J=8Hz),8.83(1H,
s),9.04(1H,d,J=2Hz)
(3) 3−ブロモ−8−[4−(ジメチルカルバモイル)ベンゾイルアミノ]
キノリンを実施例232−(3)と同様にして得た。
mp: 196-198℃
NMR(DMSO-d6,δ): 2.91(3H,s),3.02(3H,s),7.62
(2H,d,J=9Hz),7.69-7.80(2H,m),8.08(2H,d,J=9Hz),8.70
(1H,m),8.84(1H,d,J=2Hz),9.02(1H,d,J=2Hz)実施例234
(1) 3−ブロモ−8−(2,3,4−トリメトキシベンゾイルアミノ)キノ
リンを、実施例232−(1)と同様にして、8−アミノ−3−ブロモキノリン
と2,3,4−トリメトキシ安息香酸から得た。
mp: 158-161℃
NMR(CDCl3,δ): 3.96(3Hx2,s),4.23(3H,s),6.84
(1H,d,J=8Hz),7.44(1H,d,J=8Hz),7.60(1H,t,J=8Hz),8.09
(1H,d,J=8Hz),8.32(1H,d,J=2Hz),8.89(1H,d,J=2Hz),9.03
(1H,d,J=8Hz)
(2) 3−ブロモ−8−(2,3,4−トリメトキシベンゾイルアミノ)キノ
リン(700mg)のジクロロメタン(10ml)中の溶液に、1M三臭化ホウ
素のジクロロメタン溶液(5.5ml)を氷冷下で加え、混合物を室温で2時間
攪拌した。混合物に氷水を加え、混合物を1.5時間攪拌した。混合物を1N水
酸化ナトリウム溶液でpH4に調整し、それに酢酸エチルを加えた。混合物を室
温で一夜攪拌し、不溶物を濾去した。濾液を真空中で濃縮し、残留物をカラムク
ロマトグラフイー(メタノール−ジクロロメタン)で精製して、3−ブロモ−8
−(2,3,4−トリヒドロキシベンゾイルアミノ)キノリン(110mg)を
得た。
mp: 183-193℃
NMR(DMSO-d6,δ): 6.46(1H,d,J=8Hz),7.41(1H,d,
J=8Hz),7.60-7.71(2H,m),8.77(1H,d,J=2Hz),8.84-8.94(2H,
m)実施例235
(1) 3−ブロモ−8−(2−ニトロベンゾイルアミノ)キノリンを、実施例
1と同様にして、8−アミノ−3−ブロモキノリンと塩化2−ニトロベンゾイル
から得た。
mp: 168-171℃
NMR(CDCl3,δ): 7.50(1H,d,J=8Hz),7.59-7.85(4H,
m),8.15(1H,d,J=8Hz),8.35(1H,d,J=2Hz),8.74(1H,s),
8.90(1H,d,J=8Hz)
(2) 塩化アンモニウム(50.9mg)の水(2ml)中の溶液に、エタノ
ール(10ml)を加え、混合物を50℃で攪拌した。混合物に3−ブロモ−8
−(2−ニトロベンゾイルアミノ)キノリン(590mg)と鉄(531mg)
を加え、混合物を1時間還流した。濾過後、濾液を真空中で濃縮し、残留物を熱
80%エタノールに懸濁し、室温まで冷却させた。生じた沈殿物を濾過により集
めて、8−(2−アミノベンゾイルアミノ)−3−ブロモキノリン(470mg
)を淡褐色固形物として得た。
mp: 147-150℃
NMR(CDCl3,δ): 5.72(2H,br s),6.75(1H,d,J=8Hz),
6.79(1H,t,J=8Hz),7.29(1H,t,J=8Hz),7.45(1H,d,J=8Hz),
7.61(1H,t,J=8Hz),7.73(1H,d,J=8Hz),8.33(1H,d,J=2Hz),
8.83(1H,d,J=2Hz),8.87(1H,d,J=8Hz)
(3) 8−(2−アミノベンゾイルアミノ)−3−ブロモキノリン(200m
g)、無水酢酸(71.6mg)とピリジン(139mg)の塩化エチレン(4
ml)中の混合物を室温で20時間攪拌した。混合物をジクロロメタンで希釈し
、水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物を
熱エタノールに懸濁し、室温まで冷却させた。生じた沈殿物を濾過により集めて
、8−(2−アセトアミドベンゾイルアミノ)−3−ブロモキノリン(200m
g)を黄色粉末として得た。
mp: 206℃
NMR(DMSO-d6,δ): 2.03(3H,s),7.34(1H,t,J=8Hz),
7.58(1H,t,J=8Hz),7.67-7.76(2H,m),7.84-7.93(2H,m),
8.70(1H,d,J=8Hz),8.81(1H,d,J=2Hz),8.96(1H,d,J=2Hz),
10.46(2H,br s)実施例236
(1) 3−ブロモ−8−(3−ニトロベンゾイルアミノ)キノリンを、実施例
1と同様にして、8−アミノ−3−ブロモキノリンと塩化3−ニトロベンゾイル
から得た。
mp: 258℃
NMR(DMSO-d6,δ): 7.69-7.84(2H,m),7.90(1H,t,
J=8Hz),8.43-8.52(2H,m),8.60(1H,d,J=6Hz),8.76-8.88(2H,
m),9.03(1H,d,J=2Hz)
(2) 8−(3−アミノベンゾイルアミノ)−3−ブロモキノリンを実施例2
35−(2)と同様にして得た。
mp: 209-211℃
NMR(DMSO-d6,δ): 5.49(2H,br s),6.81(1H,dd,J=8,
2Hz),7.10(1H,br d,J=8Hz),7.18-7.28(2H,m),7.67-7.74
(2H,m),8.24(1H,m),8.81(1H,d,J=2Hz),9.01(1H,d,
J=2Hz)
(3) 8−(3−アセトアミドベンゾイルアミノ)−3−ブロモキノリンを実
施例235−(3)と同様にして得た。
mp: 198-202℃
NMR(DMSO-d6,δ): 2.09(3H,s),7.54(1H,t,J=8Hz),
7.63-7.78(3H,m),7.86(1H,br d,J=8Hz),8.24(1H,s),8.72
(1H,m),8.81(1H,s),9.00(1H,d,J=2Hz)実施例237
3−ブロモ−8−(3−メチル−2−ニトロベンゾイルアミノ)キノリンを、
実施例232−(1)と同様にして、2−アミノ−3−ブロモキノリンと3−メ
チル−2−ニトロ安息香酸から得た。
mp: 203-209℃
NMR(DMSO-d6,δ): 2.37(3H,s),7.65-7.80(4H,m),
7.82-7.93(1H,m),8.52(1H,d,J=8Hz),8.83(1H,d,J=2Hz),
8.99(1H,d,J=2Hz)実施例238
3−ブロモ−8−(2−トリフルオロメチルベンゾイルアミノ)キノリンを、
実施例1と同様にして、2−アミノ−3−ブロモキノリンと塩化2−トリフルオ
ロメチルベンゾイルから得た。
mp: 138-141℃
NMR(CDCl3,δ): 7.50(1H,d,J=8Hz),7.60-7.84(4H,
m),8.35(1H,s),8.75(1H,s),8.94(1H,d,J=8Hz)実施例239
3−ブロモ−8−[(2−クロロピリジン−3−イルカルボニル)アミノ]キ
ノリンを、実施例232−(1)と同様にして、2−アミノ−3−ブロモキノリ
ンと2−クロロ−3−ピリジンカルボン酸から得た。
mp: 164-168℃
NMR(DMSO-d6,δ): 7.50-7.63(1.2H,m),7.66-7.80
(2.1H,m),8.00(0.4H,d,J=8Hz),8.11-8.28(1.2H,m),8.52-
8.60(0.8H,m),8.67-8.76(0.8H,m),8.80(0.7H,br s),8.87
(0.3H,t,J=6Hz),8.95(0.5H,m)実施例240
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチル−4−
ヒドラジノキノリンを、実施例139−(1)と同様にして、4−クロロ−8−
(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチルキノリンとヒドラジ
ン一水和物から得た。
NMR(DMSO-d6,δ): 1.84(3H,s),1.93(3H,s),4.15-
4.33(2H,m),6.60(1H,d,J=8Hz),7.16-7.33(1H,m),7.40-
7.71(4H,m),10.01(1H,s)
(2) 4−(2−アセチルヒドラジノ)−8−(2,6−ジクロロベンゾイル
アミノ)−3,5−ジメチルキノリンを実施例86と同様にして得た。
mp: 234-238℃
NMR(DMSO-d6,δ): 1.76(2x3H,s),2.03(3H,s),
7.23-7.73(6H,m),8.80(1H,s),9.45(1H,br),9.73(1H,br)実施例241
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチル−4−
[(2−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にして、4
−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチルキノ
リンとN−メチルエチレンジアミンから得た。
mp: 151-152℃
NMR(DMSO-d6,δ): 2.26(3H,s),2.37(3H,s),2.58
(2H,t,J=6Hz),2.86(3H,s),3.25(2H,dt,J=6,5Hz),5.56
(1H,t,J=5Hz),7.24(1H,d,J=7.5Hz),7.48-7.63(3H,m),8.34
(1H,s),8.43(1H,d,J=7.5Hz),10.41(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチル−4−
(3−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例92−
(2)と同様にして得た。
mp: >300℃
NMR(DMSO-d6,δ): 2.34(3H,s),2.68(3H,s),2.80
(3H,s),3.52-3.74(4H,m),7.45(1H,d,J=8Hz),7.48-7.62
(3H,m),8.53(1H,d,J=8Hz),8.83(1H,s),10.66(1H,s)実施例242
8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチル−4−(3−
メチル−2−チオキソイミダゾリジン−1−イル)キノリンを、実施例92−(
2)と同様にして、8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメ
チル−4−[(2−メチルアミノエチル)アミノ]キノリンと1,1’−チオカ
ルボニルジイミダゾールから得た。
mp: 275-278℃
NMR(DMSO-d6,δ): 2.35(3H,s),2.67(3H,s),3.15
(3H,s),3.78-4.03(4H,m),7.45(1H,d,J=8Hz),7.48-7.63
(3H,m),8.54(1H,d,J=8Hz),8.85(1H,s),10.68(1H,s)実施例243
8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチル−4−(ピリ
ジン−3−イルオキシ)キノリンを、実施例220と同様にして、4−クロロ−
8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチルキノリンと3−
ヒドロキシピリジンから得た。
mp: 234-237℃
NMR(DMSO-d6,δ): 2.16(3H,s),2.57(3H,s),7.12
(1H,dd,J=9.0,2.0Hz),7.32(1H,dd,J=9.0,4.0Hz),7.43(1H,
d,J=8.0Hz),7.48-7.60(3H,m),8.30-8.35(2H,m),8.59(1H,
d,J=8.0Hz),8.85(1H,s)実施例244
8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチル−4−(イミ
ダゾール−2−イルチオ)キノリンを、実施例25と同様にして、4−クロロ−
8−(2,6−ジクロロベンゾイルアミノ)−3,5−ジメチルキノリンと2−
メルカプトイミダゾールから得た。
mp: 263-266℃
NMR(DMSO-d6,δ): 2.43(3H,s),3.03(3H,s),6.85
(1H,s),7.11(1H,s),7.48-7.59(4H,m),8.54(1H,d,
J=8.0Hz),8.75(1H,s),10.67(1H,s)実施例245
(1) 5−クロロ−1,4−ジヒドロ−3−ヒドロキシメチル−8−ニトロ−
4−オキソキノリンを、実施例172−(3)と同様にして、5−クロロ−1,
4−ジヒドロ−8−ニトロ−4−オキソキノリンから得た。
mp: >250℃
NMR(DMSO-d6,δ): 4.37(2H,s),7.45(1H,d,J=8Hz),
7.93(1H,d,J=4Hz),8.52(1H,d,J=8Hz)
(2) 5−クロロ−1,4−ジヒドロ−3−メチル−8−ニトロ−4−オキソ
キノリンを実施例104−(2)と同様にして得た。
mp: >250℃
NMR(DMSO-d6,δ): 1.97(3H,s),7.42(1H,d,J=8Hz),
7.87(1H,d,J=6Hz),8.49(1H,d,J=8Hz)
(3) 4,5−ジクロロ−3−メチル−8−ニトロキノリンを製造例2−(1
)と同様にして得た。
mp: 136-138℃
NMR(CDCl3,δ): 2.61(3H,s),7.73(1H,d,J=8Hz),
7.80(1H,d,J=8Hz),8.84(1H,s)
(4) 8−アミノ−4,5−ジクロロ−3−メチルキノリンを製造例2−(3
)と同様にして得た。
mp: 128-130℃
NMR(CDCl3,δ): 2.53(3H,s),5.07(2H,s),6.79(1H,
d,J=8Hz),7.42(1H,d,J=8Hz),8.55(1H,s)
(5) 4,5−ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−
メチルキノリンを実施例1と同様にして得た。
mp: 222-233℃
NMR(CDCl3,δ): 2.56(3H,s),7.30-7.44(3H,m),7.71
(1H,d,J=8Hz),8.58(1H,s),8.83(1H,d,J=8Hz)
(6) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミ
ダゾール−1−イル)−3−メチルキノリンを実施例8同様にして得た。
mp: 260-262℃
NMR(DMSO-d6,δ): 2.14(3H,s),7.19(1H,s),7.40
(1H,s),7.50-7.60(3H,m),7.79(2H,d,J=8Hz),7.83(1H,s),
8.69(1H,d,J=8Hz),9.04(1H,s)実施例246
5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−
(ピリジン−3−イルオキシ)キノリンを、実施例220と同様にして、4,5
−ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリン
と3−ヒドロキシピリジンから得た。
mp: 232-236℃
NMR(CDCl3,δ): 2.28(3H,s),6.96(1H,dd,J=8,
2Hz),7.21(1H,dd,J=8,5Hz),7.31-7.45(3H,m),7.60(1H,d,
J=8Hz),8.25(1H,d,J=2Hz),8.34(1H,d,J=5Hz),8.70(1H,
s),8.87(1H,d,J=8Hz)実施例247
5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−4−(イミダゾー
ル−2−イルチオ)−3−メチルキノリンを、実施例25と同様にして、4,5
−ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチルキノリン
と2−メルカプトイミダゾールから得た。
mp: >288℃(分解)
NMR(CDCl3,δ): 2.40(3H,s),7.30-7.49(5H,m),7.76
(1H,s),8.47(1H,s),8.98(1H,d,J=8Hz)実施例248
(1) 8−アミノ−1,4−ジヒドロ−3−メトキシメチル−4−オキソキノ
リンを、製造例2−(3)と同様にして、1,4−ジヒドロ−3−メトキシメチ
ル−8−ニトロ−4−オキソキノリンから得た。
mp: >300℃
NMR(DMSO-d6,δ): 3.30(3H,s),4.30(2H,s),5.45
(2H,s),6.90(1H,d,J=8Hz),7.04(1H,dd,J=8,8Hz),7.39
(1H,d,J=8Hz),7.85(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2,6−ジクロロ
ベンゾイルオキシ)−3−メトキシメチルキノリンを、実施例1と同様にして、
8−アミノ−1,4−ジヒドロ−3−メトキシメチル−4−オキソキノリンと塩
化2,6−ジクロロベンゾイルから得た。
mp: 241-243℃
NMR(DMSO-d6,δ): 3.36(3H,s),4.80(2H,s),7.46-
7.62(3H,m),7.72(1H,m),7.79-7.87(3H,m),8.01(1H,d,
J=8Hz),8.81(1H,d,J=8Hz),9.07(1H,s),11.01(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2,6−ジクロロ
ベンゾイルオキシ)−3−メトキシメチルキノリン(4.88g)のエタノール
(100ml)と1N水酸化ナトリウム溶液(30ml)の懸濁液を90℃で2
時間攪拌した。溶媒を留去後、残留物を水で希釈し、溶液を1N塩酸で中和した
。生じた沈殿物を濾過により集め、水とジエチルエーテルで洗浄して、8−(2
,6−ジクロロベンゾイルアミノ)−1,4−ジヒドロ−3−メトキシメチル−
4−オキソキノリン(3.41g)を白色粉末として得た。
mp: 290℃(分解)
NMR(DMSO-d6,δ): 3.32(3H,s),4.32(2H,s),7.40
(1H,dd,J=8,8Hz),7.52-7.68(3H,m),8.01(1H,d,J=7Hz),
8.05(1H,d,J=8Hz),8.10(1H,d,J=8Hz),10.45(1H,s),10.66
(1H,d,J=7Hz)
(4) 8−(2,6−ジクロロベンゾイルアミノ)−1,4−ジヒドロ−3−
メトキシメチル−4−オキソキノリン(209mg)のN−メチルピロリドン(
4ml)中の溶液に、3−クロロメチルピリジン塩酸塩(109mg)、炭酸カ
リウム(153mg)とヨウ化ナトリウム(20mg)を加え、混合物を80℃
で4時間攪拌した。混合物を酢酸エチルと水との間に分配し、分離した有機層を
食塩水で洗浄し、硫酸マグネシウムで乾燥後、真空中で溶媒を留去した。残留物
をエタノールから結晶化して、8−(2,6−ジクロロベンゾイルアミノ)−3
−メトキシメチル−4−(ピリジン−3−イルメトキシ)キノリン(170mg
)を白色結晶として得た。
mp: 174-176℃
NMR(DMSO-d6,δ): 3.33(3H,s),4.65(2H,s),5.32
(2H,s),7.46-7.61(4H,m),7.67(1H,dd,J=8,8Hz),7.90(1H,
d,J=8Hz),8.00(1H,m),8.61(1H,d,J=5Hz),8.70-8.77(2H,
m),8.85(1H,s),10.80(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−メトキシメチル−4
−(ピリジン−2−イルメトキシ)キノリンを、実施例248−(4)と同様に
して、8−(2,6−ジクロロベンゾイルアミノ)−1,4−ジヒドロ−3−メ
トキシメチル−4−オキソキノリンと2−クロロメチルピリジンから得た。
mp: 112-113℃
NMR(DMSO-d6,δ): 2.50(3H,s),4.66(2H,s),5.33
(2H,s),7.40-7.44(1H,m),7.48-7.73(5H,m),7.90-7.98(2H,
m),8.62(1H,d,J=4.0Hz),8.73(1H,d,J=8.0Hz),8.85(1H,
s),10.80(1H,s)実施例249
下記の化合物を実施例220と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−4−(3−メトキシフェ
ノキシ)−3−メチルキノリン
mp: 168-170℃
NMR(DMSO-d6,δ): 2.27(3H,s),3.73(3H,s),6.31
(1H,dd,J=7.5,2.0Hz),6.56(1H,m),6.67(1H,dd,J=7.5,
2.0Hz),7.20(1H,dd,J=7.5,7.5Hz),7.50-7.60(5H,m),8.67-
8.70(1H,m),8.88(1H,s),10.85(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(ピリ
ジン−2−イルオキシ)キノリン
mp: 185-186℃
NMR(DMSO-d6,δ): 2.25(3H,s),7.11-7.16(1H,m),
7.33(1H,d,J=7.5Hz),7.48-7.60(5H,m),7.93-8.00(2H,m),
8.65(1H,d,J=7.5Hz),8.85(1H,s)
(3) 4−(2−クロロピリジン−3−イルオキシ)−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−メチルキノリン
mp: 186-187℃
NMR(DMSO-d6,δ): 2.28(3H,s),7.00(1H,d,
J=8.0Hz),7.22-7.27(1H,m),7.49-7.67(5H,m),8.16(1H,d,
J=2.0Hz),8.22(1H,d,J=8.0Hz),8.93(1H,s),10.91(1H,s)
(4) 4−(5−クロロピリジン−3−イルオキシ)−8−(2,6−ジクロ
ロベンゾイルアミノ)−3−メチルキノリン
mp: 163-165℃
NMR(DMSO-d6,δ): 2.30(3H,s),7.49-7.66(6H,m),
8.35(1H,d,J=2.0Hz),8,41(1H,d,J=1.0Hz),8.72(1H,d,
J=8.0Hz),8.90(1H,s),10.90(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(2−
メチルピリジン−3−イルオキシ)キノリン
mp: 159-160℃
NMR(DMSO-d6,δ); 2.25(3H,s),2.73(3H,s),6.65
(1H,d,J=8.0Hz),7.01-7.05(1H,m),7.49-7.65(5H,m),8.16
(1H,d,J=4.0Hz),8.70(1H,d,J=8.0Hz),8.90(1H,s),10.89
(1H,s)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(6−
メチルピリジン−3−イルオキシ)キノリン
NMR(DMSO-d6,δ): 2.27(3H,s),2.43(3H,s),7.10
(1H,dd,J=9.0,2.0Hz),7.15(1H,d,J=7.5Hz),7.50-7.66(5H,
m),8.23(1H,d,J=2.0Hz),8.70(1H,dd,J=9.0,2.0Hz),8.88
(1H,s),10.85(1H,s)
(7) 8−(2,6−ジクロロベンゾイルアミノ)−4−[2−(ジメチルア
ミノメチル)ピリジン−3−イルオキシ]−3−メチルキノリン
NMR(DMSO-d6,δ): 2.26(3H,s),2.35(6H,s),6.70
(1H,d,J=8.0Hz),7.10-7.15(1H,m),7.50-7.70(5H,m),8.22
(1H,d,J=4.0Hz),8.70(1H,d,J=8.0Hz),8.90(1H,s)
(8) 4−(1H−ベンズイミダゾール−2−イルオキシ)−8−(2,6−
ジクロロベンゾイルアミノ)−3−メチルキノリン
mp: 106-110℃
NMR(DMSO-d6,δ): 2.36(5/9x3H,s),2.55(4/9x3H,s),
6.50(5/9H,d,J=7.5Hz),6.86-7.00(2H,m),7.11(5/9H,dd,
J=7.5,7.5Hz),7.16-7.23((1+4/9)H,m),7.49-7.90((4+4/9)H,
m),8.41(4/9H,d,J=7.5Hz),8.70(5/9H,d,J=7.5Hz),8.77
(4/9H,s),9.04(5/9H,s),10.34(4/9H,s),10.95(5/9H,s),
11.00(4/9H,br s),11.40(5/9H,br s)
(9) 8−(2,6−ジクロロベンゾイルアミノ)−4−(2−メトキシフェ
ノキシ)−3−メチルキノリン
mp: 189-190℃
NMR(DMSO-d6,δ): 2.23(3H,s),3.93(3H,s),6.38
(1H,d,J=7.5Hz),6.75(1H,dd,J=7.5,7.5Hz),7.05(1H,dd,
J=7.5,7.5Hz),7.21(1H,d,J=7.5Hz),7.50-7.60(5H,m),8.64-
8.67(1H,m),8.84(1H,s),10.83(1H,s)実施例250
4−ヒドロキシピリジン(114mg)のN−メチルピロリドン(3ml)中
の溶液に、水素化ナトリウム(油状物中60%、28.9mg)を氷冷下で加え
、混合物を30分間攪拌した。混合物に、4−クロロ−8−(2,6−ジクロロ
ベンゾイルアミノ)−3−メチルキノリン(200mg)を加え、混合物を12
0℃で1.5時間攪拌した。混合物を酢酸エチルで抽出し、抽出物を水と食塩水
で洗浄し、硫酸マグネシウムで乾燥後、真空中で濃縮した。残留物をフラッシュ
クロマトグラフィー(酢酸エチル−メタノール−ジクロロメタン)で精製し、ジ
エチルエーテルから結晶化して、8−(2,6−ジクロロベンゾイルアミノ)−
3−メチル−4−(1,4−ジヒドロ−4−オキソピリジン−1−イル)キノリ
ン(185mg)を白色結晶として得た。
mp: 280-282℃
NMR(DMSO-d6,δ): 2.35(3H,s),6.34(2H,d,
J=7.0Hz),7.22(1H,d,J=8.0Hz),7.50-7.60(3H,m),7.75(1H,
dd,J=8.0,8.0Hz),7.82(2H,d,J=7.0Hz),8.74(1H,d,
J=8.0Hz),9.01(1H,s),10.98(1H,s)実施例251
下記の化合物を実施例25と同様にして得た。
(1) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(チア
ゾリン−2−イルチオ)キノリン
mp: 206-209℃
NMR(DMSO-d6,δ): 2.68(3H,s),3.18-3.25(2H,m),
3.75(1H,dd,J=8.0,8.0Hz),4.05(1H,dd,J=8.0,8.0Hz),
7.48-7.61(3H,m),7.74(1H,dd,J=8.0,8.0Hz),8.25(1H,d,
J=8.0Hz),8.70(1H,d,J=8.0Hz),8.72(1H,s),10.80(1H,s)
(2) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(5−
メチル−1,3,4−チアジアゾール−2−イルチオ)キノリン
mp: 186-187℃
NMR(DMSO-d6,δ): 2.57(3H,s),2.70(3H,s),7.50-
7.59(3H,m),7.76(1H,dd,J=8.0,8.0Hz),8.13(1H,d,
J=8.0Hz),8.22(1H,d,J=8.0Hz),9.00(1H,s),10.94(1H,s)
(3) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(ピリ
ジン−4−イルチオ)キノリン
mp: 202-203℃
NMR(DMSO-d6,δ): 2.60(3H,s),6.95(2H,d,
J=6.0Hz),7.49-7.60(3H,s),7.70(1H,dd,J=8.0,8.0Hz),8.01
(1H,d,J=8.0Hz),8.32(1H,d,J=6.0Hz),8.72(1H,d,
J=8.0Hz),9.01(1H,s),10.95(1H,s)
(4) 4−(1H−ベンズイミダゾール−2−イルチオ)−8−(2,6−ジ
クロロベンゾイルアミノ)−3−メチルキノリン
mp: 162-164℃
NMR(DMSO-d6,δ): 2.60(3H,s),7.08-7.12(2H,m),
7.35-7.39(2H,m),7.50-7.61(3H,m),7.68(1H,dd,J=8.0,
8.0Hz),8.11(1H,d,J=8.0Hz),8.69(1H,d,J=8.0Hz),8.95
(1H,s),10.90(1H,s)
(5) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(1−
メチルテトラゾール−5−イルチオ)キノリン
mp: 194-203℃
NMR(CDCl3,δ): 2.66(3H,s),4.05(3H,s),7.30-7.45
(3H,m),7.69(1H,t,J=8Hz),8.03(1H,d,J=8Hz),8.76(1H,
s),8.97(1H,d,J=8Hz)
(6) 8−(2,6−ジクロロベンゾイルアミノ)−3−メチル−4−(4−
メチル−4H−1,2,4−トリアゾール−3−イルチオ)キノリン
mp: 234-235℃
NMR(DMSO-d6,δ): 2.62(3H,s),3.59(3H,s),7.47-
7.59(3H,m),7.71(1H,dd,J=8.0,8.0Hz),8.20(1H,d,
J=8.0Hz),8.58(1H,s),8.69(1H,d,J=8.0Hz),8.90(1H,s),
10.85(1H,s)実施例252
(1) 4−クロロ−3−メチル−8−(2−ニトロベンゾイルアミノ)キノリ
ンを、実施例1と同様にして、8−アミノ−4−クロロ−3−メチルキノリンと
塩化2−ニトロベンゾイルから得た。
mp: 178-182℃
NMR(CDCl3,δ): 2.57(3H,s),7.60-7.70(2H,m),
7.71-7.80(2H,m),7.96(1H,d,J=8Hz),8.14(1H,d,J=8Hz),
8.55(1H,s),8.86(1H,d,J=8Hz)
(2) 4−(イミダゾール−1−イル)−3−メチル−8−(2−ニトロベン
ゾイルアミノ)キノリンを実施例8と同様にして得た。
mp: 199-204℃
NMR(DMSO-d6,δ): 2.25(3H,s),7.01(1H,d,J=8Hz),
7.30(1H,s),7.54(1H,d,J=2Hz),7.67(1H,t,J=8Hz),7.77-
7.96(4H,m),7.99(1H,s),8.20(1H,d,J=8Hz),8.64(1H,br
d,J=9Hz),8.98(1H,s)実施例253
(1) 4−クロロ−8−(2−ニトロベンゾイルアミノ)−3,5−ジメチル
キノリンを、実施例1と同様にして、8−アミノ−4−クロロ−3,5−ジメチ
ルキノリンと塩化2−ニトロベンゾイルから得た。
mp: 165-166℃
NMR(DMSO-d6,δ): 2.51(3H,s),2.98(3H,s),7.53
(1H,d,J=8Hz),7.77(1H,ddd,J=8,8,2Hz),7.82-7.93(2H,
m),8.17(1H,d,J=8Hz),8.50(1H,d,J=8Hz),8.77(1H,s),
10.66(1H,s)
(2) 3,5−ジメチル−4−(イミダゾール−1−イル)−8−(2−ニト
ロベンゾイルアミノ)キノリンを実施例8と同様にして得た。
mp: 231-233℃
NMR(DMSO-d6,δ): 1.92(3H,s),2.08(3H,s),7.23
(1H,s),7.43-7.50(2H,m),7.75-7.95(4H,m),8.08(1H,d,
J=8Hz),8.53(1H,d,J=8Hz),8.93(1H,s),10.75(1H,s)実施例254
(1) 4−クロロ−3−メトキシメチル−8−(2−ニトロベンゾイルアミノ
)キノリンを、実施例1と同様にして、8−アミノ−4−クロロ−3−メトキシ
メチルキノリンと塩化2−ニトロベンゾイルから得た。
mp: 174-175℃
NMR(DMSO-d6,δ): 3.40(3H,s),4.78(2H,s),7.75-
7.91 (4H,m),8.02(1H,d,J=8.0Hz),8.20(1H,d,J=8.0Hz),
8.73(1H,br d,J=8.0Hz),8.90(1H,s)
(2) 4−(イミダゾール−1−イル)−3−メトキシメチル−8−(2−ニ
トロベンゾイルアミノ)キノリン塩酸塩を実施例8と同様にして得た。
mp: 175-185℃
NMR(DMSO-d6,δ): 3.23(3H,s),4.49(2H,s),7.20
(1H,d,J=8Hz),7.75-7.97(4H,m),8.00(1H,d,J=0.5Hz),8.07
(1H,d,J=0.5Hz),8.21(1H,d,J=8Hz),8.77(1H,d,J=7Hz),
9.14(1H,s),9.35(1H,s),11.00(1H,s)実施例255
(1) 3−メトキシメチル−4−[(2−メチルアミノエチル)アミノ]−8
−(2−ニトロベンゾイルアミノ)キノリンを、実施例8と同様にして、4−ク
ロロ−3−メトキシメチル−8−(2−ニトロベンゾイルアミノ)キノリンとN
−メチルエチレンジアミンから得た。
NMR(CDCl3,δ): 2.48(3H,s),2.88(2H,m),3.37(3H,
s),3.76(2H,m),4.59(2H,s),6.11(1H,m),7.43(1H,t,
J=8Hz),7.63(1H,dd,J=8,2Hz),7.70-7.84(4H,m),8.11(1H,
d,J=8Hz),8.26(1H,s),8.79(1H,d,J=8Hz)
(2) 3−メトキシメチル−4−(3−メチル−2−オキソイミダゾリジン−
1−イル)−8−(2−ニトロベンゾイルアミノ)キノリンを実施例92−(2
)と同様にして得た。
mp: 156-159℃
NMR(CDCl3,δ): 2.98(3H,s),3.41(3H,s),3.59-3.79
(3H,m),3.85-3.98(1H,m),4.54(1H,d,J=9Hz),4.70(1H,d,
J=9Hz),7.58-7.70(3H,m),7.71-7.81(2H,m),8.13(1H,d,
J=8Hz),8.82(1H,s),8.88(1H,t,J=5Hz)実施例256
4−(イミダゾール−2−イルチオ)−3−メトキシメチル−8−(2−ニト
ロベンゾイルアミノ)キノリンを、実施例25と同様にして、4−クロロ−3−
メトキシメチル−8−(2−ニトロベンゾイルアミノ)キノリンと2−メルカプ
トイミダゾールから得た。
mp; 196-203℃
NMR(DMSO-d6,δ): 3.38(3H,s),4.90(2H,s),6.92
(1H,s),7.16(1H,s),7.67(1H,t,J=8Hz),7.75-7.95(3H,m),
8.16-8.20(2H,m),8.63(1H,d,J=8Hz),8.94(1H,s)
実施例257
3−メトキシメチル−8−(2−ニトロベンゾイルアミノ)−4−(ピリジン
−3−イルオキシ)キノリンを、実施例220と同様にして、4−クロロ−3−
メトキシメチル−8−(2−ニトロベンゾイルアミノ)キノリンと3−ヒドロキ
シピリジンから得た。
NMR(DMSO-d6,δ): 3.23(3H,s),4.53(2H,s),7.22
(1H,dd,J=8.0,3.0Hz),7.31-7.36(1H,m),7.56-7.67(2H,m),
7.76-7.95(3H,m),8.20(1H,d,J=7.5Hz),8.33(1H,d,
J=3.0Hz),8.41(1H,d,J=2.0Hz),8.70(1H,d,J=7.5Hz),8.98
(1H,s),10.85(1H,s)実施例258
(1) 4−クロロ−3−メチル−8−(2−トリフルオロメチルベンゾイルア
ミノ)キノリンを、実施例1と同様にして、8−アミノ−4−クロロ−3−メチ
ルキノリンと塩化2−トリフルオロメチルベンゾイルから得た。
mp: 169-173℃
NMR(CDCl3,δ): 2.57(3H,s),7.58-7.86(5H,m),
7.95(1H,d,J=8Hz),8.55(1H,s),8.90(1H,d,J=8Hz)
(2) 4−(イミダゾール−1−イル)−3−メチル−8−(2−トリフルオ
ロメチルベンゾイルアミノ)キノリンを実施例8と同様にして得た。
NMR(CDCl3,δ): 2.30(3H,s),7.09(1H,d,J=9Hz),
7.11(1H,s),7.40(1H,s),7.56-7.85(6H,m),8.25(1H,s),
8.94(1H,d,J=9Hz)
その塩酸塩
mp: 189-196℃
NMR(DMSO-d6,δ): 2.31(3H,s),7.13(1H,d,J=8Hz),
7.69-7.94(5H,m),8.04-8.13(2H,m),8.70(1H,d,J=9Hz),
9.07(1H,s),9.47(1H,s)実施例259
(1) 3−メチル−4−[(2−メチルアミノエチル)アミノ]−8−(2−
トリフルオロメチルベンゾイルアミノ)キノリンを、実施例8と同様にして、4
−クロロ−3−メチル−8−(2−トリフルオロメチルベンゾイルアミノ)キノ
リンとN−メチルエチレンジアミンから得た。
NMR(CDCl3,δ): 2.40(3H,s),2.50(3H,s),2.88(2H,
t,J=6Hz),3.62(2H,q,J=6Hz),5.30(1H,s),7.48(1H,t,
J=8Hz),7.55-7.85(5H,m),8.30(1H,s),8.80(1H,d,J=8Hz)
(2) 3−メチル−4−(3−メチル−2−オキソイミダゾリジン−1−イル
)−8−(2−トリフルオロメチルベンゾイルアミノ)キノリンを実施例92−
(2)と同様にして得た。
mp: 182-191℃
NMR(CDCl3,δ): 2.45(3H,s),2.99(3H,s),3.63-3.93
(4H,m),7.55-7.85(6H,m),8.68(1H,s),8.87(1H,dd,J=8,
2Hz)実施例260
(1) 4−ヒドラジノ−3−メチル−8−(2−トリフルオロメチルベンゾイ
ルアミノ)キノリンを、実施例139−(1)と同様にして、4−クロロ−3−
メチル−8−(2−トリフルオロメチルベンゾイルアミノ)キノリンとヒドラジ
ン一水和物から得た。
mp: 160-167℃
NMR(DMSO-d6,δ): 2.40(3H,s),4.70(2H,s),7.33
(1H,t,J=8Hz),7.70-7.88(4H,m),7.91(1H,d,J=8Hz),8.18
(1H,s),8.51(1H,d,J=8Hz),8.64(1H,d,J=8Hz)
(2) 4−(2−アセチルヒドラジノ)−3−メチル−8−(2−トリフルオ
ロメチルベンゾイルアミノ)キノリンを実施例86と同様にして得た。
mp: 209-211℃
NMR(DMSO-d6,δ): 1.88(3H,s),2.35(3H,s),7.48
(1H,t,J=8Hz),7.70-7.88(3H,m),7.90(1H,d,J=8Hz),8.11
(1H,d,J=8Hz),8.28(1H,d,J=2Hz),8.33(1H,s),8.56(1H,
d,J=8Hz)
実施例261
3−メチル−4−(ピリジン−3−イルオキシ)−8−(2−トリフルオロメ
チルベンゾイルアミノ)キノリンを、実施例220と同様にして、4−クロロ−
3−メチル−8−(2−トリフルオロメチルベンゾイルアミノ)キノリンと3−
ヒドロキシピリジンから得た。
mp: 102-108℃
NMR(CDCl3,δ): 2.29(3H,s),6.98(1H,dd,J=8,
3Hz),7.15-7.29(2H,m),7.48-7.85(6H,m),8.30-8.40(2H,m),
8.67(1H,s),8.88(1H,d,J=8Hz)実施例262
4−(イミダゾール−2−イルチオ)−3−メチル−8−(2−トリフルオロ
メチルベンゾイルアミノ)キノリンを、実施例25と同様にして、4−クロロ−
3−メチル−8−(2−トリフルオロメチルベンゾイルアミノ)キノリンと2−
メルカプトイミダゾールから得た。
mp: 216-220℃
NMR(CDCl3,δ): 2.59(3H,s),6.97(2H,br s),7.55-
7.83(5H,m),8.22(1H,d,J=8Hz),8.60(1H,s),8.80(1H,d,
J=8Hz)実施例263
8−(2,6−ジクロロベンゾイルアミノ)−4−(4−ヒドロキシインドー
ル−1−イル)キノリンを、実施例8と同様にして、4−クロロ−8−(2,6
−ジクロロベンゾイルアミノ)キノリンと4−ヒドロキシインドールから得た。
mp: 289-290℃
NMR(DMSO-d6,δ): 6.12(1H,br s),6.58(1H,d,
J=5.5Hz),6.94(1H,d,J=7.5Hz),7.22(1H,t,J=7.5Hz),7.35
(1H,t,J=4.0Hz),7.43(1H,d,J=7.5Hz),7.51-7.60(3H,m),
7.74(1H,dd,J=8.0,8.0Hz),8.20(1H,d,J=8.0Hz),8.62(1H,
d,J=5.5Hz),8.82(1H,d,J=8.0Hz),10.73(1H,s),11.45(1H,
br s)
実施例264
(1) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチル
−4−[(2−メチルアミノエチル)アミノ]キノリンを、実施例8と同様にし
て、4,5−ジクロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチ
ルキノリンとN−メチルエチレンジアミンから得た。
mp: 127-129℃
NMR(DMSO-d6,δ): 2.40(3H,s),2.47(3H,s),2.84
(2H,t,J=6Hz),3.23(2H,dt,J=6,5Hz),6.56(1H,br t,
J=5Hz),7.27-7.40(3H,m),7.45(1H,d,J=8Hz),8.30(1H,s),
8.71(1H,d,J=8Hz),10.23(1H,s)
(2) 5−クロロ−8−(2,6−ジクロロベンゾイルアミノ)−3−メチル
−4−(3−メチル−2−オキソイミダゾリジン−1−イル)キノリンを実施例
92−(2)と同様にして得た。
mp: 280-292℃(分解)
NMR(DMSO-d6,δ): 2.38(3H,s),2.78(3H,s),
3.56-3.66(2H,m),3.70-3.80(2H,m),7.47-7.63(3H,m),7.77
(1H,d,J=8Hz),8.63(1H,d,J=8Hz),8.93(1H,s),10.89(1H,
s)DETAILED DESCRIPTION OF THE INVENTION
Heterocyclic compounds as H + -ATPase
Technical field
The present invention relates to novel heterocyclic compounds and pharmaceutically acceptable salts thereof.
I do.
More specifically, the present invention provides a vacuolar H+-Adenosine triphosphatase (H+
-ATPase), especially osteoclast H+-ATPase inhibitory activity and bone resorption inhibition
It has harmful activity and is therefore a human or animal drug as a bone resorption inhibitor or a bone metastasis inhibitor.
Complex useful for prevention and / or treatment of bone disease due to abnormal bone metabolism in food
It relates to cyclic compounds and pharmaceutically acceptable salts thereof.
Furthermore, the present invention provides a method for producing the above-mentioned compounds, and a pharmaceutical composition containing them.
A method for preventing and / or treating the above-mentioned diseases in humans or animals, and
In humans or animals, the compounds and pharmaceutically acceptable salts thereof described above.
The use for the prevention and / or treatment of the aforementioned diseases.
Background art
For example, in J.I. Chem. Soc. Pak. (1995), 17 (4), 23
2-6; Am. Chem. Soc. (1994), 116 (24), 110
14-19; or Chem. Pharm. Bull. (1990), 38 (1
0), 2841-6, some heterocyclic compounds are known.
Have been. However, if the compound is vacuolar H+-ATPase inhibitory activity
It is not known to have bone resorption inhibiting activity.
Disclosure of the invention
The object heterocyclic compound of the present invention is a novel compound represented by the following general formula [I]
[Wherein, R1Is a heterocyclic group or an aryl group, each of which is substituted with an appropriate substituent
May be
A is -CONH- or -NHCO-,
n is an integer of 0 or 1,
(Where RTwoIs hydrogen, halogen, lower alkyl group, lower alkoxy group or ha.
B (lower) alkyl group,
RThreeIs hydrogen, halogen, lower alkyl, lower alkoxy or halo (lower
Class) alkyl group,
RFourIs hydrogen, halogen, lower alkyl, lower alkoxy or halo (lower
Class) alkyl group,
X1Is O, S or NH,
Are respectively shown. ) Group,
(Where RFiveIs hydrogen or a lower alkyl group,
R8And R9Is a lower alkyl group,
R6Is hydrogen, halogen, cyano, amino, lower alkyl, substituted
Lower alkyl group, lower alkenyl group, substituted lower alkenyl group, lower alkyl
Nil group, substituted lower alkynyl group, lower alkylthio group, lower alkylsulfur
Finyl group, lower alkylsulfonyl group, heterocyclic thio group, acyl group, acylamido
A group, an aryl group, a substituted aryl group or a heterocyclic group,
R7Is hydrogen, halogen, lower alkyl group, substituted lower alkyl group, lower alkyl group.
Alkenyl, substituted lower alkenyl, azido, amino, substituted
Amino group, hydrazino group, substituted hydrazino group, semicarbazide group, substituted
Semicarbazide group, thiosemicarbazide group, substituted thiosemicarbazide group
, Hydroxy, substituted hydroxy, mercapto, substituted mercap
A group, an acyl group, or a substituted or unsubstituted heterocyclic group, or
R6And R7Together, the expression
(Where RTenIs hydrogen or a lower alkyl group,
R11Is a group consisting of hydrogen, an acyl group, or a heterocyclic group and lower alkoxy
A lower alkyl group optionally substituted with a substituent selected from
R12Is a hydroxy group,
R15Is O or NR16, Where R16Is hydrogen or an acyl group,
Are respectively shown. ) To form a group represented by
Are respectively shown. ) Group,
Respectively. Where R6And R7Are each hydrogen,
R1Is a 2,6-dichlorophenyl group]
Can be represented by
The target compound [I] or a salt thereof can be produced by various methods shown in the following reaction formulas.
Can beManufacturing method 1
Manufacturing method 2
Manufacturing method 3
Manufacturing method 4
Manufacturing method 5
Manufacturing method 6
[In each of the above formulas, R13Is a group consisting of hydrogen, or hydroxy and lower alkoxy
A lower alkyl group optionally substituted with a substituent selected from
R14Is hydrogen; an aryl group optionally substituted with halo (lower) alkyl
Or a member selected from the group consisting of hydroxy, lower alkoxy and heterocyclic groups
A lower alkyl group optionally substituted with a substituent; or
R13And R14Is optionally substituted with lower alkyl, together with the attached nitrogen atom.
Forming a heterocyclic group which may be
Q1Is a lower alkylene group,
A substituted or unsubstituted N-containing heterocyclic-N-yl group,
R17Is hydrogen or a lower alkyl group,
R18Is an acyl group,
R19Is hydrogen or a lower alkyl group,
QTwoIs a lower alkylene group,
XTwoIs O or S,
As defined above,
Are respectively shown. ]
In the above and following description of this specification, species included in the scope of the present invention
Preferred examples of each definition are described in detail below.
"Lower" means a group having 1 to 6 carbon atoms unless otherwise specified.
In this regard, the lower alkenyl or lower alkynyl moiety in various definitions
"Lower" in this context means a group having 2 to 6 carbon atoms.
In this connection, the lower alkenoyl, lower alkinoyl and various alkinoyl moieties in the various definitions
And "lower" in the cyclo (lower) alkyl moiety is from 3 to 6 carbon atoms
Means a group having
Suitable “heterocyclic group” and “heterocyclic (lower) alkyl”, “heterocyclic carbonyl”
, "Heterocyclic thio" and the like in this specification and in the claims.
All suitable heterocyclic moieties in are a nitrogen atom, an oxygen atom or a sulfur atom.
Saturated or unsaturated monocyclic or polycyclic having at least one heteroatom such as
Cyclic, more preferably N, O and / or S-containing heterocyclic groups
Can be, more preferably, morpholinyl, piperazinyl, pyridyl,
Dihydropyridyl, tetrahydropyridyl, pyrimidinyl, hexahydropyrim
Dinyl, piperidyl, thienyl, furyl, oxazolyl, oxazolidinyl, i
Soxazolyl, thiazolyl, thiazolinyl, oxadiazolyl, thiadiazol
, Triazolyl, tetrazolyl, imidazolyl, pyrrolidinyl, pyrrolyl, e
Xylanyl, tetrahydrofuryl, piperonyl, indolyl, quinolyl, isoki
Noryl, benzimidazolyl, benzimidazolidinyl, imidazolinyl, imi
Dazolidinyl, hirazolyl, pyrazolidinyl, imidazo [4,5-b] pyridyl
And the like.
With preferred aryl moieties in preferred "aryl" and "aryloxy"
Phenyl, naphthyl, fluorenyl, phenyl substituted with lower alkyl
[For example, tolyl, xylyl, mesityl, cumenyl, di (tert-butyl) phenyl
And the like, and more preferred are phenyl and na
Futyl and tolyl can be mentioned.
Suitable "halogens" include fluorine, chlorine, bromine and iodine
Can be.
Preferred "lower alkoxy" and "lower alkoxy (lower) alkyl"
Suitable lower alkoxy moieties include straight or branched ones, such as
Xy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, tertiary
Butoxy, pentyloxy, hexyloxy, and the like.
The best thing is C1-CFourAlkoxy, such as methoxy, ethoxy or
Isopropoxy can be mentioned.
Preferred "lower alkyl" and "heterocyclic (lower) alkyl", "hydroxy (
Lower) alkyl "," lower alkoxy (lower) alkyl "," lower alkylthio
"," Lower alkylsulfinyl "," lower alkylsulfonyl "," lower alkyl
In the various definitions set forth in this specification and claims, such as
All suitable lower alkyl moieties are straight or branched, e.g.
Methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl
, Pentyl, hexyl, etc., more preferably,
C1-CFourAlkyl, such as methyl, ethyl, propyl, isobutyl or tertiary
Grade butyl.
Suitable "lower alkenyl" includes vinyl, allyl, 1-propenyl, methyl
Lupropenyl, butenyl, pentenyl and the like can be mentioned.
Suitable "lower alkynyl" includes ethynyl, propynyl, butynyl, pen
Thinyl, hexynyl and the like can be mentioned.
Suitable “acyl” and “acylamino”, “acyl (lower) alkyl” and
Suitable acyl moieties in and acyloxy include lower alkanoyl [
For example, formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl
, Isovaleryl, pivaloyl, hexanoyl, 3,3-dimethylbutyryl, etc.]
, Hydroxy (lower) alkanoyl [eg glycoloyl, lactoyl, 3-
Hydroxypropionyl, hydroxybutyryl, 3-hydroxy-3-methyl
Rubutyryl etc.], lower alkanoyloxy (lower) alkanoyl [eg
Cetyloxyacetyl, acetyloxypropionyl, etc.], lower alkoxy (
Lower) alkanoyl [eg methoxyacetyl, methoxypropionyl, eth
Xyacetyl, etc.), lower alkanoylamino (lower) alkanoyl [eg
Acetylaminoacetyl, acetylaminopropionyl, etc.], lower alkyl
Mino (lower) alkanoyl [eg methylaminoacetyl, dimethylaminoa
Cetyl, dimethylaminopropionyl, etc.), halo (lower) alkanoyl
Chloroacetyl, trifluoroacetyl, etc.], carboxy (lower) alka
Noyl [eg carboxyacetyl, carboxypropionyl, carboxy
Tyryl, etc.], al (lower) alkanoyl [eg phenylacetyl, phenyl
Lepropionyl, etc.), heterocyclic (lower) alkanoyl [eg thienyl acetyl
, Imidazolylacetyl, pyridylacetyl, pyridylpropionyl, etc.],
Lower alkenoyl [eg acryloyl, methacryloyl, crotonoyl, i
Socrotonoyl etc.], al (lower) alkenoyl [eg cinnamoyl etc.
], Cyclo (lower) alkylcarbonyl [eg cyclopropylcarbonyl,
Cyclobutyl carbonyl, cyclopentyl carbonyl, cyclohexyl carbonyl
Carboxy, for example, lower alkoxycarbonyl [for example, methoxy
Carbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycal
Bonyl, butoxycarbonyl, isobutoxycarbonyl, tertiary butoxycarbo
, Benzyloxycarbonyl, hexyloxycarbonyl, etc.]
Tellurized carboxy, a heterocyclic carbonyl optionally substituted with a substituent
For example, floyl, thenoyl, pyridylcarbonyl, imidazolylcarbonyl,
Rufolinocarbonyl, piperidinocarbonyl, 1-methylimidazolylcarbony
4-Methyl-1-piperazinylcarbonyl, 4-ethyl-1-piperazinyl
Carbonyl, dimethylaminopiperidinocarbonyl, 4-methylcarbonyl-1
-Piperazinylcarbonyl, 4-acetyl-1-piperazinylcarbonyl, 4-
Phenyl-1-piperazinylcarbonyl, chlorothenoyl, 1,2,3,6-te
Trahydropyridyl carbonyl, pyrrolidinyl carbonyl, indolyl carbonyl
Aroyl which may be substituted with a substituent [eg benzoyl, naph
Toyl, methoxybenzoyl, dichlorobenzoyl, trifluoromethylbenzo
Yl, etc.], oxamoyl such as carbamoyl, lower alkylcarbamoyl
[For example, methylcarbamoyl, ethylcarbamoyl, propylcarbamoyl,
Isopropylcarbamoyl, butylcarbamoyl, isobutylcarbamoyl,
Tertiary butylcarbamoyl, pentylcarbamoyl, dimethylcarbamoyl, die
Tylcarbamoyl, N-ethyl-N-methylcarbamoyl, etc.), N- (lower
Lucoxy) -N- (lower alkyl) carbamoyl [eg N-methoxy-N-
Methylcarbamoyl, N-methoxy-N-ethylcarbamoyl, etc.], carboxy
Di (lower) alkylcarbamoyl [eg carboxymethylcarbamoyl,
Such as lower alkoxycarbonyl (lower alkoxycarbonyl).
) Alkylcarbamoyl [eg methoxycarbonylmethylcarbamoyl,
Ethoxycarbonylmethylcarbamoyl, ethoxycarbonylethylcarbamoyl
Carboxy (lower) alkyl carbamoyl, such as
Roxy (lower) alkylcarbamoyl [eg hydroxyethylcarbamoyl
, Hydroxypropylcarbamoyl, di (hydroxyethyl) carbamoyl, di
Hydroxypropylcarbamoyl, 1,1-dimethyl-2-hydroxyethylca
Rubamoyl, etc.), lower alkoxy (lower) alkyl carbamoyl [eg
Toxiethylcarbamoyl, methoxypropylcarbamoyl, di (methoxyethyl
L) carbamoyl, etc.), N- [lower alkoxy (lower) alkyl] -N- (low
Tert-alkyl) carbamoyl [eg N-methoxymethyl-N-methylcarbamo
Yl, N-methoxyethyl-N-methylcarbamoyl, N-methoxyethyl-N
-Ethylcarbamoyl, etc.], carbamoyl (lower) alkylcarbamoyl
For example, carbamoylmethylcarbamoyl, carbamoylethylcarbamoyl, etc.
], For example arylcarbamoyl [eg phenylcarbamoyl, tolylka
Rubamoyl, xylylcarbamoyl, naphthylcarbamoyl, ethylphenylca
Rubamoyl, etc.), halo (lower) alkylarylcarbamoyl [eg tri
Or unsubstituted aryl such as fluoromethylphenylcarbamoyl]
Carbamoyl, heterocyclic carbamoyl [eg pyridylcarbamoyl, imidazo
Rilcarbamoyl, pyrazolylcarbamoyl, etc.]
Class) alkylcarbamoyl [eg, pyridylmethylcarbamoyl, pyridyl
Tylcarbamoyl, oxadiazolylmethylcarbamoyl, furylmethylcarba
Moyl, thienylmethylcarbamoyl, tetrahydrofurylmethylcarbamoyl
, Piperonylmethylcarbamoyl, indolylethylcarbamoyl, imidazoly
And lower alkyl heterocyclic (lower) alkyl carbamoy
[For example, methylpyridylmethylcarbamoyl, methyloxadiazolylmethyl
Or a substituted or unsubstituted heterocyclic (lower) alkylcarbayl
Substituted or unsubstituted carbamoyl such as moyl, lower alkylsulfonyl
For example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, etc.], aryl
Rusulfonyl [eg phenyl, tolylsulfonyl, etc.], substituted with substituents
Optionally substituted heterocyclic sulfonyls [eg pyridylsulfonyl, thienylsulfonyl
Nyl, furylsulfonyl, thiazolylsulfonyl, 2-acetamido-4-methyl
Ru-5-thiazolylsulfonyl, etc.), ar (lower) alkylsulfonyl
Benzylsulfonyl, phenethylsulfonyl, etc.], al (lower) alkenyl
Rusulfonyl [eg styrylsulfonyl, cinnamylsulfonyl, etc.]
Can be mentioned.
Suitable "halo (lower) alkyl" include chloromethyl, bromomethyl, di
Chloromethyl, difluoromethyl, trifluoromethyl and the like can be mentioned.
You.
Suitable "lower alkylene" includes straight-chain or branched ones such as methyl
Len, ethylene, trimethylene, methylmethylene, tetramethylene, ethylethyl
Len, propylene, pentamethylene, hexamethylene and the like,
Most preferred is methylene.
Suitable "ar (lower) alkyl" include benzyl, phenethyl, benzhi
Drill, trityl, naphthylmethyl and the like can be mentioned.
R1`` Heterocyclic group or aryl group, each of which is substituted with a suitable substituent
May be a halogen; hydroxy; lower alkyl.
Lower alkyl; halo (lower) alkyl; nitro; lower alkyl or reed
(Optionally substituted with lower alkanoyl etc.)
R; aryl; acyl [more preferably carboxy, lower alkoxycarbonyl
, Lower alkylcarbamoyl, etc.]; optionally substituted with lower alkyl.
Heterocyclic groups; and more preferred are halogen,
Name lower alkyl, lower alkoxy, halo (lower) alkyl or nitro.
Can be. Preferably, R1“Heterocyclic group or aryl group” is one or more of the above
Or two substituents. R1Is phenyl, these substituents
Preferred positions include positions 2 and / or 6 of the phenyl group.
it can.
Suitable substituents for lower alkyl of "substituted lower alkyl" include aryl
, Nitro, halogen, cyano, hydroxy, lower alkoxy, lower alkyl
E, aryloxy, acyloxy, acyl, hydroxyimino, amino, lower
Alkylamino, N- [lower alkoxy (lower) alkyl] -N- (lower alkyl
L) amino, N- [hydroxy (lower) alkyl] -N- (lower alkyl) ami
And substituted or unsubstituted heterocyclic groups, heterocyclic thio, and the like.
Suitable substituents for lower alkenyl of "substituted lower alkenyl" include
And sill.
Suitable substituents for lower alkynyl of "substituted lower alkynyl" include
Examples include secondary alkyl, hydroxy, and heterocyclic groups.
Suitable substituents for aryl of "substituted aryl" include amino, acyl
Examples include amino, lower alkoxy, and heterocyclic groups.
Suitable substituents for amino of "substituted amino" include lower alkyl, alky
(Lower) alkyl, hydroxy (lower) alkyl, lower alkoxy (lower) al
Kill, amino (lower) alkyl, lower alkylamino (lower) alkyl, heterocycle
(Lower) alkyl, lower alkoxy, aryl, substituted aryl, N-acy
Ru-N- (lower alkyl) amino (lower) alkyl, acyl, substituted or unsubstituted
And the like.
Suitable substituents for hydroxy of "substituted hydroxy" include lower alkyl
, Lower alkoxy (lower) alkyl, ar (lower) alkyl, heterocyclic (lower)
Alkyl, acyl (lower) alkyl, lower alkenyl, aryl, substituted
Reel, acyl, alk (lower) alkenyl [eg styryl, cinnamyl, etc.
], Substituted or unsubstituted heterocyclic groups, aryloxy (lower) alkyl [eg
Phenoxymethyl, phenoxyethyl, etc.], phthalimide (lower) alkyl [
For example, phthalimidomethyl].
Preferred substituents for mercapto in “substituted mercapto” include acyl (lower
Class) alkyl and substituted or unsubstituted heterocyclic groups.
“Substituted or unsubstituted heterocyclic group” or “substituted or unsubstituted N-containing heterocyclic ring”
-N-yl group "as a suitable substituent of the heterocyclic group, halogen, lower alkyl,
Lower alkylamino (lower) alkyl, lower alkylthio, oxo, thioxo,
Examples include hydroxy, aryl, ar (lower) alkyl, and heterocyclic groups.
Wear.
Suitable substituents for hydrazino in "substituted hydrazino" include lower alkyl
, Lower alkylidene [such as isopropylidene], hydroxy (lower)
Alkyl, lower alkoxy (lower) alkyl, acyl and the like.
.
`` Substituted semicarbazide '' or `` substituted thiosemicarbazide ''
Preferred substituents for micarbazide or thiosemicarbazide include lower alkyl
, Aryl and the like.
R13, R14And a suitable "heterocyclic group" formed by a bonded nitrogen atom
, Morpholino, thiomorpholino, pyrrolidin-1-yl, piperidino, 1,2,2
Includes 3,6-tetrahydropyridin-1-yl, piperazin-1-yl and the like
be able to.
Suitable “N-containing heterocyclic-N-yl group” include morpholino, thiomorpholin
, Pyrrolidin-1-yl, piperidino, 1,2,3,6-tetrahydropyridi
1-yl, piperazin-1-yl, imidazol-1-yl, imidazoline
-1-yl, imidazolidine-1-yl, benzimidazol-1-yl, ben
Zimidazolidin-1-yl, pyrazol-1-yl, pyrazolidin-1-yl
, Hexahydropyrimidin-1-yl and the like.
Suitable pharmaceutically acceptable salts of the target compound [I] are conventional non-toxic salts.
And metal salts such as alkali metal salts [eg sodium salt, potassium salt
Etc.] and alkaline earth metal salts [eg, calcium salts, magnesium salts, etc.]
, Ammonium salts, organic base salts [eg, trimethylamine salts, triethylamido salts
Salt, pyridine salt, picoline salt, dicyclohexylamine salt, N, N'-diben
Zirethylenediamine salt, etc.), organic acid addition salts [formate, acetate, tri
Fluoroacetate, maleate, tartrate, oxalate, methanesulfonate,
Benzenesulfonate, toluenesulfonate, etc.], inorganic acid addition salts [eg
Hydrochloride, hydrobromide, sulfate, phosphate, etc.], salts with amino acids [eg,
Ginine salt, aspartate, glutamate etc.]
Can be.
Regarding the salts of Compounds [Ia] to [Ij] in Production Methods 1 to 6,
Since these compounds fall within the scope of compound [I], salts of these compounds are preferred.
Suitable examples include the same as those described for the target compound [I].
.
Preferred specific examples of the target compound [I] include the following.
You.
R1Is a heterocyclic group or an aryl group, each of which is halogen, lower alkyl, lower
Alkoxy, imidazolyl optionally substituted with lower alkyl, hydro
From xy, nitro, amino, acylamino, halo (lower) alkyl and acyl
Substituted with a substituent selected from the group consisting of
Phenyl substituted with a logen, phenyl substituted with a nitro, halo (lower)
Phenyl substituted by kill and pyridyl substituted by one or two halogens
Le],
n is an integer of 0 or 1,
A is -CONH- or -NHCO-,
[Wherein, RTwoIs hydrogen, halogen, lower alkyl, lower alkoxy or halo
(Lower) alkyl groups,
RThreeIs hydrogen, halogen, lower alkyl, lower alkoxy or halo (lower
) Alkyl groups,
RFourIs hydrogen, halogen, lower alkyl, lower alkoxy or halo (lower
) Alkyl groups,
RFiveIs hydrogen or a lower alkyl group,
Lower alkyl groups [more preferably aryl, nitro, halogen, hydroxy,
Lower alkoxy, lower alkylthio, aryloxy, acyloxy (for example,
Lower alkanoyloxy, lower alkylcarbamoyloxy, etc.)
For example, carboxy, lower alkoxycarbonyl, carbamoyl, lower alkyl
Rubamoyl, etc.), hydroxyimino, heterocyclic groups (eg imidazolyl, benzene
Diimidazolyl, morpholinyl, etc.) and heterocyclic thio groups (for example, imidazolyl
Lower thio substituted with a substituent selected from the group consisting of
Alkyl group], a lower alkenyl group, a substituted lower alkenyl group [more preferably
, Acyl (eg carboxy, lower alkoxycarbonyl, carbamoyl, low
Alkenyl group substituted with lower alkylcarbamoyl, etc.), lower alkynyl
Or a substituted lower alkynyl group [more preferably, a lower alkyl,
And a substituent selected from the group consisting of
Lower alkynyl group], lower alkylthio group, lower alkylsulfinyl
Group, lower alkylsulfonyl group, heterocyclic thio group
For example, pyridylthio), an acyl group [more preferably, a lower alkanoyl,
Ruboxy, lower alkoxycarbonyl, carbamoyl, lower alkylcarbamoy
, N- (lower alkoxy) -N- (lower alkyl) carbamoyl or heterocycle
Carbonyl (eg, morpholinocarbonyl, piperidinocarbonyl, etc.)],
Acylamino group [more preferably, lower alkanoylamino or lower alkoxy]
Cyclocarbonylamino], an aryl group, a substituted aryl group [more preferably,
Aryl group substituted with amino] or heterocyclic group [more preferably pyridyl]
,
Preferably, halogen, cyano, hydroxy, lower alkoxy, acyloxy (
Lower alkanoyloxy, etc.), acyl (eg, carboxy, lower
Alkoxycarbonyl, carbamoyl, lower alkylcarbamoyl, heterocyclic (lower
) Alkylcarbamoyl (eg pyridyl (lower) alkylcarbamoyl
), Hydroxy (lower) alkylcarbamoyl, N- [lower alkoxy (lower)
Alkyl] -N- (lower alkyl) carbamoyl, substituted or unsubstituted aryl
Carbamoyl (eg, phenylcarbamoyl, halo (lower) alkylphenyl
Carbamoyl, etc.), substituted or unsubstituted heterocyclic carbonyl (eg,
Carbonyl, piperidinocarbonyl, lower alkylpiperazinylcarbonyl
)), Amino, lower alkylamino, N- [lower alkoxy (lower)
Kill] -N- (lower alkyl) amino, N- [hydroxy (lower) alkyl]-
N- (lower alkyl) amino, a substituted or unsubstituted heterocyclic group (for example, lower
Imidazo optionally substituted with kill, lower alkylthio or phenyl
Lil; benzimidazolyl; morpholinyl; pyridyl; optionally substituted with lower alkyl
Optionally substituted imidazolinyl; optionally with lower alkyl and / or oxo
And an optionally substituted imidazolidinyl; and the like; and a heterocyclic thio (eg,
Substituted with a substituent selected from the group consisting of imidazolylthio, pyridylthio, etc.
Lower alkyl groups], lower alkenyl groups, substituted lower alkenyl groups [more
Preferably, acyl (eg, carboxy, lower alkoxycarbonyl, carb
Moyl, lower alkyl carb
Lower alkenyl group substituted with moyl, etc.), azido group, amino group,
Amino group [more preferably, lower alkyl, lower alkoxy, lower alkoxy
(Lower) alkyl, hydroxy (lower) alkyl, ar (lower) alkyl (
Benzyl, phenethyl, etc.), amino (lower) alkyl, lower alkylamido
(Lower) alkyl, heterocyclic (lower) alkyl (eg, pyridyl (lower) alkyl
Kill, etc.), aryl (eg, phenyl, tolyl, etc.), substituted aryl
(Eg, phenyl substituted with amino, pyridylcarbonylamino
Phenyl), N-acyl-N- (lower alkyl) amino (lower) alkyl
(For example, N-pyridylcarbonyl-N- (lower alkyl) amino (lower)
Kill, N-imidazolylcarbonyl-N- (lower alkyl) amino (lower) alkyl
N-pyridylcarbamoyl-N- (lower alkyl) amino (lower) alkyl
Acyl) (eg, lower alkanoyl, etc.) and substituted or unsubstituted
Heterocyclic groups (e.g., pyrazolyl, imidazolyl, triazolyl, morpholino,
Piperazinyl optionally substituted with tertiary alkyl, optionally substituted with oxo
Oxazolidinyl which may be optionally substituted with oxo
Amino group substituted with a substituent selected from the group consisting of
And a substituted hydrazino group [more preferably, a lower alkyl, a lower alkyl
Den, hydroxy (lower) alkyl, lower alkoxy (lower) alkyl and
Sil (eg, lower alkanoyl, halo (lower) alkanoyl, cyclo (lower)
Alkylcarbonyl, carboxy, lower alkoxycarbonyl, carboxy (low
Grade) alkanoyl, hydroxy (lower) alkanoyl, lower alkanoyloxy
(Lower) alkanoyl, lower alkoxy (lower) alkanoyl, lower alkanoy
Ruamino (lower) alkanoyl, lower alkylamino (lower) alkanoyl, e
Kisamoyl, lower alkenoyl, lower alkylsulfonyl, arylsulfonyl
, Thienylsulfonyl, thiazolylsulfonyl, wherein the thiazolylsulfonyl is lower
Optionally substituted with alkyl and / or lower alkanoylamino
, Al (lower) alkylsulfonyl, al (lower) alkenylsulfonyl, allo
And the aroyl is optionally substituted with lower alkoxy or halo (lower) alkyl.
May be
Al (lower) alkenoyl, thienyl (lower) alkanoyl, imidazolyl (low
Class) alkanoyl, pyridyl (lower) alkanoyl, thienylcarbonyl, fluoro
Imyl, imidazolylcarbonyl optionally substituted with lower alkyl,
Hydrazino substituted with a substituent selected from the group consisting of
Group], semicarbazide group, substituted semicarbazide group [more preferably, lower
Semicarbazide group substituted with alkyl or phenyl], thiosemicarbazide
Group, substituted thiosemicarbazide group [more preferably, lower alkyl or
Thiosemicarbazide group substituted with phenyl], hydroxy group, substituted hydro
A xy group [more preferably a lower alkyl, a lower alkoxy (lower) alkyl,
(Lower) alkyl, heterocyclic (lower) alkyl (for example, furyl (lower) alkyl
, Pyridyl (lower) alkyl, benzimidazolyl (lower) alkyl, etc.),
Acyl (lower) alkyl (eg, carboxy (lower) alkyl, lower alkoxy
Cicarbonyl (lower) alkyl, carbamoyl (lower) alkyl, lower alkyl
Carbamoyl (lower) alkyl, etc.), lower alkenyl, aryl, substituted
Aryl (eg phenyl substituted by lower alkoxy, substituted by imidazolyl
Phenyl), acyl (such as dichlorobenzoyl), al (lower)
Alkenyl (eg styryl, cinnamyl, etc.), substituted or unsubstituted heterocycle
Groups (eg, pyridyl, benzimidazolyl, pyridyl substituted with halogen,
Pyridyl substituted with lower alkyl, substituted with lower alkylamino (lower) alkyl
Substituted pyridyl, etc.), aryloxy (lower) alkyl and phthalimide
A hydroxy group substituted with a substituent selected from the group consisting of (lower) alkyl],
Mercapto group, substituted mercapto group [more preferably, acyl (lower)
(E.g., carboxy (lower) alkyl, lower alkoxycarbonyl (lower)
) Alkyl, carbamoyl (lower) alkyl, lower alkylcarbamoyl (lower)
) Alkyl, heterocyclic (lower) alkylcarbamoyl (lower) alkyl (eg,
Pyridyl (lower) alkylcarbamoyl (lower) alkyl, etc.)
Substituted or unsubstituted heterocyclic groups (eg, imidazolyl, pyridyl, lower alkyl
Midazolyl, imidazo [4,5-b] pyridyl, pyrimidinyl, benzimidazo
Lil,
Thiazolyl, thiazolinyl, thiazi optionally substituted with lower alkyl
Azolyl, tetrazolyl optionally substituted with lower alkyl, lower alkyl
Selected from the group consisting of triazolyl optionally substituted with a kill)
A mercapto group substituted with a substituent], an acyl group [more preferably a lower alkano
Yl, carboxy, lower alkoxycarbonyl, carbamoyl or lower alkyl
Rucarbamoyl] or a substituted or unsubstituted heterocyclic group [more preferably, a lower
Imidazo optionally substituted with alkyl or lower alkylcarbamoyl
Lil; benzimidazolyl optionally substituted by pyridyl; optional by oxo
Optionally substituted dihydropyridyl; morpholino; piperidino;
Piperazinyl optionally substituted with alkyl; optionally substituted with hydroxy
Optionally substituted pyrazolyl; indoli optionally substituted with hydroxy
Triazolyl; lower alkyl, ar (lower) alkyl, oxo and / or
Is imidazolidinyl optionally substituted with thioxo; lower alkyl, a
Optionally substituted with a (lower) alkyl, oxo and / or thioxo
Good hexahydropyrimidinyl; lower alkyl, ar (lower) alkyl, oxo
And / or benzimidazolidinyl optionally substituted with thioxo
Or lower alkyl, ar (lower) alkyl, oxo and / or thioxo
Pyrazolidinyl optionally substituted with
R8Is a lower alkyl group,
R9Is a lower alkyl group,
RTenIs hydrogen or a lower alkyl group,
R11Is hydrogen, an acyl group [more preferably, lower alkanoyl or lower alcohol
Xycarbonyl], or a heterocyclic group (eg, pyridyl) and a lower alcohol
Lower alkyl optionally substituted with a substituent selected from the group consisting of xy
Group,
R12Is a hydroxy group,
R15Is O or NR16, Where R16Is hydrogen or an acyl group (more preferably
Lower alkanoyl),
X1Is O, S or NH,
Are respectively shown. A group represented by
It is.
The method for producing the target compound [I] will be described in detail below.Manufacturing method 1
The target compound [Ia] or a salt thereof is a compound [II] or an amino group.
The reactive derivative or its salt is added to the compound [III] or the carboxy group.
Or a reactive derivative thereof or a salt thereof.
You.
Suitable reactive derivatives at the amino group of compound [II] include compounds [II]
Bis (trimethylsilyl) acetamide or mono (trimethylsilyl) acetate
It may be a silyl derivative formed by reacting with an amide or the like.
Suitable salts of compound [II] and its reactive derivative include compounds [I]
The same ones as shown can be mentioned.
Suitable reactive derivatives at the carboxy group of compound [III] include acids
Examples thereof include a logenide, an acid anhydride, an active amide, and an active ester.
Preferred examples of the reactive derivative include acid chloride; acid azide; dialkyl phosphoric acid, sulfuric acid.
Mixed anhydrides with acids such as acids, aliphatic carboxylic acids or aromatic carboxylic acids; symmetric
Acid anhydrides; active amides with imidazole; or active esters [e.g.
Trophenyl ester]. These reactive derivatives are
It can be arbitrarily selected depending on the type of the compound [III] used.
Suitable salts of compound [III] and its reactive derivative include compound [I]
The same ones as shown in can be mentioned.
This reaction usually involves methylene chloride, chloroform, ethylene chloride, pyridine,
Conventional dioxane, tetrahydrofuran, N, N-dimethylformamide and the like
Performed in a solvent. When compound [III] is used in the form of a free acid or salt
This reaction is carried out using a conventional condensing agent such as N, N'-dicyclohexylcarbodiimide.
It is preferred to be carried out in the presence of
The reaction temperature is not particularly limited, and the reaction is performed under cooling, at room temperature, or under heating.
This reaction can be carried out in the presence of a conventional inorganic base or a conventional organic base.
preferable.Manufacturing method 2
The target compound [Ib] or a salt thereof is added to the compound [IV] or a carboxy group.
The reactive derivative thereof or a salt thereof at the compound [V] or the amino group.
By reacting with a reactive derivative or a salt thereof.
Suitable salts of compounds [IV] and [V] and their reactive derivatives include
And the same compounds as those described for compound [I].
This reaction isManufacturing method 1The reaction is carried out in substantially the same manner as
And the reaction conditionsManufacturing method 1May be referred to.Manufacturing method 3
The target compound [Id] or a salt thereof is added to the compound [Ic] or the carboxy group.
Or a salt thereof at the compound [VI] or at the amino group
It can be produced by reacting with its reactive derivative or its salt
.
Suitable salts of compound [VI] and its reactive derivative include compounds [I]
The same ones as shown can be mentioned.
This reaction isManufacturing method 1The reaction is carried out in substantially the same manner as
And the reaction conditionsManufacturing method 1May be referred to.Manufacturing method 4
The target compound [If] or a salt thereof is the same as the compound [Ie] or a salt thereof,
VII] or a salt thereof.
Suitable salts of compound [VII] include the same as those shown for compound [I].
Can be mentioned.
This reaction is usually carried out in tetrahydrofuran, dioxane, N, N-dimethylforme.
It is carried out in a conventional solvent such as muamide, N-methylpyrrolidone.
The reaction temperature is not particularly limited, and the reaction is usually performed under heating or heating.Manufacturing method 5
The target compound [Ih] or a salt thereof is obtained by acylating the compound [Ig] or a salt thereof.
It can be manufactured by doing.
Acylation is performed in the presence of an acylating agent.
Suitable acylating agents include those of the formula R18-OH (wherein, R18Represents an acyl group. )
Carboxylic acid or sulfonic acid compounds represented by
And the corresponding isocyanic or isothiocyanic acid compounds
.
Suitable reactive derivatives include acid halides, acid anhydrides, active amides and the like.
And active esters. Suitable examples include acid chlorides and acids
Acid halides such as bromide, various acids [eg, dialkyl phosphoric acid
Such substituted phosphoric acid, sulfuric acid, aliphatic carboxylic acid, aromatic carboxylic acid, etc.]
Mixed anhydrides, symmetric anhydrides, active amides with various imidazoles, and p-
Activities such as nitrophenyl ester and N-hydroxysuccinimide ester
Sex esters. This type of reactive derivative is based on the acyl group to be introduced.
Can be selected according to the type.
This reaction usually involves methylene chloride, chloroform, pyridine, dioxane,
The reaction is carried out in a conventional solvent such as trahydrofuran, N, N-dimethylformamide.
You. If the acylating agent is a liquid, it can also be used as a solvent. Carvone
An acid or sulfonic acid compound is used as the acylating agent in the form of the free acid or salt.
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide,
Reaction in the presence of a conventional condensing agent such as N, N'-dicyclohexylcarbodiimide
Is preferably performed.
The reaction temperature is not particularly limited, and the reaction is performed under cooling, at room temperature, or under heating.
This reaction is preferably carried out in the presence of a conventional inorganic base or a conventional organic base.
Good.Manufacturing method 6
The target compound [Ij] is obtained by converting the compound [Ii] or a salt thereof to a carbonyl group or a thiol group.
It can be produced by subjecting to an introduction reaction of an ocarbonyl group.
This reaction involves a reagent that introduces a carbonyl or thiocarbonyl group, for example,
Phosgene, haloformic acid compounds [for example, ethyl chloroformate, trichlorochloroformate
Methyl, etc.], 1,1'-carbonyldiimidazole, 1,1'-thiocarboni
The reaction is performed in the presence of ludiimidazole or the like.
This reaction is usually performed, for example, with dioxane, tetrahydrofuran, benzene,
Ruene, chloroform, methylene chloride, N, N-dimethylformamide or
The reaction is performed in another organic solvent that does not adversely affect the reaction.
The reaction temperature is not particularly limited, and is usually performed under cooling or heating.
The target compound [I] and the starting compound were prepared according to the following Production Examples and Examples.
It can also be produced by a similar method or a conventional method.
The compound obtained according to the above-mentioned production method is crushed, recrystallized,
It can be separated and purified by a conventional method such as reprecipitation.
Compound [I] and other compounds include those based on asymmetric carbon atoms and double bonds.
One or more isomers and geometric isomers may exist,
All of the isomers and mixtures thereof are also included in the scope of the present invention.
The compound of formula [I] and salts thereof may be solvates, which are also
Of the invention. Preferred solvates include hydrates and ethanolate
Can be mentioned.
The target compound [I] and a pharmaceutically acceptable salt thereof are vacuolar H+-ATP
ase, especially osteoclast H+-Has ATPase inhibitory activity and bone resorption inhibitory activity
Therefore, as a bone resorption inhibitor or bone metastasis inhibitor in humans or animals
Bone diseases due to abnormal bone metabolism, such as osteoporosis (particularly postmenopausal osteoporosis);
Hyperparathyroidism; Paget's disease; Osteolysis; with or without bone metastasis
Malignant hypercalcemia without rheumatoid arthritis; periodontitis; osteoarthritis; bone
Pain; osteopenia; cancer cachexia; useful for the prevention and / or treatment of malignant tumors
It is.
Further, the target compound [I] of the present invention and a pharmaceutically acceptable salt thereof are as follows:
For tumors in humans or animals, especially renal, melanoma, colorectal, lung and leukemia
Tumors involved; viral symptoms (eg Semliki fever, vesicular stomatitis, new
Those associated with Castle disease, influenza A and B, HIV virus);
Ulcers (eg, chronic gastritis, peptic ulcers induced by Helicobacter pylori);
Autoimmune disease; organ transplantation; hypercholesterolemia and atherosclerotic disease;
Alzheimer's disease; vascular causes such as diabetic retinopathy, psoriasis and solid tumors
Useful in the prevention and / or treatment of diseases such as
It is expected to be useful in regulating male fertility in animals.
In order to show the usefulness of the target compound [I], some representatives of the compound [I] were used.
Pharmacological test data of the compound are shown below.Test 1
(Vacuum type H+-Inhibition of ATPase proton transport)Test method
(A) Preparation of microsomes from mouse peritoneal macrophages
Intraperitoneal injection of 2 ml of 3% thioglycolate medium into 7 week old male ddy mice
did. After 3 to 5 days, the mice are decapitated and treated with 5 to 6 ml of Hanks' solution (HBSS).
Peritoneal washing was performed to obtain peritoneal macrophages. Cells were washed twice with cold HBSS.
The vesicles were prepared from the cells and 10 ml of 250 ml were prepared using a Dounce homogenizer.
mM sucrose, 5 mM Tris, 1 mM EGTA, 1 mM KHCOThreeAnd 1 mM di
Homogenized 20 times in a thiotreitol (pH 7.0 at 4 ° C.). First centrifuge
After separation (5 minutes at 1000 × g), the supernatant is centrifuged (15 minutes at 6000 × g).
To remove mitochondria and lysosomes. Supernatant at 42000xg
The microsomal pellet was collected by centrifugation for 30 minutes and stored at -80 ° C.
(B) Measurement of proton transport
Proton transport was performed using 150 mM KCl, 10 mM bis-trispropane, 2 m
MMgClTwo, 10 mM acridine orange, 1 mM valinomycin, 10 mg
/ Ml oligomycin and test compound (concentration: 1x10-6Reaction buffer containing M)
Acridine using an aliquot of membrane vesicles suspended in 300 ml of liquid (pH 7.0)
Dual-wavelength spectrophotometer (reference wavelength 540 nm, measurement of orange uptake)
At a wavelength of 492 nm) [H. C. Blair, J .; C
ell. Biol. , 102, 1164 (1986)]. The reaction was 1 mM ATP
Was started by the addition of The results were expressed as percentage inhibition relative to controls.Test results
Test 2 (Bone tissue culture)Test method
The calvaria was excised from Wistar rats and the test compound (concentration: 1 × 10-6M)
In the presence of 10% fetal calf serum and 10%-8M human parathyroid hormone fragments (1-3
4) 12-well culture containing 2 ml of Dulbecco's modified essential medium supplemented with [PTH]
Cultured in the wells of the dish. No PTH was added to control wells. Control and
The PTH control was exposed to an equal concentration of the medium. Six days later, calcium ([Ca] in the medium)
) The concentration was measured by the methyl xylenol blue method, and the inhibition rate of PTH-induced bone resorption was determined as follows.
It was calculated by the following equation.
CP: [Ca] of PTH control well
CD: [Ca] of test compound well
CO: [Ca] of control wellTest results
For treatment, compounds [I] of the present invention and pharmaceutically acceptable salts thereof
Orally, using one of the above compounds as an active ingredient; intravenously, intramuscularly, subcutaneously or
Is parenteral administration such as intra-articular administration; external application such as transdermal, enteral, rectal, vaginal, inhalation
Organic or inorganic solid, semi-solid or liquid suitable for intraocular, intranasal or sublingual administration
Used in the form of pharmaceutical preparations containing pharmaceutically acceptable carriers such as excipients
be able to. The pharmaceutical preparations include capsules, tablets, sugars, granules, suppositories, solutions,
Lotions, suspensions, emulsions, ointments, gels, creams and the like may be used. Must
If necessary, the above preparations may contain auxiliary agents, stabilizers, wetting or emulsifying agents, buffers and
Other common additives may be included.
The dose of Compound [I] will vary with the age and symptoms of the patient, but Compound [I]
0.1 mg, 1 mg, 10 mg, 50 mg, 100 mg, 25
0 mg, 500 mg and 1000 mg are effective in preventing and / or treating the aforementioned diseases.
It is effective for medical treatment. Generally, a dose in the range of 0.1 mg to about 1000 mg per day
The perimeter dose may be administered per person.
Example
The following Production Examples and Examples are provided to illustrate the invention.Production Example 1
8-Nitro-4-methylquinoline (250 mg), ferric chloride hexahydrate (7.
18 mg) and activated carbon (38 mg) in a stirred mixture in methanol were added with hydrazine-
Hydrate (266 mg) was added at 65 ° C., and the mixture was stirred at the same temperature for 1 hour. Insoluble matter
Was filtered off and the filtrate was concentrated in vacuo. Dissolve the mixture in ethyl acetate and wash with brine
After drying with magnesium sulfate, the solvent was distilled off in vacuo to give 8-amino-4-
Methylquinoline (208.8 mg) was obtained.
mp: 76-77 ℃
NMR (CDClThree, δ): 2.65 (3H, s), 4.99 (2H, br s), 6.92
(1H, d, J = 8Hz), 7.20 (1H, d, J = 4Hz), 7.25-7.50 (2H, m), 8.62
(1H, d, J = 4Hz)Production Example 2
(1) 3-acetyl-1,4-dihydro-8-nitro-4-oxoquinoline (
(500 mg) and phosphoryl chloride was heated at 115 ° C. for 15 minutes. After cooling
The mixture was poured into ice water and extracted with ethyl acetate. Organic layer saturated sodium bicarbonate
After washing with a solution and brine, drying over magnesium sulfate, the solvent was distilled off in vacuo,
3-Acetyl-4-chloro-8-nitroquinoline (485 mg) was obtained.
NMR (CDClThree, δ): 2.80 (3H, s), 7.81 (1H, t, J = 8Hz),
8.15 (1H, d, J = 8Hz), 8.61 (1H, d, J = 8Hz), 9.08 (1H, s)
(2) Diacetyl of 3-acetyl-4-chloro-8-nitroquinoline (339 mg)
A solution of 28% sodium methoxide in methanol (0.5%
(2 mg) was added under ice cooling, and the mixture was stirred at room temperature for 30 minutes. The mixture is treated with ethyl acetate
Diluted with water, washed with water and brine, dried over magnesium sulfate, and evaporated in vacuo.
Distilled off. The residue was subjected to silica gel column chromatography (ethyl acetate: n-
Xane, 2: 3, v / v) to give 3-acetyl-4-methoxy-8-nitro
Roquinoline (239.3 mg) was obtained.
mp: 100-105 ℃
NMR (CDClThree, δ): 2.77 (3H, s), 4.13 (3H, s), 7.68
(1H, t, J = 8Hz), 8.11 (1H, d, J = 8Hz), 8.48 (1H, d, J = 8Hz), 9.18
(1H, s)
(3) 3-acetyl-4-methoxy-8-nitroquinoline (230 mg), salt
Ammonium (30 mg) and iron (313 mg) in ethanol (3 ml) and water (
(0.8 ml) was refluxed for 2 hours. The insoluble material is removed by filtration, and the filtrate is concentrated in vacuo.
Shrunk. The residue was dissolved in ethyl acetate, and the solution was added with saturated sodium bicarbonate solution and brine.
After washing with water and drying over magnesium sulfate, the solvent is distilled off in vacuo to give 3-acetyl
Ru-8-amino-4-methoxyquinoline (175.7 mg) was obtained.
mp: 76-77 ℃
NMR (CDClThree, δ): 2.76 (3H, s), 4.07 (3H, s), 5.01
(2H, br s), 7.00 (1H, d, J = 8Hz), 7.38 (1H, t, J = 8Hz), 7.49
(1H, d, J = 8Hz), 8.95 (1H, s)Production Example 3
4-Chloro-3-ethoxycarbonyl-8-nitroquinoline was prepared according to Production Example 2- (
In the same manner as in 1), 3-ethoxycarbonyl-1,4-dihydro-8-nitro-
Obtained from 4-oxoquinoline.
mp: 81-83 ℃
NMR (CDClThree, δ): 1.47 (3H, t, J = 7Hz), 4.52 (2H, q,
J = 7Hz), 7.80 (1H, t, J = 8Hz), 8.14 (1H, d, J = 8Hz), 8.65 (1H, d,
J = 8Hz), 9.33 (1H, s)Production Example 4
4-ethoxy-3-ethoxycarbonyl-8-nitroquinoline was prepared according to Production Example 2-
In the same manner as in (2), 4-chloro-3-ethoxycarbonyl-8-nitroquinolyl
And sodium ethoxide.
NMR (CDClThree, δ): 1.45 (3H, t, J = 7 Hz), 1.55 (3H, t,
J = 7Hz), 4.39 (2H, q, J = 7Hz), 4.48 (2H, q, J = 7Hz), 7.65 (1H, t,
J = 8Hz), 8.10 (1H, d, J = 8Hz), 8.51 (1H, d, J = 8Hz), 9.27 (1H, s)Production Example 5
4-chloro-3-ethoxycarbonyl-8-nitroquinoline (199 mg),
Of dimethylamine hydrochloride (63.6 mg) and triethylamine (78.9 mg)
The mixture in dioxane was refluxed for 3 hours. After cooling, the mixture was diluted with ethyl acetate
After washing with water and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Silica gel column chromatography (ethyl acetate: n-hexane, 1: 2, v
/ V) to give 4-dimethylamino-3-ethoxycarbonyl-8-nitro
Quinoline (122 mg) was obtained.
mp: 76-77 ℃
NMR (CDClThree, δ): 1.43 (3H, t, J = 7Hz), 3.14 (6H, s),
4.45 (2H, q, J = 7Hz), 7.55 (1H, d, J = 8Hz), 7.97 (1H, t, J = 8Hz),
8.35 (1H, d, J = 8Hz), 8.99 (1H, s)Production Example 6
(1) The dime of 1,4-dihydro-4-oxo-8-nitroquinoline (10 g)
To the stirred mixture in tilformamide (100 ml) was added N-bromosuccinimide
(9.83 g) was added dropwise over 2 minutes under ice cooling, and the mixture was stirred at 4 ° C. for 30 minutes.
Was. Water was added thereto under ice cooling, and the mixture was stirred for 1 hour. The resulting precipitate is filtered
And the residue was washed with water and hot ethanol to give 3-bromo-1,4-diphenyl.
Dro-8-nitro-4-oxoquinoline (12.12 g) was obtained.
mp: 279-282 ℃
NMR (DMSO-d6, δ): 7.57 (1H, t, J = 7.5 Hz), 8.34 (1H,
s), 8.60 (1H, d, J = 7.5Hz), 8.68 (1H, d, J = 7.5Hz)
(2) 3-bromo-4-chloro-8-nitroquinoline was prepared in the same manner as in Production Example 2- (1).
Obtained in a similar manner.
mp: 135-136 ℃
NMR (CDClThree, δ): 7.76 (1H, t, J = 7.5 Hz), 8.09 (1H, d,
J = 7.5Hz), 8.49 (1H, d, J = 7.5Hz), 9.07 (1H, s)Production Example 7
(1) In a mixture of diethyl malonate (368 mg) and N-methylpyrrolidone,
Potassium tert-butoxide (246 mg) was added at 0 ° C., and the mixture was stirred at room temperature for 30 minutes.
While stirring. The mixture was added to 3-bromo-4-chloro-8-nitroquinoline (300 m
g) was added and the mixture was stirred at room temperature for 30 minutes and at 50 ° C. for 30 minutes. Satiate the mixture
The solution was poured into a solution of ammonium chloride and extracted with ethyl acetate. Organic layer with water and saline
After washing and drying over magnesium sulfate, the solvent is distilled off in vacuo to give 4- [bis (d
Toxicarbonyl) methyl] -3-bromo-8-nitroquinoline (315.6 m
g) was obtained.
mp: 94-95 ℃
NMR (CDClThree, δ): 1.23 (6H, t, J = 7Hz), 4.15-4.35 (4H,
m), 5.79 (1H, s), 7,65 (1H, t, J = 8Hz), 8.00 (1H, d, J = 8Hz),
8.25 (1H, d, J = 8Hz), 9,13 (1H, s)
(2) 4- [bis (ethoxycarbonyl) methyl] -3-bromo-8-nitro
Quinoline (316 mg), lithium chloride (65.1 mg) and water (13.8 mg)
Of dimethylsulfoxide was stirred at 130 ° C. for 20 minutes. Vinegar mixture
Partition between ethyl acid and water, wash the organic layer with brine and dry over magnesium sulfate.
After drying, the solvent was distilled off in vacuo to give 3-bromo-4-ethoxycarbonylmethyl-
8-Nitroquinoline (236.8 mg) was obtained.
mp: 163-164 ℃
NMR (CDClThree, δ): 1.24 (3H, t, J = 7 Hz), 4.19 (2H, q,
J = 7Hz), 4.35 (2H, s), 7.70 (1H, t, J = 8Hz), 8.02 (1H, d,
J = 8Hz), 8.19 (1H, d, J = 8Hz), 9.11 (1H, s)Production Example 8
(1) 4-hydroxy-8-nitroquinoline (200 mg) and allyl bromide (1
40 mg) in dimethylformamide (2 ml) was added to potassium carbonate (29).
(0 mg) at 0 ° C. and the mixture was stirred at 50 ° C. for 6 hours. Dichlorome
Diluted with tan, washed with water, dried over magnesium sulfate and evaporated in vacuo.
Was. The residue was dissolved in hot ethyl acetate (2ml) and the solution was stirred at room temperature. Arising
The resulting precipitate was collected by filtration and treated with 4-allyloxy-8-nitroquinoline (120
mg).
mp: 127 ℃
NMR (CDClThree, δ): 4.81 (2H, d, J = 7 Hz), 5.43 (1H, d,
J = 10Hz), 5.53 (1H, d, J = 15Hz), 6.05-6.22 (1H, m), 6.85 (1H, d,
J = 5Hz), 7.54 (1H, t, J = 7.5Hz), 8.00 (1H, d, J = 7.5Hz), 8.46
(1H, d, J = 7.5Hz), 8.87 (1H, d, J = 7.5Hz)
(2) 4-allyloxy-8-nitroquinoline (110 mg) and iron (268 m
g) in acetic acid (0.4 ml) and ethanol (1.6 ml) at reflux for 1 hour
did. The insoluble material was removed by filtration, and the filtrate was concentrated in vacuo. Dissolve the residue in dichloromethane
Dissolve, wash solution with saturated sodium bicarbonate solution and water, and dry over magnesium sulfate
Thereafter, the solvent was distilled off in vacuo. Flash chromatography of the residue
The residue was purified with tyl-n-hexane to give 8-amino-4-allyloxyquinoline (8
7 mg).
NMR (CDClThree, δ): 4.74 (2H, d, J = 5 Hz), 4.90 (2H, br s),
5.37 (1H, d, J = 11Hz), 5.51 (1H, d, J = 17Hz), 6.05-6.21 (1H, m),
6.70 (1H, d, J = 4Hz), 6.92 (1H, d, J = 7.5Hz), 7.29 (1H, t,
J = 7.5Hz), 7.54 (1H, d, J = 7.5Hz), 8.59 (1H, d, J = 7.5Hz)Production Example 9
(1) 4-benzyloxy-8-nitroquinoline was prepared in the same manner as in Production Example 8- (1).
And reacting 4-hydroxy-8-nitroquinoline with benzyl bromide.
Was.
mp: 162.3 ° C
NMR (CDClThree, Δ): 5.32 (2H, s), 6.92 (1H, d, J = 5Hz),
7.35-7.54 (5H, m), 7.55 (1H, t, J = 7.5Hz), 8.00 (1H, d,
J = 7.5Hz), 8.46 (1H, d, J = 7.5Hz), 8.86 (1H, d, J = 7.5Hz)
(2) 8-amino-4-benzyloxyquinoline was prepared in the same manner as in Production Example 8- (2).
I got it.
mp: 114.8 ℃
NMR (CDClThree, Δ): 4.91 (2H, br s), 5.26 (2H, s), 6.77
(1H, d, J = 5Hz), 6.93 (1H, d, J = 7.5Hz), 7.21-7.54 (6H, m), 7.58
(1H, d, J = 7.5Hz), 8.59 (1H, d, J = 5Hz)Production Example 10
(1) 4-ethoxycarbonylmethoxy-8-nitroquinoline was prepared according to Production Example 8-
In the same manner as in (1), 4-hydroxy-8-nitroquinoline and ethyl bromoacetate
And obtained by reacting
mp: 108.4 ℃
NMR (CDClThree, Δ): 1.31 (3H, t, J = 7.5 Hz), 4.31 (2H, q,
J = 7.5Hz), 4.88 (2H, s), 6.74 (1H, d, J = 5Hz), 7.60 (1H, t,
J = 7.5Hz), 8.04 (1H, d, J = 7.5Hz), 8.53 (1H, d, J = 7.5Hz), 8.89
(1H, d, J = 7.5Hz)
(2) 4-ethoxycarbonylmethoxy-8-nitroquinoline (404 mg)
And 10% palladium on carbon in ethanol (5 ml) and dioxane (5 ml)
The mixture was stirred under a hydrogen atmosphere at room temperature for 5 hours. The insoluble material is removed by filtration, and the filtrate is removed in vacuo.
Concentrated. The residue was triturated with diethyl ether to give 8-amino-4- (ethoxy
Carbonylmethoxy) quinoline (234 mg) was obtained.
mp: 94 ℃
NMR (CDClThree, δ): 1.30 (3H, t, J = 7.5 Hz), 4.30 (2H, q,
J = 7.5Hz), 4.82 (2H, s), 4.92 (2H, br s), 6.58 (1H, d, J = 5Hz),
6.94 (1H, d, J = 7.5Hz), 7.30 (1H, t, J = 7.5Hz), 7.60 (1H, d, J = 7.5Hz)
J = 7.5Hz), 8.60 (1H, d, J = 5Hz)Production Example 11
(1) Biallyl of 4-allyloxy-8-nitroquinoline (3.72 g)
2.59 g) and a solution in diphenyl ether (7.4 g) at 200 ° C. for 10 minutes
Heated. After cooling, n-hexane (40 ml) was added thereto and the mixture was brought to 90 ° C.
Heated. After cooling, the resulting precipitate was collected by filtration to give 3-allyl-1,4-diene.
Hydro-8-nitro-4-oxoquinoline (3.13 g) was obtained.
mp: 242.3 ° C
NMR (CDClThree, δ): 3.36 (2H, br d, J = 7 Hz), 5.12-5.25
(2H, m), 5.90-6.08 (1H, m), 7.43 (1H, t, J = 7.5Hz), 7.65 (1H,
d, J = 6Hz), 8.65 (1H, d, J = 7.5Hz), 8.83 (1H, d, J = 7.5Hz), 11.08
(1H, br s)
(2) 4-chloro-8-nitro-3-allylquinoline was prepared in the same manner as in Production Example 2- (1).
Obtained in a similar manner.
mp: 64-66 ℃
NMR (CDClThree, Δ): 3.77 (2H, d, J = 8Hz), 5.10-5.30 (2H,
m), 6.00 (1H, m), 7.71 (1H, t, J = 8Hz), 8.03 (1H, d, J = 8Hz),
8.19 (1H, d, J = 8Hz), 8.89 (1H, s)
(3) 4-dimethylamino-8-nitro-3- (1-propenyl) quinoline
In the same manner as in Production Example 5, 4-chloro-8-nitro-3-allylquinoline and dimethyl
Obtained by reacting with tylamine hydrochloride.
mp: 121-123 ℃
NMR (CDClThree, Δ): 2.00 (3H, d, J = 7 Hz), 6.21 (1H, dq,
J = 7, 15Hz), 6.63 (1H, d, J = 15Hz), 7.49 (1H, t, J = 8Hz), 7.87
(1H, d, J = 8Hz), 8.26 (1H, d, J = 8Hz), 8.91 (1H, s)
(4) Production Example 1 of 8-amino-4-dimethylamino-3-propylquinoline
In the same manner as in 0- (2), 4-dimethylamino-8-nitro-3- (1-propane
Nyl) quinoline.
NMR (CDClThree, Δ): 1.01 (3H, t, J = 7Hz), 1.65 (2H, m),
2.76 (2H, m), 3.04 (6H, s), 4.90 (2H, br s), 6.84 (1H, d,
J = 8Hz), 7.25 (1H, t, J = 8Hz), 7.38 (1H, d, J = 8Hz), 8.51 (1H, s)Production Example 12
(1) 4-hydroxy-8-nitroquinoline (5.0 g), 2,6-lutidine
(4.23 g) and a stirred mixture of dimethylaminopyridine (321 mg)
Fluoromethanesulfonic anhydride (8.16 g) in dichloromethane (100 ml)
) Was added dropwise over 30 minutes under ice-cooling, and the mixture was allowed to stand at the same temperature for 2 hours and at room temperature for 1 hour.
Stirred for hours. Add saturated ammonium chloride solution to the mixture and extract with dichloromethane.
Issued. The organic layer is washed with water and brine, dried over magnesium sulfate, and then dissolved in vacuum.
The medium was distilled off. The residue was purified by flash chromatography (dichloromethane-n-
Hexane) to give 8-nitro-4- (trifluoromethanesulfonyloxy).
B) Quinoline (6.17 g) was obtained.
mp: 108 ℃
NMR (CDClThree, Δ): 7.58 (1H, d, J = 4 Hz), 7.80 (1H, t,
J = 7.5Hz), 8.15 (1H, d, J = 7.5Hz), 8.30 (1H, d,
J = 7.5Hz), 9.14 (1H, d, J = 4Hz)
(2) 8-nitro-4- (trifluoromethanesulfonyloxy) quinoline (
6.0 g), tri-n-butyl (vinyl) tin (6.49 g), tetrakis (tri
Phenylphosphine) palladium (0) (1.08 g) and lithium chloride (2.3
A mixture of 7 g) in dioxane (120 ml) was refluxed for 1.5 hours. The mixture
Concentrate in vacuo and add ethyl acetate (200 ml) to the residue. Mix for 1 hour
The mixture was stirred, and insoluble materials were removed by filtration. The residue was flash chromatographed (ethyl acetate
And purified with 8-nitro-4-vinylquinoline (2.39 g).
) Got.
mp: 134 ℃
NMR (CDClThree, Δ): 5.76 (1H, d, J = 11 Hz), 6.04 (1H, d,
J = 18Hz), 7.40 (1H, dd, J = 18, 11Hz), 7.60 (1H, d, J = 4Hz), 7.65
(1H, t, J = 7.5Hz), 8.00 (1H, d, J = 7.5Hz), 8.30 (1H, d,
J = 7.5Hz), 9.02 (1H, d, J = 4Hz)Production Example 13
8-amino-3-bromoquinoline (200 mg) and sodium thiomethoxide
(109 mg) in N, N-dimethylformamide (2 ml) at room temperature
Stir for 2 days. After dilution with ethyl acetate, the resulting mixture was washed with water and brine,
After drying over sodium hydrogen sulfate, the solvent was distilled off in vacuo. Silica gel chromatography of the residue
Purification by chromatography (n-hexane-ethyl acetate) gave 8-amino-3-meth
Tilthioquinoline (113 mg) was obtained as an oil.
NMR (CDClThree, Δ): 2.60 (3H, s), 4.86 to 4.99 (2H, m), 6.86
(1H, d, J = 8Hz), 7.05 (1H, d, J = 8Hz), 7.31 (1H, t, J = 8Hz), 7.83
(1H, s), 8.65 (1H, s)Production Example 14
8-nitro-3-bromoquinoline (300 mg), tri-n-butyl (vinyl
) Tin (491mg) and tetrakis (triphenylphosphine) palladium
A mixture of (0) (28 mg) in dimethoxyethane (6 ml) was refluxed for 1 hour.
. The mixture is concentrated in vacuo and the residue is purified by column chromatography on silica gel (n
-Hexane-toluene) to give 8-nitro-3-vinylquinoline (127
mg).
mp: 116-117 ℃
NMR (CDClThree, Δ): 5.59 (1H, d, J = 12 Hz), 6.05 (1H, d,
J = 17Hz), 6.90 (1H, dd, J = 12, 17Hz), 7.62 (1H, t, J = 8Hz), 8.02
(2H, d, J = 8Hz), 8.17 (1H, s), 9.19 (1H, s)Production Example 15
8-Nitro-3- (1-pentynyl) quinoline was prepared in the same manner as in Production Example 14.
From 3-bromo-8-nitroquinoline and tri-n-butyl (1-pentynyl) tin
Obtained.
mp: 71-73 ℃
NMR (CDClThree, Δ): 1.10 (3H, t, J = 7Hz), 1.63-1.78 (2H,
m), 2.49 (2H, t, J = 7Hz), 7.62 (1H, t, J = 8Hz), 7.88 (1H, d,
J = 8Hz), 8.02 (1H, d, J = 8Hz), 8.25 (1H, s), 9.00 (1H, s)Production Example 16
(1) 3-bromo-8-nitroquinoline (253 mg), phenylboric acid (1
59 mg), tetrakis (triphenylphosphine) palladium (0) (23 m
g) and a 2M aqueous solution of sodium carbonate (2.5 ml) in 1,2-dimethoxyethane (
(3.5 ml) was refluxed for 4 hours. Add phenylboric acid (122m
g) was added and the mixture was refluxed for a further 3 hours. The resulting mixture is diluted with ethyl acetate.
After washing, wash with 3% aqueous sodium bicarbonate and brine and dry over anhydrous sodium sulfate.
After drying, the solvent was distilled off in vacuo. The residue was chromatographed on silica gel (n-
(Hexane-ethyl acetate), and the obtained oil was crystallized from diethyl ether.
To give 8-nitro-3-phenylquinoline (104 mg).
mp: 112-114 ℃
NMR (CDClThree, Δ): 7.46-7.61 (3H, m), 7.67 (1H, t,
J = 8Hz), 7.72 (2H, d, J = 8Hz), 8.07 (1H, d, J = 8Hz), 8.11 (1H, d,
J = 8Hz), 8.40 (1H, s), 9.35 (1H, s)
(2) 8-amino-3-phenylquinoline was obtained in the same manner as in Production Example 1.
mp: 64-66 ℃
NMR (CDClThree, Δ): 4.42-5.07 (2H, m), 6.93 (1H, d,
J = 8Hz), 7.23 (1H, t, J = 8Hz), 7.38 (1H, t, J = 8Hz), 7.44 (1H, d,
J = 8Hz), 7.50 (1H, d, J = 8Hz), 7.53 (1H, d, J = 8Hz), 7.71 (2H, d,
J = 8Hz), 8.21 (1H, s),
9.02 (1H, s)Production Example 17
(1) 4- [bis (ethoxycarbonyl) methyl] -8-nitroquinazoline
In the same manner as in Production Example 7- (1), 4-chloro-8-nitroquinazoline and malon were prepared.
Obtained by reaction with diethyl acid.
mp: 157-159 ℃
NMR (CDClThree, Δ): 1.28-1.40 (6H, m), 4.28 (2H, q,
J = 7Hz), 4.36 (2H, q, J = 7Hz), 7.39 (1H, t, J = 8Hz), 7.83 (1H, d,
J = 8Hz), 7.87 (1H, d, J = 8Hz), 7.95 (1H, s)
(2) Production Example 7 of 4- (ethoxycarbonylmethyl) -8-nitroquinazoline
-Obtained in the same manner as in (2).
mp: 162-164 ℃
NMR (CDClThree, Δ): 1.33 (3H, t, J = 7 Hz), 4.23 (2H, q,
J = 7Hz), 5.57 (2H, s), 7.41 (1H, t, J = 8Hz), 7.80-7.93 (3H, m)Production Example 18
3-acetyl-4-chloro-8-nitroquinoline (140 mg) and methyl hydride
A mixture of azine (77.2 mg) in ethylene chloride was refluxed for 30 minutes. mixture
Was concentrated in vacuo and the residue was purified by silica gel column chromatography (methanol
-Dichloroethane) to give 2,3-dimethyl-6-nitro-2H-pyrazo.
[4,3-c] quinoline (61.2 mg) was obtained.
mp: 235-236 ℃
NMR (CDClThree, Δ): 2.70 (3H, s), 4.49 (3H, s), 7.73 (1H,
t, J = 8Hz), 7.97 (1H, d, J = 8Hz), 8.56 (1H, d, J = 8Hz), 9.22 (1H,
s)Production Example 19
(1) 3-Formyl-8-nitroquinoline was prepared in the same manner as in Example 29,
Obtained from nitro-3-vinylquinoline.
NMR (CDClThree, Δ): 7.78 (1H, t, J = 8 Hz), 8.20 (1H, d,
J = 8Hz), 8.26 (1H, d, J = 8Hz), 8.76 (1H, s), 9.52 (1H, s), 10.32
(1H, s)
(2) 3-formyl-8-nitroquinoline (65 mg) and (triphenylphos
(Holanylidene) Mixing ethyl acetate (123 mg) in dichloromethane (3 ml)
The material was stirred at room temperature for 2 hours. The mixture is concentrated in vacuo and the residue is
Purification by column chromatography (ethyl acetate-n-hexane) gave 3-((E)
-2-ethoxycarbonylvinyl) -8-nitroquinoline (92 mg) was obtained.
NMR (CDClThree, Δ): 1.39 (3H, t, J = 7Hz), 4.33 (2H, q,
J = 7Hz), 6.71 (1H, d, J = 16Hz), 7.68 (1H, t, J = 8Hz), 7.84 (1H,
d, J = 16Hz), 8.09 (2H, d, J = 8Hz), 8.32 (1H, d, J = 2Hz), 9.24
(1H, d, J = 2Hz)Production Example 20
4-methyl-8-nitroquinoline (2.80 g) and selenium (IV) oxide (1.
A mixture of 82 g) in ethanol (45 ml) was refluxed for 4 hours. Activate the mixture
Treated with charcoal and filtered through a pad of celite. The filtrate is concentrated in vacuo to a brown solid
I got This residue was treated with methanol (10 ml) and tetrahydrofuran (10 ml).
) And cooled in an ice bath. Sodium borohydride (
170 mg) and stirred at the same temperature for half an hour. Add saturated ammonium chloride to this mixture.
The solution was added and extracted with methylene chloride. Dry the organic layer over anhydrous magnesium sulfate
Thereafter, the solvent was distilled off under reduced pressure. The residue is taken up in methylene chloride and then in methylene chloride.
Silica gel flash chromatography using 3% methanol as eluent
The solid was obtained by purification with an organic solvent. This solid is coagulated with diethyl ether,
4-Hydroxymethyl-8-nitroquinoline (665 mg) as a brown solid
Obtained.
mp: 148 ℃
NMR (CDClThree-CDThreeOD, δ): 5.18 (2H, s), 7.64 (1H, t,
J = 7.5Hz), 7.72 (1H, d, J = 4Hz), 8.02 (1H, d, J = 7.5Hz), 8.21
(1H, d, J = 7.5Hz), 8.98 (1H, d, J = 4Hz)Production Example 21
3-bromo-8-nitroquinoline (300 mg), trimethylsilyl acetylene
(140 mg), barium (II) chloride (38 mg), a catalytic amount of copper iodide (
I) of triethylamine (3 ml) and triphenylphosphine (113 mg)
The mixture in acetonitrile (3 ml) was stirred at room temperature for 3 hours. Diet the mixture
The mixture was diluted with toluene and insoluble materials were removed by filtration. The filtrate is concentrated in vacuo and the residue is
Purification by Kagel column chromatography (n-hexane-ethyl acetate) gave 8
-Nitro-3- (trimethylsilylethynyl) quinoline (210 mg) was obtained.
NMR (CDClThree, Δ): 0.30 (9H, s), 7.26 (1H, s), 7.63 (1H, s)
t, J = 8Hz), 7.99 (1H, d, J = 8Hz), 8.03 (1H, d, J = 8Hz), 8.32 (1H,
s), 9.03 (1H, s)Production Example 22
The following compound was obtained in the same manner as in Production Example 21.
(1) 8-nitro-3-[(2-pyridyl) ethynyl] quinoline
(From 3-bromo-8-nitroquinoline and 2-ethynylpyridine)
mp: 185-187 ℃
NMR (CDClThree, Δ): 7.33 (1H, m), 7.62 (1H, d, J = 8Hz),
7.70 (1H, d, J = 8Hz), 7.77 (1H, t, J = 8Hz), 8.03 (1H, d, J = 8Hz),
8.08 (1H, d, J = 8Hz), 8.48 (1H, s), 8.68 (1H, d, J = 8Hz), 9.19
(1H, s)
(2) 3- (3-hydroxy-3-methyl-1-butynyl) -8-nitroquino
Rin
(3-Bromo-8-nitroquinoline and 3-hydroxy-3-methyl-1-butyi)
From)
mp: 120-121 ℃
NMR (CDClThree, Δ): 1.68 (6H, s), 2.13 (1H, s), 7.63 (1H, s)
t, J = 8Hz), 7.98 (1H, d, J = 8Hz), 8.03 (1H, d, J = 8Hz), 8.30 (1H,
s), 9.00 (1H, s)Production Example 23
(1) 4-chloro-3-ethoxycarbonyl-8-nitroquinoline (500 m
g) and tert-butoxycarbonylhydrazine (283 mg) in dioxane
The mixture was refluxed for 1 hour. The mixture is concentrated in vacuo to give 2-tert-butoxycarbo.
Nyl-2,3-dihydro-6-nitro-1H-pyrazolo [4,3-c] quinoline
-3-One (458 mg) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.56 (9H, s), 7.71 (1H, t, J = 8Hz),
8.41 (1H, s), 8.53 (1H, d, J = 8Hz), 8.58 (1H, d, J = 8Hz)
(2) 2-tert-butoxycarbonyl-2,3-dihydro-6-nitro-1H
-Pyrazolo [4,3-c] quinolin-3-one (450 mg) and potassium carbonate (
To a mixture of 565 mg) in dimethylformamide was added methyl iodide (580 mg).
) Was added and the mixture was stirred at 60 ° C. for 2 hours. Pour the mixture into water and add ethyl acetate
Extracted. The organic layer is washed with brine, dried over magnesium sulfate, and then dried in vacuo.
Was distilled off. The residue was subjected to silica gel column chromatography (dichloromethane-
Ethyl acetate) to give 2-tert-butoxycarbonyl-2,3-dihydro-
1-methyl-6-nitro-1H-pyrazolo [4,3-c] quinolin-3-one (
114 mg).
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.60 (9H, s), 3.82 (3H, s), 7.89
(1H, d, J = 8Hz), 8.42 (1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 9.09
(1H, s)
(3) 6-amino-2-tert-butoxycarbonyl-2,3-dihydro-1-
Methyl-1H-pyrazolo [4,3-c] quinolin-3-one was prepared according to Production Example 10- (2
).
mp:> 250 ℃
NMR (CDClThree-CDThreeOD, δ): 1.62 (9H, s), 4.40 (3H, s),
7.04 (1H, d, J = 8Hz), 7.45 (1H, t, J = 8Hz), 7.66 (1H, d, J = 8Hz),
8.82 (1H, s)Production Example 24
The following compound was obtained in the same manner as in Production Example 2- (3).
(1) 8-amino-4-chloro-3-ethoxycarbonylquinoline
mp: 112-113 ℃
NMR (CDClThree, Δ): 1.46 (3H, t, J = 7 Hz), 4.50 (2H, q,
J = 7Hz), 5.05 (2H, brs), 7.03 (1H, d, J = 8Hz), 7.47 (1H, t,
J = 8Hz), 7.68 (1H, d, J = 8Hz), 9.02 (1H, s)
(2) 8-amino-4-ethoxy-3-ethoxycarbonylquinoline
NMR (CDClThree, Δ): 1.45 (3H, t, J = 7 Hz), 1.53 (3H, t,
J = 7Hz), 4.29 (2H, q, J = 7Hz), 4.45 (2H, q, J = 7Hz), 4.98 (2H, br
s), 6.99 (1H, d, J = 8 Hz), 7.35 (1H, t, J = 8 Hz), 7.56 (1H, d,
J = 8Hz) 、 9.05 (1H, s)
(3) 8-amino-4-dimethylamino-3-ethoxycarbonylquinoline
NMR (CDClThree, Δ): 1.43 (3H, t, J = 7Hz), 3.09 (6H, s),
4.44 (2H, q, J = 7Hz), 4.96 (2H, brs), 6.91 (1H, d, J = 8Hz),
7.29 (1H, t, J = 8Hz), 7.44 (1H, d, J = 8Hz), 8.77 (1H, s)
(4) 8-amino-3-bromo-4-chloroquinoline
mp: 130-131 ℃
NMR (DMSO-d6, Δ): 5.02 (2H, brs), 6.95 (1H, d,
J = 8Hz), 7.42 (1H, t, J = 8Hz), 7.50 (1H, d, J = 8Hz), 8.75 (1H,
s)
(5) 8-amino-3-bromo-4- (ethoxycarbonylmethyl) quinoline
mp: 139-140 ℃
NMR (CDClThree, Δ): 1.22 (3H, t, J = 7 Hz), 4.17 (2H, q,
J = 7Hz), 4.26 (2H, s), 5.03 (2H, br s), 6.93 (1H, d, J = 8Hz),
7.22 (1H, d, J = 8Hz), 7.37 (1H, t, J = 8Hz), 8.79 (1H, s)
(6) 8-amino-4-chloro-3-allylquinoline
mp: 111-112 ℃
NMR (CDClThree, Δ): 3.70 (2H, d, J = 7 Hz), 5.01 (2H, br s),
5.00-5.20 (2H, m), 6.02 (1H, m), 6.92 (1H, d, J = 8Hz), 7.40
(1H, t, J = 8Hz), 7.53 (1H, d, J = 8Hz), 8.56 (1H, s)
(7) 8-amino-4-vinylquinoline
NMR (CDClThree, Δ): 5.01 (2H, brs), 5.60 (1H, d,
J = 11Hz), 5.93 (1H, d, J = 17Hz), 6.91 (1H, d, J = 7.5Hz), 7.27-
7.54 (4H, m), 8.80 (1H, d, J = 4Hz)
(8) 8-amino-3-vinylquinoline
NMR (CDClThree, Δ): 4.84-5.03 (2H, m), 5.43 (1H, d,
J = 12Hz), 5.97 (1H, d, J = 17Hz), 6.80-6.93 (2H, m), 7.15 (1H, d,
J = 8Hz), 7.32 (1H, t, J = 8Hz), 8.00 (1H, s), 8.88 (1H, s)
(9) 8-amino-3- (1-benthynyl) quinoline
mp: 75-76 ℃
NMR (CDClThree, Δ): 1.09 (3H, t, J = 7 Hz), 1.62-1.76 (2H,
m), 2.45 (2H, t, J = 7Hz), 4.86-5.02 (2H, m), 6.89 (1H, d,
J = 8Hz), 7.08 (1H, d, J = 8Hz), 7.31 (1H, t, J = 8Hz), 8.08 (1H, d,
J = 2Hz), 8.71 (1H, d, J = 2Hz)
(10) 8-amino-3-[(2-pyridyl) ethynyl] quinoline
mp: 105-107 ℃
NMR (CDClThree, Δ): 4.92-5.03 (2H, m), 6.95 (1H, d,
J = 8Hz), 7.14 (1H, d, J = 8Hz), 7.25-7.32 (1H, m), 7.38 (1H, t,
J = 8Hz), 7.60 (1H, d, J = 8Hz), 7.73 (1H, t, J = 8Hz), 8.31 (1H,
s), 8.67 (1H, m), 8.89 (1H, s)
(11) 8-amino-3- (3-hydroxy-3-methyl-1-butynyl) ki
Norin
mp: 130-131 ℃
NMR (CDClThree, Δ): 1.67 (6H, s), 2.24 (1H, s), 4.90-5.00
(2H, m), 6.92 (1H, d, J = 8Hz), 7.10 (1H, d, J = 8Hz), 7.33 (1H,
t, J = 8Hz), 8.12 (1H, s), 8.72 (1H, s)
(12) 8-amino-4- (ethoxycarbonylmethyl) quinazoline
mp: 132-134 ℃
(13) 6-amino-2,3-dimethyl-2H-pyrazolo [4,3-c] quino
Rin
mp: 214-215 ℃
NMR (CDClThree, Δ): 2.65 (3H, s), 4.41 (3H, s), 5.11 (2H,
br s), 7.00 (1H, d, J = 8 Hz), 7.42 (1H, t, J = 8 Hz), 7.67 (1H, d,
J = 8Hz), 8.94 (1H, s)
(14) 8-Amino-3-((E) -2-ethoxycarbonylvinyl) quinoli
N
NMR (CDClThree, Δ): 1.38 (3H, t, J = 7 Hz), 4.30 (2H, q,
J = 7Hz), 4.90-5.02 (2H, m), 6.63 (1H, d, J = 15Hz), 6.95 (1H, d,
J = 8Hz), 7.18 (1H, d, J = 8Hz), 7.38 (1H, t, J = 8Hz), 7.81 (1H, d,
J = 15Hz), 8.15 (1H, d, J = 2Hz), 8.91 (1H, d, J = 2Hz)
(15) 8-amino-4-hydroxymethylquinoline
NMR (DMSO-d6, Δ): 4.95 (2H, d, J = 6 Hz), 5.50 (1H, t,
J = 6Hz), 5.93 (2H, brs), 6.85 (1H, d, J = 7.5Hz), 7.04 (1H, d,
J = 7.5Hz), 7.28 (1H, t, J = 7.5Hz), 7.54 (1H, d, J = 4Hz), 8.69
(1H, d, J = 4Hz)
(16) 8-amino-1,4-dihydro-4-oxoquinoline
NMR (CDClThree-CDThreeOD, δ): 3.35 (2H, m), 6.30 (1H, d,
J = 6Hz), 6.99 (1H, d, J = 7.5Hz), 7.18 (1H, t, J = 7.5Hz), 7.64
7.83 (2H, m)
(17) 8-amino-3- (trimethylsilylethynyl) quinoline
mp: 78-80 ℃
NMR (CDClThree, Δ): 0.30 (9H, s), 4.88-5.01 (2H, m), 6.92
(1H, d, J = 8Hz), 6.99 (1H, d, J = 8Hz), 7.33 (1H, t, J = 8Hz), 8.15
(1H, s), 8.73 (1H, s)Production Example 25
8-amino-4-chloro-3-ethoxycarbonylquinoline (45 mg),
Diethylamine (0.026ml) and 10% palladium on carbon (15mg)
The mixture in xane was stirred at room temperature under a hydrogen atmosphere at 3 atm for 7 hours. Filter insoluble matter
Removed and the filtrate was concentrated in vacuo. Silica gel column chromatography of the residue
(Ethyl acetate-dichloromethane) to give 8-amino-3-ethoxycarbo.
Nilquinoline (24.5 mg) was obtained.
mp: 95-96 ℃
NMR (CDClThree, Δ): 1.46 (3H, t, J = 7 Hz), 4.47 (2H, q,
J = 7Hz), 5.04 (2H, brs), 7.02 (1H, d, J = 8Hz),
7.25 (1H, d, J = 8Hz), 7.40 (1H, t, J = 8Hz), 8.74 (1H, s), 9.28
(1H, s)Example 1
8-amino-6-methoxyquinoline (121 mg), 2,6-dichlorobenzo
Ethyl chloride of ilchloride (175mg) and triethylamine (91.4mg)
The mixture in ren (3 ml) was refluxed for 3 hours. After cooling, the mixture was diluted with ethyl acetate.
And washed with water, saturated sodium bicarbonate solution and brine, and dried over magnesium sulfate.
After drying, the solvent was distilled off in vacuo. Silica gel column chromatography of the residue
(Ethyl acetate: n-hexane, 1: 2, v / v) to give 8- (2,6-di-
Chlorobenzoylamino) -6-methoxyquinoline (164.5 mg) was obtained.
mp: 180-182 ℃
NMR (CDClThree, Δ): 3.97 (3H, s), 6.88 (1H, s), 7.30-7.50
(4H, m), 8.06 (1H, d, J = 8Hz), 8.60 (1H, m), 8.70 (1H, s)
Its hydrochloride
mp: 236-244 ℃
NMR (DMSO-d6, Δ): 3.93 (3H, s), 7.22 (1H, s), 7.40-
7.70 (4H, m), 8.34 (1H, d, J = 8Hz), 8.43 (1H, s), 8.73 (1H, d,
(J = 8Hz)Example 2
The following compound was obtained in the same manner as in Example 1.
(1) 8- (2,6-dichlorobenzoylamino) -7-methylquinoline
mp: 200-201 ℃
NMR (DMSO-d6, Δ): 2.57 (3H, s), 7.40-7.60 (5H, m),
7.87 (1H, d, J = 8Hz), 8.37 (1H, d, J = 8Hz), 8.91 (1H, m)
Its hydrochloride
mp: 235-247 ° C
NMR (DMSO-d6, Δ): 2.58 (3H, s), 7.40-7.70 (5H, m),
7.91 (1H, d, J = 8Hz), 8.46 (1H, d, J = 8Hz),
8.95 (1H, d, J = 5Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4-methylquinoline
mp : 231-232 ℃
NMR (CDClThree, Δ): 2.72 (3H, s), 7.45-7.60 (4H, m),
7.68 (1H, t, J-8Hz), 7.89 (1H, d, J = 8Hz), 8.70-8.75 (2H, m)
Its hydrochloride
mp: 230-231 ℃
NMR (DMSO-d6, Δ): 2.74 (3H, s), 7.45-7.65 (4H, m),
7.70 (1H, t, J = 8Hz), 7.92 (1H, d, J = 8Hz), 8.74 (1H, d, J = 8Hz),
8.77 (1H, d, J = 6Hz)
(3) 4-chloro-8- (2,6-dichlorobenzoylamino) quinoline
mp: 215-217 ° C
NMR (CDClThree, Δ): 7.30-7.50 (3H, m), 7.56 (1H, d,
J = 5Hz), 7.72 (1H, t, J = 8Hz), 7.99 (1H, d, J = 8Hz), 8.64 (1H, d,
J = 5Hz), 9.03 (1H, d, J = 8Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4-methoxyquinoline
mp: 236-237 ℃
NMR (CDClThree, Δ): 4.07 (3H, s), 6.79 (1H, d, J = 6Hz),
7.30-7.50 (3H, m), 7.57 (1H, t, J = 8Hz), 7.94 (1H, d, J = 8Hz),
8.62 (1H, d, J = 6Hz), 8.95 (1H, s)
Its hydrochloride
mp: 197-199 ° C
NMR (CDClThree-CDThreeOD, δ): 4.34 (3H, s), 7.21 (1H, d,
J = 7Hz), 7.30-7.50 (3H, m), 7.87 (1H, t, J = 8Hz), 8.19 (1H, d,
J = 8Hz), 8.92 (1H, d, J = 7Hz), 9.14 (1H, d, J = 8Hz)
(5) 8- (2,6-dichlorobenzoylamino) -3-methylquinoline
mp: 219-220 ℃
NMR (CDClThree, Δ): 2.53 (3H, s), 7.30-7.50 (3H, m), 7.53
(1H, d, J = 8Hz), 7.58 (1H, t, J = 8Hz), 7.96 (1H, s), 8.63 (1H,
s), 8.89 (1H, d, J = 8Hz)
Its hydrochloride
mp: 242-256 ℃
NMR (DMSO-d6, Δ): 2.52 (3H, s), 7.40-7.80 (5H, m),
8.22 (1H, s), 8.45 (1H, d, J = 8Hz), 8.77 (1H, s)
(6) 3-acetyl-8- (2,6-dichlorobenzoylamino) -4-meth
Xyquinoline
mp: 179-180 ℃
NMR (CDClThree, Δ): 2.77 (3H, s), 4.12 (3H, s), 7.30-7.50
(3H, m), 7.68 (1H, t, J = 8Hz), 7.96 (1H, d, J = 8Hz), 8.97 (1H,
s), 9.05 (1H, d, J = 8Hz)
Its hydrochloride
mp: 143-148 ° C (decomposition)
NMR (CDClThree, Δ): 2.79 (3H, s), 4.25 (3H, s), 7.30-7.50
(3H, m), 7.87 (1H, t, J = 8Hz), 8.18 (1H, d, J = 8Hz), 9.03 (1H,
s), 9.24 (1H, d, J = 8Hz)
(7) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
Quinoline
mp: 199-200 ℃
NMR (DMSO-d6, Δ): 1.40 (3H, t, J = 7 Hz), 4.43 (2H, q,
J = 7Hz), 7.50-7.60 (3H, m), 7.78 (1H, t, J = 8Hz), 8.03 (1H, d,
J = 8Hz), 8.85 (1H, d, J = 8Hz), 9.07 (1H, s), 9.29 (1H, s)
(8) 8- (2,6-dichlorobenzoylamino) -4-ethoxy-3-ethoxy
Xycarbonylquinoline
mp: 155-156 ℃
NMR (CDClThree, Δ): 1.45 (3H, t, J = 7 Hz), 1.56 (3H, t,
J = 7Hz), 4.34 (2H, q, J = 7Hz), 4.47 (2H, q, J = 7Hz), 7.30-7.50
(3H, m), 7.65 (1H, t, J = 8Hz), 8.03 (1H, d, J = 8Hz), 9.04 (1H,
d, J = 8Hz), 9.07 (1H, s)
Its hydrochloride
mp: 220-222 ℃
NMR (CDClThree, Δ): 1.45 (3H, t, J = 7 Hz), 1.62 (3H, t,
J = 7Hz), 4.48 (2H, q, J = 7Hz), 4.63 (2H, q, J = 7Hz), 7.30-7.50
(3H, m), 7.88 (1H, t, J = 8Hz), 8.26 (1H, d, J = 8Hz), 9.18 (1H,
s), 9.26 (1H, d, J = 8Hz)
(9) 8- (2,6-dichlorobenzoylamino) -4-dimethylamino-3
-Ethoxycarbonylquinoline
mp: 163-165 ℃
NMR (CDClThree, Δ): 1.42 (3H, t, J = 7Hz), 3.13 (6H, s),
4.43 (2H, q, J = 7Hz), 7.30-7.50 (3H, m), 7.57 (1H, t, J = 8Hz),
7.89 (1H, d, J = 8Hz), 8.75 (1H, s), 8.95 (1H, d, J = 8Hz)
Its hydrochloride
mp: 200-202 ℃
NMR (CDClThree, Δ): 1.43 (3H, t, J = 7 Hz), 4.42 (2H, q,
J = 7Hz), 7.30-7.50 (3H, m), 7.72 (1H, t, J = 8Hz), 8.01 (1H, d,
J = 8Hz), 8.83 (1H, s), 8.99 (1H, d, J = 8Hz)
(10) 3-bromo-4-chloro-8- (2,6-dichlorobenzoylamido
No) Quinoline
mp: 240-242 ℃
NMR (CDClThree, Δ): 7.30-7.50 (3H, m), 7.75 (1H, t,
J = 8Hz), 8.00 (1H, d, J = 8Hz), 8.81 (1H, s), 9.04 (1H, d,
J = 8Hz), 9.87 (1H, s)
(11) 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (d
Toxylcarbonylmethyl) quinoline
mp: 166-168 ℃
NMR (CDClThree, Δ): 1.23 (3H, t, J = 7 Hz), 4.18 (2H, q,
J = 7Hz), 4.31 (2H, s), 7.30-7.50 (3H, m), 7.60-7.75 (2H, m),
8.82 (1H, s), 8.98 (1H, d, J = 8Hz)
(12) 8- (2,6-dichlorobenzoylamino) -4-allyloxyquino
Rin
mp: 199-243.2 ℃
NMR (CDClThree, Δ): 4.78 (2H, d, J = 5 Hz), 5.39 (1H, d,
J = 10Hz), 5.51 (1H, d, J = 15Hz), 6.07-6.23 (1H, m), 6.77 (1H, d,
J = 5Hz), 7.26-7.42 (3H, m), 7.55 (1H, t, J = 7.5Hz), 7.97 (1H, d,
J = 7.5Hz), 8.57 (1H, d, J = 7.5Hz), 8.95 (1H, d, J = 7.5Hz)
(13) 4-benzyloxy-8- (2,6-dichlorobenzoylamino) ki
Norin
mp: 192.8 ℃
NMR (CDClThree, Δ): 5.31 (2H, s), 6.84 (1H, d, J = 5Hz),
7.25-7.52 (8H, m), 7.55 (1H, t, J = 7.5Hz), 8.00 (1H, d,
J = 7.5Hz), 8.56 (1H, d, J = 5Hz), 8.94 (1H, d, J = 7.5Hz)
(14) 8- (2,6-dichlorobenzoylamino) -4- (ethoxycarbo
Nylmethoxy) quinoline
mp: 134 ℃
NMR (CDClThree, Δ): 1.32 (3H, t, J = 7.5 Hz), 4.30 (2H, q,
J = 7.5Hz), 4.85 (2H, s), 6.65 (1H, d, J = 5Hz), 7.30-7.42 (3H, m),
7.60 (1H, t, J = 7.5Hz), 8.04 (1H, d, J = 7.5Hz), 8.59 (1H, d,
J = 5Hz), 8.97 (1H, d, J = 7.5Hz)
(15) 8- (2,6-dichlorobenzoylamino) -4-dimethylamino-
3-propylquinoline hydrochloride
mp: 195-200 ℃
NMR (DMSO-d6, Δ): 0.95 (3H, t, J = 7Hz), 1.58 (2H, m),
2.83 (2H, m), 3.19 (6H, s), 7.50-7.70 (4H, m), 7.98 (1H, d,
J = 8Hz), 8.56 (1H, d, J = 8Hz), 8.60 (1H, s)
(16) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-ali
Lucinoline
mp: 127-128 ℃
NMR (CDClThree, Δ): 3.72 (2H, d, J = 7 Hz), 5.00-5.20 (2H,
m), 6.00 (1H, m), 7.30-7.50 (3H, m), 7.69 (1H, t, J = 8Hz), 7.98
(1H, d, J = 8Hz), 8.58 (1H, s), 8.96 (1H, d, J = 8Hz)
(17) 8- (2,6-dichlorobenzoylamino) -4-vinylquinoline
mp: 210.2 ℃
NMR (CDClThree, Δ): 5.70 (1H, d, J = 11 Hz), 6.00 (1H, d,
J = 18Hz), 7.27-7.50 (4H, m), 7.54 (1H, d, J = 4Hz), 7.64 (1H, t,
J = 7.5Hz), 7.85 (1H, d, J = 7.5Hz), 8.72 (1H, d, J = 4Hz), 8.97
(1H, d, J = 7.5Hz)
(18) 8- (2,6-dichlorobenzoylamino) -3-methylthioquinoli
N
mp: 206-207 ℃
NMR (CDClThree, Δ): 2.61 (3H, s), 7.31-7.45 (3H, m), 7.51
(1H, d, J = 8Hz), 7.61 (1H, t, J = 8Hz), 7.92 (1H, s), 8.68 (1H,
s), 8.90 (1H, d, J = 8Hz)
(19) 8- (2,6-dichlorobenzoylamino) -3-vinylquinoline
mp: 178-180 ℃
NMR (CDClThree, Δ): 5.48 (1H, d, J = 12 Hz), 6.00 (1H, d,
J = 17Hz), 6.88 (1H, dd, J = 12, 17Hz), 7.34-7.46 (3H, m), 7.56-
7.46 (2H, m), 8.12 (1H, s), 8.86 (1H, s), 8.94 (1H, d, J = 8Hz),
10.00 (1H, br s)
(20) 8- (2,6-dichlorobenzoylamino) -3- (1-pentynyl)
) Quinoline
mp: 153-154 ℃
NMR (CDClThree, Δ): 1.10 (3H, t, J = 7Hz), 1.62-1.77 (2H,
m), 2.47 (2H, t, J = 7Hz), 7.30-7.47 (3H, m), 7.53 (1H, d,
J = 8Hz), 7.62 (1H, t, J = 8Hz), 8.20 (1H, s), 8.72 (1H, s), 8.93
(1H, d, J = 8Hz)
Its hydrochloride
mp: 145-147 ° C
NMR (CDClThree, Δ): 1.09 (3H, t, J = 7 Hz), 1.62-1.76 (2H,
m), 2.49 (2H, t, J = 7Hz), 7.31-7.44 (3H, m), 7.78 (1H, d,
J = 8Hz), 7.90 (1H, t, J = 8Hz), 8.69 (1H, s), 8.90 (1H, s), 9.21
(1H, d, J = 8Hz)
Its methanesulfonate
mp: 139-140 ℃
NMR (CDClThree, Δ): 1.08 (3H, t, J = 7 Hz), 1.63-1.76 (2H,
m), 2.49 (3H, t, J = 7Hz), 2.53 (3H, s), 7.33-7.46 (3H, m), 7.83
(1H, d, J = 8Hz), 7.92 (1H, t, J = 8Hz), 8.71 (1H, s), 8.95 (1H,
d, J = 8Hz), 9.19 (1H, s)
(21) 8- (2,6-dichlorobenzoylamino) -3-phenylquinoline
mp: 190-192 ℃
NMR (CDClThree, Δ): 7.30-7.46 (4H, m), 7.54 (2H, t,
J = 8Hz), 7.60-7.76 (4H, m), 8.34 (1H, s), 8.96 (1H, m), 9.04
(1H, s), 10.06 (1H, br s)
(22) 8- (2,6-dichlorobenzoylamino) -3-[(2-pyridyl
) Ethynyl] quinoline hydrochloride
mp: 196-197 ℃
NMR (DMSO-d6, Δ): 7.46-7.62 (4H, m), 7.72-7.82 (2H,
m), 7.86 (1H, d, J = 8 Hz), 7.96 (1H, t, J = 8 Hz), 8.66 (1H, d, J
J = 6Hz), 8.76-8.82 (2H, m), 9.06 (1H, s), 10.94 (1H, s)
(23) 8- (2,6-dichlorobenzoylamino) -3- (3-hydroxy
-3-Methyl-1-butynyl) quinoline
mp: 216-217 ℃
NMR (CDClThree, Δ): 1.66 (6H, s), 2.08 (1H, s), 7.30-7.44
(3H, m), 7.54 (1H, d, J = 8Hz), 7.64 (1H, t, J = 8Hz), 8.24 (1H,
s), 8.74 (1H, s), 8.96 (1H, d, J = 8Hz), 9.90 (1H, br s)
(24) 5- (2,6-dichlorobenzoylamino) -2,3-dimethylquino
Oxaline
mp: 252-254 ℃
NMR (CDClThree, Δ): 2.70 (3H, s), 2.75 (3H, s), 7.30-7.48
(3H, m), 7.68-7.80 (2H, m), 8.89 (1H, m), 9.71 (1H, br s)
(25) 5- (2,6-dichlorobenzoylamino) quinoxaline
mp: 200-201 ℃
NMR (CDClThree, Δ): 7.30-7.47 (3H, m), 7.80-7.95 (2H,
m), 8.72 (1H, s), 8.93 (1H, s), 9.01 (1H, d, J = 7Hz), 9.71 (1H, s)
br s)
(26) 8- (2,6-dichlorobenzoylamino) -4- (ethoxycarbo
Nylmethyl) quinazoline
mp: 193-195 ℃
NMR (CDClThree, Δ): 1.32 (3H, t, J = 7 Hz), 4.21 (2H, q,
J = 7Hz), 5.50 (1H, s), 7.27-7.50 (5H, m), 7.71 (1H, s), 8.87
(1H, d, J = 8Hz), 9.41 (1H, br s)
(27) 8- (2,6-dichlorobenzoylamino) -2-methylquinoline
mp: 181-182 ℃
NMR (CDClThree, Δ): 2.70 (3H, s), 7.25 to 7.48 (4H, m),
7.50-7.60 (2H, m), 8.05 (1H, d, J = 9Hz), 8.92 (1H, t, J = 5Hz),
10.09 (1H, brs)
(28) 8- (2,6-dichlorobenzoylamino) quinoline
mp: 223-224 ℃
NMR (CDClThree, Δ): 7.30-7.50 (4H, m), 7.55-7.68 (2H, m),
8.20 (1H, d, J = 8Hz), 8.78 (1H, d, J = 4Hz), 8.98 (1H, d, J = 8Hz)
(29) 8- (2,6-dichlorobenzoylamino) -4-methoxyquinazoly
N
mp: 214-215 ℃
NMR (CDClThree, Δ): 4.20 (3H, s), 7.30-7.45 (3H, m), 7.62
(1H, t, J = 8Hz), 7.89 (1H, d, J = 8Hz), 8.72 (1H, s), 9.07 (1H,
d, J = 8Hz), 9.66 (1H, br s)
(30) 3-bromo-8- (2,6-dichlorobenzoylamino) quinoline
mp: 223-225 ℃
NMR (CDClThree, Δ): 7.30-7.45 (3H, m), 7.52 (1H, d,
J = 8Hz), 7.65 (1H, t, J = 8Hz), 8.34 (1H, s), 8.77 (1H, s), 8.97
(1H, d, J = 8Hz), 9.33 (1H, br s)
(31) 6- (2,6-dichlorobenzoylamino) -2,3-dimethyl-2
H-pyrazolo [4,3-c] quinoline
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.62 (3H, s), 4.43 (3H, s), 7.45
7.65 (3H, m), 7.78 (1H, t, J = 8Hz), 8.34 (1H, d, J = 8Hz), 8.80
(1H, d, J = 8Hz), 9.17 (1H, s)
Its hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.63 (3H, s), 4.45 (3H, s),
7.50-7.70 (3H, m), 7.80 (1H, t, J = 8Hz), 8.36 (1H, d, J = 8Hz),
8.78 (1H, d, J = 8Hz), 9.22 (1H, s)
(32) 8- (2,6-dichlorobenzoylamino) -4- (2-methylphen
Nylamino) -3- (1-oxobutyl) quinoline
mp: 208-210 ℃
NMR (CDClThree, Δ): 1.06 (3H, t, J = 7 Hz), 1.83 (2H, m),
2.37 (3H, s), 3.09 (2H, t, J = 7Hz), 6.99 (1H, d, J = 7Hz), 7.05-
7.25 (4H, m), 7.30-7.45 (4H, m), 8.85 (1H, d, J = 7Hz), 9.04
(1H, s)
(33) 3- (2,6-dichlorobenzoylamino) -thieno [3,2-b]
Pyridine hydrochloride
mp: 205-232 ℃
NMR (DMSO-d6, Δ): 7.45-7.57 (4H, m), 8.50-8.60 (2H,
m), 8.70 (1H, d, J = 4Hz)
(34) 8- (2,6-dichlorobenzoylamino) -3-((E) -2-e
Toxicarbonylvinyl) quinoline
mp: 186-188 ℃
NMR (CDClThree, Δ): 1.38 (3H, t, J = 7Hz), 4.32 (2H, q,
J = 7Hz), 6.64 (1H, d, J = 17Hz), 7.34-7.46 (3H, m), 7.60-7.72
(2H, m), 7.84 (1H, d, J = 17Hz), 8.26 (1H, s), 8.94 (1H, s),
9.00 (1H, d, J = 8Hz), 9.94 (1H, br s)
(35) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-ethoxy
Xycarbonylquinoline
mp: 129.4 ℃
NMR (CDClThree, Δ): 1.44 (3H, t, J = 7.5 Hz), 4.48 (2H, q,
J = 7.5Hz), 7.30-7.46 (3H, m), 7.76 (1H, t, J = 7.5Hz), 8.15 (1H,
d, J = 7.5Hz), 9.06 (1H, s), 9.10 (1H, d, J = 7.5Hz)
(36) 8- (2,6-dichlorobenzoylamino) -3- (trimethylsilyl)
Ruethynyl) quinoline
mp: 201-202 ℃
NMR (CDClThree, Δ): 0.30 (9H, s), 7.31-7.43 (3H, m), 7.53
(1H, d, J = 8Hz), 7.62 (1H, t, J = 8Hz), 8.28 (1H, s), 8.75 (1H,
s), 8.97 (1H, d, J = 8Hz)
(37) 2-tert-butoxycarbonyl-6- (2,6-dichlorobenzoyl
Amino) -2,3-dihydro-1-methyl-1H-pyrazolo [4,3-c] quino
Phosphorus-3-one
mp:> 250 ℃
NMR (CDClThree, Δ): 1.68 (9H, s), 3.78 (3H, s), 7.30-7.50
(3H, m), 7.74 (1H, d, J = 8Hz), 7.89 (1H, d, J = 8Hz), 9.00 (1H,
s), 9.17 (1H, d, J = 8Hz)Example 3
(1) 8-amino-4-hydroxymethylquinoline (85 mg), 2,6 chloride
-Chlorination of dichlorobenzoyl (225 mg) and triethylamine (198 mg)
The mixture in ethylene (1.5 ml) was stirred at 80 ° C. overnight. After cooling, the mixture
Dilute with dichloromethane, wash with brine, dry over magnesium sulfate, and add
The solvent is distilled off with 4- (2,6-dichlorobenzoyloxymethyl) -8- (
2,6-Dichlorobenzoylamino) quinoline (116 mg) was obtained.
mp: 237 ° C (decomposition)
NMR (DMSO-d6, Δ): 6.00 (2H, s), 7.46-7.65 (6H, m),
7.74 (1H, t, J = 7.5Hz), 7.78 (1H, d, J = 4Hz), 7.95 (1H, d, J = 4Hz)
J = 7.5Hz), 8.76 (1H, d, J = 7.5Hz), 8.92 (1H, d, J = 4Hz)
(2) 4- (2,6-dichlorobenzoyloxymethyl) -8- (2,6-di
Chlorobenzoylamino) quinoline (100mg), 1N sodium hydroxide solution
(0.4 ml) of a mixture of ethanol (2 ml) and dioxane (1 ml)
Refluxed for hours. After cooling, the mixture was diluted with dichloromethane and saturated sodium bicarbonate
After washing with a solvent solution and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Was purified by flash chromatography (ethyl acetate-n-hexane) to give 8
-(2,6-dichlorobenzoylamino) -4-hydroxymethylquinoline (2
0 mg).
mp: 234.8-239.0 ℃
NMR (CDClThree-CDThreeOD, δ): 5.16 (2H, s), 7.30-7.46 (3H,
m), 7.57-7.71 (3H, m), 8.75 (1H, d, J = 5Hz), 8.92 (1H, d,
(J = 7.5Hz)
Its hydrochloride
mp: 222-228 ℃
NMR (CDClThree-CDThreeOD, δ); 5.34 (2H, s), 7.35-7.47 (3H,
m), 7.87-7.98 (2H, m), 8.18 (1H, d, J = 7Hz), 8.94-9.06 (2H, m)Example 4
(1) 8-amino-4-hydroxyquinoline (300 mg), 2,6-dichloride
Chlorobenzoyl (432 mg), triethylamine (569 mg) and a catalytic amount
A mixture of dimethylaminopyridine in dimethylacetamide (3 ml) was cooled on ice.
For 1 hour. Water (3 ml) was added to the mixture, and the resulting precipitate was collected by filtration.
I did. The residue was suspended in hot ethanol (10 ml) with stirring. The resulting precipitate
The residue was collected by filtration and the residue was flash chromatographed (ethyl acetate-
Dichloromethane) to give 8-amino-4- (2,6-dichlorobenzoyl
Oxy) quinoline (240 mg) was obtained.
NMR (CDClThree, Δ): 5.03 (2H, brs), 6.95 (1H, d,
J = 7.5Hz), 7.30-7.52 (6H, m), 8.79 (1H, d, J = 5Hz)
(2) 8-amino-4- (2,6-dichlorobenzoyloxy) quinoline (2
10 mg), 2,6-dichlorobenzoyl chloride (145 mg) and triethylamido
(191 mg) in ethylene chloride (3 ml) was stirred at 70 ° C. for 24 hours.
did. Dilute the mixture with dichloromethane, wash with water and dry over magnesium sulfate
Thereafter, the solvent was distilled off in vacuo. The residue was washed with diethyl ether to give 4- (2
, 6-Dichlorobenzoyloxy) -8- (2,6-dichlorobenzoylamino
) Quinoline (290 mg) was obtained.
mp: 248 ℃
NMR (CDClThree, Δ): 7.30-7.50 (6H, m), 7.58 (1H, d,
J = 4Hz), 7.66 (1H, t, J = 7.5Hz), 7.94 (1H, d, J = 7.5Hz), 8.84
(1H, d, J = 4Hz), 9.03 (1H, d, J = 7.5Hz)
(3) 8- (2,6-dichlorobenzoylamino) -1,4-dihydro-4-
Oxoquinoline was obtained in the same manner as in Example 3- (2).
mp: 342 ℃
NMR (DMSO-d6, Δ): 5.95-6.27 (1H, m), 7.31-7.46 (2H,
m), 7.49-7.70 (3H, m), 7.88-8.09 (2H, m), 8.12 (1H, br s)Example 5
8- (2,6-dichlorobenzoylamino) -3- (trimethylsilylethini
L) To a solution of quinoline (150 mg) in tetrahydrofuran (3 ml) was added 1M
A solution of tetrabutylammonium fluoride in tetrahydrofuran (0.04 ml)
The mixture was added under ice cooling, and the mixture was stirred at the same temperature for 2 hours. Dilute the mixture with dichloromethane
And washed with water and brine, dried over magnesium sulfate and evaporated in vacuo
. The residue was subjected to silica gel column chromatography (ethyl acetate: n-hexane,
1: 4, v / v) to give 8- (2,6-dichlorobenzoylamino) -3.
-Ethynylquinoline (111 mg) was obtained.
mp: 219-220 ℃
NMR (CDClThree, Δ): 3.30 (1H, s), 7.30-7.46 (3H, m), 7.56
(1H, d, J = 8Hz), 7.66 (1H, t, J = 8Hz), 8.32 (1H, s), 8.80 (1H,
s), 9.00 (1H, d, J = 8Hz), 9.92 (1H, br s)Example 6
2-tert-butoxycarbonyl-6- (2,6-dichlorobenzoylamino)
-2,3-dihydro-1-methyl-1H-pyrazolo [4,3-c] quinoline-3
-On (30 mg) in methanol (1 ml) was added to a solution of
Chill solution (1 ml) was added at room temperature and the mixture was stirred at the same temperature for 1 hour. True mixture
Concentrate in air and crystallize the residue from ethanol-ethyl acetate to give 6- (2,6
-Dichlorobenzoylamino) -2,3-dihydro-1-methyl-1H-pyrazo
B [4,3-c] quinolin-3-one hydrochloride (17.9 mg) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 4.30 (3H, s), 7.50-7.70 (3H, m),
7.78 (1H, t, J = 8Hz), 8.32 (1H, d, J = 8Hz), 8.76 (1H, d, J = 8Hz),
9.13 (1H, s)
Example 7
6- (2,6-dichlorobenzoylamino) -2,3-dihydro-1-methyl
-1H-pyrazolo [4,3-c] quinolin-3-one hydrochloride (85 mg), 4-
Chloromethylpyridine hydrochloride (40mg) and potassium carbonate (111mg)
The mixture in tilformamide (1 ml) was stirred at room temperature for 3 hours. Acetic acid mixture
Partitioned between ethyl and water. Wash the organic layer with brine and dry over magnesium sulfate
After drying, the solvent was distilled off in vacuo. Silica gel column chromatography of the residue
To give 6- (2,6-dichlorobenzoylamino) -2,3-dihydro-
1-methyl-2- (pyridin-4-ylmethyl) -1H-pyrazolo [4,3-c
] Quinolin-3-one was obtained.
The resulting compound is dissolved in a solution of hydrogen chloride in methanol and the mixture is removed in vacuo.
Concentrate to give 6- (2,6-dichlorobenzoylamino) -2,3-dihydro-1
-Methyl-2- (pyridin-4-ylmethyl) -1H-pyrazolo [4,3-c]
This yielded 83 mg of kiya-n-3-one dihydrochloride.
mp: 226-234 ℃
NMR (DMSO-d6, Δ): 4.33 (3H, s), 5.83 (2H, s),
7.48-7.65 (3H, m), 7.80 (1H, t, J = 8Hz), 8.18 (2H, d, J = 6Hz),
8.32 (1H, d, J = 8Hz), 8.81 (1H, d, J = 8Hz), 8.93 (2H, d, J = 6Hz),
9.18 (1H, s)Example 8
4-chloro-8- (2,6-dichlorobenzoylamino) quinoline (100 m
g) and 2-methoxyethylamine (314 mg) in N-methylpyrrolidone (1 m
The mixture in l) was heated at 120 ° C. overnight. Add water (3ml) under ice-cooling
The mixture was stirred for 1 hour. The resulting precipitate is collected by filtration and the residue is
After purification by chromatography (methanol-dichloromethane), 8- (2,6
-Dichlorobenzoylamino) -4- (2-methoxyethylamino) quinoline (
65 mg).
mp: 166 ℃
NMR (CDClThree, Δ): 3.43-3.53 (2H, m), 3.44 (3H, s), 3.71
(2H, t, J = 6Hz), 5.44 (1H, brt, J = 6Hz), 6.45 (1H, d, J = 5Hz),
7.25-7.40 (3H, m), 7.42-7.55 (2H, m), 8.40 (1H, d, J = 5Hz),
8.89 (1H, d, J = 7.5Hz)Example 9
The following compound was obtained in the same manner as in Example 8.
(1) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Il) quinoline
mp: 236 ℃
NMR (CDClThree, Δ): 7.31-7.46 (6H, m), 7.60 (1H, d,
J = 7.5Hz), 7.70 (1H, t, J = 7.5Hz), 7.88 (1H, s), 8.86 (1H, d,
J = 4Hz), 9.08 (1H, d, J = 7.5Hz)
Its hydrochloride
mp: 238-241 ℃
NMR (DMSO-d6, Δ): 7.46-7.63 (4H, m), 7.81 (1H, t,
J = 8Hz), 8.00 (1H, d, J = 4Hz), 8.07 (1H, s), 8.26 (1H, s), 8.85
(1H, d, J = 8Hz), 9.14 (1H, d, J = 4Hz), 9.69 (1H, s)
(2) 4- (1H-benzimidazol-1-yl) -8- (2,6-dichloro
Lobenzoylamino) quinoline
mp: 244.0 ° C
NMR (CDClThree, Δ): 7.23 (1H, d, J = 8 Hz), 7.29-7.46 (6H,
m), 7.56 (1H, d, J = 5Hz), 7.66 (1H, t, J = 7.5Hz), 7.96 (1H, d, J = 7.5Hz)
J = 7.5Hz), 8.19 (1H, s), 8.94 (1H, d, J = 5Hz), 9.08 (1H, d,
(J = 7.5Hz)
(3) 8- (2,6-dichlorobenzoylamino) -4- [2- (dimethyla
Mino) ethylamino] quinoline
mp: 171 ℃
NMR (CDClThree, Δ): 2.29 (6H, s), 2.69 (2H, t, J = 7.5Hz),
3.23-3.34 (2H, m), 5.97 (1H, m), 6.40 (1H, d, J = 5Hz), 7.24
7.40 (3H, m), 7.47 (1H, t, J = 7.5Hz), 7.54 (1H, d, J = 7.5Hz),
8.47 (1H, d, J = 5Hz), 8.88 (1H, d, J = 7.5Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3- (1-propenyl) quinoline hydrochloride
(3-allyl-4-chloro-8- (2,6-dichlorobenzoylamino) quino
From phosphorus and imidazole)
mp: 220-229 ℃
NMR (DMSO-d6, Δ): 1.88 (3H, d, J = 6 Hz), 6.07 (1H, d,
J = 15Hz), 6.83 (1H, m), 7.06 (1H, d, J = 8Hz), 7.45-7.60 (3H, m),
7.73 (1H, t, J = 8Hz), 7.95-8.05 (2H, m), 8.73 (1H, d, J = 8Hz),
9.27 (1H, s), 9.37 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (Imidazol-1-yl) quinoline
mp: 219-220 ℃
NMR (CDClThree, Δ): 1.17 (3H, t, J = 7 Hz), 4.23 (2H, q,
J = 7Hz), 7.18 (1H, s), 7.25-7.50 (5H, m), 7.66 (1H, s), 7.71
(1H, t, J = 8Hz), 9.13 (1H, d, J = 8Hz), 9.29 (1H, s)
Its hydrochloride
mp: 219-221 ℃ (decomposition)
NMR (DMSO-d6, Δ): 1.14 (3H, t, J = 7 Hz), 4.22 (2H, q,
J = 7Hz), 7.32 (1H, d, J = 8Hz), 7.45 to 7.65 (3H, m), 7.88 (1H, t,
J = 8Hz), 8.00 (1H, s), 8.08 (1H, s), 8.92 (1H, d, J = 8Hz), 9.41
(1H, s), 9.45 (1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-[(pyridin-2-ylmethyl) amino] quinoline dihydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.31 (3H, t, J = 7 Hz), 4.34 (2H, q,
J = 7Hz), 5.32 (2H, brs), 7.40-7.70 (5H, m), 7.75 (1H, t,
J = 8Hz), 8.03 (1H, t, J = 8Hz), 8.52 (1H, d, J = 8Hz), 8.62 (1H, d,
J = 8Hz), 8.70 (1H, d, J = 5Hz), 8.85 (1H, s)
(7) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-morpholinoquinoline
mp: 186-187 ℃
NMR (CDClThree, Δ): 1.44 (3H, t, J = 7Hz), 3.37 (4H, m),
3.97 (4H, m), 4.47 (2H, q, J = 7Hz), 7.30-7.50 (3H, m), 7.61
(1H, t, J = 8Hz), 7.91 (1H, d, J = 8Hz), 8.75 (1H, s), 8.98 (1H,
d, J = 8Hz)
Its hydrochloride
mp: 178-181 ℃
NMR (DMSO-d6, Δ): 1.37 (3H, t, J = 8Hz), 3.28 (4H, m),
3.87 (4H, m), 4.41 (2H, q, J = 7Hz), 7.40-7.60 (3H, m), 7.70
(1H, t, J = 8Hz), 8.00 (1H, d, J = 8Hz), 8.74 (1H, d, J = 8Hz), 8.77
(1H, s)
(8) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (4-Methylpiperazin-1-yl) quinoline
mp: 177-178 ℃
NMR (CDClThree, Δ): 1.41 (3H, t, J = 7 Hz), 2.43 (3H, s),
2.69 (4H, m), 3.39 (4H, m), 4.44 (2H, q, J = 7Hz), 7.30-7.50
(3H, m), 7.59 (1H, t, J = 8Hz), 7.89 (1H, d, J = 8Hz), 8.71 (1H,
s), 8.95 (1H, d, J = 8Hz)
Its hydrochloride
mp: 156-162 ℃
NMR (DMSO-d6, Δ): 1.40 (3H, t, J = 7Hz), 2.90 (3H, s),
3.40-3.60 (8H, m), 4.43 (2H, q, J = 7Hz), 7.40-7.60 (3H, m),
7.74 (1H, t, J = 8Hz), 7.97 (1H, d, J = 8Hz), 8.78 (1H, d, J = 8Hz),
8.83 (1H, s)
(9) 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (imi
Dazol-1-yl) quinoline
mp: 220-221 ℃
NMR (DMSO-d6, Δ): 7.06 (1H, d, J = 8 Hz), 7.30 (1H, s),
7.45-7.60 (3H, m), 7.77 (1H, t, J = 8Hz), 8.02 (1H, s), 8.79
(1H, d, J = 8Hz), 9.20 (1H, s)
Its hydrochloride
mp: 234-236 ℃
NMR (DMSO-d6, Δ): 7.22 (1H, d, J = 8 Hz), 7.45-7.60 (3H,
m), 7.81 (1H, t, J = 8Hz), 7.95 (1H, s), 8.02 (1H, s), 8.83 (1H,
d, J = 8Hz), 9.25 (1H, s), 9.28 (1H, s)
(10) 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (4
-Methylpiperazin-1-yl) quinoline
mp: 152-153 ℃
NMR (CDClThree, Δ): 2.43 (3H, s), 2.67 (4H, m), 3.50 (4H,
m), 7.30-7.50 (3H, m), 7.59 (1H, t, J = 8Hz), 7.93 (1H, d,
J = 8Hz), 8.67 (1H, s), 8.92 (1H, d, J = 8Hz)
Its dihydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.91 (3H, s), 3.35 to 4.40 (8H,
br m), 7.45-7.60 (3H, m), 7.74 (1H, t, J = 8Hz), 8.03 (1H, m),
8.73 (1H, d, J = 8Hz), 8.87 (1H, s)Example 10
4-chloro-8- (2,6-dichlorobenzoylamino) quinoline (130 m
g) and 2-methoxyethylamine (210 mg) in dimethylformamide (1.
5 ml) was heated at 100 ° C. for 5 hours. The mixture is concentrated in vacuo and the residue
The distillate was purified by preparative thin layer chromatography to give 8- (2,6-dichlorobenzo).
(Ilamino) -4-dimethylaminoquinoline (94 mg) was obtained.
mp: 215-216 ℃
NMR (CDClThree, Δ): 3.06 (6H, s), 6.77 (1H, d, J = 5Hz),
7.26-7.52 (3H, m), 7.50 (1H, t, J = 7.5Hz), 7.79 (1H, d,
J = 7.5Hz), 8.48 (1H, d, J = 5Hz), 8.89 (1H, d, J = 7.5Hz)Example 11
8- (2,6-dichlorobenzoylamino) -4-phenoxyquinoline was
In the same manner as in Production Example 2- (2), 4-chloro-8- (2,6-dichlorobenzoyl
It was obtained by reacting amino) quinoline with sodium phenoxide.
mp: 170.4 ° C
NMR (CDClThree, Δ): 6.60 (1H, d, J = 5Hz), 7.14-7.53 (8H,
m), 7.65 (1H, t, J = 7.5Hz), 8.11 (1H, d, J = 7.5Hz), 8.51 (1H, d,
J = 5Hz), 9.01 (1H, d, J = 7.5Hz)Example 12
(1) 8- (2,6-dichlorobenzoylamino) -3-methylquinoline (1
08mg), N-bromosuccinimide (69.6mg) and 2,2'-azobis
(2,4-dimethyl-4-methoxyvaleronitrile) (10.1 mg) in dichloromethane
The mixture in dichloromethane and carbon tetrachloride was refluxed for 2 hours. After cooling, the mixture was washed with ethyl acetate.
Diluted with water, washed with water, saturated sodium bicarbonate solution and brine, and dried over magnesium sulfate.
After drying in vacuo, the solvent was evaporated in vacuo to give 3-bromomethyl-8- (2,6-dichloromethane.
A residue containing (lorobenzoylamino) quinoline was obtained. Dimethylform residue
Dissolve in amide and add acetic acid (27.5 mg) and potassium carbonate (63.2 mg)
Was added. After stirring at room temperature for 3 hours, the mixture was poured into water and extracted with ethyl acetate. Yes
The organic layer was washed with brine, dried over magnesium sulfate, and the solvent was distilled off in vacuo.
Silica gel column chromatography of the residue (ethyl acetate-dichloromethane)
And purified with 3-acetoxymethyl-8- (2,6-dichlorobenzoylamino
) Quinoline (48.4 mg) was obtained.
mp: 199-201 ℃
NMR (CDClThree, Δ): 2.12 (3H, s), 5.30 (2H, s), 7.30-7.50
(3H, m), 7.50-7.70 (2H, m), 8.19 (1H, s), 8.78 (1H, s), 8.98
(1H, d, J = 8Hz)
(2) 3-acetoxymethyl-8- (2,6-dichlorobenzoylamino) ki
Dioxin of norin (25.9 mg) and 1N sodium hydroxide solution (0.24 ml)
A mixture of the solution in the sun and dimethylformamide (4 drops) was stirred at room temperature for 2 hours
.
The mixture was poured into water and extracted with ethyl acetate. Wash the organic layer with saline
After drying with nesium, the solvent was distilled off in vacuo. The residue was ethyl acetate-n-hexa.
Recrystallized from 8-butane, 8- (2,6-dichlorobenzoylamino) -3-hydroxy.
Cimethylquinoline (20 mg) was obtained.
mp: 224-226 ° C
NMR (CDClThree, Δ): 1.92 (1H, t, J = 7Hz), 4.95 (1H, d,
J = 7Hz), 7.30-7.50 (3H, m), 7.50-7.70 (2H, m), 8.18 (1H, s),
8.79 (1H, s), 8.96 (1H, d, J = 8Hz)
Its hydrochloride
mp: 217 ℃
NMR (DMSO-d6, Δ): 4.75 (2H, s), 7.49-7.61 (3H, m),
7.65 (1H, t, J = 8Hz), 7.78 (1H, d, J = 8Hz), 8.31 (1H, s), 8.68
(1H, d, J = 8Hz), 8.85 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethylki
To a solution of norin (300 mg) in tetrahydrofuran was added carbon tetrabromide (573 m).
g) and triphenylphosphine (453 mg) were added and the mixture was allowed to stand at room temperature for 30 minutes.
Stirred. The insoluble material was removed by filtration, and the solvent was distilled off from the filtrate in vacuo. Silica residue
Purification by gel column chromatography (dichloromethane) yields 3-bromomethyl
8- (2,6-dichlorobenzoylamino) quinoline (253.4 mg)
Obtained.
mp: 223-224 ℃
NMR (CDClThree, Δ): 4.66 (2H, s), 7.30-7.50 (3H, m), 7.59
(1H, d, J = 8Hz), 7.66 (1H, t, J = 8Hz), 8.18 (1H, s), 8.81 (1H,
s), 8.98 (1H, d, J = 8Hz)
(4) 8- (2,6-dichlorobenzoylamino) -3-methoxymethylquino
Phosphorus was prepared in the same manner as in Production Example 2- (2), using 3-bromomethyl-8- (2,6-di
Obtained by reacting chlorobenzoylamino) quinoline with sodium methoxide
.
mp: 163 ℃
NMR (CDClThree, Δ): 3.47 (3H, s), 4.67 (2H, s), 7.30-7.50
(3H, m), 7.50-7.70 (2H, m), 8.15 (1H, s), 8.76 (1H, s), 8.96
(1H, d, J = 8Hz)
Its hydrochloride
mp: 159-166 ℃
NMR (DMSO-d6, Δ): 3.37 (3H, s), 4.67 (2H, s), 7.40-
7.60 (3H, m), 7.67 (1H, t, J = 8Hz), 7.79 (1H, d, J = 8Hz), 8.36
(1H, s), 8.70 (1H, d, J = 8Hz), 8.85 (1H, s)
(5) 3-bromomethyl-8- (2,6-dichlorobenzoylamino) quinoli
(120 mg) and phenol (30.3 mg) in dimethylformamide
To the solution was added potassium tert-butoxide (72.2 mg), and the mixture was stirred at room temperature for 1 hour.
While stirring. The mixture was poured into a saturated ammonium chloride solution and extracted with ethyl acetate
. The organic layer was washed with brine, dried over magnesium sulfate and evaporated in vacuo.
Was. The residue was subjected to silica gel column chromatography (ethyl acetate-n-hexane).
) To give 8- (2,6-dichlorobenzoylamino) -3-phenoxyme
Tilquinoline (87.1 mg) was obtained.
mp: 157 ℃
NMR (CDClThree, Δ): 5.28 (2H, s), 6.90-7.10 (3H, m),
7.25-7.50 (5H, m), 7.55-7.70 (2H, m), 8.26 (1H, s), 8.86 (1H,
s), 9.98 (1H, d, J = 8Hz)
Its hydrochloride
mp: 164-171 ℃
NMR (DMSO-d6, Δ): 4.59 (2H, s), 6.18 (1H, t, J = 8Hz),
6.20-6.30 (2H, m), 6.45-6.55 (2H, m), 6.60-6.80 (3H, m), 7.00
(1H, t, J = 8Hz), 7.14 (1H, d, J = 8Hz), 7.90 (1H, d, J = 8Hz), 8.29
(1H, s)Example 13
8- (2,6-dichlorobenzoylamino) -3-hydroxymethylquinoline
(100 mg) and thionyl chloride (1 ml) in dichloromethane (1 ml)
The material was stirred at room temperature for 2 hours. After concentration, the residue was washed with N, N-dimethylformamide.
(1 ml), and 2-mercaptoimidazole (32 mg) and potassium carbonate were added to the solution.
Lithium (60 mg) was added. The mixture was stirred at room temperature for 3 hours. The resulting mixture
Poured into cold water and extracted with ethyl acetate. Eat the organic layer with saturated aqueous sodium bicarbonate
After washing with brine and drying over anhydrous sodium sulfate, the solvent was distilled off in vacuo. Residue
Is purified by silica gel using dichloromethane: methanol (20: 1) as an elution solvent.
Purification by column chromatography gave an oil. 10% of the obtained oil
Treatment with methanolic hydrogen chloride and evaporation of the solvent in vacuo. Acetic acid
Crystallized from ethyl to give 8- (2,6-dichlorobenzoylamino) -3-[(
Imidazol-2-yl) thiomethyl] quinoline hydrochloride (102 mg) was obtained.
mp:> 250 ℃
NMR (CDClThree, Δ): 4.79 (2H, s), 7.48-7.61 (3H, m),
7.63-7.72 (4H, m), 8.20 (1H, s), 8.71 (1H, dd, J = 15,8Hz),
8.83 (1H, s)Example 14
8- (2,6-dichlorobenzoylamino) -3-methylquinoline (250 m
g), N-bromosuccinimide (175 mg) and 2,2'-azobis (2,4
-Dimethyl-4-methoxyvaleronitrile) (23.3 mg) in dichloromethane
The mixture therein was refluxed for 2 hours. After cooling, the mixture was diluted with ethyl acetate, saturated with water,
Wash with sodium bicarbonate solution and brine, dry over magnesium sulfate, and vacuum
The solvent was distilled off. The residue was subjected to silica gel column chromatography (dichlorometa
5-bromo-8- (2,6-dichlorobenzoylamino) -3
-Methylquinoline (54.2 mg) was obtained.
mp: 238-239 ℃
NMR (CDClThree, Δ): 2.49 (3H, s), 7.30-7.50 (3H, m), 7.85
(1H, d, J = 8Hz), 8.31 (1H, s), 8.64 (1H, s), 8.78 (1H, d,
(J = 8Hz)Example 15
8- (2,6-dichlorobenzoylamino) -3-methylquinoline (104 m
g), N-bromosuccinimide (67.1 mg) and 2,2'-azobis (2,
4-dimethyl-4-methoxyvaleronitrile) (20.1 mg) of carbon tetrachloride (
(3 ml) was refluxed for 2 hours. After cooling, the mixture was washed with water, saturated sodium bicarbonate
After washing with sodium chloride solution and brine, drying over magnesium sulfate, the solvent was distilled off in vacuo.
To give 3-bromomethyl-8- (2,6-dichlorobenzoylamino) quinoline
A residue was obtained. The residue was dissolved in ethylene chloride and imidazole (64
. 1 mg) was added. After stirring at 60 ° C. for 2.5 hours, the mixture was washed with water and brine.
After drying over magnesium sulfate, the solvent was distilled off in vacuo. Silica gel residue
Purification by column chromatography (ethyl acetate-dichloromethane) gave 8- (2
, 6-Dichlorobenzoylamino) -3- (imidazol-1-ylmethyl) ki
Norin (36.2 mg) was obtained.
mp: 177-179 ℃
NMR (CDClThree, Δ): 5.34 (2H, s), 6.94 (1H, s), 8.98 (1H,
d, J = 8Hz), 7.15 (1H, s), 7.30-7.50 (3H, m), 7.55 (1H, d,
J = 8Hz), 7.6-7.7 (2H, m), 7.90 (1H, s), 8.63 (1H, s)Example 16
3-acetyl-8- (2,6-dichlorobenzoylamino) -4-methoxy
To a solution of norin (115 mg) in tetrahydrofuran was added sodium borohydride.
(16.8 mg) was added at 0 ° C., and the mixture was stirred at the same temperature for 30 minutes. The mixture
Poured into water and extracted with ethyl acetate. The organic layer is washed with a saline solution and magnesium sulfate
After drying in vacuo, the solvent was distilled off in vacuo to give 8- (2,6-dichlorobenzoylamino).
) -3- (1-Hydroxyethyl) -4-methoxyquinoline (85.1 mg)
Obtained.
To a solution of the obtained compound (75 mg) in ethyl acetate was added hydrogen chloride in ethyl acetate.
A 4N solution in (0.25 ml) was added and the solvent was removed in vacuo to give 8- (2,6
-Dichlorobenzoylamino) -3- (1-hydroxyethyl) -4-methoxy
Quinoline hydrochloride (70 mg) was obtained.
mp:> 210 ° C (decomposition)
NMR (CDClThree, Δ): 1.61 (3H, br s), 4.32 (3H, s), 5.54
(1H, br s), 7.30-7.50 (4H, m), 8.07 (1H, d, J = 8Hz), 9.16 (1H,
d, J = 8Hz), 9.43 (1H, br s)Example 17
0.9M methylmagnesium bromide in tetrahydrofuran solution (1.8ml)
, 8- (2,6-Dichlorobenzoylamino) -3-ethoxycarbonylquinol
(100 mg) in anhydrous tetrahydrofuran (4 ml) was added dropwise at 4 ° C.
The mixture was stirred at the same temperature for 30 minutes. Add saturated ammonium chloride solution to the mixture
And extracted with ethyl acetate. Wash the organic layer with brine and dry over magnesium sulfate
The solvent was distilled off in vacuo. The residue was purified by silica gel column chromatography (vinegar).
Ethyl-n-hexane) to give 8- (2,6-dichlorobenzoylamino).
No) -3- (1-Hydroxy-1-methylethyl) quinoline (55.1 mg)
Obtained.
mp: 187-189 ℃
NMR (CDClThree, Δ): 1.70 (6H, s), 1.89 (1H, s), 7.30-7.50
(3H, m), 7.50-7.70 (2H, m), 8.27 (1H, s), 8.90-9.00 (2H, m)Example 18
8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonylquinol
(300 mg) and 1N sodium hydroxide solution (1.95 ml) in tetrahydro
The mixture in furan (10 ml) was stirred at 50 ° C. for 6 hours. Concentrate the mixture in vacuo
And water was added to the residue. The solution was washed with diethyl ether, and the aqueous layer was washed with 1N hydrochloric acid.
The pH was adjusted to 3 with. The resulting precipitate was collected by filtration, washed with water,
Boxy-8- (2,6-dichlorobenzoylamino) quinoline (251.1 mg
) Got.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.40-7.60 (3H, m), 7.76 (1H, t,
J = 8Hz), 8.00 (1H, d, J = 8Hz), 8.81 (1H, d, J = 8Hz), 9.02 (1H,
s), 9.29 (1H, s)Example 19
3-carboxy-8- (2,6-dichlorobenzoylamino) quinoline (12
Oxalyl chloride (170 mg) and dimethyl
Ruformamide (1 drop) was added dropwise and the mixture was stirred at room temperature for 1 hour. True mixture
Concentrate in air and dissolve the residue in anhydrous tetrahydrofuran (3 ml). In solution
A concentrated ammonia solution (5 ml) was added with stirring and the mixture was stirred at room temperature for 1 hour.
Was. Dilute the mixture with ethyl acetate, wash with brine and dry over magnesium sulfate
The solvent was distilled off in vacuo. The residue was recrystallized from ethyl acetate-n-hexane.
, 3-carbamoyl-8- (2,6-dichlorobenzoylamino) quinoline (9
7.9 mg).
mp:> 250 ℃
NMR (DMSO6, Δ): 7.40-7.60 (3H, m), 7.70-7.80 (2H,
7.74 (1H, t, J = 8Hz), 7.88 (1H, d, J = 8Hz), 8.38
(1H, br s), 8.80 (1H, d, J = 8Hz), 8.91 (1H, s), 9.28 (1H, s)Example 20
8- (2,6-dichlorobenzoylamino) -3- (morpholinocarbonyl)
Quinoline was prepared in the same manner as in Example 19, using 3-carboxy-8- (2,6-dichloromethane).
Robenzoylamino) quinoline and morpholine.
mp: 204-205 ℃
NMR (CDClThree, Δ): 3.40-4.00 (8H, m), 7.30-7.50 (3H, m),
7.65 (1H, d, J = 8Hz), 7.70 (1H, t, J = 8Hz), 8.27 (1H, s), 8.84
(1H, s), 9.06 (1H, d, J = 8Hz)Example 21
8- (2,6-dichlorobenzoylamino) -4-ethoxy-3-ethoxyca
A solution of rubonylquinoline (179 mg) in tetrahydrofuran was added to a solution of borohydride.
Lithium oxide (22.5 mg) was added and the mixture was stirred at 50 ° C. for 4 hours. mixture
To the mixture was added a saturated ammonium chloride solution dropwise, and the mixture was extracted with ethyl acetate. Organic layer saturated weight
Wash with sodium carbonate solution and brine, dry over magnesium sulfate, and dissolve in vacuo.
The medium was distilled off. The residue was subjected to silica gel column chromatography (ethyl acetate-n
-Hexane) to give 8- (2,6-dichlorobenzoylamino) -4-e
Toxi-3-hydroxymethylquinoline (55.9 mg) was obtained.
To a solution of the obtained compound (50 mg) in ethyl acetate was added hydrogen chloride in ethyl acetate.
4N solution (0.15 ml) was added and the resulting precipitate was collected by filtration to give 8-
(2,6-dichlorobenzoylamino) -4-ethoxy-3-hydroxymethyl
Quinoline hydrochloride (47 mg) was obtained.
mp:> 250 ℃
NMR (CDClThree, Δ): 1.63 (3H, t, J = 7Hz), 4.77 (2H, q,
J = 7Hz), 4.96 (2H, s), 7.30-7.50 (3H, m), 8.15 (1H, d, J = 8Hz),
9.09 (1H, d, J = 8Hz), 9.14 (1H, s)Example 22
(1) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-e
Toxiquinoline was prepared in the same manner as in Example 18 by using 8- (2,6-dichlorobenzoic acid).
Lamino) -4-ethoxy-3-ethoxycarbonylquinoline.
mp: 207-208 ℃
NMR (CDClThree, Δ): 1.60 (3H, t, J = 7Hz), 4.46 (2H, q,
J = 7Hz), 7.30-7.50 (3H, m), 7,70 (1H, t, J = 8Hz), 7.96 (1H, d,
J = 8Hz), 9.09 (1H, d, J = 8Hz), 9.25 (1H, s)
(2) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-e
To a solution of toxic quinoline (153 mg) in dimethylformamide was added 1-ethyl
-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (109 mg)
1-Hydroxybenzotriazole (76.5 mg) was added and the mixture was allowed
Stirred for hours. A concentrated ammonia solution (0.2 ml) was added to the mixture while stirring,
The mixture was stirred at room temperature for 6 hours. The mixture was poured into water and extracted with ethyl acetate. Yes
The organic layer is washed with saturated ammonium chloride solution, saturated sodium bicarbonate solution and brine.
After drying over magnesium sulfate, the solvent was distilled off in vacuo. Is the residue ethanol?
And then crystallized to give 3-carbamoyl-8- (2,6-dichlorobenzoylamino)
-4-ethoxyquinoline (128.3 mg) was obtained.
mp: 242-245 ℃
NMR (DMSO-d6, Δ): 1.44 (3H, t, J = 7 Hz), 4.38 (2H, q,
J = 7Hz), 7.40-7.60 (3H, m), 7.69 (1H, t, J = 8Hz), 7.85 (1H, s),
8.00 (1H, d, J = 8Hz), 8.10 (1H, s), 8.75 (1H, d, J = 8Hz), 8.80
(1H, s)
(3) 3-carbamoyl-8- (2,6-dichlorobenzoylamino) -4-
To a solution of ethoxyquinoline (122 mg) in dimethylformamide was added thiochloride.
Nyl (53.9 mg) was added and the mixture was stirred at room temperature for 30 minutes. Saturate the mixture
Poured into sodium bicarbonate solution and extracted with ethyl acetate. Wash the organic layer with saline
After drying over magnesium sulfate, the solvent was distilled off in vacuo. Silica gel residue
Purification by column chromatography (ethyl acetate-n-hexane) gave 3-cyano
-8- (2,6-Dichlorobenzoylamino) -4-ethoxyquinoline (89.
9 mg).
mp: 200-201 ℃
NMR (CDClThree, Δ): 1.63 (3H, t, J = 7Hz), 4.92 (2H, q,
J = 7Hz), 7.30-7.45 (3H, m), 7.66 (1H, t, J = 8Hz), 8.00 (1H, d,
J = 8Hz), 8.66 (1H, s), 9.08 (1H, d, J = 8Hz), 9.81 (1H, s)
Its hydrochloride
mp: 191-193 ℃
NMR (CDClThree-CDThreeOD, δ): 1.63 (3H, t, J = 7Hz), 4.92 (2H,
q, J = 7Hz), 7.30-7.50 (3H, m), 7.66 (1H, t, J = 8Hz), 8.00 (1H,
d, J = 8Hz), 8.66 (1H, s), 9.06 (1H, d, J = 8Hz)Example 23
8- (2,6-dichlorobenzoylamino) -4-dimethylamino-3-hydrido
Roxymethylquinoline hydrochloride was prepared in the same manner as in Example 21 by using 8- (2,6-dichloromethane).
(Rolobenzoylamino) -3-ethoxycarbonyl-4-dimethylaminoquinolyl
Obtained from
mp: 124-156 ℃
NMR (CDClThree, Δ): 3.46 (6H, s), 4.88 (2H, s), 7.30-7.50
(3H, m), 7.66 (1H, t, J = 8Hz), 7.87 (1H, d, J = 8Hz), 8.80-8.90
(2H, m)Example 24
(1) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-di
Methylaminoquinoline was prepared in the same manner as in Example 18 by using 8- (2,6-dichlorobenzene).
Nzoylamino) -3-ethoxycarbonyl-4-dimethylaminoquinoline
Obtained.
mp: 160-163 ℃
NMR (DMSO-d6, Δ): 3.10 (6H, s), 7.40-7.60 (4H, m),
7.98 (1H, d, J = 8Hz), 8.72 (1H, d, J = 8Hz), 8.76 (1H, s)
(2) 3-carbamoyl-8- (2,6-dichlorobenzoylamino) -4-
Dimethylaminoquinoline was obtained in the same manner as in Example 22- (2).
mp: 222-223 ℃
NMR (DMSO-d6, Δ): 3.06 (6H, s), 7.40-7.65 (4H, m),
7.71 (1H, br s), 7.92 (1H, d, J = 8 Hz), 8.03 (1H, br s), 8.53
(1H, s), 8.67 (1H, d, J = 8Hz)
(3) 3-cyano-8- (2,6-dichlorobenzoylamino) -4-dimethyl
Luminoquinoline was obtained in the same manner as in Example 22- (3).
mp: 227-228 ℃
NMR (DMSO-d6, δ): 3.39 (6H, s), 7.40-7.70 (4H, m), 7.93
(1H, d, J = 8Hz), 8.64 (1H, s), 8.73 (1H, d, J = 8Hz)
Its hydrochloride
mp: 219-223 ℃
NMR (DMSO-d6, Δ): 3.40 (6H, s), 7.40-7.70 (4H, m),
7.93 (1H, d, J = 8Hz), 8.65 (1H, s), 8.73 (1H, d, J = 8Hz)Example 25
3-bromo-4-chloro-8- (2,6-dichlorobenzoylamino) quinoli
(120 mg) in N-methylpyrrolidone was added to 2-mercaptoimidazolone.
(33.5 mg) and potassium carbonate (50.1 mg) were added, and the mixture was allowed to stand at room temperature.
The mixture was stirred for 40 minutes at 40 ° C. for 1 hour, at 80 ° C. for 1 hour, and at 90 ° C. for 1 hour.
Water was added to the mixture and the resulting precipitate was collected by filtration, washed with water and ethanol.
, 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (imidazo
Le
-2-ylthio) quinoline (88.0 mg) was obtained.
mp: 249-251 ℃
NMR (DMSO-d6, Δ): 6.93 (1H, br s), 7.18 (1H, br s),
7.45-7.60 (3H, m), 7.70 (1H, t, J = 8Hz), 8.07 (1H, d, J = 8Hz),
8.71 (1H, d, J = 8Hz), 9.03 (1H, s)
Its hydrochloride
mp: 240-242 ℃
NMR (DMSO-d6, Δ): 7.45-7.60 (5H, m), 7.80 (1H, t,
J = 8Hz), 8.10 (1H, d, J = 8Hz), 8.79 (1H, d, J = 8Hz), 9.10 (1H, s)Example 26
(1) 4-carboxymethyl-3-bromo-8- (2,6-dichlorobenzoi
Ruamino) quinoline was prepared in the same manner as in Example 18 by using 3-bromo-8- (2,6-
From dichlorobenzoylamino) -4- (ethoxycarbonylmethyl) quinoline
Obtained.
mp:> 250 ℃
NMR (CDCl3, δ): 4.33 (2H, s), 7.30-7.50 (3H, m), 7.69
(1H, t, J = 8Hz), 7.74 (1H, d, J = 8Hz), 8.84 (1H, s), 8.99 (1H,
d, J = 8Hz)
(2) In a mixture of dimethylformamide (17.4 mg) and dichloromethane,
Oxalyl chloride (27.7 mg) was added and the mixture was stirred at room temperature for 30 minutes. Mixed
The compound was added to 3-bromo-4-carboxymethyl-8- (2,6-dichlorobenzoyl
Amino) quinoline (90 mg) was added at 0 ° C. and the mixture was stirred at the same temperature for 1 hour.
2-Aminomethylpyridine (107 mg) was added to the mixture at 0 ° C, and the mixture was cooled to room temperature.
For 30 minutes. Mix the mixture with dichloromethane and saturated ammonium chloride solution.
Dispensed between. Wash the organic layer with saturated sodium bicarbonate solution and brine,
After drying with nesium, the solvent was distilled off in vacuo. Preparative thin-layer chromatography of the residue
And purified by recrystallization from ethanol to give 3-bromo-8- (2,6-dichloromethane.
Lorobenzoylamino) -4-[(pyridin-2-ylmethyl) carbamoylmeth
[Chill] quinoline (58.0 mg) was obtained.
mp: 197-199 ° C
NMR (DMSO-d6, Δ): 4.34 (2H, s), 4.39 (2H, d, J = 7Hz),
7.27 (1H, dd, J = 5, 8Hz), 7.32 (1H, d, J = 8Hz), 7.45 to 7.60 (3H,
m), 7.72 (1H, t, J = 8 Hz), 7.77 (1H, t, J = 8 Hz), 7.98 (1H, d,
J = 8Hz), 8.51 (1H, d, J = 5Hz), 8.73 (1H, d, J = 8Hz), 8.85 (1H, t,
J = 7Hz), 8.96 (1H, s)
Its hydrochloride
mp: 241-248 ℃
NMR (DMSO-d6, Δ): 4.39 (2H, s), 4.56 (2H, d, J = 7Hz),
7.45-7.75 (6H, m), 7.98 (1H, d, J = 8Hz), 8.24 (1H, t, J = 8Hz),
8.70 (1H, d, J = 5Hz), 8.76 (1H, d, J = 8Hz), 8.95 (1H, s), 9.06
(1H, t, J = 7Hz)Example 27
(1) 4-carboxymethoxy-8- (2,6-dichlorobenzoylamino)
Quinoline was prepared in the same manner as in Example 18 by using 8- (2,6-dichlorobenzoylamido).
No) -4- (Ethoxycarbonylmethoxy) quinoline.
mp: 190-204 ℃
NMR (DMSO-d6, Δ): 4.64 (2H, s), 6.87 (1H, d, J = 5Hz),
7.45-7.63 (4H, m), 7.95 (1H, d, J = 7.5Hz), 8.63 (1H, d, J = 5Hz),
8.68 (1H, d, J = 7.5Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (dimethylcarbamo
Ilmethoxy) quinoline was converted to 4-carboxy as described in Example 22- (2).
Methoxy-8- (2,6-dichlorobenzoylamino) quinoline and dimethylamido
Obtained from the hydrochloride salt.
mp: 222-224.5 ℃
NMR (CDClThree, Δ): 2.99 (3H, s), 3.14 (3H, s), 4.97 (2H,
s), 6.84 (1H, d, J = 4 Hz), 7.26-7.43 (3H, m), 7.57 (1H, t,
J = 7.5Hz), 7.98 (1H, d, J = 7.5Hz), 8.57 (1H, d, J = 4Hz), 8.96
(1H, d, J = 7.5Hz)
Example 28
8- (2,6-dichlorobenzoylamino) -4- (imidazol-2-yl
Thio) -3-allylquinoline was prepared in the same manner as in Example 25.
Rollo-8- (2,6-dichlorobenzoylamino) quinoline and 2-mercaptoy
Obtained by reacting with midazole.
mp: 206-208 ℃
NMR (DMSO-d6, Δ): 3.91 (2H, d, J = 6 Hz), 5.00 (1H, d,
J = 17Hz), 5.07 (1H, d, J = 11Hz), 5.99 (1H, m), 7.02 (2H, brs),
7.40-7.60 (3H, m), 7.67 (1H, t, J = 8Hz), 8.20 (1H, d, J = 8Hz),
8.66 (1H, d, J = 8Hz), 8.72 (1H, s)
Its dihydrochloride
mp: 138-170 ℃
NMR (DMSO-d6, Δ): 3.90 (2H, d, J = 6 Hz), 4.94 (1H, d,
J = 16Hz), 5.05 (1H, d, J = 11Hz), 5.97 (1H, m), 7.45-7.60 (3H,
m), 7.74 (1H, t, J = 8Hz), 8.00 (1H, d, J = 8Hz), 8.74 (1H, d,
J = 8Hz), 8.94 (1H, s)Example 29
8- (2,6-dichlorobenzoylamino) -4-vinylquinoline (150 m
g) in dioxane and water suspension, add a catalytic amount of male tetroxide in tertiary butanol
Mium was added under ice cooling and the mixture was stirred for 5 minutes. Sodium periodate in the mixture
(206 mg) was added under ice cooling, and the mixture was stirred at the same temperature for 30 minutes and at room temperature for 6 hours.
did. To the mixture was added a saturated sodium bicarbonate solution and extracted with dichloromethane.
After the organic layer was dried over magnesium sulfate, the solvent was distilled off in vacuo. Flush residue
After purification by chromatography (dichloromethane-n-hexane), 8- (
2,6-Dichlorobenzoylamino) -4-formylquinoline (85 mg) was obtained.
Was.
mp: 239.3 ℃
NMR (CDClThree, Δ): 7.29-7.46 (3H, m), 7.81 (1H, t,
J = 7.5Hz), 7.86 (1H, d, J = 5Hz), 8.70 (1H, d, J = 7.5Hz), 9.03
(1H, d, J = 5Hz), 9.06 (1H, d, J = 7.5Hz), 10.02 (1H, br s), 10.27
(1H, s)Example 30
8- (2,6-dichlorobenzoylamino) -4-formylquinoline (100
mg), N- (2-methoxyethyl) methylamine (28 mg) and acetic acid (17 m
g) in a stirred suspension of sodium triacetoxyborohydride (91.6 mg)
Was added in small portions at room temperature over 5 minutes, and the resulting mixture was stirred at the same temperature for 4 hours. Coarse
The product was partitioned between dichloromethane and saturated aqueous sodium bicarbonate. Organic layer
Was dried over anhydrous magnesium sulfate, filtered, and the solvent was distilled off under reduced pressure. Residue
Purification by preparative thin-layer chromatography (5% methanol-dichloromethane)
Recrystallization from ethanol gave 8- (2,6-dichlorobenzoylamino) -4-
[N- (2-methoxyethyl) -N-methylaminomethyl] quinoline (77 mg
) Was obtained as a colorless powder.
mp: 127.7-133.7 ℃
NMR (CDClThree, Δ): 2.32 (3H, s), 2.72 (2H, t, J = 7.5Hz),
3.36 (3H, s), 3.58 (2H, t, J = 7.5Hz), 3.99 (2H, s), 7.26-7.44
(3H, m), 7.54 (1H, d, J = 5Hz), 7.61 (1H, t, J = 7.5Hz), 7.96 (1H,
d, J = 7.5Hz), 8.70 (1H, d, J = 5Hz), 8.95 (1H, d, J = 7.5Hz)Example 31
8- (2,6-dichlorobenzoylamino) -4-((E) -2-ethoxyca
Rubonylvinyl) quinoline was prepared in the same manner as in Production Example 19- (2), using 8- (2,6).
-Dichlorobenzoylamino) -4-formylquinoline and (triphenylphospho)
(Ranylidene) obtained by reacting with ethyl acetate.
mp: 157.4 ° C
NMR (CDClThree, Δ): 1.39 (3H, t, J = 7.5 Hz), 4.34 (2H, q,
J = 7.5Hz), 6.64 (1H, d, J = 18Hz), 7.29-7.44 (3H, m), 7.59 (1H,
d, J = 4Hz), 7.70 (1H, t, J = 7.5Hz), 7.90 (1H, d, J = 7.5Hz), 8.38
(1H, d, J = 18Hz), 8.77 (1H, d, J = 4Hz), 9.01 (1H, d, J = 7.5Hz)Example 32
8- (2,6-dichlorobenzoylamino) -3-methylthioquinoline (10
M-chloroperbenzoic acid (68 mg) in a solution of 6 mg) in dichloromethane and water.
Was added under ice cooling, and the mixture was stirred for 1 hour. Mixture is saturated sodium bicarbonate solution
After washing with sodium chloride and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residual
The product was purified by preparative thin-layer chromatography (dichloromethane-methanol).
8- (2,6-dichlorobenzoylamino) -3-methylsulfinylquinoline
(71 mg) and 8- (2,6-dichlorobenzoylamino) -3-methylsulfo
Nilquinoline (68 mg) was obtained.
8- (2,6-dichlorobenzoylamino) -3-methylsulfinylquinol
N
mp: 229-231 ℃
NMR (CDClThree, Δ): 2.89 (3H, s), 7.32 to 7.45 (3H, m),
7.69-7.78 (2H, m), 8.60 (1H, d, J = 2Hz), 8.87 (1H, d, J = 2Hz),
9.09 (1H, d, J = 8Hz)
8- (2,6-dichlorobenzoylamino) -3-methylsulfonylquinoline
mp: 253-255 ℃
NMR (CDClThree, Δ): 3.19 (3H, s), 7.35 to 7.48 (3H, m),
7.74-7.86 (2H, m), 8.83 (1H, s), 9.16-9.22 (2H, m)Example 33
(1) 8- (2,6-dichlorobenzoylamino) -3-formylquinoline
In the same manner as in Example 29, 8- (2,6-dichlorobenzoylamino) -3-
Obtained from vinylquinoline.
mp: 232-233 ℃
NMR (CDClThree, Δ): 7.32-7.46 (3H, m), 7.70-7.80 (2H, m),
8.64 (1H, s), 9.14 (1H, d, J = 7.5 Hz), 9.24 (1H, s), 10.00 (1H,
br s), 10.28 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-formylquinoline (
150 mg), nitromethane (1.5 ml) and ammonium acetate (30 mg).
The mixture in dioxane (1 ml) was stirred at 90 ° C. for 2 hours. Mixture in vacuum
The solvent was distilled off from. The residue was subjected to silica gel column chromatography (dichloro
(Methane-methanol) to give 8- (2,6-dichlorobenzoylamino)
-3- (1-Hydroxy-2-nitroethyl) quinoline (126 mg) was obtained.
mp: 190-191 ℃
NMR (CDClThree-CDThreeOD, δ): 4.62 (1H, dd, J = 4, 14Hz), 4.71
(1H, dd, J = 8, 14Hz), 5.68 (1H, dd, J = 4, 8Hz), 7.32-7.46 (3H,
m), 7.60-7.70 (2H, m), 8.29 (1H, s), 8.82 (1H, s), 8.97 (1H,
d, J = 8Hz)Example 34
(1) 8- (2,6-dichlorobenzoylamino) -3-formylquinoline (
700 mg) and methyl methylsulfinylmethyl sulfide (302 mg)
To a mixture of the above in tetrahydrofuran was added potassium tert-butoxide (501 mg).
Was added at 4 ° C., and the mixture was stirred at the same temperature for 30 minutes and refluxed for 1.5 hours. The mixture
Poured into cold saturated ammonium chloride solution and extracted with ethyl acetate. Organic layer with salt
After washing with water and drying over magnesium sulfate, the solvent was distilled off in vacuo. Dichlorome
The resulting residue in tan (3 ml) and 34% hydrogen chloride in ethanol (5 ml)
) Was stirred at room temperature for 2 hours. The mixture is concentrated in vacuo and the residue is
Partitioned between ethyl and saturated sodium bicarbonate solution. Wash the organic layer with saline
After drying over magnesium sulfate, the solvent was distilled off in vacuo. Silica gel residue
Purification by column chromatography (ethyl acetate-n-hexane) gave 8- (2,2)
6-dichlorobenzoylamino) -3- (ethoxycarbonylmethyl) quinoline
(329 mg) was obtained.
mp: 151 ℃
NMR (CDClThree, Δ): 1.27 (3H, t, J = 7Hz), 3.81 (2H, s),
4.18 (2H, q, J = 7Hz), 7.30-7.50 (3H, m), 7.56 (1H, d, J = 8Hz),
7.62 (1H, t, J = 8Hz), 8.10 (1H, s), 8.70 (1H, s), 8.94 (1H, d,
(J = 8Hz)
Its hydrochloride
mp: 174-184 ℃
NMR (DMSO-d6, Δ): 1.20 (3H, t, J = 7Hz), 3.97 (2H, s),
4.30 (2H, overlap), 7.40-7.60 (3H, m), 7.66 (1H, t, J = 8Hz),
7.75 (1H, d, J = 8Hz), 8.31 (1H, s), 8.68 (1H, d, J = 8Hz), 8.82
(1H, s)
(2) 3-carboxymethyl-8- (2,6-dichlorobenzoylamino) ki
Norin was obtained in the same manner as in Example 18.
mp:> 250 ℃
NMR (CDClThree, Δ): 3.81 (2H, s), 7.30-7.50 (3H, m), 7.57
(1H, d, J = 8Hz), 7.62 (1H, d, J = 8Hz), 8.11 (1H, s), 8.71 (1H,
s), 8.92 (1H, d, J = 8Hz)
(3) 3-carbamoylmethyl-8- (2,6-dichlorobenzoylamino)
Quinoline was obtained in the same manner as in Example 22- (2).
mp: 251-253 ℃
NMR (DMSO-d6, Δ): 3.66 (2H, s), 7.04 (1H, br s),
7.40-7.70 (5H, m), 7.74 (1H, d, J = 8Hz), 8.24 (1H, s), 8.67
(1H, d, J = 8Hz), 8.78 (1H, s)
Its hydrochloride
mp: 248-251 ℃
NMR (DMSO-d6, Δ): 3.66 (2H, s), 7.05 (1H, br s),
7.40-7.70 (5H, m), 7.74 (1H, d, J = 8Hz), 8.25 (1H, s), 8.67
(1H, d, J = 8Hz), 8.79 (1H, s)Example 35
(1) 8- (2,6-dichlorobenzoylamino) -3- (1-hydroxyd
Cyl) quinoline was prepared in the same manner as in Example 17 by using 8- (2,6-dichlorobenzoyl).
Ruamino) -3-formylquinoline and methylmagnesium bromide.
Was.
mp: 215-217 ° C
NMR (CDClThree, Δ): 1.62 (3H, d, J = 7 Hz), 2.03 (1H, d,
J = 5Hz), 5.16 (1H, m), 7.30-7.50 (3H, m), 7.59 (1H, d, J = 8Hz),
7.62 (1H, t, J = 8Hz), 8.17 (1H, s), 8.80 (1H, s), 8.93 (1H, d,
(J = 8Hz)
Its hydrochloride
mp: 200-204 ℃
NMR (DMSO-d6, Δ): 1.46 (3H, d, J = 7Hz), 5.01 (1H, m),
7.40-7.70 (4H, m), 7.78 (1H, d, J = 8Hz), 8.33 (1H, s), 8.67
(1H, (1, J = 8Hz), 8.90 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3- (1-hydroxyd
Oxidation to a solution of tyl) quinoline (562 mg) in dichloromethane (20 ml)
Manganese (IV) (2.71 g) was added and the mixture was stirred at room temperature overnight. Insoluble matter
Was filtered off and the filtrate was concentrated in vacuo. The residue was crystallized from ethanol to give 3-
Acetyl-8- (2,6-dichlorobenzoylamino) quinoline (101 mg)
I got
mp: 243-245 ℃
NMR (CDClThree, Δ): 2.75 (3H, s), 7.30-7.50 (3H, m),
7.60-7.80 (2H, m), 8.74 (1H, s), 9.10 (1H, d, J = 8Hz), 9.30
(1H, s), 9.98 (1H, s)
(3) 3-acetyl-8- (2,6-dichlorobenzoylamino) quinoline (
399 mg), hydroxylamine hydrochloride (232 mg) and sodium bicarbonate (
(467 mg) in ethanol was refluxed for 5 hours. Pour the mixture into water and
Extracted with chloromethane. Wash the organic layer with brine and dry over magnesium sulfate
The solvent was distilled off in vacuo. The residue was crystallized from ethanol to give 8- (2,6
-Dichlorobenzoylamino) -3- (1-hydroxyiminoethyl) quinoline
(313 mg) was obtained.
mp: 215-243 ℃
NMR (DMSO-d6, Δ): 2.30 (3H, m), 7.45 to 7.60 (3H, m),
7.69 (1H, t, J = 8Hz), 7.84 (1H, d, J = 8Hz), 8.59 (1H, s), 8.72
(1H, d, J = 8Hz), 9.26 (1H, s), 10.81 (1H, s), 11.66 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -3- (1-hydroxyi
To a solution of (minoethyl) quinoline (168 mg) in pyridine was added phosphoryl chloride (
(516 mg) at 4 ° C. and the mixture was stirred at the same temperature for 50 minutes. Pour the mixture into ice
And extracted with dichloromethane. Organic layer with saturated sodium bicarbonate solution and brine
After washing and drying over magnesium sulfate, the solvent was distilled off in vacuo. Ethano residue
Recrystallized from toluene and water to give 3-acetylamino-8- (2,6-dichlorobenzo
(Ilamino) quinoline (19 mg) was obtained.
mp: 244-245 ℃
NMR (DMSO-d6, Δ): 2.14 (3H, s), 7.40-7.65 (4H, m),
7.71 (1H, d, J = 8Hz), 8.59 (1H, d, J = 8Hz), 8.73 (1H, s), 8.89
(1H, s), 10.50 (1H, s), 10.71 (1H, s)Example 36
8- (2,6-dichlorobenzoylamino) -3- (α-hydroxybenzyl
) Quinoline was prepared in the same manner as in Example 17 by using 8- (2,6-dichlorobenzoyla).
Mino) -3-formylquinoline obtained by reacting with phenylmagnesium bromide.
.
mp: 218-220 ℃
NMR (DMSO-d6, Δ): 6.02 (1H, d, J = 4 Hz), 6.28 (1H, d,
J = 4Hz), 7.23 (1H, t, J = 7Hz), 7.33 (2H, t, J = 7Hz), 7.45 (2H, d,
J = 7Hz), 7.50-7.60 (3H, m), 7.64 (1H, t, J = 8Hz), 7.77 (1H, d,
J = 8Hz), 8.37 (1H, s), 8.66 (1H, d, J = 8Hz), 8.86 (1H, s)
Its hydrochloride
mp: 130-134 ℃
NMR (DMSO-d6, Δ): 6.01 (1H, s), 7.23 (1H, t, J = 7Hz),
7.33 (2H, t, J = 7Hz), 7.45 (2H, d, J = 7Hz), 7.45-7.60 (3H, m),
7.64 (1H, t, J = 8Hz), 7.78 (1H, d, J = 8Hz), 8.37 (1H, s), 8.66
(1H, d, J = 8Hz), 8.86 (1H, s)Example 37
8- (2,6-dichlorobenzoylamino) -4-ethoxycarbonylmethyl
Quinazoline (90mg) and 1N sodium hydroxide solution (1ml) in ethanol
(5 ml) was refluxed for 30 minutes. The mixture was diluted with water and the resulting precipitate
Was collected by filtration, washed with water and treated with 8- (2,6-dichlorobenzoylamino).
) -4-Methylquinazoline (70 mg) was obtained.
mp: 223-225 ℃
NMR (CDClThree, Δ): 2.98 (3H, s), 7.30-7.45 (3H, m), 7.70
(1H, t, J = 8Hz), 7.84 (1H, d, J = 8Hz), 9.09 (1H, s), 9.11 (1H,
d, J = 8Hz), 9.80 (1H, br s)Example 38
8- (2,6-dichlorobenzoylamino) -3- (pyridin-2-yl) ki
Norin hydrochloride was prepared in the same manner as in Production Example 14 by using 3-bromo-8- (2,6-dichloromethane).
Robenzoylamino) quinoline and tri-n-butyl (2-pyridyl) tin
.
mp: 248-249 ℃
NMR (DMSO-d6, Δ): 7.50-7.62 (4H, m), 7.74 (1H, t,
J = 8Hz), 7.93 (1H, d, J = 8Hz), 8.12 (1H, t, J = 8Hz), 8.31 (1H, d,
J = 8Hz), 8.78 (1H, d, J = 8Hz), 8.82 (1H, d, J = 8Hz), 9.13 (1H,
s), 9.59 (1H, s)Example 39
3- (3-aminophenyl) -8- (2,6-dichlorobenzoylamino) ki
Norin was prepared in the same manner as in Production Example 16- (1), using 3-bromo-8- (2,6-dichloromethane).
Rolobenzoylamino) quinoline and 3-aminophenylboric acid.
mp: 193-194 ℃
NMR (CDClThree, Δ): 3.83 (2H, br s), 6.78 (1H, dd, J = 2,
8Hz), 7.00 (1H, d, J = 2Hz), 7.08 (1H, d, J = 8Hz), 7.28-7.38 (2H,
m), 7.40-7.45 (2H, m), 7.62-7.66 (2H, m), 8.30 (1H, d, J = 2Hz),
8.95 (1H, t, J = 8Hz), 9.00 (1H, d, J = 2Hz)Example 40
(1) 8- (2,6-dichlorobenzoylamino) -3-((E) -2-cal
Boxyvinyl) quinoline was prepared in the same manner as in Example 18 by using 8- (2,6-dichloro
Benzoylamino) -3-((E) -2-ethoxycarbonylvinyl) quinoline
Obtained from.
mp:> 250 ℃
NMR (CDClThree, Δ): 6.89 (1H, d, J = 16Hz), 7.45 to 7.60 (3H,
m), 7.70 (1H, t, J = 8Hz), 7.78-7.85 (2H, m), 8.72 (1H, d,
J = 8Hz), 8.77 (1H, s), 9.20 (1H, s)
(2) 3-((E) -2-carbamoylvinyl) -8- (2,6-dichlorobe
(Nzoylamino) quinoline hydrochloride was obtained in the same manner as in Example 19.
mp: 210-225 ℃
NMR (DMSO-d6, Δ): 6.91 (1H, d, J = 16 Hz), 7.26 (1H, br
s), 7.50-7.80 (5H, m), 7.83 (1H, d, J = 8Hz), 8.62 (1H, s), 8.74
(1H, d, J = 8Hz), 9.11 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-[(E) -2- (di
Methylcarbamoyl) vinyl] quinoline was obtained in the same manner as in Example 19.
mp: 241-242 ℃
NMR (CDClThree, Δ): 3.11 (3H, s), 3.22 (3H, s), 7.11 (1H,
d, J = 15Hz), 7.30-7.50 (3H, m), 7.50-7.70 (2H, m), 7.82 (1H, d,
J = 15Hz), 8.27 (1H, s), 8.94 (1H, s), 8.97 (1H, d, J = 8Hz)
Its hydrochloride
mp: 241-243 ℃
NMR (CDClThree, Δ): 3.12 (3H, s), 3.23 (3H, s), 7.14 (1H,
d, J = 15Hz), 7.30-7.50 (3H, m), 7.60-7.80 (2H, m), 7.83 (1H, d,
J = 15Hz), 8.35 (1H, s), 8.98 (1H, s), 9.02 (1H, d, J = 8Hz)Example 41
8- (2,6-dichlorobenzoylamino) -3-((E) -2-ethoxyca
Dicarbonyl of (rubonylvinyl) quinoline (40mg) and platinum (IV) oxide (5mg)
The mixture in sun (1 ml) was stirred under a hydrogen atmosphere at room temperature for 3 hours. Filter insoluble matter
Removed and the filtrate was concentrated in vacuo. The residue was separated by preparative thin-layer chromatography (acetic acid
And purified by 8- (2,6-dichlorobenzoylamino).
-3- (2-Ethoxycarbonylethyl) quinoline (16 mg) was obtained.
mp: 110-111 ℃
NMR (CDClThree, Δ): 1.22 (3H, t, J = 7 Hz), 2.73 (2H, t,
J = 7Hz), 3.15 (2H, t, J = 7Hz), 4.13 (2H, q, J = 7Hz), 7.30-7.50
(3H, m), 7.52 (1H, d, J = 8Hz), 7.59 (1H, t, J = 8Hz), 8.00 (1H,
s), 8.66 (1H, s), 8.91 (1H, d, J = 8Hz)Example 42
8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl-4-
Vinyl quinoline was prepared in the same manner as in Production Example 12- (2), using 4-chloro-8- (2,
6-dichlorobenzoylamino) -3-ethoxycarbonylquinoline and tri-n
-Butyl (vinyl) tin.
mp: 155-156 ℃
NMR (CDClThree, Δ): 1.42 (3H, t, J = 7 Hz), 4.43 (2H, q,
J = 7Hz), 5.00 (1H, d, J = 15Hz), 5.88 (1H, d, J = 11Hz), 7.30-7.50
(4H, m), 7.67 (1H, t, J = 8Hz), 8.04 (1H, d, J = 8Hz), 9.05 (1H,
d, J = 8Hz), 9.17 (1H, s)Example 43
The following compound was obtained in the same manner as in Example 18.
(1) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4- (
Imidazol-1-yl) quinoline
mp:> 250 ℃
NMR (DMSO-d6, δ): 7.13 (1H, d, J = 8 Hz), 7.22 (1H, s),
7.50-7.70 (4H, m), 7.79 (1H, t, J = 8Hz), 7.97 (1H, s), 8.86
(1H, d, J = 8Hz), 9.31 (1H, s)
(2) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-mo
Ruholinoquinoline
mp: 155-164 ℃
NMR (CDClThree, Δ): 3.61 (4H, m), 4.07 (4H, m), 7.30-7.50
(3H, m), 7.75 (1H, t, J = 8Hz), 8.05 (1H, d, J = 8Hz), 9.12 (1H,
d, J = 8Hz), 9.53 (1H, s)
(3) 3-carboxy-4-chloro-8- (2,6-dichlorobenzoylamido
No) Quinoline
mp: 243-244 ° C
NMR (DMSO-d6, Δ): 7.40-7.60 (3H, m), 7.90 (1H, t,
J = 8Hz), 8.16 (1H, d, J = 8Hz), 8.87 (1H, d, J = 8Hz), 9.12 (1H, s)Example 44
The following compounds were obtained in the same manner as in Example 19 or 22- (2).
(1) 3-carbamoyl-8- (2,6-dichlorobensoylamino) -4-
(Imidazol-1-yl) quinoline
mp: 232-233 ℃
NMR (CDClThree, Δ): 5.34 (1H, br s), 5.67 (1H, br s),
7.20-7.50 (6H, m), 7.73 (1H, t, J = 8Hz), 7.79 (1H, s), 9.13
(1H, d, J = 8Hz), 9.23 (1H, s)
(2) 3-carbamoyl-8- (2,6-dichlorobenzoylamino) -4-
Morpholinoquinoline
mP:> 250 ° C
NMR (DMSO-d6, Δ): 3.45 (4H, m), 3.97 (4H, m), 5.95
(1H, br s), 6.44 (1H, br s), 7.30-7.50 (3H, m), 7.61 (1H, t,
J = 8Hz), 7.89 (1H, d, J = 8Hz), 8.74 (1H, s), 8.95 (1H, d, J = 8Hz)
(3) 3-carbamoyl-4-chloro-8- (2,6-dichlorobenzoyla
Mino) Quinoline
mp:> 251 ℃
NMR (DMSO-d6, Δ): 7.45-7.60 (3H, m), 7.87 (1H, t,
J = 8Hz), 8.00 (1H, s), 8.07 (1H, d, J = 8Hz), 8.21 (1H, s), 8.82
(1H, d, J = 8Hz), 8.84 (1H, s)Example 45
3-carbamoyl-8- (2,6-dichlorobenzoylamino) -4- (4-
Methylpiperazin-1-yl) quinoline was prepared as in Examples 18 and 22- (2).
Thus, 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
From 4- (4-methylpiperazin-1-yl) quinoline and concentrated ammonia solution
Obtained.
mp: 195-198 ℃
NMR (CDClThree, Δ): 2.34 (3H, s), 2.69 (4H, m), 3.50 (4H,
m), 5.93 (1H, br s), 6.74 (1H, br s), 7.30-7.50 (3H, m), 7.59
(1H, t, J = 8Hz), 7.91 (1H, d, J = 8Hz), 8.82 (1H, s), 8.96 (1H,
d, J = 8Hz)Example 46
The following compound was obtained in the same manner as in Example 22- (3).
(1) 3-cyano-8- (2,6-dichlorobenzoylamino) -4- (imi
Dazol-1-yl) quinoline
mp: 211-212 ℃
NMR (CDClThree, Δ): 7.30-7.50 (5H, m), 7.52 (1H, d,
J = 8Hz), 7.82 (1H, t, J = 8Hz), 7.89 (1H, s), 9.02 (1H, s), 9.23
(1H, d, J = 8Hz), 9.37 (1H, s)
Its hydrochloride
mp: 213-215 ℃
NMR (DMSO-d6, δ): 7.48 (1H, d, J = 8 Hz), 7.50-7.70 (3H,
m), 7.79 (1H, s), 7.92 (1H, t, J = 8Hz), 8.06 (1H, s), 8.95 (1H,
d, J = 8Hz), 9.04 (1H, s), 9.45 (1H, s)
(2) 3-cyano-8- (2,6-dichlorobenzoylamino) -4-morpho
Linoquinoline
mp: 236-237 ℃
NMR (CDClThree, Δ): 3.76 (4H, m), 4.00 (4H, m), 7.30-7.50
(3H, m), 7.62 (1H, t, J = 8Hz), 7.73 (1H, d, J = 8Hz), 8.62 (1H,
s), 9.04 (1H, d, J = 8Hz)
Its hydrochloride
mp: 145-150 ℃
NMR (DMSO-d6, Δ): 3.70 (4H, m), 3.90 (4H, m), 7.40-
7.60 (3H, m), 7.69 (1H, t, J = 8Hz), 7.88 (1H, d, J = 8Hz), 8.77
(1H, d, J = 8Hz), 8.78 (1H, s)
(3) 3-cyano-8- (2,6-dichlorobenzoylamino) -4- (4-
Methylpiperazin-1-yl) quinoline
mp: 196-200 ℃
NMR (DMSO-d6, Δ): 2.30 (3H, s), 2.62 (4H, m), 3.69
(4H, m), 7.40-7.60 (3H, m), 7.67 (1H, t, J = 8Hz), 7.84 (1H ,, d,
J = 8Hz), 8.73 (1H, s), 8.76 (1H, d, J = 8Hz)
Its dihydrochloride
mp: 211-220 ℃
NMR (DMSO-d6, Δ): 2.90 (3H, s), 3.43 (2H, m), 3.60
(2H, m), 3.80-4.20 (4H, m), 7.40-7.60 (3H, m), 7.73 (1H, t,
J = 8Hz), 7.85 (1H, d, J = 8Hz), 8.80 (1H, d, J = 8Hz), 8.84 (1H, s)
(4) 4-chloro-3-cyano-8- (2,6-dichlorobenzoylamino)
Quinoline
mp: 239-241 ℃
NMR (CDClThree, Δ): 7.30-7.50 (3H, m), 7.86 (1H, t,
J = 8Hz), 8.06 (1H, d, J = 8Hz), 8.85 (1H, s), 9.20 (1H, d,
J = 8Hz), 9.83 (1H, br s)Example 47
(1) 8- (2,6-dichlorobenzoylamino) -3- (N-methoxy-N
-Methylcarbamoyl) -4-morpholinoquinoline as in Example 22- (2)
Thus, 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-
Obtained from morpholinoquinoline and N-methoxy-N-methylamine hydrochloride.
mp: 236-237 ℃
NMR (CDClThree, Δ): 3.31 (4H, m), 3.43 (3H, s), 3.47 (3H,
s), 3.94 (4H, m), 7.30-7.50 (3H, m), 7.59 (1H, t, J = 8Hz), 7.82
(1H, d, J = 8Hz), 8.48 (1H, s), 8.95 (1H, d, J = 8Hz)
(2) 0.9M methylmagnesium bromide solution in tetrahydrofuran (1.3 m
1) has 8- (2,6-dichlorobenzoylamino) -3- (N-methoxy-N
-Methylcarbamoyl) -4-morpholinoquinoline (107 mg) in anhydrous tetra
The solution in hydrofuran (1 ml) was added dropwise in an ice bath with cooling. The mixture
The mixture was stirred at room temperature for 1 hour, at room temperature for 1 hour, and at 50 ° C. for 2 hours. The mixture is treated with ethyl acetate
And saturated aqueous ammonium chloride. Wash the organic layer with saline,
After drying over anhydrous magnesium sulfate, the solvent was distilled off in vacuo. The residue is separated
Purified by Ricagel chromatography. The obtained oil is crystallized from ethanol
To give 3-acetyl-8- (2,6-dichlorobenzoylamino) -4-mol
Horinoquinoline (19 mg) was obtained as white crystals.
mp: 231-233 ℃
NMR (CDClThree, Δ): 2.67 (3H, s), 3.28 (4H, m), 3.96 (4H,
m), 7.30-7.50 (3H, m), 7.61 (1H, t, J = 8Hz), 7.89 (1H, d,
J = 8Hz), 8.68 (1H, s), 8.97 (1H, d, J = 8Hz)Example 48
3-cyano-8- (2,6-dichlorobenzoylamino) -4-[(pyridine
-2-ylmethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro-
8- (2,6-dichlorobenzoylamino) -3-cyanoquinoline and 2-amino
Obtained by reacting with methylpyridine.
mp: 247-249 ℃
NMR (DMSO-d6, Δ): 5.17 (2H, d, J = 6 Hz), 7.29 (1H, dd,
J = 6, 8Hz), 7.35 (1H, d, J = 8Hz), 7.45-7.60 (3H, m), 7.67 (1H,
t, J = 8Hz), 7.78 (1H, t, J = 8Hz), 8.20 (1H, d, J = 8Hz), 8.45 (1H,
s), 8.53 (1H, d, J = 6Hz), 8.77 (1H, d, J = 8Hz), 8.92 (1H, m)
Its dihydrochloride
mp: 241-250 ℃
NMR (CDClThree, Δ): 5.34 (2H, d, J = 6 Hz), 7.45-7.60 (3H,
m), 7.65 to 7.80 (3H, m), 8.24 (1H, m), 8.32 (1H, d, J = 8Hz), 8.51
(1H, s), 8.70-8.80 (2H, m), 9.13 (1H, m)Example 49
(1) 4- [bis (ethoxycarbonyl) methyl] -3-cyano-8- (2,
6-Dichlorobenzoylamino) quinoline was prepared in the same manner as in Production Example 7- (1).
4-chloro-8- (2,6-dichlorobenzoylamino) -3-cyanoquinoline
And diethyl malonate.
NMR (CDClThree, Δ): 1.20-1.40 (6H, m), 4.20-4.40 (4H, m),
5.61 (1H, s), 7.30-7.50 (3H, m), 7.78 (1H, t, J = 8Hz), 7.88
(1H, d, J = 8Hz), 8.94 (1H, s), 9.15 (1H, d, J = 8Hz)
(2) 3-cyano-8- (2,6-dichlorobenzoylamino) -4- (etho
(Xycarbonylmethyl) quinoline was obtained in the same manner as in Production Example 7- (2).
mp: 171-173 ℃
NMR (CDClThree, Δ): 1.26 (3H, t, J = 7 Hz), 4.20 (2H, q,
J = 7Hz), 4.37 (2H, s), 7.30-7.50 (3H, m), 7.79 (2H, m), 8.90
(1H, s), 9.13 (1H, m)
(3) 8- (2,6-dichlorobenzoylamino) -3-cyano-4- (ethoxy
(Xycarbonylmethyl) quinoline (255 mg) and 1N sodium hydroxide in dioxane
The mixture of thorium solutions was stirred at room temperature for 20 minutes. Neutralize the mixture with 1N hydrochloric acid,
Extracted with dichloromethane. Wash the organic layer with brine and dry over magnesium sulfate
Thereafter, the solvent was distilled off in vacuo to give 4-carboxymethyl-8- (2,6-dichloro
A residue containing (benzoylamino) -3-cyanoquinoline was obtained.
To a mixture of dimethylformamide (49.9 mg) and dichloromethane was added
Xalil (86.7 mg) was added and the mixture was stirred at room temperature for 30 minutes. To the mixture
The residue obtained above was added at 0 ° C. and the mixture was stirred at the same temperature for 20 minutes. mixture
To the mixture was added 2-aminomethylpyridine (568 mg) at 0 ° C, and the mixture was added at the same temperature for 40 minutes.
Stirred for minutes. The mixture was partitioned between ethyl acetate and saturated ammonium chloride solution.
Was. Wash the organic layer with saturated sodium bicarbonate solution and brine, and add magnesium sulfate.
After drying, the solvent was distilled off in vacuo. Silica gel column chromatography of the residue
To give 3-cyano-8- (2,6-dichlorobenzoylamino) -4-
[(Pyridin-2-ylmethyl) carbamoylmethyl] quinoline was obtained.
To a solution of the obtained compound in dichloromethane was dissolved 10% hydrogen chloride in methanol.
Liquid (1.2 ml) was added and the mixture was concentrated in vacuo to give 3-cyano-8- (2,
6-dichlorobenzoylamino) -4-[(pyridin-2-ylmethyl) carba
[Moylmethyl] quinoline hydrochloride (133.2 mg) was obtained.
mp: 240-245 ℃ (decomposition)
NMR (DMSO-d6, δ): 4.45 (2H, s), 4.58 (2H, d, J = 6 Hz),
7.40-7.60 (3H, m), 7.60-7.70 (2H, m), 7.84 (1H, t, J = 8Hz),
8.12 (1H, d, J = 8Hz), 8.22 (1H, t, J = 8Hz), 8.71 (1H, d, J = 5Hz),
9.15 (1H, s), 9.31 (1H, t, J = 6Hz)Example 50
3-cyano-8- (2,6-dichlorobenzoylamino) -4-[(2-hydr
Roxyethyl) carbamoylmethyl] quinoline was prepared in the same manner as in Example 49- (3).
To give 8- (2,6-dichlorobenzoylamino) -3-cyano-4-ethoxy
Obtained from carbonylquinoline and 2-hydroxyethylamine.
mp: 234-236 ℃
NMR (DMSO-d6, Δ): 3.16 (2H, q, J = 6 Hz), 3.44 (2H, q,
J = 6Hz), 4.29 (2H, s), 4.75 (1H, t, J = 6Hz), 7.40-7.60 (3H, m),
7.83 (1H, t, J = 8Hz), 8.03 (1H, d, J = 8Hz), 8.49 (1H, t, J = 6Hz),
8.84 (1H, d, J = 8Hz), 9.13 (1H, s)Example 51
3-cyano-8- (2,6-dichlorobenzoylamino) -4-methylquinol
Was converted to 8- (2,6-dichlorobenzoylamino)-in the same manner as in Example 37.
Obtained from 3-cyano-4- (ethoxycarbonylmethyl) quinoline.
mp: 236-237 ℃
NMR (CDClThree, Δ): 2.98 (3H, s), 7.30-7.50 (3H, m), 7.77
(1H, t, J = 8Hz), 7.85 (1H, d, J = 8Hz), 8.83 (1H, s), 9.13 (1H,
d, J = 8Hz)Example 52
8- (2,6-dichlorobenzoylamino) -3-cyano-4-methylquinol
(139 mg), N-bromosuccinimide (312 mg) and 2,2'-azo
Bis (isobutyronitrile) (38.8mg) with ethylene chloride (1ml) and tetrasalt
The mixture in carbon fluoride (4 ml) was refluxed for 7 hours. After cooling, mix the mixture with water and dichloro
Between methane and the organic layer was washed with saturated sodium thiosulfate solution and brine.
After drying over magnesium sulfate, the solvent was distilled off in vacuo to give 4-bromomethyl-8.
The residue containing-(2,6-dichlorobenzoylamino) -3-cyanoquinoline
Obtained.
The residue was dissolved in ethylene chloride, and imidazole (79.7 mg) was added thereto.
Was. After stirring at 65 ° C. for 30 minutes, the mixture was partitioned between water and dichloromethane.
The organic layer was washed with brine, dried over magnesium sulfate, and the solvent was distilled off in vacuo
. The residue is purified by preparative thin-layer chromatography (methanol-dichloromethane).
To give 3-cyano-8- (2,6-dichlorobenzoylamino) -4- (imida
(Zol-1-ylmethyl) quinoline was obtained.
To a solution of the obtained compound in dichloromethane was dissolved 10% hydrogen chloride in methanol.
Liquid (0.5 ml) was added and the mixture was concentrated in vacuo to give 3-cyano-8- (2,
6-dichlorobenzoylamino) -4- (imidazol-1-ylmethyl) quino
Phosphorus hydrochloride (59.8 mg) was obtained.
mp:> 250 ℃
NMR (CDClThree, Δ): 6.20 (2H, s), 7.40-7.60 (3H, m), 7.70
(1H, s), 7.75 (1H, s), 7.90 (1H, t, J = 8Hz), 8.13 (1H, d,
J = 8Hz), 8.90 (1H, d, J = 8Hz), 9.19 (1H, s), 9.27 (1H, s)Example 53
(1) 4-bromomethyl-8- (2,6-dichlorobenzoylamino) -3-
Dimethylform of cyanoquinoline (238mg) and sodium acetate (94mg)
The mixture in amide (1 ml) was stirred at room temperature overnight. Water was added to the residue, and
Extracted with chill. The organic layer is washed with brine, dried over magnesium sulfate, and then dried in vacuo.
The solvent was distilled off with. The residue was separated by preparative thin-layer chromatography (n-hexane-dichloromethane).
Chloromethane) to give 4-acetoxymethyl-3-cyano-8- (2,6-
Dichlorobenzoylamino) quinoline (54 mg) was obtained.
mp: 201-203 ℃
NMR (CDClThree, Δ): 2.15 (3H, s), 5.75 (2H, s), 7.33-7.47
(3H, m), 7.81 (1H, t, J = 7.5Hz), 7.89 (1H, d, J = 7.5Hz), 8.91
(1H, s), 9.16 (1H, d, J = 7.5Hz)
(2) 3-cyano-8- (2,6-dichlorobenzoylamino) -4-hydro
Xymethylquinoline was obtained in the same manner as in Example 12- (2).
mp: 249-250 ℃
NMR (DMSO-d6, Δ): 5.81 (2H, s), 7.48-7.60 (3H, m),
7.78-7.86 (2H, m), 8.88 (1H, dd, J = 7 and 4Hz), 9.24 (1H, br
s), 11.00 (1H, s)Example 54
4-chloro-8- (2,6-dichlorobenzoylamino) -3-ethoxycal
To a solution of bonylquinoline (251 mg) in N-methylpyrrolidone (2 ml)
2-Mercaptoimidazole (89 mg) was added and the mixture was stirred at 65 ° C. for 1 hour
did. The mixture was poured into water and extracted with ethyl acetate. Ammonium chloride saturated organic layer
Solution, saturated sodium bicarbonate solution and brine, and dried over magnesium sulfate
Thereafter, the solvent was distilled off in vacuo. The residue was crystallized from ethanol to give 4- (2,2
6-dichlorobenzoylamino) -7H-imidazo [2 ', 1': 2,3] [1
[3,3] thiazino [5,6-c] quinolin-7-one (248.2 mg) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.45-7.65 (4H, m), 7.93 (1H, t,
J = 8Hz), 8.15 (1H, d, J = 8Hz), 8.30 (1H, s), 8.95 (1H, d,
J = 8Hz), 9.57 (1H, s), 11.14 (1H, s)Example 55
(1) 4- [bis (ethoxycarbonyl) methyl] -8- (2,6-dichloro
Benzoylamino) -3-ethoxycarbonylquinoline was prepared according to Production Example 7- (1).
Similarly, 4-chloro-8- (2,6-dichlorobenzoylamino) -3-e
It was obtained by reacting toxic quinoline with diethyl malonate.
mp: 139.5 ℃
NMR (CDClThree, Δ): 1.20 (6H, t, J = 7.5 Hz), 1.41 (3H, t,
J = 7.5Hz), 4.11-4.30 (4H, m), 4.44 (2H, q, J = 7.5Hz), 6.31 (1H,
s), 7.29-7.45 (3H, m), 7.67 (1H, t, J = 7.5Hz), 7.85 (1H, d,
J = 7.5Hz), 9.03 (1H, d, J = 7.5Hz), 9.25 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (Ethoxycarbonylmethyl) quinoline was prepared in the same manner as in Production Example 7- (2).
Obtained.
mp: 158.7 ° C
NMR (CDClThree, Δ): 1.25 (3H, t, J = 7.5 Hz), 1.42 (3H, t,
J = 7.5Hz), 4.17 (2H, q, J = 7.5Hz), 4.45 (2H, q, J = 7.5Hz), 4.63
(2H, s), 7.30-7.45 (3H, m), 7.70 (1H, t, J = 7.5Hz), 7.84 (1H,
d, J = 7.5Hz), 9.05 (1H, d, J = 7.5Hz), 9.26 (1H, s)Example 56
(1) 4- [bis (tert-butoxycarbonyl) methyl] -8- (2,6-di
Chlorobenzoylamino) -3-ethoxycarbonylquinoline was prepared according to Production Example 7- (
In the same manner as in 1), 4-chloro-8- (2,6-dichlorobenzoylamino)-
Obtained by reacting 3-ethoxycarbonylquinoline with di-tert-butyl malonate
.
mp: 154 ℃
NMR (CDClThree, Δ): 1.43 (18H, s), 1.44 (3H, t, J = 7.5Hz),
4.46 (2H, q, J = 7.5Hz), 6.10 (1H, s), 7.30-7.44 (3H, m), 7.65
(1H, t, J = 7.5Hz), 7.94 (1H, d, J = 7.5Hz), 9.00 (1H, d,
J = 7.5Hz), 9.20 (1H, s)
(2) 4- [bis (tert-butoxycarbonyl) methyl] -8- (2,6-di
Chlorobenzoylamino) -3-ethoxycarbonylquinoline (5.8 g)
Trifluoroacetic acid (45 ml) was added to a solution in chloromethane (15 ml) under ice-cooling.
And the mixture was stirred at room temperature for 1 hour. The mixture is concentrated in vacuo and the residue
Trituration with diethyl ether gave 4-carboxymethyl-8- (2,6-dichloro
(Benzoylamino) -3-ethoxycarbonylquinoline (4.08 g) was obtained.
mp: 149-159 ℃
NMR (CDClThree, Δ): 1.44 (3H, t, J = 7.5 Hz), 4.47 (2H, q,
J = 7.5Hz), 5.60 (2H, s), 7.27-7.46 (3H, m), 7.75 (1H, t,
J = 7.5Hz), 7.95 (1H, d, J = 7.5Hz), 9.07 (1H, d, J = 7.5Hz), 9.25
(1H, s)Example 57
The following compound was obtained in the same manner as in Example 26- (2).
(1) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-[(pyridin-2-ylmethyl) carbamoylmethyl] quinoline hydrochloride
mp: 217-220 ℃
NMR (DMSO-d6, Δ): 1.33 (3H, t, J = 7 Hz), 4.37 (2H, q,
J = 7Hz), 4.54 (2H, d, J = 6Hz), 4.62 (2H, s), 7.45-7.60 (3H, m),
7.60-7.70 (2H, m), 7.78 (1H, t, J = 8Hz), 8.12 (1H, d, J = 8Hz),
8.23 (1H, m), 8.70 (1H, m), 8.80 (1H, d, J = 8Hz), 8.93 (1H, m),
9.17 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-[(2-hydroxyethyl) carbamoylmethyl] quinoline
mp: 131-136 ℃
NMR (CDClThree, Δ): 1.46 (3H, t, J = 7Hz), 2.39 (1H, t,
J = 6Hz), 3.35 (2H, m), 3.67 (2H, m), 4.38 (2H, s), 4.50 (2H, q,
J = 7Hz), 7.30-7.50 (3H, m), 7.77 (1H, t, J = 8Hz), 8.32 (1H, d,
J = 8Hz), 9.08 (1H, d, J = 8Hz), 9.18 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (dimethylcarbamoylmethyl) quinoline
mp: 185-186 ℃
NMR (CDClThree, Δ): 1.42 (3H, t, J = 7Hz), 3.03 (3H, s),
3.30 (3H, s), 4.41 (2H, q, J = 7Hz), 4.67 (2H, s), 7.30-7.50
(3H, m), 7.68 (1H, t, J = 8Hz), 7.79 (1H, d, J = 8Hz), 9.03 (1H,
d, J = 8Hz), 9.29 (1H, s)
(4) 4-carbamoylmethyl-8- (2,6-dichlorobenzoylamino)
-3-ethoxycarbonylquinoline
mp: 226-228 ℃
NMR (CDClThree, Δ): 1.47 (3H, t, J = 7Hz), 4.38 (2H, s),
4.50 (2H, q, J = 7Hz), 5.31 (1H, br s), 6.95 (1H, br s), 7.30-
7.50 (3H, m), 7.78 (1H, t, J = 8Hz), 8.30 (1H, d, J = 8Hz), 9.07
(1H, d, J = 8Hz), 9.19 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (morpholinocarbonylmethyl) quinoline
mp: 168.5 ° C
NMR (CDClThree, Δ): 1.40 (3H, t, J = 7.5Hz), 3.57-3.90 (8H,
m), 4.40 (2H, q, J = 7.5Hz), 4.65 (2H, s), 7.28-7.44 (3H, m),
7.68 (1H, t, J = 7.5Hz), 7.78 (1H, d, J = 7.5Hz), 9.02 (1H, d,
J = 7.5Hz), 9.29 (1H, s)
Its hydrochloride
mp: 175 ℃
NMR (DMSO-d6, Δ): 1.33 (3H, t, J = 7.5Hz), 3.40-3.49
(2H, m), 3.55-3.64 (2H, m), 3.67-3.80 (4H, m), 4.35 (2H, q,
J = 7.5Hz), 4.65 (2H, s), 7.48-7.62 (3H, m), 7.76 (1H, t,
J = 7.5Hz), 8.04 (1H, d, J = 7.5Hz), 8.79 (1H, d, J = 7.5Hz), 9.19
(1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- [N- (2-methoxyethyl) -N-methylcarbamoylmethyl] quinoli
N
mp: 163 ℃
NMR (CDClThree, Δ): 1.32-1.45 (3H, m), 3.00 (1.5H, s),
3.34 (1.5H, s), 3.35 (1.5H, s), 3.47-3.53 (2H, m), 3.51 (1.5H, s)
s), 4.33-4.47 (2H, m), 4.65 (1H, s), 4.84 (1H, s), 7.27-7.44
(3H, m), 7.60-7.70 (1H, m), 7.77 (0.5H, d, J = 7.5Hz), 7.89
(0.5H, d, J = 7.5Hz), 8.94-9.05 (1H, m), 9.26 (0.5H, s), 9.27
(0.5H, s)
(7) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-[(3-trifluoromethylphenyl) carbamoylmethyl] quinoline
mp: 218-222 ℃
NMR (CDClThree, Δ): 1.50 (3H, t, J = 7.5Hz), 4.46 (2H, s),
4.59 (2H, q, J = 7.5Hz), 7.25-7.44 (5H, m), 7.70 (1H, br d,
J = 9Hz), 7.74 (1H, brs), 7.82 (1H, t, J = 7.5Hz), 8.48 (1H, d,
J = 7.5Hz), 9.09 (1H, d, J = 7.5Hz), 9.20 (1H, s), 9.97 (1H, br s)
(8) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-[(4-Methylpiperazin-1-yl) carbonylmethyl] quinoline
mp: 232 ℃
NMR (CDClThree, Δ): 1.40 (3H, t, J = 7.5 Hz), 2.36 (3H, s),
2.38-2.47 (2H, m), 2.50-2.62 (2H, m), 3.60-3.69 (2H, m), 3.70-
3.80 (2H, m), 4.38 (2H, q, J = 7.5Hz), 4.65 (2H, s), 7.28-7.43
(3H, m), 7.67 (1H, t, J = 7.5Hz), 7.76 (1H, d, J = 7.5Hz), 9.01
(1H, d, J = 7.5Hz), 9.26 (1H, s)Example 58
(1) 4-carboxymethyl-8- (2,6-dichlorobenzoylamino)-
3-ethoxycarbonylquinoline (2.5 g) in 1,2-dichloroethane (60
The suspension in (ml) was refluxed for 14 hours. The solvent is removed under reduced pressure and the residual solid is
Treatment with ethanol (45 ml) gave 8- (2,6-dichlorobenzoylamino).
) -3-Ethoxycarbonyl-4-methylquinoline (2.08 g)
I got it as
mp: 159-162 ℃
NMR (CDClThree, Δ): 1.42 (3H, t, J = 7.5Hz), 3.00 (3H, s),
4.45 (2H, q, J = 7.5Hz), 7.28-7.45 (3H, m), 7.69 (1H, t,
J = 7.5Hz), 7.92 (1H, d, J = 7.5Hz), 9.02 (1H, d, J = 7.5Hz), 9.10
(1H, s)
Its hydrochloride
mp: 171 ℃
NMR (DMSO-d6, Δ): 1.36 (3H, t, J = 7.5 Hz), 2.94 (3H,
s), 4.40 (2H, q, J = 7.5Hz), 7.46-7.61 (3H, m), 7.78 (1H, t,
J = 7.5Hz), 8.09 (1H, d, J = 7.5Hz), 8.80 (1H, d, J = 7.5Hz), 9.07
(1H, s)
(2) 4-bromomethyl-8- (2,6-dichlorobenzoylamino) -3-
Ethoxycarbonylquinoline was obtained in the same manner as in the first step of Example 52.
mp: 199 ℃
NMR (CDClThree, Δ): 1.47 (3H, t, J = 7.5 Hz), 4.40 (2H, q,
J = 7.5Hz), 5.37 (2H, s), 7.27-7.46 (3H, m), 7.79 (1H, t,
J = 7.5Hz), 8.00 (1H, d, J = 7.5Hz), 9.06 (1H, d, J = 7.5Hz), 9.23
(1H, s)Example 59
4-bromomethyl-8- (2,6-dichlorobenzoylamino) -3-ethoxy
Dimethoxine of cicarbonylquinoline (150mg) and imidazole (106mg)
The mixture in cyethane was stirred at 70 ° C. for 1 hour. Evaporate solvent from the mixture in vacuo
The residue was purified by preparative thin-layer chromatography (methanol-dichloromethane).
To produce 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
4- (Imidazol-1-ylmethyl) quinoline (110 mg) was obtained.
NMR (CDClThree, Δ): 1.41 (3H, t, J = 7.5 Hz), 4.47 (2H, q,
J = 7.5Hz), 6.00 (2H, s), 6.90 (1H, s), 6.99 (1H, s), 7.30-7.47
(3H, m), 7.60 (1H, s), 7.76 (1H, t, J = 7.5Hz), 7.94 (1H, d,
J = 7.5Hz), 9.08 (1H, d, J = 7.5Hz), 9.28 (1H, s)
Its dihydrochloride
mp: 240-245 ℃
NMR (DMSO-d6, Δ): 1.30 (3H, t, J = 7.5 Hz), 4.40 (2H, q,
J = 7.5Hz), 6.18 (2H, s), 7.46-7.61 (3H, m), 7.65 (1H, d,
J = 2Hz), 7.72 (1H, d, J = 2Hz), 7.84 (1H, t, J = 7.5Hz), 8.14 (1H,
d, J = 7.5Hz), 8.84 (1H, d, J = 7.5Hz), 9.07 (1H, brs), 9.30 (1H,
s)Example 60
The following compound was obtained in the same manner as in Example 59.
(1) 4- (1H-benzimidazol-1-ylmethyl) -8- (2,6-
Dichlorobenzoylamino) -3-ethoxycarbonylquinoline
mp: 202 ℃
NMR (CDClThree, Δ): 1.30 (3H, t, J = 7.5 Hz), 4.38 (2H, q,
J = 7.5Hz), 6.10 (2H, s), 7.21-7.51 (6H, m), 7.63 (1H, s), 7.70
(1H, t, J = 7.5Hz), 7.75-7.86 (2H, m), 9.07 (1H, d, J = 7.5Hz),
9.27 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- [N- (2-methoxyethyl) -N-methylaminomethyl] quinoline
NMR (CDClThree, Δ): 1.42 (3H, t, J = 7.5 Hz), 2.24 (3H, s),
2.67 (2H, t, J = 6Hz), 3.31 (3H, s), 3.50 (2H, t, J = 6Hz), 4.26
(2H, s), 4.43 (2H, q, J = 7.5Hz), 7.28-7.43 (3H, m), 7.66 (1H,
t, J = 7.5Hz), 8.16 (1H, d, J = 7.5Hz), 8.91 (1H, s), 9.00 (1H, d,
(J = 7.5Hz)
Its hydrochloride
mp: 187-191 ℃
NMR (DMSO6, Δ): 1.41 (3H, t, J = 7.5 Hz), 2.70 (3H, s),
3.35 (3H, m), 3.52-3.68 (2H, m), 3.75-3.88 (2H, m), 4.46 (2H, m
q, J = 7.5Hz), 5.13-5.26 (1H, m), 5.30-5.41 (1H, m), 7.48-7.63
(3H, m), 7.91 (1H, t, J = 7.5Hz), 8.43 (1H, d, J = 7.5Hz), 8.88
(1H, d, J = 7.5Hz), 9.34 (1H, br s), 9.40 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4-dimethylaminomethyl
Ru-3-ethoxycarbonylquinoline
mp: 121 ℃
NMR (CDClThree, Δ): 1.43 (3H, t, J = 7.5Hz), 2.26 (6H, s),
4.14 (2H, s), 4.44 (2H, q, J = 7.5Hz), 7.28-7.46 (3H, m), 7.69
(1H, t, J = 7.5Hz), 8.10 (1H, d, J = 7.5Hz), 8.94 (1H, s), 9.01
(1H, d, J = 7.5Hz)Example 61
4-bromomethyl-8- (2,6-dichlorobenzoylamino) -3-ethoxy
Cycarbonylquinoline (100 mg), 2-methoxyethylamine (18.7 m
g) and N, N-diisopropyl-N-ethylamine (134 mg) in ethyl chloride
The mixture in toluene (1 ml) was stirred at room temperature for 2 hours. Dilute the mixture with dichloromethane
And washed with saturated sodium bicarbonate solution, dried over magnesium sulfate and
The solvent was distilled off with. The residue was separated by preparative thin-layer chromatography (methanol-dichloromethane).
Methane) to give 6- (2,6-dichlorobenzoylamino) -2,3-
Dihydro-2- (2-methoxyethyl) -1H-pyrrolo [3,4-c] quinoline
-3-One (76 mg) was obtained.
mp: 246 ℃
NMR (CDClThree, Δ): 3.39 (3H, s), 3.69 (2H, t, J = 6Hz),
3.88 (2H, t, J = 6Hz), 4.95 (2H, s), 7.30-7.46 (3H, m), 7.64
(1H, t, J = 7.5Hz), 7.74 (1H, d, J = 7.5Hz), 9.10 (1H, d,
J = 7.5Hz), 9.15 (1H, s)Example 62
2-mercaptoimidazole (27.4 mg) in dimethylformamide (1.
Potassium carbonate (51.6 mg) was added to the solution under ice-cooling.
The mixture was stirred at the same temperature for 15 minutes. The mixture was added to 4-bromomethyl-8- (2,6-dichloro
Benzoylamino) -3-ethoxycarbonylquinoline (120 mg) under ice cooling
And the mixture was stirred at room temperature for 1 hour. Water was added to the mixture under ice cooling, and the resulting precipitate
The residue was collected by filtration, washed with water, and treated with 8- (2,6-dichlorobenzoylamido).
No) -3-ethoxycarbonyl-4-[(imidazol-2-yl) thiomethyl
] Quinoline (115 mg) was obtained.
mp: 120-123 ℃
NMR (CDClThree, Δ): 1.44 (3H, t, J = 7.5 Hz), 4.46 (2H, q,
J = 7.5Hz), 5.01 (2H, s), 6.94 (1H, s), 7.18 (1H, s), 7.29-7.46
(3H, m), 7.55-7.63 (2H, m), 8.96-9.05 (1H, m), 9.10 (1H, s),
9.16 (1H, brs)
Its hydrochloride
mp: 219-224 ℃
NMR (DMSO6, Δ): 1.32 (3H, t, J = 7.5 Hz), 4.26 (2H, q,
J = 7.5Hz), 5.20 (2H, s), 7.47-7.61 (3H, m), 7.75 (2H, s), 7.76
(1H, t, J = 7.5Hz), 7.97 (1H, d, J = 7.5Hz), 8.80 (1H, d,
J = 7.5Hz), 9.13 (1H, s)Example 63
8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl-4-
[(Pyridin-4-yl) thiomethyl] quinoline was obtained as in Example 62.
.
mp: 179-181 ℃
NMR (CDClThree, Δ): 1.39 (3H, t, J = 7.5 Hz), 4.40 (2H, q,
J = 7.5Hz), 5.15 (2H, s), 7.24 (2H, d, J = 6Hz), 7.29-7.45 (3H,
m), 7.72 (1H, t, J = 7.5Hz), 7.90 (1H, d, J = 7.5Hz), 8.86 (2H, d,
J = 6Hz) 9.07 (1H, d, J = 7.5Hz), 9.23 (1H, s)
Its hydrochloride
mp: 206 ℃
NMR (DMSO-d6, Δ): 1.28 (3H, t, J = 7.5 Hz), 4.37 (2H, q,
J = 7.5Hz), 5.36 (2H, s), 7.46-7.61 (3H, m), 7.84 (1H, t,
J = 7.5Hz), 7.95 (2H, d, J = 7Hz), 8.20 (1H, d, J = 7.5Hz), 8.70
(2H, d, J = 7Hz), 8.84 (1H, d, J = 7.5Hz), 9.21 (1H, s)Example 64
4-acetoxymethyl-8- (2,6-dichlorobenzoylamino) -3-e
Toxylcarbonylquinoline was obtained in the same manner as in Example 53- (1).
mp: 138-142 ℃
NMR (CDClThree, Δ): 1.45 (3H, t, J = 7.5Hz), 2.05 (3H, s),
4.49 (2H, q, J = 7.5Hz), 5.91 (2H, s), 7.30-7.46 (3H, m), 7.74
(1H, t, J = 7.5Hz), 7.93 (1H, d, J = 7.5Hz), 9.05 (1H, d,
J = 7.5Hz), 9.16 (1H, s)Example 65
Sodium sulfide nonahydrate (202 mg) in dimethylformamide (5 ml)
To the mixture of 4-chloro-8- (2,6-dichlorobenzoylamino) -3-e
Toxicarbonylquinoline (297 mg) was added dropwise, and the mixture was stirred at room temperature for 1 hour.
did. Ice water was added to the mixture, and the mixture was adjusted to pH 3 with 1N hydrochloric acid. The resulting precipitate
The product was collected by filtration, washed with water, and treated with 8- (2,6-dichlorobenzoylamino).
) -3-Ethoxycarbonyl-4-mercaptoquinoline (260 mg) was obtained.
mp: 197-199 ° C
NMR (CDClThree, Δ): 1.43 (3H, t, J = 7 Hz), 4.47 (2H, q,
J = 7Hz), 7.27-7.45 (3H, m), 7.68 (1H, t, J = 8Hz), 7.99 (1H, d,
J = 8Hz), 8.49 (1H, s), 9.03 (1H, d, J = 8Hz), 9.21 (1H, s)Example 66
(1) 4- (tert-butoxycarbonylmethylthio) -8- (2,6-dichloro
Robenzoylamino) -3-ethoxycarbonylquinoline was prepared according to Production Example 8- (1).
8- (2,6-dichlorobenzoylamino) -3-ethoxycal
Obtained by reacting bonyl-4-mercaptoquinoline with tert-butyl bromoacetate
.
NMR (CDClThree, Δ): 1.24 (9H, s), 1.45 (3H, t, J = 7Hz),
3.66 (2H, s), 7.29-7.45 (3H, m), 7.76 (1H, t, J = 8Hz), 8.88
(1H, d, J = 8Hz), 8.98 (1H, s), 9.05 (1H, d, J = 8Hz)
(2) 4- (tert-butoxycarbonylmethylthio) -8- (2,6-dichloro
Robenzoylamino) -3-ethoxycarbonylquinoline (140 mg)
A solution of N hydrogen chloride in ethyl acetate was allowed to stand at room temperature for 1 hour. Vacuum the mixture
And the residue was dissolved in ethyl acetate. Wash the solution with saline and add
After drying with nesium, the solvent was distilled off in vacuo to give 4-carboxymethylthio-8-.
(2,6-dichlorobenzoylamino) -3-ethoxycarbonylquinoline (1
10 mg).
mp: 174-175 ℃
NMR (CDClThree, Δ): 1.45 (3H, t, J = 7Hz), 3.79 (2H, s),
4.51 (2H, q, J = 7Hz), 7.30-7.46 (3H, m), 7.79 (1H, t, J = 8Hz),
8.86 (1H, d, J = 8Hz), 8.99 (1H, s), 9.08 (1H, d, J = 8Hz)
(3) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4-[[N- (pyridin-2-ylmethyl) carbamoyl] methylthio] quino
Phosphorus was prepared in the same manner as in Example 22- (2), using 4-carboxymethylthio-8- (
2,6-dichlorobenzoylamino) -3-ethoxycarbonylquinoline and 2-
Obtained from aminomethylpyridine.
NMR (DMSO-d6, Δ): 1.34 (3H, t, J = 7Hz), 3.75 (2H, s),
4.22 (2H, d, J = 7Hz), 4.39 (2H, q, J = 7Hz), 6.96 (1H, d, J = 8Hz),
7.20 (1H, d, J = 7Hz), 7.45-7.70 (4H, m), 7.78 (1H, t, J = 8Hz),
8.32 (1H, d, J = 8Hz), 8.42 (1H, m), 8.55 (1H, m), 8.80 (1H, d,
J = 8Hz), 8.99 (1H, s)
Its hydrochloride
mp: 191-194 ℃
NMR (DMSO-d6, Δ): 1.35 (3H, t, J = 7Hz), 3.78 (2H, s),
4.35-4.50 (4H, m), 7.40 (1H, d, J = 8Hz), 7.45-7.60 (3H, m),
7.64 (1H, t, J = 7Hz), 7.80 (1H, t, J = 8Hz), 8.17 (1H, t, J = 7Hz),
8.32 (1H, t, J = 8Hz), 8.64 (1H, d, J = 6Hz), 8.75-8.85 (2H, m),
8.99 (1H, s)Example 67
The following compound was obtained in the same manner as in Example 25.
(1) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (1-Methylimidazol-2-ylthio) quinoline hydrochloride
mp: 234-236 ℃
NMR (DMSO-d6, Δ): 1.31 (3H, t, J = 7Hz), 3.53 (3H, s),
4.28 (2H, q, J = 7Hz), 6.98 (1H, s), 7.30 (1H, s), 7.45-7.60
(3H, m), 7.75 (1H, t, J = 8Hz), 8.18 (1H, d, J = 8Hz), 8.78 (1H,
d, J = 8Hz), 8.98 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonyl
-4- (pyridin-4-ylthio) quinoline
mp: 183-185 ℃
NMR (DMSO-d6, Δ): 1.19 (3H, t, J = 7 Hz), 4.27 (2H, q,
J = 7Hz), 7.04 (2H, d, J = 6Hz), 7.45-7.62 (3H, m), 7.79 (1H, t,
J = 8Hz), 8.06 (1H, d, J = 8Hz), 8.33 (2H, d, J = 6Hz), 8.83 (1H, d,
J = 8Hz), 9.17 (1H, s)
Its hydrochloride
mp: 204-205 ℃
NMR (DMSO-d6, Δ): 1.19 (3H, t, J = 7Hz), 4.30 (2H, q,
J = 7Hz), 7.45-7.65 (5H, m), 7.83 (1H, t, J = 8Hz), 8.08 (1H, d,
J = 8Hz), 8.52 (2H, d, J = 6Hz), 8.87 (1H, d, J = 8Hz), 9.28 (1H, s)Example 68
4-chloro-8- (2,6-dichlorobenzoylamino) -3-ethoxycal
Ethanol of bonylquinoline (297 mg) and hydrazine monohydrate (175 mg)
The mixture in toluene (3 ml) was refluxed for 1 hour. Ice water was added to the mixture and the resulting precipitate
Is collected by filtration, washed with water and treated with 6- (2,6-dichlorobenzoylamino)
-2,3-dihydro-1H-pyrazolo [4,3-c] quinolin-3-one (25
0 mg).
A suspension of the compound obtained in ethanol (20 ml) was added to ethanol suspension of hydrogen chloride.
Solution was added and the mixture was stirred at 60 ° C. for 15 minutes. The resulting precipitate is filtered
Collected and washed with ethanol to give 6- (2,6-dichlorobenzoylamino)
-2,3-Dihydro-1H-pyrazolo [4,3-c] quinolin-3-one hydrochloride
(220 mg).
mp:> 250 ℃
NMR (DMSO6, Δ): 7.50-7.65 (3H, m), 7.79 (1H, t,
J = 8Hz), 8.20 (1H, d, J = 8Hz), 8.63 (1H, d, J = 8Hz), 9.25 (1H, s)Example 69
(1) 3-bromo-8- (2,6-dichlorobenzoylamino) -4-methyl
Quinoline was prepared in the same manner as in Example 58- (1), using 3-bromo-4-carboxymethine.
Obtained from tyl-8- (2,6-dichlorobenzoylamino) quinoline.
mp:> 250 ℃
NMR (CDClThree, Δ): 2.82 (3H, s), 7.30-7.50 (3H, m), 7.66
(1H, t, J = 8Hz), 7.79 (1H, d, J = 8Hz), 8.77 (1H, s), 8.97 (1H,
d, J = 8Hz)
(2) 3-bromo-4-bromomethyl-8- (2,6-dichlorobenzoyla
Mino) quinoline was obtained in a similar manner to the first step of Example 52.
mp: 210-213 ℃
NMR (CDClThree, Δ): 5.00 (2H, s), 7.30-7.50 (3H, m), 7.77
(1H, t, J = 8Hz), 7.85 (1H, d, J = 8Hz), 8.82 (1H, s), 9.03 (1H,
d, J = 8Hz)
(3) 4-acetoxymethyl-3-bromo-8- (2,6-dichlorobenzoy
(Lamino) quinoline was obtained in the same manner as in Example 53- (1).
mp: 201-202 ℃
NMR (CDClThree, Δ): 2.10 (3H, s), 5.70 (2H, s), 7.30-7.50
(3H, m), 7.71 (1H, t, J = 8Hz), 7.80 (1H, d, J = 8Hz), 8.85 (1H,
s), 9.00 (1H, d, J = 8Hz)
(4) 3-bromo-8- (2,6-dichlorobenzoylamino) -4-hydro
Xymethylquinoline was obtained in the same manner as in Example 12- (2).
mp: 246-247 ℃
NMR (DMSO-d6, δ): 5.07 (2H, d, J = 5 Hz), 5.67 (1H, t,
J = 5Hz), 7.45 to 7.60 (3H, m), 7.76 (1H, t, J = 8Hz), 8.12 (1H, d,
J = 8Hz), 8.72 (1H, d, J = 8Hz), 8.96 (1H, s)Example 70
3-bromo-8- (2,6-dichlorobenzoylamino) -4- (imidazo
Ru-1-ylmethyl) quinoline was prepared in the same manner as in Example 59, using 3-bromo-4-.
Bromomethyl-8- (2,6-dichlorobenzoylamino) quinoline and imidazo
And obtained by reacting the same.
mp: 217-218 ℃
NMR (DMSO-d6, Δ): 5.84 (2H, s), 6.85 (1H, s), 7.08
(1H, s), 7.45-7.60 (3H, m), 7.77 (1H, t, J = 8Hz), 7.83 (1H, s),
8.14 (1H, d, J = 8Hz), 8.76 (1H, d, J = 8Hz), 9.05 (1H, s)
Its hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 3.07 (2H, s), 7.45-7.60 (3H, m),
7.67 (2H, s), 7.81 (1H, t, J = 8Hz), 8.10 (1H, d, J = 8Hz), 8.80
(1H, d, J = 8Hz), 9.10 (2H, s)Example 71
(1) 4-carboxymethyl-8- (2,6-dichlorobenzoylamino)-
3-Vinylquinoline was prepared in the same manner as in Example 18 by using 8- (2,6-dichlorobenzene).
Zoylamino) -4-ethoxycarbonylmethyl-3-vinylquinoline
.
mp: 252-253 ℃
NMR (DMSO-d6, Δ): 4.25 (2H, s), 5.60 (1H, d, J = 13Hz),
6.02 (1H, d, J = 15Hz), 7.21 (1H, dd, J = 13,15Hz), 7.45-7.60
(3H, m), 7.68 (1H, t, J = 8Hz), 7.92 (1H, d, J = 8Hz), 8.69 (1H,
d, J = 8Hz), 9.06 (1H, s)
(2) 4-carboxymethyl-8- (2,6-dichlorobenzoylamino)-
To a solution of 3-vinylquinoline (190.1 mg) was added bivaloyl chloride (62.8 m
g) and triethylamine (52.7 mg) were added at 0 ° C., and the mixture was kept at the same temperature for 1 hour.
Stirred. 2-Aminomethylpyridine (154 mg) was added to the mixture at 0 ° C.
The mixture was stirred at the same temperature for 30 minutes and at room temperature for 1 hour. Mix the mixture with dichloromethane and water
Was distributed between The organic layer is washed with brine, dried over magnesium sulfate, and then dried in vacuo.
The solvent was distilled off with. The residue was separated by preparative thin-layer chromatography (methanol-dichloromethane).
And purified with 8- (2,6-dichlorobenzoylamino) -4-[(
Pyridin-2-ylmethyl) carbamoylmethyl] -3-vinylquinoline (34
. 4 mg).
mp: 194-195 ℃
NMR (DMSO-d6, δ): 4.24 (2H, s), 4.38 (2H, d, J = 7Hz),
5.58 (1H, d, J = 12Hz), 6.01 (1H, d, J = 17Hz), 7.20-7.25 (3H, m),
7.50-7.60 (3H, m), 7.67 (1H, t, J = 8Hz), 7.75 (1H, t, J = 8Hz),
8.01 (1H, d, J = 8Hz), 8.51 (1H, d, J = 6Hz), 8.68 (1H, d, J = 8Hz),
8.86 (1H, t, J = 7Hz), 9.05 (1H, s)Example 72
Mixture of dimethylformamide (80.5mg) and dichloromethane (2ml)
To this was added oxalyl chloride (140 mg) and the mixture was stirred at room temperature for 30 minutes.
The mixture contains 4-carboxymethyl-8- (2,6-dichlorobenzoylamino)-
3-vinylquinoline (340 mg) is added at 0 ° C. and the mixture is stirred at the same temperature for 30 minutes
did. To the mixture was added 2-aminomethylpyridine (458 mg) in dichloromethane (2
ml) at 0 ° C. and the mixture was stirred at the same temperature for 30 minutes. Jig the mixture
Partitioned between dichloromethane and saturated sodium bicarbonate solution. The organic layer is
After washing with ammonium solution and brine, drying over magnesium sulfate and removing the solvent in vacuo
Distilled off. The residue was subjected to silica gel column chromatography (dichloromethane-me
) To give 4- (2,6-dichlorobenzoylamino) -9-hydr
Roxyphenanthridine (75.7 mg) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.33 (1H, d, J = 8 Hz), 7.45 to 7.60 (3H,
m), 7.72 (1H, t, J = 8Hz), 8.00 (1H, s), 8.13 (1H, d, J = 8Hz),
8.35 (1H, d, J = 8Hz), 8.74 (1H, d, J = 8Hz), 9.17 (1H, s)Example 73
(1) 4-carboxymethyl-8- (2,6-dichlorobenzoylamino)-
3-Ethylquinoline was prepared in the same manner as in Example 41, using 4-carboxymethyl-8-
Obtained from (2,6-dichlorobenzoylamino) -3-vinylquinoline.
mp: 115-116 ℃
NMR (CDClThree, Δ): 1.27 (3H, t, J = 7 Hz), 2.37 (1H, q,
J = 7Hz), 4.13 (2H, s), 7.30-7.55 (3H, m), 7.61 (1H, t, J = 8Hz),
7.68 (1H, d, J = 8Hz), 8.63 (1H, s), 8.90 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4-[(pi
Lysin-2-ylmethyl) carbamoylmethyl] quinoline was prepared according to Example 26- (2).
Was obtained in the same manner as described above.
mp: 162-163 ℃
NMR (DMSO-d6, Δ): 1.21 (3H, t, J = 7 Hz), 2.89 (2H, q,
J = 7Hz), 4.17 (2H, s), 4.38 (2H, d, J = 7Hz), 7.20-7.30 (2H, m),
7.45-7.65 (4H, m), 7.75 (1H, t, J = 8Hz), 7.92 (1H, d, J = 8Hz),
8.51 (1H, d, J = 5Hz), 8.65 (1H, d, J = 8Hz), 8.74 (1H, s), 8.87
(1H, t, J = 7Hz)
Its dihydrochloride
mp: 223-237 ℃
NMR (DMSO-d6, Δ): 1.19 (3H, t, J = 7 Hz), 2.88 (2H, q,
J = 7Hz), 4.23 (2H, s), 4.61 (1H, d, J = 7Hz),
7.50-7.70 (4H, m), 7.70-7.80 (2H, m), 7.90 (1H, d, J = 8Hz),
8.37 (1H, t, J = 8Hz), 8.64 (1H, d, J = 8Hz), 8.74 (1H, s), 8.70-
8.80 (1H, overlap), 9.17 (1H, t, J = 7Hz)Example 74
8- (2,6-dichlorobenzoylamino) quinoline (100 mg) and m-co
A solution of loroperbenzoic acid (71 mg) in ethylene chloride was stirred at 40 ° C. for 1 hour
. Add 5% sodium thiosulfate solution to the mixture and saturate the mixture with dichloromethane
Partitioned between sodium bicarbonate solution. After drying the organic layer over magnesium sulfate,
The solvent was removed in vacuo. The residue was recrystallized from dichloromethane-methanol.
, 8- (2,6-dichlorobenzoylamino) quinoline 1-oxide (48 m
g) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.50-7.60 (2H, m), 7.60-7.67 (2H,
m), 7.77 (1H, t, J = 8Hz), 7.87 (1H, d, J = 8Hz), 8.15 (1H, d,
J = 8Hz), 8.55 (1H, d, J = 8Hz), 9.02 (1H, d, J = 8Hz)Example 75
8-quinolinecarboxylic acid (100 mg), oxalyl chloride (0.08 ml)
Mix a mixture of dimethylformamide (1 drop) in dichloromethane (3 ml) at room temperature
Stir for 4 hours. The mixture is concentrated in vacuo and the residue is diluted with dichloromethane (3 ml)
Was dissolved. 2,6-dichloroaniline (93mg) and triethylamine
(117 mg) was added and the mixture was stirred at room temperature for 2 hours. Wash the mixture with water,
After drying over magnesium sulfate, the solvent was distilled off in vacuo. Silica gel residue
And purified by column chromatography (n-hexane-ethyl acetate) to give 8- [N- (
2,6-Dichlorophenyl) carbamoyl] quinoline (78 mg) was obtained.
mp: 168-169 ℃
NMR (CDClThree, Δ): 7.20 (1H, t, J = 8Hz), 7.43 (2H, d,
J = 8Hz), 7.56 (1H, m), 7.75 (1H, t, J = 8Hz), 8.06 (1H, d,
J = 8Hz), 8.36 (1H, d, J = 8Hz), 8.94-9.01 (2H, m)Example 76
8-nitrocinnoline (104 containing 10% palladium on activated carbon (15 mg)
mg) in N, N-dimethylacetamide (1 ml) at room temperature under atmospheric pressure
Hydrogenated for 6 hours. The catalyst is removed by filtration and hot N, N-dimethylacetamide
And hot chloroform. The combined filtrate was concentrated under reduced pressure to a small volume
. To this solution was added triethylamine (87 mg) and 2,6-dichlorobenzoyl chloride.
(144 mg) was added and the resulting mixture was stirred at 95 ° C. for 1 hour. Acetic acid mixture
Partitioned between ethyl and saturated aqueous ammonium chloride. Organic layer saturated sodium bicarbonate
Wash with aqueous thorium solution and brine, dry over anhydrous magnesium sulfate, and dissolve in vacuo.
The medium was distilled off. The residue was purified by preparative thin-layer silica gel chromatography. Profit
The obtained oil was crystallized from ethanol to give 8- (2,6-dichlorobenzoyl).
Amino) cinnoline (9 mg) was obtained as gray crystals.
mp: 226-228 ℃
NMR (CDClThree, Δ): 7.30-7.50 (3H, m), 7.60 (1H, d,
J = 8Hz), 7.85 (1H, t, J = 8Hz), 7.92 (1H, d, J = 6Hz), 9.09 (1H, d,
J = 8Hz), 9.36 (1H, d, J = 6Hz)Example 77
The following compound was obtained in the same manner as in Example 22- (2).
(1) 8- (2,6-dichlorobenzoylamino) -4-[(pyridine-2-
Ylmethyl) carbamoylmethyl] -3-vinylquinoline
(4-carboxymethyl-8- (2,6-dichlorobenzoylamino) -3-
From vinylquinoline and 2-aminomethylpyridine)
(2) 4-carbamoylmethyl-8- (2,6-dichlorobenzoylamino)
-3-vinylquinoline
(4-carboxymethyl-8- (2,6-dichlorobenzoylamino) -3-
(From vinylquinoline and concentrated ammonia solution)
mp: 232-234 ℃
NMR (DMSO-d6, Δ): 4.08 (2H, s), 5.58 (1H, d, J = 11Hz),
6.00 (1H, d, J = 17Hz), 7.15 (1H, brs), 7.22 (1H, dd, J = 11,
17Hz), 7.50-7.65 (3H, m), 7.67 (1H, t, J = 8Hz), 7.70 (1H, brs),
7.95 (1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 9.03 (1H, s)
Its hydrochloride
mp: 199-205 ℃
NMR (DMSO-d6, Δ): 4.09 (2H, s), 5.57 (1H, d, J = 11Hz),
6.00 (1H, d, J = 17Hz), 7.15 (1H, brs), 7.22 (1H, dd, J = 11,
17Hz), 7.50-7.65 (3H, m), 7.67 (1H, t, J = 8Hz), 7.72 (1H, brs),
7.95 (1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 9.03 (1H, s)Example 78
(1) 4-acetoxymethyl-8- (2,6-dichlorobenzoylamino)-
3-Vinylquinoline was prepared in the same manner as in Production Example 14 by using 4-acetoxymethyl-3-.
Bromo-8- (2,6-dichlorobenzoylamino) quinoline and tri-n-butyl
(Vinyl) tin.
mp: 166-167 ℃
NMR (CDClThree, Δ): 2.08 (3H, s), 5.61 (2H, s), 5.55-5.65
(1H, overlap), 7.30-7.45 (3H, m), 7.68 (1H, t, J = 8Hz), 7.85
(1H, t, J = 8Hz), 8.91 (1H, s), 8.95 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4-hydroxymethyl-
3-Vinylquinoline was obtained in the same manner as in Example 12- (2).
mp: 243-244 ° C
NMR (DMSO-d6, Δ): 4.99 (2H, d, J = 5Hz), 5.48 (1H, t,
J = 5Hz), 5.60 (1H, d, J = 12Hz), 6.01 (1H, d, J = 16Hz), 7.32 (1H,
(dd, J = 12, 16Hz), 7.50-7.60 (3H, m), 7.69 (1H, t, J = 8Hz), 8.09
(1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 9.05 (1H, s)
Its hydrochloride
mp: 215-221 ° C
NMR (DMSO-d6, Δ): 4.98 (2H, s), 5.60 (1H, d, J = 12Hz),
6.02 (1H, d, 16Hz), 7.32 (1H, dd, J = 12, 16Hz), 7.50-7.60 (3H,
m), 7.68 (1H, t, J = 8Hz), 8.09 (1H, d, J = 8Hz), 8.66 (1H, d,
J = 8Hz) 、 9.05 (1H, s)
(3) Thionyl chloride (73.2m) was added to N, N-dimethylformamide (1ml).
g) was added and the mixture was stirred at room temperature for 15 minutes. 8- (2,6-dichloro) was added to the mixture.
Robenzoylamino) -4-hydroxymethyl-3-vinylquinoline (176.
7 mg) was added and the mixture was stirred at room temperature for 30 minutes. Saturated sodium bicarbonate in the mixture
Solution (10 ml) was added under ice-cooling, and the mixture was stirred at the same temperature for 15 minutes. Arising
The precipitate formed was collected by filtration, washed with water and treated with 4-chloromethyl-8- (2,6-
Dichlorobenzoylamino) -3-vinylquinoline (182.8 mg) was obtained.
mp: 184-186 ℃
NMR (CDClThree, Δ): 5,05 (2H, s), 5.70 (1H, d, J = 10Hz),
5.93 (1H, d, J = 17Hz), 7.17 (1H, d, J = 10, 17Hz), 7.30-7.45 (3H,
m), 7.72 (1H, t, J = 8Hz), 7.88 (1H, d, J = 8Hz), 8.90 (1H, s),
8.97 (1H, d, J = 8Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Ylmethyl) -3-vinylquinoline was obtained in the same manner as in Example 59.
mp: 189-191 ℃
NMR (DMSO-d6, Δ): 5.67 (1H, d, J = 10 Hz), 5.83 (2H, s),
6.10 (1H, d, J = 16Hz), 6.82 (1H, s), 6.98 (1H, s), 7.45 (1H,
dd, J = 10, 16Hz), 7.45-7.60 (3H, m), 7.72 (1H, t, J = 8Hz), 7.23
(1H, s), 8.13 (1H, d, J = 8Hz), 8.70 (1H, d, J = 8Hz), 9.14 (1H,
s)
Its hydrochloride
mp: 244-247 ° C
NMR (DMSO-d6, Δ): 5.69 (1H, d, J = 11 Hz), 6.07 (2H, s),
6.13 (1H, d, J = 17Hz), 7.38 (1H, dd, J = 11, 17Hz), 7.50-7.65
(5H, m), 7.74 (1H, t, J = 8Hz), 8.05 (1H, d, J = 8Hz), 8.73 (1H,
d, J = 8Hz), 9.03 (1H, s), 9.19 (1H, s)Example 79
(1) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4-hydro
Xymethylquinoline was prepared in the same manner as in Example 41 by using 8- (2,6-dichlorobenzene).
Zoylamino) -4-hydroxymethyl-3-vinylquinoline.
mp: 226-228 ℃
NMR (DMSO-d6, Δ): 1.24 (3H, t, J = 7 Hz), 2.92 (2H, q,
J = 7Hz), 4.95 (2H, d, J = 5Hz), 5.39 (1H, t, J = 5Hz), 7.50-7.60
(3H, m), 7.65 (1H, t, J = 8Hz), 8.05 (1H, d, J = 8Hz), 8.64 (1H,
d, J = 8Hz), 8.75 (1H, s)
Its hydrochloride
mp: 220-225 ℃
NMR (DMSO-d6, Δ): 1.25 (3H, t, J = 7 Hz), 2.93 (2H, q,
J = 7Hz), 4.95 (2H, s), 7.50-7.60 (3H, m), 7.66 (1H, t, J = 8Hz),
8.06 (1H, d, J = 8Hz), 8.64 (1H, d, J = 8Hz), 8.76 (1H, s)
(2) 4-chloromethyl-8- (2,6-dichlorobenzoylamino) -3-
Ethylquinoline was obtained in the same manner as in Example 78- (3).
mp: 193-194 ℃
NMR (CDClThree, Δ): 1.37 (3H, t, J = 7Hz), 2.96 (2H, q,
J = 7Hz), 5.03 (2H, s), 7.30-7.55 (3H, m), 7.70 (1H, t, J = 8Hz),
7.86 (1H, d, J = 8Hz), 8.66 (1H, s), 8.94 (1H, d, J = 8Hz)
(3) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (imi
Dazol-1-ylmethyl) quinoline was obtained in the same manner as in Example 59.
NMR (CDClThree, Δ): 1.23 (3H, t, J = 7 Hz), 2.92 (2H, q,
J = 7Hz), 5.58 (2H, s), 6.78 (1H, s), 7.03 (1H, s), 7.30-7.55
(3H, m), 7.60-7.70 (2H, m), 8.72 (1H, s), 8.94 (1H, d, J = 8Hz)
Its hydrochloride
mp: 258-260 ℃ (decomposition)
NMR (DMSO-d6, Δ): 1.18 (3H, t, J = 7Hz), 2.99 (2H, q,
J = 7Hz), 5.99 (2H, s), 7.50-7.60 (4H, m), 7.65 (1H, s), 7.69
(1H, t, J = 8Hz), 7.91 (1H, d, J = 8Hz), 8.71 (1H, d, J = 8Hz), 8.92
(1H, s), 9.02 (1H, s)Example 80
(1) 4-bromomethyl-8- (2,6-dichlorobenzoylamino) quinoli
Was converted to 8- (2,6-dichlorobenzoyl) in the same manner as in the first step of Example 52.
Amino) -4-methylquinoline.
NMR (CDClThree, Δ): 4.97 (2H, s), 7.30-7.45 (3H, m),
7.50 (1H, d, J = 5Hz), 7.73 (1H, t, J = 8Hz), 7.88 (1H, d, J = 8Hz),
8.74 (1H, d, J = 5Hz), 9.01 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
(-Ylmethyl) quinoline was obtained in the same manner as in Example 59.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 5.85 (2H, s), 6.97 (1H, d, J = 4Hz),
7.00 (1H, s), 7.45 to 7.60 (3H, m), 7.74 (1H, t, J = 8Hz), 7.85
(1H, s), 8.01 (1H, d, J = 8 Hz), 8.77 (1H, d, J = 8 Hz), 8.83 (1H,
d, J = 4Hz)
Its hydrochloride
mp: 167-172 ℃
NMR (DMSO-d6, Δ): 6.08 (2H, s), 7.28 (1H, d, J = 4Hz),
7.45-7.60 (3H, m), 7.76 (1H, s), 7.78 (1H, t, J = 8Hz), 7.83
(1H, s), 8.00 (1H, d, J = 8Hz), 8.79 (1H, d, J = 8Hz), 8.90 (1H,
d, J = 4Hz), 9.26 (1H, s)Example 81
(1) 4- (bromomethyl) -8- (2,6-dichlorobenzoylamino) ki
Norin was prepared in the same manner as in Example 12- (3), using 8- (2,6-dichlorobenzoyl).
Ruamino) -4-hydroxymethylquinoline.
NMR (CDClThree, Δ): 4.85 (2H, s), 7,29 (3H, m), 7.49
(1H, d, J = 4Hz), 7.73 (1H, t, J = 8Hz), 7.87 (1H, d, J = 8Hz), 8.72
(1H, d, J = 4Hz), 9.00 (1H, d, J = 8Hz)
(2) N, N-dimethylformamide of benzimidazole (26.5 mg)
(1%) in a stirred solution of sodium hydride (60% in oil, 8.3 mg)
Was added in an ice bath, and the mixture was stirred at the same temperature for half an hour. 4-Bromomethyl
8- (2,6-dichlorobenzoylamino) quinoline (80 mg) at a time
The reaction mixture was stirred at the same temperature for half an hour and at room temperature for one hour. Add water to it,
The resulting precipitate was collected by filtration. The solid substance is heated to 95% ethanol aqueous solution (1 ml)
And cooled to room temperature. The solid was collected by filtration, air dried and
(1H-benzbenzimidazol-1-ylmethyl) -8- (2,6-dichloro
(Lobenzoylamino) quinoline (65 mg) was obtained as an off-white solid.
mp: 248-253 ℃
NMR (CDClThree, Δ): 5.89 (2H, s), 6.69 (1H, d, J = 4Hz),
7.17-7.25 (1H, m), 7.26-7.45 (5H, m), 7.70-7.81 (2H, m), 7.90
(1H, d, J = 8Hz), 8.01 (1H, s), 8.60 (1H, d, J = 4Hz), 9.06 (1H,
(br d, J = 8Hz)Example 82
(1) 4- [bis (ethoxycarbonyl) methyl] -8-nitroquinoline is
In the same manner as in Production Example 7- (1), 4-chloro-8-nitroquinoline and malonic acid
Obtained by reacting with ethyl.
mp: 48-50 ℃
NMR (CDClThree, Δ): 1.20-1.30 (6H, m), 4.20-4.32 (4H, m),
7.63-7.72 (2H, m), 8.01 (1H, d, J = 8Hz), 8.20 (1H, dd, J = 8,
2Hz), 9.07 (1H, d, J = 5Hz)
(2) 8-Nitro-4- (ethoxycarbonylmethyl) quinoline was prepared in Production Example 7-
Obtained in the same manner as in (2).
mp: 67-69 ℃
NMR (CDClThree, Δ): 1.23 (3H, t, J = 6Hz), 4.10 (2H, s),
4.18 (2H, q, J = 6Hz), 7.49 (1H, d, J = 4Hz), 7.67 (1H, t, J = 8Hz),
8.00 (1H, d, J = 8Hz), 8.23 (1H, d, J = 8Hz), 9.00 (1H, d, J = 5Hz)
(3) 8-amino-4- (ethoxycarbonylmethyl) quinoline was prepared in Production Example 2-
Obtained in the same manner as (3).
mp: 71-77 ℃
NMR (CDClThree, Δ): 1.22 (3H, t, J = 6 Hz), 4.00 (2H, s),
4.16 (2H, q, J = 6Hz), 5.03 (2H, s), 6.94 (1H, d, J = 8Hz), 7.28-
7.40 (3H, m), 8.70 (1H, d, J = 5Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4- (ethoxycarbonyl
(Methyl) quinoline was obtained in the same manner as in Example 1.
mp: 150-152 ℃
NMR (CDClThree, Δ): 1.24 (3H, t, J = 6Hz), 4.08 (2H, s),
4.18 (2H, q, J = 6Hz), 7.30-7.44 (4H, m), 7.65 (1H, t, J = 8Hz),
7.75 (1H, d, J = 8Hz), 8.72 (1H, d, J = 4Hz), 8.99 (1H, d, J = 8Hz)
(5) 4-ethoxycarbonylmethyl-8- (2,6-dichlorobenzoyla
To a suspension of mino) quinoline (1.03 g) in ethanol (6 ml) was added 1N hydroxylic acid.
An aqueous sodium chloride solution (3.83 ml) was added, and the mixture was stirred at 50 ° C. for 2 hours.
. The organic solvent is removed in vacuo, the aqueous residue is neutralized with 1N hydrochloric acid and ethyl acetate
Extracted. The extract was dried and the solvent was distilled off. Crystallize the residue naturally and remove it
Trituration with ethyl acetate gave 4-carboxymethyl-8- (2,6-dichlorobenzo).
(Ilamino) quinoline (703 mg) was obtained.
mp: 228-230 ℃
NMR (DMSO-d6, Δ): 4.18 (2H, s), 7.50-7.64 (4H, m),
7.70 (1H, t, J = 8Hz), 7.85 (1H, d, J = 8Hz), 8.75 (1H, d, J = 8Hz),
8.83 (1H, d, J = 4Hz)
(6) 4- (morpholinocarbonylmethyl) -8- (2,6-dichlorobenzo
(Ilamino) quinoline was prepared in the same manner as in Example 22- (2), using 4-carboxymethine.
From tyl-8- (2,6-dichlorobenzoylamino) quinoline and morpholine
Was.
mp: 245-251 ° C
NMR (CDClThree, Δ): 3.47 (2H, t, J = 6Hz), 3.62 (2H, t,
J = 6Hz), 3.70 (4H, s), 4.15 (2H, s), 7.30-7.45 (4H, m), 7.60-
7.70 (2H, m), 8.71 (1H, d, J = 5Hz), 8.95-9.01 (1H, m)Example 83
(1) 4- [cyano (ethoxycarbonyl) methyl] -8- (2,6-dichloro
Robenzoylamino) quinoline was prepared in the same manner as in Production Example 7- (1), using 4-chloro
-8- (2,6-dichlorobenzoylamino) quinoline and ethyl cyanoacetate
The reaction was obtained.
NMR (CDClThree, Δ): 1.28 (3H, t, J = 6 Hz), 4.28 (2H, q,
J = 6Hz), 5.40 (1H, s), 7.30-7.45 (3H, m), 7.20-7.77 (3H, m),
8.85 (1H, d, J = 4Hz), 9.02-9.08 (1H, m)
(2) 4-cyanomethyl-8- (2,6-dichlorobenzoylamino) quinoli
Was obtained in the same manner as in Production Example 7- (2).
mp: 234-236 ℃
NMR (CDClThree, Δ): 4.20 (2H, s), 7.30-7.45 (3H, m), 7.60
(1H, d, J = 8Hz), 7.66 (1H, d, J = 4Hz), 7.75 (1H, t, J = 8Hz), 8.80
(1H, d, J = 4Hz), 9.05 (1H, d, J = 8Hz)Example 84
(1) 4- [bis (ethoxycarbonyl) methyl] -8- (2,6-dichloro
Benzoylamino) quinoline was prepared in the same manner as in Production Example 7- (1), using 4-chloro-
Reaction of 8- (2,6-dichlorobenzoylamino) quinoline with diethyl malonate
Obtained in response.
mp: 127-128 ℃
NMR (CDClThree, Δ): 1.38 (6H, t, J = 6 Hz), 4.28 (4H, q,
J = 6Hz), 5.43 (1H, s), 7.30-7.45 (3H, m), 7.61 (1H, d, J = 5Hz),
7.64-7.76 (2H, m), 8.80 (1H, d, J = 5Hz), 9.01 (1H, d, J = 8Hz)
(2) 4- [bis (ethoxycarbonyl) methyl] -8- (2,6-dichloro
Benzoylamino) quinoline (200 mg) and hydrazine-hydrate (211 mg
) In ethanol (2 ml) was refluxed overnight. After cooling, the resulting precipitate
The residue was collected by filtration, and the residue was washed with ethanol to give 8- (2,6-dichlorobenzene).
Zoylamino) -4- (3,5-dihydroxypyrazol-4-yl) quinoline
Was obtained as a solid. The solid obtained is treated with a solution of hydrogen chloride in ethanol to precipitate it.
The precipitate was collected and recrystallized from isopropyl alcohol to give 8- (2,6-dichloro
Benzoylamino) -4- (3,5-dihydroxypyrazol-4-yl) quino
Phosphorus hydrochloride (95 mg) was obtained.
mp: 210-230 ℃
NMR (DMSO-d6, Δ): 7.50-7.67 (5H, m), 7.84 (1H, d,
J = 8Hz), 8.65 (1H, d, J = 8Hz), 8.78 (1H, d, J = 5Hz)Example 85
The following compound was obtained in the same manner as in Example 8.
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-methylimida
Zol-1-yl) quinoline
mp: 210-212 ℃
NMR (CDClThree, Δ): 2.25 (3H, s), 7.10 (1H, s), 7.17-7.30
(2H, m), 7.33-7.48 (4H, m), 7.68 (1H, t, J = 8Hz), 8.91 (1H, d,
J = 4Hz), 9.08 (1H, d, J = 8Hz)
Its hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.46 (3H, s), 7.36 (1H, d, J = 8Hz),
7.50-7.62 (3H, m), 7.80 (1H, t, J = 8Hz), 7.91-8.02 (3H, m),
8.87 (1H, d, J = 8Hz), 9.17 (1H, d, J = 4Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (pyrazole-1-
Ill) quinoline
mp: 194-197 ° C
NMR (CDClThree, Δ): 6.59-6.65 (1H, m), 7.30-7.46 (3H, m),
7.55 (1H, d, J = 5Hz), 7.69 (1H, t, J = 8Hz), 7.91 (1H, d, J = 2Hz),
7.96 (1H, d, J = 3Hz), 7.99 (1H, d, J = 8Hz), 8.82 (1H, d, J = 5Hz),
9.03 (1H, d, J = 8Hz)
Its hydrochloride
mp: 204-207 ℃
NMR (DMSO-d6, Δ): 6.71 (1H, d, J = 2 Hz), 7.48-7.62 (3H,
m), 7.70-7.81 (2H, m), 8.00 (1H, d, J = 2Hz), 8.11 (1H, d,
J = 8Hz), 8.46 (1H, t, J = 2Hz), 8.80 (1H, d, J = 8Hz), 8.99 (1H, d,
(J = 6Hz)
(3) 8- (2,6-dichlorobenzoylamino) -4- (1,2,4-tri
Azol-1-yl) quinoline
mp: 210-214 ℃
NMR (CDClThree, Δ): 7.31-7.46 (3H, m), 7.56 (1H, d,
J = 5Hz), 7.73 (1H, t, J = 8Hz), 7.80 (1H, d, J = 8Hz), 8.30 (1H,
s), 8.60 (1H, s), 8.90 (1H, d, J = 5Hz), 9.09 (1H, d, J = 8Hz)
Its hydrochloride
mp: 220-232 ℃
NMR (DMSO-d6, Δ): 7.47-7.62 (3H, m), 7.75 (1H, t,
J = 8Hz), 7.88 (1H, d, J = 8Hz), 8.00 (1H, d, J = 5Hz), 8.48 (1H,
s), 8.81 (1H, d, J = 8Hz), 9.06 (1H, d, J = 5Hz), 9.26 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -4- (N-methylamino
) Quinoline
mp: 226-228 ℃
NMR (DMSO-d6, Δ): 2.90 (3H, d, J = 6Hz), 6.46 (1H, d,
J = 6Hz), 7.37-7.68 (5H, m), 7.90 (1H, d, J = 8Hz), 8.36 (1H, d,
J = 6Hz), 8.60 (1H, d, J = 8Hz)
(5) 8- (2,6-dichlorobenzoylamino) -4- [N- (2-methoxy
Siethyl) -N-methylamino] quinoline
mp: 156-158 ℃
NMR (CDClThree, Δ): 3.05 (3H, s), 3.38 (3H, s), 3.53 (2H,
t, J = 5Hz), 3.70 (2H, t, J = 5Hz), 6.88 (1H, d, J = 5Hz), 7.27-7.42
(4H, m), 7.51 (1H, t, J = 8Hz), 7.90 (1H, d, J = 8Hz), 8.51 (1H,
d, J = 5Hz), 8.90 (1H, d, J = 8Hz)
(6) 4-[(3-aminopropyl) amino] -8- (2,6-dichloroben
Zoylamino) quinoline
mp: 146-150 ℃
NMR (CDClThree, Δ): 1.30-1.70 (3H, br), 1.90 (2H, quint.,
J = 6Hz), 3.05 (2H, t, J = 6Hz), 3.43 (2H, q, J = 6Hz), 6.39 (1H, d,
J = 5Hz), 7.25-7.48 (4H, m), 7.55 (1H, d, J = 8Hz), 8.38 (1H, d,
J = 5Hz), 8.88 (1H, d, J = 8Hz)
(7) 8- (2,6-dichlorobenzoylamino) -4- [N- (2-methyl
Aminoethyl) -N-methylamino] quinoline
mp: 173-178 ℃
NMR (CDClThree, Δ): 2.45 (3H, s), 2.91 (2H, t, J = 8Hz),
3.01 (3H, s), 3.44 (2H, t, J = 8Hz), 6.87 (1H, d, J = 6Hz), 7.27-
7.42 (3H, m), 7.52 (1H, t, J = 8Hz), 7.88 (1H, d, J = 8Hz), 8.50
(1H, d, J = 6Hz), 8.90 (1H, d, J = 8Hz)
(8) 8- (2,6-dichlorobenzoylamino) -4- (pyrazole-3-
Ilamino) quinoline hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 6.45 (1H, d, J = 4Hz), 7.52-7.65 (3H,
m), 7.86 (1H, t, J = 8Hz), 7.90 (1H, s), 7.97 (1H, ds, J = 8Hz),
8.55-8.70 (3H, m)
(9) 8- (2,6-dichlorobenzoylamino) -4- (1,2,4-tri
Azol-4-ylamino) quinoline
mp: 236-238 ℃
NMR (DMSO-d6, Δ): 6.61 (1H, d, J = 5Hz), 7.00 (2H, s),
7.42 (1H, t, J = 8Hz), 7.50-7.63 (3H, m), 7.93 (1H, d, J = 8Hz),
8.26 (1H, d, J = 5Hz), 8.61 (1H, d, J = 8Hz)
(10) 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (2
-Methylimidazol-1-yl) quinoline
mp: 200 ℃
NMR (CDClThree, Δ): 2.16 (3H, s), 6.97 (1H, s), 7.04 (1H,
d, J = 8Hz), 7.24 (1H, s), 7.32-7.48 (3H, m), 7.68 (1H, t,
J = 8Hz), 8.97 (1H, s), 9.06 (1H, d, J = 8Hz)
Its hydrochloride
mp: 269 ℃
NMR (DMSO6, Δ): 2.41 (3H, s), 7.28 (1H, d, J = 8Hz),
7.49-7.64 (3H, m), 7.84 (1H, t, J = 8Hz), 7.92 (1H, s), 7.96
(1H, s), 8.86 (1H, d, J = 8Hz), 9.30 (1H, s)
(11) 8- (2,6-dichlorobenzoylamino) -3-ethoxycarboni
4- [N- (2-hydroxyethyl) -N-methylamino] quinoline
mp: 139-141 ℃
NMR (CDClThree, Δ): 1.43 (3H, t, J = 6Hz), 3.05 (3H, s),
3.72-3.87 (4H, m), 4.48 (2H, q, J = 6Hz), 7.28-7.43 (3H, m),
7.57 (1H, t, J = 7Hz), 7.82 (1H, d, J = 7Hz), 8.83 (1H, s), 8.97
(1H, d, J = 7Hz)
(12) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (pi
Lazol-1-yl) quinoline
mp: 236 ℃
NMR (CDClThree, Δ): 2.30 (3H, s), 6.60-6.65 (1H, m), 7.11
(1H, d, J = 8Hz), 7.30-7.45 (3H, m), 7.57 (1H, d, J = 8Hz), 7.65
(1H, s), 7.90 (1H, s), 8.75 (1H, s), 8.93 (1H, d, J = 8Hz)
(13) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (1
, 2,4-Triazol-1-yl) quinoline
mp: 248-250 ℃
NMR (DMSO-d6, Δ): 2.26 (3H, s), 7.02 (1H, d, J = 8Hz),
7.48-7.61 (3H, m), 7.69 (1H, t, J = 8Hz), 8.48 (1H, s), 8.73
(1H, d, J = 8Hz), 9.03 (1H, s), 9.08 (1H, s)
(14) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-
4- (piperidino) quinoline
NMR (CDClThree, Δ): 1.67-1.88 (6H, m), 3.23-3.35 (4H, m),
3.38 (3H, s), 4.63 (2H, s), 7.28-7.44 (3H, m), 7.54 (1H, dd,
J = 8, 8Hz), 7.91 (1H, d, J = 8Hz), 8.57 (1H, s), 8.88 (1H, d,
J = 8Hz), 10.12 (1H, s)
(15) 8- (2,6-dichlorobenzoylamino) -4- (pyridine-3-
Ylmethylamino) quinoline
NMR (CDClThree, Δ): 4.61 (2H, d, J = 6 Hz), 5.50 (1H, t,
J = 6Hz), 6.46 (1H, d, J = 5Hz), 7.25-7.42 (4H, m), 7.49-7.56 (2H,
m), 7.72 (1H, d, J = 8Hz), 8.40 (1H, d, J = 5Hz), 8.60 (1H, d,
J = 5Hz), 8.69 (1H, s), 8.90-8.96 (1H, m)
Its dihydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 5.03 (2H, d, J = 5 Hz), 6.95 (1H, d,
J = 8Hz), 7.50-7.65 (3H, m), 7.80-7.90 (2H, m), 8.42 (1H, d,
J = 8Hz), 8.55 (1H, d, J = 8Hz), 8.55 (2H, m), 8.63 (1H, d,
J = 8Hz), 8.78 (1H, d, J = 5Hz), 9.00 (1H, s)Example 86
8- (2,6-dichlorobenzoylamino) -4-methylaminoquinoline (1
A suspension of 30 mg) in acetic anhydride (2 ml) was heated at 120 ° C. for 3 hours. vacuum
The solvent was removed in and the residue was dissolved in methanol (3 ml). 1N hydroxyl in solution
Sodium chloride solution (0.5 ml) was added and the mixture was stirred for 30 minutes. In a vacuum
The solvent was removed and the residue was washed with hot 50% ethanol (2 ml) and filtered. Remaining
The distillate was washed with hot 95% ethanol (1 ml) and the filtrate was allowed to come to room temperature.
Was. The resulting precipitate was collected by filtration, dried and treated with 8- (2,6-dichlorobenzo).
Ilamino) -4- (N-methylacetamido) quinoline (90 mg) was obtained.
mp: 227-230 ℃
NMR (CDClThree, Δ): 1.80 (3H, s), 3.36 (3H, s), 7.29-
7.48 (4H, m), 7.57 (1H, d, J = 8Hz), 7.71 (1H, t, J = 8Hz), 8.83
(1H, d, J = 5Hz), 9.04 (1H, d, J = 8Hz)Example 87
8- (2,6-dichlorobenzoylamino) -4- [N- (2-methylamino
Ethyl) -N-methylamino] quinoline (130 mg), 3-pyridylcarbamido
Phenylformate (76mg) and triethylamine (97.9mg)
The mixture in muamide (1.5 ml) was stirred at room temperature for 1 hour. The mixture is treated with ethyl acetate
Diluted with 1N sodium hydroxide solution, water and brine, and magnesium sulfate.
After drying with a solvent, the solvent was distilled off in vacuo. The residue was separated by preparative thin-layer chromatography (
Purification with methanol-dichloromethane) gave 8- (2,6-dichlorobenzoyl).
Amino) -4- [N- [2- [1-methyl-3- (3-pyridyl) ureido] d
[Tyl] -N-methylamino] quinoline (168 mg) was obtained.
NMR (CDClThree, Δ): 2.73 (3H, s), 3.10 (3H, s), 3.60-3.75
(4H, m), 6.20 (1H, br s), 6.88 (1H, d, J = 6Hz), 7.22 (1H, dd,
J = 8, 7Hz), 7.28-7, 41 (3H, m), 7.49 (1H, t, J = 8Hz), 7.77 (1H,
d, J = 8Hz), 7.85 (1H, dd, J = 7, 2Hz), 8.27 (1H, d, J = 7Hz), 8.36
(1H, d, J = 2Hz), 8.44 (1H, d, J = 6Hz), 8.88 (1H, d, J = 8Hz)
Its dihydrochloride
mp: 261-266 ℃
NMR (DMSO-d6, Δ): 2.97 (3H, s), 3.48 (3H, s), 3.71-
3.83 (2H, m), 3.94-4.08 (2H, m), 7.16 (1H, d, J = 8Hz), 7.49-
7.67 (4H, m), 7.83 (1H, dd, J = 8, 7Hz), 8.11 (1H, d, J = 8Hz),
8.39-8.51 (4H, m), 9.00 (1H, s), 9.40 (1H, br s)
Example 88
8- (2,6-dichlorobenzoylamino) -4- [N- [2- [1-methyl
-3- (4-pyridyl) ureido] ethyl] -N-methylamino] quinoline,
In the same manner as in Example 87, 8- (2,6-dichlorobenzoylamino) -4- [
N- (2-methylaminoethyl) -N-methylamino] quinoline and 4-pyridyl
Obtained by reacting with phenyl carbamate.
mp: 283-290 ℃
NMR (CDClThree, Δ): 2.74 (3H, s), 3.11 (3H, s), 3.60-3.76
(4H, m), 6.32 (1H, br s), 6.89 (1H, d, J = 6Hz), 7.18-7.44 (5H,
m), 7.49 (1H, t, J = 8Hz), 7.77 (1H, d, J = 8Hz), 8.35-8.46 (3H,
m), 8.89 (1H, d, J = 8Hz)Example 89
8- (2,6-dichlorobenzoylamino) -4- [N- (2-methylamino
Ethyl) -N-methylamino] quinoline (130 mg), 3-pyridinecarbyl
Bonyl (60.3mg) and triethylamine (97.9mg) in dichloromethane
(2 ml) was stirred overnight at room temperature. Dilute the mixture with dichloromethane
After washing with water and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Crystallized from ethanol and collected by filtration. Wash the residue with ethanol
, 8- (2,6-dichlorobenzoylamino) -4- [N- [2- (N-methyl
-3-pyridinecarboxamido) ethyl] -N-methylamino] quinoline (15
0 mg).
mp: 195-203 ℃
NMR (CDClThree, Δ): 2.80 (3H, br s), 3.17 (3H, br s),
3.36-3.93 (4H, m), 6.95 (1H, br d), 7.27-7.47 (5H, m), 7.53
(1H, t, J = 8Hz), 7.80 (1H, br d), 8.40-8.66 (3H, m), 8.90 (1H,
d, J = 8Hz)Example 90
(1) 4- (2-aminophenylamino) -8- (2,6-dichlorobenzoi
Ruamino) quinoline was converted to 4-chloro-8- (2,6-di
(Chlorobenzoylamino) quinoline and 1,2-phenylenediamine.
mp: 224-228 ° C
NMR (CDClThree, Δ): 3.80 (2H, br s), 6.36-6.46 (2H, m),
6.80-6.91 (2H, m), 7.13-7.22 (2H, m), 7.29-7.44 (3H, m), 7.60
(1H, t, J = 8Hz), 7.70 (1H, d, J = 8Hz), 8.37 (1H, d, J = 5Hz), 8.98
(1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-pyridi
[Carboxamido) phenylamino] quinoline was obtained in the same manner as in Example 89.
mp: 151-154 ℃
NMR (CDClThree, Δ): 6.63 (1H, d, J = 6Hz), 7.37-7.70 (7H,
m), 7.84 (1H, t, J = 8 Hz), 7.87 (1H, d, J = 8 Hz), 8.40 (1H, br d,
J = 9Hz), 8.47 (1H, d, J = 6Hz), 8.52 (1H, d, J = 8Hz), 8.73-8.81
(2H, m), 9.10 (1H, br s)
Its hydrochloride
mp: 277-283 ℃
NMR (DMSO-d6, Δ): 6.63 (1H, d, J = 6Hz), 7.37-7.70 (7H,
m), 7.84 (1H, t, J = 8 Hz), 7.87 (1H, d, J = 8 Hz), 8.40 (1H, br d,
J = 9Hz), 8.47 (1H, d, J = 6Hz), 8.52 (1H, d, J = 8Hz), 8.73-8.81
(2H, m), 9.10 (1H, br s)
(3) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-pyridi
Solution of (carboxamido) phenylamino] quinoline (150 mg) in acetic acid
Refluxed for 60 hours. After cooling, the mixture was concentrated in vacuo and diluted with ethyl acetate.
Wash the solution with saturated sodium bicarbonate solution, dry over magnesium sulfate,
The solvent was distilled off with. The residue was crystallized from acetonitrile and collected by filtration,
8- (2,6-dichlorobenzoylamino) -4- [2- (3-pyridyl) -1
[H-benzimidazol-1-yl] quinoline (136 mg) was obtained.
mp: 203-204 ℃
NMR (CDClThree, Δ): 6.93 (1H, d, J = 8Hz), 7.20-7.48 (8H,
m), 7.60 (1H, t, J = 8 Hz), 7.89 (1H, dd, J = 8, 3 Hz), 7.98 (1H, t,
J = 8Hz), 8.54 (1H, m), 8.66 (1H, d, J = 3Hz), 8.87 (1H, m), 9.08
(1H, d, J = 8Hz)
Its dihydrochloride
mp: 249-254 ℃
NMR (DMSO-d6, Δ): 7.10 (1H, d, J = 8 Hz), 7.16 (1H, d,
J = 8Hz), 7.31 (1H, t, J = 8Hz), 7.40-7.69 (6H, m), 7.92-8.04 (3H,
m), 8.62 (1H, d, J = 6Hz), 8.80 (1H, d, J = 8Hz), 8.83 (1H, brs),
9.10 (1H, d, J = 6Hz)Example 91
8- (2,6-dichlorobenzoylamino) -4- (imidazol-2-yl
Thio) quinoline was prepared in the same manner as in Example 25 by using 4-chloro-8- (2,6-dicane).
Reaction of (Rolobenzoylamino) quinoline with 2-mercaptoimidazole
Obtained.
mp: 211-215 ℃
NMR (CDClThree, Δ): 6.80 (1H, d, J = 4Hz), 7.28-7.45 (6H,
m), 7.61 (1H, d, J = 8 Hz), 8.42 (1H, d, J = 4 Hz), 8.86 (1H, d, J
(J = 8Hz)Example 92
(1) 4- (2-aminoethylamino) -8- (2,6-dichlorobenzoyl
Amino) quinoline was prepared in the same manner as in Example 8 by using 4-chloro-8- (2,6-dicane).
(Rolobenzoylamino) quinoline and ethylenediamine.
mp: 184-192 ℃
NMR (CDClThree, Δ): 3.07-3.16 (2H, m), 3.30-3.40 (2H, m),
5.78 (1H, m), 6.44 (1H, d, J = 6Hz), 7.22-7.40 (3H, m), 7.42-
7.59 (2H, m), 8.39 (1H, d, J = 6Hz), 8.90 (1H, d, J = 8Hz),
(2) 8- (2,6-dichlorobenzoylamino) -4- (2-aminoethyl
To a suspension of amino) quinoline (250 mg) in dioxane (3 ml) was added 1,1
'-Carbonyldiimidazole (119 mg) was added at room temperature and the mixture was added at room temperature for 1 hour.
Stirred for hours. 1,8-diazabicyclo [5.4.0] undec-7 was added to the mixture.
A solution of -ene (112 mg) in dioxane (1 ml) was added and the mixture was heated
For 2 hours. The mixture is concentrated in vacuo and the residue is crystallized from ethanol
To give 8- (2,6-dichlorobenzoylamino) -4- (2-oxoimidazoli
(Gin-1-yl) quinoline (200 mg) was obtained.
mp: 265-269 ℃
NMR (DMSO-d6, Δ): 3.55 (2H, t, J = 8 Hz), 4.02 (2H, t,
J = 8Hz), 7.31 (1H, br s), 7.47-7.65 (5H, m), 7.80 (1H, d,
J = 8Hz), 8.70 (1H, d, J = 8Hz), 8.81 (1H, d, J = 5Hz)Example 93
(1) 8- (2,6-dichlorobenzoylamino) -4- [2- (N-methyl
Amino) ethylamino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro-8-
(2,6-dichlorobenzoylamino) quinoline and N-methylethylenediamine
And obtained by reacting
mp: 172-175 ℃
NMR (CDClThree, Δ): 2.49 (3H, s), 2.99 (2H, t, J = 8Hz),
3.30-3.40 (2H, m), 5.32-5.41 (1H, m), 6.43 (1H, d, J = 6Hz),
7.26-7.56 (5H, m), 8.38 (1H, d, J = 6Hz), 8.88 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (3-methyl-2-
Oxoimidazolidin-1-yl) quinoline was prepared in the same manner as in Example 92- (2).
Obtained.
mp: 238-242 ℃
NMR (CDClThree, Δ): 2.98 (3H, s), 3.65 (2H, t, J = 8Hz),
3.96 (2H, t, J = 8Hz), 7.29-7.45 (4H, m), 7.60 (1H, t, J = 8Hz),
7.75 (1H, d, J = 8Hz), 8.25 (1H, d, J = 6Hz), 8.97 (1H, d, J = 8Hz)
(3) 8- (2,6-dichlorobenzoylamino) -4- (3-methyl-2-
Thioxoimidazolidin-1-yl) quinoline was prepared in the same manner as in Example 92-2 (2).
To give 8- (2,6-dichlorobenzoylamino) -4- [2- (N-methyla
Mino) ethylamino] quinoline and 1,1'-thiocarbonyldiimidazole
The reaction was obtained.
mp: 295 ℃
NMR (CDClThree, Δ): 3.30 (3H, s), 3.87-4.09 (4H, m),
7.27-7.42 (3H, m), 7.50 (1H, d, J = 5Hz), 7.59-7.69 (2H, m),
8.81 (1H, d, J = 5Hz), 8.96 (1H, dd, J = 8, 5Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4- (2-methylamino
Ethylamino) quinoline (120mg) in tetrahydrofuran (2.5ml)
1,1′-carbonyldiimidazole (90 mg) was added to the solution of
The mixture was stirred at room temperature for 2 hours. The mixture is concentrated in vacuo and the residue is ethanol
And crystallized from 8- (2,6-dichlorobenzoylamino) -4- [2- [N
-(1-Imidazolylcarbonyl) -N-methylamino] ethylamino] quinoli
(148 mg) was obtained.
mp: 202 ℃
NMR (DMSO-d6, Δ): 3.08 (3H, s), 3.56-3.74 (4H, m),
6.66 (1H, m), 6.97 (1H, s), 7.36-7.62 (6H, m), 7.92 (1H, d,
J = 8Hz), 7.98 (1H, brs), 8.35 (1H, d, J = 6Hz), 8.63 (1H, d,
(J = 8Hz)Example 94
(1) 4- (2-methylaminoethylamino) -8-nitroquinazoline is
In the same manner as in Example 8, 4-chloro-8-nitroquinazoline and N-methylethylene
Obtained by reacting with diamine.
mp: 166-169 ℃
NMR (DMSO-d6, Δ): 2.31 (3H, s), 2.73 (2H, t, J = 6Hz),
3.63 (2H, t, J = 6Hz), 7.62 (1H, t, J = 7Hz), 8.22 (1H, d, J = 7Hz),
8.50 (1H, d, J = 7Hz), 8.51 (1H, s)
(2) 4- (3-methyl-2-oxoimidazolidin-1-yl) -8-nito
Loquinazoline was obtained in the same manner as in Example 92- (2).
mp: 207-210 ℃
NMR (CDClThree, Δ): 3.01 (3H, s), 3.67 (2H, t, J = 6Hz),
4.23 (2H, t, J = 6Hz), 7.59 (1H, t, J = 7Hz), 8.20 (1H, d, J = 7Hz),
8.48 (1H, d, J = 7Hz), 9.10 (1H, s)
(3) 8-amino-4- (3-methyl-2-oxoimidazolidin-1-yl
) Quinazoline was obtained in the same manner as in Production Example 2- (3).
mp: 187-189 ℃
NMR (DMSO-d6, Δ): 2.84 (3H, s), 3.56 (2H, t, J = 6Hz),
4.07 (2H, t, J = 6Hz), 5.92 (2H, brs), 6.99 (1H, d, J = 7Hz),
7.22 (1H, d, J = 7Hz), 7.28 (1H, t, J = 7Hz), 8.87 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -4- (3-methyl-2-
Oxoimidazolidin-1-yl) quinazoline was obtained in the same manner as in Example 1.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.88 (3H, s), 3.60 (2H, t, J = 6Hz),
4.12 (2H, t, J = 6Hz), 7.45-7.58 (3H, m), 7.62 (1H, t, J = 7Hz),
7.98 (1H, d, J = 7Hz), 8.79 (1H, d, J = 7Hz), 9.00 (1H, s)Example 95
8- (2,6-dichlorobenzoylamino) -4- (3,4,5,6-tetra
Hydro-2 (1H) -pyrimidinone-1-yl) quinoline was prepared according to Example 92- (2
)) And 4- (3-aminopropylamino) -8- (2,6-dichloro
Reaction of benzoylamino) quinoline with 1,1'-carbonyldiimidazole
I got it.
mp:> 250 ℃
NMR (CDClThree, Δ): 2.08-2.40 (2H, br), 3.50-3.60 (2H,
m), 3.64-3.82 (2H, m), 5.18 (1H, s), 7.29-7.43 (4H, m), 7.59-
7.62 (2H, m), 8.79 (1H, d, J = 5Hz), 8.91-9.00 (1H, m)Example 96
4- (benzimidazolidin-1-yl) -8- (2,6-dichlorobenzoy
(Amino) quinoline was converted to 4- (2-aminophenyl) in the same manner as in Example 92- (2).
Enylamino) -8- (2,6-dichlorobenzoylamino) quinoline and 1,1
It was obtained by reacting with '-carbonyldiimidazole.
mp: 246-248 ℃
NMR (CDClThree, Δ): 6.70 (1H, d, J = 8Hz), 7.01-7.25 (3H,
m), 7.32-7.50 (4H, m), 7.58-7.68 (2H, m), 8.98 (1H, d, J = 5Hz),
9.06 (1H, d, J = 8Hz), 9.31 (1H, s)Example 97
4- (1H-imidazo [4,5-b] pyridin-2-ylthio) -8- (2
6-Dichlorobenzoylamino) quinoline hydrochloride was prepared in the same manner as in Example 25,
4-chloro-8- (2,6-dichlorobenzoylamino) quinoline and 2-merca
It was obtained by reacting with pto-1H-imidazo [4,5-b] pyridine.
mp: 182-190 ℃
NMR (DMSO-d6, Δ): 7.44-7.63 (4H, m), 7.77 (1H, t,
J = 8Hz), 7.88 (1H, d, J = 4Hz), 8.01 (1H, d, J = 8Hz), 8.25 (1H, d,
J = 8Hz), 8.46 (1H, d, J = 4Hz), 8.80 (1H, d, J = 8Hz), 8.91 (1H, d,
(J = 4Hz)Example 98
(1) 3-chloro-1,4-dihydro-8-nitro-4-oxoquinoline
1,4-dihydro-8-nitro-4-oxooxo was prepared in the same manner as in Production Example 6- (1).
It was obtained by reacting noline with N-chlorosuccinimide.
mp: 290-297 ℃
NMR (DMSO-d6, Δ): 7.59 (1H, t, J = 8Hz), 8.26 (1H, s),
8.61 (1H, dd, J = 8, 2Hz), 8.78 (1H, dd, J = 8, 2Hz)
(2) 3,4-Dichloro-8-nitroquinoline was prepared in the same manner as in Production Example 2- (1).
I got it.
mp: 123 ℃
NMR (CDClThree, Δ): 7.76 (1H, t, J = 8 Hz), 8.06 (1H, d,
J = 8Hz), 8.45 (1H, d, J = 8Hz), 8.98 (1H, s)
(3) 4- [bis (ethoxycarbonyl) methyl] -3-chloro-8-nitro
Quinoline was obtained in the same manner as in Production Example 7- (1).
mp: 101.5 ℃
NMR (CDClThree, Δ): 1.23 (6H, t, J = 8 Hz), 4.14-4.33 (4H,
m), 5.75 (1H, s), 7.67 (1H, t, J = 8Hz), 7.99 (1H, d, J = 8Hz),
8.27 (1H, d, J = 8Hz), 9.02 (1H, s)
(4) 3-chloro-4- (ethoxycarbonylmethyl) -8-nitroquinoline
Was obtained in the same manner as in Production Example 7- (2).
mp: 156 ℃
NMR (CDClThree, Δ); 1.23 (3H, t, J = 8 Hz), 4.18 (2H, q,
J = 8Hz), 4.30 (2H, s), 7.70 (1H, t, J = 8Hz), 8.00 (1H, d,
J = 8Hz), 8.16 (1H, d, J = 8Hz), 8.98 (1H, s)
(5) 8-amino-3-chloro-4- (ethoxycarbonylmethyl) quinoline
Was obtained in the same manner as in Production Example 2- (3).
mp: 144 ℃
NMR (CDClThree, Δ): 1.21 (3H, t, J = 8 Hz), 4.14 (2H, q,
J = 8Hz), 4.20 (2H, s), 5.01 (2H, br s), 6.90 (1H, d, J = 8Hz),
7.20 (1H, d, J = 8Hz), 7.38 (1H, t, J = 8Hz), 8.67 (1H, s)
(6) 3-chloro-8- (2,6-dichlorobenzoylamino) -4- (ethoxy
(Xycarbonylcarbonyl) quinoline was obtained in the same manner as in Example 1.
mp: 161 ℃
NMR (CDClThree, Δ): 1.23 (3H, t, J = 8 Hz), 4.18 (2H, q,
J = 8Hz), 4.26 (2H, s), 7.30-7.45 (3H, m), 7.66-7.71 (2H, m),
8.70 (1H, s), 8.91-9.01 (1H, s)
(7) 4-carboxymethyl-3-chloro-8- (2,6-dichlorobenzoy
(Lamino) quinoline was obtained in the same manner as in Example 18.
mp: 257-259 ℃
NMR (DMSO-d6, Δ): 4.31 (2H, s), 7.47-7.61 (3H, m),
7.75 (1H, t, J = 8Hz), 7.96 (1H, d, J = 8Hz), 8.72 (1H, d, J = 8Hz),
8.99 (1H, s)
(8) 4-carbamoylmethyl-3-chloro-8- (2,6-dichlorobenzo
(Ilamino) quinoline was obtained in the same manner as in Example 22- (2).
mp:> 300 ℃
NMR (DMSO-d6, Δ): 4.17 (2H, s), 7.20 (1H, br s),
7.46-7.61 (3H, m), 7.70 (1H, br s), 7.72 (1H, t, J = 8Hz), 7.90
(1H, d, J = 8Hz), 8.70 (1H, d, J = 8Hz), 8.86 (1H, s)
(9) 3-chloro-8- (2,6-dichlorobenzoylamino) -4-methyl
Quinoline was prepared in the same manner as in Example 37 by using 3-chloro-8- (2,6-dichlorobenzene).
Obtained from benzoylamino) -4- (ethoxycarbonylmethyl) quinoline.
mp: 259 ℃
NMR (DMSO-d6, Δ): 2.76 (3H, s), 7.46-7.60 (3H, m),
7.75 (1H, t, J = 8Hz), 7.96 (1H, d, J = 8Hz), 8.70 (1H, d, J = 8Hz),
8.80 (1H, d, J = 8Hz)Example 99
Cerium (III) chloride heptahydrate (580 mg) was dried at 150 ° C. under reduced pressure.
The mixture was cooled to room temperature under a nitrogen atmosphere, and suspended in tetrahydrofuran (2 ml).
The suspension was added with 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (ethoxy
(Xycarbonylmethyl) quinoline (300mg) and 0.9M methylmagnesium bromide
Solution (3.5 ml) was added under ice-cooling, and the mixture was stirred for 1 hour.
Stirred. The mixture was poured into a saturated ammonium chloride solution and extracted with ethyl acetate.
The organic layer was washed with brine, dried over magnesium sulfate, and the solvent was distilled off in vacuo
. The residue was crystallized from isopropyl alcohol to give 3-bromo-8- (2,6
-Dichlorobenzoylamino) -4- (2-hydroxy-2-methylpropyl)
Quinoline (216 mg) was obtained.
mp: 260-262 ℃
NMR (CDClThree, Δ): 1.38 (6H, s), 3.56 (2H, s), 7.30-
7.55 (3H, m), 7.67 (1H, t, J = 8Hz), 8.02 (1H, d, J = 8Hz), 8.82
(1H, s), 8.97 (1H, d, J = 8Hz)Example 100
3-carboxy-8- (2,6-dichlorobenzoylamino) -4- (imida
Zol-1-yl) quinoline (147.6 mg) and triethylamine (12.2)
mg) in dioxane was added to diphenylphosphoryl azide (99.8 m
g) was added at 90 ° C., and the mixture was stirred at the same temperature for 2 hours. After cooling to 70 ° C,
Methanol (12.2 mg) was added and the mixture was stirred at 85 ° C. for 1 hour. mixture
Was partitioned between ethyl acetate and water. The organic layer is washed with saline and magnesium sulfate
After drying with a solvent, the solvent was distilled off in vacuo. The residue was separated by preparative thin-layer chromatography (
Methanol-dichloromethane) and crystallized from isopropyl alcohol
To give 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1-
Yl) -3- (Methoxycarbonylamino) quinoline (21.3 mg) was obtained.
mp: 236-238 ℃
NMR (CDClThree, Δ): 3.78 (3H, s), 6.59 (1H, br s), 6.96
(1H, d, J = 8Hz), 7.12 (1H, br s), 7.30-7.50 (4H, m), 7.60 (1H,
t, J = 8Hz), 7.65 (1H, br s), 8.93 (1H, d, J = 8Hz), 9.67 (1H, s)Example 101
(1) 3-tert-butoxycarbonylamino-8- (2,6-dichlorobenzo
(Illamino) -4- (imidazol-1-yl) quinoline was prepared in the same manner as in Example 100.
Thus, 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-
Obtained from (imidazol-1-yl) quinoline and tertiary butanol.
mp: 205-206 ℃
NMR (CDClThree, Δ): 1.50 (9H, s), 6.30 (1H, s), 6.94
(1H, d, J = 8Hz), 7.13 (1H, s), 7.30-7.50 (4H, m), 7.59 (1H, t,
J = 8Hz), 7.67 (1H, s), 8.91 (1H, d, J = 8Hz), 9.69 (1H, s)
(2) 3-tert-butoxycarbonylamino-8- (2,6-dichlorobenzo
Dicyl of ylamino) -4- (imidazol-1-yl) quinoline (869 mg)
To a solution in dichloromethane (2 ml) was added trifluoroacetic acid (5 ml) under ice cooling.
The mixture was stirred at room temperature for 2 hours. Mix the mixture with dichloromethane and saturated sodium bicarbonate
And the aqueous solution. Wash the organic layer with brine and dry over magnesium sulfate
Thereafter, the solvent was distilled off in vacuo. Crystallize the residue from isopropyl alcohol
, 3-amino-8- (2,6-dichlorobenzoylamino) -4- (imidazo
(L-1-yl) quinoline (581.4 mg) was obtained.
mp:> 250 ℃
NMR (CDClThree, Δ): 4.01 (2H, s), 6.93 (1H, d, J = 8Hz),
7.12 (1H, s), 7.30-7.50 (4H, m), 7.53 (1H, t, J = 8Hz), 7.68
(1H, s), 8.51 (1H, s), 8.77 (1H, d, J = 8Hz), 9.88 (1H, s)
Its dihydrochloride
mp: 248-250 ℃
NMR (DMSO-d6, Δ): 6.23 (2H, br), 6.68 (1H, d, J = 8Hz),
7.45-7.60 (4H, m), 7.95 (1H, s), 8.09 (1H, s), 8.42 (1H, d,
J = 8Hz), 8.71 (1H, s), 9.52 (1H, s)Example 102
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -3- (4-Pyridylthio) quinoline was prepared in the same manner as in Example 25, using 3-bromine.
Mo-8- (2,6-dichlorobenzoylamino) -4- (imidazole-1-i
Ii) It was obtained by reacting quinoline with 4-mercaptopyridine.
mp: 218-220 ℃
NMR (DMSO-d6, Δ): 7.10-7.20 (4H, m), 7.45-7.60 (4H,
m), 7.82 (1H, t, J = 7Hz), 7.90 (1H, s), 8.34 (2H, d, J = 5Hz),
8.86 (1H, d, J = 7Hz), 9.03 (1H, s)
The dimethane sulfonate
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.32 (6H, s), 7.34 (1H, d, J = 7Hz),
7.48-7.62 (5H, m), 7.88 (1H, s), 7.91 (1H, t, J = 7Hz), 7.97
(1H, s), 8.55 (2H, d, J = 6Hz), 8.94 (1H, d, J = 7Hz), 9.21 (1H,
s), 9.23 (1H, s)Example 103
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -3- (Methylthio) quinoline hydrochloride was prepared in the same manner as in Production Example 13,
Mo-8- (2,6-dichlorobenzoylamino) -4- (imidazole-1-i
G) It was obtained by reacting quinoline with sodium thiomethoxide.
mp: 212-216 ℃
NMR (DMSO-d6, Δ): 2.19 (3H, s), 7.12 (1H, d, J = 7Hz),
7.47-7.63 (3H, m), 7.77 (1H, t, J = 7Hz), 8.02 (2H, brs), 8.73
(1H, d, J = 7Hz), 9.14 (1H, s), 9.38 (1H, br s)Example 104
(1) 3-chloromethyl-1,4-dihydro-8-nitro-4-oxoquinoli
(2.0 g) in water (30 ml) is refluxed for 15 minutes and allowed to reach room temperature.
It was left still. The resulting precipitate was collected by filtration, washed with water and 1,4-dihydro
-3-Hydroxymethyl-8-nitro-4-oxoquinoline (1.82 g) was obtained.
Was.
mp: 182-184 ℃
NMR (DMSO-d6, Δ): 4.41 (2H, s), 5.14 (1H, br), 7.49
(1H, t, J = 7Hz), 8.00 (1H, s), 8.59 (1H, d, J = 7Hz), 8.66 (1H,
d, J = 7Hz)
(2) 1,4-dihydro-3-hydroxymethyl-8-nitro-4-oxo
Norin (3.1 g) in trifluoroacetic acid (10 ml) and dichloromethane (10 m
l) To the solution in 1), triethylsilane (6.55 g) was added and the mixture was allowed to stand at room temperature overnight.
Stirred. The mixture was partitioned between dichloromethane and saturated sodium bicarbonate solution.
Was. The organic layer was washed with brine, dried over sodium sulfate and evaporated in vacuo.
Was. The residue was purified by silica gel column chromatography to give 1,4-dihydrogen.
2--3-Methyl-8-nitro-4-oxoquinoline (2.3 g) was obtained.
mp: 235-243 ℃
NMR (CDClThree, Δ): 2.16 (3H, s), 7.41 (1H, t, J = 7Hz),
7.69 (1H, d, J = 7Hz), 8.65 (1H, d, J = 7Hz), 8.82 (1H, d, J = 7Hz)
(3) 4-chloro-3-methyl-8-nitroquinoline was prepared in the same manner as in Production Example 2- (1).
Obtained in a similar manner.
mp: 126 ℃
NMR (CDClThree, Δ): 2.61 (3H, s), 7.68 (1H, t, J = 8Hz),
8.00 (1H, d, J = 8Hz), 8.46 (1H, d, J = 8Hz), 8.88 (1H, s)
(4) 8-amino-4-chloro-3-methylquinoline was prepared in the same manner as in Production Example 2- (3).
Obtained in a similar manner.
mp: 112-114 ℃
NMR (CDClThree, Δ): 2.54 (3H, s), 4.99 (2H, brs), 6.90
(1H, d, J = 8Hz), 7.38 (1H, t, J = 8Hz), 7.50 (1H, d, J = 8Hz), 8.55
(1H, s)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-methyl
Quinoline was obtained in the same manner as in Example 1.
mp: 216-227 ℃
NMR (CDClThree, Δ): 2.57 (3H, s), 7.28-7.46 (3H, m), 7.67
(1H, t, J = 8Hz), 7.96 (1H, d, J = 8Hz), 8.59 (1H, s), 8.94 (1H,
d, J = 8Hz)
(6) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-methylquinoline was obtained in the same manner as in Example 8.
mp: 224-228 ° C
NMR (CDClThree, Δ): 2.30 (3H, s), 7.09 (1H, d, J = 8Hz),
7.10 (1H, s), 7.30-7.45 (4H, m), 7.60 (1H, t, J = 8Hz), 7.63
(1H, s), 8.77 (1H, s), 8.96 (1H, d, J = 8Hz)
Its hydrochloride
mp: 231-235 ℃
NMR (DMSO-d6, Δ): 2.30 (3H, s), 7.11 (1H, d, J = 8Hz),
7.47-7.66 (4H, m), 7.75 (1H, t, J = 8Hz), 8.00-8.14 (2H, m),
8.75 (1H, d, J = 8Hz), 9.08 (1H, s), 9.37 (1H, s)Example 105
(1) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- [2-
(N-methylamino) ethylamino] quinoline was prepared in the same manner as in Example 8 by using 4-
Chloro-8- (2,6-dichlorobenzoylamino) -3-methylquinoline and N
-Methylethylenediamine.
mp: 274-278 ° C
NMR (DMSO-d6, Δ): 2.40 (3H, s), 2.56 (3H, s), 3.07-
3.20 (2H, m), 3.69-3.75 (2H, m), 6.19 (1H, brt, J = 7Hz), 7.41-
7.66 (4H, m), 8.03 (1H, d, J = 8 Hz), 8.37 (1H, s), 8.59 (1H, d,
J = 8Hz), 8.74 (1H, brs)
(2) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (3-
Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp: 288 ℃
NMR (DMSO-d6, Δ): 2.36 (3H, s), 2.81 (3H, s), 3.56-
3.86 (4H, m), 7.46-7.61 (3H, m), 7.65-7.70 (2H, m), 8.65 (1H,
t, J = 8Hz), 8.85 (1H, s)Example 106
(1) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-vinylquinoline was prepared in the same manner as in Production Example 14 by using 3-bromo-8-
(2,6-dichlorobenzoylamino) -4- (imidazol-1-yl) quino
Obtained from phosphorus and tri-n-butyl (vinyl) tin.
mp: 194-195 ℃
NMR (CDClThree, Δ): 5.53 (1H, d, J = 11 Hz), 5.96 (1H, d,
J = 15Hz), 6.45 (1H, dd, J = 11, 15Hz), 7.10-7.20 (2H, overlap
Lap), 7.30-7.50 (3H, m), 7.63 (1H, t, J = 8Hz), 7.66 (1H, s),
9.00 (1H, d, J = 8Hz), 9.10 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (imi
(Guzol-1-yl) quinoline was obtained in the same manner as in Example 41.
mp: 187-188 ℃
NMR (CDClThree, Δ): 1.21 (3H, t, J = 7 Hz), 2.63 (2H, q,
J = 7Hz), 7.05 (1H, d, J = 8Hz), 7.13 (1H, s), 7.30-7.50 (4H, m),
7.60 (1H, t, J = 8Hz), 7.64 (1H, s), 8.82 (1H, s), 8.98 (1H, d,
(J = 8Hz)
Its hydrochloride
mp: 238-242 ℃
NMR (DMSO-d6, Δ): 1.16 (3H, t, J = 7 Hz), 2.59 (2H, q,
J = 7Hz), 7.07 (1H, d, J = 8Hz), 7.50-7.60 (3H, m), 7.75 (1H, t,
J = 8Hz), 8.04 (1H, s), 8.10 (1H, s), 8.77 (1H, d, J = 8Hz), 9.12
(1H, s), 9.41 (1H, s)Example 107
8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-methyl
Imidazol-1-yl) quinoline was prepared in the same manner as in Example 106- (1) and (2).
Thus, 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (2
-Methylimidazol-1-yl) quinoline.
NMR (CDClThree, Δ): 1.20 (3H, t, J = 8Hz), 2.10 (3H, s),
2.46-2.70 (2H, m), 6.90 (1H, d, J = 8Hz), 6.95 (1H, s), 7.20-
7.71 (5H, m), 8.81 (1H, s), 8.97 (1H, d, J = 8Hz)
Its hydrochloride
mp: 169-176 ℃
NMR (DMSO-d6, Δ): 1.17 (3H, t, J = 8 Hz), 2.36 (3H, s),
2.40-2.56 (1H, m), 2.58-2.76 (1H, m), 7.05 (1H, d, J = 8Hz),
7.48-7.63 (3H, m), 7.74 (1H, t, J = 8Hz), 7.98-8.07 (2H, m),
8.76 (1H, d, J = 8Hz), 9.13 (1H, s)Example 108
(1) 4-carbogishimethyl-8- (2,6-dichlorobenzoylamino)-
To a solution of 3-ethylquinoline (405 mg) in dimethylformamide was added carbonate
Lithium (305 mg) and methyl iodide (314 mg) were added and the mixture was stirred at room temperature for 2 hours.
Stirred for hours. The mixture was partitioned between ethyl acetate and water. Wash the organic layer with saline
After washing and drying over magnesium sulfate, the solvent was distilled off in vacuo. Silica gel residue
Column chromatography (ethyl acetate: n-hexane, 1: 3, v / v)
Purified and crystallized from ethanol-water to give 8- (2,6-dichlorobenzoyla
Mino) -3-ethyl-4- (methoxycarbonylmethyl) quinoline (282 mg)
) Got.
mp: 167-168 ℃
NMR (CDClThree, Δ): 1.28 (3H, t, J = 7Hz), 2.90 (2H, q,
J = 7Hz), 3.69 (3H, s), 4.64 (2H, s), 7.30-7.45 (3H, m), 7.62
(1H, t, J = 8Hz), 7.72 (1H, d, J = 8Hz), 8.63 (1H, s), 8.90 (1H,
d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
(Hydroxy-2-methylpropyl) quinoline was obtained in the same manner as in Example 99.
mp: 203-204 ℃
NMR (CDClThree, Δ): 1.24 (3H, t, J = 7Hz), 1.33 (6H, s),
2.97 (2H, q, J = 7Hz), 3.38 (2H, s), 7.30-7.45 (3H, m), 7.59
(1H, t, J = 8Hz), 7.91 (1H, d, J = 8Hz), 8.63 (1H, s), 8.88 (1H,
d, J = 8Hz)Example 109
4-carbamoylmethyl-8- (2,6-dichlorobenzoylamino) -3-
Ethylquinoline was converted to 4-carboxymethyl- in the same manner as in Example 22- (2).
8- (2,6-dichlorobenzoylamino) -3-ethylquinoline and concentrated ammonium
A.
mp: 180-182 ℃
NMR (DMSO-d6, Δ): 1.21 (3H, t, J = 7 Hz), 2.86 (2H, q,
J = 7Hz), 4.02 (2H, s), 7.12 (2H, brs), 7.50-7.65 (4H, m), 7.71
(1H, br s), 7.87 (1H, d, J = 8Hz), 8.64 (1H, d, J = 8Hz), 8.73
(1H, s)
Its hydrochloride
mp: 223-227 ℃
NMR (DMSO-d6, Δ): 1.20 (3H, t, J = 7 Hz), 2.87 (2H, q,
J = 7Hz), 4.03 (2H, s), 7.13 (1H, br s), 7.50-7.65 (4H, m), 7.73
(1H, br s), 7.88 (1H, d, J = 8Hz), 8.64 (1H, d, J = 8Hz), 8.74
(1H, s)Example 110
(1) 3-bromo-4-carboxymethyl-8- (2,6-dichlorobenzoy
Lamino) quinoline (130 mg) in anhydrous tetrahydrofuran.
A solution of M borane-methyl sulfide complex in tetrahydrofuran (0.286 ml) was added at room temperature
And the mixture was stirred at the same temperature for 4 hours. Stop the reaction of the mixture by adding 1N hydrochloric acid
And stirred at the same temperature for 1 hour. Extract the mixture with ethyl acetate and extract the extract with saturated
Wash with sodium acid solution and brine, dry over magnesium sulfate, and remove solvent in vacuo.
Was distilled off. The residue was subjected to silica gel column chromatography (ethyl acetate: n-
Hexane, 1: 2, v / v) and crystallized from ethyl acetate-n-hexane.
To give 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (2-hydr
Roxyethyl) quinoline (68.4 mg) was obtained.
mp: 199-200 ℃
NMR (CDClThree, Δ): 1.53 (1H, t, J = 6 Hz), 3.58 (2H, t,
J = 6Hz), 4.01 (2H, q, J = 6Hz), 7.30-7.45 (3H, m), 7.68 (1H, t,
J = 8Hz), 7.87 (1H, d, J = 8Hz), 8.79 (1H, s), 8.98 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (2-hydroxye
(Tyl) -3-vinylquinoline was obtained in the same manner as in Production Example 14.
mp: 133-135 ℃
NMR (CDClThree, Δ): 1.50 (1H, t, J = 6Hz), 3.48 (2H, t,
J = 6Hz), 3.97 (2H, q, J = 6Hz), 5.58 (1H, d, J = 11Hz), 5.84 (1H,
d, J = 17Hz), 7.22 (1H, dd, J = 11, 17Hz), 7.30-7.50 (3H, m), 7.65
(1H, t, J = 8Hz), 7.86 (1H, d, J = 8Hz), 8.89 (1H, s), 8.94 (1H,
d, J = 8Hz)
Its hydrochloride
mp: 187-203 ℃
NMR (DMSO-d6, Δ): 3.36 (2H, t, J = 6 Hz), 3.65 (2H, t,
J = 6Hz), 5.57 (1H, d, J = 11Hz), 5.98 (1H, d, J = 17Hz), 7.27 (1H,
dd, J = 11, 17Hz), 7.50-7.60 (3H, m), 7.67 (1H, t, J = 8Hz), 8.00
(1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 9.00 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
(Hydroxyethyl) quinoline was obtained in the same manner as in Example 41.
mp: 180-182 ℃
NMR (CDClThree, Δ): 1.31 (3H, t, J = 7Hz), 1.51 (1H, t,
J = 6Hz), 2.92 (2H, q, J = 7Hz), 3.42 (2H, t, J = 6Hz), 3.97 (1H, q,
J = 6Hz), 7.30-7.45 (3H, m), 7.61 (1H, t, J = 8Hz), 7.80 (1H, d,
J = 8Hz), 8.60 (1H, s), 8.89 (1H, d, J = 8Hz)
(4) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
To a solution of (hydroxyethyl) quinoline (405 mg) in dichloromethane was added N-
Bromosuccinimide (241 mg) and triphenylphosphine (355 mg)
Was added under water cooling, and the mixture was stirred at the same temperature for 30 minutes. The mixture is concentrated in vacuo,
The residue was purified by silica gel column chromatography (dichloromethane),
Crystallized from -hexane to give 4- (2-bromoethyl) -8- (2,6-dichloromethane.
(Lobenzoylamino) -3-ethylquinoline (424 mg) was obtained.
mp: 187-188 ℃
NMR (CDClThree, Δ): 1.32 (3H, t, J = 7 Hz), 2.90 (2H, q,
J = 7Hz), 3.62 (4H, m), 7.30-7.45 (3H, m), 7.65 (1H, t, J = 8Hz),
7.73 (1H, d, J = 8Hz), 8.62 (1H, s), 8.92 (1H, d, J = 8Hz), 10.14
(1H, br s)Example 111
8- (2,6-dichlorobenzoylamino) -3-ethyl-4- [2- (imi
Dazol-2-ylthio) ethyl] quinoline was prepared in the same manner as in Example 62 by using 4-
(2-bromoethyl) -8- (2,6-dichlorobenzoylamino) -3-ethyl
It was obtained by reacting lucinoline with 2-mercaptoimidazole.
mp: 214-215 ℃
NMR (DMSO-d6, Δ): 1.18 (3H, t, J = 7 Hz), 2.81 (2H, q,
J = 7Hz), 3.20 (2H, m), 3.44 (2H, m), 7.16 (2H, brs), 7.50-7.70
(4H, m), 7.93 (1H, d, J = 8Hz), 8.65 (1H, d, J = 8Hz), 8.71 (1H,
s)
Its dihydrochloride
mp: 233-235 ℃
NMR (DMSO-d6, Δ): 1.18 (3H, t, J = 7 Hz), 2.79 (2H, q,
J = 7Hz), 3.42 (2H, m), 3.55 (2H, m), 7.50-7.60 (3H, m), 7.65
(1H, t, J = 8Hz), 7.72 (2H, s), 7.79 (1H, d, J = 8Hz), 8.66 (1H,
d, J = 8Hz), 8.73 (1H, s)Example 112
The following compound was prepared in the same manner as in Example 8 to give 4- (2-bromoethyl) -8- (
2,6-dichlorobenzoylamino) -3-ethylquinoline and amine or imine
Obtained from the compound.
(1) 8- (2,6-dichlorobenzoylamino) -4- [2- (N, N-di
Methylamino) ethyl] -3-ethylquinoline
mp: 73-75 ℃
NMR (CDClThree, Δ): 1.81 (3H, t, J = 7Hz), 2.41 (6H, s),
2.55 (1H, m), 2.87 (2H, q, J = 7Hz), 3.28 (2H, m), 7.30-7.45
(3H, m), 7.61 (1H, t, J = 8Hz), 7.78 (1H, d, J = 8Hz), 8.58 (1H,
s), 8.89 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- [2-
[N- (2-hydroxyethyl) -N-methylamino] ethyl] quinoline
mp: 123-125 ℃
NMR (DMSO-d6, Δ): 1.27 (3H, t, J = 7Hz), 2.38 (3H, s),
2.56 (2H, t, J = 6Hz), 2.62 (2H, m), 2.87 (2H, q, J = 7Hz), 3.25
(2H, m), 3.50 (2H, q, J = 6Hz), 4.42 (1H, t, J = 6Hz), 7.45-7.60
(3H, m), 7.66 (1H, t, J = 8Hz), 7.79 (1H, d, J = 8Hz), 9.65 (1H,
d, J = 7Hz), 9.71 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- [2-
(Imidazol-1-yl) ethyl] quinoline
mp: 190-191 ℃
NMR (DMSO-d6, Δ): 1.17 (3H, t, J = 7 Hz), 2.67 (2H, q,
J = 7Hz), 3.55 (2H, t, J = 7Hz), 4.27 (2H, t, J = 7Hz), 6.86 (1H,
s), 7.20 (1H, s), 7.45 to 7.65 (4H, m), 7.66 (1H, t, J = 8Hz), 7.96
(1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 8.71 (1H, s)
Its dihydrochloride
mp: 219-222 ℃
NMR (DMSO-d6, Δ): 1.20 (3H, t, J = 7 Hz), 2.77 (2H, q,
J = 7Hz), 3.69 (2H, t, J = 7Hz), 4.48 (2H, t, J = 7Hz), 7.50-7.65
(3H, m), 7.67 (1H, t, J = 8Hz), 7.68 (1H, s), 7.89 (1H, s), 7.97
(1H, d, J = 8Hz), 8.68 (1H, d, J = 8Hz), 8.76 (1H, s), 9.13 (1H,
s)
(4) 4- [2- (1H-benzimidazol-1-yl) ethyl] -8- (
2,6-dichlorobenzoylamino) -3-ethylquinoline
mp: 196-1907 ℃
NMR (DMSO-d6, Δ): 1.08 (3H, t, J = 7 Hz), 2.56 (2H, q,
J = 7Hz), 3.65 (2H, t, J = 7Hz), 4.58 (2H, t, J = 7Hz), 7.15-7.25
(2H, m), 7.43 (1H, dd, J = 3, 7 Hz), 7.45 to 7.70 (5H, m), 7.95 (1H,
d, J = 8Hz), 8.09 (1H, s), 8,67 (1H, s), 8.68 (1H, d, J = 8Hz)
Its dihydrochloride
mp: 236-238 ℃
NMR (DMSO-d6, Δ): 1.17 (3H, t, J = 7 Hz), 2.75 (2H, q,
J = 7Hz), 3.83 (2H, t, J = 7Hz), 4.78 (2H, t, J = 7Hz), 7.50-7.70
(6H, m), 7.80-7.95 (3H, m), 8.68 (1H, d, J = 8Hz), 8.75 (1H, s),
9.65 (1H, s)Example 113
(1) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4-hydro
Dimethyl of xymethylquinoline (300mg) and triethylamine (404mg)
To a solution of lusulfoxide (3 ml) and dichloromethane (1 ml), add sulfur trioxide
-Pyridine complex (191 mg) was added under ice cooling, and the mixture was stirred at the same temperature for 1 hour.
. Partition the mixture between dichloroethane and water, wash the organic layer with water,
After drying with nesium, the solvent was distilled off in vacuo to give 8- (2,6-dichlorobenzoic acid).
L-amino) -3-ethyl-4-formylquinoline (235 mg) was obtained.
mp: 208 ℃
NMR (CDClThree, Δ): 1.37 (3H, t, J = 8 Hz), 3.14 (2H, q,
J = 8Hz), 7.30-7.47 (3H, m), 7.72 (1H, t, J = 8Hz), 8.38 (1H, d,
J = 8Hz), 8.76 (1H, s), 8.96 (1H, d, J = 8Hz), 10.95 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4-((E) -2-ethoxy
(Xycarbonylcarbonyl) -3-ethylquinoline was prepared in the same manner as in Production Example 19- (2).
I got it.
mp: 115-118 ℃
NMR (CDClThree, Δ): 1.27 (3H, t, J = 7 Hz), 1.40 (3H, t,
J = 7Hz), 2.86 (2H, q, J = 7Hz), 4.35 (2H, q, J = 7Hz), 6.30 (1H, d,
J = 15Hz), 7.30-7.45 (3H, m), 7.61 (1H, t, J = 8Hz), 7.73 (1H, d,
J = 8Hz), 8.07 (1H, d, J = 15Hz), 8.67 (1H, s), 8.93 (1H, d,
(J = 8Hz)
(3) 4-((E) -2-carboxyvinyl) -8- (2,6-dichloroben
Zoylamino) -3-ethylquinoline was obtained in the same manner as in Example 18.
mp: 235-236 ℃
NMR (DMSO-d6, Δ): 1.22 (3H, t, J = 7 Hz), 2.83 (2H, q,
J = 7Hz), 6.28 (1H, d, J = 15Hz), 7.50-7.60 (3H, m), 7.67 (1H, t,
J = 8Hz), 7.74 (1H, d, J = 8Hz), 7.99 (1H, d, J = 15Hz), 8.68 (1H,
d, J = 8Hz), 8.83 (1H, s)
(4) 4-((E) -2-carbamoylvinyl) -8- (2,6-dichlorobe
(Nzoylamino) -3-ethylquinoline was obtained in the same manner as in Example 22- (2).
.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.22 (3H, t, J = 7 Hz), 2.33 (2H, q,
J = 7Hz), 6.43 (1H, d, J = 15Hz), 7.40 (1H, brs), 7.50-7.60 (3H,
m), 7.67 (1H, t, J = 8Hz), 7.77 (1H, d, J = 8Hz), 7.80 (1H, brs),
7.82 (1H, d, J = 15Hz), 8.69 (1H, d, J = 8Hz), 8.82 (1H, s)Example 114
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-ethoxycal
(Bonylethyl) -3-ethylquinoline was prepared in the same manner as in Example 41 by using 8- (2,2).
6-dichlorobenzoylamino) -4-((E) -2-ethoxycarbonylvinyl)
G) obtained from 3-ethylquinoline.
mp: 88-90 ℃
NMR (CDClThree, Δ): 1.29 (3H, t, J = 7 Hz), 1.31 (311, t,
J = 7Hz), 2.63 (2H, t, J = 7Hz), 2.87 (2H, q, J = 7Hz), 3.43 (2H, t,
J = 7Hz), 4.18 (2H, q, J = 7Hz), 7.30-7.45 (3H, m), 7.62 (1H, t,
J = 8Hz), 7.75 (1H, d, J = 8Hz), 8.58 (1H, s), 8.89 (1H, d, J = 8Hz)
(2) 4- (2-carboxyethyl) -8- (2,6-dichlorobenzoyla
Mino) -3-ethylquinoline was obtained in the same manner as in Example 18.
mp: 236-237 ℃
NMR (DMSO-d6, Δ): 1.24 (3H, t, J = 7Hz), 2.45-2.55 (2H,
m), 2.88 (1H, q, J = 7Hz), 3.30-3.40 (2H, m), 7.45-7.60 (3H, m),
7.67 (1H, t, J = 8Hz), 7.90 (1H, d, J = 8Hz), 8.66 (1H, d, J = 8Hz),
8.72 (1H, s)
(3) 4- (2-carbamoylethyl) -8- (2,6-dichlorobenzoyl
Amino) -3-ethylquinoline was obtained in the same manner as in Example 22- (2).
mp: 235-236 ℃
NMR (DMSO-d6, Δ): 1.24 (3H, t, J = 7Hz), 2.37 (2H, m),
2.88 (2H, q, J = 7Hz), 3.30-3.40 (2H, m), 6.91 (1H, brs), 7.41
(1H, brs), 7.50-7.60 (3H, m), 7.66 (1H, t, J = 8Hz), 7.92 (1H,
d, J = 8Hz), 8.65 (1H, d, J = 8Hz), 8.71 (1H, s)
Its hydrochloride
mp: 230-232 ℃
NMR (DMSO-d6, Δ): 1.25 (3H, t, J = 7 Hz), 2.38 (2H, t,
J = 8Hz), 2.88 (2H, q, J = 7Hz), 3.32 (2H, t, J = 8Hz), 6.92 (1H, br
s), 7.43 (1H, brs), 7.50-7.60 (3H, m), 7.67 (1H, t, J = 8Hz),
7.93 (1H, d, J = 8Hz), 8.66 (1H, d, J = 8Hz), 8.72 (1H, s)Example 115
8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (3-hydro
Xy-3-methylbutyl) quinoline was prepared in the same manner as in Example 99 by using 8- (2,6).
-Dichlorobenzoylamino) -4- (2-ethoxycarbonylethyl) -3-
It was obtained by reacting ethylquinoline with methylmagnesium bromide.
mp: 158-160 ℃
NMR (CDClThree, Δ): 1.33 (3H, t, J = 7Hz), 1.40 (6H, s),
1.78 (2H, m), 2.86 (2H, q, J = 7Hz), 3.21 (2H, m), 7.30-7.45
(3H, m), 7.61 (1H, t, J = 8Hz), 7.81 (1H, d, J = 8Hz), 8.58 (1H,
s), 7.89 (1H, d, J = 8Hz)
Its hydrochloride
mp: 211-214 ℃
NMR (CDClThree, Δ): 1.41 (3H, t, J = 7Hz), 1.78 (2H, m),
2.99 (2H, q, J = 7Hz), 3.44 (2H, m), 7.30-7.45 (3H, m), 7.91
(1H, t, J = 8Hz), 8.09 (1H, d, J = 8Hz), 8.74 (1H, s), 9.14 (1H,
d, J = 8Hz)Example 116
(1) Sodium dihydrogen phosphate (395 mg) and 2-methyl-2-butene (57
8-mg) in a solution of tert-butanol (6 ml) and water (1.5 ml) was added to 8- (
2,6-dichlorobenzoylamino) -3-ethyl-4-formylquinoline (6
15 mg) at room temperature, and sodium chlorite (298 mg) was added to the mixture at the same temperature.
Added little by little. The mixture was stirred at the same temperature for 3 hours. Reaction of the mixture with the addition of dilute hydrochloric acid
Was stopped and extracted with dichloromethane. After drying the extract over magnesium sulfate,
The solvent was removed in vacuo. The residue was recrystallized from ethyl acetate-n-hexane,
4-carboxy-8- (2,6-dichlorobenzoylamino) -3-ethylquino
Phosphorus (404 mg) was obtained.
mp: 231-233 ℃
NMR (CDClThree, Δ): 1.35 (3H, t, J = 7Hz), 2.94 (2H, q,
J = 7Hz), 7.30-7.45 (3H, m), 7,67 (1H, t, J = 8Hz), 7.73 (1H, d,
J = 8Hz), 8.73 (1H, s), 8.94 (1H, d, J = 8Hz)
(2) 4-carbamoyl-8- (2,6-dichlorobenzoylamino) -3-
Ethylquinoline was obtained in the same manner as in Example 22- (2).
mp: 247-248 ℃
NMR (DMSO-d6, Δ): 1.27 (3H, t, J = 7 Hz), 2.80 (2H, q,
J = 7Hz), 7.50-7.60 (4H, m), 7.68 (1H, t, J = 8Hz), 8.05 (1H, br
s), 8.20 (1H, br s), 8.66 (1H, d, J = 8Hz), 8.85 (1H, s)Example 117
(1) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (meth
Xycarbonyl) quinoline was converted to 4-carbo in the same manner as in Example 108- (1).
Xy-8- (2,6-dichlorobenzoylamino) -3-ethylquinoline and iodine
Obtained from methyl chloride.
mp: 160-161 ℃
NMR (CDClThree, Δ): 1.31 (3H, t, J = 7 Hz), 2.82 (2H, q,
J = 7Hz), 4.07 (3H, s), 7.30-7.50 (3H, m), 7.51 (1H, d, J = 8Hz),
7.64 (1H, t, J = 8Hz), 8.70 (1H, s), 8.93 (1H, d, J = 8Hz)
(2) 4-acetyl-8- (2,6-dichlorobenzoylamino) -3-ethyl
Luquinoline was obtained in the same manner as in Example 99.
mp: 194-195 ℃
NMR (CDClThree, Δ): 1.33 (3H, t, J = 7Hz), 2.67 (3H, s),
2.75 (2H, q, J = 7Hz), 7.30-7.45 (4H, m), 7.64 (1H, t, J = 8Hz),
8.69 (1H, s), 8.95 (1H, d, J = 8Hz)Example 118
8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (methoxymeth
Cyl) quinoline was prepared in the same manner as in Production Example 2- (2), using 4-chloromethyl-8- (
2,6-dichlorobenzoylamino) -3-ethylquinoline and sodium methoxy
Obtained by reacting with SID.
mp: 142-143 ℃
NMR (CDClThree, Δ): 1.29 (3H, t, J = 7 Hz), 2.95 (2H, q,
J = 7Hz), 3.48 (3H, s), 4.89 (2H, s), 7.30-7.45 (3H, m), 7.63
(1H, t, J = 8Hz), 7.90 (1H, d, J = 8Hz), 8.63 (1H, s), 8.88 (1H,
d, J = 8Hz)
Its hydrochloride
mp: 155-163 ℃
NMR (CDClThree, Δ): 1.38 (3H, t, J = 7Hz), 3.06 (2H, q,
J = 7Hz), 3.55 (3H, s), 5.00 (2H, s), 7.30-7.45 (3H, m), 7.92
(1H, t, J = 8Hz), 8.14 (1H, d, J = 8Hz), 8.82 (1H, s), 9.17 (1H,
d, J = 8Hz)Example 119
The following compound was obtained in the same manner as in Example 59.
(1) 8- (2,6-dichlorobenzoylamino) -4-dimethylaminomethyl
Ru-3-ethylquinoline
NMR (CDClThree, Δ): 1.27 (3H, t, J = 7Hz), 2.29 (6H, s),
2.95 (2H, q, J = 7Hz), 3.84 (2H, s), 7.30-7.45 (3H, m), 7.60
(1H, t, J = 8Hz), 8.05 (1H, d, J = 8Hz), 8.60 (1H, s), 8.87 (1H,
d, J = 8Hz)
Its hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.24 (3H, t, J = 7Hz), 2.86 (3H, s),
2.87 (3H, s), 3.05 (2H, q, J = 7Hz), 4.88 (2H, brs), 7.50-7.60
(3H, m), 7.77 (1H, t, J = 8Hz), 8.15 (1H, d, J = 8Hz), 8.73 (1H,
d, J = 8Hz), 8.92 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
Methyl-2-imidazolin-1-ylmethyl) quinoline
mp: 203-205 ℃
NMR (DMSO-d6, Δ): 1.23 (3H, t, J = 7 Hz), 2.17 (3H, s),
2.89 (2H, t, J = 8Hz), 2.96 (2H, q, J = 7Hz), 3.35 (2H, t, J = 8Hz),
4.82 (2H, s), 7.50-7.60 (3H, m), 7.68 (1H, t, J = 8Hz), 8.03
(1H, d, J = 8Hz), 8.67 (1H, d, J = 8Hz), 8.80 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- [N-
(2-Hydroxyethyl) -N-methylaminomethyl] quinoline
NMR (CDClThree, Δ): 1.30 (3H, t, J = 7Hz), 2.30 (3H, s),
2.65 (2H, t, J = 5Hz), 2.95 (2H, q, J = 7Hz), 3.60 (2H, t, J = 5Hz),
4.03 (2H, s), 7.30-7.50 (3H, m), 7.62 (1H, t, J = 8Hz), 7.99
(1H, d, J = 8Hz), 8.62 (2H, s), 8.89 (1H, d, J = 8Hz)
Its hydrochloride
mp: 215-217 ° C
NMR (DMSO-d6, Δ): 1.24 (3H, t, J = 7 Hz), 2.73 (3H, br
s), 3.06 (2H, q, J = 7 Hz), 3.44 (2H, m), 3.91 (2H, m), 4.84 (1H,
m), 5.07 (1H, m), 5.58 (1H, brs), 7.50-7.65 (3H, m), 7.78
(1H, t, J = 8Hz), 8.16 (1H, d, J = 8Hz), 8.74 (1H, d, J = 8Hz), 8.92
(1H, s), 9.05 (1H, br s)
(4) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
Methyl imidazol-1-ylmethyl) quinoline
NMR (DMSO-d6, Δ): 1.24 (3H, t, J = 7Hz), 2.63 (3H, s),
2.88 (2H, q, J = 8Hz), 5.41 (2H, s), 6.25 (1H, s), 6.80 (1H, s),
7.30-7.50 (3H, m), 7.53 (1H, d, J = 8Hz), 7.63 (1H, t, J = 8Hz),
8.73 (1H, s), 8.95 (1H, d, J = 8Hz)
Its hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.18 (3H, t, J = 7Hz), 2.81 (3H, s),
2.92 (2H, q, J = 7Hz), 5.80 (2H, s), 6.84 (1H, s), 7.43 (1H, s),
7.50-7.65 (3H, m), 7.67 (1H, t, J = 8Hz), 7.73 (1H, d, J = 8Hz),
8.71 (1H, d, J = 8Hz), 8.93 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
Phenylimidazol-1-ylmethyl) quinoline
NMR (CDClThree, Δ): 1.10 (3H, t, J = 7 Hz), 2.72 (2H, q,
J = 7Hz), 5.62 (2H, s), 6.47 (1H, s), 6.99 (1H, s), 7.30-7.45
(3H, m), 7.45-7.65 (5H, m), 7.79 (2H, d, J = 8Hz), 8.66 (1H, s),
8.92 (1H, d, J = 8Hz)
Its hydrochloride
mp: 237-239 ℃
NMR (DMSO-d6, Δ): 1.11 (3H, t, J = 7 Hz), 2.80 (2H, q,
J = 7Hz), 5.91 (2H, s), 7.19 (1H, s), 7.45 to 7.80 (9H, m), 7.99
(2H, d, J = 8Hz), 8.69 (1H, d, J = 8Hz), 8.87 (1H, s)
(6) 4- (1H-benzimidazol-1-ylmethyl) -8- (2,6-
Dichlorobenzoylamino) -3-ethylquinoline
NMR (CDCl3, δ): 1.23 (3H, t, J = 7 Hz), 2.92 (2H, q,
J = 7Hz), 5.71 (2H, s), 7.30-7.50 (6H, m), 7.50-7.60 (3H, m),
7.83 (1H, d, J = 8Hz), 8.77 (1H, s), 8.94 (1H, d, J = 8Hz)
Its hydrochloride
mp: 246-248 ℃
NMR (CDClThree, Δ): 1.27 (3H, t, J = 7Hz), 3.00 (2H, q,
J = 7Hz), 6.05 (2H, brs), 7.30-7.50 (3H, m), 7.52 (1H, m),
7.60-7.70 (4H, m), 8.02 (1H, m), 8.82 (1H, s), 8.90-9.00 (2H,
m)
(7) 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (2-
Methylthioimidazol-1-ylmethyl) quinoline
NMR (CDClThree, Δ): 1.21 (3H, t, J = 7 Hz), 2.76 (3H, s),
2.90 (2H, q, J = 7Hz), 5.45 (2H, s), 6.37 (1H, s), 6.93 (1H, s),
7.30-7.45 (3H, m), 7.55-7.65 (2H, m), 8.70 (1H, s), 8.93 (1H,
d, J = 8Hz)
Its hydrochloride
mp: 195-203 ℃
NMR (DMSO-d6, Δ): 1.17 (3H, t, J = 7 Hz), 2.94 (2H, q,
J = 7Hz), 5.82 (2H, s), 7.20 (1H, s), 7.50-7.65 (3H, m), 7.65
7.75 (3H, m), 8.71 (1H, t, J = 4Hz), 8.93 (1H, s)
Example 120
4-chloromethyl-8- (2,6-dichlorobenzoylamino) -3-ethyl
1,2 of quinoline (150 mg) and N-methylethylenediamine (141 mg)
-The mixture in dimethoxyethane was stirred at 70 ° C for 2 hours. Dichloroe mixture
After partitioning between tan and water, the organic layer was washed with brine and dried over magnesium sulfate.
The solvent was distilled off in vacuo to give 8- (2,6-dichlorobenzoylamino) -3-
Residue containing ethyl-4-[(2-methylaminoethylamino) methyl] quinoline
I got something. Solution of the obtained residue in 1,3-dimethyl-2-imidazolidinone
Was added with 1,1'-carbonyldiimidazole (309 mg), and the mixture was added to 70
The mixture was stirred at 30 ° C for 30 minutes, at 100 ° C for 1 hour, and further at 150 ° C for 1 hour. To the mixture
Water was added and the resulting precipitate was collected by filtration. Preparative thin-layer chromatography of the residue
(Methanol-dichloromethane) and purified from isopropyl alcohol
After crystallization, 8- (2,6-dichlorobenzoylamino) -3-ethyl-4- (
3-methyl-2-oxoimidazolidin-1-ylmethyl) quinoline (28.6
mg).
mp: 202-203 ℃
NMR (CDClThree, Δ): 1.29 (3H, t, J = 7 Hz), 2.95 (2H, q,
J = 7Hz), 3.05 (2H, m), 3.18 (2H, m), 4.87 (2H, s), 7.30-7.45
(3H, m), 7.63 (1H, t, J = 8Hz), 7.99 (1H, d, J = 8Hz), 8.62 (1H,
s), 8.90 (1H, d, J = 8Hz)Example 121
8- (2,6-dichlorobenzoylamino) -3-ethyl-4-[(imidazo
2-yl) thiomethyl] quinoline was prepared in the same manner as in Example 62, using 4-chloro
Romethyl-8- (2,6-dichlorobenzoylamino) -3-ethylquinoline
Obtained by reacting with 2-mercaptoimidazole.
mp: 203-204 ℃
NMR (DMSO-d6, Δ): 1.18 (3H, t, J = 7 Hz), 2.70 (2H, q,
J = 7Hz), 4.70 (2H, s), 7.10 (2H, br s), 7.45 to 7.60 (3H, m), 7.63
(1H, t, J = 8Hz), 7.84 (1H, d, J = 8Hz), 8.64 (1H, d, J = 8Hz), 8.72
(1H, s)
Its hydrochloride
mp: 237-239 ℃
NMR (DMSO-d6, Δ): 1.22 (3H, t, J = 7Hz) 2.76 (2H, q,
J = 7Hz), 4.99 (2H, s), 7.50-7.65 (3H, m), 7.67 (1H, t, J = 8Hz),
7.75 (2H, s), 7.95 (1H, t, J = 8Hz), 8.68 (1H, t, J = 8Hz), 8.78
(1H, s)Example 122
(1) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-((E) -1-propenyl) quinoline was prepared in the same manner as in Example 8.
3-allyl-4-chloro-8- (2,6-dichlorobenzoylamino) quinoline
And imidazole.
mp: 205-206 ℃
NMR (DMSO-d6, Δ): 1.84 (3H, d, J = 7 Hz), 6.00 (1H, d,
J = 15Hz), 6.69 (1H, dq, J = 7, 15Hz), 6.96 (1H, d, J = 8Hz), 7.30
(1H, s), 7.50-7.60 (4H, m), 7.67 (1H, t, J = 8Hz), 7.94 (1H, s),
8.69 (1H, d, J = 8Hz), 9.30 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-propylquinoline was obtained in the same manner as in Example 41.
mp: 160-161 ℃
NMR (CDClThree, Δ): 0.91 (3H, t, J = 7Hz), 1.59 (2H, m),
2.58 (2H, m), 7.04 (1H, d, J = 8Hz), 7.12 (1H, s), 7.30-7.50
(4H, m), 7.61 (1H, t, J = 8Hz), 7.64 (1H, s), 8.81 (1H, s), 8.99
(1H, d, J = 8Hz)
Its hydrochloride
mp: 220-222 ℃
NMR (CDClThree, Δ): 0.94 (3H, t, J = 7Hz), 1.63 (2H, m),
2.59 (2H, m), 6.87 (1H, d, J = 8Hz), 7.32 (1H, s), 7.35-7.50
(3H, m), 7.71 (1H, t, J = 8Hz), 7.79 (1H, s), 8.74 (1H, s), 8.88
(1H, s), 9.06 (1H, d, J = 8Hz)Example 123
(1) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3- (trimethylsilylethynyl) quinoline was prepared in the same manner as in Production Example 21.
To give 3-bromo-8- (2,6-dichlorobenzoylamino) -4- (imida
(Zol-1-yl) quinoline and trimethylsilylacetylene.
mp: 213 ℃
NMR (CDClThree, Δ): 0.20 (9H, s), 7.30-7.48 (6H, m), 7.67
(1H, t, J = 8Hz), 7.80 (1H, br s), 8.85 (1H, s), 9.04 (1H, d,
(J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-ethynyl-4- (a
Midazol-1-yl) quinoline was obtained in the same manner as in Example 5.
mp: 235 ° C (decomposition)
NMR (CDClThree, Δ): 3.35 (1H, s), 7.23-7.50 (6H, m), 7.69
(1H, t, J = 8Hz), 7.82 (1H, s), 8.90 (1H, s), 9.05 (1H, d,
(J = 8Hz)
Its hydrochloride
mp: 293 ℃
NMR (DMSO-d6, Δ): 4.86 (1H, s), 7.34 (1H, d, J = 8Hz),
7.47-7.62 (3H, m), 7.83 (1H, t, J = 8Hz), 7.99 (1H, s), 8.10
(1H, s), 8.83 (1H, d, J = 8Hz), 9.18 (1H, s), 9.44 (1H, s)Example 124
(1) 1,4-dihydro-8-nitro-4-oxoquinoline (10 g) and 1,
3,5-Trioxane (23.7 g) in dioxane (100 ml) and concentrated hydrochloric acid (2
00 ml) was stirred at 90 ° C. for 3.5 hours and allowed to come to room temperature.
. Ice water (700 g) was added to the mixture and the mixture was stirred for 1 hour. The resulting precipitate
Is collected by filtration, washed with cold water and treated with 3-chloromethyl-1,4-dihydro-
8-Nitro-4-oxoquinoline (6.5 g) was obtained.
mp: 228-235 ℃
NMR (DMSO-d6, Δ): 4.70 (2H, s), 7.53 (1H, t, J = 7Hz),
8.25 (1H, d, J = 7Hz), 8.59 (1H, d, J = 7Hz), 8.66 (1H, d, J = 7Hz)
(2) 3-chloromethyl-1,4-dihydro-8-nitro-4-oxoquinoli
(2 g) in dichloromethane (70 ml) and methanol (30 ml)
Was refluxed for 15 minutes and concentrated in vacuo. The crystalline residue was dissolved in hot methanol (30 ml
) And allowed the mixture to stand at room temperature. The resulting precipitate is collected by filtration.
1,4-dihydro-3-methoxymethyl-8-nitro-4-oxoquinoli
(1.5 g) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 3.33 (3H, s), 4.32 (2H, s), 7.51
(1H, t, J = 7Hz), 7.98 (1H, d, J = 7Hz), 8.59 (1H, d, J = 7Hz), 8.67
(1H, d, J = 7Hz)
(3) Production Example 2- (4-chloro-3-methoxymethyl-8-nitroquinoline)
Obtained in the same manner as in 1).
mp: 91-94 ℃
NMR (CDClThree, Δ): 3.51 (3H, s), 4.81 (2H, s), 7.73 (1H,
t, J = 8Hz), 8.05 (1H, d, J = 8Hz), 8.48 (1H, d, J = 8Hz), 9.10 (1H,
s)
(4) Production Example 2 of 8-amino-4-chloro-3- (methoxymethyl) quinoline
-Obtained in the same manner as in (3).
mp: 107 ° C
NMR (CDClThree, Δ: 3.50 (3H, s), 4.79 (2H, s), 5.03 (2H, s)
brs), 6.95 (1H, d, J = 8 Hz), 7.41 (1H, t, J = 8 Hz), 7.54 (1H, d,
J = 8Hz), 8.77 (1H, s)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -3- (meth
(Xymethyl) quinoline was obtained in the same manner as in Example 1.
mp: 177 ℃
NMR (CDClThree, Δ: 3.50 (3H, s), 4.79 (2H, s), 7.30-7.44
(3H, m), 7.70 (1H, t, J = 8Hz), 8.00 (1H, d, J = 8Hz), 8.80 (1H,
s), 9.00 (1H, d, J = 8Hz)
(6) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3- (methoxymethyl) quinoline was obtained in the same manner as in Example 8.
mp: 145-150 ℃
NMR (CDClThree, Δ): 3.36 (3H, s), 4.31 (2H, s), 7.14-7.22
(2H, m), 7.31-7.46 (4H, m), 7.63 (1H, t, J = 8Hz), 7.70 (1H, s),
8.95 (1H, s), 9.01 (1H, d, J = 8Hz)
Its methanesulfonate
mp: 188-196 ℃
NMR (DMSO-d6, Δ): 2.30 (3H, s), 3.22 (3H, s), 4.48
(2H, s), 7.20 (1H, d, J = 8Hz), 7.49-7.63 (3H, m), 7.80 (1H, t,
J = 8Hz), 8.02 (1H, d, J = 1Hz), 8.08 (1H, d, J = 1Hz), 8.82 (1H, d,
J = 8Hz), 9.15 (1H, d, J = 1Hz), 9.36 (1H, brs)
(7) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-4
-(Pyrazol-1-yl) quinoline was prepared in the same manner as in Example 8 by using 4-chloro-
8- (2,6-dichlorobenzoylamino) -3-methoxymethylquinoline and
Obtained from Lazole.
mp: 156-157 ℃
NMR (DMSO-d6, Δ): 3.23 (3H, s), 4.38 (2H, s), 6.71
(1H, d, J = 2Hz), 7.15 (1H, d, J = 8Hz), 7.48-7.62 (3H, m), 7.70
(1H, dd, J = 8, 8Hz), 7.95 (1H, s), 8.20 (1H, d, J = 2Hz), 8.77
(1H, d, J = 8Hz), 9.09 (1H, s), 11.00 (1H, s)Example 125
(1) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-h
(Droxymethyl) quinoline was converted to 4-acetoxymethyl in the same manner as in Example 18.
-8- (2,6-dichlorobenzoylamino) -3-ethoxycarbonylquinol
Obtained from
mp: 244-247 ° C (decomposition)
NMR (DMSO-d6, Δ): 5.05 (2H, s), 7.50-7.60 (3H, m),
7.76 (1H, t, J = 8Hz), 8.21 (1H, d, J = 8Hz), 8.78 (1H, d, J = 8Hz),
9.08 (1H, s)
(2) 3-carboxy-8- (2,6-dichlorobenzoylamino) -4-h
To a solution of droxymethylquinoline (1.11 g) in dimethylformamide was added
Midazole (637 mg) and tert-butyldiphenylsilyl chloride (2.57 g)
Was added under ice-cooling, and the mixture was stirred at room temperature for 5 hours. Mix the mixture with ethyl acetate and water.
The organic layer was washed with brine, dried over magnesium sulfate, and dissolved in vacuo.
The medium was distilled off. To a solution of the obtained residue in dioxane (10 ml) was added 1N hydroxide.
Sodium solution (2.9 ml) was added and the mixture was stirred at room temperature for 30 minutes. mixture
The material was diluted with water and washed with diethyl ether. The aqueous layer is acidified with 1N hydrochloric acid and vinegar
Extracted with ethyl acid. The extract is washed with water and saline, and dried over magnesium sulfate.
The solvent was distilled off in vacuo. Residue is isopropyl alcohol-diisopropyl
It was dissolved in ether and the insoluble matter was removed by filtration. The filtrate is concentrated in vacuo to give 4- (tertiary
Butyldiphenylsilyloxymethyl) -3-carboxy-8- (2,6-dic
Lolobenzoylamino) quinoline (1.22 g) was obtained.
NMR (CDClThree, Δ): 1.00 (9H, s), 5.49 (2H, s), 7.30-7.50
(9H, m), 7.59 (1H, t, J = 8Hz), 7.64 (4H, d, J = 8Hz), 7.79 (1H,
d, J = 8Hz), 9.04 (1H, d, J = 8Hz), 9.14 (1H, s)
(3) 4- (tert-butyldiphenylsilyloxymethyl) -8- (2,6-
Dichlorobenzoylamino) -3- (N-methoxy-N-methylcarbamoyl)
Quinoline was obtained in the same manner as in Example 22- (2).
NMR (CDClThree, Δ): 1.03 (9H, s), 3.24 (3H, s), 3.29 (3H,
s), 5.16 (2H, s), 7.30-7.50 (9H, m), 7.62 (1H, t, J = 8Hz), 7.70
(4H, d, J = 8Hz), 7.89 (1H, d, J = 8Hz), 8.68 (1H, s), 8.99 (1H,
d, J = 8Hz)
(4) 4- (tert-butyldiphenylsilyloxymethyl) -8- (2,6-
Dichlorobenzoylamino) -3- (N-methoxy-N-methylcarbamoyl)
To a solution of quinoline (1.03 g) in tetrahydrofuran (10 ml) was added 1M water.
A solution of diisobutylaluminum tetrahydrofuran (15 ml) was added to -5.
The mixture was added dropwise at 5C, and the mixture was stirred at -60 to -45C for 50 minutes. Saturated ammonium chloride
Reaction of the mixture by adding a 10% aqueous solution of potassium solution and potassium sodium tartrate.
Stopped. Diethyl ether (50 ml) was added to the mixture and the mixture was added at room temperature for 1 hour.
. Stir for 5 hours. The separated aqueous layer was extracted with ethyl acetate. Eat the combined organic layers
After washing with brine and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Purify by silica gel column chromatography (ethyl acetate-n-hexane)
, 4- (tert-butyldiphenylsilyloxymethyl) -8- (2,6-dichloro
(Lobenzoylamino) -3-formylquinoline (809 mg) was obtained.
NMR (CDClThree, Δ): 1.01 (9H, s), 5.48 (2H, s), 7.30-7.50
(10H, m), 7.63 (4H, cl, J = 8Hz), 7.77 (1H, d, J = 8Hz), 9.06 (1H,
d, J = 8Hz), 9.02 (1H, s), 10.07 (1H, s), 10.46 (1H, s)
(5) 4- (tert-butyldiphenylsilyloxymethyl) -8- (2,6-
Example 16: dichlorobenzoylamino) -3- (hydroxymethyl) quinoline
Was obtained in the same manner as described above.
NMR (CDClThree, Δ): 1.03 (9H, s), 2.53 (1H, t, J = 6Hz),
4.78 (2H, d, J = 8Hz), 5.22 (2H, s), 7.30-7.80 (15H, m), 8.77
(1H, s), 8.92 (1H, d, J = 8Hz)
(6) 3-bromomethyl-4- (tert-butyldiphenylsilyloxymethyl
) -8- (2,6-Dichlorobenzoylamino) quinoline was prepared in Example 110- (4
).
NMR (CDClThree, Δ): 1.04 (9H, s), 4.42 (2H, s), 5.22 (2H,
s), 7.30-7.50 (9H, m), 7.59 (1H, t, J = 8Hz), 7.65-7.75 (4H, m),
7.82 (1H, d, J = 8Hz), 8.65 (1H, s), 8.95 (1H, d, J = 8Hz)
(7) 4- (tert-butyldiphenylsilyloxymethyl) -8- (2,6-
Production Example 2- (Dichlorobenzoylamino) -3- (methoxymethyl) quinoline
Obtained in the same manner as in 2).
NMR (CDClThree, Δ): 1.03 (9H, s), 3.22 (3H, s), 4.32 (2H, s)
s), 5.16 (2H, s), 7.30-7.50 (9H, m), 7.60 (1H, t, J = 8Hz), 7.67
(4H, d, J = 8Hz), 7.96 (1H, d, J = 8Hz), 8.68 (1H, s), 8.94 (1H,
d, J = 8Hz)
(8) 4- (tert-butyldiphenylsilyloxymethyl) -8- (2,6-
Dichlorobenzoylamino) -3- (methoxymethyl) quinoline (359 mg)
Of 1M tetrabutylammonium fluoride in tetrahydrofuran
A solution of lahydrofuran (0.684 ml) was added at room temperature, and the mixture was stirred at the same temperature for 1 hour.
Stirred. The mixture was partitioned between water and ethyl acetate, the organic layer was washed with brine,
After drying over magnesium acid, the solvent was distilled off in vacuo. The residue is isopropyl alcohol
Crystallized from coal to give 8- (2,6-dichlorobenzoylamino) -4-hydr
Roxymethyl-3- (methoxymethyl) quinoline (186 mg) was obtained.
mp: 199-200 ℃
NMR (CDClThree, Δ): 2.88 (1H, t, J = 7Hz), 3.50 (3H, s),
4.77 (2H, s), 5.14 (2H, d, J = 7Hz), 7.30-7.50 (3H, m), 7.70
(1H, t, J = 8Hz), 8.02 (1H, d, J = 8Hz), 8.71 (1H, s), 8.98 (1H,
d, J = 8Hz)
(9) 4-chloromethyl-8- (2,6-dichlorobenzoylamino) -3-
(Methoxymethyl) quinoline was obtained in the same manner as in Example 78- (3).
mp: 164 ℃
NMR (CDClThree, Δ): 3.47 (3H, s), 4.76 (2H, s), 5.10 (2H, s)
s), 7.30-7.50 (3H, m), 7.73 (1H, t, J = 8Hz), 7.90 (1H, d,
J = 8Hz), 8.77 (1H, s), 9.00 (1H, d, J = 8Hz)
(10) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-
1-ylmethyl) -3- (methoxymethyl) quinoline was prepared in the same manner as in Example 59.
Obtained.
mp: 190-191 ℃
NMR (CDClThree, Δ): 3.45 (3H, s), 4.67 (2H, s), 5.67 (2H,
s), 6.84 (1H, s), 7.03 (1H, s), 7.30-7.50 (3H, m), 7.53 (1H,
s), 7.66 (1H, t, J = 8Hz), 7.73 (1H, d, J = 8Hz), 8.79 (1H, s),
8.99 (1H, d, J = 8Hz)
Its hydrochloride
mp: 238-240 ℃
NMR (DMSO-d6, Δ): 4.82 (2H, s), 6.02 (2H, s), 7.50-
7.70 (5H, m), 7.73 (1H, t, J = 8Hz), 7.95 (1H, d, J = 8Hz), 8.76
(1H, d, J = 8Hz), 9.00 (1H, s), 9.03 (1H, s)Example 126
(1) 8- (2,6-dichlorobenzoylamino) -3-formyl-4- (a
Midazol-1-yl) quinoline was prepared in the same manner as in Example 29 by using 8- (2,6-
Dichlorobenzoylamino) -4- (imidazol-1-yl) -3-vinylki
Obtained from Norin.
NMR (CDClThree, Δ): 7.35-7.50 (7H, m), 7.77 (1H, t,
J = 8Hz), 7.84 (1H, s), 9.21 (1H, d, J = 8Hz), 9.32 (1H, s), 9.89
(1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
4- (Imidazol-1-yl) quinoline was obtained in the same manner as in Example 16.
mp: 196-198 ℃
NMR (CDClThree, Δ): 4.37 (2H, d, J = 6 Hz), 7.18 (1H, d,
J = 8Hz), 7.21 (1H, s), 7.30-7.50 (4H, m), 7.65 (1H, t, J = 8Hz),
7.73 (1H, s), 9.03 (1H, d, J = 8Hz), 9.06 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
4- (Imidazol-1-yl) quinoline was obtained in the same manner as in Example 8.
NMR (DMSO-d6, Δ): 4.44 (2H, d, J = 6 Hz), 5.59 (1H, t,
J = 6Hz), 7.07 (1H, d, J = 8Hz), 7.28 (1H, s), 7.50-7.65 (4H, m),
7.70 (1H, t, J = 8Hz), 7.97 (1H, s), 8.76 (1H, d, J = 8Hz), 9.15
(1H, s)
(4) Thionyl chloride (52.8 mg) was added dropwise to dimethylformamide at room temperature.
The mixture was stirred at the same temperature for 10 minutes. Add 8- (2,6-dichlorobenzoy) to the mixture.
Lumino) -3-hydroxymethyl-4- (imidazol-1-yl) quinoline
(141 mg) was added and the mixture was stirred at room temperature for 20 minutes. Saturated bicarbonate mixture
Partition between sodium solution and ethyl acetate, wash the organic layer with brine,
After drying with gnesium, the solvent was distilled off in vacuo. The resulting residue is
Dissolved in methanol, and sodium (17.3 mg) was added to anhydrous methanol (1.
5 ml) to the sodium methoxide solution prepared by adding
And stirred at room temperature for 15 minutes. The mixture was stirred at 40 ° C. for 3 hours. Mixture with saturated salt
Partition between ammonium chloride solution and ethyl acetate, wash the organic layer with brine,
After drying over magnesium acid, the solvent was distilled off in vacuo. Preparative thin layer chromatography of the residue
After purification by chromatography, 8- (2,6-dichlorobenzoylamino) -4- (a
Midazol-1-yl) -3- (methoxymethyl) quinoline (55 mg) was obtained.
.
mp: 145-150 ℃
NMR (CDClThree, Δ): 3.36 (3H, s), 4.31 (2H, s), 7.14-7.22
(2H, m), 7.31-7.46 (4H, m), 7.63 (1H, t, J = 8Hz), 7.70 (1H, s),
8.95 (1H, s), 9.01 (1H, d, J = 8Hz)Example 127
(1) 3-bromomethyl-4-chloro-8- (2,6-dichlorobenzoyla
Mino) quinoline was prepared in the same manner as in Example 110- (4), using 4-chloro-8- (2
, 6-Dichlorobenzoylamino) -3-hydroxymethylquinoline.
NMR (CDClThree, Δ): 4.79 (2H, s), 7.30-7.50 (3H, m), 7.74
(1H, t, J = 8Hz), 8.02 (1H, d, J = 8Hz), 8.75 (1H, s), 9.03 (1H,
d, J = 8Hz)
(2) 4-chloro-8- (2,6-dichlorobenzoylamino) -3- (meth
(Xymethyl) quinoline was obtained in the same manner as in Production Example 2- (2).
(3) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-4
-[2- (Methylamino) ethylamino] quinoline was obtained in the same manner as in Example 8.
.
NMR (CDClThree, Δ): 2.48 (3H, s), 2.88 (2H, t, J = 6Hz),
3.37 (3H, s), 3.75 (2H, dt, J = 6, 6 Hz), 4.58 (2H, s), 6.08 (1H,
br t, J = 6Hz), 7.27-7.49 (4H, m), 7.81 (1H, d, J = 8Hz), 8.28
(1H, s), 8.86 (1H, d, J = 8Hz), 10.15 (1H, br)
(4) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-4
-(3-Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared in Example 92.
-Obtained in the same manner as in (2).
mp: 199-201 ℃
NMR (DMSO-d6, Δ): 2.83 (3H, s), 3.33 (3H, s), 3.59-
3.73 (3H, m), 3.85 (1H, m), 4.57 (1H, d, J = 12Hz), 4.61 (1H, d,
J = 12Hz), 7.48-7.62 (3H, m), 7.70 (2x1H, d, J = 7Hz), 8.73 (1H,
dd, J = 4, 4Hz) 7.98 (1H, d, J = 8Hz), 8.95 (1H, s), 10.86 (1H,
s).
(5) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-4
-(3-Methyl-2-thioxoimidazolidin-1-yl) quinoline was prepared according to the examples.
In the same manner as in 92- (2), 8- (2,6-dichlorobenzoylamino) -3-
Methoxymethyl-4- [2- (methylamino) ethylamino] quinoline and 1,1
Obtained from '-thiocarbonyldiimidazole.
mp: 184-185 ℃
NMR (DMSO-d6, Δ): 3.16 (3H, s), 3.37 (3H, s), 3.85
4.08 (4H, m), 4.56 (1H, d, J = 12Hz), 4.64 (1H, d, J = 12Hz),
6.98-7.15 (4H, m), 7.21 (1H, dd, J = 7.5, 7.5Hz), 8.73 (1H, d,
J = 7.5Hz), 9.00 (1H, s), 10.91 (1H, s)Example 128
4-chloromethyl-8- (2,6-dichlorobenzoylamino) -3-methoxy
1,2-Dimethoxine of cimethylquinoline (70mg) and potassium carbonate (26mg)
The mixture in cyethane and methanol was refluxed for 2 hours. After cooling, the mixture was saturated
Partition between ammonium solution and dichloromethane, wash the organic layer with brine,
After drying over magnesium sulfate, the solvent was distilled off in vacuo. Preparative thin layer chromatographic separation
Purified by chromatography and crystallized from isopropyl alcohol to give 3,4-bis
(Methoxymethyl) -8- (2,6-dichlorobenzoylamino) quinoline (1
9.2 mg).
mp: 160-161 ℃
NMR (CDClThree, Δ): 3.45 (3H, s), 3.46 (3H, s), 4.73 (2H,
s), 4.96 (2H, s), 7.30-7.45 (3H, m), 7.66 (1H, t, J = 8Hz), 7.97
(1H, d, J = 8Hz), 8.77 (1H, s), 8.95 (1H, d, J = 8Hz)Example 129
(1) 1,4-dihydro-3-methylthiomethyl-8-nitro-4-oxo
Norin was prepared in the same manner as in Production Example 13 by using 3-chloromethyl-1,4-dihydro-8.
-Nitro-4-oxoquinoline obtained by reacting sodium thiomethoxide
.
mp: 200-203 ℃
NMR (CDClThree, Δ): 2.13 (3H, s), 3.70 (2H, s), 7.44 (1H,
t, J = 7Hz), 7.90 (1H, d, J = 7Hz), 8.67 (1H, d, J = 7Hz), 8.82 (1H,
d, J = 7Hz)
(2) Production Example 2- of 4-chloro-3-methylthiomethyl-8-nitroquinoline
Obtained in the same manner as in (1).
mp: 96-98 ℃
NMR (CDClThree, Δ): 2.10 (3H, s), 4.03 (2H, s), 7.74 (1H,
t, J = 7Hz), 8.06 (1H, d, J = 7Hz), 8.49 (1H, d, J = 7Hz), 8.98 (1H,
s)
(3) Production example of 8-amino-4-chloro-3- (methylthiomethyl) quinoline
Obtained in the same manner as in 2- (3).
mp: 107-108 ℃
NMR (CDClThree, Δ): 2.08 (3H, s), 3.99 (2H, s), 5.00 (2H,
br s), 6.93 (1H, d, J = 7 Hz), 7.41 (1H, t, J = 7 Hz), 7.52 (1H, d,
J = 7Hz), 8.67 (1H, s)
(4) 4-chloro-8- (2,6-dichlorobenzoylamino) -3- (methyl
(Luthiomethyl) quinoline was obtained in the same manner as in Example 1.
mp: 173-175 ℃
NMR (CDClThree, Δ): 2.09 (3H, s), 4.02 (2H, s), 7.28-7.45
(3H, m), 7.72 (1H, t, J = 7Hz), 7.99 (1H, d, J = 7Hz), 8.72 (1H,
s), 9.00 (1H, d, J = 7Hz)
(5) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3- (methylthiomethyl) quinoline was obtained in the same manner as in Example 8.
mp: 198-200 ℃
NMR (DMSO-d6, Δ): 1.92 (3H, s), 3.68 (2H, s), 6.98
(1H, d, J = 7Hz), 7.29 (1H, s), 7.48-7.63 (3H, m), 7.70 (1H, t,
J = 7Hz), 7.99 (1H, s), 8.75 (1H, d, J = 7Hz), 9.08 (1H, s)
Its methanesulfonate
mp: 209-211 ℃
NMR (DMSO-d6, Δ): 1.96 (3H, s), 2.31 (3H, s), 3.77
(1H, d, J = 14Hz), 3.82 (1H, d, J = 14Hz), 7.12 (1H, d, J = 7Hz),
7.47-7.61 (3H, m), 7.76 (1H, t, J = 7Hz), 8.02 (1H, s), 8.08 (1H,
s), 8.80 (1H, s), 9.15 (1H, s), 9.38 (1H, s)Example 130
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -3-Phenylquinoline was prepared in the same manner as in Production Example 16- (1), using 3-bromo-
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl)
Obtained from quinoline and phenylboric acid.
mp: 261 ℃
NMR (CDClThree, Δ): 7.02 (1H, s), 7.07-7.16 (2H, m), 7.20
(1H, s), 7.30-7.49 (8H, m), 7.68 (1H, t, J = 8Hz), 8.93 (1H, s),
9.05 (1H, d, J = 8Hz)
Its hydrochloride
mp: 249-254 ℃
NMR (DMSO-d6, Δ): 7.25-7.65 (9H, m), 7.78-7.90 (2H,
m), 7.99 (1H, s), 8.86 (1H, d, J = 8Hz), 9.14 (1H, s), 9.24 (1H,
br s)Example 131
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -3- (2-Pyridyl) quinoline was prepared in the same manner as in Production Example 12- (2).
Bromo-8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) quinoline and tri-n-butyl (2-pyridyl) tin.
mp: 253-265 ℃
NMR (CDClThree, Δ): 6.82 (1H, d, J = 8Hz), 7.10 (1H, s),
7.23-7.30 (1H, m), 7.32-7.46 (4H, m), 7.51 (1H, s), 7.59 (1H,
t, J = 8Hz), 7.67-7.75 (2H, m), 8.71 (1H, br d, J = 6Hz), 9.07
(1H, d, J = 7Hz), 9.24 (1H, s)Example 132
9-Fluorenecarboxylic acid (158 mg) and dimethylformamide (1 drop)
Oxalyl chloride (191 mg) is added dropwise to a solution in dichloromethane (2 ml).
The mixture was stirred at room temperature for 1 hour. The mixture is concentrated in vacuo and the residue is
1-3-bromoquinoline (112 mg) and triethylamine (152 mg)
, 3-Dimethyl-2-imidazolidinone (1 ml). The mixture
Stir at room temperature for 3 hours. The mixture was partitioned between ethyl acetate and water, and the organic layer was
After washing with water and drying over magnesium sulfate, the solvent was distilled off in vacuo. Remove the residue
Purified by Ricagel column chromatography, diethyl ether-diisopro
Crystallization from pill ether gave 3-bromo-8-[(fluoren-9-yl) ca
[Rubonylamino] quinoline (22 mg) was obtained.
mp: 196-198 ℃
NMR (CDClThree, Δ): 5.03 (1H, s), 7.32-7.43 (3H, m),
7.45-7.55 (3H, m), 7.80-7.90 (4H, m), 8.20 (1H, s), 8.50 (1H,
s), 8.75 (1H, d, J = 7Hz), 9.65 (1H, br s)Example 133
3-bromo-8- (2,6-dichlorobenzoylamino) -4- (imidazo
L-1-yl) quinoline (50 mg) and N-methylvirolidone
Dazol (11 mg), potassium carbonate (22.4 mg) and copper (I) oxide (7.7)
4 mg) and the mixture was stirred at 60 ° C. for 1.5 hours and at 80 ° C. for 1 hour. mixture
The product was partitioned between dichloromethane and water, the organic layer was washed with brine and dried over magnesium sulfate.
After drying over sodium, the solvent was distilled off in vacuo. Preparative thin-layer chromatography of the residue
And crystallized from diisopropyl ether to give 3-bromo-8- [2,
6-bis (imidazol-1-yl) benzoylamino] -4- (imida
(Zol-1-yl) quinoline (17 mg) was obtained.
mp: 175-185 ℃
NMR (CDClThree, Δ): 7.00-7.15 (4H, m), 7.20-7.30 (1H,
7.37 (1H, s), 7.50-7.60 (3H, m), 7.67 (1H, s),
7.70-7.85 (3H, m), 8.65 (1H, d, J = 8Hz), 8.83 (1H, s), 9.55
(1H, s)Example 134
(1) 8-Amino-1,4-dihydro-4-oxoquinazoline was prepared in the same manner as in Production Example 1.
Similarly, it was obtained from 1,4-dihydro-8-nitro-4-oxoquinazoline.
mp:> 250 ℃
NMR (DMSO-d6, δ): 5.65 (2H, brs), 6.98 (1H, d,
J = 7Hz), 7.18 (1H, t, J = 7Hz), 7.22 (1H, d, J = 7Hz), 7.98 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (2,6-dichloro
Benzoyloxy) quinazoline was converted to 8-amino as described in Example 3- (1).
-1,4-dihydro-4-oxoquinoline and 2,6-dichlorobenzoyl chloride
Was reacted.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.45-7.70 (7H, m), 7.90 (1H, d,
J = 7Hz), 8.75 (1H, d, J = 7Hz), 8.91 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- (2,6-dichloro
Benzoyloxy) quinazoline (40 mg) and imidazole (53.7 mg)
A mixture in 1,3-dimethyl-2-imidazolidinone (0.6 ml) was added at room temperature for 1 hour.
Stirred for hours. Cold water was added to the mixture, and the resulting precipitate was collected by filtration to give 8- (
2,6-dichlorobenzoylamino) -1,4-dihydro-4-oxoquinazolyl
(23 mg) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.45-7.60 (4H, m), 7.90 (1H, d,
J = 7Hz), 8.13 (1H, s), 8.70 (1H, d, J = 7Hz)Example 135
4-chloro-8- (2,6-dichlorobenzoylamino) -3-ethoxycal
Bonylquinoline (200 mg), formamidine acetate (246 mg) and N-methyl
The mixture of lupyrrolidone is heated at 100 ° C for 4 hours, 120 ° C for 45 minutes,
Stirred for hours. The mixture was partitioned between water and ethyl acetate. Wash the organic layer with water
The solvent was distilled off in vacuo. The residue is crystallized from isopropyl alcohol,
Collected by filtration, 7- (2,6-dichlorobenzoylamino) -3,4-dihydroxy.
Dropirimide [5,4-c] quinolin-4-one (116 mg) was obtained.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.50-7.60 (3H, m), 7.84 (1H, t,
J = 8Hz), 8.57 (1H, d, J = 8Hz), 8.60 (1H, s), 8.91 (1H, d,
J = 8Hz), 9.39 (1H, s)Example 136
(1) 3- (imidazol-1-ylthiomethyl) -1,4-dihydro-8-
Nitro-4-oxoquinoline was prepared as in Example 62 using 3-chloromethyl-
1,4-dihydro-8-nitro-4-oxoquinoline and 2-mercaptoimidazo
Obtained from
mp: 185-189 ° C
NMR (DMSO-d6, Δ): 4.09 (2H, s), 6.90-7.20 (2H, m),
7.50 (1H, t, J-7Hz), 7.90 (1H, s), 8.58 (1H, d, J = 7Hz), 8.62
(1H, d, J = 7Hz)
(2) 3- (imidazol-1-ylthiomethyl) -1,4-dihydro-8-
Suspension of nitro-4-oxoquinoline (185 mg) in phosphoryl chloride (1 ml)
The suspension was stirred at 100 ° C. for 1 hour. After cooling, diethyl ether was added thereto,
The resulting precipitate was collected by filtration and washed with diethyl ether. Dichloro to residue
Methane-methanol and saturated sodium bicarbonate solution were added. Eating the separated organic layer
After washing with brine and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Purification by silica gel column chromatography gave 4-nitro-7H-imidazo
[2 ', 1': 2,3] [1,3] thiazino [5,4-c] quinoline (135 m
g) was obtained.
mp: 236-242 ℃
NMR (DMSO-d6, Δ): 4.39 (2H, s), 7.33 (1H, s), 7.88
(1H, t, J = 7Hz), 8.24 (1H, s), 8.36 (1H, d, J = 7Hz), 8.60 (1H,
d, J = 7Hz), 9.13 (1H, s)
(3) 4-amino-7H-imidazo [2 ', 1': 2,3] [1,3] thiazi
No [5,4-c] quinoline was obtained in the same manner as in Production Example 2- (3).
mp:> 250 ℃
NMR (DMSO-d6, Δ): 4.29 (2H, s), 6.18 (2H, br s), 6.93
(1H, t, J = 7Hz), 7.24 (1H, s), 7.37-7.47 (2H, m), 8.12 (1H, s),
8.81 (1H, s)
(4) 4- (2,6-dichlorobenzoylamino) -7H-imidazo [2 ',
1 ': 2,3] [1,3] thiazino [5,4-c] quinoline in the same manner as in Example 1.
I got it.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 4.37 (2H, s), 7.32 (1H, s), 7.47-
7.62 (3H, m), 7.80 (1H, t, J = 7Hz), 8.14 (1H, d, J = 7Hz), 8.23
(1H, s), 8.80 (1H, d, J = 7Hz), 9.01 (1H, s)Example 137
3-bromo-8- [2- (2-ethylimidazol-1-yl) benzoyla
Mino] quinoline was prepared in the same manner as in Example 132, using 2- (2-ethylimidazole).
-1-yl) benzoic acid and 8-amino-3-bromoquinoline.
mp: 168-169 ℃
NMR (CDClThree, Δ): 1.26 (3H, t, J = 7Hz), 2.67 (2H, q,
J = 711z), 7.00 (1H, s), 7.10 (1H, s), 7.34 (1H, m), 7.42 (1H, d,
J = 8Hz), 7.57 (1H, t, J = 8Hz), 7.60-7.70 (2H, m), 8.09 (1H, m),
8.30 (1H, d, J = 2Hz), 8.70 (1H, d, J = 2Hz), 9.74 (1H, brs)Example 138
(1) 4-chloro-8- (2,6-dichlorobenzoylamino) quinoline (2
00 mg) and hydrazine-hydrate (285 mg) in ethanol (4 ml) and N-
The mixture in methylpyrrolidone (1 ml) was heated at 100 ° C. overnight. After cooling, raw
The resulting precipitate was collected by filtration, and the residue was recrystallized from ethanol to give 8- (2,2).
6-dichlorobenzoylamino) -4-hydrazinoquinoline (173 mg) was obtained.
Was.
mp: 204-206 ℃
NMR (CDClThree-CDThreeOD, δ): 6.92 (1H, d, J = 6Hz), 7.28-7.59
(511, m), 8.44 (1H, d, J = 6Hz), 8.85 (1H, d, J = 8Hz)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) quinoline was obtained as in Example 86.
mp: 252 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 6.64 (1H, d, J = 6Hz),
7.45-7.64 (4H, m), 7.99 (1H, d, J = 8Hz), 8.41 (1H, d, J = 6Hz),
8.65 (1H, d, J = 8 Hz), 9.27 (1H, br s), 10.02 (1H, br s), 10.51
(1H, s)Example 139
(1) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-3-me
Tylquinoline was converted to 4-chloro-8- (2,6-dichloro
(Benzoylamino) -3-methylquinoline and hydrazine-hydrate.
mp: 190-197 ℃
NMR (CDClThree, Δ): 2.30 (3H, s), 4.04 (2H, br s), 5.93
(1H, br s), 7.20-7.51 (4H, m), 8.12 (1H, d, J = 8Hz), 8.31 (1H,
s), 8.83 (1H, d, J = 8Hz)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -3-methylquinoline was obtained as in Example 86.
mp: 249-254 ℃
NMR (DMSO-d6, Δ): 1.87 (3H, s), 2.35 (3H, s), 7.42-
7.63 (4H, m), 8.10 (1H, d, J = 8Hz), 8.25 (1H, s), 8.33 (1H, s),
8.57 (1H, d, J = 8Hz)Example 140
8- (2,6-dichlorobenzoylamino) -4-hydrazino-3-hydroxy
A suspension of cimethylquinoline (100 mg) in dichloroethane (3 ml)
Water acetic acid (30 mg) was added. After stirring at room temperature for 7 hours, the solvent was distilled off from the reaction mixture.
The residue was triturated with a minimum amount of hot ethanol to give 3-acetoxymethyl-4- (
2-acetylhydrazino) -8- (2,6-dichlorobenzoylamino) quinol
Was obtained as pale yellow crystals (53 mg). The solvent is distilled off from the mother liquor and the silica gel
Purified by ram chromatography (methanol: ethyl acetate = 1: 10, V / V)
To give 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyla
Mino) -3-hydroxymethylquinoline was obtained as a pale yellow powder (35 mg).
4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoylamino
) -3-Hydroxymethylquinoline
mp: 142-145 ℃
NMR (DMSO-d6, Δ): 1.87 (3H, s), 4.73 (2H, d, J = 6Hz),
5.30 (1H, t, J = 6Hz), 7.45-7.63 (4H, m), 8.13 (1H, d, J = 8Hz),
8.33 (1H, s), 8.58 (1H, s), 8.62 (1H, d, J = 8 Hz), 10.15 (1H, s)
s), 10.58 (1H, s)
3-acetoxymethyl-4- (2-acetylhydrazino) -8- (2,6-di
Chlorobenzoylamino) quinoline
mp: 181-183 ℃
NMR (DMSO-d6, Δ): 1.87 (3H, s), 2.02 (3H, s), 5.23
(2H, s), 7.46-7.63 (4H, m), 8.14 (1H, d, J = 8Hz), 8.45 (1H, s),
8.66 (1H, d, J = 8Hz), 8.79 (1H, s), 10.22 (1H, s), 10.55 (1H,
s)Example 141
The following compound was obtained in the same manner as in Example 139- (1).
(1) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-3-me
Toximethylquinoline
mp: 176-178 ℃
NMR (DMSO-d6, Δ): 3.28 (3H, s), 4.81 (2H, s), 4.82
(211, s), 7.38 (1H, dd, J = 8, 8Hz), 7.49-7.63 (3H, m), 8.20 (1H,
br s), 8.29 (1H, s), 8.35 (1H, d, J = 8 Hz), 8.53 (1H, d, J = 8 Hz),
10.46 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-3-i
Sopropoxymethylquinoline
NMR (DMSO-d6, Δ): 1.25 (2x3x2 / 3H, d, J = 7Hz), 1.27
(3x1 / 3H, d, J = 7Hz), 3.67 (1H, qq, J = 7, 7Hz), 4.75-4.92 (4H,
m), 7.34 to 7.63 (4H, m), 8.13 (1x2 / 3H, s), 8.32 (1x2 / 3H, s),
8.45 (1x2 / 3H, d, J = 8Hz), 8.48 (1x1 / 3H, s), 8.57 (1x2 / 3H, d,
J = 8Hz), 8.63 (1x1 / 3H, d, J = 8Hz), 8.82 (1x1 / 3H, d, J = 8Hz),
10.46 (1x2 / 3H, s), 10.55 (1x1 / 3H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- (2-methylhydra
Zino) quinoline
mp: 223-225 ℃
NMR (CDClThree, Δ): 3.26 (3H, s), 3.90 (2H, s), 7.07 (1H,
d, J = 6Hz), 7.27-7.44 (3H, m), 7.52 (1H, t, J = 8Hz), 8.03 (1H,
d, J = 8Hz), 8.54 (1H, d, J = 6Hz), 8.90 (1H, d, J = 8Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4- (2,2-dimethyl
Hydrazino) quinoline
mp: 202-204 ℃
NMR (DMSO-d6, Δ): 3.03 (2x3H, s), 6.95 (1H, d,
J = 6Hz), 7.48-7.63 (4H, m), 7.84 (1H, d, J = 8Hz), 8.55 (1H, d,
J = 6Hz), 8.65 (1H, d, J = 8Hz), 10.58 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -4- (4-methylpipera
Zin-1-ylamino) quinoline
mp: 196-200 ℃
NMR (CDClThree, Δ): 2.44 (3H, s), 2.72 (4H, t, J = 5Hz),
3.29 (4H, t, J = 5Hz), 6.90 (1H, d, J = 5Hz), 7.30-7.44 (3H, m),
7.53 (1H, t, J = 8Hz), 7.75 (1H, d, J = 8Hz), 8.58 (1H, d, J = 5Hz),
8.90 (1H, d, J = 8Hz)
Its dihydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.88 (3H, d, J = 4 Hz), 3.45-3.90 (8H,
m), 7.25 (1H, d, J = 6Hz), 7.50-7.62 (3H, m), 7.70 (1H, t,
J = 8Hz), 7.87 (1H, d, J = 8Hz), 8.68 (1H, d, J = 8Hz), 8.74 (1H, d,
(J = 6Hz)
(6) 8- (2,6-dichlorobenzoylamino) -4- (morpholinoamino
) Quinoline
mp: 258-260 ℃
NMR (CDClThree, Δ): 3.20-3.30 (4H, m), 3.95-4.63 (4H, m),
6.90 (1H, d, J = 4Hz), 7.30-7.45 (3H, m), 7.55 (1H, t, J = 8Hz),
7.75 (1H, d, J = 8Hz), 8.60 (1H, d, J = 4Hz), 8.92 (1H, d, J = 7Hz)
Its hydrochloride
mp:> 260 ℃
NMR (CDClThree, Δ): 3.74-3.86 (4H, m), 3.99-4.09 (4H, m),
7.05 (1H, d, J = 7Hz), 7.30-7.45 (3H, m), 7.70-7.85 (2H, m),
8.62 (1H, d, J = 7Hz), 8.88-8.97 (1H, m)Example 142
The following compound was obtained in the same manner as in Example 86.
(1) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -3-methoxymethylquinoline
mp: 186-187 ℃
NMR (DMSO-d6, Δ): 1.87 (3H, s), 3.32 (3H, s), 4.60
(2H, s), 7.47-7.63 (4H, m), 8.15 (1H, d, J = 8Hz), 8.46 (1H, s),
8.46 (1H, s), 8.65 (1H, d, J = 8Hz), 10.17 (1H, s), 10.57 (1H,
s)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -3-isopropoxymethylquinoline
mp: 106-110 ℃
NMR (DMSO-d6, Δ): 1.15 (2x3H, d, J = 7Hz), 1.87 (3H,
s), 3.65 (1H, qq, J = 7, 7Hz), 4.70 (2H, s), 7.47-7.63 (4H, m),
8.14 (1H, d, J = 8Hz), 8.32 (1H, s), 8.53 (1H, s), 8.63 (1H, d,
J = 8Hz), 10.17 (1H, s), 10.55 (1H, s)Example 143
8- (2,6-dichlorobenzoylamino) -4- (2-methylhydrazino)
Quinoline (500 mg) and triethylamine (700 mg) in dichloromethane (
Acetic anhydride (155 mg) was added to the stirred suspension in 5 ml) at room temperature and the mixture was added to 1 ml.
It was allowed to stand at the same temperature for 0 days. Dilute the mixture with dichloromethane, wash with water and vacuum
The solvent was distilled off in. The residue obtained was dissolved in methanol (10 ml) and
To this was added a 28% sodium methoxide methanol solution (0.53 ml) under ice cooling.
I got it. The mixture was stirred at the same temperature for 1 hour and neutralized with 1N hydrochloric acid. Concentrate the mixture in vacuo
And extracted with dichloromethane. Wash the organic layer with water and dry over magnesium sulfate
After drying, the solvent was distilled off in vacuo. Silica gel column chromatography of the residue
(Ethyl acetate) and crystallized from ethanol to give 4- (2-acetyl-
2-methylhydrazino) -8- (2,6-dichlorobenzoylamino) quinoline
(544 mg).
mp: 215 ℃
NMR (DMSO-d6, Δ): 1.80 (3H, s), 3.22 (3H, s), 7.04
(1H, d, J = 6Hz), 7.45-7.62 (4H, m), 7.98 (1H, d, J = 8Hz), 8.59
(1H, d, J = 6Hz), 8.64 (1H, d, J = 8Hz)Example 144
4- (2-acetyl-2-methylhydrazino) -8- (2,6-dichloroben
Zoylamino) quinoline (140 mg) in N-methylpyrrolidone (1.5 ml)
Potassium tertiary butoxide (40.9 mg) was added to the solution under ice-cooling and mixed.
The thing was stirred at the same temperature for 30 minutes. Add methyl iodide (59.1 mg) under ice-cooling
The mixture was stirred at room temperature for 12 hours. Dilute the mixture with ethyl acetate, add water and
After washing with brine and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Purification by preparative thin-layer chromatography (methanol-dichloromethane)
To give 4- (2-acetyl-1,2-dimethylhydrazino) -8.
-(2,6-Dichlorobenzoylamino) quinoline (62 mg) was obtained.
mp: 243-244 ° C
NMR (DMSO-d6, Δ): 2.17 (3H, s), 2.96 (3H, s), 3.34
(3H, s), 6.99 (1H, d, J = 6Hz), 7.47-7.62 (4H, m), 7.74 (1H, d,
J = 8Hz), 8.63 (1H, d, J = 6Hz), 8.70 (1H, d, J = 8Hz)Example 145
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (20
0 mg) in a suspension of ethylene chloride (2 ml) in propionic anhydride (82.
(5 mg) was added dropwise at room temperature, and the mixture was stirred overnight at the same temperature. Dissolve from the mixture in a vacuum
The medium is distilled off and the residue is crystallized from ethanol to give 8- (2,6-dichlorobenzene).
Zoylamino) -4- (2-propionylhydrazino) quinoline (40 mg)
Obtained.
mp: 246-248 ℃
NMR (DMSO-d6, Δ): 1.15 (3H, t, J = 7.5 Hz), 2.30 (2H, q,
J = 7.5Hz), 6.63 (1H, d, J = 7.0Hz), 7.50-7.62 (4H, m), 8.00 (1H,
d, J = 8.0Hz), 8.42 (1H, d, J = 7.0Hz), 8.66 (1H, d, J = 8.0Hz),
9.27 (1H, brs)Example 146
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (20
0 mg), crotonic acid (54.5 mg), 1-ethyl-3- (3-dimethylamido)
Nopropyl) carbodiimide hydrochloride (133 mg) and 1-hydroxybenzotri
A mixture of azole (93.4 mg) in dimethylformamide (4 ml) was added at room temperature.
And stirred overnight. Dilute the mixture with ethyl acetate, add water, saturated sodium bicarbonate solution
After washing with sodium chloride and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residual
The product was purified by silica gel column chromatography (methanol-dichloromethane).
To produce 4- (2-crotonoylhydrazino) -8- (2,6-dichlorobenzo
Ilamino) quinoline (90 mg) and 8- (2,6-dichlorobenzoylamido)
No) -4- (3-Methyl-5-oxopyrazolidin-1-yl) quinoline (25
mg).
4- (2-crotonoylhydrazino) -8- (2,6-dichlorobenzoyla
Mino) Quinoline
mp: 257-259 ℃
NMR (DMSO-d6, Δ): 1.86 (3H, d, J = 7.5 Hz), 6.10 (1H, d,
J = 15.0Hz), 6.58 (1H, d, J = 6.0Hz), 6.83 (1H, dq, J = 15.0,
7.5Hz), 7.50-7.60 (4H, m), 8.01 (1H, d, J = 8.0Hz), 8.43 (1H, d,
J = 6.0Hz), 8.68 (1H, d, J = 8.0Hz), 9.37 (1H, s), 10.06 (1H, s),
10.26 (1H, s)
8- (2,6-dichlorobenzoylamino) -4- (3-methyl-5-oxo
Pyrazolidin-1-yl) quinoline
mp: 228-230 ℃
NMR (DMSO-d6, Δ): 1.32 (3H, d, J = 7.0 Hz), 2.46 (1H,
dd, J = 16.0, 7.5Hz), 2.85 (1H, dd, J = 16.0, 7.5Hz), 3.88 (1H,
dddq, J = 9.0, 7.5, 7.5, 7.0Hz), 6.58 (1H, d, J = 9.0Hz), 7.48-
7.64 (5H, m), 7.89 (1H, d, J = 8.0Hz), 8.70 (1H, d, J = 8.0Hz),
8.88 (1H, d, J = 5.0Hz), 10.73 (1H, s)Example 147
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (20
0 mg), methacrylic acid (54.5 mg), 1-ethyl-3- (3-dimethyla
Minopropyl) carbodiimide hydrochloride (133 mg) and 1-hydroxybenzoto
A mixture of liazole (93.4 mg) in dimethylformamide (4 ml) was added to the chamber.
Stirred at warm for 4.5 hours. Dilute the mixture with ethyl acetate, add water, saturated sodium bicarbonate
And a saline solution. Collect insolubles by filtration and recrystallize from ethanol
To give 8- (2,6-dichlorobenzoylamino) -4- (2-methacryloyl
(Hydrazino) quinoline (190 mg) was obtained.
mp: 277-280 ℃
NMR (DMSO-d6, Δ): 1.97 (3H, s), 5.53 (1H, s), 5.87
(1H, s), 6.64 (1H, d, J = 7.0Hz), 7.48-7.60 (4H, m), 8.03 (1H,
d, J = 8.0Hz), 8.44 (1H, d, J = 7.0Hz), 8.66 (1H, d, J = 8.0Hz),
9.33 (1H, s)Example 148
The following compound was obtained in the same manner as in Example 147.
(1) 4- (2-cyclopropanecarbonylhydrazino) -8- (2,6-di
Chlorobenzoylamino) quinoline
mp: 267-269 ℃
NMR (DMSO-d6, Δ): 0.78-0.84 (4H, m), 1.71-1.80 (1H,
m), 6.61 (1H, d, J = 7.0Hz), 7.50-7.60 (4H, m), 7.99 (1H, d,
J = 8.0Hz), 8.45 (1H, d, J = 7.0Hz), 8.66 (1H, d, J = 8.0Hz), 9.31
(1H, s)
(2) 4- (2-cyclopentanecarbonylhydrazino) -8- (2,6-di
Chlorobenzoylamino) quinoline
mp: 249-251 ℃
NMR (DMSO-d6, Δ): 1.54-1.77 (6H, m), 1.86-1.93 (2H,
m), 2.76 (1H, qn, J = 7.5Hz), 6.57 (1H, d, J = 6.0Hz), 7.47-7.60
(4H, m), 8.00 (1H, d, J = 8.0Hz), 8.43 (1H, d, J = 6.0Hz), 8.66
(1H, d, J = 8.0Hz), 9.30 (1H, br s)
(3) 8- (2,6-dichlorobenzoylamino) -4- (2-methoxyacetate
Tylhydrazino) quinoline
mp: 223-225 ℃
NMR (DMSO-d6, Δ): 3.41 (3H, s), 4.08 (2H, s), 6.63
(1H, d, J = 6Hz), 7.48-7.63 (4H, m), 8.00 (1H, d, J = 8Hz), 8.43
(1H, d, J = 6Hz), 8.67 (1H, d, J = 8Hz), 9.30 (1H, s), 10.18 (1H,
s), 10.52 (1H, s)
(4) 4- (2-acetamidoacetylhydrazino) -8- (2,6-dichloro
Lobenzoylamino) quinoline
mp: 263-269 ℃
NMR (DMSO-d6, Δ): 1.90 (3H, s), 3.85 (2H, d, J = 6Hz),
6.71 (1H, d, J = 6Hz), 7.46-7.63 (4H, m), 8.00 (1H, d, J = 8Hz),
8.32 (1H, t, J = 6Hz), 8.42 (1H, d, J = 6Hz), 8.66 (1H, t, J = 8Hz),
9.32 (1H, s), 10.13 (1H, s), 10.52 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-furyl
Carbonyl) hydrazino] quinoline hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 6.78 (1H, d, J = 3 Hz), 6.96 (1H, d,
J = 5Hz), 7.45 (1H, d, J = 4Hz), 7.50-7.68 (3H, m), 7.86 (1H, t,
J = 8Hz), 8.04 (1H, s), 8.43 (1H, d, J = 8Hz), 8.55-8.65 (2H, m)
(6) 8- (2,6-dichlorobenzoylamino) -4- [2- (1-methyl
Imidazol-2-ylcarbonyl) hydrazino] quinoline
mp: 217-220 ℃
NMR (DMSO-d6, Δ): 3.95 (3H, s), 6.65 (1H, d, J = 6Hz),
7.10 (1H, s), 7.47 (1H, s), 7.49-7.63 (4H, m), 8.05 (1H, d,
J = 8Hz), 8.42 (1H, d, J = 6Hz), 8.68 (1H, d, J = 8Hz), 9.45 (1H, s)
(7) 8- (2,6-dichlorobenzoylamino) -4- [2- (pyridine-
2-ylcarbonyl) hydrazino] quinoline dihydrochloride
mp: 200-220 ℃
NMR (DMSO-d6, Δ): 6.95 (1H, d, J = 6Hz), 7.52-7.68 (3H,
m), 7.77 (1H, t, J = 6Hz), 7.90 (1H, t, J = 8Hz), 8.08-8.18 (2H,
m), 8.50 (1H, d, J = 8Hz), 8.55-8.67 (2H, m), 8.80 (1H, d,
(J = 4Hz)Example 149
(1) 4- (2-acetoxyacetylhydrazino) -8- (2,6-dichloro
Benzoylamino) quinoline was prepared in the same manner as in Example 147, using 8- (2,6-di-
(Chlorobenzoylamino) -4-hydrazinoquinoline and acetoxyacetic acid
.
mp: 234-236 ℃
NMR (DMSO-d6, Δ): 2.14 (3H, s), 4.70 (2H, s), 6.68
(1H, d, J = 6.0Hz), 7.50-7.60 (4H, m), 8.00 (1H, d, J = 8.0Hz),
8.43 (1H, d, J = 6.0Hz), 8.66 (1H, d, J = 8.0Hz), 9.36 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (2-hydroxya
(Cetylhydrazino) quinoline was obtained in the same manner as in Example 12- (2).
mp: 248-250 ℃
NMR (DMSO-d6, Δ): 4.07 (2H, d, J = 7.0 Hz), 5.63 (1H, t,
J = 7.0Hz), 6.65 (1H, d, J = 6.0Hz), 7.48-7.61 (4H, m), 8.03 (1H,
d, J = 8.0Hz), 8.43 (1H, d, J = 6.0Hz), 8.65 (1H, d, J = 8.0Hz),
9.25 (1H, s)Example 150
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (20
0 mg) in a stirred suspension in pyridine (2 ml) was added ethyl chloroformate (68.8).
mg) in dichloromethane (0.5 ml) was added under ice-cooling and the mixture was brought to room temperature.
For 1 hour. The mixture is concentrated in vacuo and the residue is diluted with dichloromethane.
Was. The mixture is washed with water and brine, dried over magnesium sulfate and evaporated in vacuo.
Distilled off. The residue was recrystallized from ethanol to give 8- (2,6-dichlorobenzo).
Ilamino) -4- (2-ethoxycarbonylhydrazino) quinoline (115 m
g) was obtained.
mp: 151-155 ℃
NMR (DMSO-d6, Δ): 1.24 (3H, brt, J = 8 Hz), 4.11 (2H,
br q, J = 8Hz), 6.64 (1H, d, J = 6Hz), 7.46-7.63 (4H, m), 7.94
(1H, d, J = 8Hz), 8.44 (1H, d, J = 5Hz), 8.66 (1H, d, J = 8Hz), 9.31
(1H, br s), 9.49 (1H, br s)Example 151
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (20
0 mg) and methyl isothiocyanate (54.8 mg) in ethylene chloride (4 ml)
The suspension in was stirred at room temperature for 2 hours and then gently refluxed for 24 hours. The mixture
Concentrate in vacuo and recrystallize the residue from ethanol to give 8- (2,6-dichloro
Benzoylamino) -4- [4- (methyl) thiosemicarbazide] quinoline (2
13 mg).
mp:> 258 ℃
NMR (DMSO-d6, Δ): 2.87 (3H, d, J = 5 Hz), 6.60 (1H, d,
J = 5Hz), 7.47-7.64 (4H, m), 7.98 (1H, d, J = 8Hz), 8.26 (1H, br
q, J = 5Hz), 8.47 (1H, d, J = 5Hz), 8.67 (1H, d, J = 8Hz), 9.43 (1H,
br s), 9.63 (1H, br s)Example 152
The following compound was obtained in the same manner as in Example 151.
(1) 8- (2,6-dichlorobenzoylamino) -4- (4-phenylsemi
Carbazide) quinoline
mp:> 234 ° C
NMR (DMSO-d6, Δ): 6.77 (1H, d, J = 6 Hz), 6.94 (1H, t,
J = 8Hz), 7.19-7.29 (2H, m), 7.45-7.64 (6H, m), 8.03 (1H, d,
J = 8Hz), 8.47 (1H, d, J = 6Hz), 8.53 (1H, brs), 8.67 (1H, d,
J = 8Hz), 8.93 (1H, br s), 9.30 (1H, br s)
(2) 8- (2,6-dichlorobenzoylamino) -4- [4- (phenyl)
Thioamicarbazide] quinoline
mp: 227-232 ℃
NMR (DMSO-d6, Δ): 6.71 (1H, d, J = 6 Hz), 7.16 (1H, t,
J = 8Hz), 7.25-7.36 (2H, m), 7.38-7.47 (2H, m), 7.49-7.70 (4H,
m), 8.03 (1H, d, J = 8Hz), 8.55 (1H, d, J = 6Hz), 8.67 (1H, d,
J = 8Hz), 9.63 (1H, br s), 9.91-10.13 (2H, m), 10.56 (1H, s)Example 153
(1) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-hydro
Xyethyl) hydrazino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro-8.
-(2,6-dichlorobenzoylamino) quinoline and 2-hydroxyethyl hydride
Obtained from Razine.
mp: 125-137 ℃
NMR (CDClThree, Δ): 1.92 (1H, br), 3.10-3.20 (2H, m),
3.83-3.41 (2H, m), 4.05 (1H, t, J = 6Hz), 6.57 (1H, s), 7.12
(1H, d, J = 5Hz), 7.28-7.50 (4H, m), 8.47 (1H, d, J = 5Hz), 8.91
(1H, d, J = 6Hz)
Its dihydrochloride
mp: 153-167 ℃
NMR (DMSO-d6, Δ): 3.02 (2H, t, J = 6 Hz), 3.54 (2H, t,
J = 6Hz), 7.33 (1H, d, J = 8Hz), 7.50-7.67 (3H, m), 7.75 (1H, t,
J = 6Hz), 8.39 (1H, d, J = 8Hz), 8.40-8.50 (2H, m)
(2) 8- (2,6-dichlorobenzoylamino) -4- (2-oxazolidy
(Non-3-ylamino) quinoline was obtained in the same manner as in Example 92- (2).
mp:> 250 ℃
NMR (CDClThree, Δ): 3.92 (2H, t, J = 8 Hz), 4.58 (2H, t,
J = 8Hz), 6.81 (1H, d, J = 4Hz), 7.33-7.44 (3H, m), 7.50-7.67 (2H,
m), 8.53 (1H, d, J = 4Hz), 8.93 (1H, d, J = 6Hz)Example 154
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (21
To a stirred suspension of 6 mg) in pyridine (2 ml) was added methanesulfonyl chloride (78 mg).
. 4 mg) in dimethylformamide is added under ice-cooling and the mixture is added at the same temperature for 5 minutes.
Stirred for 0 minutes. Concentrate the mixture in vacuo, leaving ethyl acetate, methanol and water
Added to things. The separated organic layer is washed with water and brine, and dried over magnesium sulfate.
The solvent was distilled off in vacuo. The residue was purified by preparative thin-layer chromatography,
Recrystallization from ethanol gave 8- (2,6-dichlorobenzoylamino) -4-
(2-Methanesulfonylhydrazino) quinoline (16 mg) was obtained.
mp: 156-164 ℃
NMR (DMSO-d6, Δ): 3.10 (3H, s), 7.10 (1H, d, J = 6Hz),
7.48-7.63 (4H, m), 8.05 (1H, d, J = 8Hz), 8.50 (1H, d, J = 6Hz),
8.68 (1H, d, J = 8Hz), 9.45 (1H, s), 9.56 (1H, s), 10.55 (1H, s)Example 155
4- (2-benzenesulfonylhydrazino) -8- (2,6-dichlorobenzo
Ilamino) quinoline was prepared in the same manner as in Example 154 by using 8- (2,6-dichloro
Benzoylamino) -4-hydrazinoquinoline and benzenesulfonyl chloride
And obtained by reacting
mp: 197-201 ℃
NMR (DMSO-d6, Δ): 6.89 (1H, d, J = 6Hz), 7.43-7.73 (7H,
m), 7.80-7.92 (3H, m), 8.38 (1H, d, J = 6Hz), 8.64 (1H, d,
J = 8Hz), 9.34 (1H, s), 10.12 (1H, s), 10.52 (1H, s)Example 156
(1) 8- (2,6-dichlorobenzoylamino) -4-[(2-ethylamido
Noethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro-8- (2
, 6-Dichlorobenzoylamino) quinoline and N-ethylethylenediamine
Obtained.
mp: 140-144 ℃
NMR (CDClThree, Δ): 1.17 (3H, t, J = 8 Hz), 2.73 (2H, q,
J = 8Hz), 3.06 (2H, t, J = 7Hz), 3.37 (2H, q, J = 7Hz), 5.93 (1H, t,
J = 7Hz), 6.46 (1H, d, J = 6Hz), 7.30-7.43 (3H, m), 7.45-7.57 (2H,
m), 8.40 (1H, d, J = 6Hz), 8.92 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (3-ethyl-2-
Oxoimidazolidin-1-yl) quinoline was prepared in the same manner as in Example 92- (2).
Obtained.
mp: 249-253 ℃
NMR (CDClThree, Δ): 1.25 (3H, t, J = 8 Hz), 3.45 (2H, q,
J = 8Hz), 3.65 (2H, t, J = 6Hz), 3.97 (2H, t, J = 8Hz), 7.30-7.45
(4H, m), 7.62 (1H, t, J = 8Hz), 7.77 (1H, d, J = 8Hz), 8.73 (1H,
d, J = 5Hz), 8.98 (1H, d, J = 8Hz)Example 157
4-chloro-8- (2,6-dichlorobenzoylamino) quinoline (400 m
g) and N-benzylethylenediamine (854 mg) at 130 ° C. for 6 hours
While stirring. The mixture was partitioned between ethyl acetate and water, and the organic layer was washed with water and brine.
After washing and drying over magnesium sulfate, the solvent was distilled off in vacuo. Silica gel residue
Purified by flash chromatography (methanol-dichloromethane)
4- (2-benzylaminoethylamino) -8- (2,6-dichlorobenzoyl
A residue containing (amino) quinoline was obtained. The resulting residue, 1,1'-carbonyl
Diimidazole (221 mg) and 1,8-diazabicyclo [5.4.0] unde
A mixture of qu-7-ene (191 mg) in dimethylformamide at room temperature for 4 hours
And stirred at 130 ° C. for 2 hours. The mixture was partitioned between ethyl acetate and water and the organic layer
Was washed with water and brine, dried over magnesium sulfate, and evaporated in vacuo.
The residue was subjected to silica gel flash chromatography (methanol-dichlorometa).
) To give 4- (3-benzyl-2-oxoimidazolidin-1-yl)
-8- (2,6-Dichlorobenzoylamino) quinoline (150 mg) was obtained.
mp: 178-191 ℃
NMR (CDClThree, Δ): 3.52 (2H, t, J = 8 Hz), 3.93 (2H, t,
J = 8Hz), 4.55 (2H, s), 7.30-7.45 (9H, m), 7.62 (1H, t, J = 8Hz),
7.75 (1H, d, J = 8Hz), 8.74 (1H, d, J = 5Hz), 8.98 (1H, d, J = 8Hz)Example 158
8- (2,6-dichlorobenzoylamino) -4- (3-methyl-3,4,5
, 6-Tetrahydro-2 (1H) -pyrimidinone-1-yl) quinoline was
Analogously to Example 157, 4-chloro-8- (2,6-dichlorobenzoylamino
) Obtained from quinoline and 3-methylaminopropylamine.
mp: 252-254 ℃
NMR (CDClThree, Δ): 2.60-2.45 (4H, m), 3.07 (3H, s),
3.47-3.85 (6H, m), 7.30-7.45 (4H, m), 7.58-7.65 (2H, m), 8.76
(1H, d, J = 5Hz), 8.90-8.98 (1H, m)Example 159
8- (2,6-dichlorobenzoylamino) -3-methyl-4- (3-methyl
-2-thioxoimidazolidin-1-yl) quinoline was prepared according to Example 92-2 (2).
Similarly, 8- (2,6-dichlorobenzoylamino) -3-methyl-4- [
(2-Methylaminoethyl) amino] quinoline and 1,1'-thiocarbonyldi
Obtained from imidazole.
mp: 248-250 ℃
NMR (DMSO-d6, Δ): 2.37 (3H, s), 3.16 (3H, s), 3.82-
4.08 (4H, m), 7.48-7.70 (5H, m), 8.65 (1H, d, J = 8Hz), 8.89
(1H, s)Example 160
(1) 3-tert-butyldimethylsilyloxymethyl-4-chloro-8- (2
, 6-Dichlorobenzoylamino) quinoline was prepared in the same manner as in Example 125- (2).
To give 4-chloro-8- (2,6-dichlorobenzoylamino) -3-hydroxy
Obtained from cimethylquinoline and tert-butyldimethylsilyl chloride.
mp: 205-207 ℃
NMR (CDClThree, Δ): 0.16 (2x3H, s), 0.96 (3x3H, s), 5.02
(2H, s), 7.30-7.44 (3H, m), 7.70 (1H, dd, J = 8,8Hz), 7.97 (1H,
d, J = 8Hz), 8.93 (1H, s), 9.00 (1H, d, J = 8Hz), 10.09 (1H, br s)
(2) 3-tert-butyldimethylsilyloxymethyl-8- (2,6-dichloro
Robenzoylamino) -4-[(2-methylaminoethyl) amino] quinoline
Obtained in the same manner as in Example 8.
NMR (DMSO-d6, Δ): 0.06 (2x3H, s), 0.86 (3x3H, s),
2.31 (3H, s), 2.73 (2H, t, J = 6Hz), 3.69 (2H, dt, J = 6, 6Hz),
4.84 (2H, s), 6.45 (1H, t, J = 6Hz), 7.43-7.62 (4H, m), 7.98
(1H, d, J = 8Hz), 8.37 (1H, s), 8.61 (1H, d, J = 8Hz), 10.51 (1H,
s)
(3) 3-tert-butyldimethylsilyloxymethyl-8- (2,6-dichloro
Robenzoylamino) -4- (3-methyl-2-oxoimidazolidin-1-i
L) Quinoline was obtained in the same manner as in Example 92- (2).
NMR (DMSO-d6, Δ): 0.10 (3H, s), 0.12 (3H, s), 0.90
(3x3H, s), 2.81 (3H, s), 3.60 (1H, m), 3.63-3.75 (2H, m), 3.83
(1H, m), 4.86 (2H, s), 7.47-7.61 (3H, m), 7.66-7.74 (2H, m),
8.73 (1H, m), 9.00 (1H, s), 10.86 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
Example 1 4- (3-methyl-2-oxoimidazolidin-1-yl) quinoline
Obtained similarly to 25- (8).
mp: 251-253 ℃
NMR (DMSO-d6, Δ): 2.82 (3H, s), 3.55-3.77 (3H, m),
3.83 (1H, m), 4.65 (2H, d, J = 6Hz), 5.45 (1H, t, J = 6Hz), 7.48-
7.62 (3H, m), 7.69 (1H, d, J = 5Hz), 8.70 (1H, dd, J = 5, 5Hz),
9.03 (1H, s), 11.06 (1H, s)Example 161
(1) 3-ethoxymethyl-1,4-dihydro-8-nitro-4-oxoquino
Phosphorus was prepared in the same manner as in Example 124- (2), using 3-chloromethyl-1,4-diphenyl
Obtained from dro-8-nitro-4-oxoquinoline and ethanol.
mp: 175-180 ℃
NMR (DMSO-d6, Δ): 1.17 (3H, t, J = 8 Hz), 3.55 (2H, q,
J = 8Hz), 4.37 (2H, s), 7.50-7.60 (1H, m), 7.99 (1H, d, J = 6Hz),
8.57-8.69 (2H, m)
(2) Production Example 2- (4-chloro-3-ethoxymethyl-8-nitroquinoline)
Obtained in the same manner as in 1).
mp: 110-126 ℃
NMR (CDClThree, Δ): 1.30 (3H, t, J = 8Hz), 3.68 (2H, q,
J = 8Hz), 4.85 (2H, s), 7.73 (1H, t, J = 8Hz), 8.05 (1H, d,
J = 8Hz), 8.48 (1H, d, J = 8Hz), 9.13 (1H, s)
(3) Production Example 2- (8-amino-4-chloro-3-ethoxymethylquinoline)
Obtained in the same manner as in 3).
mp: 90-93 ℃
NMR (CDClThree, Δ): 1.30 (3H, t, J = 8Hz), 3.64 (2H, q,
J = 8Hz), 4.82 (2H, s), 5.05 (2H, s), 6.95 (1H, d, J = 8Hz), 7.41
(1H, t, J = 8Hz), 7.53 (1H, d, J = 8Hz), 8.78 (1H, s)
(4) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-ethoxy
Cimethylquinoline was obtained in the same manner as in Example 1.
mp: 121-123 ℃
NMR (CDClThree, Δ): 1.30 (3H, t, J = 8Hz), 3.66 (2H, d,
J = 8Hz), 4.85 (2H, s), 7.30-7.45 (3H, m), 7.71 (1H, t, J = 8Hz),
8.01 (1H, d, J = 8Hz), 8.85 (1H, s), 9.01 (1H, d, J = 8Hz)
(5) 8- (2,6-dichlorobenzoylamino) -3-ethoxymethyl-4
-(3-Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared in Example 15
Obtained in the same manner as 7.
mp: 173-177 ℃
NMR (CDClThree, Δ): 1.25 (3H, t, J = 8Hz), 2.98 (3H, s),
3.53-3.99 (6H, m), 4.57-4.80 (2H, m), 7.28-7.44 (3H, m), 7.63
(2H, d, J = 4Hz), 8.88 (1H, s), 8.96 (1H, t, J = 4Hz)Example 162
(1) 3-tert-butyldiphenylsilyloxymethyl-1,4-dihydro-
8-Nitro-4-oxoquinoline was prepared in the same manner as in Example 125- (2) by using 1,
4-dihydro-3-hydroxymethyl-8-nitro-4-oxoquinoline and chloride
Obtained from tert-butyldiphenylsilyl.
mp: 168-171 ℃
NMR (CDClThree, Δ): 1.14 (9H, s), 4.83 (2H, s), 7.32-7.47
(7H, m), 7.53-7.63 (4H, m), 8.06 (1H, d, J = 7Hz), 8.65 (1H, d,
J = 8Hz), 8.76 (1H, d, J = 7.5Hz)
(2) 3-tert-butyldiphenylsilyloxymethyl-4-chloro-8-ni
Troquinoline was obtained in the same manner as in Production Example 2- (1).
mp: 100-105 ℃
NMR (CDClThree, Δ): 1.11 (3x3H, s), 5.04 (2H, s), 7.33
7.50 (6H, m), 7.65-7.75 (5H, m), 8.05 (1H, d, J = 7.5Hz), 8.42
(1H, d, J = 7.5Hz), 9.40 (1H, s)
(3) 8-amino-3-tert-butyldiphenylsilyloxymethyl-4-c
Loloquinoline was obtained in the same manner as in Production Example 2- (3).
mp: 107-108 ℃
NMR (DMSO-d6, Δ): 1.06 (3x3H, s), 5.04 (2H, s), 6.15
(2H, s), 6.93 (1H, d, J = 8Hz), 7.23 (1H, d, J = 8Hz), 7.39-7.53
(7H, m), 7.68 (4x1H, d, J = 7.5Hz), 8.86 (1H, s)
(4) 3-tert-butyldiphenylsilyloxymethyl-4-chloro-8- (
2,6-Dichlorobenzoylamino) quinoline was obtained in the same manner as in Example 1.
mp: 123-124 ℃
NMR (DMSO-d6, Δ): 1.06 (3x3H, s), 5.10 (2H, s), 7.40-
7.62 (9H, m), 7.67 (4x1H, d, J = 7.5Hz), 7.82 (1H, dd, J = 8,
8Hz), 7.97 (1H, d, J = 8Hz), 8.82 (1H, d, J = 8Hz), 9.06 (1H, s),
10.98 (1H, s)
(5) 3-tert-butyldiphenylsilyloxymethyl-4- (imidazole
-1-yl) -8- (2,6-dichlorobenzoylamino) quinoline in Example 8
Was obtained in the same manner as described above.
NMR (CDClThree, Δ): 1.04 (9H, s), 4.61 (2H, s), 6.99 (1H,
s), 7.09 (1H, d, J = 7.5Hz), 7.27 (1H, d, J = 7.5Hz), 7.31-7.47
(9H, m), 7.50-7.65 (6H, m), 8.98-9.05 (2H, m)
(6) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
4- (Imidazol-1-yl) quinoline was prepared in the same manner as in Example 125- (8).
Obtained.
mp: 205-207 ℃
NMR (DMSO-d6, Δ): 4.44 (2H, d, J = 6 Hz), 5.59 (1H, t,
J = 6Hz), 7.07 (1H, d, J = 8Hz), 7.28 (1H, s), 7.49-7.63 (4H, m),
7.70 (1H, dd, J = 8, 8Hz), 7.97 (1H, s), 8.76 (1H, d, J = 8Hz),
9.14 (1H, s), 11.00 (1H, s)Example 163
8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-4- (
Imidazol-1-yl) quinoline (250 mg) in dichloromethane (3 ml)
Pyridine (57.4 mg) and acetic anhydride (0.12 ml) were added to the suspension.
The mixture was stirred at room temperature for 22 hours. The mixture is concentrated in vacuo and the residual
Was dissolved in ethyl acetate. After washing the mixture with water and drying over magnesium sulfate,
The solvent was removed in vacuo. The residue was subjected to silica gel flash chromatography (
Purified with methanol-dichloromethane) to give 3-acetoxymethyl-8- (2,
6-dichlorobenzoylamino) -4- (imidazol-1-yl) quinoline (
270 mg).
NMR (CDClThree, Δ): 2.07 (3H, s), 5.00 (1H, d, J = 13.5Hz),
5.13 (1H, d, J = 13.5Hz), 7.16-7.23 (2H, m), 7.34-7.45 (2H, m),
7.67 (1H, t, J = 8.0Hz), 7.74 (1H, s), 8.95 (1H, s), 9.06 (1H,
d, J = 8.0Hz)Example 164
(1) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
4- (Imidazol-1-yl) quinoline (800 mg) in dichloromethane (1
Pyridine (230 mg) and phenyl chloroformate (333).
mg) was added dropwise at room temperature and the mixture was stirred at room temperature for 1 hour. The mixture is saturated with
Washed with sodium hydroxide solution, saturated sodium bicarbonate solution and brine,
After drying with, the solvent was distilled off in vacuo. The residue is purified by silica gel column chromatography.
(Ethyl acetate-n-hexane) to give 8- (2,6-dichlorobenzo).
Ylamino) -4- (imidazol-1-yl) -3- (phenoxycarbonyl
(Oxymethyl) quinoline (100 mg) was obtained.
NMR (CDClThree, Δ): 5.23 (2H, d, J = 7.0Hz), 7.12-7.45
(11H, m), 7.67 (1H, t, J = 7.5Hz), 7.75 (1H, s), 9.03-9.10 (2H,
m)
(2) 8- (2,6-dichlorobenzoylamino) -3- (phenoxycarbo
Nyloxymethyl) -4- (imidazol-1-yl) quinoline (100 mg)
Of methanol in methanol (4 ml) was added to a solution of 2M methylamine in methanol (4 ml).
l) was added dropwise under ice cooling, and the mixture was stirred at room temperature for 1 hour. Concentrate the mixture in vacuo
And the residue is crystallized from ethanol to give 8- (2,6-dichlorobenzoyl alcohol).
Mino) -4- (imidazol-1-yl) -3- (methylcarbamoyloxime
Cyl) quinoline (50 mg) was obtained.
mp: 240-242 ℃
NMR (CDClThree, Δ): 2.80 (3H, d, J = 6.0Hz), 4.70 (1H, br),
4.99 (1H, d, J = 8.0Hz), 5.15 (1H, d, J = 8.0Hz), 7.16 (1H, d, J = 8.0Hz)
J = 8.0Hz), 7.23 (1H, s), 7.34-7.45 (4H, m), 7.65 (1H, t,
J = 8.0Hz), 7.73 (1H, s), 9.00 (1H, s), 9.05 (1H, d, J = 8.0Hz)Example 165
(1) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
4- (Imidazol-1-yl) quinoline (300 mg) in dichloromethane (5
ml), triethylamine (294 mg) and phenyl chloroformate (
(375 mg) was added dropwise under ice cooling, and the mixture was stirred at room temperature for 2.5 hours. To the mixture
Further phenyl chloroformate (250 mg) was added and the mixture was stirred at room temperature for 1.5 hours.
Stirred. The insoluble material was removed by filtration, and the filtrate was concentrated in vacuo. Residue in dichloromethane
Dissolve and add phenyl chloroformate (375 mg) and diisopropylethylamine.
(0.506 ml) was added. The solvent is distilled off from the mixture in vacuo and the residue is
Purified by Ricagel flash chromatography (ethyl acetate-n-hexane)
To give 8- [N- (2,6-dichlorobenzoyl) -N-phenoxycarbonyla
Mino] -4- [2- (phenoxycarbonyl) imidazol-1-yl] -3-
(Phenoxycarbonyloxymethyl) quinoline (250 mg) was obtained.
NMR (CDClThree, Δ): 5.22 (2H, d, J = 8.5 Hz), 6.86 (2H, d,
J = 7.5Hz), 6.93 (2H, t, J = 7.0Hz), 7.02-7.45 (14H, m), 7.65-7.75
(3H, m), 8.03-8.06 (1H, m), 9.02 (1H, s), 9.27 (1H, s)
(2) 8- [N- (2,6-dichlorobenzoyl) -N-phenoxycarbonyl
Ruamino] -4- [2- (phenoxycarbonyl) imidazol-1-yl]-
Methanol of 3- (phenoxycarbonyloxymethyl) quinoline (250 mg)
To a solution in toluene (4 ml) was added a 50% aqueous solution of dimethylamine (8 ml).
The mixture was stirred at room temperature for 66 hours. The mixture is concentrated in vacuo and the residue is separated.
Purification by chromatography (ethyl acetate) yielded 8- (2,6-dichlorobenzoic acid).
Ruamino) -4- [2- (dimethylcarbamoyl) imidazol-1-yl]-
3- (Dimethylcarbamoyloxymethyl) quinoline (25 mg) was obtained.
NMR (CDClThree, Δ): 2.87 (9H, s), 3.54 (3H, s), 5.07 (1H,
d, J = 14.0Hz), 5.16 (1H, d, J = 14.0Hz), 6.82 (1H, d, J = 8.0Hz),
7.16 (1H, s), 7.32-7.43 (4H, m), 7.57 (1H, t, J = 8.0Hz), 8.96
(1H, s), 8.99 (1H, d, J = 8.0Hz), 10.02 (1H, s)Example 166
(1) 3-Isopropoxymethyl-1,4-dihydro-8-nitro-4-oxo
Soquinoline was prepared in the same manner as in Example 124- (2), using 3-chloromethyl-1,4.
-Dihydro-8-nitro-4-oxoquinoline and isopropyl alcohol
Was.
mp: 167-170.5 ℃
NMR (CDClThree, Δ): 1.26 (2x3H, d, J = 7Hz), 3.79 (1H, qq,
J = 7, 7 Hz), 4.55 (2H, s), 7.43 (1H, dd, J = 8, 8 Hz), 7.95 (1H, d,
J = 6Hz), 8.67 (1H, d, J = 8Hz), 8.82 (1H, d, J = 8Hz)
(2) Production example of 4-chloro-3-isopropoxymethyl-8-nitroquinoline
Obtained in the same manner as in 2- (1).
mp: 83-86 ℃
NMR (CDClThree, Δ): 1.27 (2x3H, d, J = 7Hz), 3.79 (1H, qq,
J = 7, 7 Hz), 4.83 (2H, s), 7.71 (1H, dd, J = 8, 8 Hz), 8.04 (1H, d,
J = 8Hz), 8.47 (1H, d, J = 8Hz), 9.15 (1H, s)
(3) Production example of 8-amino-4-chloro-3-isopropoxymethylquinoline
Obtained in the same manner as in 2- (3).
mp: 94-95 ℃
NMR (CDClThree, Δ): 1.27 (2x3H, d, J = 7Hz), 3.77 (1H, qq,
J = 7, 7Hz), 4.80 (2H, s), 5.02 (2H, br), 6.93 (1H, d, J = 8Hz),
7.40 (1H, dd, J = 8, 8Hz), 7.52 (1H, d, J = 8Hz), 8.80 (1H, s)
(4) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-isoprop
Loxymethylquinoline was obtained in the same manner as in Example 1.
mp: 117-118 ℃
NMR (CDClThree, Δ): 1.27 (2x3H, d, J = 7Hz), 3.78 (1H, qq,
J = 7, 7Hz), 4.82 (2H, s), 7.30-7.43 (3H, m), 7.70 (1H, dd, J = 8,
8Hz), 7.98 (1H, d, J = 8Hz), 8.86 (1H, s), 8.98 (1H, d, J = 8Hz),
10.03 (1H, br s)
(5) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-isopropoxymethylquinoline was obtained in the same manner as in Example 8.
NMR (DMSO-d6, Δ): 1.05 (2x3H, d, J = 7Hz), 3.54 (1H,
qq, J = 7, 7Hz), 4.40 (2H, s), 7.07 (1H, d, J = 8Hz), 7.28 (1H,
s), 7.48-7.63 (4H, m), 7.72 (1H, dd, J = 8, 8Hz), 7.97 (1H, s),
8.77 (1H, d, J = 8Hz), 9.10 (1H, s), 10.98 (1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -3-isopropoxymethi
4- (pyrazol-1-yl) quinoline was prepared in the same manner as in Example 8,
Rollo-8- (2,6-dichlorobenzoylamino) -3-isopropoxymethyl
Obtained from quinoline and pyrazole.
mp: 153-154 ℃
NMR (DMSO-d6, Δ): 1.03 (2x3H, d, J = 7Hz), 3.54 (1H,
qq, J = 7, 7Hz), 4.43 (2H, s), 6.70 (1H, dd, J = 1.5, 1Hz), 7.15
(1H, d, J = 8Hz), 7.49-7.62 (3H, m), 7.70 (1H, dd, J = 8, 8Hz),
7.95 (1H, d, J = 1 Hz), 8.20 (1H, d, J = 1.5 Hz), 8.75 (1H, d, J = 1 Hz)
J = 8Hz), 9.09 (1H, s), 10.46 (1H, s)Example 167
2-methoxyethanol (130 mg) in N-methylpyrrolidone (2 ml)
Potassium tert-butoxide (172 mg) was added to the stirred solution of
The material was stirred at room temperature for 30 minutes. Add 4-chloro-8- (2,6-dichlorobe
(Nzoylamino) quinoline (200 mg) was added and the mixture was stirred at 80 ° C. for 5 hours
did. Dilute the mixture with ethyl acetate, wash with water and brine, and add magnesium sulfate.
After drying, the solvent was distilled off in vacuo. The residue was recrystallized from ethanol to give 8- (
2,6-dichlorobenzoylamino) -4- (2-methoxyethoxy) quinoline
(175 mg) was obtained.
mp: 150-152 ℃
NMR (CDClThree, Δ): 3.50 (3H, s), 3.87-3.96 (2H, m),
4.30-4.40 (2H, m), 6.78 (1H, d, J = 6Hz), 7.28-7.43 (3H, m),
7.56 (1H, t, J = 8Hz), 7.98 (1H, d, J = 8Hz), 8.59 (1H, d, J = 6Hz),
8.94 (1H, d, J = 8Hz)Example 168
The following compound was obtained in the same manner as in Example 167.
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-methoxyethoxy
Xy) -3-methylquinoline
(4-chloro-8- (2,6-dichlorobenzoylamino) -3-methylquino
From phosphorus and 2-methoxyethanol)
mp: 118-119 ℃
NMR (CDClThree, Δ): 2.48 (3H, s), 3.51 (3H, s), 3.80-3.83
(2H, m), 4.23-4.27 (2H, m), 7.30-7.43 (3H, m), 7.60 (1H, t,
J = 8.0Hz), 7.91 (1H, d, J = 8.0Hz), 8.58 (1H, s), 8.89 (1H, d,
(J = 8.0Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-isopropoxymethyl
Ru-4- (2-methoxyethoxy) quinoline
(4-chloro-8- (2,6-dichlorobenzoylamino) -3-isopropo
From xymethylquinoline and 2-methoxyethanol)
mp: 86-87 ℃
NMR (DMSO-d6, Δ): 1.17 (2x3H, d, J = 7Hz), 3.36 (3H,
s), 3.66-3.80 (3H, m), 4.31-4.38 (2H, m), 4.71 (2H, s), 7.48-
7.62 (3H, m), 7.67 (1H, dd, J = 8, 8Hz), 7.97 (1H, d, J = 8Hz),
8.70 (1H, d, J = 8Hz), 8.83 (1H, s), 10.74 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- (2-furylmethoxy)
Shi) Quinoline
(4-chloro-8- (2,6-dichlorobenzoylamino) quinoline and 2-phenyl
From rilmethanol)
mp: 145-149 ℃
NMR (CDClThree, Δ): 5.25 (2H, s), 6.40-6.45 (1H, m), 6.55
(1H, d, J = 4Hz), 6.94 (1H, d, J = 5Hz), 7.30-7.43 (3H, m), 7.50
(1H, d, J = 4Hz), 7.55 (1H, t, J = 8Hz), 7.95 (1H, d, J = 8Hz), 8.61
(1H, d, J = 5Hz), 8.95 (1H, d, J = 8Hz)Example 169
4-chloro-8- (2,6-dichlorobenzoylamino) -3-hydroxy
To a solution of tilquinoline (297 mg) in N-methylpyrrolidone (4 ml) was added
Drazine-hydrate (390 mg) was added and the mixture was stirred at 90 C for 3 hours. Mixed
The mixture was diluted with ethyl acetate, washed with water and brine, dried over magnesium sulfate,
The solvent was removed in vacuo. The residue was purified by silica gel flash chromatography.
Purification by preparative thin-layer chromatography yielded 8- (2,6-dichlorobenzoyl)
Mino) -4-hydrazino-3-hydroxymethylquinoline (127 mg) and 6-
(2,6-dichlorobenzoylamino) -1H-pyrazolo [4,3-c] quinoli
(90 mg).
8- (2,6-dichlorobenzoylamino) -4-hydrazino-3-hydroxy
Cimethylquinoline
NMR (DMSO-d6, Δ): 4.70 (2H, d, J = 6Hz), 5.19 (2H, s),
5.35 (1H, t, J = 6Hz), 7.39 (1H, dd, J = 8, 8Hz), 7.49-7.63 (3H,
m), 8.15 (1H, d, J = 8 Hz), 8.28 (1H, s), 8.40 (1H, s), 8.56 (1H,
d, J = 8Hz), 10.46 (1H, s)
6- (2,6-dichlorobenzoylamino) -1H-pyrazolo [4,3-c]
Quinoline
NMR (DMSO-d6, Δ): 7.49-7.63 (3H, m), 7.77 (1H, dd,
J = 8,8Hz), 8.20 (1H, d, J = 8Hz), 8.46 (1H, brs), 8.78 (1H, d,
J = 8Hz), 9.25 (1H, s), 10.76 (1H, s)Example 170
4-chloro-8- (2,6-dichlorobenzoylamino) -3-cyanoquinoli
To a solution of pyridine (300 mg) in N-methylvirolidone (6 ml) was added hydrazine-
Hydrate (399 mg) was added dropwise and the mixture was stirred at 90 ° C. for 2 hours. And water (
15 ml) was added and the resulting precipitate was collected by filtration to give 3-amino-6- (2,
6-dichlorobenzoylamino) -1H-pyrazolo [4,3-c] quinoline (2
60 mg).
mp:> 300 ℃
NMR (DMSO-d6, Δ): 5.93 (2H, br s), 7.50-7.61 (3H, m),
7.64 (1H, t, J = 8.0Hz), 8.02 (1H, d, J = 8.0Hz), 8.70 (1H, d,
J = 8.0Hz), 9.09 (1H, s)Example 171
3-amino-6- (2,6-dichlorobenzoylamino) -1H-pyrazolo [
4,3-c] quinoline (200 mg) in 1,2-dichloroethane (2 ml)
Acetic anhydride (302 mg) was added to the suspension and the reaction mixture was refluxed for 12 hours. Dissolution
The solution was allowed to cool to room temperature and the solvent was removed in vacuo. Residue is pulverized with water-ethanol
Crushed and the precipitate was collected. The crude product is subjected to silica gel column chromatography (vinegar
(Ethyl acetate-n-hexane) to give 2-acetyl-6- (2,6-dichloro
Benzoylamino) -2,3-dihydro-3-imino-1H-pyrazolo [4,3
-C] quinoline as yellow crystals (60 mg) and further 3-acetamido-6-
(2,6-dichlorobenzoylamino) -1H-pyrazolo [4,3-c] quinoli
Was obtained as white crystals (30 mg).
2-acetyl-6- (2,6-dichlorobenzoylamino) -2,3-dihydrido
B-3-Imino-1H-pyrazolo [4,3-c] quinoline
mp:> 300 ℃
NMR (DMSO-d6, Δ): 2.76 (3H, s), 7.47-7.60 (4H, m),
7.96 (1H, d, J = 8.0Hz), 8.46 (1H, br), 8.68 (1H, d, J = 8.0Hz),
9.05 (1H, s)
3-acetamido-6- (2,6-dichlorobenzoylamino) -1H-pyra
Zoro [4,3-c] quinoline
mp:> 300 ℃
NMR (DMSO-d6, Δ): 2.16 (3H, s), 7.48-7.61 (3H, m),
7.74 (1H, t, J = 8.0Hz), 8.14 (1H, d, J = 8.0Hz), 8.75 (1H, d, J = 8.0Hz)
J = 8.0Hz), 9.42 (1H, s), 10.77 (1H, s), 10.98 (1H, br)Example 172
(1) Ethanol (20 m) of 5-methyl-2-nitroaniline (10.0 g)
1), add 2,2-dimethyl-1,3-dioxane-4,6-dioxane to the stirred suspension in
(9.59 g) and triethyl orthoformate (10.7 g) were added at 50 ° C. Raw
The mixture was heated at 120 ° C for 1 hour while ethanol (20 ml) was mixed.
Then, the released ethanol was distilled off. After cooling, add ethyl acetate (40m
l) was added and the resulting precipitate was collected by filtration. The solid is heated in hot ethanol (40m
Washed in l) and allowed to cool to room temperature. The precipitate was collected by filtration, air dried,
(5-methyl-2-nitroanilino) isopropylidene methylenemalonate (15
. 2g) were obtained as yellow needles.
mp: 218-220 ℃
NMR (CDClThree, Δ): 1.77 (6H, s), 2.50 (3H, s), 7.16 (1H,
d, J = 8Hz), 7.40 (1H, brs), 8.20 (1H, d, J = 8Hz), 8.73 (1H, d,
(J = 15Hz)
(2) To a stirred mixture of diphenyl ether (37 g) and biphenyl (13 g)
Isopropylidene (5-methyl-2-nitroanilino) methylenemalonate (1
4.6 g) were added at 220 ° C. and the mixture was heated at the same temperature for half an hour. 1 reaction mixture
After cooling to 00 ° C., n-hexane (100 ml) was added dropwise to the mixture. Room
After cooling to warm, the precipitate was collected by filtration. Hot solid (70ml)
And cooled to room temperature. The solid was collected by filtration, air dried, and 1,
4-Dihydro-5-methyl-8-nitro-4-oxoquinoline (8.8 g) was darkened.
Obtained as a brown solid.
mp: 219-225 ℃
NMR (DMSO-d6, Δ): 2.87 (3H, s), 6.15 (1H, d, J = 8Hz),
7.20 (1H, d, J = 8Hz), 7.86 (1H, d, J = 8Hz), 8.45 (1H, d, J = 8Hz)
(3) 1,4-dihydro-5-methyl-8-nitro-4-oxoquinoline (1
. 5 g) and 1,3,5-trioxane (3.31 g) in dioxane (15 ml)
During ~
Concentrated hydrochloric acid (30 ml) was added to the stirred mixture, and the mixture was stirred at 100 ° C. overnight.
. The mixture was evaporated in vacuo and the residue treated with acetonitrile to give 1,1
4-dihydro-3-hydroxymethyl-5-methyl-8-nitro-4-oxo
Norin (1.3 g) was obtained.
mp: 251-255 ℃
NMR (DMSO-d6, Δ): 4.37 (2H, s), 7.20 (1H, d, J = 8Hz),
7.93 (1H, d, J = 6Hz), 8.47 (1H, d, J = 8Hz)
(4) 1,4-dihydro-3-hydroxymethyl-5-methyl-8-nitro-
To a suspension of 4-oxoquinoline (1.12 g) in dichloromethane (10 ml)
A solution of thionyl chloride (569 mg) in dichloromethane (5 ml) under ice-cooling
The mixture was added dropwise, and the mixture was stirred at the same temperature for 1 hour and at room temperature for 2 hours. Concentrate the mixture in vacuo
And suspended in dichloromethane-methanol and refluxed for 2 hours. Mixture in vacuum
And the residue was recrystallized from methanol to give 1,4-dihydro-3-
Methoxymethyl-5-methyl-8-nitro-4-oxoquinoline (889 mg)
I got
mp: 210-213 ℃
NMR (CDClThree, Δ): 3.05 (3H, s), 3.50 (3H, s), 4.45 (2H,
s), 7.14 (1H, d, J = 8Hz), 7.77 (1H, d, J = 6Hz), 8.48 (1H, d,
(J = 8Hz)
(5) 4-chloro-3-methoxymethyl-5-methyl-8-nitroquinoline
Obtained in the same manner as in Production Example 2- (1).
mp: 120-124 ℃
NMR (CDClThree, Δ): 3.10 (3H, s), 3.53 (3H, s), 4.76 (2H,
s), 7.43 (1H, d, J = 8Hz), 7.80 (1H, d, J = 8Hz) 9.01 (1H, s)
(6) 8-amino-4-chloro-3-methoxymethyl-5-methylquinoline
Obtained in the same manner as in Production Example 2- (3).
NMR (CDClThree, Δ): 2.90 (3H, s), 3.50 (3H, s), 4.75 (2H,
s), 4.92 (2H, br s), 6.82 (1H, d, J = 8Hz), 7.16 (1H, d, J = 8Hz),
8.71 (1H, s)
(7) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-methoxy
Cimethyl-5-methylquinoline was obtained in the same manner as in Example 1.
mp: 180 ℃
NMR (CDClThree, Δ): 3.01 (3H, s), 3.52 (3H, s), 4.75 (2H,
s), 7.28-7.48 (4H, m), 8.75 (1H, s), 8.82 (1H, d, J = 8Hz)
(8) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-methoxymethyl-5-methylquinoline was obtained analogously to Example 8.
Was.
mp: 179-180 ℃
NMR (CDClThree, Δ): 1.99 (3H, s), 3.31 (3H, s), 4.15 (2H,
s), 7.10 (1H, br s), 7.31-7.48 (5H, m), 7.61 (1H, br s), 8.88
(1H, d, J = 8Hz), 8.90 (1H, s)
Its hydrochloride
mp: 207-214 ℃
NMR (DMSO-d6, Δ): 1.94 (3H, s), 3.20 (3H, s), 4.30
(2H, s), 7.48-7.63 (4H, m), 7.94 (1H, br s), 8.06 (1H, br s),
8.70 (1H, d, J = 8Hz), 9.10 (1H, s), 9.31 (1H, br s)Example 173
(1) 4-chloro-5-methyl-8-nitroquinoline was prepared according to Production Example 2- (1).
Similarly, 1,4-dihydro-5-methyl-8-nitro-4-oxoquinoline
Obtained from.
mp: 125-130 ℃
NMR (CDClThree, Δ): 3.10 (3H, s), 7.44 (1H, d, J = 8Hz),
7.60 (1H, d, J = 6Hz), 7.84 (1H, d, J = 8Hz), 8.80 (1H, d, J = 6Hz)
(2) 8-amino-4-chloro-5-methylquinoline was prepared in the same manner as in Production Example 2- (3).
Obtained in a similar manner.
mp: 104-107 ℃
NMR (CDClThree, Δ): 2.90 (3H, s) 6.87 (1H, d, J = 8Hz),
7.18 (1H, d, J = 8Hz), 7.46 (1H, d, J = 5Hz), 8.54 (1H, d, J = 5Hz)
(3) 4-chloro-8- (2,6-dichlorobenzoylamino) -5-methyl
Quinoline was obtained in the same manner as in Example 1.
mp: 258-260 ℃
NMR (DMSO-d6, Δ): 2.98 (3H, s), 7.47-7.63 (4H, m),
7.80 (1H, d, J = 5Hz), 8.66 (1H, d, J = 8Hz), 8.74 (1H, d, J = 5Hz)
(4) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -5-methylquinoline was obtained in the same manner as in Example 8.
mp: 236 ℃
NMR (DMSO-d6, Δ): 1.96 (3H, s), 7.19 (1H, s), 7.47-
7.65 (6H, m), 7.98 (1H, s), 8.68 (1H, d, J = 8Hz), 8.97 (1H, d,
(J = 6Hz)
Its hydrochloride
mp: 220-223 ℃
NMR (DMSO-d6, Δ): 1.98 (3H, s), 7.48-7.65 (4H, m),
7.87 (1H, d, J = 4 Hz), 7.95 (1H, br s), 8.13 (1H, br s), 8.73
(1H, d, J = 8Hz), 9.09 (1H, d, J = 4Hz), 9.46 (1H, br s)
(5) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-5-me
Tylquinoline was converted to 4-chloro-8- (2,6-dichloro
(Benzoylamino) -5-methylquinoline and hydrazine monohydrate.
mp: 225-237 ° C
NMR (DMSO-d6, Δ): 2.84 (3H, s), 4.40 (2H, br s),
7.10-7.21 (2H, m), 7.46-7.65 (4H, m), 8.34 (1H, d, J = 6Hz),
8.45 (1H, d, J = 8Hz)
(6) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -5-methylquinoline was obtained as in Example 86.
mp: 230-234 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 2.90 (3H, s), 6.80
(1H, d, J = 6Hz), 7.27 (1H, d, J = 8Hz), 7.48-7.62 (3H, m), 8.11
(1H, br s), 8.40 (1H, d, J = 6Hz), 8.51 (1H, d, J = 8Hz)
Example 174
(1) (4-methyl-2-nitroanilino) methylenemalonic acid isopropylide
And 4-methyl-2-nitroaniline in the same manner as in Example 172- (1).
Obtained from isopropylidene malonate.
mp: 193-195 ℃
NMR (DMSO-d6, Δ): 1.68 (2x3H, s), 2.40 (3H, s), 7.67
(1H, dd, J = 8, 1Hz), 7.97 (1H, d, J = 8Hz), 8.08 (1H, d, J = 1Hz),
8.73 (1H, d, J = 14Hz)
(2) 1,4-dihydro-6-methyl-8-nitro-4-oxoquinoline
Obtained in the same manner as in Example 172- (2).
mp: 209-212 ℃
NMR (CDClThree, Δ): 2.54 (3H, s), 6.40 (1H, d, J = 7.5Hz),
7.73 (1H, dd, J = 7.5, 7Hz), 8.50 (1H, s), 8.60 (1H, s), 11.09
(1H, br)
(3) 1,4-dihydro-3-hydroxymethyl-6-methyl-8-nitro-
4-oxoquinoline was obtained in the same manner as in Example 172- (3).
mp:> 240 ℃
NMR (CDClThree, Δ): 2.57 (3H, s), 3.21 (1H, t, J = 7Hz),
4.67 (2H, d, J = 7Hz), 7.78 (1H, d, J = 7Hz), 8.52 (1H, d, J = 1Hz),
8.61 (1H, d, J = 1Hz)
(4) 1,4-dihydro-3-methoxymethyl-6-methyl-8-nitro-4
-Oxoquinoline was obtained in the same manner as in Example 172- (4).
mp:> 240 ℃
NMR (CDClThree, Δ): 2.54 (3H, s), 3.50 (3H, s), 4.49 (2H,
s), 7.85 (1H, d, J = 7 Hz), 8.50 (1H, d, J = 1 Hz), 8.62 (1H, d,
J = 1Hz)
(5) 4-chloro-3-methoxymethyl-6-methyl-8-nitroquinoline
Obtained in the same manner as in Production Example 2- (1).
mp: 107-111 ℃
NMR (CDClThree, Δ): 2.65 (3H, s), 3.51 (3H, s), 4.78 (2H,
s), 7.90 (1H, d, J = 1 Hz), 8.24 (1H, d, J = 1 Hz), 9.02 (1H, s)
(6) 8-amino-4-chloro-3-methoxymethyl-6-methylquinoline
Obtained in the same manner as in Production Example 2- (3).
mp: 135-138 ℃
NMR (CDClThree, δ): 2.40 (3H, s), 3.39 (3H, s), 4.70 (2H, s)
s), 6.06 (2H, s), 6.78 (1H, s), 7.08 (1H, s), 8.63 (1H, s)
(7) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-methoxy
Cimethyl-6-methylquinoline was obtained in the same manner as in Example 1.
mp: 156-158 ℃
NMR (CDClThree, Δ): 2.61 (3H, s), 3.40 (3H, s), 4.75 (2H,
s), 7.48-7.60 (3H, m), 7.80 (1H, s), 8.68 (1H, s), 8.83 (1H,
s), 10.86 (1H, s)
(8) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3-methoxymethyl-6-methylquinoline was obtained analogously to Example 8.
Was.
mp: 99-101 ℃
NMR (DMSO-d6, Δ): 2.50 (3H, s), 3.24 (3H, s), 4.33
(2H, s), 6.85 (1H, s), 7.28 (1H, s), 7.48-7.63 (4H, m), 7.95
(1H, s), 8.67 (1H, s), 9.00 (1H, s), 10.93 (1H, s)
(9) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-6
-Methyl-4-[(2-methylaminoethyl) amino] quinoline was prepared as in Example 8.
Similarly, 4-chloro-8- (2,6-dichlorobenzoylamino) -3-me
Obtained from toxicmethyl-6-methylquinoline and N-methylethylenediamine.
NMR (CDClThree, Δ): 2.50 (3H, s), 2.57 (3H, s), 2.88 (2H,
t, J = 5Hz), 3.37 (3H, s), 3.73 (2H, dt, J = 5, 5Hz), 4.59 (2H,
s), 5.92 (1H, t, J = 5Hz), 7.27-7.42 (3H, m), 7.57 (1H, s), 8.24
(1H, s), 8.75 (1H, s)
(10) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-
6-methyl-4- (3-methyl-2-oxoimidazolidin-1-yl) quinoli
Was obtained in the same manner as in Example 92- (2).
mp: 221-223 ℃
NMR (DMSO-d6, Δ): 2.57 (3H, s), 2.83 (3H, s), 3.32
(3H, s), 3.56-3.73 (3H, m), 3.88 (1H, m), 4.54 (1H, d,
J = 13Hz), 4.57 (1H, d, J = 13Hz), 7.47-7.61 (4H, m), 8.61 (1H,
s), 8.86 (1H, s), 10.79 (1H, s)
(11) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-
6-methyl-4- (3-methyl-2-thioxoimidazolidin-1-yl) quino
Phosphorus was converted into 8- (2,6-dichlorobenzoyl) in the same manner as in Example 9- (2).
Amino) -3-methoxymethyl-6-methyl-4-[(2-methylaminoethyl
) Amino] quinoline and 1,1'-thiocarbonyldiimidazole.
mp: 194-196 ℃
NMR (DMSO-d6, Δ): 2.57 (3H, s), 3.17 (3H, s), 3.35
(3H, s), 3.80-4.10 (4H, m), 4.54 (1H, d, J = 12Hz), 4.61 (1H, d,
J = 12Hz), 7.40 (1H, s), 7.48-7.62 (3H, m), 8.62 (1H, s), 8.91
(1H, s), 10.83 (1H, s)Example 175
The following compound was obtained in the same manner as in Example 1.
(1) 3-bromo-8- (2-chlorobenzoylamino) quinoline
mp: 193-195 ℃
NMR (CDClThree, Δ): 7.36-7.54 (4H, m), 7.63 (1H, d,
J = 8Hz), 7.81 (1H, dd, J = 8, 2Hz), 8.34 (1H, d, J = 2Hz), 8.80
(1H, s), 8.97 (1H, d, J = 8Hz)
(2) 3-bromo-8- (3-chlorobenzoylamino) quinoline
mp: 189 ℃
NMR (CDClThree, Δ): 7.43-7.68 (4H, m), 7.86-7.95 (1H, m),
8.03 (1H, brs), 8.35 (1H, d, J = 2Hz), 8.85 (1H, d, J = 2Hz),
8.91 (1H, d, J = 8Hz)
(3) 3-bromo-8- (4-chlorobenzoylamino) quinoline
mp: 204 ℃
NMR (CDClThree, Δ): 7.44-7.57 (3H, m), 7.63 (1H, t,
J = 8Hz), 7.96-8.03 (2H, d, J = 9Hz), 8.34 (1H, d, J = 1Hz), 8.84
(1H, d, J = 2Hz), 8.92 (1H, d, J = 8Hz)
(4) 3-bromo-8- (2-methylbenzoylamino) quinoline
mp: 163-165 ℃
NMR (CDClThree, Δ): 2.58 (3H, s), 7.26-7.49 (4H, m),
7.55-7.70 (2H, m), 8.30 (1H, d, J = 2Hz), 8.74 (1H, d, J = 2Hz),
8.94 (1H, d, J = 8Hz)
(5) 3-bromo-8- (3-methylbenzoylamino) quinoline
mp: 160-163 ℃
NMR (CDClThree, Δ): 2.48 (3H, s), 7.35 to 7.50 (3H, m), 7.60
(1H, t, J = 8Hz), 7.80-7.90 (2H, m), 8.34 (1H, d, J = 2Hz), 8.83
(1H, d, J = 1Hz), 8.94 (1H, d, J = 8Hz)
(6) 3-bromo-8- (4-methylbenzoylamino) quinoline
mp: 142 ℃
NMR (CDClThree, Δ): 2.44 (3H, s), 7.35 (2H, d, J = 9Hz),
7.45 (1H, d, J = 8Hz), 7.61 (1H, d, J = 8Hz), 7.95 (2H, d, J = 9Hz),
8.33 (1H, d, J = 1 Hz), 8.83 (1H, d, J = 1 Hz), 8.94 (1H, d, J = 8 Hz)
(7) 3-bromo-8- (2-methoxybenzoylamino) quinoline
mp: 192-194 ℃
NMR (CDClThree, Δ): 4.20 (3H, s), 7.09 (1H, d, J = 8Hz),
7.15 (1H, t, J = 8Hz), 7.44 (1H, d, J = 8Hz), 7.54 (1H, t, J = 8Hz),
7.62 (1H, t, J = 8Hz), 8.30-8.39 (2H, m), 8.87 (1H, d, J = 2Hz),
9.05 (1H, d, J = 8Hz)
(8) 3-bromo-8- (3-methoxybenzoylamino) quinoline
mp: 171 ℃
NMR (CDClThree, Δ): 3.91 (3H, s), 7.11 (1H, dd, J = 8,
2Hz), 7.40-7.50 (2H, m), 7.57-7.67 (3H, m), 8.35 (1H, d,
J = 2Hz), 8.83 (1H, s), 8.95 (1H, d, J = 8Hz)
(9) 3-bromo-8- (4-methoxybenzoylamino) quinoline
mp: 158 ℃
NMR (CDClThree, Δ): 3.89 (3H, s), 7.03 (2H, d, J = 9Hz),
7.44 (1H, d, J = 8Hz), 7.60 (1H, t, J = 8Hz), 8.03 (2H, d, J = 9Hz),
8.33 (1H, d, J = 2Hz), 8.83 (1H, d, J = 2Hz), 8.94 (1H, d, J = 8Hz)Example 176
8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline (20
0 mg) in formic acid (4 ml), add formamide (26 mg) and mix
The material was stirred at room temperature for 3 hours. The solvent was removed azeotropically with toluene. Residue
Diluted with ethyl acetate, washed with water and saturated aqueous sodium bicarbonate,
After drying over sodium, it was concentrated in vacuo. The residual solid is treated with hot ethanol (2 ml).
And cooled to room temperature, filtered, washed with ethanol and treated with 8- (2,6-dichloromethane).
Lorobenzoylamino) -4- (2-formylhydrazino) quinoline (180 m
g) was obtained as pale yellow crystals.
mp: 261-263 ℃
NMR (DMSO-d6, Δ): 6.70 (1H, d, J = 5.5Hz), 7.50-7.62
(4H, m), 8.00 (1H, d, J = 8.0Hz), 8.26 (1H, s), 8.45 (1H, d,
J = 5.5Hz), 8.68 (1H, d, J = 8.0Hz), 9.34 (1H, br), 10.18 (1H,
br), 10.52 (1H, s)Example 177
8- (2,6-dichlorobenzoylamino) -4- (2-formyl-2-methyl
Ruhydrazino) quinoline was prepared in the same manner as in Example 176 by using 8- (2,6-dichloromethane).
Robenzoylamino) -4- (2-methylhydrazino) quinoline.
mp: 250-262 ℃
NMR (DMSO-d6, Δ): 3.17 (3Hx1 / 5, d, J = 6Hz), 3.26
(3Hx4 / 5, d, J = 6Hz), 7.12 (1Hx4 / 5, d, J = 6Hz), 7.26 (1Hx1 / 5, d,
J = 6Hz), 7.47-7.67 (4H, m), 7.88-8.01 (9 / 5H, m), 8.37 (1Hx1 / 5,
d, J = 8Hz), 8.61-8.76 (2H, m), 10.25 (1H x 1/5, d, J = 8Hz), 10.57-
10.72 (9 / 5H, m)Example 178
The following compound was obtained in the same manner as in Example 145.
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-trifluoro
Acetylhydrazino) quinoline
mp: 299-302 ℃
NMR (DMSO-d6, Δ): 6.68 (1H, brs), 7.50-7.63 (4H, m),
7.97 (1H, br), 8.51 (1H, brs), 8.70 (1H, br), 9.68 (1H, br)
s), 10.56 (1H, s), 11.86 (1H, br s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (2-crotonoyl
-2-Methylhydrazino) quinoline
mp: 244-249 ° C (decomposition)
NMR (DMSO-d6, Δ): 1.80 (3H, d, J = 7Hz), 3.24 (3H, s),
5.87 (1H, d, J = 15 Hz), 6.66 (1H, dq, J = 15, 7 Hz), 7.06 (1H, d,
J = 6Hz), 7.43-7.63 (4H, m), 7.96 (1H, d, J = 8Hz), 8.60 (1H, d,
J = 6Hz), 8.62 (1H, d, J = 8Hz), 10.60 (1H, s)Example 179
The following compound was obtained in the same manner as in Example 150.
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-acryloyl
Hydrazino) quinoline
mp: 232-235 ℃
NMR (DMSO-d6, Δ): 5.81 (1H, dd, J = 9.0, 1.5Hz), 6.27
(1H, dd, J = 15.5, 1.5Hz), 6.42 (1H, dd, J = 15.5, 9.0Hz), 6.61
(1H, d, J = 7.0Hz), 7.50-7.60 (4H, m), 8.01 (1H, d, J = 8.0Hz),
8.45 (1H, d, J = 7.0Hz), 8.68 (1H, d, J = 8.0Hz), 9.43 (1H, brs),
10.48 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-thienyl
Ruacetyl) hydrazino] quinoline
mp: 140-142 ℃
NMR (DMSO-d6, Δ): 3.86 (2H, s), 6.62 (1H, d,
J = 5.5Hz), 6.99-7.03 (2H, m), 7.41 (1H, d, J = 5.0Hz), 7.50-7.61
(4H, m), 7.99 (1H, d, J = 8.0Hz), 8.41 (1H, d, J = 5.0Hz), 8.66
(1H, d, J = 8.0Hz), 9.40 (1H, s), 10.33 (1H, s), 10.52 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- (4,4-dimethyl
Semicarbazide) quinoline
mp: 265-268 ℃
NMR (DMSO-d6, Δ): 2.92 (6H, s), 6.70 (1H, d,
J = 6.0Hz), 7.45-7.60 (4H, m), 8.03 (1H, d, J = 8.0Hz), 8.40 (1H,
d, J = 6.0Hz), 8.65 (1H, d, J = 8.0Hz), 8.73 (1H, s), 9.05 (1H, s)Example 180
The following compound was obtained in the same manner as in Example 147.
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-cinnamoyl
Hydrazino) quinoline
mp: 281-283 ℃
NMR (DMSO-d6, Δ): 6.66 (1H, d, J = 7.0 Hz), 6.82 (1H, d,
J = 15.0Hz), 7.43-7.68 (10H, m), 8.03 (1H, d, J = 8.0Hz), 8.43
(1H, d, J = 7.0Hz), 8.69 (1H, d, J = 8.0Hz), 9.47 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- [2- (4-imida
Zolylacetyl) hydrazino] quinoline
mp: 248-250 ℃
NMR (DMSO-d6, Δ): 3.53 (2H, br), 6.71 (1H, br), 7.00
(1H, br), 7.47-7.64 (5H, m), 8.00 (1H, d, J = 8Hz), 8.40 (1H, d,
J = 6Hz), 8.65 (1H, d, J = 8Hz), 9.33 (1H, br), 10.52 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-pyridi
Ruacetyl) hydrazino] quinoline dihydrochloride
mp: 208-232 ℃
NMR (DMSO-d6, Δ): 4.27 (2H, s), 7.27 (1H, d,
J = 7.5Hz), 7.52-7.62 (3H, m), 7.77-7.95 (3H, m), 8.34 (1H, br
t, J = 7.5Hz), 8.46 (1H, d, J = 8.0Hz), 8.61-8.67 (2H, m), 8.85
(1H, d, J = 5.0Hz), 11.24 (1H, s), 11.39 (1H, br), 11.48 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-pyridi
Ruacetyl) hydrazino] quinoline
mp: 238-242 ℃
NMR (DMSO-d6, Δ): 3.69 (2H, s), 6.63 (1H, d, J = 6Hz),
7.38 (1H, dd, J = 8, 6Hz), 7.48-7.64 (4H, m), 7.78 (1H, br d,
J = 8Hz), 7.96 (1H, d, J = 8Hz), 8.40 (1H, d, J = 6Hz), 8.48 (1H, d,
J = 6Hz), 8.57 (1H, d, J = 2Hz), 8.67 (1H, d, J = 8Hz), 9.38 (1H, br
s)
Its dihydrochloride
mp: 216-240 ℃
NMR (DMSO-d6, Δ): 4.05 (2H, s), 7.03 (1H, d, J = 8Hz),
7.40-7.66 (3H, m), 7.82 (1H, t, J = 8Hz), 7.96 (1H, dd, J = 8,
6Hz), 8.36-8.49 (2H, m), 8.56-8.65 (2H, m), 8.81 (1H, d,
J = 6Hz), 8.90 (1H, brs)
(5) 4- (2-benzoylhydrazino) -8- (2,6-dichlorobenzoy
Ruamino) quinoline hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.00 (1H, d, J = 4 Hz), 7.50-7.75 (6H,
m), 7.88 (1H, t, J = 8Hz), 8.05 (2H, d, J = 8Hz), 8.45 (1H, d,
J = 8Hz), 8.60 (2H, t, J = 8Hz)
(6) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-methoxy
Cibenzoyl) hydrazino] quinoline
mp: 263-266 ℃
NMR (DMSO-d6, Δ): 3.94 (3H, s), 6.80 (1H, d, J = 5Hz),
7.08 (1H, t, J = 8Hz), 7.20 (1H, d, J = 8Hz), 7.48-7.61 (4H, m),
7.66 (1H, d, J = 8Hz), 8.08 (1H, d, J = 8Hz), 8.47 (1H, d, J = 5Hz),
8.68 (1H, d, J = 6Hz), 9.54 (1H, s)
(7) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-methoxy
Cibenzoyl) hydrazino] quinoline
mp: 247-252 ℃
NMR (DMSO-d6, Δ): 3.84 (3H, s), 6.70 (1H, d, J = 5Hz),
7.19 (1H, dd, J = 8, 2Hz), 7.41-7.64 (6H, m), 8.07 (1H, d,
J = 8Hz), 8.43 (1H, d, J = 5Hz), 8.68 (1H, d, J = 8Hz), 9.53 (1H, s)
(8) 8- (2,6-dichlorobenzoylamino) -4- [2- (4-methoxy
Cibenzoyl) hydrazino] quinoline hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 6.97 (1H, d, J = 4 Hz), 7.12 (2H, d,
J = 8Hz), 7.53-7.68 (3H, m), 7.85 (1H, t, J = 8Hz), 8.01 (2H, d,
J = 8Hz), 8.45 (1H, d, J = 8Hz), 8.58 (2H, t, J = 8Hz)
(9) 8- (2,6-dichlorobenzoylamino) -4- [2- (4-trif
Fluoromethylbenzoyl) hydrazino] quinoline hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.05 (1H, d, J = 4 Hz), 7.52-7.67 (4H,
m), 7.85 (1H, t, J = 8Hz), 8.00 (2H, d, J = 8Hz), 8.24 (2H, d,
J = 8Hz), 8.40 (1H, d, J = 4Hz), 8.60 (2H, t, J = 4Hz)
(10) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-free
Lecarbonyl) hydrazino] quinoline
mp:> 250 ℃
NMR (DMSO-d6, Δ): 6.68 (1H, d, J = 4 Hz), 7.00 (1H, s),
7.50-7.63 (4H, m), 7.35 (1H, s), 8.06 (1H, d, J = 9Hz), 8.40
(1H, s), 8.45 (1H, d, J = 4Hz), 8.70 (1H, d, J = 6Hz), 9.49 (1H,
s)
Its hydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 6.95 (1H, d, J = 6Hz), 7.05 (1H, s),
7.52-7.66 (3H, m), 7.80-7.95 (2H, m), 8.42 (1H, d, J = 6Hz),
8.50 (1H, s), 8.55-8.65 (2H, m)
(11) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-thiene
Nylcarbonyl) hydrazino] quinoline
mp: 263-265 ℃
NMR (DMSO-d6, Δ): 6.71 (1H, d, J = 7.0Hz), 7.27 (1H,
dd, J = 5.5, 4.0Hz), 7.50-7.62 (4H, m), 7.91 (1H, d, J = 7.0Hz),
7.99 (1H, d, J = 4.0Hz), 8.06 (1H, d, J = 8.0Hz), 8.45 (1H, d,
J = 5.5Hz), 8.70 (1H, d, J = 8.0Hz), 9.55 (1H, s)
(12) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-thiene
Nylcarbonyl) hydrazino] quinoline
mp: 277-279CC
NMR (DMSO-d6, Δ): 6.70 (1H, d, J = 6.0Hz), 7.49-7.65
(5H, m), 7.69-7.71 (1H, m), 8.07 (1H, d, J = 8.0Hz), 8.36 (1H,
d, J = 3.0Hz), 8.45 (1H, d, J = 6.0Hz), 8.70 (1H, d, J = 8.0Hz),
9.53 (1H, s)
(13) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-pyr
Zircarbonyl) hydrazino] quinoline dihydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.15 (1H, d, J = 6Hz), 7.52-7.68 (3H,
m), 7.24 (1H, dd, J = 6, 4Hz), 7.90 (1H, t, J = 8Hz), 8.48-8.55
(2H, m), 8.58-8.65 (2H, m), 8.90 (1H, d, J = 4Hz), 9.29 (1H, s)
(14) 8- (2,6-dichlorobenzoylamino) -4- [2- (4-pyri
Zircarbonyl) hydrazino] quinoline
mp: 249-251 ℃
NMR (DMSO-d6, Δ): 6.76 (1H, d, J = 5Hz), 7.50-7.63 (4H,
m), 7.90 (1H, d, J = 6Hz), 8.07 (1H, d, J = 9Hz), 8.46 (1H, d,
J = 4Hz), 8.70 (1H, d, J = 6Hz), 8.83 (2H, m), 9.61 (1H, s)
Its dihydrochloride
mp:> 250 ℃
NMR (DMSO-d6, Δ): 7.12 (1H, d, J = 6Hz), 7.52-7.66 (3H,
m), 7.90 (1H, t, J = 8Hz), 8.07 (2H, m), 8.50 (1H, d, J = 8Hz),
8.62 (2H, m), 8.93 (2H, m)
(15) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-hydrido
Roxy-3-methylbutyryl) hydrazino] quinoline
mp: 243-245 ℃
NMR (DMSO-d6, Δ): 1.27 (2x3H, s), 2.39 (2H, s), 4.73
(1H, s), 6.75 (1H, d, J = 6Hz), 7.48-7.63 (4H, m), 8.01 (1H, d,
J = 8Hz), 8.42 (1H, d, J = 6Hz), 8.67 (1H, d, J-8Hz), 9.30 (1H,
s), 9.95 (1H, s), 10.52 (1H, s)
(16) 8- (2,6-dichlorobenzoylamino) -4- (2-isobutylyl)
Ruhydrazino) quinoline
mp: 269-272 ℃ (decomposition)
NMR (DMSO-d6, Δ): 1.15 (3H, d, J = 7 Hz), 2.60 (1H, qq,
J = 7, 7Hz), 6.59 (1H, d, J = 6Hz), 7.47-7.64 (4H, m), 8.00 (1H,
d, J = 8Hz), 8.44 (1H, d, J = 6Hz), 8.67 (1H, d, J = 8Hz), 9.30 (1H,
s), 10.03 (1H, s), 10.52 (1H, s)
(17) 8- (2,6-dichlorobenzoylamino) -4- [2- (N, N-
Dimethylaminoacetyl) hydrazino] quinoline
mp: 234-238 ℃
NMR (DMSO-d6, Δ): 2.31 (2x3H, s), 3.11 (2H, s), 6.63
(1H, d, J = 6Hz), 7.47-7.63 (4H, m), 8.00 (1H, d, J = 8Hz), 8.43
(1H, d, J = 6Hz), 8.67 (1H, d, J = 8Hz), 9.29 (1H, s), 10.06 (1H,
s), 10.52 (1H, s)
(18) 8- (2,6-dichlorobenzoylamino) -4- (2-oxamoi
Ruhydrazino) quinoline
mp: 249-252 ℃ (decomposition)
NMR (DMSO-d6, Δ): 6.58 (1H, d, J = 6Hz), 7.48-7.63 (4H,
m), 7.97 (1H, br s), 8.00 (1H, d, J = 8Hz), 8.28 (1H, br s),
8.44 (1H, d, J = 6Hz), 8.68 (1H, d, J = 8Hz), 9.42 (1H, s), 10.55
(1H, s), 10.97 (1H, s)Example 181
8- (2,6-dichlorobenzoylamino) -4- (4-methylsemicarbadi
C) Quinoline was prepared in the same manner as in Example 87 by using 8- (2,6-dichlorobenzoyl).
Reacting amino) -4-hydrazinoquinoline with phenyl methylcarbamate
I got it.
mp: 274-277 ℃
NMR (DMSO-d6, Δ): 2.58 (3H, d, J = 5 Hz), 6.60 (1H, br
q, J = 5Hz), 6.70 (1H, d, J = 6Hz), 7.45-7.63 (4H, m), 7.99 (1H,
d, j = 8Hz), 8.20 (1H, s), 8.45 (1H, d, J = 6Hz), 8.66 (1H, d,
J = 8Hz), 9.19 (1H, s)Example 182
(1) 8- (2,6-dichlorobenzoylamino) -4-hydrazinoquinoline
(298 mg) in dimethylformamide (4 ml) was added to a solution of succinic anhydride (
94 mg) and the mixture was stirred at room temperature for 12 hours. Water (10 ml) in the mixture
Was added and the precipitate was collected. Treat the solid with hot ethanol (5 ml) and bring to room temperature
Allow to cool, filter, wash with water and add 8- (2,6-dichlorobenzoylamino)
4- [2- (3-carboxypropanoyl) hydrazino] quinoline is converted to yellow crystals
(105 mg).
mp: 166-170 ℃
NMR (DMSO-d6, Δ): 2.36-2.62 (4H, m), 6.73 (1H, d,
J = 6Hz), 7.47-7.64 (4H, m), 8.00 (1H, d, J = 8Hz), 8.40 (1H, d,
J = 6Hz), 8.66 (1H, d, J = 8Hz), 9.31 (1H, s), 10.09 (1H, s),
10.51 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- [2- (3-carbo
Xypropanoyl) hydrazino] quinoline (138 mg) in dimethylformamide
1-hydroxybenzotriazole (45.9 mg)
And 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (6
(5.1 mg) at room temperature and the mixture was stirred at the same temperature overnight. Add water to the mixture,
The resulting precipitate was collected by filtration to give 8- (2,6-dichlorobenzoylamino)
-4- (2,5-Dioxopyrrolidin-1-ylamino) quinoline (72 mg)
I got
mp: 170-173 ℃
NMR (DMSO-d6, Δ): 2.83-2.98 (4H, m), 6.72 (1H, d,
J = 6Hz), 7.48-7.68 (4H, m), 8.03 (1H, d, J = 8Hz), 8.45 (1H, d,
J = 6Hz), 9.72 (1H, d, J = 8Hz), 9.82 (1H, s), 10.58 (1H, s)Example 183
The following compound was obtained in the same manner as in Example 154.
(1) 8- (2,6-dichlorobenzoylamino) -4- (2-ethanesulfo
Nilhydrazino) quinoline
mp: 178-180 ℃
NMR (DMSO-d6, Δ): 1.32 (3H, t, J = 7.5 Hz), 3.23 (2H, q,
J = 7.5Hz), 7.10 (1H, d, J = 6.0Hz), 7.48-7.60 (4H, m), 8.01 (1H,
d, J = 8.0Hz), 8.52 (1H, d, J = 6.0Hz), 8.67 (1H, d, J = 8.0Hz),
9.35 (1H, s), 9.58 (1H, s), 10.55 (1H, s)
(2) 4- (2-benzylsulfonylhydrazino) -8- (2,6-dichloro
Benzoylamino) quinoline
mp: 191-193 ℃
NMR (DMSO-d6, Δ): 4.53 (2H, s), 7.08 (1H, d,
J = 6.0Hz), 7.36-7.60 (9H, m), 8.05 (1H, d, J = 8.0Hz), 8.50 (1H,
d, J = 6.0Hz), 8.69 (1H, d, J = 8.0Hz), 9.45 (1H, s), 9.71 (1H,
s), 10.58 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- [2- (p-tolue
Nsulfonyl) hydrazino] quinoline
mp: 219-221 ℃
NMR (DMSO-d6, Δ): 2.40 (3H, s), 6.92 (1H, d, J = 6.0Hz),
7.41 (2H, d, J = 7.5Hz), 7.45-7.60 (4H, m), 7.74 (2H, d,
J = 7.5Hz), 7.88 (1H, d, J = 8.0Hz), 8.40 (1H, d, J = 6.0Hz), 8.65
(1H, d, J = 8.0Hz), 9.27 (1H, s), 10.06 (1H, s), 10.56 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -4- (2-styrylsul
Honylhydrazino) quinoline
mp: 188-190 ℃
NMR (DMSO = d6, Δ): 7.14 (1H, d, J = 6.0Hz), 7.33-7.61
(7H, m), 7.70-7.75 (2H, m), 7.96 (1H, d, J = 8.0Hz), 8.49 (1H,
d, J = 6.0Hz), 8.65 (1H, d, J = 8.0Hz), 9.46 (1H, s), 9.84 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -4- [2- (2-thienyl
Rusulfonyl) hydrazino] quinoline
mp: 208-210 ℃
NMR (DMSO-d6, Δ): 6.88 (1H, d, J = 5.5 Hz), 7.21 (1H, t,
J = 4.0Hz), 7.46-7.60 (4H, m), 7.66 (1H, d, J = 3.0Hz), 7.93 (1H,
d, J = 8.0Hz), 8.00 (1H, d, J = 5.0Hz), 8.40 (1H, d, J = 5.5Hz),
8.65 (1H, d, J = 8.0Hz), 9.43 (1H, s)
(6) 4- [2- (2-acetamido-4-methylthiazol-5-ylsul)
Honyl) hydrazino] -8- (2,6-dichlorobenzoylamino) quinoline
mp: 181-183 ℃
NMR (DMSO-d6, Δ): 2.17 (3H, s), 2.40 (3H, s), 6.98
(1H, d, J = 5.5Hz), 7.47-7.62 (4H, m), 7.92 (1H, d, J = 8.0Hz),
8.45 (1H, d, J = 5.5Hz), 8.67 (1H, d, J = 8.0Hz), 9.39 (1H, s)Example 184
(1) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-3-p
Ropyrquinoline was prepared in the same manner as in Example 139- (1), using 4-chloro-8- (2
, 6-Dichlorobenzoylamino) -3-propylquinoline and hydrazine monohydrate
Obtained from things.
NMR (DMSO-d6, Δ): 0.93 (3H, t, J = 7.5Hz), 1.50 (2H,
qt, J = 7.5, 7.5Hz), 2.84 (2H, t, J = 7.5Hz), 4.65 (2H, s), 7.35
(1H, t, J = 8.0Hz), 7.50-7.60 (3H, m), 7.73 (1H, s), 8.16 (1H,
s), 8.53 (2H, d, J = 8.0Hz)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -3-propylquinoline was obtained in the same manner as in Example 86.
mp: 223-226 ℃
NMR (DMSO-d6, Δ): 0.95 (3H, brt, J = 7.5 Hz), 1.56 (2H,
br), 1.86 (3H, s), 2.76 (2H, brt, J = 7.5Hz), 7.43-7.60 (4H,
m), 8.10 (1H, br d, J = 8.0Hz), 8.16 (1H, s), 8.35 (1H, s), 8.57
(1H, br d, J = 8.0Hz), 10.20 (1H, s), 10.52 (1H, s)Example 185
(1) 4- (2-aminoethylamino) -8- (2,6-dichlorobenzoyl
Amino) -3-methylquinoline was converted to 4-chloro-8- (
2,6-dichlorobenzoylamino) -3-methylquinoline and ethylenediamine
Obtained from.
mp: 128-142 ℃
NMR (CDClThree, Δ): 2.40 (3H, s), 3.00 (2H, t, J = 6Hz),
3.56 (2H, q, J = 6Hz), 5.65 (1H, brs), 7.29-7.42 (3H, m), 7.47
(1H, t, J = 8Hz), 7.78 (1H, d, J = 8Hz), 8.32 (1H, s), 8.83 (1H,
d, J = 6Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (2-
Oxoimidazolidin-1-yl) quinoline was prepared in the same manner as in Example 92- (2).
Obtained.
mp:> 250 ℃
NMR (CDClThree, Δ): 2.48 (3H, s), 3.73-4.04 (4H, m), 4.94
(1H, s), 7.30-7.45 (3H, m), 7.60-7.67 (2H, m), 8.70 (1H, s),
8.92 (1H, t, J = 4Hz)
(3) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (2-
Thioxoimidazolidin-1-yl) quinoline was prepared in the same manner as in Example 92-2 (2).
To give 4- (2-aminoethylamino) -8- (2,6-dichlorobenzoyl
Mino) -3-methylquinoline and 1,1'-thiocarbonyldiimidazole
Was.
mp: 165-170 ℃
NMR (CDClThree, Δ): 2.50 (3H, s), 3.92-4.27 (4H, m), 6.19
(1H, s), 7.32 to 7.45 (3H, m), 7.55 (1H, d, J = 6Hz), 7.67 (1H, t,
J = 6Hz), 8.75 (1H, s), 8.95 (1H, d, J = 6Hz)Example 186
(1) 3-tert-butyldimethylsilyloxymethyl-8- (2,6-dichloro
Lobenzoylamino) -4- (3-methyl-2-thioxoimidazolidin-1-
Yl) quinoline was prepared in the same manner as in Example 92- (2), using 3-tert-butyl dimethyl
Lucylyloxymethyl-8- (2,6-dichlorobenzoylamino) -4-[(
2-methylaminoethyl) amino] quinoline and 1,1'-thiocarbonyldiimi
Obtained from Dazol.
mp: 234-236 ℃
NMR (DMSO-d6, Δ): 0.11 (3H, s), 0.13 (3H, s), 0.92
(3x3H, s), 3.17 (3H, s), 3.87-4.09 (4H, m), 4.92 (2H, s),
7.49-7.63 (4H, m), 7.71 (1H, d, J = 8Hz), 8.74 (1H, d, J = 8Hz),
9.05 (1H, s), 10.91 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-hydroxymethyl-
Example of 4- (3-methyl-2-thioxoimidazolidin-1-yl) quinoline
Obtained in the same manner as in 125- (8).
mp: 253-254 ℃
NMR (DMSO-d6, Δ): 3.15 (3H, s), 3.89-4.06 (4H, m),
4.67 (2H, d, J = 6Hz), 5.49 (1H, t, J = 6Hz), 7.49-7.63 (4H, m),
7.70 (1H, dd, J = 8, 8Hz), 8.70 (1H, d, J = 8Hz), 9.07 (1H, s),
10.93 (1H, s)Example 187
(1) 4- (2-aminoethylamino) -8- (2,6-dichlorobenzoyl
Amino) -3-methoxymethylquinoline was prepared in the same manner as in Example 8 by using 4-chloro
-8- (2,6-dichlorobenzoylamino) -3-methoxymethylquinoline
Obtained from ethylenediamine.
mp: 130-131 ℃
NMR (DMSO-d6, Δ): 2.80 (2H, t, J = 7.0Hz), 3.29 (3H,
s), 3.57 (2H, td, J = 7.0, 7.0Hz), 4.53 (2H, s), 6.60 (1H, brt,
J = 7.0Hz), 7.43-7.60 (4H, m), 8.00 (1H, d, J = 8.0Hz), 8.32 (1H,
s), 8.61 (1H, d, J = 8.0Hz), 10.50 (1H, br s)
(2) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-4
-(2-Oxoimidazolidin-1-yl) quinoline was prepared in the same manner as in Example 92- (2).
Obtained in a similar manner.
mp: 210-212 ℃
NMR (DMSO-d6, Δ): 3.34 (3H, s), 3.56-3.80 (3H, m),
3.88-3.95 (1H, m), 4.58 (1H, d, J = 13.5Hz), 4.63 (1H, d,
J = 13.5Hz), 7.01 (1H, s), 7.47-7.59 (3H, m), 7.68-7.75 (2H, m),
8.70-8.73 (1H, m), 8.94 (1H, s)Example 188
(1) Isopropylide (5-chloro-2-nitroanilino) methylenemalonate
And 5-chloro-2-nitroaniline in the same manner as in Example 172- (1).
Obtained from isopropylidene malonate.
mp: 217-220 ℃
NMR (CDClThree, Δ): 1.78 (6H, s), 7.34 (1H, d, J = 7Hz),
7.62 (1H, brs), 8.28 (1H, d, J = 7Hz), 8.67 (1H, d, J = 9Hz),
13.60 (1H, br d, J = 9Hz)
(2) 5-chloro-1,4-dihydro-8-nitro-4-oxoquinoline
Obtained in the same manner as in Example 172- (2).
mp: 220-225 ℃ (decomposition)
NMR (DMSO-d6, Δ): 6.21 (1H, d, J = 8 Hz), 7.45 (1H, d,
J = 8Hz), 7.87 (1H, t, J = 8Hz), 8.50 (1H, d, J = 8Hz), 11.88 (1H,
br s)
(3) 4,5-Dichloro-8-nitroquinoline was prepared in the same manner as in Production Example 2- (1).
I got it.
mp: 116-118 ℃
NMR (CDClThree, Δ): 7.68 (1H, d, J = 6 Hz), 7.74 (1H, d,
J = 8Hz), 7.86 (1H, d, J = 8Hz), 8.85 (1H, d, J = 6Hz)
(4) 8-amino-4,5-dichloroquinoline was prepared in the same manner as in Production Example 2- (3).
I got it.
mp: 135 ℃
NMR (CDCl3, δ): 5.10 (2H, brs), 6.85 (1H, d, J = 8Hz),
7.43 (1H, d, J = 8Hz), 7.50 (1H, d, J = 6Hz), 8.55 (1H, d, J = 6Hz)
(5) 4,5-dichloro-8- (2,6-dichlorobenzoylamino) quinoli
Was obtained in the same manner as in Example 1.
mp: 243-247 ℃
NMR (DMSO-d6, Δ): 7.46-7.61 (3H, m), 7.88-7.95 (2H,
m), 8.75 (1H, d, J = 8Hz), 8.81 (1H, d, J = 4Hz)
(6) 5-chloro-8- (2,6-dichlorobenzoylamino) -4- (imi
Dazol-1-yl) quinoline was obtained in the same manner as in Example 8.
mp: 259-263 ℃
NMR (DMSO-d6, Δ): 7.13 (1H, s), 7.47-7.62 (4H, m),
7.74 (1H, d, J = 5Hz), 7.84 (1H, d, J = 8Hz), 7.94 (1H, s), 8.78
(1H, d, J = 8Hz), 9.05 (1H, d, J = 5Hz)
Its hydrochloride
mp: 263-272 ℃
NMR (DMSO-d6, Δ): 7.49-7.62 (3H, m), 7.89-7.97 (2H,
m), 8.04 (1H, d, J = 2Hz), 8.10 (1H, s), 8.83 (1H, d, J = 8Hz),
9.20 (1H, d, J = 4Hz), 9.44 (1H, br s)Example 189
(1) 5-chloro-8- (2,6-dichlorobenzoylamino) -4-hydra
Dinoquinoline was prepared in the same manner as in Example 139- (1), using 4,5-dichloro-8-.
Obtained from (2,6-dichlorobenzoylamino) quinoline and hydrazine monohydrate
.
mp: 253-263 ℃
NMR (DMSO-d6, Δ): 4.61 (2H, brs), 7.23 (1H, d,
J = 6Hz), 7.45-7.64 (4H, m), 8.38 (1H, d, J = 6Hz), 8.52 (1H, br
s), 8.54 (1H, d, J = 8Hz)
(2) 4- (2-acetylhydrazino) -5-chloro-8- (2,6-dichloro
(Lobenzoylamino) quinoline was obtained in the same manner as in Example 86.
mp: 158-161 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 6.88 (1H, d, J = 6Hz),
7.47-7.63 (4H, m), 8.45 (1H, d, J = 6Hz), 8.60 (1H, d, J = 8Hz),
8.94 (1H, brs)Example 190
(1) 5-chloro-8- (2,6-dichlorobenzoylamino) -4-[(2
-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4,5-
Dichloro-8- (2,6-dichlorobenzoylamino) quinoline and N-methyl
Obtained from tylenediamine.
mp: 233-238 ℃
NMR (DMSO-d6, Δ): 2.33 (3H, s), 2.80-2.87 (2H, m),
3.24-3.39 (2H, m), 6.63 (1H, d, J = 6Hz), 7.48-7.62 (4H, m),
7.92 (1H, brt, J = 7Hz), 8.36 (1H, d, J = 6Hz), 8.57 (1H, d,
(J = 8Hz)
(2) 5-chloro-8- (2,6-dichlorobenzoylamino) -4- (3-
Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp: 259-263 ℃
NMR (CDClThree, Δ): 2.96 (3H, s), 3.50-3.86 (3H, m),
3.94-4.10 (1H, m), 7.30-7.44 (4H, m), 7.65 (1H, d, J = 8Hz),
8.75 (1H, d, J = 6Hz), 8.87 (1H, d, J = 8Hz)Example 191
(1) 8- (2,6-dichlorobenzoylamino) -5-methyl-4-[(2
-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro
B-8- (2,6-Dichlorobenzoylamino) -5-methylquinoline and N-meth
Obtained from tylethylenediamine.
mp: 247-250 ℃
NMR (CDClThree, Δ): 2.47 (3H, s), 2.92 (3H, s), 2.97-3.04
(2H, m), 3.20-3.30 (2H, m), 6.37 (1H, d, J = 6Hz), 6.60 (1H, m),
7.16 (1H, d, J = 8Hz), 7.24-7.41 (3H, m), 8.30 (1H, d, J = 6Hz),
8.70 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -5-methyl-4- (3-
Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp: 262-264 ℃
NMR (DMSO-d6, Δ): 2.66 (3H, s), 2.80 (3H, s), 3.50-
3.64 (2H, m), 3.83 (1H, m), 3.97 (1H, m), 7.40 (1H, d, J = 8Hz),
7.48-7.61 (4H, m), 8.59 (1H, d, J = 8Hz), 8.85 (1H, d, J = 6Hz)Example 192
(1) 8- (2,6-dichlorobenzoylamino) -4-[(2-ethylamido
Noethyl) amino] -5-methylquinoline was prepared in the same manner as in Example 8 by using 4-chloro
B-8- (2,6-Dichlorobenzoylamino) -5-methylquinoline and NE
Obtained from tylethylenediamine.
mp: 201-205 ℃
NMR (DMSO-d6, Δ): 1.04 (3H, t, J = 8 Hz), 2.57 (2H, q,
J = 8Hz), 2.80-2.94 (2H, m), 2.89 (3H, s), 3.18-3.29 (2H, m),
6.52 (1H, d, J = 6Hz), 6.78 (1H, brs), 7.19 (1H, d, J = 8Hz),
7.48-7.63 (3H, m), 8.30 (1H, d, J = 6Hz), 8.47 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -4- (3-ethyl-2-
Oxoimidazolidin-1-yl) -5-methylquinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp: 235-236 ℃
NMR (DMSO-d6, Δ): 1.12 (3H, t, J = 8Hz), 2.67 (3H, s),
3.26 (2H, q, J = 8Hz), 3.54-3.64 (2H, m), 3.78-3.89 (1H, m),
3.91-4.07 (1H, m), 7.41 (1H, d, J = 8Hz), 7.49-7.64 (4H, m),
8.59 (1H, d, J = 8Hz), 8.84 (1H, d, J = 6Hz)Example 193
(1) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-5
-Methyl-4-[(2-methylaminoethyl) amino] quinoline was prepared as in Example 8.
Similarly, 4-chloro-8- (2,6-dichlorobenzoylamino) -3-me
Obtained from toxicmethyl-5-methylquinoline and N-methylethylenediamine.
NMR (CDClThree, Δ): 2.46 (3H, s), 2.69-2.79 (2H, m), 2.90
(3H, s), 3.32-3.47 (2H, m), 3.40 (3H, s), 4.59 (2H, s), 5.59
(1H, brt, J = 6Hz), 7.20-7.43 (4H, m), 8.29 (1H, s), 8.73 (1H,
d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-5
-Methyl-4- (3-methyl-2-oxoimidazolidin-1-yl) quinoline
Was obtained in the same manner as in Example 92- (2).
mp: 105-112 ℃
NMR (CDClThree, Δ): 2.74 (3H, s), 2.96 (3H, s), 3.44 (3H, s)
s), 3.58-3.85 (4H, m), 4.40 (1H, d, J = 9Hz), 4.66 (1H, d,
J = 9Hz), 7.27-7.46 (4H, m), 8.81 (1H, d, J = 8Hz), 8.85 (1H, s)Example 194
(1) 1,4-dihydro-3-hydroxymethyl-5-methyl-8-nitro-
4-oxoquinoline was prepared in the same manner as in Example 172- (3), using 1,4-dihydro
Obtained from -5-methyl-8-nitro-4-oxoquinoline.
mp: 251-255 ℃
NMR (DMSO-d6, Δ): 4.37 (2H, s), 7.20 (1H, d, J = 8Hz),
7.93 (1H, d, J = 6Hz), 8.47 (1H, d, J = 8Hz)
(2) 1,4-dihydro-3,5-dimethyl-8-nitro-4-oxoquinoli
Was obtained in the same manner as in Example 104- (2).
mp: 250-262 ℃
NMR (DMSO-d6, Δ): 1.96 (3H, s), 2.90 (3H, s), 7.17
(1H, d, J = 8Hz), 7.83 (1H, d, J = 6Hz), 8.44 (1H, d, J = 8Hz)
(3) Production Example of 4-chloro-3,5-dimethyl-8-nitroquinoline 2- (1
).
NMR (CDClThree, Δ): 2.58 (3H, s), 3.10 (3H, s), 7.41 (1H,
d, J = 8Hz), 7.78 (1H, d, J = 8Hz), 8.79 (1H, s)
(4) 8-amino-4-chloro-3,5-dimethylquinoline was prepared in Production Example 2- (3
).
mp: 120-122 ℃
NMR (DMSO-d6, Δ): 2.46 (3H, s), 2.81 (3H, s), 5.83
(2H, br s), 6.76 (1H, d, J = 8Hz), 7.15 (1H, d, J = 8Hz), 8.60
(1H, s)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -3,5-di
Methylquinoline was obtained in the same manner as in Example 1.
mp: 236-240 ℃
NMR (DMSO-d6, Δ): 2.52 (3H, s), 2.98 (3H, s), 7.47-
7.61 (4H, m), 8.57 (1H, d, J = 8Hz), 8.78 (1H, s), 10.69 (1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -3,5-dimethylquinoline was obtained as in Example 8.
mp: 214-216 ℃
NMR (DMSO-d6, Δ): 1.92 (3H, s), 2.08 (3H, s), 7.24
(1H, s), 7.43-7.62 (5H, m), 7.90 (1H, s), 8.59 (1H, d, J = 8Hz),
8.93 (1H, s), 10.79 (1H, s)Example 195
(1) Isopropyl (5-methoxy-2-nitroanilino) methylenemalonate
Den was prepared in the same manner as in Example 172- (1), using 5-methoxy-2-nitroanili.
And isopropylidene malonate.
mp: 210-220 ℃
NMR (CDClThree, Δ): 1.77 (6H, s), 3.98 (3H, s), 6.84 (1H,
dd, J = 8, 2Hz), 6.98 (1H, d, J = 2Hz), 8.32 (1H, d, J = 8Hz), 8.70
(1H, d, J = 10Hz)
(2) 1,4-dihydro-5-methoxy-8-nitro-4-oxoquinoline
Obtained in the same manner as in Example 172- (2).
mp: 195-200 ℃
NMR (DMSO-d6, Δ): 4.00 (3H, s), 6.10 (1H, d, J = 8Hz),
7.00 (1H, d, J = 8Hz), 7.80 (1H, d, J = 8Hz), 8.60 (1H, d, J = 8Hz)
(3) 4-chloro-5-methoxy-8-nitroquinoline was prepared according to Production Example 2- (1).
Obtained similarly.
mp; 125-138 ℃
NMR (CDClThree, Δ): 4.07 (3H, s), 6.92 (1H, d, J = 8Hz),
7.55 (1H, d, J = 4Hz), 8.09 (1H, d, J = 8Hz), 8.83 (1H, d, J = 4Hz)
(4) 8-amino-4-chloro-5-methoxyquinoline was prepared according to Production Example 2- (3).
Obtained similarly.
mp: 111-115 ℃
NMR (CDClThree, Δ): 3.90 (3H, s), 4.74 (2H, br s), 6.87-
6.95 (2H, m), 7.40 (1H, d, J = 4Hz), 8.57 (1H, d, J = 4Hz)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -5-methoxy
Shikinoline was obtained in the same manner as in Example 1.
mp: 238-242 ℃
NMR (CDClThree, Δ): 4.00 (3H, s), 7.01 (1H, d, J = 8Hz),
7.30-7.45 (3H, m), 7.48 (1H, d, J = 4Hz), 8.56 (1H, d, J = 4Hz),
8.95 (1H, d, J = 8Hz), 9.90 (1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-5-me
Toxiquinoline was obtained in the same manner as in Example 139- (1).
mp:> 250 ℃
NMR (DMSO-d6, Δ): 3.97 (3H, s), 4.54 (2H, s), 6.88
(1H, d, J = 6Hz), 7.01 (1H, d, J = 4Hz), 7.49-7.62 (3H, m), 8.28
(1H, d, J = 4Hz), 8.50 (1H, d, J = 6Hz), 8.77 (1H, s)
(7) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -5-methoxyquinoline was obtained as in Example 86.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 3.98 (3H, s), 6.68
(1H, d, J = 4Hz), 6.97 (1H, d, J = 8Hz), 7.48-7.61 (3H, m), 8.36
(1H, d, J = 4Hz), 8.57 (1H, d, J = 8Hz), 9.25 (1H, s)Example 196
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -5-Methoxyquinoline was converted to 4-chloro-8- (2,
6-dichlorobenzoylamino) -5-methoxyquinoline and imidazole
Was.
mp: 155-189 ℃
NMR (CDClThree, Δ): 3.70 (3H, s), 6.99 (1H, d, J = 8Hz),
7.16 (1H, d, J = 2Hz), 7.22 (1H, d, J = 2Hz), 7.32-7.45 (4H, m),
7.66 (1H, s), 8.83 (1H, d, J = 3Hz), 9.01 (1H, d, J = 8Hz)Example 197
(1) 8- (2,6-dichlorobenzoylamino) -5-methoxy-4-[(
2-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8,
Rollo-8- (2,6-dichlorobenzoylamino) -5-methoxyquinoline and N
-Obtained from methylethylenediamine.
mp: 210-217 ℃
NMR (CDClThree, Δ): 2.50 (3H, s), 2.95 (2H, t, J = 6Hz),
3.35 (2H, q, J = 6Hz), 3.99 (3H, s), 6.33 (1H, d, J = 4Hz), 6.76
(1H, d, J = 8Hz), 7.25-7.43 (4H, m), 8.08 (1H, br), 8.27 (1H, d,
J = 6Hz), 8.79 (1H, d, J = 8Hz)
(2) 8- (2,6-dichlorobenzoylamino) -5-methoxy-4- (3
-Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92-.
Obtained in the same manner as in (2).
mp: 227-237 ℃
NMR (CDClThree, Δ): 2.95 (3H, s), 3.57 (2H, t, J = 6Hz),
3.82 (2H, t, J = 6Hz), 3.44 (3H, s), 6.97 (1H, d, J = 8Hz), 7.30-
7.45 (4H, m), 8.70-8.75 (1H, m), 8.90 (1H, d, J = 8Hz)Example 198
(1) 4-chloro-6-methyl-8-nitroquinoline was prepared according to Production Example 2- (1).
Similarly, 1,4-dihydro-6-methyl-8-nitro-4-oxoquinoline
Obtained from.
mp: 139-141 ℃
NMR (DMSO-d6, Δ): 2.66 (3H, s), 7.60 (1H, d, J = 6Hz),
7.92 (1H, s), 8.23 (1H, s), 8.86 (1H, d, J = 6Hz)
(2) 8-amino-4-chloro-6-methylquinoline was prepared in the same manner as in Production Example 2- (3).
Obtained in a similar manner.
mp: 115-116 ℃
NMR (DMSO-d6, Δ): 2.40 (3H, s), 6.04 (2H, s), 6.79
(1H, s), 7.05 (1H, s), 7.62 (1H, d, J = 5Hz), 8.05 (1H, d,
(J = 5Hz)
(3) 8- (2,6-dichlorobenzoylamino) -4-chloro-6-methyl
Quinoline was obtained in the same manner as in Example 1.
mp: 203-205 ℃
NMR (DMSO-d6, Δ): 2.61 (3H, s), 7.48-7.61 (3H, m),
7.78 (1H, d, J = 1 Hz), 7.83 (1H, d, J = 6 Hz), 8.70 (1H, d, J = 1 Hz),
8.75 (1H, d, J = 6Hz), 10.82 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-1
-Yl) -6-methylquinoline was obtained in the same manner as in Example 8.
mp: 260-261 ℃
NMR (DMSO-d6, Δ): 2.54 (3H, s), 7.28 (1H, d, J = 1 Hz),
7.34 (1H, d, J = 1Hz), 7.48-7.63 (3H, m), 7.70 (1H, d, J = 5Hz),
7.73 (1H, d, J = 0.5Hz), 8.16 (1H, d, J = 0.5Hz), 8.71 (1H, s),
8.93 (1H, d, J = 5Hz), 10.86 (1H, s)Example 199
(1) 8- (2,6-dichlorobenzoylamino) -6-methyl-4-[(2
-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro
B-8- (2,6-Dichlorobenzoylamino) -6-methylquinoline and N-meth
Obtained from tylethylenediamine.
NMR (DMSO-d6, Δ): 0.06 (2x3H, s), 0.86 (3x3H, s),
2.31 (3H, s), 2.73 (2H, t, J = 6Hz), 3.69 (2H, dt, J = 6, 6Hz),
4.84 (2H, s), 6.45 (1H, t, J = 6Hz), 7.43-7.62 (4H, m), 7.98
(1H, d, J = 8Hz), 8.37 (1H, s), 8.61 (1H, d, J = 8Hz), 10.51 (1H,
s)
(2) 8- (2,6-dichlorobenzoylamino) -6-methyl-4- (3-
Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp: 277-279 ℃
NMR (DMSO-d6, Δ): 2.54 (3H, s), 2.84 (3H, s), 3.60
(2H, t, J = 7.5Hz), 3.93 (2H, t, J = 7.5Hz), 7.48 (1H, d, J = 6Hz),
7.50-7.62 (4H, m), 8.60 (1H, s), 8.75 (1H, d, J = 6Hz), 10.66
(1H, s)Example 200
8- (2,6-dichlorobenzoylamino) -6-methyl-4- (3-methyl
-2-thioxoimidazolidin-1-yl) quinoline was prepared according to Example 92-2 (2).
Similarly, 8- (2,6-dichlorobenzoylamino) -6-methyl-4- [
(2-Methylaminoethyl) amino] quinoline and 1,1'-thiocarbonyldii
Obtained from midazole.
mp: 264-266 ℃
NMR (DMSO-d6, Δ): 2.55 (3H, s), 3.17 (3H, s), 3.96
4.10 (4H, m), 7.47-7.65 (5H, m), 8.62 (1H, s), 8.87 (1H, d,
J = 6Hz), 10.75 (1H, s)Example 201
(1) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-6-meth
Tylquinoline was prepared in the same manner as in Example 139- (1), using 4-chloro-8- (2,
6-dichlorobenzoylamino) -6-methylquinoline and hydrazine monohydrate
I got it.
mp: 221-224 ℃
NMR (DMSO-d6, Δ): 2.48 (3H, s), 4.34 (2H, s), 6.92
(1H, d, J = 6Hz), 7.50-7.63 (3H, m), 7.73 (1H, s), 8.30 (1H, d,
J = 6Hz), 8.47-8.55 (2H, m), 10.39 (1H, s)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -6-methylquinoline was obtained as in Example 86.
mp: 263-266 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 2.53 (3H, s), 6.61
(1H, d, J = 6Hz), 7.50-7.63 (3H, m), 7.81 (1H, s), 8.36 (1H, d,
J = 6Hz), 8.56 (1H, s), 9.14 (1H, s), 10.00 (1H, s), 10.46 (1H, s)
s)Example 202
8- (2,6-dichlorobenzoylamino) -4- (2-methanesulfonyl)
Drazino) -6-methylquinoline was converted to 8- (2,6) in the same manner as in Example 154.
-Dichlorobenzoylamino) -4-hydrazino-6-methylquinoline and methyl chloride
Obtained from Sill.
mp: 156-161 ℃
NMR (DMSO-d6, Δ): 2.54 (3H, s), 3.10 (3H, s), 7.06
(1H, d, J = 6Hz), 7.48-7.63 (3H, m), 7.83 (1H, s), 8.44 (1H, d,
J = 6Hz), 8.57 (1H, s), 9.34 (1H, br s), 9.53 (1H, s), 10.49
(1H, s)Example 203
(1) 4-chloro-8- (2,6-dichlorobenzoylamino) -6-methyl
To a solution of quinoline (562 mg) in N-methylpyrrolidone (6 ml) was added hydra.
Gin hydrate was added and the mixture was heated at 90 ° C. for 6 hours. Dilute the mixture with ethyl acetate
The mixture was washed with water and brine, dried over magnesium sulfate, and concentrated. Salt the residue
It was dissolved in methylene chloride and acetone and concentrated. Residual solid was dissolved in hot ethanol (5 ml
), Allowed to cool to room temperature, filtered, washed with ethanol and treated with 8- (2,6
-Dichlorobenzoylamino) -6-methyl-4- (2-isopropylidene hydride
Radino) quinoline (560 mg) was obtained as off-white crystals.
mp: 242-245 ℃
NMR (DMSO-d6, Δ): 2.07 (3H, s), 2.12 (3H, s), 2.55
(3H, s), 7.23 (1H, d, J = 6Hz), 7.49-7.63 (3H, m), 7.85 (1H, s),
8.40 (1H, d, J = 6Hz), 8.56 (1H, s), 9.27 (1H, s), 10.46 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -6-methyl-4- (2-
Isopropylidenehydrazino) quinoline (159 mg) in methanol (5 ml)
Sodium cyanoborohydride (25 mg) and acetic acid (50 mg)
Was added and the mixture was stirred at room temperature for 24 hours. The mixture was concentrated to dryness and the residue was
5 ml) and filtered. Treat the solid with hot water (5 ml) and cool to room temperature
Filtered, washed with water and treated with 8- (2,6-dichlorobenzoylamino) -6
-Methyl-4- (2-isopropylhydrazino) quinoline (117 mg) in pale yellow
Obtained as a colored powder.
mp: 154-156 ℃
NMR (DMSO-d6, Δ): 1.03 (2x3H, d, J = 7Hz), 2.54 (3H,
s), 3.28 (1H, m), 7.20 (1H, m), 7.51-7.68 (3H, m), 8.27-8.44
(3H, m), 10.51 (1H, s)Example 204
(1) Isopropylide (4-chloro-2-nitroanilino) methylenemalonic acid
And 4-chloro-2-nitroaniline in the same manner as in Example 172- (1).
Obtained from isopropylidene malonate.
mp: 204-206 ℃
NMR (CDClThree, Δ): 7.58 (1H, d, J = 8 Hz), 7.74 (1H, dd,
J = 8, 2Hz), 8.33 (1H, s), 8.69 (1H, d, J = 10Hz)
(2) 6-chloro-1,4-dihydro-8-nitro-4-oxoquinoline
Obtained in the same manner as in Example 172- (2).
mp: 238-241 ℃
NMR (DMSO-d6, Δ): 6.27 (1H, d, J = 6Hz), 8.00 (1H, d,
J = 6Hz), 8.45 (1H, d, J = 2Hz), 8.64 (1H, d, J = 2Hz)
(3) 4,6-Dichloro-8-nitroquinoline was prepared in the same manner as in Production Example 2- (1).
I got it.
mp: 149-164 ℃
NMR (CDClThree, Δ): 7.68 (1H, d, J = 4 Hz), 8.04 (1H, d,
J = 2Hz), 8.45 (1H, s), 8.91 (1H, d, J = 4Hz)
(4) 8-amino-4,6-dichloroquinoline was prepared in the same manner as in Production Example 2- (3).
I got it.
mp: 132-134 ℃
NMR (CDClThree, Δ): 5.15 (2H, brs), 6.90 (1H, s), 7.45
7.49 (2H, m), 8.57 (1H, d, J = 4Hz)
(5) 4,6-dichloro-8- (2,6-dichlorobenzoylamino) quinoli
Was obtained in the same manner as in Example 1.
mp: 201-205 ℃
NMR (CDClThree, Δ): 7.32 to 7.45 (3H, m), 7.58 (1H, d,
J = 4Hz), 7.98 (1H, s), 8.62 (1H, d, J = 4Hz), 9.06 (1H, d, J = 2Hz)
(6) 6-chloro-8- (2,6-dichlorobenzoylamino) -4-hydra
Dinoquinoline was obtained in the same manner as in Example 139- (1).
mp: 142-150 ℃
(7) 4- (2-acetylhydrazino) -6-chloro-8- (2,6-dichloro
(Lobenzoylamino) quinoline was obtained in the same manner as in Example 86.
mp: 117-180 ℃
NMR (CDClThree, Δ): 2.20 (3H, s), 6.72 (1H, d, J = 4Hz),
7.28-7.40 (4H, m), 8.40 (1H, d, J = 4Hz), 8.86 (1H, d, J = 2Hz)Example 205
6-chloro-8- (2,6-dichlorobenzoylamino) -4- (imidazo
Ru-1-yl) quinoline was converted to 4,6-dichloro-8- (
2,6-dichlorobenzoylamino) quinoline and imidazole.
mp: 179-181 ℃
NMR (CDClThree, Δ): 7.30-7.48 (6H, m), 7.57 (1H, s), 7.85
(1H, s), 8.85 (1H, d, J = 4Hz), 9.10 (1H, s)Example 206
(1) 6-chloro-8- (2,6-dichlorobenzoylamino) -4-[(2
-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4,6-
Dichloro-8- (2,6-dichlorobenzoylamino) quinoline and N-methyl
Obtained from tylenediamine.
mp: 185-198 ℃
NMR (CDClThree, Δ): 2.50 (3H, s), 3.00 (2H, t, J = 6Hz),
3.34 (2H, q, J = 6Hz), 5.80 (1H, br), 6.45 (1H, d, J = 4Hz), 7.30-
7.43 (3H, m), 7.51 (1H, d, J = 2Hz), 8.36 (1H, d, J = 4Hz), 8.93
(1H, s)
(2) 6-chloro-8- (2,6-dichlorobenzoylamino) -4- (3-
Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.85 (3H, s), 3.60 (1H, t, J = 6Hz),
3.97 (1H, t, J = 6Hz), 7.50-7.62 (4H, m), 7.80 (1H, s), 7.73
(1H, s), 8.86 (1H, d, J = 4Hz)Example 207
(1) Isopropyl (4-fluoro-2-nitroanilino) methylenemalonate
Den was prepared in the same manner as in Example 172- (1), using 4-fluoro-2-nitroanili.
And isopropylidene malonate.
mp: 195-196 ℃
NMR (CDClThree, Δ): 1.78 (2x3H, s), 7.53 (1H, ddd, J = 8,
5,3Hz), 7.63 (1H, dd, J = 8,5Hz), 8.05 (1H, dd, J = 8,3Hz),
8.67 (1H, d, J = 15Hz)
(2) 6-fluoro-1,4-dihydro-8-nitro-4-oxoquinoline
Obtained in the same manner as in Example 172- (2).
mp: 178-182 ℃
NMR (CDClThree, Δ): 6.40 (1H, d, J = 7.5 Hz), 7.76 (1H, dd,
J = 7.5, 7Hz), 8.42 (1H, dd, J = 7, 1Hz), 8.50 (1H, dd, J = 8, 1Hz)
(3) 4-chloro-6-fluoro-8-nitroquinoline was prepared according to Production Example 2- (1).
Obtained similarly.
mp: 120-130 ℃
NMR (CDClThree, Δ): 7.68 (1H, d, J = 6 Hz), 7.90 (1H, dd,
J = 7,3Hz), 8.12 (1H, dd, J = 8,3Hz), 8.90 (1H, d, J = 6Hz)
(4) 8-amino-4-chloro-6-fluoroquinoline was prepared according to Production Example 2- (3).
Obtained similarly.
mp: 98-103 ℃
NMR (DMSO-d6, Δ): 6.54 (2H, s), 6.72 (1H, dd, J = 11,
2Hz), 6.87 (1H, dd, J = 11, 2Hz), 7.73 (1H, d, J = 5Hz), 8.60 (1H,
d, J = 5Hz)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -6-fluoro
Roquinoline was obtained in the same manner as in Example 1.
mp: 200-213 ℃
NMR (DMSO-d6, Δ): 7.48-7.63 (3H, m), 7.70 (1H, dd,
J = 12,3Hz), 7.94 (1H, d, J = 6Hz), 8.71 (1H, dd, J = 12,3Hz),
8.82 (1H, d, J = 6Hz), 11.27 (1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -6-fluoro-4- (a
(Midazol-1-yl) quinoline was obtained in the same manner as in Example 8.
mp: 154-159 ℃
NMR (DMSO-d6, Δ): 7.21 (1H, dd, J = 10, 2 Hz), 7.28 (1H,
s), 7.49-7.66 (3H, m), 7.76 (1H, s), 7.80 (1H, d, J = 4Hz), 8.18
(1H, s), 8.71 (1H, dd, J = 10, 2Hz), 9.00 (1H, d, J = 4Hz), 11.31
(1H, s)Example 208
(1) 8- (2,6-dichlorobenzoylamino) -6-fluoro-4-[(
2-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8,
Rollo-8- (2,6-dichlorobenzoylamino) -6-fluoroquinoline and N
-Obtained from methylethylenediamine.
mp: 198-200 ℃
NMR (DMSO-d6, Δ): 2.32 (3H, s), 2.77 (2H, t, J = 6Hz),
3.36 (1H, dt, J = 6, 5Hz), 6.60 (1H, d, J = 6Hz), 7.15 (1H, t,
J = 5Hz), 7.50-7.63 (3H, m), 7.87 (1H, dd, J = 11, 2Hz), 8.34 (1H,
d, J = 6Hz), 8.50 (1H, dd, J = 11, 2Hz), 10.72 (1H, br s)
(2) 8- (2,6-dichlorobenzoylamino) -6-fluoro-4- (3
-Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2
).
mp: 268-272 ℃
NMR (DMSO-d6, Δ): 2.84 (3H, s), 3.59 (2H, t, J = 7Hz),
3.94 (2H, t, J = 7Hz), 7.48-7.61 (5H, m), 8.60 (1H, dd, J = 11,
2Hz), 8.81 (1H, d, J = 6Hz), 11.06 (1H, s)Example 209
(1) 8- (2,6-dichlorobenzoylamino) -6-fluoro-4-hydride
Radinoquinoline was prepared in the same manner as in Example 139- (1), using 4-chloro-8- (2
, 6-Dichlorobenzoylamino) -6-fluoroquinoline and hydrazine monohydrate
Obtained from things.
mp: 208-212 ℃
NMR (DMSO-d6, Δ): 4.51 (2H, s), 6.99 (1H, d, J = 6Hz),
7.49-7.63 (3H, m), 7.75 (1H, dd, J = 12, 3Hz), 8.37 (1H, d,
J = 6Hz), 8.47 (1H, dd, J = 12, 3Hz), 8.56 (1H, s), 10.72 (1H, s)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -6-fluoroquinoline was obtained as in Example 86.
mp: 250-254 ℃
NMR (DMSO-d6, Δ): 2.01 (3H, s), 6.68 (1H, d, J = 6Hz),
7.48-7.62 (3H, m), 7.81 (1H, dd, J = 10, 2Hz), 8.42 (1H, d,
J = 6Hz), 8.54 (1H, dd, J = 10, 2Hz), 9.18 (1H, s), 10.06 (1H, s),
10.82 (1H, s)Example 210
(1) (2-nitro-4-trifluoromethylanilino) methylenemalonic acid
Sopropylidene was prepared in the same manner as in Example 172- (1), using 2-nitro-4-triene.
Obtained from fluoromethylaniline and isopropylidene malonate.
mp: 218-220 ℃
NMR (CDClThree, Δ): 1.79 (6H, s), 7.77 (1H, d, J = 8Hz),
8.00 (1H, dd, J = 8, 2Hz), 8.61 (1H, d, J = 2Hz) 8.76 (1H, d,
(J = 10Hz)
(2) 1,4-dihydro-8-nitro-4-oxo-6-trifluoromethyl
Quinoline was obtained in the same manner as in Example 172- (2).
mp: 153-156 ℃
NMR (DMSO-d6, Δ): 6.33 (1H, d, J = 7.5 Hz), 8.03 (1H,
(dd, J = 7.5, 7Hz), 8.73 (1H, d, J = 1Hz), 8.83 (1H, d, J = 1Hz)
(3) Production Example 2 of 4-chloro-8-nitro-6-trifluoromethylquinoline
-Obtained in the same manner as in (1).
mp: 100-107 ℃
NMR (CDClThree, δ): 7.77 (1H, d, J = 5Hz) 8.25 (1H, s),
8.78 (1H, s), 9.05 (1H, d, J = 5Hz)
(4) Production Example 2 of 8-amino-4-chloro-6-trifluoromethylquinoline
-Obtained in the same manner as in (3).
mp: 57-58 ℃
NMR (CDClThree, Δ): 5.15 (2H, br s), 7.07 (1H, d, J = 2 Hz),
7.55 (1H, d, J = 6Hz), 7.80 (1H, br), 8.70 (1H, d, J = 6Hz)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -6-trif
Fluoromethylquinoline was obtained in the same manner as in Example 1.
mp: 150-157 ℃
NMR (DMSO-d6, Δ): 7.47-7.61 (3H, m), 8.05 (1H, d,
J = 6Hz), 8.29 (1H, s), 9.00 (1H, d, J = 2Hz), 9.10 (1H, s), 11.15
(1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-6-to
Lifluoromethylquinoline was obtained in the same manner as in Example 139- (1).
mp: 228-232 ℃
NMR (DMSO-d6, Δ): 4.61 (2H, s), 7.09 (1H, d, J = 6Hz),
7.50-7.63 (3H, m), 8.35 (1H, s), 8.37 (1H, d, J = 6Hz), 8.85
(1H, s), 9.10 (1H, s), 10.74 (1H, s)
(7) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -6-trifluoromethylquinoline was obtained in the same manner as in Example 86.
mp: 174-178 ℃
NMR (DMSO-d6, Δ): 2.03 (3H, s), 6.78 (1H, d, J = 6Hz),
7.49-7.63 (3H, m), 8.54 (1H, s), 8.56 (1H, d, J = 6Hz), 8.92
(1H, s), 9.69 (1H, s), 10.15 (1H, s), 10.86 (1H, s)Example 211
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -6-Trifluoromethylquinoline was converted to 4-chloro-
8- (2,6-dichlorobenzoylamino) -6-trifluoromethylquinoline
And obtained from imidazole.
mp: 201-203 ℃
NMR (DMSO-d6, Δ): 7.32 (1H, s), 7.49-7.64 (3H, m),
7.83 (2x1H, s), 7.93 (1H, d, J = 6Hz), 8.25 (1H, s), 9.09 (1H,
s), 9.19 (1H, d, J = 6Hz), 11.40 (1H, s)Example 212
(1) 8- (2,6-dichlorobenzoylamino) -4-[(2-methylamido
Noethyl) amino] -6-trifluoromethylquinoline was prepared as in Example 8.
To give 4-chloro-8- (2,6-dichlorobenzoylamino) -6-trifluoro
Obtained from romethylquinoline and N-methylethylenediamine.
mp: 202-206 ℃
NMR (DMSO-d6, Δ): 2.36 (3H, s), 2.82 (2H, t, J = 7Hz),
3.43 (2H, dt, J = 7, 5Hz), 6.72 (1H, d, J = 7Hz), 7.50-7.63 (3H,
m), 7.74 (1H, brt, J = 5Hz), 8.46 (1H, d, J = 7Hz), 8.53 (1H, s),
8.87 (1H, s), 10.75 (1H, br s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (3-methyl-2-
Oxoimidazolidin-1-yl) -6-trifluoromethylquinoline
Obtained in the same manner as in 92- (2).
mp:> 285 ° C
NMR (DMSO-d6, Δ): 2.87 (3H, s), 3.63 (2H, t, J = 7.5 Hz),
4.02 (2H, t, J = 7.5Hz), 7.48-7.61 (3H, m), 7.64 (1H, d, J = 6Hz),
8.13 (1H, d, J = 0.5Hz), 8.94 (1H, d, J = 0.5Hz), 8.98 (1H, d, J = 0.5Hz)
J = 6Hz), 11.12 (1H, s)Example 213
(1) Isopropylide (3-methyl-2-nitroanilino) methylenemalonate
Was converted to 3-methyl-2-nitroaniline in the same manner as in Example 172- (1).
Obtained from isopropylidene malonate.
mp: 187-190 ℃
NMR (CDClThree, Δ): 1.75 (6H, s), 2.50 (3H, s), 7.25 (1H,
d, J = 8Hz), 7.35 (1H, d, J = 8Hz), 7.52 (1H, t, J = 8Hz), 8.55 (1H,
d, J = 10Hz)
(2) 1,4-dihydro-7-methyl-8-nitro-4-oxoquinoline
Obtained in the same manner as in Example 172- (2).
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.46 (3H, s), 6.20-6.50 (1H, br),
7.42 (1H, d, J = 8Hz), 7.90-8.20 (1H, br), 8.22 (1H, d, J = 8Hz)
(3) 4-chloro-7-methyl-8-nitroquinoline was prepared in the same manner as in Production Example 2- (1).
Obtained in a similar manner.
mp: 140-147 ℃
NMR (CDClThree, Δ): 2.56 (3H, s), 3.52-3.60 (2H, m), 8.26
(1H, d, J = 8Hz), 8.83 (1H, d, J = 4Hz)
(4) 8-Amino-4-chloro-7-methylquinoline was prepared in the same manner as in Production Example 2- (3).
Obtained in a similar manner.
mp: 75-77 ℃
NMR (CDClThree, Δ): 2.37 (3H, s), 4.98 (2H, br s), 7.36
(1H, d, J = 8Hz), 7.41 (1H, d, J = 4Hz), 7.49 (1H, d, J = 8Hz), 8.59
(1H, d, J = 4Hz)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -7-methyl
Quinoline was obtained in the same manner as in Example 1.
mp: 202-205 ℃
NMR (CDClThree, Δ): 2.70 (3H, s), 7.30-7.45 (3H, m), 7.48
(1H, d, J = 4Hz), 7.60 (1H, d, J = 8Hz), 8.05 (1H, d, J = 8Hz), 8.68
(1H, d, J = 4Hz), 9.07 (1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -4-hydrazino-7-me
Tilquinoline was obtained in the same manner as in Example 139- (1).
mp: 202-204 ℃
NMR (DMSO-d6, Δ): 2.60 (3H, s), 7.46-7.62 (3H, m),
7.70-7.78 (2H, m), 8.10 (1H, d, J = 8Hz), 8.85 (1H, d, J = 4Hz)
(7) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -7-methylquinoline was obtained in the same manner as in Example 86.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 2.50 (3H, s), 6.55
(1H, d, J = 4Hz), 7.37-7.70 (4H, m), 8.06 (2H, d, J = 8Hz), 8.45
(1H, d, J = 4Hz), 9.12 (1H, s)
Example 214
8- (2,6-dichlorobenzoylamino) -4- (imidazol-1-yl
) -7-Methylquinoline was converted to 4-chloro-8- (2,6
-Dichlorobenzoylamino) -7-methylquinoline and imidazole.
mp: 220-222 ℃
NMR (DMSO-d6, Δ): 2.59 (3H, s), 7.28 (1H, s),
7.46-7.68 (6H, m), 7.73 (1H, s), 8.16 (1H, s), 9.02 (1H, d,
(J = 4Hz)
Its hydrochloride
mp: 170-174 ℃
NMR (DMSO-d6, Δ): 2.62 (3H, s), 7.47-7.67 (4H, m),
7.74 (1H, d, J = 8Hz), 7.89 (1H, d, J = 4Hz), 8.08 (1H, d, J = 2Hz),
8.28 (1H, d, J = 2Hz), 9.17 (1H, d, J = 4Hz), 9.72 (1H, s)Example 215
(1) 8- (2,6-dichlorobenzoylamino) -7-methyl-4-[(2
-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8 by using 4-chloro
B-8- (2,6-Dichlorobenzoylamino) -7-methylquinoline and N-meth
Obtained from tylethylenediamine.
mp: 217-230 ℃
NMR (CDClThree, Δ): 2.50 (3H, s), 2.63 (3H, s), 3.00 (2H,
t, J = 6Hz), 3.35 (2H, q, J = 6Hz), 5.75 (1H, br), 6.40 (1H, d,
J = 4Hz), 7.28-7.44 (4H, m), 7.58 (1H, d, J = 8Hz), 8.42 (1H, d,
(J = 4Hz)
(2) 8- (2,6-dichlorobenzoylamino) -7-methyl-4- (3-
Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (2).
Was obtained in the same manner as described above.
mp:> 250 ℃
NMR (CDClThree, Δ): 2.68 (3H, s), 2.98 (3H, s), 3.63 (2H,
t, J = 7Hz), 3.92 (2H, t, J = 7Hz), 7.25-7.44 (4H, m), 7.47 (1H,
d, J = 8Hz), 7.79 (1H, d, J = 8Hz), 8.75 (1H, d, J = 4Hz), 9.12 (1H,
s)Example 216
(1) (4,5-dimethyl-2-nitroanilino) methylenemalonic acid isopro
Pyridene was prepared in the same manner as in Example 172- (1), using 4,5-dimethyl-2-nitto.
Obtained from roaniline and isopropylidene malonate.
mp; 242-244 ° C
NMR (CDClThree, Δ): 1.77 (6H, s), 2.36 (3H, s), 2.41 (3H,
s), 7.36 (1H, s), 8.07 (1H, s), 8.71 (1H, d, J = 10Hz)
(2) 1,4-dihydro-5,6-dimethyl-8-nitro-4-oxoquinoli
Was obtained in the same manner as in Example 172- (2).
mp: 197-227 ℃
NMR (DMSO-d6, Δ): 2.40 (3H, s), 2.85 (3H, s), 6.15
(1H, d, J = 8Hz), 7.84 (1H, d, J = 8Hz), 8.45 (1H, s)
(3) Production Example of 4-chloro-5,6-dimethyl-8-nitroquinoline 2- (1
).
mp: 153-157 ℃
NMR (CDClThree, Δ): 2.55 (3H, s), 2.96 (3H, s), 7.57 (1H,
d, J = 3Hz), 7.83 (1H, s), 8.75 (1H, d, J = 3Hz)
(4) Production example of 8-amino-4-chloro-5,6-dimethylquinoline 2- (3
).
mp: 95-97 ℃
NMR (CDClThree, Δ): 2.40 (3H, s), 2.77 (3H, s), 4.85 (2H, s)
s), 6.86 (1H, s), 7.40 (1H, d, J = 6Hz), 8.46 (1H, d, J = 4Hz)
(5) 4-chloro-8- (2,6-dichlorobenzoylamino) -5,6-di
Methylquinoline was obtained in the same manner as in Example 1.
mp: 190-193 ℃
NMR (CDClThree, Δ): 2.55 (3H, s), 2.88 (3H, s), 7.29-7.44
(3H, m), 7.50 (1H, d, J = 4Hz), 8.47 (1H, d, J = 4Hz), 8.89 (1H,
s)
(6) 8- (2,6-dichlorobenzoylamino) -5,6-dimethyl-4-
The hydrazinoquinoline was obtained in the same manner as in Example 139- (1).
mp: 190-198 ℃
NMR (DMSO-d6, Δ): 2.41 (3H, s), 2.68 (3H, s), 4.38
(2H, s), 7.17 (1H, d, J = 4Hz), 7.45 to 7.67 (4H, m), 8.29 (1H, d,
J = 4Hz), 8.49 (1H, s)
(7) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -5,6-dimethylquinoline was obtained as in Example 86.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.99 (3H, s), 2.45 (3H, s), 2.75
(3H, s), 6.79 (1H, d, J = 4 Hz), 7.45 to 7.63 (3H, m), 8.33 (1H, d,
J = 4Hz), 8.54 (1H, s)Example 217
8- (2,6-dichlorobenzoylamino) -5,6-dimethyl-4- (imi
Dazol-1-yl) quinoline was prepared in the same manner as in Example 8 by using 4-chloro-8- (
2,6-dichlorobenzoylamino) -5,6-dimethylquinoline and imidazo
Obtained from Le.
mp: 200-215 ℃
NMR (CDClThree, Δ): 1.88 (3H, s), 2.52 (3H, s), 7.17 (1H,
s), 7.30-7.47 (5H, m), 7.67 (1H, s), 8.24 (1H, d, J = 4Hz), 8.96
(1H, s)Example 218
(1) 8- (2,6-dichlorobenzoylamino) -5,6-dimethyl-4-
[(2-Methylaminoethyl) amino] quinoline was converted to 4 in the same manner as in Example 8.
-Chloro-8- (2,6-dichlorobenzoylamino) -5,6-dimethylquino
Obtained from phosphorus and N-methylethylenediamine.
mp: 162-166 ℃
NMR (CDClThree, Δ): 2.47 (3H, s), 2.50 (3H, s), 2.78 (3H, s)
s), 3.00 (2H, t, J = 6Hz), 3.26 (2H, q, J = 6Hz), 6.35-7.00 (2H,
m), 7.25-7.42 (3H, m), 8.26 (1H, d, J = 4Hz), 8.75 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -5,6-dimethyl-4-
(3-Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92-.
Obtained in the same manner as in (2).
mp: 213-216 ℃
NMR (CDClThree, Δ): 2.53 (3H, s), 2.65 (3H, s), 2.98 (3H, s)
s), 3.55-3.90 (4H, m), 7.30-7.45 (4H, m), 8.64 (1H, d, J = 4Hz),
8.85 (1H, s)Example 219
The following compound was obtained in the same manner as in Example 167.
(1) 8- (2,6-dichlorobenzoylamino) -4- (3-pyridylmethoate
Xy) quinoline hydrochloride
mp: 188-195 ℃
NMR (DMSO-d6, Δ): 5.69 (2H, s), 7.36 (1H, d, J = 4Hz),
7.50-7.63 (3H, m), 7.70 (1H, t, J = 8Hz), 8.03-8.11 (2H, m),
8.71 (1H, d, J = 8Hz), 8.76 (1H, d, J = 8Hz), 8.85 (1H, d, J = 4Hz),
8.95 (1H, d, J = 4Hz), 9.15 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4-ethoxy-3-methyl
Lucinoline
mp: 155-157 ℃
NMR (DMSO-d6, Δ): 1.45 (3H, t, J = 7.0Hz), 2.43 (3H,
s), 4.18 (2H, q, J = 7.0Hz), 7.47-7.65 (4H, m), 7.85 (1H, d,
J = 8.0Hz), 8.15 (1H, d, J = 8.0Hz), 8.73 (1H, s), 10.70 (1H, s)
(3) 4-n-butoxy-8- (2,6-dichlorobenzoylamino) -3-
Methylquinoline
mp: 136-140 ℃
NMR (DMSO-d6, Δ): 0.98 (3H, t, J = 7.0Hz), 1.56 (2H,
m), 1.85 (2H, q, J = 7.0Hz), 2.43 (3H, s), 4.11 (2H,
t, J = 7.0Hz), 7.48-7.66 (4H, m), 7.84 (1H, d,
J = 8.0Hz), 8.66 (1H, d, J = 8.0Hz), 8.73 (1H, s)
(4) 8- (2,6-dichlorobenzoylamino) -4-isopropoxy-3
-Methylquinoline
mp: 145-150 ℃
NMR (DMSO-d6, Δ): 1.35 (6H, d, J = 6.0Hz), 2.43 (3H,
s), 4.59 (1H, qq, J = 6.0, 6.0Hz), 7.48-7.64 (4H, m), 7.86 (1H,
d, J = 8.0Hz), 8.65 (1H, d, J = 8.0Hz), 8.73 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (2-
Propenyloxy) quinoline
mp: 130-133 ℃
NMR (DMSO-d6, Δ): 2.43 (3H, s), 4.67 (2H, d,
J = 7.0Hz), 5.30 (1H, dd, J = 8.0, 1.0Hz), 5.50 (1H, dd, J = 17.0,
1.0Hz), 6.18 (1H, tdd, J = 17.0, 8.0, 7.0Hz), 7.48-7.65 (4H, m),
7.85 (1H, d, J = 8.0Hz), 8.65 (1H, d, J = 8.0Hz), 8.76 (1H, s)
(6) 4-benzyloxy-8- (2,6-dichlorobenzoylamino) -3
-Methylquinoline
mp: 173-175 ℃
NMR (DMSO-d6, Δ): 2.41 (3H, s), 5.19 (2H, s), 7.39-
7.66 (9H, m), 7.84 (1H, d, J = 8Hz), 8.66 (1H, d, J = 8Hz), 8.75
(1H, s), 10.72 (1H, s)
(7) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (2-
Phenoxyethoxy) quinoline
mp: 149-150 ℃
NMR (DMSO-d6, Δ): 2.45 (3H, s), 4.38 (2H, m), 4.50
(2H, m), 6.93-7.00 (3H, m), 7.30-7.36 (2H, m), 7.49-7.62 (4H,
m), 7.97 (1H, d, J = 8.0Hz), 8.65 (1H, d, J = 8.0Hz), 8.73 (1H,
s), 10.70 (1H, s)
(8) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- [3-
(2-pyridyl) propoxy] quinoline
mp: 106-107 ℃
NMR (DMSO-d6, Δ): 2.29 (2H, tt, J = 7.5, 7Hz), 2.41
(3H, s), 3.02 (2H, t, J = 7.5Hz), 4.15 (2H, t, J = 7Hz), 7.23 (1H,
(dd, J = 7.5, 5Hz), 7.35 (1H, d, J = 7.5Hz), 7.48-7.66 (4H, m),
7.72 (1H, dd, J = 7.5, 7.5Hz), 7.87 (1H d, J = 7.5Hz), 8.51 (1H,
d, J = 5Hz), 8.66 (1H, d, J = 7.5Hz), 8.72 (1H, s), 10.69 (1H, s)Example 220
Sodium hydride (60% in oil, 28.9 mg) and N-methylpyrrolidone
(3 ml), phenol (113 mg) was added under ice-cooling, and the mixture was added to 3 ml.
Stirred for 0 minutes. Add 4-chloro-8- (2,6-dichlorobenzoylamino) to the mixture.
No) -3-Methylquinoline (200 mg) was added and the mixture was stirred at room temperature for 30 minutes.
The mixture was stirred at 20 ° C for 4.5 hours. The mixture was extracted with ethyl acetate and the extract was extracted with water, 1N
Wash with sodium hydroxide solution and brine, dry over magnesium sulfate, and vacuum
Concentrated. The residue was crystallized from ethanol to give 8- (2,6-dichlorobenzo).
(Ilamino) -3-methyl-4-phenoxyquinoline (170 mg) as white crystals
As obtained.
mp: 168-170 ℃
NMR (DMSO-d6, Δ): 2.26 (3H, s), 6.88 (2H, d,
J = 7.5Hz), 7.09 (1H, dd, J = 7.5, 7.5Hz), 7.34 (2H, dd, J = 7.5,
7.5Hz), 7.50-7.60 (5H, m), 8.66-8.70 (1H, m), 8.87 (1H, s),
10.84 (1H, s)Example 221
The following compound was obtained in the same manner as in Example 220.
(1) 8- (2,6-dichlorobenzoylamino) -4- (4-methoxy
Nonoxy) -3-methylquinoline
mp: 149-150 ℃
NMR (DMSO-d6, Δ): 2.26 (3H, s), 3.69 (3H, s), 6.81
(2H, d, J = 8.0Hz), 6.90 (2H, d, J = 8.0Hz), 7.50-7.61 (5H, m),
8.65-8.68 (1H, m), 8.85 (1H, s), 10.81 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (pyri
Zin-3-yloxy) quinoline
mp: 202-204 ℃
NMR (DMSO-d6, Δ): 2.27 (3H, s), 7.20 (1H, dd, J = 8.0,
2.0Hz), 7.31-7.36 (1H, m), 7.49-7.64 (5H, m), 8.31 (1H, d,
J = 6.0Hz), 8.40 (1H, d, J = 2.0Hz), 8.70 (1H, dd, J = 7.0, 2.0Hz),
8.90 (1H, s), 10.88 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- [4- (imidazo
Ru-1-yl) phenoxy] quinoline
mp: 229-232 ℃
NMR (DMSO-d6, Δ): 6.80 (1H, d, J = 6Hz), 7.14 (1H, s),
7.46-7.65 (5H, m), 7.72 (1H, dd, J = 8,8Hz), 7.79-7.89 (3H, m),
8.10 (1H, d, J = 8Hz), 8.31 (1H, s), 8.71 (1H, d, J = 6Hz), 8.80
(1H, d, J = 8Hz), 10.77 (1H, s)Example 222
(1) 4-chloro-8- (2,6-dichlorobenzoylamino) -3-methyl
A solution of quinoline (500 mg) in acetic acid (16 ml) and 6N hydrochloric acid (20 ml)
Heated at 130 ° C. for 5 days. Concentrate the mixture in vacuo, collect the precipitate and wash with water
did. The residue was subjected to silica gel column chromatography (methanol: methyl chloride).
(1:20, V / V) to obtain yellow crystals. The solids are dissolved in hot ethanol (
5 ml), cooled to room temperature, filtered, washed with water and treated with 8- (2,6-
Dichlorobenzoylamino) -1,4-dihydro-3-methyl-4-oxoquino
Phosphorus (280 mg) was obtained as yellow crystals.
mp:> 300 ℃
NMR (DMSO-d6, Δ): 2.00 (3H, s), 7.35 (1H, t,
J = 8.0Hz), 7.52-7.57 (1H, m), 7.63-7.66 (2H, m), 7.95 (1H, br),
8.04 (1H, d, J = 8.0Hz), 8.12 (1H, br d, J = 8.0Hz), 10.36 (1H,
br), 10.52 (1H, br)
(2) 8- (2,6-dichlorobenzoylamino) -1,4-dihydro-3-
Methyl-4-oxoquinoline (130 mg), potassium carbonate (155 mg) and N
-To a suspension of methylpyrrolidone (3 ml) was added cinnamyl bromide (81.2 mg).
The mixture was stirred at room temperature for 2.5 hours. Extract the mixture with ethyl acetate and extract
The product was washed with water and brine, dried over magnesium sulfate, and concentrated in vacuo. Residual
The product was crystallized from ethanol to give 4-cinnamyloxy-8- (2,6-dichloromethane.
(Lobenzoylamino) -3-methylquinoline (125 mg) as white crystals.
Was.
mp: 169-171 ℃
NMR (DMSO-d6, Δ): 2.48 (3H, s), 4.85 (2H, d,
J = 7.0Hz), 6.67 (1H, td, J = 14.5, 7.0Hz), 7.25-7.38 (3H, m),
7.48-7.67 (6H, m), 7.92 (1H, d, J = 8.0Hz), 8.13 (1H, d,
J = 8.0Hz), 8.75 (1H, s), 10.70 (1H, s)Example 223
8- (2,6-dichlorobenzoylamino) -3-methyl-4- (phthalimime
Tomethoxy) quinoline was prepared in the same manner as in Example 222- (2), using 8- (2,6-
Dichlorobenzoylamino) -1,4-dihydro-3-methyl-4-oxoquino
Obtained from phosphorus and 2-bromomethylphthalimide.
mp: 217-219 ℃
NMR (DMSO-d6, Δ): 2.42 (3H, s), 5.66 (2H, s), 7.47-
7.60 (4H, m), 7.82 (1H, d, J = 8.0Hz), 7.90-7.97 (4H, m), 8.62
(1H, d, J = 8.0Hz), 8.75 (1H, s), 10.73 (1H, s)Example 224
The following compound was obtained in the same manner as in Example 25.
(1) 8- (2,6-dichlorobenzoylamino) -4- (imidazole-2
-Ylthio) -3-methylquinoline
mp: 193-195 ℃
NMR (DMSO-d6, Δ): 2.58 (3H, s), 7.02 (2H, br), 7.48-
7.57 (3H, m), 7.65 (1H, dd, J = 8.0, 8.0Hz), 8.22 (1H, d,
J = 8.0Hz), 8.63 (1H, d, J = 8.0Hz), 8.82 (1H, s), 10.79 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (1-
Methyl imidazol-2-ylthio) quinoline
mp: 244-246 ° C
NMR (DMSO-d6, Δ): 2.52 (3H, s), 3.56 (3H, s), 6.90
(1H, s), 7.26 (1H, s), 7.47-7.58 (3H, m), 7.47-7.58 (3H, m),
7.67 (1H, dd, J = 8.0, 8.0Hz), 8.23 (1H, d, J = 8.0Hz), 8.67 (1H,
d, J = 8.0Hz), 8.80 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (pyri
(Midin-2-ylthio) quinoline
mp: 267-270 ℃
NMR (DMSO-d6, Δ): 2.58 (3H, s), 7.24 (1H, dd, J = 5.0,
5.0Hz), 7.49-7.68 (4H, m), 8.06 (1H, d, J = 8.0Hz), 8.54 (2H, d,
J = 5.0Hz), 8.66 (1H, d, J = 8.0Hz), 8.97 (1H, s)Example 225
(1) 4-chloro-8- (2,6-dichlorobenzoylamino) quinoline (6
To a solution of 59 mg) in dimethyl sulfoxide (10 ml) was added sodium azide
(487 mg) was added and the mixture was stirred at 90 ° C. for 8 hours. Mix the mixture with water (20m
l) and the precipitate is filtered, washed with water and treated with 4-azido-8- (2,6-di
(Chlorobenzoylamino) quinoline (560 mg) was obtained as a white solid.
mp: 188-193 ℃
NMR (DMSO-d6, Δ): 7.48-7.61 (4H, m), 7.67 (1H, dd,
J = 8, 8Hz), 7.81 (1H, d, J = 8Hz), 8.36 (1H, d, J = 8Hz), 8.43 (1H,
d, J = 6Hz), 10.76 (1H, s)
(2) 4-azido-8- (2,6-dichlorobenzoylamino) quinoline (5
18 mg) in ethyl acetate (5 ml) was added to a suspension of triphenylphosphine (3.
83 mg) was added and the mixture was stirred at 45 ° C. for 3 hours. The resulting precipitate is filtered off.
The residue was recrystallized from ethanol to give 8- (2,6-dichlorobenzoic acid).
Ruamino) -4-[(triphenylphosphoranylidene) amino] quinoline (84
6 mg) as white crystals.
mp: 276-281 ℃
NMR (CDClThree, Δ); 6.17 (1H, d, J = 6Hz), 7.21-7.39 (3H,
m), 7.44-7.64 (10H, m), 7.75-7.87 (6H, m), 8.05 (1H, d,
J = 6Hz), 8.55 (1H, d, J = 8Hz), 8.87 (1H, d, J = 8Hz), 10.14 (1H,
br s)
(3) 8- (2,6-dichlorobenzoylamino) -4-[(triphenylpho
Suphoranylidene) amino] quinoline (310 mg), 6N hydrochloric acid (5 ml) and acetic acid
(5 ml) was heated at 130 ° C. for 3 hours. After cooling, the mixture was hydroxylated with 6N
Neutralized with sodium solution and the insolubles were collected by filtration. Residue from ethyl acetate
Recrystallize to give 4-amino-8- (2,6-dichlorobenzoylamino) quinoline
(174 mg) was obtained.
mp: 265-275 ℃
NMR (DMSO-d6, Δ): 6.87 (1H, d, J = 7Hz), 7.50-7.64 (3H,
m), 7.75 (1H, dd, J = 8, 8Hz), 8.34 (1H, d, J = 8Hz), 8.40 (1H, d,
J = 8Hz), 8.51 (1H, d, J = 7Hz), 9.07-9.35 (2H, br), 11.07 (1H, s)
(4) 4-amino-8- (2,6-dichlorobenzoylamino) quinoline (1
A suspension of 34 mg) in acetic anhydride (2 ml) was stirred at 120 ° C. for 2 hours. mixture
The residue was concentrated to dryness, and the residue was subjected to silica gel flash chromatography (ethyl acetate).
(N: hexane = 1: 1, V / V). Collect the initial fraction from the column
, 4- (N, N-diacetylamino) -8- (2,6-dichlorobenzoylamido
(No) Quinoline was obtained as white crystals (33 mg). Collect the late separations and add
Toamide-8- (2,6-dichlorobenzoylamino) quinoline was converted to white crystals (1
4 mg).
4- (N, N-diacetylamino) -8- (2,6-dichlorobenzoylamino
No) Quinoline
mp: 192-195 ℃
NMR (DMSO-d6, Δ): 2.33 (2x3H, s), 7.32-7.50 (5H, m),
7.60 (1H, dd, J = 8, 8Hz), 8.88 (1H, d, J = 6Hz), 9.04 (1H, d,
J = 8Hz), 10.05 (1H, s)
4-acetamido-8- (2,6-dichlorobenzoylamino) quinoline
mp: 286-288 ℃ (decomposition)
NMR (DMSO-d6, Δ): 2.37 (3H, s), 7.30-7.43 (3H, m),
7.53-7.66 (2H, m), 7.99 (1H, s), 8.38 (1H, d, J = 8Hz), 8.70
(1H, d, J = 6Hz), 8.97 (1H, d, J = 8Hz), 10.18 (1H, s)Example 226
The following compound was obtained in the same manner as in Example 8.
(1) 8- (2,6-dichlorobenzoylamino) -4-phenethylaminoki
Norin
mp: 220-226 ℃
NMR (DMSO-d6, Δ): 2.99 (2H, t, J = 7 Hz), 3.54 (2H, dt,
J = 7,5Hz), 6.63 (1H, d, J = 6Hz), 7.16-7.36 (5H, m), 7.42-7.63
(5H, m), 7.98 (1H, d, J = 8Hz), 8.36 (1H, d, J = 6Hz), 8.63 (1H,
d, J = 6Hz), 10.46 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (N-methoxy-N
-Methylamino) quinoline
mp: 155-157 ℃
NMR (DMSO-d6, Δ); 3.18 (3H, s), 3.64 (3H, s), 7.40
(1H, d, J = 6.0Hz), 7.49-7.65 (4H, m), 7.75 (1H, d, J = 8.0Hz),
8.69 (1H, d, J = 8.0Hz), 8.76 (1H, d, J = 6.0Hz)Example 227
(1) 4-Chloro-8- (2-nitrobenzoylamino) quinoline was prepared in Examples
8-amino-4-chloroquinoline and 2-nitrobenzoyl chloride
Obtained from.
mp: 221-223 ℃
NMR (CDClThree, Δ): 7.55 (1H, d, J = 4 Hz), 7.65 to 7.80 (4H,
m), 7.99 (1H, d, J = 8Hz), 8.16 (1H, d, J = 8Hz), 8.62 (1H, d,
J = 4Hz), 8.97 (1H, d, J = 8Hz)
(2) Implement 4-hydrazino-8- (2-nitrobenzoylamino) quinoline
Obtained in the same manner as in Example 139- (1).
mp: 198-203 ℃
NMR (DMSO-d6, Δ): 4.50 (2H, s), 6.98 (1H, d, J = 4Hz),
7.41 (1H, t, J = 8Hz), 7.76-7.95 (4H, m), 8.15 (1H, d, J = 8Hz),
8.39 (1H, d, J = 4Hz), 8.55 (1H, d, J = 8Hz), 8.68 (1H, s)
(3) 4- (2-acetylhydrazino) -8- (2-nitrobenzoylamino
) Quinoline was obtained in the same manner as in Example 86.
mp: 232-235 ℃
NMR (DMSO-d6, Δ): 3.32 (3H, s), 6.65 (1H, d, J = 4Hz),
7.52 (1H, t, J = 8Hz), 7.75-7.93 (3H, m), 7.99 (1H, d, J = 8Hz),
8.17 (1H, d, J = 8Hz), 8.45 (1H, d, J = 4Hz), 8.60 (1H, d, J = 8Hz),
9.29 (1H, s)Example 228
4- (imidazol-1-yl) -8- (2-nitrobenzoylamino) quino
Phosphorus was converted to 4-chloro-8- (2-nitrobenzoylamido in the same manner as in Example 8.
G) Obtained from quinoline and imidazole.
mp: 195-198 ℃
NMR (DMSO-d6, Δ): 7.26 (1H, s), 7.57 (1H, d, J = 8Hz),
7.70-7.95 (6H, m), 8.18 (1H, s), 8.20 (1H, d, J = 8Hz), 8.74
(1H, br d, J = 8Hz), 9.01 (1H, d, J = 2Hz)
Its hydrochloride
mp: 227-235 ℃
NMR (DMSO-d6, Δ): 7.52 (1H, d, J = 8Hz), 7.75-8.03 (6H,
m), 8.17-8.24 (2H, m), 8.78 (1H, br d, J = 8Hz), 9.13 (1H, d,
J = 5Hz), 9.53 (1H, s)Example 229
(1) 4-[(2-methylaminoethyl) amino] -8- (2-nitrobenzo
Ilamino) quinoline was prepared in the same manner as in Example 8 by using 4-chloro-8- (2-nitro)
(Benzoylamino) quinoline and N-methylethylenediamine.
NMR (DMSO-d6, Δ): 2.37 (3H, s), 2.84 (2H, t, J = 6Hz),
3.29-3.48 (2H, m), 6.59 (1H, d, J = 6Hz), 7.30 (1H, t, J = 5Hz),
7.45 (1H, dd, J = 8,8Hz), 7.75-7.96 (3H, m), 8.00 (1H, d,
J = 8Hz), 8.15 (1H, d, J = 8Hz), 8.37 (1H, d, J = 6Hz), 8.56 (1H, d,
J = 7.5Hz), 10.58 (1H, s)
(2) 4- (3-methyl-2-oxoimidazolidin-1-yl) -8- (2
(Nitrobenzoylamino) quinoline was obtained in the same manner as in Example 92- (2).
mp: 226-228 ℃
NMR (DMSO-d6, Δ): 2.85 (3H, s), 3.60 (2H, t,
J = 7.5Hz), 3.96 (2H, t, J = 7.5Hz), 7.51 (1H, d, J = 6Hz), 7.60
(1H, dd, J = 8, 8Hz), 7.75 to 7.83 (2H, m), 7.85 to 7.94 (2H, m), 8.19
(1H, d, J = 8Hz), 8.63 (1H, d, J = 7Hz), 8.84 (1H, d, J = 6Hz),
10.72 (1H, s)Example 230
(1) 4-chloro-3-methoxymethyl-8- (2-trifluoromethylben
Zoylamino) quinoline was converted to 8-amino-4-chloro-
Obtained from 3-methoxymethylquinoline and 2-trifluoromethylbenzoyl chloride
.
mp: 121-122 ℃
NMR (DMSO-d6, Δ): 3.40 (3H, s), 4.77 (2H, s), 7.74
7.91 (5H, m), 8.02 (1H, d, J = 8.0Hz), 8.73 (1H, d, J = 8.0Hz),
8.90 (1H, s)
(2) 4- (imidazol-1-yl) -3-methoxymethyl-8- (2-t
(Lifluoromethylbenzoylamino) quinoline was obtained in the same manner as in Example 8.
mp: 126-127 ℃
NMR (DMSO-d6, Δ): 3.26 (3H, s), 4.35 (2H, s), 7.08
(1H, d, J = 8.0Hz), 7.28 (1H, s), 7.56 (1H, s), 1.69-7.92 (5H,
m), 7.97 (1H, s), 8.72 (1H, d, J = 7.5Hz), 9.06 (1H, s)Example 231
(1) 3-methoxymethyl-4-[(2-methylaminoethyl) amino] -8
-(2-Trifluoromethylbenzoylamino) quinoline was prepared in the same manner as in Example 8.
To give 4-chloro-3-methoxymethyl-8- (2-trifluoromethylbenzo
Ylamino) quinoline and N-methylethylenediamine.
NMR (DMSO-d6, Δ): 2.33 (3H, s), 2.76 (2H, t, J = 6Hz),
3.17 (3H, s), 3.67 (2H, dt, J = 6, 5 Hz), 4.53 (2H, s), 6.59 (1H,
t, J = 5Hz), 7.47 (1H, dd, J = 8, 8Hz), 7.78 (1H, m), 7.83-7.87
(2H, m), 7.90 (1H, d, J = 8Hz), 7.97 (1H, d, J = 8Hz), 8.32 (1H,
s), 8.60 (1H, s), 10.32 (1H, s)
(2) 3-methoxymethyl-4- (3-methyl-2-oxoimidazolidin-
Implement 1-yl) -8- (2-trifluoromethylbenzoylamino) quinoline
Obtained in the same manner as in Example 92- (2).
mp: 156 ℃
NMR (DMSO-d6, Δ): 2.82 (3H, s), 3.33 (3H, s), 3.59-
3.74 (3H, m), 3.85 (1H, m), 4.56 (1H, d, J = 12Hz), 4.61 (1H, d,
J = 12Hz), 7.67-7.73 (2H, m), 7.78 (1H, m), 7.83-7.88 (2H, m),
7.90 (1H, d, J = 8Hz), 8.67 (1H, m), 8.93 (1H, s), 10.45 (1H, s)Example 232
(1) 8-amino-3-bromoquinoline (330 mg), 3-methoxycarbo
Nylbenzoic acid (267 mg), 1-ethyl-3- (3-dimethylaminopropyl
) Carbodiimide hydrochloride (369 mg) and 1-hydroxybenzotriazole (
(300 mg) in dimethylformamide (5 ml) was stirred at room temperature overnight.
Was. Water was added to the mixture, and the resulting precipitate was collected by filtration and washed with hot methanol.
And dried to give 3-bromo-8- [3- (methoxycarbonyl) benzoylamido.
[N] quinoline (390 mg) was obtained as a pale yellow solid.
mp: 157 ℃
NMR (CDClThree, Δ): 3.99 (3H, s), 7.49 (1H, d, J = 8Hz),
7.60-7.70 (2H, m), 8.22-8.30 (2H, m), 8.37 (1H, brs), 8.70
(1H, br s), 8.86 (1H, br s), 8.95 (1H, d, J = 8Hz)
(2) 3-bromo-8- [3- (methoxycarbonyl) benzoylamino] ki
Methanol of norin (356mg) and 1N sodium hydroxide aqueous solution (1.1ml)
(5 ml) and a mixture of dioxane (5 ml) were gently refluxed for 2 hours. cold
After rejection, the mixture was neutralized with 1N hydrochloric acid. Remove the solvent in vacuo and heat the residue to 95%
Washed with ethanol and collected by filtration to give 3-bromo-8- (3-carboxybenzene.
(Nzoylamino) quinoline (397 mg) was obtained as a light brown solid.
mp: 275-277 ℃
NMR (DMSO-d6, Δ): 7.65-7.80 (3H, m), 8.14-8.25 (2H,
m), 8.54 (1H, m), 8.70 (1H, dd, J = 8, 2 Hz), 8.81 (1H, d,
J = 2Hz), 9.03 (1H, d, J = 2Hz)
(3) 3-bromo-8- (3-carboxybenzoylamino) quinoline (20
0 mg), dimethylamine hydrochloride (65.9 mg), 1-ethyl-3- (3-di
Methylaminopropyl) carbodiimide (100 mg) and 1-hydroxybenzo
Mix a mixture of triazole (109 mg) in dimethylformamide (3 ml)
Stir for 3 hours at warm. Dilute the mixture with ethyl acetate, wash with water, and add magnesium sulfate.
After drying over water, the solvent was distilled off in vacuo. Preparative thin-layer chromatography of the residue
(Ethyl acetate) and recrystallized from ethanol to give 3-bromo-8- [3-
(Dimethylcarbamoyl) benzoylamino] quinoline (120 mg) in pale yellow
Obtained as a solid.
mp: 157 ℃
NMR (DMSO-d6, Δ): 2.95 (3H, br s), 3.03 (3H, br s),
7.64-7.80 (4H, m), 8.03 (1H, brs), 8.10 (1H, m), 8.68 (1H, d,
J = 8Hz), 8.84 (1H, d, J = 2Hz), 9.04 (1H, d, J = 2Hz)Example 233
(1) 3-bromo-8- [4- (methoxycarbonyl) benzoylamino] ki
Norin was prepared in the same manner as in Example 232- (1), using 8-amino-3-bromoquinolyl.
And 4-methoxycarbonylbenzoic acid.
mp: 174-176 ℃
NMR (CDClThree, Δ): 3.99 (3H, s), 7.48 (1H, d, J = 8Hz),
7.64 (1H, t, J = 8Hz), 8.10 (2H, d, J = 8Hz), 8.20 (2H, d, J = 8Hz),
8.35 (1H, d, J = 3Hz), 8.84 (1H, d, J = 3Hz), 8.94 (1H, d, J = 8Hz)
(2) Implement 3-bromo-8- (4-carboxybenzoylamino) quinoline
Obtained in the same manner as in Example 232- (2).
mp:> 300 ℃
NMR (DMSO-d6, Δ): 7.68-7.79 (2H, m), 8.07 (2H, d,
J = 9Hz), 8.11 (2H, d, J = 9Hz), 8.20 (1H, d, J = 8Hz), 8.83 (1H,
s), 9.04 (1H, d, J = 2Hz)
(3) 3-bromo-8- [4- (dimethylcarbamoyl) benzoylamino]
Quinoline was obtained in the same manner as in Example 232- (3).
mp: 196-198 ℃
NMR (DMSO-d6, δ): 2.91 (3H, s), 3.02 (3H, s), 7.62
(2H, d, J = 9Hz), 7.69-7.80 (2H, m), 8.08 (2H, d, J = 9Hz), 8.70
(1H, m), 8.84 (1H, d, J = 2Hz), 9.02 (1H, d, J = 2Hz)Example 234
(1) 3-bromo-8- (2,3,4-trimethoxybenzoylamino) quino
Phosphorus was converted into 8-amino-3-bromoquinoline in the same manner as in Example 232- (1).
And 2,3,4-trimethoxybenzoic acid.
mp: 158-161 ℃
NMR (CDClThree, Δ): 3.96 (3Hx2, s), 4.23 (3H, s), 6.84
(1H, d, J = 8Hz), 7.44 (1H, d, J = 8Hz), 7.60 (1H, t, J = 8Hz), 8.09
(1H, d, J = 8Hz), 8.32 (1H, d, J = 2Hz), 8.89 (1H, d, J = 2Hz), 9.03
(1H, d, J = 8Hz)
(2) 3-bromo-8- (2,3,4-trimethoxybenzoylamino) quino
To a solution of phosphorus (700 mg) in dichloromethane (10 ml) was added 1M borane tribromide.
Dichloromethane solution (5.5 ml) was added under ice-cooling, and the mixture was allowed to stand at room temperature for 2 hours.
Stirred. Ice water was added to the mixture and the mixture was stirred for 1.5 hours. Mix 1N water
The pH was adjusted to 4 with a sodium oxide solution, and ethyl acetate was added thereto. Mix room
The mixture was stirred overnight at room temperature, and insoluble materials were removed by filtration. The filtrate is concentrated in vacuo and the residue is
Purification by chromatography (methanol-dichloromethane) gives 3-bromo-8.
-(2,3,4-trihydroxybenzoylamino) quinoline (110 mg)
Obtained.
mp: 183-193 ℃
NMR (DMSO-d6, Δ): 6.46 (1H, d, J = 8 Hz), 7.41 (1H, d,
J = 8Hz), 7.60-7.71 (2H, m), 8.77 (1H, d, J = 2Hz), 8.84-8.94 (2H,
m)Example 235
(1) 3-Bromo-8- (2-nitrobenzoylamino) quinoline was prepared in Examples
8-amino-3-bromoquinoline and 2-nitrobenzoyl chloride
Obtained from.
mp: 168-171 ℃
NMR (CDClThree, Δ): 7.50 (1H, d, J = 8 Hz), 7.59-7.85 (4H,
m), 8.15 (1H, d, J = 8Hz), 8.35 (1H, d, J = 2Hz), 8.74 (1H, s),
8.90 (1H, d, J = 8Hz)
(2) To a solution of ammonium chloride (50.9 mg) in water (2 ml) was added ethanol.
(10 ml) was added and the mixture was stirred at 50 ° C. 3-bromo-8 in the mixture
-(2-nitrobenzoylamino) quinoline (590 mg) and iron (531 mg)
Was added and the mixture was refluxed for 1 hour. After filtration, the filtrate is concentrated in vacuo and the residue is
Suspended in 80% ethanol and allowed to cool to room temperature. The resulting precipitate is collected by filtration.
First, 8- (2-aminobenzoylamino) -3-bromoquinoline (470 mg)
) Was obtained as a light brown solid.
mp: 147-150 ℃
NMR (CDClThree, Δ): 5.72 (2H, br s), 6.75 (1H, d, J = 8Hz),
6.79 (1H, t, J = 8Hz), 7.29 (1H, t, J = 8Hz), 7.45 (1H, d, J = 8Hz),
7.61 (1H, t, J = 8Hz), 7.73 (1H, d, J = 8Hz), 8.33 (1H, d, J = 2Hz),
8.83 (1H, d, J = 2Hz), 8.87 (1H, d, J = 8Hz)
(3) 8- (2-aminobenzoylamino) -3-bromoquinoline (200 m
g), acetic anhydride (71.6 mg) and pyridine (139 mg) in ethylene chloride (4
ml) was stirred at room temperature for 20 hours. Dilute the mixture with dichloromethane
After washing with water and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Suspended in hot ethanol and allowed to cool to room temperature. Collect the resulting precipitate by filtration
, 8- (2-acetamidobenzoylamino) -3-bromoquinoline (200 m
g) was obtained as a yellow powder.
mp: 206 ℃
NMR (DMSO-d6, Δ): 2.03 (3H, s), 7.34 (1H, t, J = 8Hz),
7.58 (1H, t, J = 8Hz), 7.67-7.76 (2H, m), 7.84-7.93 (2H, m),
8.70 (1H, d, J = 8Hz), 8.81 (1H, d, J = 2Hz), 8.96 (1H, d, J = 2Hz),
10.46 (2H, brs)Example 236
(1) 3-bromo-8- (3-nitrobenzoylamino) quinoline was prepared according to the examples.
8-amino-3-bromoquinoline and 3-nitrobenzoyl chloride in the same manner as in 1.
Obtained from.
mp: 258 ℃
NMR (DMSO-d6, Δ): 7.69-7.84 (2H, m), 7.90 (1H, t,
J = 8Hz), 8.43-8.52 (2H, m), 8.60 (1H, d, J = 6Hz), 8.76-8.88 (2H,
m), 9.03 (1H, d, J = 2Hz)
(2) Example 2 was performed using 8- (3-aminobenzoylamino) -3-bromoquinoline.
Obtained in the same manner as in 35- (2).
mp: 209-211 ℃
NMR (DMSO-d6, Δ): 5.49 (2H, br s), 6.81 (1H, dd, J = 8,
2Hz), 7.10 (1H, br d, J = 8Hz), 7.18-7.28 (2H, m), 7.67-7.74
(2H, m), 8.24 (1H, m), 8.81 (1H, d, J = 2Hz), 9.01 (1H, d,
(J = 2Hz)
(3) 8- (3-acetamidobenzoylamino) -3-bromoquinoline
Obtained in the same manner as in Example 235- (3).
mp: 198-202 ℃
NMR (DMSO-d6, Δ): 2.09 (3H, s), 7.54 (1H, t, J = 8Hz),
7.63-7.78 (3H, m), 7.86 (1H, brd, J = 8Hz), 8.24 (1H, s), 8.72
(1H, m), 8.81 (1H, s), 9.00 (1H, d, J = 2Hz)Example 237
3-bromo-8- (3-methyl-2-nitrobenzoylamino) quinoline is
In the same manner as in Example 232- (1), 2-amino-3-bromoquinoline and
Obtained from tyl-2-nitrobenzoic acid.
mp: 203-209 ℃
NMR (DMSO-d6, Δ): 2.37 (3H, s), 7.65 to 7.80 (4H, m),
7.82-7.93 (1H, m), 8.52 (1H, d, J = 8Hz), 8.83 (1H, d, J = 2Hz),
8.99 (1H, d, J = 2Hz)Example 238
3-bromo-8- (2-trifluoromethylbenzoylamino) quinoline is
In the same manner as in Example 1, 2-amino-3-bromoquinoline and 2-trifluorofluorochloride were used.
Obtained from romethylbenzoyl.
mp: 138-141 ℃
NMR (CDClThree, Δ): 7.50 (1H, d, J = 8Hz), 7.60-7.84 (4H,
m), 8.35 (1H, s), 8.75 (1H, s), 8.94 (1H, d, J = 8Hz)Example 239
3-bromo-8-[(2-chloropyridin-3-ylcarbonyl) amino] ki
Norin was prepared in the same manner as in Example 232- (1), using 2-amino-3-bromoquinolyl.
And 2-chloro-3-pyridinecarboxylic acid.
mp: 164-168 ℃
NMR (DMSO-d6, Δ): 7.50-7.63 (1.2H, m), 7.66-7.80
(2.1H, m), 8.00 (0.4H, d, J = 8Hz), 8.11-8.28 (1.2H, m), 8.52-
8.60 (0.8H, m), 8.67-8.76 (0.8H, m), 8.80 (0.7H, brs), 8.87
(0.3H, t, J = 6Hz), 8.95 (0.5H, m)Example 240
(1) 8- (2,6-dichlorobenzoylamino) -3,5-dimethyl-4-
The hydrazinoquinoline was prepared in the same manner as in Example 139- (1), using 4-chloro-8-
(2,6-dichlorobenzoylamino) -3,5-dimethylquinoline and hydrazi
From monohydrate.
NMR (DMSO-d6, Δ): 1.84 (3H, s), 1.93 (3H, s), 4.15
4.33 (2H, m), 6.60 (1H, d, J = 8Hz), 7.16-7.33 (1H, m), 7.40-
7.71 (4H, m), 10.01 (1H, s)
(2) 4- (2-acetylhydrazino) -8- (2,6-dichlorobenzoyl
Amino) -3,5-dimethylquinoline was obtained as in Example 86.
mp: 234-238 ℃
NMR (DMSO-d6, Δ): 1.76 (2x3H, s), 2.03 (3H, s),
7.23-7.73 (6H, m), 8.80 (1H, s), 9.45 (1H, br), 9.73 (1H, br)Example 241
(1) 8- (2,6-dichlorobenzoylamino) -3,5-dimethyl-4-
[(2-Methylaminoethyl) amino] quinoline was converted to 4 in the same manner as in Example 8.
-Chloro-8- (2,6-dichlorobenzoylamino) -3,5-dimethylquino
Obtained from phosphorus and N-methylethylenediamine.
mp: 151-152 ℃
NMR (DMSO-d6, Δ): 2.26 (3H, s), 2.37 (3H, s), 2.58
(2H, t, J = 6Hz), 2.86 (3H, s), 3.25 (2H, dt, J = 6, 5Hz), 5.56
(1H, t, J = 5Hz), 7.24 (1H, d, J = 7.5Hz), 7.48-7.63 (3H, m), 8.34
(1H, s), 8.43 (1H, d, J = 7.5Hz), 10.41 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3,5-dimethyl-4-
(3-Methyl-2-oxoimidazolidin-1-yl) quinoline was prepared according to Example 92-.
Obtained in the same manner as in (2).
mp:> 300 ℃
NMR (DMSO-d6, Δ): 2.34 (3H, s), 2.68 (3H, s), 2.80
(3H, s), 3.52-3.74 (4H, m), 7.45 (1H, d, J = 8Hz), 7.48-7.62
(3H, m), 8.53 (1H, d, J = 8Hz), 8.83 (1H, s), 10.66 (1H, s)Example 242
8- (2,6-dichlorobenzoylamino) -3,5-dimethyl-4- (3-
Methyl-2-thioxoimidazolidin-1-yl) quinoline was prepared according to Example 92- (
In the same manner as in 2), 8- (2,6-dichlorobenzoylamino) -3,5-dimethyl
Tyl-4-[(2-methylaminoethyl) amino] quinoline and 1,1'-thioca
Obtained from rubonyl diimidazole.
mp: 275-278 ℃
NMR (DMSO-d6, Δ): 2.35 (3H, s), 2.67 (3H, s), 3.15
(3H, s), 3.78-4.03 (4H, m), 7.45 (1H, d, J = 8Hz), 7.48-7.63
(3H, m), 8.54 (1H, d, J = 8Hz), 8.85 (1H, s), 10.68 (1H, s)Example 243
8- (2,6-dichlorobenzoylamino) -3,5-dimethyl-4- (pyri
(Gin-3-yloxy) quinoline was converted to 4-chloro-
8- (2,6-dichlorobenzoylamino) -3,5-dimethylquinoline and 3-
Obtained from hydroxypyridine.
mp: 234-237 ° C
NMR (DMSO-d6, Δ): 2.16 (3H, s), 2.57 (3H, s), 7.12
(1H, dd, J = 9.0, 2.0Hz), 7.32 (1H, dd, J = 9.0, 4.0Hz), 7.43 (1H,
d, J = 8.0Hz), 7.48-7.60 (3H, m), 8.30-8.35 (2H, m), 8.59 (1H,
d, J = 8.0Hz), 8.85 (1H, s)Example 244
8- (2,6-dichlorobenzoylamino) -3,5-dimethyl-4- (imi
Dazol-2-ylthio) quinoline was prepared in the same manner as in Example 25 by using 4-chloro-
8- (2,6-dichlorobenzoylamino) -3,5-dimethylquinoline and 2-
Obtained from mercaptoimidazole.
mp: 263-266 ℃
NMR (DMSO-d6, Δ): 2.43 (3H, s), 3.03 (3H, s), 6.85
(1H, s), 7.11 (1H, s), 7.48-7.59 (4H, m), 8.54 (1H, d,
J = 8.0Hz), 8.75 (1H, s), 10.67 (1H, s)Example 245
(1) 5-chloro-1,4-dihydro-3-hydroxymethyl-8-nitro-
4-oxoquinoline was prepared in the same manner as in Example 172- (3), using 5-chloro-1,
Obtained from 4-dihydro-8-nitro-4-oxoquinoline.
mp:> 250 ℃
NMR (DMSO-d6, Δ): 4.37 (2H, s), 7.45 (1H, d, J = 8Hz),
7.93 (1H, d, J = 4Hz), 8.52 (1H, d, J = 8Hz)
(2) 5-chloro-1,4-dihydro-3-methyl-8-nitro-4-oxo
Quinoline was obtained in the same manner as in Example 104- (2).
mp:> 250 ℃
NMR (DMSO-d6, Δ): 1.97 (3H, s), 7.42 (1H, d, J = 8Hz),
7.87 (1H, d, J = 6Hz), 8.49 (1H, d, J = 8Hz)
(3) Production example of 4-5-dichloro-3-methyl-8-nitroquinoline 2- (1
).
mp: 136-138 ℃
NMR (CDClThree, Δ): 2.61 (3H, s), 7.73 (1H, d, J = 8Hz),
7.80 (1H, d, J = 8Hz), 8.84 (1H, s)
(4) Production example of 8-amino-4,5-dichloro-3-methylquinoline 2- (3
).
mp: 128-130 ℃
NMR (CDClThree, Δ): 2.53 (3H, s), 5.07 (2H, s), 6.79 (1H,
d, J = 8Hz), 7.42 (1H, d, J = 8Hz), 8.55 (1H, s)
(5) 4,5-dichloro-8- (2,6-dichlorobenzoylamino) -3-
Methylquinoline was obtained in the same manner as in Example 1.
mp: 222-233 ℃
NMR (CDClThree, Δ): 2.56 (3H, s), 7.30-7.44 (3H, m), 7.71
(1H, d, J = 8Hz), 8.58 (1H, s), 8.83 (1H, d, J = 8Hz)
(6) 5-chloro-8- (2,6-dichlorobenzoylamino) -4- (imi
Dazol-1-yl) -3-methylquinoline was obtained in the same manner as in Example 8.
mp: 260-262 ℃
NMR (DMSO-d6, Δ): 2.14 (3H, s), 7.19 (1H, s), 7.40
(1H, s), 7.50-7.60 (3H, m), 7.79 (2H, d, J = 8Hz), 7.83 (1H, s),
8.69 (1H, d, J = 8Hz), 9.04 (1H, s)Example 246
5-chloro-8- (2,6-dichlorobenzoylamino) -3-methyl-4-
(Pyridin-3-yloxy) quinoline was prepared in the same manner as in Example 220 by using 4,5
-Dichloro-8- (2,6-dichlorobenzoylamino) -3-methylquinoline
And 3-hydroxypyridine.
mp: 232-236 ℃
NMR (CDClThree, Δ): 2.28 (3H, s), 6.96 (1H, dd, J = 8,
2Hz), 7.21 (1H, dd, J = 8, 5Hz), 7.31-7.45 (3H, m), 7.60 (1H, d,
J = 8Hz), 8.25 (1H, d, J = 2Hz), 8.34 (1H, d, J = 5Hz), 8.70 (1H,
s), 8.87 (1H, d, J = 8Hz)Example 247
5-chloro-8- (2,6-dichlorobenzoylamino) -4- (imidazo
Ru-2-ylthio) -3-methylquinoline was prepared in the same manner as in Example 25 by using 4,5
-Dichloro-8- (2,6-dichlorobenzoylamino) -3-methylquinoline
And 2-mercaptoimidazole.
mp:> 288 ° C (decomposition)
NMR (CDClThree, Δ): 2.40 (3H, s), 7.30-7.49 (5H, m), 7.76
(1H, s), 8.47 (1H, s), 8.98 (1H, d, J = 8Hz)Example 248
(1) 8-amino-1,4-dihydro-3-methoxymethyl-4-oxoquino
Phosphorus was converted to 1,4-dihydro-3-methoxymethyl in the same manner as in Production Example 2- (3).
Obtained from ru-8-nitro-4-oxoquinoline.
mp:> 300 ℃
NMR (DMSO-d6, Δ): 3.30 (3H, s), 4.30 (2H, s), 5.45
(2H, s), 6.90 (1H, d, J = 8Hz), 7.04 (1H, dd, J = 8, 8Hz), 7.39
(1H, d, J = 8Hz), 7.85 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -4- (2,6-dichloro
Benzoyloxy) -3-methoxymethylquinoline was prepared in the same manner as in Example 1.
8-Amino-1,4-dihydro-3-methoxymethyl-4-oxoquinoline and salts
Obtained from 2,6-dichlorobenzoyl compound.
mp: 241-243 ℃
NMR (DMSO-d6, Δ): 3.36 (3H, s), 4.80 (2H, s), 7.46-
7.62 (3H, m), 7.72 (1H, m), 7.79-7.87 (3H, m), 8.01 (1H, d,
J = 8Hz), 8.81 (1H, d, J = 8Hz), 9.07 (1H, s), 11.01 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -4- (2,6-dichloro
Benzoyloxy) -3-methoxymethylquinoline (4.88 g) in ethanol
(100 ml) and a 1N sodium hydroxide solution (30 ml) at 90 ° C. for 2 hours.
Stirred for hours. After evaporating the solvent, the residue was diluted with water and the solution was neutralized with 1N hydrochloric acid
. The resulting precipitate was collected by filtration, washed with water and diethyl ether to give 8- (2
, 6-Dichlorobenzoylamino) -1,4-dihydro-3-methoxymethyl-
4-oxoquinoline (3.41 g) was obtained as a white powder.
mp: 290 ° C (decomposition)
NMR (DMSO-d6, Δ): 3.32 (3H, s), 4.32 (2H, s), 7.40
(1H, dd, J = 8, 8Hz), 7.52-7.68 (3H, m), 8.01 (1H, d, J = 7Hz),
8.05 (1H, d, J = 8Hz), 8.10 (1H, d, J = 8Hz), 10.45 (1H, s), 10.66
(1H, d, J = 7Hz)
(4) 8- (2,6-dichlorobenzoylamino) -1,4-dihydro-3-
Methoxymethyl-4-oxoquinoline (209 mg) and N-methylpyrrolidone (
4 ml), 3-chloromethylpyridine hydrochloride (109 mg), potassium carbonate.
Lithium (153 mg) and sodium iodide (20 mg) were added, and the mixture was heated to 80 ° C.
For 4 hours. The mixture was partitioned between ethyl acetate and water, and the separated organic layer was separated.
After washing with brine and drying over magnesium sulfate, the solvent was distilled off in vacuo. Residue
Is crystallized from ethanol to give 8- (2,6-dichlorobenzoylamino) -3.
-Methoxymethyl-4- (pyridin-3-ylmethoxy) quinoline (170 mg
) Was obtained as white crystals.
mp: 174-176 ℃
NMR (DMSO-d6, Δ): 3.33 (3H, s), 4.65 (2H, s), 5.32
(2H, s), 7.46-7.61 (4H, m), 7.67 (1H, dd, J = 8, 8Hz), 7.90 (1H,
d, J = 8Hz), 8.00 (1H, m), 8.61 (1H, d, J = 5Hz), 8.70-8.77 (2H,
m), 8.85 (1H, s), 10.80 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-methoxymethyl-4
-(Pyridin-2-ylmethoxy) quinoline was prepared in the same manner as in Example 248- (4).
To give 8- (2,6-dichlorobenzoylamino) -1,4-dihydro-3-meth
Obtained from toxicmethyl-4-oxoquinoline and 2-chloromethylpyridine.
mp: 112-113 ℃
NMR (DMSO-d6, Δ): 2.50 (3H, s), 4.66 (2H, s), 5.33
(2H, s), 7.40-7.44 (1H, m), 7.48-7.73 (5H, m), 7.90-7.98 (2H,
m), 8.62 (1H, d, J = 4.0Hz), 8.73 (1H, d, J = 8.0Hz), 8.85 (1H,
s), 10.80 (1H, s)Example 249
The following compound was obtained in the same manner as in Example 220.
(1) 8- (2,6-dichlorobenzoylamino) -4- (3-methoxyfe
Nonoxy) -3-methylquinoline
mp: 168-170 ℃
NMR (DMSO-d6, Δ): 2.27 (3H, s), 3.73 (3H, s), 6.31
(1H, dd, J = 7.5, 2.0Hz), 6.56 (1H, m), 6.67 (1H, dd, J = 7.5,
2.0Hz), 7.20 (1H, dd, J = 7.5, 7.5Hz), 7.50-7.60 (5H, m), 8.67-
8.70 (1H, m), 8.88 (1H, s), 10.85 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (pyri
Zin-2-yloxy) quinoline
mp: 185-186 ℃
NMR (DMSO-d6, Δ): 2.25 (3H, s), 7.11-7.16 (1H, m),
7.33 (1H, d, J = 7.5Hz), 7.48-7.60 (5H, m), 7.93-8.00 (2H, m),
8.65 (1H, d, J = 7.5Hz), 8.85 (1H, s)
(3) 4- (2-chloropyridin-3-yloxy) -8- (2,6-dichloro
Robenzoylamino) -3-methylquinoline
mp: 186-187 ℃
NMR (DMSO-d6, Δ): 2.28 (3H, s), 7.00 (1H, d,
J = 8.0Hz), 7.22-7.27 (1H, m), 7.49-7.67 (5H, m), 8.16 (1H, d,
J = 2.0Hz), 8.22 (1H, d, J = 8.0Hz), 8.93 (1H, s), 10.91 (1H, s)
(4) 4- (5-chloropyridin-3-yloxy) -8- (2,6-dichloro
Robenzoylamino) -3-methylquinoline
mp: 163-165 ℃
NMR (DMSO-d6, Δ): 2.30 (3H, s), 7.49-7.66 (6H, m),
8.35 (1H, d, J = 2.0Hz), 8,41 (1H, d, J = 1.0Hz), 8.72 (1H, d, J = 1.0Hz)
J = 8.0Hz), 8.90 (1H, s), 10.90 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (2-
Methylpyridin-3-yloxy) quinoline
mp: 159-160 ℃
NMR (DMSO-d6, Δ); 2.25 (3H, s), 2.73 (3H, s), 6.65
(1H, d, J = 8.0Hz), 7.01-7.05 (1H, m), 7.49-7.65 (5H, m), 8.16
(1H, d, J = 4.0Hz), 8.70 (1H, d, J = 8.0Hz), 8.90 (1H, s), 10.89
(1H, s)
(6) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (6-
Methylpyridin-3-yloxy) quinoline
NMR (DMSO-d6, Δ): 2.27 (3H, s), 2.43 (3H, s), 7.10
(1H, dd, J = 9.0, 2.0Hz), 7.15 (1H, d, J = 7.5Hz), 7.50-7.66 (5H,
m), 8.23 (1H, d, J = 2.0Hz), 8.70 (1H, dd, J = 9.0, 2.0Hz), 8.88
(1H, s), 10.85 (1H, s)
(7) 8- (2,6-dichlorobenzoylamino) -4- [2- (dimethyla
Minomethyl) pyridin-3-yloxy] -3-methylquinoline
NMR (DMSO-d6, Δ): 2.26 (3H, s), 2.35 (6H, s), 6.70
(1H, d, J = 8.0Hz), 7.10-7.15 (1H, m), 7.50-7.70 (5H, m), 8.22
(1H, d, J = 4.0Hz), 8.70 (1H, d, J = 8.0Hz), 8.90 (1H, s)
(8) 4- (1H-benzimidazol-2-yloxy) -8- (2,6-
Dichlorobenzoylamino) -3-methylquinoline
mp: 106-110 ℃
NMR (DMSO-d6, Δ): 2.36 (5 / 9x3H, s), 2.55 (4 / 9x3H, s),
6.50 (5 / 9H, d, J = 7.5Hz), 6.86-7.00 (2H, m), 7.11 (5 / 9H, dd,
J = 7.5, 7.5Hz), 7.16-7.23 ((1 + 4/9) H, m), 7.49-7.90 ((4 + 4/9) H,
m), 8.41 (4 / 9H, d, J = 7.5Hz), 8.70 (5 / 9H, d, J = 7.5Hz), 8.77
(4 / 9H, s), 9.04 (5 / 9H, s), 10.34 (4 / 9H, s), 10.95 (5 / 9H, s),
11.00 (4 / 9H, br s), 11.40 (5 / 9H, br s)
(9) 8- (2,6-dichlorobenzoylamino) -4- (2-methoxyphen)
Nonoxy) -3-methylquinoline
mp: 189-190 ℃
NMR (DMSO-d6, Δ): 2.23 (3H, s), 3.93 (3H, s), 6.38
(1H, d, J = 7.5Hz), 6.75 (1H, dd, J = 7.5, 7.5Hz), 7.05 (1H, dd,
J = 7.5, 7.5Hz), 7.21 (1H, d, J = 7.5Hz), 7.50-7.60 (5H, m), 8.64
8.67 (1H, m), 8.84 (1H, s), 10.83 (1H, s)Example 250
4-Hydroxypyridine (114 mg) in N-methylpyrrolidone (3 ml)
Sodium hydride (60% in oil, 28.9 mg) was added to the solution of
The mixture was stirred for 30 minutes. Add 4-chloro-8- (2,6-dichloro
(Benzoylamino) -3-methylquinoline (200 mg) was added and the mixture was
Stirred at 0 ° C. for 1.5 hours. Extract the mixture with ethyl acetate and extract the extract with water and brine.
, Dried over magnesium sulfate and concentrated in vacuo. Flush residue
Purification by chromatography (ethyl acetate-methanol-dichloromethane)
Crystallized from ethyl ether to give 8- (2,6-dichlorobenzoylamino)-
3-methyl-4- (1,4-dihydro-4-oxopyridin-1-yl) quinoli
(185 mg) as white crystals.
mp: 280-282 ℃
NMR (DMSO-d6, Δ): 2.35 (3H, s), 6.34 (2H, d,
J = 7.0Hz), 7.22 (1H, d, J = 8.0Hz), 7.50-7.60 (3H, m), 7.75 (1H,
dd, J = 8.0, 8.0Hz), 7.82 (2H, d, J = 7.0Hz), 8.74 (1H, d,
J = 8.0Hz), 9.01 (1H, s), 10.98 (1H, s)Example 251
The following compound was obtained in the same manner as in Example 25.
(1) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (thia
Zolin-2-ylthio) quinoline
mp: 206-209 ℃
NMR (DMSO-d6, Δ): 2.68 (3H, s), 3.18-3.25 (2H, m),
3.75 (1H, dd, J = 8.0, 8.0Hz), 4.05 (1H, dd, J = 8.0, 8.0Hz),
7.48-7.61 (3H, m), 7.74 (1H, dd, J = 8.0, 8.0Hz), 8.25 (1H, d,
J = 8.0Hz), 8.70 (1H, d, J = 8.0Hz), 8.72 (1H, s), 10.80 (1H, s)
(2) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (5-
Methyl-1,3,4-thiadiazol-2-ylthio) quinoline
mp: 186-187 ℃
NMR (DMSO-d6, Δ): 2.57 (3H, s), 2.70 (3H, s), 7.50-
7.59 (3H, m), 7.76 (1H, dd, J = 8.0, 8.0Hz), 8.13 (1H, d,
J = 8.0Hz), 8.22 (1H, d, J = 8.0Hz), 9.00 (1H, s), 10.94 (1H, s)
(3) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (pyri
Zin-4-ylthio) quinoline
mp: 202-203 ℃
NMR (DMSO-d6, Δ): 2.60 (3H, s), 6.95 (2H, d,
J = 6.0Hz), 7.49-7.60 (3H, s), 7.70 (1H, dd, J = 8.0, 8.0Hz), 8.01
(1H, d, J = 8.0Hz), 8.32 (1H, d, J = 6.0Hz), 8.72 (1H, d,
J = 8.0Hz), 9.01 (1H, s), 10.95 (1H, s)
(4) 4- (1H-benzimidazol-2-ylthio) -8- (2,6-di
Chlorobenzoylamino) -3-methylquinoline
mp: 162-164 ℃
NMR (DMSO-d6, Δ): 2.60 (3H, s), 7.08-7.12 (2H, m),
7.35-7.39 (2H, m), 7.50-7.61 (3H, m), 7.68 (1H, dd, J = 8.0,
8.0Hz), 8.11 (1H, d, J = 8.0Hz), 8.69 (1H, d, J = 8.0Hz), 8.95
(1H, s), 10.90 (1H, s)
(5) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (1-
Methyltetrazol-5-ylthio) quinoline
mp: 194-203 ℃
NMR (CDClThree, Δ): 2.66 (3H, s), 4.05 (3H, s), 7.30-7.45
(3H, m), 7.69 (1H, t, J = 8Hz), 8.03 (1H, d, J = 8Hz), 8.76 (1H,
s), 8.97 (1H, d, J = 8Hz)
(6) 8- (2,6-dichlorobenzoylamino) -3-methyl-4- (4-
Methyl-4H-1,2,4-triazol-3-ylthio) quinoline
mp: 234-235 ℃
NMR (DMSO-d6, Δ): 2.62 (3H, s), 3.59 (3H, s), 7.47-
7.59 (3H, m), 7.71 (1H, dd, J = 8.0, 8.0Hz), 8.20 (1H, d,
J = 8.0Hz), 8.58 (1H, s), 8.69 (1H, d, J = 8.0Hz), 8.90 (1H, s),
10.85 (1H, s)Example 252
(1) 4-chloro-3-methyl-8- (2-nitrobenzoylamino) quinoli
Was converted to 8-amino-4-chloro-3-methylquinoline in the same manner as in Example 1.
Obtained from 2-nitrobenzoyl chloride.
mp: 178-182 ℃
NMR (CDClThree, Δ): 2.57 (3H, s), 7.60-7.70 (2H, m),
7.71-7.80 (2H, m), 7.96 (1H, d, J = 8Hz), 8.14 (1H, d, J = 8Hz),
8.55 (1H, s), 8.86 (1H, d, J = 8Hz)
(2) 4- (imidazol-1-yl) -3-methyl-8- (2-nitroben
Zoylamino) quinoline was obtained in the same manner as in Example 8.
mp: 199-204 ℃
NMR (DMSO-d6, Δ): 2.25 (3H, s), 7.01 (1H, d, J = 8Hz),
7.30 (1H, s), 7.54 (1H, d, J = 2Hz), 7.67 (1H, t, J = 8Hz), 7.77-
7.96 (4H, m), 7.99 (1H, s), 8.20 (1H, d, J = 8Hz), 8.64 (1H, br
d, J = 9Hz), 8.98 (1H, s)Example 253
(1) 4-chloro-8- (2-nitrobenzoylamino) -3,5-dimethyl
Quinoline was prepared in the same manner as in Example 1 by using 8-amino-4-chloro-3,5-dimethyl
Obtained from luquinoline and 2-nitrobenzoyl chloride.
mp: 165-166 ℃
NMR (DMSO-d6, Δ): 2.51 (3H, s), 2.98 (3H, s), 7.53
(1H, d, J = 8Hz), 7.77 (1H, ddd, J = 8, 8, 2Hz), 7.82-7.93 (2H,
m), 8.17 (1H, d, J = 8Hz), 8.50 (1H, d, J = 8Hz), 8.77 (1H, s),
10.66 (1H, s)
(2) 3,5-dimethyl-4- (imidazol-1-yl) -8- (2-nitro
(Lobenzoylamino) quinoline was obtained in the same manner as in Example 8.
mp: 231-233 ℃
NMR (DMSO-d6, Δ): 1.92 (3H, s), 2.08 (3H, s), 7.23
(1H, s), 7.43-7.50 (2H, m), 7.75-7.95 (4H, m), 8.08 (1H, d,
J = 8Hz), 8.53 (1H, d, J = 8Hz), 8.93 (1H, s), 10.75 (1H, s)Example 254
(1) 4-chloro-3-methoxymethyl-8- (2-nitrobenzoylamino
) Quinoline was prepared in the same manner as in Example 1 by using 8-amino-4-chloro-3-methoxy.
Obtained from methylquinoline and 2-nitrobenzoyl chloride.
mp: 174-175 ℃
NMR (DMSO-d6, Δ): 3.40 (3H, s), 4.78 (2H, s), 7.75
7.91 (4H, m), 8.02 (1H, d, J = 8.0Hz), 8.20 (1H, d, J = 8.0Hz),
8.73 (1H, br d, J = 8.0Hz), 8.90 (1H, s)
(2) 4- (imidazol-1-yl) -3-methoxymethyl-8- (2-d
(Trobenzoylamino) quinoline hydrochloride was obtained in the same manner as in Example 8.
mp: 175-185 ℃
NMR (DMSO-d6, Δ): 3.23 (3H, s), 4.49 (2H, s), 7.20
(1H, d, J = 8Hz), 7.75-7.97 (4H, m), 8.00 (1H, d, J = 0.5Hz), 8.07
(1H, d, J = 0.5Hz), 8.21 (1H, d, J = 8Hz), 8.77 (1H, d, J = 7Hz),
9.14 (1H, s), 9.35 (1H, s), 11.00 (1H, s)Example 255
(1) 3-methoxymethyl-4-[(2-methylaminoethyl) amino] -8
-(2-Nitrobenzoylamino) quinoline was prepared in the same manner as in Example 8,
Rollo-3-methoxymethyl-8- (2-nitrobenzoylamino) quinoline and N
-Obtained from methylethylenediamine.
NMR (CDClThree, Δ): 2.48 (3H, s), 2.88 (2H, m), 3.37 (3H,
s), 3.76 (2H, m), 4.59 (2H, s), 6.11 (1H, m), 7.43 (1H, t,
J = 8Hz), 7.63 (1H, dd, J = 8, 2Hz), 7.70-7.84 (4H, m), 8.11 (1H,
d, J = 8Hz), 8.26 (1H, s), 8.79 (1H, d, J = 8Hz)
(2) 3-methoxymethyl-4- (3-methyl-2-oxoimidazolidin-
1-yl) -8- (2-nitrobenzoylamino) quinoline was prepared according to Example 92- (2
).
mp: 156-159 ℃
NMR (CDClThree, Δ): 2.98 (3H, s), 3.41 (3H, s), 3.59-3.79
(3H, m), 3.85-3.98 (1H, m), 4.54 (1H, d, J = 9Hz), 4.70 (1H, d,
J = 9Hz), 7.58-7.70 (3H, m), 7.71-7.81 (2H, m), 8.13 (1H, d,
J = 8Hz), 8.82 (1H, s), 8.88 (1H, t, J = 5Hz)Example 256
4- (imidazol-2-ylthio) -3-methoxymethyl-8- (2-nitro
Robenzoylamino) quinoline was prepared in the same manner as in Example 25 by using 4-chloro-3-
Methoxymethyl-8- (2-nitrobenzoylamino) quinoline and 2-mercap
Obtained from toimidazole.
mp; 196-203 ℃
NMR (DMSO-d6, Δ): 3.38 (3H, s), 4.90 (2H, s), 6.92
(1H, s), 7.16 (1H, s), 7.67 (1H, t, J = 8Hz), 7.75 to 7.95 (3H, m),
8.16-8.20 (2H, m), 8.63 (1H, d, J = 8Hz), 8.94 (1H, s)
Example 257
3-methoxymethyl-8- (2-nitrobenzoylamino) -4- (pyridine
-3-yloxy) quinoline was converted to 4-chloro-3-
Methoxymethyl-8- (2-nitrobenzoylamino) quinoline and 3-hydroxy
Obtained from cypyridine.
NMR (DMSO-d6, Δ): 3.23 (3H, s), 4.53 (2H, s), 7.22
(1H, dd, J = 8.0,3.0Hz), 7.31-7.36 (1H, m), 7.56-7.67 (2H, m),
7.76-7.95 (3H, m), 8.20 (1H, d, J = 7.5Hz), 8.33 (1H, d,
J = 3.0Hz), 8.41 (1H, d, J = 2.0Hz), 8.70 (1H, d, J = 7.5Hz), 8.98
(1H, s), 10.85 (1H, s)Example 258
(1) 4-chloro-3-methyl-8- (2-trifluoromethylbenzoyla
Mino) quinoline was prepared in the same manner as in Example 1 by using 8-amino-4-chloro-3-methyi.
Obtained from luquinoline and 2-trifluoromethylbenzoyl chloride.
mp: 169-173 ℃
NMR (CDClThree, Δ): 2.57 (3H, s), 7.58-7.86 (5H, m),
7.95 (1H, d, J = 8Hz), 8.55 (1H, s), 8.90 (1H, d, J = 8Hz)
(2) 4- (imidazol-1-yl) -3-methyl-8- (2-trifluoro
(Romethylbenzoylamino) quinoline was obtained in the same manner as in Example 8.
NMR (CDClThree, Δ): 2.30 (3H, s), 7.09 (1H, d, J = 9Hz),
7.11 (1H, s), 7.40 (1H, s), 7.56-7.85 (6H, m), 8.25 (1H, s),
8.94 (1H, d, J = 9Hz)
Its hydrochloride
mp: 189-196 ℃
NMR (DMSO-d6, Δ): 2.31 (3H, s), 7.13 (1H, d, J = 8Hz),
7.69-7.94 (5H, m), 8.04-8.13 (2H, m), 8.70 (1H, d, J = 9Hz),
9.07 (1H, s), 9.47 (1H, s)Example 259
(1) 3-methyl-4-[(2-methylaminoethyl) amino] -8- (2-
Trifluoromethylbenzoylamino) quinoline was converted to 4
-Chloro-3-methyl-8- (2-trifluoromethylbenzoylamino) quino
Obtained from phosphorus and N-methylethylenediamine.
NMR (CDClThree, Δ): 2.40 (3H, s), 2.50 (3H, s), 2.88 (2H,
t, J = 6Hz), 3.62 (2H, q, J = 6Hz), 5.30 (1H, s), 7.48 (1H, t,
J = 8Hz), 7.55-7.85 (5H, m), 8.30 (1H, s), 8.80 (1H, d, J = 8Hz)
(2) 3-methyl-4- (3-methyl-2-oxoimidazolidin-1-yl
) -8- (2-Trifluoromethylbenzoylamino) quinoline was prepared in Example 92-
Obtained in the same manner as in (2).
mp: 182-191 ℃
NMR (CDClThree, Δ): 2.45 (3H, s), 2.99 (3H, s), 3.63-3.93
(4H, m), 7.55-7.85 (6H, m), 8.68 (1H, s), 8.87 (1H, dd, J = 8,
2Hz)Example 260
(1) 4-hydrazino-3-methyl-8- (2-trifluoromethylbenzoy
Ruamino) quinoline was prepared in the same manner as in Example 139- (1), using 4-chloro-3-
Methyl-8- (2-trifluoromethylbenzoylamino) quinoline and hydrazine
From monohydrate.
mp: 160-167 ℃
NMR (DMSO-d6, Δ): 2.40 (3H, s), 4.70 (2H, s), 7.33
(1H, t, J = 8Hz), 7.70-7.88 (4H, m), 7.91 (1H, d, J = 8Hz), 8.18
(1H, s), 8.51 (1H, d, J = 8Hz), 8.64 (1H, d, J = 8Hz)
(2) 4- (2-acetylhydrazino) -3-methyl-8- (2-trifluoro
(Romethylbenzoylamino) quinoline was obtained in the same manner as in Example 86.
mp: 209-211 ℃
NMR (DMSO-d6, Δ): 1.88 (3H, s), 2.35 (3H, s), 7.48
(1H, t, J = 8Hz), 7.70-7.88 (3H, m), 7.90 (1H, d, J = 8Hz), 8.11
(1H, d, J = 8Hz), 8.28 (1H, d, J = 2Hz), 8.33 (1H, s), 8.56 (1H,
d, J = 8Hz)
Example 261
3-methyl-4- (pyridin-3-yloxy) -8- (2-trifluoromethyl
Tylbenzoylamino) quinoline was converted to 4-chloro-
3-methyl-8- (2-trifluoromethylbenzoylamino) quinoline and 3-
Obtained from hydroxypyridine.
mp: 102-108 ℃
NMR (CDClThree, Δ): 2.29 (3H, s), 6.98 (1H, dd, J = 8,
3Hz), 7.15-7.29 (2H, m), 7.48-7.85 (6H, m), 8.30-8.40 (2H, m),
8.67 (1H, s), 8.88 (1H, d, J = 8Hz)Example 262
4- (imidazol-2-ylthio) -3-methyl-8- (2-trifluoro
Methylbenzoylamino) quinoline was converted to 4-chloro-
3-methyl-8- (2-trifluoromethylbenzoylamino) quinoline and 2-
Obtained from mercaptoimidazole.
mp: 216-220 ℃
NMR (CDClThree, Δ): 2.59 (3H, s), 6.97 (2H, br s), 7.55-
7.83 (5H, m), 8.22 (1H, d, J = 8 Hz), 8.60 (1H, s), 8.80 (1H, d,
(J = 8Hz)Example 263
8- (2,6-dichlorobenzoylamino) -4- (4-hydroxyindole
Ru-1-yl) quinoline was converted to 4-chloro-8- (2,6
-Dichlorobenzoylamino) quinoline and 4-hydroxyindole.
mp: 289-290 ℃
NMR (DMSO-d6, Δ): 6.12 (1H, br s), 6.58 (1H, d,
J = 5.5Hz), 6.94 (1H, d, J = 7.5Hz), 7.22 (1H, t, J = 7.5Hz), 7.35
(1H, t, J = 4.0Hz), 7.43 (1H, d, J = 7.5Hz), 7.51-7.60 (3H, m),
7.74 (1H, dd, J = 8.0, 8.0Hz), 8.20 (1H, d, J = 8.0Hz), 8.62 (1H,
d, J = 5.5Hz), 8.82 (1H, d, J = 8.0Hz), 10.73 (1H, s), 11.45 (1H,
br s)
Example 264
(1) 5-chloro-8- (2,6-dichlorobenzoylamino) -3-methyl
-4-[(2-Methylaminoethyl) amino] quinoline was prepared in the same manner as in Example 8.
4,5-dichloro-8- (2,6-dichlorobenzoylamino) -3-methyl
Obtained from luquinoline and N-methylethylenediamine.
mp: 127-129 ℃
NMR (DMSO-d6, Δ): 2.40 (3H, s), 2.47 (3H, s), 2.84
(2H, t, J = 6Hz), 3.23 (2H, dt, J = 6, 5Hz), 6.56 (1H, br t,
J = 5Hz), 7.27-7.40 (3H, m), 7.45 (1H, d, J = 8Hz), 8.30 (1H, s),
8.71 (1H, d, J = 8Hz), 10.23 (1H, s)
(2) 5-chloro-8- (2,6-dichlorobenzoylamino) -3-methyl
Example of 4- (3-methyl-2-oxoimidazolidin-1-yl) quinoline
Obtained in the same manner as in 92- (2).
mp: 280-292 ℃ (decomposition)
NMR (DMSO-d6, Δ): 2.38 (3H, s), 2.78 (3H, s),
3.56-3.66 (2H, m), 3.70-3.80 (2H, m), 7.47-7.63 (3H, m), 7.77
(1H, d, J = 8Hz), 8.63 (1H, d, J = 8Hz), 8.93 (1H, s), 10.89 (1H,
s)
─────────────────────────────────────────────────────
フロントページの続き
(51)Int.Cl.6 識別記号 FI
A61K 31/47 610 A61K 31/47 610
31/495 601 31/495 601
31/505 602 31/505 602
605 605
31/535 606 31/535 606
31/54 603 31/54 603
C07D 215/40 C07D 215/40
237/28 237/28
239/94 239/94
401/04 209 401/04 209
231 231
233 233
235 235
239 239
249 249
401/06 233 401/06 233
235 235
401/12 209 401/12 209
213 213
231 231
233 233
239 239
249 249
257 257
401/14 235 401/14 235
403/04 233 403/04 233
405/12 215 405/12 215
409/12 215 409/12 215
413/12 215 413/12 215
417/12 215 417/12 215
471/04 102 471/04 102
105 105A
105C
107 107E
116 116
495/04 105 495/04 105A
513/04 383 513/04 383
C07F 7/10 C07F 7/10 S
7/18 7/18 T
(81)指定国 EP(AT,BE,CH,DE,
DK,ES,FI,FR,GB,GR,IE,IT,L
U,MC,NL,PT,SE),AU,CA,CN,J
P,KR,MX,US
(72)発明者 浦野 泰治
茨城県つくば市二の宮3−23−13−C−
102
(72)発明者 吉原 耕生
茨城県土浦市真鍋2−4−38−405
(72)発明者 吉田 典子
茨城県つくば市松代2−23−4−408──────────────────────────────────────────────────の Continuation of the front page (51) Int.Cl. 6 Identification code FI A61K 31/47 610 A61K 31/47 610 31/495 601 31/495 601 31/505 602 31/505 602 605 605 605 31/535 606 31/535 606 31/54 603 31/54 603 C07D 215/40 C07D 215/40 237/28 237/28 239/94 239/94 401/04 209 401/04 209 231 231 231 233 233 235 235 235 239 239 249 249 401/06 233 401/06 233 235 235 401/12 209 401/12 209 213 213 231 231 233 233 239 239 249 249 257 257 401/14 235 401/14 235 403/04 233 403/04 233 405/12 215 405/12 215 409/12 215 409/12 215 413/12 215 4 13/12 215 417/12 215 417/12 215 471/04 102 471/04 102 105 105A 105C 107 107E 116 116 495/04 105 495/04 105A 513/04 383 513 513/04 383 C07F 7/10 C07F 7 / 10 S 7/18 7/18 T (81) Designated countries EP (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE ), AU, CA, CN, JP, KR, MX, US (72) Inventor Taiji Urano 3-23-13-C-102 102, Tsukuba-shi, Ibaraki (72) Inventor Koki Yoshihara 2 -4-38-405 (72) Inventor Noriko Yoshida 2-23-4-408 Matsushiro, Tsukuba City, Ibaraki Prefecture